STUDYID,DOMAIN,USUBJID,EXSEQ,EXTRT,EXDOSE,EXDOSU,EXDOSFRM,EXDOSFRQ,EXROUTE,VISITNUM,VISIT,VISITDY,EXSTDTC,EXENDTC,EXSTDY,EXENDY,EXADJ,EXPLDOS,TRTSDT,TRTSDTM,TRTEDTM,ASTDTM,ASTDTF,ASTTMF,AENDTM,AENDTF,AENTMF,ASTDY,AENDY,EXDURD,ASTDT,AENDT,DOSEO,PDOSEO,PARAMCD,AVAL,AVALC,PARCAT1,PARAM,PARAMN,AVALCAT1,ASEQ,SUBJID,RFSTDTC,RFENDTC,RFXSTDTC,RFXENDTC,RFICDTC,RFPENDTC,DTHDTC,DTHFL,SITEID,AGE,AGEU,SEX,RACE,ETHNIC,ARMCD,ARM,ACTARMCD,ACTARM,COUNTRY,DMDTC,DMDY,TRT01P,TRT01A,TRTSTMF,TRTETMF,TRTEDT,TRTDURD,SCRFDT,EOSDT,EOSSTT,FRVDT,RANDDT,DTHDT,DTHADY,LDDTHELD,LSTALVDT,AGEGR1,SAFFL,RACEGR1,REGION1,LDDTHGR1,DTH30FL,DTHA30FL,DTHB30FL
CDISCPILOT01,EX,01-701-1015,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-02,2014-01-16,1,15,NA,0,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-02T00:00:00Z,NA,H,2014-01-16T00:00:00Z,NA,H,1,15,15,2014-01-02,2014-01-16,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1015,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-02,2014-01-16,1,15,NA,0,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-02T00:00:00Z,NA,H,2014-01-16T00:00:00Z,NA,H,1,15,15,2014-01-02,2014-01-16,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1015,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-02,2014-01-16,1,15,NA,0,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-02T00:00:00Z,NA,H,2014-01-16T00:00:00Z,NA,H,1,15,15,2014-01-02,2014-01-16,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1015,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-02,2014-01-16,1,15,NA,0,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-02T00:00:00Z,NA,H,2014-01-16T00:00:00Z,NA,H,1,15,15,2014-01-02,2014-01-16,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1015,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-02,2014-01-16,1,15,NA,0,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-02T00:00:00Z,NA,H,2014-01-16T00:00:00Z,NA,H,1,15,15,2014-01-02,2014-01-16,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1015,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-17,2014-06-18,16,168,NA,0,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-17T00:00:00Z,NA,H,2014-06-18T00:00:00Z,NA,H,16,168,153,2014-01-17,2014-06-18,0,0,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1015,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-17,2014-06-18,16,168,NA,0,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-17T00:00:00Z,NA,H,2014-06-18T00:00:00Z,NA,H,16,168,153,2014-01-17,2014-06-18,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1015,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-17,2014-06-18,16,168,NA,0,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-17T00:00:00Z,NA,H,2014-06-18T00:00:00Z,NA,H,16,168,153,2014-01-17,2014-06-18,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1015,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-17,2014-06-18,16,168,NA,0,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-17T00:00:00Z,NA,H,2014-06-18T00:00:00Z,NA,H,16,168,153,2014-01-17,2014-06-18,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1015,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-17,2014-06-18,16,168,NA,0,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-17T00:00:00Z,NA,H,2014-06-18T00:00:00Z,NA,H,16,168,153,2014-01-17,2014-06-18,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1015,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-19,2014-07-02,169,182,NA,0,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-06-19T00:00:00Z,NA,H,2014-07-02T00:00:00Z,NA,H,169,182,14,2014-06-19,2014-07-02,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1015,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-19,2014-07-02,169,182,NA,0,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-06-19T00:00:00Z,NA,H,2014-07-02T00:00:00Z,NA,H,169,182,14,2014-06-19,2014-07-02,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1015,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-19,2014-07-02,169,182,NA,0,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-06-19T00:00:00Z,NA,H,2014-07-02T00:00:00Z,NA,H,169,182,14,2014-06-19,2014-07-02,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1015,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-19,2014-07-02,169,182,NA,0,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-06-19T00:00:00Z,NA,H,2014-07-02T00:00:00Z,NA,H,169,182,14,2014-06-19,2014-07-02,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1015,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-19,2014-07-02,169,182,NA,0,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-06-19T00:00:00Z,NA,H,2014-07-02T00:00:00Z,NA,H,169,182,14,2014-06-19,2014-07-02,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1015,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-02T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-02,2014-07-02,NA,NA,TDURD,182,NA,OVERALL,Overall duration (days),7,>=90 days,16,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1015,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-02T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-02,2014-07-02,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1015,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-02T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-02,2014-07-02,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1015,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-02T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-02,2014-07-02,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1015,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-02T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-02,2014-07-02,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1015,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-02T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-02,2014-07-02,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1015,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-02T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-02,2014-07-02,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1015,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-17T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-17,2014-07-02,NA,NA,PDURD,167,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1015,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-17T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-17,2014-07-02,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1015,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-17T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-17,2014-07-02,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1015,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-17T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-17,2014-07-02,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1015,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-17T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-17,2014-07-02,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1015,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-17T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-17,2014-07-02,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1015,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-02,2014-01-02T00:00:00Z,2014-07-02T23:59:59Z,2014-01-17T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-17,2014-07-02,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1015,2014-01-02,2014-07-02,2014-01-02,2014-07-02,NA,2014-07-02T11:45,NA,NA,701,63,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-26,-7,Placebo,Placebo,H,H,2014-07-02,182,NA,2014-07-02,COMPLETED,NA,2014-01-02,NA,NA,NA,2014-07-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1023,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-08-05,2012-08-27,1,23,NA,0,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-05T00:00:00Z,NA,H,2012-08-27T00:00:00Z,NA,H,1,23,23,2012-08-05,2012-08-27,0,0,DURD,23,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1023,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-08-05,2012-08-27,1,23,NA,0,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-05T00:00:00Z,NA,H,2012-08-27T00:00:00Z,NA,H,1,23,23,2012-08-05,2012-08-27,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1023,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-08-05,2012-08-27,1,23,NA,0,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-05T00:00:00Z,NA,H,2012-08-27T00:00:00Z,NA,H,1,23,23,2012-08-05,2012-08-27,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1023,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-08-05,2012-08-27,1,23,NA,0,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-05T00:00:00Z,NA,H,2012-08-27T00:00:00Z,NA,H,1,23,23,2012-08-05,2012-08-27,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1023,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-08-05,2012-08-27,1,23,NA,0,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-05T00:00:00Z,NA,H,2012-08-27T00:00:00Z,NA,H,1,23,23,2012-08-05,2012-08-27,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1023,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-28,2012-09-01,24,28,NA,0,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-28T00:00:00Z,NA,H,2012-09-01T00:00:00Z,NA,H,24,28,5,2012-08-28,2012-09-01,0,0,DURD,5,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1023,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-28,2012-09-01,24,28,NA,0,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-28T00:00:00Z,NA,H,2012-09-01T00:00:00Z,NA,H,24,28,5,2012-08-28,2012-09-01,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1023,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-28,2012-09-01,24,28,NA,0,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-28T00:00:00Z,NA,H,2012-09-01T00:00:00Z,NA,H,24,28,5,2012-08-28,2012-09-01,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1023,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-28,2012-09-01,24,28,NA,0,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-28T00:00:00Z,NA,H,2012-09-01T00:00:00Z,NA,H,24,28,5,2012-08-28,2012-09-01,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1023,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-28,2012-09-01,24,28,NA,0,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-28T00:00:00Z,NA,H,2012-09-01T00:00:00Z,NA,H,24,28,5,2012-08-28,2012-09-01,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-05T00:00:00Z,NA,NA,2012-09-01T00:00:00Z,NA,NA,NA,NA,NA,2012-08-05,2012-09-01,NA,NA,TDURD,28,NA,OVERALL,Overall duration (days),7,< 30 days,11,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-05T00:00:00Z,NA,NA,2012-09-01T00:00:00Z,NA,NA,NA,NA,NA,2012-08-05,2012-09-01,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-05T00:00:00Z,NA,NA,2012-09-01T00:00:00Z,NA,NA,NA,NA,NA,2012-08-05,2012-09-01,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-05T00:00:00Z,NA,NA,2012-09-01T00:00:00Z,NA,NA,NA,NA,NA,2012-08-05,2012-09-01,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-05T00:00:00Z,NA,NA,2012-09-01T00:00:00Z,NA,NA,NA,NA,NA,2012-08-05,2012-09-01,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-05T00:00:00Z,NA,NA,2012-09-01T00:00:00Z,NA,NA,NA,NA,NA,2012-08-05,2012-09-01,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-05T00:00:00Z,NA,NA,2012-09-01T00:00:00Z,NA,NA,NA,NA,NA,2012-08-05,2012-09-01,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-28T00:00:00Z,NA,NA,2012-09-01T00:00:00Z,NA,NA,NA,NA,NA,2012-08-28,2012-09-01,NA,NA,PDURD,5,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-28T00:00:00Z,NA,NA,2012-09-01T00:00:00Z,NA,NA,NA,NA,NA,2012-08-28,2012-09-01,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-28T00:00:00Z,NA,NA,2012-09-01T00:00:00Z,NA,NA,NA,NA,NA,2012-08-28,2012-09-01,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-28T00:00:00Z,NA,NA,2012-09-01T00:00:00Z,NA,NA,NA,NA,NA,2012-08-28,2012-09-01,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-28T00:00:00Z,NA,NA,2012-09-01T00:00:00Z,NA,NA,NA,NA,NA,2012-08-28,2012-09-01,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-28T00:00:00Z,NA,NA,2012-09-01T00:00:00Z,NA,NA,NA,NA,NA,2012-08-28,2012-09-01,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1023,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-05,2012-08-05T00:00:00Z,2012-09-01T23:59:59Z,2012-08-28T00:00:00Z,NA,NA,2012-09-01T00:00:00Z,NA,NA,NA,NA,NA,2012-08-28,2012-09-01,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1023,2012-08-05,2012-09-02,2012-08-05,2012-09-01,NA,2013-02-18,NA,NA,701,64,YEARS,M,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-22,-14,Placebo,Placebo,H,H,2012-09-01,28,NA,2012-09-02,DISCONTINUED,2013-02-18,2012-08-05,NA,NA,NA,2012-09-02,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1028,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-19,2013-08-01,1,14,NA,54,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-07-19T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,1,14,14,2013-07-19,2013-08-01,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1028,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-19,2013-08-01,1,14,NA,54,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-07-19T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,1,14,14,2013-07-19,2013-08-01,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1028,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-19,2013-08-01,1,14,NA,54,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-07-19T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,1,14,14,2013-07-19,2013-08-01,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1028,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-19,2013-08-01,1,14,NA,54,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-07-19T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,1,14,14,2013-07-19,2013-08-01,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1028,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-19,2013-08-01,1,14,NA,54,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-07-19T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,1,14,14,2013-07-19,2013-08-01,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1028,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-02,2014-01-06,15,172,NA,54,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-08-02T00:00:00Z,NA,H,2014-01-06T00:00:00Z,NA,H,15,172,158,2013-08-02,2014-01-06,12798,8532,DURD,158,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1028,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-02,2014-01-06,15,172,NA,54,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-08-02T00:00:00Z,NA,H,2014-01-06T00:00:00Z,NA,H,15,172,158,2013-08-02,2014-01-06,12798,8532,DOSE,12798,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1028,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-02,2014-01-06,15,172,NA,54,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-08-02T00:00:00Z,NA,H,2014-01-06T00:00:00Z,NA,H,15,172,158,2013-08-02,2014-01-06,12798,8532,PLDOSE,8532,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1028,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-02,2014-01-06,15,172,NA,54,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-08-02T00:00:00Z,NA,H,2014-01-06T00:00:00Z,NA,H,15,172,158,2013-08-02,2014-01-06,12798,8532,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1028,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-02,2014-01-06,15,172,NA,54,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-08-02T00:00:00Z,NA,H,2014-01-06T00:00:00Z,NA,H,15,172,158,2013-08-02,2014-01-06,12798,8532,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1028,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-07,2014-01-14,173,180,NA,54,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2014-01-07T00:00:00Z,NA,H,2014-01-14T00:00:00Z,NA,H,173,180,8,2014-01-07,2014-01-14,432,432,DURD,8,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1028,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-07,2014-01-14,173,180,NA,54,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2014-01-07T00:00:00Z,NA,H,2014-01-14T00:00:00Z,NA,H,173,180,8,2014-01-07,2014-01-14,432,432,DOSE,432,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1028,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-07,2014-01-14,173,180,NA,54,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2014-01-07T00:00:00Z,NA,H,2014-01-14T00:00:00Z,NA,H,173,180,8,2014-01-07,2014-01-14,432,432,PLDOSE,432,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1028,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-07,2014-01-14,173,180,NA,54,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2014-01-07T00:00:00Z,NA,H,2014-01-14T00:00:00Z,NA,H,173,180,8,2014-01-07,2014-01-14,432,432,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1028,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-07,2014-01-14,173,180,NA,54,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2014-01-07T00:00:00Z,NA,H,2014-01-14T00:00:00Z,NA,H,173,180,8,2014-01-07,2014-01-14,432,432,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2014-01-14T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2014-01-14,NA,NA,TDURD,180,NA,OVERALL,Overall duration (days),7,>=90 days,16,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2014-01-14T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2014-01-14,NA,NA,TDOSE,13986,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2014-01-14T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2014-01-14,NA,NA,AVDDSE,77.7,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2014-01-14T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2014-01-14,NA,NA,TPDOSE,9720,NA,OVERALL,Total planned dose (mg),11,NA,19,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2014-01-14T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2014-01-14,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2014-01-14T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2014-01-14,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2014-01-14T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2014-01-14,NA,NA,TDOSINT,143.88888888888889,NA,OVERALL,Overall dose intensity (%),90,NA,22,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-08-02T00:00:00Z,NA,NA,2014-01-14T00:00:00Z,NA,NA,NA,NA,NA,2013-08-02,2014-01-14,NA,NA,PDURD,166,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-08-02T00:00:00Z,NA,NA,2014-01-14T00:00:00Z,NA,NA,NA,NA,NA,2013-08-02,2014-01-14,NA,NA,PDOSE,13230,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-08-02T00:00:00Z,NA,NA,2014-01-14T00:00:00Z,NA,NA,NA,NA,NA,2013-08-02,2014-01-14,NA,NA,PPDOSE,8964,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-08-02T00:00:00Z,NA,NA,2014-01-14T00:00:00Z,NA,NA,NA,NA,NA,2013-08-02,2014-01-14,NA,NA,PAVDDSE,79.6987951807229,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-08-02T00:00:00Z,NA,NA,2014-01-14T00:00:00Z,NA,NA,NA,NA,NA,2013-08-02,2014-01-14,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-08-02T00:00:00Z,NA,NA,2014-01-14T00:00:00Z,NA,NA,NA,NA,NA,2013-08-02,2014-01-14,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1028,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-14T23:59:59Z,2013-08-02T00:00:00Z,NA,NA,2014-01-14T00:00:00Z,NA,NA,NA,NA,NA,2013-08-02,2014-01-14,NA,NA,PDOSINT,147.59036144578312,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1028,2013-07-19,2014-01-14,2013-07-19,2014-01-14,NA,2014-01-14T11:10,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-11,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-14,180,NA,2014-01-14,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1033,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-18,2014-03-31,1,14,NA,54,2014-03-18,2014-03-18T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,H,2014-03-31T00:00:00Z,NA,H,1,14,14,2014-03-18,2014-03-31,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1033,2014-03-18,2014-04-14,2014-03-18,2014-03-31,NA,2014-09-15,NA,NA,701,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-10,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-31,14,NA,2014-04-14,DISCONTINUED,2014-09-15,2014-03-18,NA,NA,NA,2014-04-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1033,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-18,2014-03-31,1,14,NA,54,2014-03-18,2014-03-18T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,H,2014-03-31T00:00:00Z,NA,H,1,14,14,2014-03-18,2014-03-31,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1033,2014-03-18,2014-04-14,2014-03-18,2014-03-31,NA,2014-09-15,NA,NA,701,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-10,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-31,14,NA,2014-04-14,DISCONTINUED,2014-09-15,2014-03-18,NA,NA,NA,2014-04-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1033,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-18,2014-03-31,1,14,NA,54,2014-03-18,2014-03-18T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,H,2014-03-31T00:00:00Z,NA,H,1,14,14,2014-03-18,2014-03-31,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1033,2014-03-18,2014-04-14,2014-03-18,2014-03-31,NA,2014-09-15,NA,NA,701,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-10,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-31,14,NA,2014-04-14,DISCONTINUED,2014-09-15,2014-03-18,NA,NA,NA,2014-04-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1033,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-18,2014-03-31,1,14,NA,54,2014-03-18,2014-03-18T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,H,2014-03-31T00:00:00Z,NA,H,1,14,14,2014-03-18,2014-03-31,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1033,2014-03-18,2014-04-14,2014-03-18,2014-03-31,NA,2014-09-15,NA,NA,701,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-10,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-31,14,NA,2014-04-14,DISCONTINUED,2014-09-15,2014-03-18,NA,NA,NA,2014-04-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1033,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-18,2014-03-31,1,14,NA,54,2014-03-18,2014-03-18T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,H,2014-03-31T00:00:00Z,NA,H,1,14,14,2014-03-18,2014-03-31,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1033,2014-03-18,2014-04-14,2014-03-18,2014-03-31,NA,2014-09-15,NA,NA,701,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-10,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-31,14,NA,2014-04-14,DISCONTINUED,2014-09-15,2014-03-18,NA,NA,NA,2014-04-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1033,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-18,2014-03-18T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2014-03-18,2014-03-31,NA,NA,TDURD,14,NA,OVERALL,Overall duration (days),7,< 30 days,6,1033,2014-03-18,2014-04-14,2014-03-18,2014-03-31,NA,2014-09-15,NA,NA,701,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-10,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-31,14,NA,2014-04-14,DISCONTINUED,2014-09-15,2014-03-18,NA,NA,NA,2014-04-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1033,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-18,2014-03-18T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2014-03-18,2014-03-31,NA,NA,TDOSE,756,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1033,2014-03-18,2014-04-14,2014-03-18,2014-03-31,NA,2014-09-15,NA,NA,701,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-10,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-31,14,NA,2014-04-14,DISCONTINUED,2014-09-15,2014-03-18,NA,NA,NA,2014-04-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1033,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-18,2014-03-18T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2014-03-18,2014-03-31,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1033,2014-03-18,2014-04-14,2014-03-18,2014-03-31,NA,2014-09-15,NA,NA,701,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-10,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-31,14,NA,2014-04-14,DISCONTINUED,2014-09-15,2014-03-18,NA,NA,NA,2014-04-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1033,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-18,2014-03-18T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2014-03-18,2014-03-31,NA,NA,TPDOSE,756,NA,OVERALL,Total planned dose (mg),11,NA,9,1033,2014-03-18,2014-04-14,2014-03-18,2014-03-31,NA,2014-09-15,NA,NA,701,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-10,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-31,14,NA,2014-04-14,DISCONTINUED,2014-09-15,2014-03-18,NA,NA,NA,2014-04-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1033,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-18,2014-03-18T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2014-03-18,2014-03-31,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1033,2014-03-18,2014-04-14,2014-03-18,2014-03-31,NA,2014-09-15,NA,NA,701,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-10,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-31,14,NA,2014-04-14,DISCONTINUED,2014-09-15,2014-03-18,NA,NA,NA,2014-04-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1033,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-18,2014-03-18T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2014-03-18,2014-03-31,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1033,2014-03-18,2014-04-14,2014-03-18,2014-03-31,NA,2014-09-15,NA,NA,701,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-10,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-31,14,NA,2014-04-14,DISCONTINUED,2014-09-15,2014-03-18,NA,NA,NA,2014-04-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1033,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-18,2014-03-18T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2014-03-18,2014-03-31,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1033,2014-03-18,2014-04-14,2014-03-18,2014-03-31,NA,2014-09-15,NA,NA,701,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-10,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-31,14,NA,2014-04-14,DISCONTINUED,2014-09-15,2014-03-18,NA,NA,NA,2014-04-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1034,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-07-01,2014-07-15,1,15,NA,54,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-01T00:00:00Z,NA,H,2014-07-15T00:00:00Z,NA,H,1,15,15,2014-07-01,2014-07-15,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1034,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-07-01,2014-07-15,1,15,NA,54,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-01T00:00:00Z,NA,H,2014-07-15T00:00:00Z,NA,H,1,15,15,2014-07-01,2014-07-15,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1034,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-07-01,2014-07-15,1,15,NA,54,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-01T00:00:00Z,NA,H,2014-07-15T00:00:00Z,NA,H,1,15,15,2014-07-01,2014-07-15,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1034,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-07-01,2014-07-15,1,15,NA,54,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-01T00:00:00Z,NA,H,2014-07-15T00:00:00Z,NA,H,1,15,15,2014-07-01,2014-07-15,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1034,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-07-01,2014-07-15,1,15,NA,54,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-01T00:00:00Z,NA,H,2014-07-15T00:00:00Z,NA,H,1,15,15,2014-07-01,2014-07-15,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1034,2,XANOMELINE,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-07-16,2014-12-17,16,170,ADVERSE EVENT,54,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-16T00:00:00Z,NA,H,2014-12-17T00:00:00Z,NA,H,16,170,155,2014-07-16,2014-12-17,0,8370,DURD,155,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1034,2,XANOMELINE,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-07-16,2014-12-17,16,170,ADVERSE EVENT,54,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-16T00:00:00Z,NA,H,2014-12-17T00:00:00Z,NA,H,16,170,155,2014-07-16,2014-12-17,0,8370,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1034,2,XANOMELINE,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-07-16,2014-12-17,16,170,ADVERSE EVENT,54,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-16T00:00:00Z,NA,H,2014-12-17T00:00:00Z,NA,H,16,170,155,2014-07-16,2014-12-17,0,8370,PLDOSE,8370,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1034,2,XANOMELINE,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-07-16,2014-12-17,16,170,ADVERSE EVENT,54,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-16T00:00:00Z,NA,H,2014-12-17T00:00:00Z,NA,H,16,170,155,2014-07-16,2014-12-17,0,8370,ADJ,NA,Y,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1034,2,XANOMELINE,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-07-16,2014-12-17,16,170,ADVERSE EVENT,54,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-16T00:00:00Z,NA,H,2014-12-17T00:00:00Z,NA,H,16,170,155,2014-07-16,2014-12-17,0,8370,ADJAE,NA,Y,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1034,3,XANOMELINE,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-12-18,2014-12-30,171,183,ADVERSE EVENT,54,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-12-18T00:00:00Z,NA,H,2014-12-30T00:00:00Z,NA,H,171,183,13,2014-12-18,2014-12-30,0,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1034,3,XANOMELINE,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-12-18,2014-12-30,171,183,ADVERSE EVENT,54,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-12-18T00:00:00Z,NA,H,2014-12-30T00:00:00Z,NA,H,171,183,13,2014-12-18,2014-12-30,0,702,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1034,3,XANOMELINE,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-12-18,2014-12-30,171,183,ADVERSE EVENT,54,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-12-18T00:00:00Z,NA,H,2014-12-30T00:00:00Z,NA,H,171,183,13,2014-12-18,2014-12-30,0,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1034,3,XANOMELINE,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-12-18,2014-12-30,171,183,ADVERSE EVENT,54,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-12-18T00:00:00Z,NA,H,2014-12-30T00:00:00Z,NA,H,171,183,13,2014-12-18,2014-12-30,0,702,ADJ,NA,Y,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1034,3,XANOMELINE,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-12-18,2014-12-30,171,183,ADVERSE EVENT,54,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-12-18T00:00:00Z,NA,H,2014-12-30T00:00:00Z,NA,H,171,183,13,2014-12-18,2014-12-30,0,702,ADJAE,NA,Y,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-01T00:00:00Z,NA,NA,2014-12-30T00:00:00Z,NA,NA,NA,NA,NA,2014-07-01,2014-12-30,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-01T00:00:00Z,NA,NA,2014-12-30T00:00:00Z,NA,NA,NA,NA,NA,2014-07-01,2014-12-30,NA,NA,TDOSE,810,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-01T00:00:00Z,NA,NA,2014-12-30T00:00:00Z,NA,NA,NA,NA,NA,2014-07-01,2014-12-30,NA,NA,AVDDSE,4.426229508196721,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-01T00:00:00Z,NA,NA,2014-12-30T00:00:00Z,NA,NA,NA,NA,NA,2014-07-01,2014-12-30,NA,NA,TPDOSE,9882,NA,OVERALL,Total planned dose (mg),11,NA,19,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-01T00:00:00Z,NA,NA,2014-12-30T00:00:00Z,NA,NA,NA,NA,NA,2014-07-01,2014-12-30,NA,NA,TADJ,NA,Y,OVERALL,Dose adjusted during study,13,NA,20,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-01T00:00:00Z,NA,NA,2014-12-30T00:00:00Z,NA,NA,NA,NA,NA,2014-07-01,2014-12-30,NA,NA,TADJAE,NA,Y,OVERALL,Dose adjusted during study due to AE,14,NA,21,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-01T00:00:00Z,NA,NA,2014-12-30T00:00:00Z,NA,NA,NA,NA,NA,2014-07-01,2014-12-30,NA,NA,TDOSINT,8.19672131147541,NA,OVERALL,Overall dose intensity (%),90,NA,22,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-16T00:00:00Z,NA,NA,2014-12-30T00:00:00Z,NA,NA,NA,NA,NA,2014-07-16,2014-12-30,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-16T00:00:00Z,NA,NA,2014-12-30T00:00:00Z,NA,NA,NA,NA,NA,2014-07-16,2014-12-30,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-16T00:00:00Z,NA,NA,2014-12-30T00:00:00Z,NA,NA,NA,NA,NA,2014-07-16,2014-12-30,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-16T00:00:00Z,NA,NA,2014-12-30T00:00:00Z,NA,NA,NA,NA,NA,2014-07-16,2014-12-30,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-16T00:00:00Z,NA,NA,2014-12-30T00:00:00Z,NA,NA,NA,NA,NA,2014-07-16,2014-12-30,NA,NA,PADJ,NA,Y,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-16T00:00:00Z,NA,NA,2014-12-30T00:00:00Z,NA,NA,NA,NA,NA,2014-07-16,2014-12-30,NA,NA,PADJAE,NA,Y,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1034,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-07-01,2014-07-01T00:00:00Z,2014-12-30T23:59:59Z,2014-07-16T00:00:00Z,NA,NA,2014-12-30T00:00:00Z,NA,NA,NA,NA,NA,2014-07-16,2014-12-30,NA,NA,PDOSINT,0,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1034,2014-07-01,2014-12-30,2014-07-01,2014-12-30,NA,2014-12-30T09:50,NA,NA,701,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-06-24,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-12-30,183,NA,2014-12-30,COMPLETED,NA,2014-07-01,NA,NA,NA,2014-12-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1047,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-12,2013-02-25,1,14,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-12T00:00:00Z,NA,H,2013-02-25T00:00:00Z,NA,H,1,14,14,2013-02-12,2013-02-25,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1047,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-12,2013-02-25,1,14,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-12T00:00:00Z,NA,H,2013-02-25T00:00:00Z,NA,H,1,14,14,2013-02-12,2013-02-25,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1047,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-12,2013-02-25,1,14,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-12T00:00:00Z,NA,H,2013-02-25T00:00:00Z,NA,H,1,14,14,2013-02-12,2013-02-25,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1047,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-12,2013-02-25,1,14,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-12T00:00:00Z,NA,H,2013-02-25T00:00:00Z,NA,H,1,14,14,2013-02-12,2013-02-25,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1047,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-12,2013-02-25,1,14,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-12T00:00:00Z,NA,H,2013-02-25T00:00:00Z,NA,H,1,14,14,2013-02-12,2013-02-25,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1047,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-26,2013-03-09,15,26,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-09T00:00:00Z,NA,H,15,26,12,2013-02-26,2013-03-09,0,0,DURD,12,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1047,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-26,2013-03-09,15,26,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-09T00:00:00Z,NA,H,15,26,12,2013-02-26,2013-03-09,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1047,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-26,2013-03-09,15,26,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-09T00:00:00Z,NA,H,15,26,12,2013-02-26,2013-03-09,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1047,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-26,2013-03-09,15,26,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-09T00:00:00Z,NA,H,15,26,12,2013-02-26,2013-03-09,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1047,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-26,2013-03-09,15,26,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-09T00:00:00Z,NA,H,15,26,12,2013-02-26,2013-03-09,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-03-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-03-09,NA,NA,TDURD,26,NA,OVERALL,Overall duration (days),7,< 30 days,11,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-03-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-03-09,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-03-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-03-09,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-03-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-03-09,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-03-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-03-09,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-03-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-03-09,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-03-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-03-09,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-03-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-03-09,NA,NA,PDURD,12,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-03-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-03-09,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-03-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-03-09,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-03-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-03-09,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-03-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-03-09,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-03-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-03-09,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1047,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-09T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-03-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-03-09,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1047,2013-02-12,2013-03-29,2013-02-12,2013-03-09,NA,2013-07-28,NA,NA,701,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-22,-21,Placebo,Placebo,H,H,2013-03-09,26,NA,2013-03-29,DISCONTINUED,2013-07-28,2013-02-12,NA,NA,NA,2013-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1097,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-01,2014-01-15,1,15,NA,54,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-01T00:00:00Z,NA,H,2014-01-15T00:00:00Z,NA,H,1,15,15,2014-01-01,2014-01-15,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1097,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-01,2014-01-15,1,15,NA,54,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-01T00:00:00Z,NA,H,2014-01-15T00:00:00Z,NA,H,1,15,15,2014-01-01,2014-01-15,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1097,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-01,2014-01-15,1,15,NA,54,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-01T00:00:00Z,NA,H,2014-01-15T00:00:00Z,NA,H,1,15,15,2014-01-01,2014-01-15,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1097,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-01,2014-01-15,1,15,NA,54,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-01T00:00:00Z,NA,H,2014-01-15T00:00:00Z,NA,H,1,15,15,2014-01-01,2014-01-15,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1097,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-01,2014-01-15,1,15,NA,54,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-01T00:00:00Z,NA,H,2014-01-15T00:00:00Z,NA,H,1,15,15,2014-01-01,2014-01-15,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1097,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-16,2014-06-18,16,169,NA,54,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-16T00:00:00Z,NA,H,2014-06-18T00:00:00Z,NA,H,16,169,154,2014-01-16,2014-06-18,8316,8316,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1097,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-16,2014-06-18,16,169,NA,54,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-16T00:00:00Z,NA,H,2014-06-18T00:00:00Z,NA,H,16,169,154,2014-01-16,2014-06-18,8316,8316,DOSE,8316,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1097,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-16,2014-06-18,16,169,NA,54,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-16T00:00:00Z,NA,H,2014-06-18T00:00:00Z,NA,H,16,169,154,2014-01-16,2014-06-18,8316,8316,PLDOSE,8316,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1097,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-16,2014-06-18,16,169,NA,54,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-16T00:00:00Z,NA,H,2014-06-18T00:00:00Z,NA,H,16,169,154,2014-01-16,2014-06-18,8316,8316,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1097,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-16,2014-06-18,16,169,NA,54,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-16T00:00:00Z,NA,H,2014-06-18T00:00:00Z,NA,H,16,169,154,2014-01-16,2014-06-18,8316,8316,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1097,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-19,2014-07-09,170,190,NA,54,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-06-19T00:00:00Z,NA,H,2014-07-09T00:00:00Z,NA,H,170,190,21,2014-06-19,2014-07-09,1134,1134,DURD,21,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1097,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-19,2014-07-09,170,190,NA,54,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-06-19T00:00:00Z,NA,H,2014-07-09T00:00:00Z,NA,H,170,190,21,2014-06-19,2014-07-09,1134,1134,DOSE,1134,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1097,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-19,2014-07-09,170,190,NA,54,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-06-19T00:00:00Z,NA,H,2014-07-09T00:00:00Z,NA,H,170,190,21,2014-06-19,2014-07-09,1134,1134,PLDOSE,1134,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1097,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-19,2014-07-09,170,190,NA,54,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-06-19T00:00:00Z,NA,H,2014-07-09T00:00:00Z,NA,H,170,190,21,2014-06-19,2014-07-09,1134,1134,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1097,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-19,2014-07-09,170,190,NA,54,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-06-19T00:00:00Z,NA,H,2014-07-09T00:00:00Z,NA,H,170,190,21,2014-06-19,2014-07-09,1134,1134,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1097,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-01T00:00:00Z,NA,NA,2014-07-09T00:00:00Z,NA,NA,NA,NA,NA,2014-01-01,2014-07-09,NA,NA,TDURD,190,NA,OVERALL,Overall duration (days),7,>=90 days,16,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1097,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-01T00:00:00Z,NA,NA,2014-07-09T00:00:00Z,NA,NA,NA,NA,NA,2014-01-01,2014-07-09,NA,NA,TDOSE,10260,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1097,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-01T00:00:00Z,NA,NA,2014-07-09T00:00:00Z,NA,NA,NA,NA,NA,2014-01-01,2014-07-09,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1097,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-01T00:00:00Z,NA,NA,2014-07-09T00:00:00Z,NA,NA,NA,NA,NA,2014-01-01,2014-07-09,NA,NA,TPDOSE,10260,NA,OVERALL,Total planned dose (mg),11,NA,19,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1097,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-01T00:00:00Z,NA,NA,2014-07-09T00:00:00Z,NA,NA,NA,NA,NA,2014-01-01,2014-07-09,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1097,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-01T00:00:00Z,NA,NA,2014-07-09T00:00:00Z,NA,NA,NA,NA,NA,2014-01-01,2014-07-09,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1097,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-01T00:00:00Z,NA,NA,2014-07-09T00:00:00Z,NA,NA,NA,NA,NA,2014-01-01,2014-07-09,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1097,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-16T00:00:00Z,NA,NA,2014-07-09T00:00:00Z,NA,NA,NA,NA,NA,2014-01-16,2014-07-09,NA,NA,PDURD,175,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1097,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-16T00:00:00Z,NA,NA,2014-07-09T00:00:00Z,NA,NA,NA,NA,NA,2014-01-16,2014-07-09,NA,NA,PDOSE,9450,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1097,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-16T00:00:00Z,NA,NA,2014-07-09T00:00:00Z,NA,NA,NA,NA,NA,2014-01-16,2014-07-09,NA,NA,PPDOSE,9450,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1097,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-16T00:00:00Z,NA,NA,2014-07-09T00:00:00Z,NA,NA,NA,NA,NA,2014-01-16,2014-07-09,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1097,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-16T00:00:00Z,NA,NA,2014-07-09T00:00:00Z,NA,NA,NA,NA,NA,2014-01-16,2014-07-09,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1097,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-16T00:00:00Z,NA,NA,2014-07-09T00:00:00Z,NA,NA,NA,NA,NA,2014-01-16,2014-07-09,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1097,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-01,2014-01-01T00:00:00Z,2014-07-09T23:59:59Z,2014-01-16T00:00:00Z,NA,NA,2014-07-09T00:00:00Z,NA,NA,NA,NA,NA,2014-01-16,2014-07-09,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1097,2014-01-01,2014-07-09,2014-01-01,2014-07-09,NA,2014-07-09T09:39,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-09,190,NA,2014-07-09,COMPLETED,NA,2014-01-01,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1111,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-07,2012-09-16,1,10,NA,54,2012-09-07,2012-09-07T00:00:00Z,2012-09-16T23:59:59Z,2012-09-07T00:00:00Z,NA,H,2012-09-16T00:00:00Z,NA,H,1,10,10,2012-09-07,2012-09-16,540,540,DURD,10,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-16,10,NA,2012-09-17,DISCONTINUED,2013-02-22,2012-09-07,NA,NA,NA,2012-09-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1111,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-07,2012-09-16,1,10,NA,54,2012-09-07,2012-09-07T00:00:00Z,2012-09-16T23:59:59Z,2012-09-07T00:00:00Z,NA,H,2012-09-16T00:00:00Z,NA,H,1,10,10,2012-09-07,2012-09-16,540,540,DOSE,540,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-16,10,NA,2012-09-17,DISCONTINUED,2013-02-22,2012-09-07,NA,NA,NA,2012-09-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1111,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-07,2012-09-16,1,10,NA,54,2012-09-07,2012-09-07T00:00:00Z,2012-09-16T23:59:59Z,2012-09-07T00:00:00Z,NA,H,2012-09-16T00:00:00Z,NA,H,1,10,10,2012-09-07,2012-09-16,540,540,PLDOSE,540,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-16,10,NA,2012-09-17,DISCONTINUED,2013-02-22,2012-09-07,NA,NA,NA,2012-09-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1111,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-07,2012-09-16,1,10,NA,54,2012-09-07,2012-09-07T00:00:00Z,2012-09-16T23:59:59Z,2012-09-07T00:00:00Z,NA,H,2012-09-16T00:00:00Z,NA,H,1,10,10,2012-09-07,2012-09-16,540,540,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-16,10,NA,2012-09-17,DISCONTINUED,2013-02-22,2012-09-07,NA,NA,NA,2012-09-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1111,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-07,2012-09-16,1,10,NA,54,2012-09-07,2012-09-07T00:00:00Z,2012-09-16T23:59:59Z,2012-09-07T00:00:00Z,NA,H,2012-09-16T00:00:00Z,NA,H,1,10,10,2012-09-07,2012-09-16,540,540,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-16,10,NA,2012-09-17,DISCONTINUED,2013-02-22,2012-09-07,NA,NA,NA,2012-09-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2012-09-16T23:59:59Z,2012-09-07T00:00:00Z,NA,NA,2012-09-16T00:00:00Z,NA,NA,NA,NA,NA,2012-09-07,2012-09-16,NA,NA,TDURD,10,NA,OVERALL,Overall duration (days),7,< 30 days,6,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-16,10,NA,2012-09-17,DISCONTINUED,2013-02-22,2012-09-07,NA,NA,NA,2012-09-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2012-09-16T23:59:59Z,2012-09-07T00:00:00Z,NA,NA,2012-09-16T00:00:00Z,NA,NA,NA,NA,NA,2012-09-07,2012-09-16,NA,NA,TDOSE,540,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-16,10,NA,2012-09-17,DISCONTINUED,2013-02-22,2012-09-07,NA,NA,NA,2012-09-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2012-09-16T23:59:59Z,2012-09-07T00:00:00Z,NA,NA,2012-09-16T00:00:00Z,NA,NA,NA,NA,NA,2012-09-07,2012-09-16,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-16,10,NA,2012-09-17,DISCONTINUED,2013-02-22,2012-09-07,NA,NA,NA,2012-09-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2012-09-16T23:59:59Z,2012-09-07T00:00:00Z,NA,NA,2012-09-16T00:00:00Z,NA,NA,NA,NA,NA,2012-09-07,2012-09-16,NA,NA,TPDOSE,540,NA,OVERALL,Total planned dose (mg),11,NA,9,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-16,10,NA,2012-09-17,DISCONTINUED,2013-02-22,2012-09-07,NA,NA,NA,2012-09-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2012-09-16T23:59:59Z,2012-09-07T00:00:00Z,NA,NA,2012-09-16T00:00:00Z,NA,NA,NA,NA,NA,2012-09-07,2012-09-16,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-16,10,NA,2012-09-17,DISCONTINUED,2013-02-22,2012-09-07,NA,NA,NA,2012-09-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2012-09-16T23:59:59Z,2012-09-07T00:00:00Z,NA,NA,2012-09-16T00:00:00Z,NA,NA,NA,NA,NA,2012-09-07,2012-09-16,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-16,10,NA,2012-09-17,DISCONTINUED,2013-02-22,2012-09-07,NA,NA,NA,2012-09-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1111,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2012-09-16T23:59:59Z,2012-09-07T00:00:00Z,NA,NA,2012-09-16T00:00:00Z,NA,NA,NA,NA,NA,2012-09-07,2012-09-16,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1111,2012-09-07,2012-09-17,2012-09-07,2012-09-16,NA,2013-02-22,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-16,10,NA,2012-09-17,DISCONTINUED,2013-02-22,2012-09-07,NA,NA,NA,2012-09-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1115,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-30,2012-12-13,1,14,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-11-30T00:00:00Z,NA,H,2012-12-13T00:00:00Z,NA,H,1,14,14,2012-11-30,2012-12-13,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1115,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-30,2012-12-13,1,14,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-11-30T00:00:00Z,NA,H,2012-12-13T00:00:00Z,NA,H,1,14,14,2012-11-30,2012-12-13,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1115,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-30,2012-12-13,1,14,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-11-30T00:00:00Z,NA,H,2012-12-13T00:00:00Z,NA,H,1,14,14,2012-11-30,2012-12-13,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1115,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-30,2012-12-13,1,14,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-11-30T00:00:00Z,NA,H,2012-12-13T00:00:00Z,NA,H,1,14,14,2012-11-30,2012-12-13,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1115,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-30,2012-12-13,1,14,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-11-30T00:00:00Z,NA,H,2012-12-13T00:00:00Z,NA,H,1,14,14,2012-11-30,2012-12-13,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1115,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-14,2013-01-23,15,55,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-12-14T00:00:00Z,NA,H,2013-01-23T00:00:00Z,NA,H,15,55,41,2012-12-14,2013-01-23,2214,2214,DURD,41,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1115,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-14,2013-01-23,15,55,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-12-14T00:00:00Z,NA,H,2013-01-23T00:00:00Z,NA,H,15,55,41,2012-12-14,2013-01-23,2214,2214,DOSE,2214,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1115,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-14,2013-01-23,15,55,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-12-14T00:00:00Z,NA,H,2013-01-23T00:00:00Z,NA,H,15,55,41,2012-12-14,2013-01-23,2214,2214,PLDOSE,2214,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1115,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-14,2013-01-23,15,55,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-12-14T00:00:00Z,NA,H,2013-01-23T00:00:00Z,NA,H,15,55,41,2012-12-14,2013-01-23,2214,2214,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1115,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-14,2013-01-23,15,55,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-12-14T00:00:00Z,NA,H,2013-01-23T00:00:00Z,NA,H,15,55,41,2012-12-14,2013-01-23,2214,2214,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-11-30T00:00:00Z,NA,NA,2013-01-23T00:00:00Z,NA,NA,NA,NA,NA,2012-11-30,2013-01-23,NA,NA,TDURD,55,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-11-30T00:00:00Z,NA,NA,2013-01-23T00:00:00Z,NA,NA,NA,NA,NA,2012-11-30,2013-01-23,NA,NA,TDOSE,2970,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-11-30T00:00:00Z,NA,NA,2013-01-23T00:00:00Z,NA,NA,NA,NA,NA,2012-11-30,2013-01-23,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-11-30T00:00:00Z,NA,NA,2013-01-23T00:00:00Z,NA,NA,NA,NA,NA,2012-11-30,2013-01-23,NA,NA,TPDOSE,2970,NA,OVERALL,Total planned dose (mg),11,NA,14,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-11-30T00:00:00Z,NA,NA,2013-01-23T00:00:00Z,NA,NA,NA,NA,NA,2012-11-30,2013-01-23,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-11-30T00:00:00Z,NA,NA,2013-01-23T00:00:00Z,NA,NA,NA,NA,NA,2012-11-30,2013-01-23,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-11-30T00:00:00Z,NA,NA,2013-01-23T00:00:00Z,NA,NA,NA,NA,NA,2012-11-30,2013-01-23,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-12-14T00:00:00Z,NA,NA,2013-01-23T00:00:00Z,NA,NA,NA,NA,NA,2012-12-14,2013-01-23,NA,NA,PDURD,41,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-12-14T00:00:00Z,NA,NA,2013-01-23T00:00:00Z,NA,NA,NA,NA,NA,2012-12-14,2013-01-23,NA,NA,PDOSE,2214,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-12-14T00:00:00Z,NA,NA,2013-01-23T00:00:00Z,NA,NA,NA,NA,NA,2012-12-14,2013-01-23,NA,NA,PPDOSE,2214,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-12-14T00:00:00Z,NA,NA,2013-01-23T00:00:00Z,NA,NA,NA,NA,NA,2012-12-14,2013-01-23,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-12-14T00:00:00Z,NA,NA,2013-01-23T00:00:00Z,NA,NA,NA,NA,NA,2012-12-14,2013-01-23,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-12-14T00:00:00Z,NA,NA,2013-01-23T00:00:00Z,NA,NA,NA,NA,NA,2012-12-14,2013-01-23,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1115,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-01-23T23:59:59Z,2012-12-14T00:00:00Z,NA,NA,2013-01-23T00:00:00Z,NA,NA,NA,NA,NA,2012-12-14,2013-01-23,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1115,2012-11-30,2013-01-23,2012-11-30,2013-01-23,NA,2013-05-20,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-23,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-23,55,NA,2013-01-23,DISCONTINUED,2013-05-20,2012-11-30,NA,NA,NA,2013-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1118,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-12,2014-03-26,1,15,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-26T00:00:00Z,NA,H,1,15,15,2014-03-12,2014-03-26,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1118,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-12,2014-03-26,1,15,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-26T00:00:00Z,NA,H,1,15,15,2014-03-12,2014-03-26,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1118,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-12,2014-03-26,1,15,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-26T00:00:00Z,NA,H,1,15,15,2014-03-12,2014-03-26,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1118,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-12,2014-03-26,1,15,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-26T00:00:00Z,NA,H,1,15,15,2014-03-12,2014-03-26,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1118,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-12,2014-03-26,1,15,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-26T00:00:00Z,NA,H,1,15,15,2014-03-12,2014-03-26,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1118,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-27,2014-08-27,16,169,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-27T00:00:00Z,NA,H,2014-08-27T00:00:00Z,NA,H,16,169,154,2014-03-27,2014-08-27,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1118,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-27,2014-08-27,16,169,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-27T00:00:00Z,NA,H,2014-08-27T00:00:00Z,NA,H,16,169,154,2014-03-27,2014-08-27,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1118,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-27,2014-08-27,16,169,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-27T00:00:00Z,NA,H,2014-08-27T00:00:00Z,NA,H,16,169,154,2014-03-27,2014-08-27,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1118,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-27,2014-08-27,16,169,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-27T00:00:00Z,NA,H,2014-08-27T00:00:00Z,NA,H,16,169,154,2014-03-27,2014-08-27,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1118,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-27,2014-08-27,16,169,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-27T00:00:00Z,NA,H,2014-08-27T00:00:00Z,NA,H,16,169,154,2014-03-27,2014-08-27,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1118,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-28,2014-09-09,170,182,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-08-28T00:00:00Z,NA,H,2014-09-09T00:00:00Z,NA,H,170,182,13,2014-08-28,2014-09-09,0,0,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1118,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-28,2014-09-09,170,182,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-08-28T00:00:00Z,NA,H,2014-09-09T00:00:00Z,NA,H,170,182,13,2014-08-28,2014-09-09,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1118,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-28,2014-09-09,170,182,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-08-28T00:00:00Z,NA,H,2014-09-09T00:00:00Z,NA,H,170,182,13,2014-08-28,2014-09-09,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1118,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-28,2014-09-09,170,182,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-08-28T00:00:00Z,NA,H,2014-09-09T00:00:00Z,NA,H,170,182,13,2014-08-28,2014-09-09,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1118,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-28,2014-09-09,170,182,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-08-28T00:00:00Z,NA,H,2014-09-09T00:00:00Z,NA,H,170,182,13,2014-08-28,2014-09-09,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-09-09T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-09-09,NA,NA,TDURD,182,NA,OVERALL,Overall duration (days),7,>=90 days,16,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-09-09T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-09-09,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-09-09T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-09-09,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-09-09T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-09-09,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-09-09T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-09-09,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-09-09T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-09-09,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-09-09T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-09-09,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-27T00:00:00Z,NA,NA,2014-09-09T00:00:00Z,NA,NA,NA,NA,NA,2014-03-27,2014-09-09,NA,NA,PDURD,167,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-27T00:00:00Z,NA,NA,2014-09-09T00:00:00Z,NA,NA,NA,NA,NA,2014-03-27,2014-09-09,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-27T00:00:00Z,NA,NA,2014-09-09T00:00:00Z,NA,NA,NA,NA,NA,2014-03-27,2014-09-09,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-27T00:00:00Z,NA,NA,2014-09-09T00:00:00Z,NA,NA,NA,NA,NA,2014-03-27,2014-09-09,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-27T00:00:00Z,NA,NA,2014-09-09T00:00:00Z,NA,NA,NA,NA,NA,2014-03-27,2014-09-09,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-27T00:00:00Z,NA,NA,2014-09-09T00:00:00Z,NA,NA,NA,NA,NA,2014-03-27,2014-09-09,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1118,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-09T23:59:59Z,2014-03-27T00:00:00Z,NA,NA,2014-09-09T00:00:00Z,NA,NA,NA,NA,NA,2014-03-27,2014-09-09,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1118,2014-03-12,2014-09-09,2014-03-12,2014-09-09,NA,2014-09-09T13:28,NA,NA,701,52,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-27,-13,Placebo,Placebo,H,H,2014-09-09,182,NA,2014-09-09,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1130,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-15,2014-03-01,1,15,NA,0,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-02-15T00:00:00Z,NA,H,2014-03-01T00:00:00Z,NA,H,1,15,15,2014-02-15,2014-03-01,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1130,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-15,2014-03-01,1,15,NA,0,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-02-15T00:00:00Z,NA,H,2014-03-01T00:00:00Z,NA,H,1,15,15,2014-02-15,2014-03-01,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1130,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-15,2014-03-01,1,15,NA,0,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-02-15T00:00:00Z,NA,H,2014-03-01T00:00:00Z,NA,H,1,15,15,2014-02-15,2014-03-01,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1130,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-15,2014-03-01,1,15,NA,0,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-02-15T00:00:00Z,NA,H,2014-03-01T00:00:00Z,NA,H,1,15,15,2014-02-15,2014-03-01,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1130,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-15,2014-03-01,1,15,NA,0,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-02-15T00:00:00Z,NA,H,2014-03-01T00:00:00Z,NA,H,1,15,15,2014-02-15,2014-03-01,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1130,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-02,2014-08-02,16,169,NA,0,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-03-02T00:00:00Z,NA,H,2014-08-02T00:00:00Z,NA,H,16,169,154,2014-03-02,2014-08-02,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1130,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-02,2014-08-02,16,169,NA,0,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-03-02T00:00:00Z,NA,H,2014-08-02T00:00:00Z,NA,H,16,169,154,2014-03-02,2014-08-02,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1130,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-02,2014-08-02,16,169,NA,0,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-03-02T00:00:00Z,NA,H,2014-08-02T00:00:00Z,NA,H,16,169,154,2014-03-02,2014-08-02,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1130,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-02,2014-08-02,16,169,NA,0,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-03-02T00:00:00Z,NA,H,2014-08-02T00:00:00Z,NA,H,16,169,154,2014-03-02,2014-08-02,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1130,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-02,2014-08-02,16,169,NA,0,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-03-02T00:00:00Z,NA,H,2014-08-02T00:00:00Z,NA,H,16,169,154,2014-03-02,2014-08-02,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1130,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-03,2014-08-16,170,183,NA,0,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-08-03T00:00:00Z,NA,H,2014-08-16T00:00:00Z,NA,H,170,183,14,2014-08-03,2014-08-16,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1130,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-03,2014-08-16,170,183,NA,0,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-08-03T00:00:00Z,NA,H,2014-08-16T00:00:00Z,NA,H,170,183,14,2014-08-03,2014-08-16,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1130,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-03,2014-08-16,170,183,NA,0,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-08-03T00:00:00Z,NA,H,2014-08-16T00:00:00Z,NA,H,170,183,14,2014-08-03,2014-08-16,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1130,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-03,2014-08-16,170,183,NA,0,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-08-03T00:00:00Z,NA,H,2014-08-16T00:00:00Z,NA,H,170,183,14,2014-08-03,2014-08-16,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1130,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-03,2014-08-16,170,183,NA,0,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-08-03T00:00:00Z,NA,H,2014-08-16T00:00:00Z,NA,H,170,183,14,2014-08-03,2014-08-16,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1130,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-02-15T00:00:00Z,NA,NA,2014-08-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-15,2014-08-16,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1130,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-02-15T00:00:00Z,NA,NA,2014-08-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-15,2014-08-16,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1130,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-02-15T00:00:00Z,NA,NA,2014-08-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-15,2014-08-16,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1130,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-02-15T00:00:00Z,NA,NA,2014-08-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-15,2014-08-16,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1130,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-02-15T00:00:00Z,NA,NA,2014-08-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-15,2014-08-16,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1130,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-02-15T00:00:00Z,NA,NA,2014-08-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-15,2014-08-16,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1130,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-02-15T00:00:00Z,NA,NA,2014-08-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-15,2014-08-16,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1130,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-03-02T00:00:00Z,NA,NA,2014-08-16T00:00:00Z,NA,NA,NA,NA,NA,2014-03-02,2014-08-16,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1130,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-03-02T00:00:00Z,NA,NA,2014-08-16T00:00:00Z,NA,NA,NA,NA,NA,2014-03-02,2014-08-16,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1130,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-03-02T00:00:00Z,NA,NA,2014-08-16T00:00:00Z,NA,NA,NA,NA,NA,2014-03-02,2014-08-16,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1130,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-03-02T00:00:00Z,NA,NA,2014-08-16T00:00:00Z,NA,NA,NA,NA,NA,2014-03-02,2014-08-16,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1130,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-03-02T00:00:00Z,NA,NA,2014-08-16T00:00:00Z,NA,NA,NA,NA,NA,2014-03-02,2014-08-16,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1130,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-03-02T00:00:00Z,NA,NA,2014-08-16T00:00:00Z,NA,NA,NA,NA,NA,2014-03-02,2014-08-16,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1130,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-15,2014-02-15T00:00:00Z,2014-08-16T23:59:59Z,2014-03-02T00:00:00Z,NA,NA,2014-08-16T00:00:00Z,NA,NA,NA,NA,NA,2014-03-02,2014-08-16,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1130,2014-02-15,2014-08-16,2014-02-15,2014-08-16,NA,2014-08-16T13:10,NA,NA,701,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-09,-6,Placebo,Placebo,H,H,2014-08-16,183,NA,2014-08-16,COMPLETED,NA,2014-02-15,NA,NA,NA,2014-08-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1133,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-28,2012-11-12,1,16,NA,54,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,H,2012-11-12T00:00:00Z,NA,H,1,16,16,2012-10-28,2012-11-12,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1133,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-28,2012-11-12,1,16,NA,54,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,H,2012-11-12T00:00:00Z,NA,H,1,16,16,2012-10-28,2012-11-12,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1133,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-28,2012-11-12,1,16,NA,54,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,H,2012-11-12T00:00:00Z,NA,H,1,16,16,2012-10-28,2012-11-12,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1133,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-28,2012-11-12,1,16,NA,54,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,H,2012-11-12T00:00:00Z,NA,H,1,16,16,2012-10-28,2012-11-12,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1133,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-28,2012-11-12,1,16,NA,54,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,H,2012-11-12T00:00:00Z,NA,H,1,16,16,2012-10-28,2012-11-12,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1133,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-13,2013-04-18,17,173,NA,54,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-13T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,17,173,157,2012-11-13,2013-04-18,12717,8478,DURD,157,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1133,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-13,2013-04-18,17,173,NA,54,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-13T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,17,173,157,2012-11-13,2013-04-18,12717,8478,DOSE,12717,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1133,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-13,2013-04-18,17,173,NA,54,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-13T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,17,173,157,2012-11-13,2013-04-18,12717,8478,PLDOSE,8478,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1133,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-13,2013-04-18,17,173,NA,54,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-13T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,17,173,157,2012-11-13,2013-04-18,12717,8478,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1133,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-13,2013-04-18,17,173,NA,54,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-13T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,17,173,157,2012-11-13,2013-04-18,12717,8478,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1133,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-19,2013-04-28,174,183,NA,54,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2013-04-19T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,174,183,10,2013-04-19,2013-04-28,540,540,DURD,10,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1133,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-19,2013-04-28,174,183,NA,54,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2013-04-19T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,174,183,10,2013-04-19,2013-04-28,540,540,DOSE,540,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1133,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-19,2013-04-28,174,183,NA,54,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2013-04-19T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,174,183,10,2013-04-19,2013-04-28,540,540,PLDOSE,540,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1133,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-19,2013-04-28,174,183,NA,54,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2013-04-19T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,174,183,10,2013-04-19,2013-04-28,540,540,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1133,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-19,2013-04-28,174,183,NA,54,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2013-04-19T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,174,183,10,2013-04-19,2013-04-28,540,540,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-28,2013-04-28,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-28,2013-04-28,NA,NA,TDOSE,14121,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-28,2013-04-28,NA,NA,AVDDSE,77.1639344262295,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-28,2013-04-28,NA,NA,TPDOSE,9882,NA,OVERALL,Total planned dose (mg),11,NA,19,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-28,2013-04-28,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-28,2013-04-28,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-28,2013-04-28,NA,NA,TDOSINT,142.89617486338798,NA,OVERALL,Overall dose intensity (%),90,NA,22,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-13T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-13,2013-04-28,NA,NA,PDURD,167,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-13T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-13,2013-04-28,NA,NA,PDOSE,13257,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-13T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-13,2013-04-28,NA,NA,PPDOSE,9018,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-13T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-13,2013-04-28,NA,NA,PAVDDSE,79.38323353293413,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-13T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-13,2013-04-28,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-13T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-13,2013-04-28,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1133,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-13T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-13,2013-04-28,NA,NA,PDOSINT,147.0059880239521,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1133,2012-10-28,2013-04-29,2012-10-28,2013-04-28,NA,2013-04-29T10:13,NA,NA,701,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-23,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-28,183,NA,2013-04-29,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1146,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-20,2013-06-03,1,15,NA,54,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-05-20T00:00:00Z,NA,H,2013-06-03T00:00:00Z,NA,H,1,15,15,2013-05-20,2013-06-03,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1146,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-20,2013-06-03,1,15,NA,54,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-05-20T00:00:00Z,NA,H,2013-06-03T00:00:00Z,NA,H,1,15,15,2013-05-20,2013-06-03,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1146,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-20,2013-06-03,1,15,NA,54,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-05-20T00:00:00Z,NA,H,2013-06-03T00:00:00Z,NA,H,1,15,15,2013-05-20,2013-06-03,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1146,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-20,2013-06-03,1,15,NA,54,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-05-20T00:00:00Z,NA,H,2013-06-03T00:00:00Z,NA,H,1,15,15,2013-05-20,2013-06-03,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1146,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-20,2013-06-03,1,15,NA,54,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-05-20T00:00:00Z,NA,H,2013-06-03T00:00:00Z,NA,H,1,15,15,2013-05-20,2013-06-03,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1146,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-04,2013-06-26,16,38,NA,54,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-06-04T00:00:00Z,NA,H,2013-06-26T00:00:00Z,NA,H,16,38,23,2013-06-04,2013-06-26,1863,1242,DURD,23,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1146,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-04,2013-06-26,16,38,NA,54,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-06-04T00:00:00Z,NA,H,2013-06-26T00:00:00Z,NA,H,16,38,23,2013-06-04,2013-06-26,1863,1242,DOSE,1863,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1146,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-04,2013-06-26,16,38,NA,54,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-06-04T00:00:00Z,NA,H,2013-06-26T00:00:00Z,NA,H,16,38,23,2013-06-04,2013-06-26,1863,1242,PLDOSE,1242,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1146,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-04,2013-06-26,16,38,NA,54,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-06-04T00:00:00Z,NA,H,2013-06-26T00:00:00Z,NA,H,16,38,23,2013-06-04,2013-06-26,1863,1242,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1146,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-04,2013-06-26,16,38,NA,54,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-06-04T00:00:00Z,NA,H,2013-06-26T00:00:00Z,NA,H,16,38,23,2013-06-04,2013-06-26,1863,1242,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-05-20T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-05-20,2013-06-26,NA,NA,TDURD,38,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-05-20T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-05-20,2013-06-26,NA,NA,TDOSE,2673,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-05-20T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-05-20,2013-06-26,NA,NA,AVDDSE,70.34210526315789,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-05-20T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-05-20,2013-06-26,NA,NA,TPDOSE,2052,NA,OVERALL,Total planned dose (mg),11,NA,14,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-05-20T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-05-20,2013-06-26,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-05-20T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-05-20,2013-06-26,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-05-20T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-05-20,2013-06-26,NA,NA,TDOSINT,130.26315789473685,NA,OVERALL,Overall dose intensity (%),90,NA,17,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-06-04T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-06-04,2013-06-26,NA,NA,PDURD,23,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-06-04T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-06-04,2013-06-26,NA,NA,PDOSE,1863,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-06-04T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-06-04,2013-06-26,NA,NA,PPDOSE,1242,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-06-04T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-06-04,2013-06-26,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-06-04T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-06-04,2013-06-26,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-06-04T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-06-04,2013-06-26,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1146,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-20,2013-05-20T00:00:00Z,2013-06-26T23:59:59Z,2013-06-04T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-06-04,2013-06-26,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1146,2013-05-20,2013-06-30,2013-05-20,2013-06-26,NA,2013-07-15,NA,NA,701,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-07,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,38,NA,2013-06-30,DISCONTINUED,NA,2013-05-20,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1148,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-23,2013-09-05,1,14,NA,54,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-08-23T00:00:00Z,NA,H,2013-09-05T00:00:00Z,NA,H,1,14,14,2013-08-23,2013-09-05,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1148,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-23,2013-09-05,1,14,NA,54,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-08-23T00:00:00Z,NA,H,2013-09-05T00:00:00Z,NA,H,1,14,14,2013-08-23,2013-09-05,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1148,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-23,2013-09-05,1,14,NA,54,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-08-23T00:00:00Z,NA,H,2013-09-05T00:00:00Z,NA,H,1,14,14,2013-08-23,2013-09-05,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1148,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-23,2013-09-05,1,14,NA,54,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-08-23T00:00:00Z,NA,H,2013-09-05T00:00:00Z,NA,H,1,14,14,2013-08-23,2013-09-05,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1148,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-23,2013-09-05,1,14,NA,54,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-08-23T00:00:00Z,NA,H,2013-09-05T00:00:00Z,NA,H,1,14,14,2013-08-23,2013-09-05,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1148,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-06,2014-02-08,15,170,NA,54,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-09-06T00:00:00Z,NA,H,2014-02-08T00:00:00Z,NA,H,15,170,156,2013-09-06,2014-02-08,12636,8424,DURD,156,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1148,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-06,2014-02-08,15,170,NA,54,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-09-06T00:00:00Z,NA,H,2014-02-08T00:00:00Z,NA,H,15,170,156,2013-09-06,2014-02-08,12636,8424,DOSE,12636,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1148,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-06,2014-02-08,15,170,NA,54,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-09-06T00:00:00Z,NA,H,2014-02-08T00:00:00Z,NA,H,15,170,156,2013-09-06,2014-02-08,12636,8424,PLDOSE,8424,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1148,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-06,2014-02-08,15,170,NA,54,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-09-06T00:00:00Z,NA,H,2014-02-08T00:00:00Z,NA,H,15,170,156,2013-09-06,2014-02-08,12636,8424,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1148,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-06,2014-02-08,15,170,NA,54,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-09-06T00:00:00Z,NA,H,2014-02-08T00:00:00Z,NA,H,15,170,156,2013-09-06,2014-02-08,12636,8424,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1148,3,XANOMELINE,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-09,2014-02-20,171,182,MEDICATION ERROR,54,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2014-02-09T00:00:00Z,NA,H,2014-02-20T00:00:00Z,NA,H,171,182,12,2014-02-09,2014-02-20,0,648,DURD,12,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1148,3,XANOMELINE,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-09,2014-02-20,171,182,MEDICATION ERROR,54,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2014-02-09T00:00:00Z,NA,H,2014-02-20T00:00:00Z,NA,H,171,182,12,2014-02-09,2014-02-20,0,648,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1148,3,XANOMELINE,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-09,2014-02-20,171,182,MEDICATION ERROR,54,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2014-02-09T00:00:00Z,NA,H,2014-02-20T00:00:00Z,NA,H,171,182,12,2014-02-09,2014-02-20,0,648,PLDOSE,648,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1148,3,XANOMELINE,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-09,2014-02-20,171,182,MEDICATION ERROR,54,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2014-02-09T00:00:00Z,NA,H,2014-02-20T00:00:00Z,NA,H,171,182,12,2014-02-09,2014-02-20,0,648,ADJ,NA,Y,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1148,3,XANOMELINE,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-09,2014-02-20,171,182,MEDICATION ERROR,54,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2014-02-09T00:00:00Z,NA,H,2014-02-20T00:00:00Z,NA,H,171,182,12,2014-02-09,2014-02-20,0,648,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2014-02-20T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2014-02-20,NA,NA,TDURD,182,NA,OVERALL,Overall duration (days),7,>=90 days,16,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2014-02-20T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2014-02-20,NA,NA,TDOSE,13392,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2014-02-20T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2014-02-20,NA,NA,AVDDSE,73.58241758241758,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2014-02-20T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2014-02-20,NA,NA,TPDOSE,9828,NA,OVERALL,Total planned dose (mg),11,NA,19,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2014-02-20T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2014-02-20,NA,NA,TADJ,NA,Y,OVERALL,Dose adjusted during study,13,NA,20,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2014-02-20T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2014-02-20,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2014-02-20T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2014-02-20,NA,NA,TDOSINT,136.26373626373626,NA,OVERALL,Overall dose intensity (%),90,NA,22,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2014-02-20T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2014-02-20,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2014-02-20T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2014-02-20,NA,NA,PDOSE,12636,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2014-02-20T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2014-02-20,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2014-02-20T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2014-02-20,NA,NA,PAVDDSE,75.21428571428571,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2014-02-20T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2014-02-20,NA,NA,PADJ,NA,Y,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2014-02-20T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2014-02-20,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1148,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-02-20T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2014-02-20T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2014-02-20,NA,NA,PDOSINT,139.28571428571428,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1148,2013-08-23,2014-02-20,2013-08-23,2014-02-20,NA,2014-02-20T15:07,NA,NA,701,57,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-20,182,NA,2014-02-20,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-02-20,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1153,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-23,2013-10-08,1,16,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-09-23T00:00:00Z,NA,H,2013-10-08T00:00:00Z,NA,H,1,16,16,2013-09-23,2013-10-08,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1153,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-23,2013-10-08,1,16,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-09-23T00:00:00Z,NA,H,2013-10-08T00:00:00Z,NA,H,1,16,16,2013-09-23,2013-10-08,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1153,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-23,2013-10-08,1,16,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-09-23T00:00:00Z,NA,H,2013-10-08T00:00:00Z,NA,H,1,16,16,2013-09-23,2013-10-08,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1153,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-23,2013-10-08,1,16,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-09-23T00:00:00Z,NA,H,2013-10-08T00:00:00Z,NA,H,1,16,16,2013-09-23,2013-10-08,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1153,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-23,2013-10-08,1,16,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-09-23T00:00:00Z,NA,H,2013-10-08T00:00:00Z,NA,H,1,16,16,2013-09-23,2013-10-08,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1153,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-09,2014-03-11,17,170,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-10-09T00:00:00Z,NA,H,2014-03-11T00:00:00Z,NA,H,17,170,154,2013-10-09,2014-03-11,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1153,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-09,2014-03-11,17,170,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-10-09T00:00:00Z,NA,H,2014-03-11T00:00:00Z,NA,H,17,170,154,2013-10-09,2014-03-11,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1153,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-09,2014-03-11,17,170,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-10-09T00:00:00Z,NA,H,2014-03-11T00:00:00Z,NA,H,17,170,154,2013-10-09,2014-03-11,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1153,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-09,2014-03-11,17,170,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-10-09T00:00:00Z,NA,H,2014-03-11T00:00:00Z,NA,H,17,170,154,2013-10-09,2014-03-11,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1153,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-09,2014-03-11,17,170,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-10-09T00:00:00Z,NA,H,2014-03-11T00:00:00Z,NA,H,17,170,154,2013-10-09,2014-03-11,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1153,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-12,2014-03-16,171,175,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-16T00:00:00Z,NA,H,171,175,5,2014-03-12,2014-03-16,0,0,DURD,5,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1153,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-12,2014-03-16,171,175,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-16T00:00:00Z,NA,H,171,175,5,2014-03-12,2014-03-16,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1153,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-12,2014-03-16,171,175,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-16T00:00:00Z,NA,H,171,175,5,2014-03-12,2014-03-16,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1153,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-12,2014-03-16,171,175,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-16T00:00:00Z,NA,H,171,175,5,2014-03-12,2014-03-16,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1153,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-12,2014-03-16,171,175,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-16T00:00:00Z,NA,H,171,175,5,2014-03-12,2014-03-16,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-09-23T00:00:00Z,NA,NA,2014-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-09-23,2014-03-16,NA,NA,TDURD,175,NA,OVERALL,Overall duration (days),7,>=90 days,16,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-09-23T00:00:00Z,NA,NA,2014-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-09-23,2014-03-16,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-09-23T00:00:00Z,NA,NA,2014-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-09-23,2014-03-16,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-09-23T00:00:00Z,NA,NA,2014-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-09-23,2014-03-16,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-09-23T00:00:00Z,NA,NA,2014-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-09-23,2014-03-16,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-09-23T00:00:00Z,NA,NA,2014-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-09-23,2014-03-16,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-09-23T00:00:00Z,NA,NA,2014-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-09-23,2014-03-16,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-10-09T00:00:00Z,NA,NA,2014-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-10-09,2014-03-16,NA,NA,PDURD,159,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-10-09T00:00:00Z,NA,NA,2014-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-10-09,2014-03-16,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-10-09T00:00:00Z,NA,NA,2014-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-10-09,2014-03-16,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-10-09T00:00:00Z,NA,NA,2014-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-10-09,2014-03-16,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-10-09T00:00:00Z,NA,NA,2014-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-10-09,2014-03-16,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-10-09T00:00:00Z,NA,NA,2014-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-10-09,2014-03-16,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1153,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-16T23:59:59Z,2013-10-09T00:00:00Z,NA,NA,2014-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-10-09,2014-03-16,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1153,2013-09-23,2014-04-01,2013-09-23,2014-03-16,NA,2014-04-01T14:25,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-17,Placebo,Placebo,H,H,2014-03-16,175,NA,2014-04-01,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-04-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1180,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-12,2013-02-25,1,14,NA,54,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-12T00:00:00Z,NA,H,2013-02-25T00:00:00Z,NA,H,1,14,14,2013-02-12,2013-02-25,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1180,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-12,2013-02-25,1,14,NA,54,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-12T00:00:00Z,NA,H,2013-02-25T00:00:00Z,NA,H,1,14,14,2013-02-12,2013-02-25,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1180,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-12,2013-02-25,1,14,NA,54,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-12T00:00:00Z,NA,H,2013-02-25T00:00:00Z,NA,H,1,14,14,2013-02-12,2013-02-25,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1180,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-12,2013-02-25,1,14,NA,54,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-12T00:00:00Z,NA,H,2013-02-25T00:00:00Z,NA,H,1,14,14,2013-02-12,2013-02-25,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1180,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-12,2013-02-25,1,14,NA,54,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-12T00:00:00Z,NA,H,2013-02-25T00:00:00Z,NA,H,1,14,14,2013-02-12,2013-02-25,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1180,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-26,2013-03-18,15,35,NA,54,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-18T00:00:00Z,NA,H,15,35,21,2013-02-26,2013-03-18,1701,1134,DURD,21,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1180,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-26,2013-03-18,15,35,NA,54,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-18T00:00:00Z,NA,H,15,35,21,2013-02-26,2013-03-18,1701,1134,DOSE,1701,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1180,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-26,2013-03-18,15,35,NA,54,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-18T00:00:00Z,NA,H,15,35,21,2013-02-26,2013-03-18,1701,1134,PLDOSE,1134,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1180,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-26,2013-03-18,15,35,NA,54,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-18T00:00:00Z,NA,H,15,35,21,2013-02-26,2013-03-18,1701,1134,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1180,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-26,2013-03-18,15,35,NA,54,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-18T00:00:00Z,NA,H,15,35,21,2013-02-26,2013-03-18,1701,1134,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1180,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-03-18,NA,NA,TDURD,35,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1180,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-03-18,NA,NA,TDOSE,2457,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1180,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-03-18,NA,NA,AVDDSE,70.2,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1180,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-03-18,NA,NA,TPDOSE,1890,NA,OVERALL,Total planned dose (mg),11,NA,14,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1180,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-03-18,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1180,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-03-18,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1180,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-03-18,NA,NA,TDOSINT,130,NA,OVERALL,Overall dose intensity (%),90,NA,17,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1180,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-03-18,NA,NA,PDURD,21,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1180,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-03-18,NA,NA,PDOSE,1701,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1180,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-03-18,NA,NA,PPDOSE,1134,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1180,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-03-18,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1180,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-03-18,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1180,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-03-18,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1180,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-03-18T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-03-18,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1180,2013-02-12,2013-03-23,2013-02-12,2013-03-18,NA,2013-04-07,NA,NA,701,56,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-18,35,NA,2013-03-23,DISCONTINUED,NA,2013-02-12,NA,NA,NA,2013-03-23,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1181,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-05,2013-12-09,1,5,NA,54,2013-12-05,2013-12-05T00:00:00Z,2013-12-09T23:59:59Z,2013-12-05T00:00:00Z,NA,H,2013-12-09T00:00:00Z,NA,H,1,5,5,2013-12-05,2013-12-09,270,270,DURD,5,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1181,2013-12-05,2013-12-12,2013-12-05,2013-12-09,NA,2014-05-23,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-26,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-12-09,5,NA,2013-12-12,DISCONTINUED,2014-05-23,2013-12-05,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1181,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-05,2013-12-09,1,5,NA,54,2013-12-05,2013-12-05T00:00:00Z,2013-12-09T23:59:59Z,2013-12-05T00:00:00Z,NA,H,2013-12-09T00:00:00Z,NA,H,1,5,5,2013-12-05,2013-12-09,270,270,DOSE,270,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1181,2013-12-05,2013-12-12,2013-12-05,2013-12-09,NA,2014-05-23,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-26,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-12-09,5,NA,2013-12-12,DISCONTINUED,2014-05-23,2013-12-05,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1181,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-05,2013-12-09,1,5,NA,54,2013-12-05,2013-12-05T00:00:00Z,2013-12-09T23:59:59Z,2013-12-05T00:00:00Z,NA,H,2013-12-09T00:00:00Z,NA,H,1,5,5,2013-12-05,2013-12-09,270,270,PLDOSE,270,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1181,2013-12-05,2013-12-12,2013-12-05,2013-12-09,NA,2014-05-23,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-26,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-12-09,5,NA,2013-12-12,DISCONTINUED,2014-05-23,2013-12-05,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1181,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-05,2013-12-09,1,5,NA,54,2013-12-05,2013-12-05T00:00:00Z,2013-12-09T23:59:59Z,2013-12-05T00:00:00Z,NA,H,2013-12-09T00:00:00Z,NA,H,1,5,5,2013-12-05,2013-12-09,270,270,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1181,2013-12-05,2013-12-12,2013-12-05,2013-12-09,NA,2014-05-23,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-26,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-12-09,5,NA,2013-12-12,DISCONTINUED,2014-05-23,2013-12-05,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1181,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-05,2013-12-09,1,5,NA,54,2013-12-05,2013-12-05T00:00:00Z,2013-12-09T23:59:59Z,2013-12-05T00:00:00Z,NA,H,2013-12-09T00:00:00Z,NA,H,1,5,5,2013-12-05,2013-12-09,270,270,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1181,2013-12-05,2013-12-12,2013-12-05,2013-12-09,NA,2014-05-23,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-26,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-12-09,5,NA,2013-12-12,DISCONTINUED,2014-05-23,2013-12-05,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1181,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-05,2013-12-05T00:00:00Z,2013-12-09T23:59:59Z,2013-12-05T00:00:00Z,NA,NA,2013-12-09T00:00:00Z,NA,NA,NA,NA,NA,2013-12-05,2013-12-09,NA,NA,TDURD,5,NA,OVERALL,Overall duration (days),7,< 30 days,6,1181,2013-12-05,2013-12-12,2013-12-05,2013-12-09,NA,2014-05-23,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-26,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-12-09,5,NA,2013-12-12,DISCONTINUED,2014-05-23,2013-12-05,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1181,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-05,2013-12-05T00:00:00Z,2013-12-09T23:59:59Z,2013-12-05T00:00:00Z,NA,NA,2013-12-09T00:00:00Z,NA,NA,NA,NA,NA,2013-12-05,2013-12-09,NA,NA,TDOSE,270,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1181,2013-12-05,2013-12-12,2013-12-05,2013-12-09,NA,2014-05-23,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-26,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-12-09,5,NA,2013-12-12,DISCONTINUED,2014-05-23,2013-12-05,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1181,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-05,2013-12-05T00:00:00Z,2013-12-09T23:59:59Z,2013-12-05T00:00:00Z,NA,NA,2013-12-09T00:00:00Z,NA,NA,NA,NA,NA,2013-12-05,2013-12-09,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1181,2013-12-05,2013-12-12,2013-12-05,2013-12-09,NA,2014-05-23,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-26,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-12-09,5,NA,2013-12-12,DISCONTINUED,2014-05-23,2013-12-05,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1181,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-05,2013-12-05T00:00:00Z,2013-12-09T23:59:59Z,2013-12-05T00:00:00Z,NA,NA,2013-12-09T00:00:00Z,NA,NA,NA,NA,NA,2013-12-05,2013-12-09,NA,NA,TPDOSE,270,NA,OVERALL,Total planned dose (mg),11,NA,9,1181,2013-12-05,2013-12-12,2013-12-05,2013-12-09,NA,2014-05-23,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-26,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-12-09,5,NA,2013-12-12,DISCONTINUED,2014-05-23,2013-12-05,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1181,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-05,2013-12-05T00:00:00Z,2013-12-09T23:59:59Z,2013-12-05T00:00:00Z,NA,NA,2013-12-09T00:00:00Z,NA,NA,NA,NA,NA,2013-12-05,2013-12-09,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1181,2013-12-05,2013-12-12,2013-12-05,2013-12-09,NA,2014-05-23,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-26,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-12-09,5,NA,2013-12-12,DISCONTINUED,2014-05-23,2013-12-05,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1181,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-05,2013-12-05T00:00:00Z,2013-12-09T23:59:59Z,2013-12-05T00:00:00Z,NA,NA,2013-12-09T00:00:00Z,NA,NA,NA,NA,NA,2013-12-05,2013-12-09,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1181,2013-12-05,2013-12-12,2013-12-05,2013-12-09,NA,2014-05-23,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-26,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-12-09,5,NA,2013-12-12,DISCONTINUED,2014-05-23,2013-12-05,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1181,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-05,2013-12-05T00:00:00Z,2013-12-09T23:59:59Z,2013-12-05T00:00:00Z,NA,NA,2013-12-09T00:00:00Z,NA,NA,NA,NA,NA,2013-12-05,2013-12-09,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1181,2013-12-05,2013-12-12,2013-12-05,2013-12-09,NA,2014-05-23,NA,NA,701,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-26,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-12-09,5,NA,2013-12-12,DISCONTINUED,2014-05-23,2013-12-05,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1188,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-15,2013-03-02,1,16,NA,54,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-02-15T00:00:00Z,NA,H,2013-03-02T00:00:00Z,NA,H,1,16,16,2013-02-15,2013-03-02,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1188,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-15,2013-03-02,1,16,NA,54,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-02-15T00:00:00Z,NA,H,2013-03-02T00:00:00Z,NA,H,1,16,16,2013-02-15,2013-03-02,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1188,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-15,2013-03-02,1,16,NA,54,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-02-15T00:00:00Z,NA,H,2013-03-02T00:00:00Z,NA,H,1,16,16,2013-02-15,2013-03-02,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1188,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-15,2013-03-02,1,16,NA,54,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-02-15T00:00:00Z,NA,H,2013-03-02T00:00:00Z,NA,H,1,16,16,2013-02-15,2013-03-02,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1188,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-15,2013-03-02,1,16,NA,54,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-02-15T00:00:00Z,NA,H,2013-03-02T00:00:00Z,NA,H,1,16,16,2013-02-15,2013-03-02,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1188,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-03,2013-03-24,17,38,NA,54,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-03-03T00:00:00Z,NA,H,2013-03-24T00:00:00Z,NA,H,17,38,22,2013-03-03,2013-03-24,1188,1188,DURD,22,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1188,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-03,2013-03-24,17,38,NA,54,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-03-03T00:00:00Z,NA,H,2013-03-24T00:00:00Z,NA,H,17,38,22,2013-03-03,2013-03-24,1188,1188,DOSE,1188,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1188,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-03,2013-03-24,17,38,NA,54,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-03-03T00:00:00Z,NA,H,2013-03-24T00:00:00Z,NA,H,17,38,22,2013-03-03,2013-03-24,1188,1188,PLDOSE,1188,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1188,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-03,2013-03-24,17,38,NA,54,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-03-03T00:00:00Z,NA,H,2013-03-24T00:00:00Z,NA,H,17,38,22,2013-03-03,2013-03-24,1188,1188,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1188,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-03,2013-03-24,17,38,NA,54,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-03-03T00:00:00Z,NA,H,2013-03-24T00:00:00Z,NA,H,17,38,22,2013-03-03,2013-03-24,1188,1188,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-02-15T00:00:00Z,NA,NA,2013-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-02-15,2013-03-24,NA,NA,TDURD,38,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-02-15T00:00:00Z,NA,NA,2013-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-02-15,2013-03-24,NA,NA,TDOSE,2052,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-02-15T00:00:00Z,NA,NA,2013-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-02-15,2013-03-24,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-02-15T00:00:00Z,NA,NA,2013-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-02-15,2013-03-24,NA,NA,TPDOSE,2052,NA,OVERALL,Total planned dose (mg),11,NA,14,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-02-15T00:00:00Z,NA,NA,2013-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-02-15,2013-03-24,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-02-15T00:00:00Z,NA,NA,2013-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-02-15,2013-03-24,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-02-15T00:00:00Z,NA,NA,2013-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-02-15,2013-03-24,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-03-03T00:00:00Z,NA,NA,2013-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-03-03,2013-03-24,NA,NA,PDURD,22,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-03-03T00:00:00Z,NA,NA,2013-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-03-03,2013-03-24,NA,NA,PDOSE,1188,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-03-03T00:00:00Z,NA,NA,2013-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-03-03,2013-03-24,NA,NA,PPDOSE,1188,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-03-03T00:00:00Z,NA,NA,2013-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-03-03,2013-03-24,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-03-03T00:00:00Z,NA,NA,2013-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-03-03,2013-03-24,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-03-03T00:00:00Z,NA,NA,2013-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-03-03,2013-03-24,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1188,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-15,2013-02-15T00:00:00Z,2013-03-24T23:59:59Z,2013-03-03T00:00:00Z,NA,NA,2013-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-03-03,2013-03-24,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1188,2013-02-15,2013-03-25,2013-02-15,2013-03-24,NA,2013-08-04,NA,NA,701,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-24,38,NA,2013-03-25,DISCONTINUED,2013-08-04,2013-02-15,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1192,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-22,2012-08-07,1,17,NA,54,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-07-22T00:00:00Z,NA,H,2012-08-07T00:00:00Z,NA,H,1,17,17,2012-07-22,2012-08-07,918,918,DURD,17,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1192,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-22,2012-08-07,1,17,NA,54,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-07-22T00:00:00Z,NA,H,2012-08-07T00:00:00Z,NA,H,1,17,17,2012-07-22,2012-08-07,918,918,DOSE,918,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1192,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-22,2012-08-07,1,17,NA,54,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-07-22T00:00:00Z,NA,H,2012-08-07T00:00:00Z,NA,H,1,17,17,2012-07-22,2012-08-07,918,918,PLDOSE,918,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1192,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-22,2012-08-07,1,17,NA,54,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-07-22T00:00:00Z,NA,H,2012-08-07T00:00:00Z,NA,H,1,17,17,2012-07-22,2012-08-07,918,918,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1192,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-22,2012-08-07,1,17,NA,54,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-07-22T00:00:00Z,NA,H,2012-08-07T00:00:00Z,NA,H,1,17,17,2012-07-22,2012-08-07,918,918,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1192,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-08,2013-01-11,18,174,NA,54,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-08-08T00:00:00Z,NA,H,2013-01-11T00:00:00Z,NA,H,18,174,157,2012-08-08,2013-01-11,8478,8478,DURD,157,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1192,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-08,2013-01-11,18,174,NA,54,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-08-08T00:00:00Z,NA,H,2013-01-11T00:00:00Z,NA,H,18,174,157,2012-08-08,2013-01-11,8478,8478,DOSE,8478,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1192,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-08,2013-01-11,18,174,NA,54,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-08-08T00:00:00Z,NA,H,2013-01-11T00:00:00Z,NA,H,18,174,157,2012-08-08,2013-01-11,8478,8478,PLDOSE,8478,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1192,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-08,2013-01-11,18,174,NA,54,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-08-08T00:00:00Z,NA,H,2013-01-11T00:00:00Z,NA,H,18,174,157,2012-08-08,2013-01-11,8478,8478,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1192,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-08,2013-01-11,18,174,NA,54,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-08-08T00:00:00Z,NA,H,2013-01-11T00:00:00Z,NA,H,18,174,157,2012-08-08,2013-01-11,8478,8478,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1192,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-01-12,2013-01-20,175,183,NA,54,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2013-01-12T00:00:00Z,NA,H,2013-01-20T00:00:00Z,NA,H,175,183,9,2013-01-12,2013-01-20,486,486,DURD,9,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1192,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-01-12,2013-01-20,175,183,NA,54,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2013-01-12T00:00:00Z,NA,H,2013-01-20T00:00:00Z,NA,H,175,183,9,2013-01-12,2013-01-20,486,486,DOSE,486,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1192,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-01-12,2013-01-20,175,183,NA,54,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2013-01-12T00:00:00Z,NA,H,2013-01-20T00:00:00Z,NA,H,175,183,9,2013-01-12,2013-01-20,486,486,PLDOSE,486,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1192,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-01-12,2013-01-20,175,183,NA,54,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2013-01-12T00:00:00Z,NA,H,2013-01-20T00:00:00Z,NA,H,175,183,9,2013-01-12,2013-01-20,486,486,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1192,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-01-12,2013-01-20,175,183,NA,54,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2013-01-12T00:00:00Z,NA,H,2013-01-20T00:00:00Z,NA,H,175,183,9,2013-01-12,2013-01-20,486,486,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-07-22T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-22,2013-01-20,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-07-22T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-22,2013-01-20,NA,NA,TDOSE,9882,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-07-22T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-22,2013-01-20,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-07-22T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-22,2013-01-20,NA,NA,TPDOSE,9882,NA,OVERALL,Total planned dose (mg),11,NA,19,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-07-22T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-22,2013-01-20,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-07-22T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-22,2013-01-20,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-07-22T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-22,2013-01-20,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-08-08T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-08-08,2013-01-20,NA,NA,PDURD,166,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-08-08T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-08-08,2013-01-20,NA,NA,PDOSE,8964,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-08-08T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-08-08,2013-01-20,NA,NA,PPDOSE,8964,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-08-08T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-08-08,2013-01-20,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-08-08T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-08-08,2013-01-20,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-08-08T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-08-08,2013-01-20,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1192,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-22,2012-07-22T00:00:00Z,2013-01-20T23:59:59Z,2012-08-08T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-08-08,2013-01-20,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1192,2012-07-22,2013-01-20,2012-07-22,2013-01-20,NA,2013-01-20T15:47,NA,NA,701,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-08,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-20,183,NA,2013-01-20,COMPLETED,NA,2012-07-22,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1203,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-02,2013-02-23,1,22,NA,0,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-02T00:00:00Z,NA,H,2013-02-23T00:00:00Z,NA,H,1,22,22,2013-02-02,2013-02-23,0,0,DURD,22,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1203,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-02,2013-02-23,1,22,NA,0,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-02T00:00:00Z,NA,H,2013-02-23T00:00:00Z,NA,H,1,22,22,2013-02-02,2013-02-23,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1203,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-02,2013-02-23,1,22,NA,0,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-02T00:00:00Z,NA,H,2013-02-23T00:00:00Z,NA,H,1,22,22,2013-02-02,2013-02-23,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1203,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-02,2013-02-23,1,22,NA,0,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-02T00:00:00Z,NA,H,2013-02-23T00:00:00Z,NA,H,1,22,22,2013-02-02,2013-02-23,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1203,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-02,2013-02-23,1,22,NA,0,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-02T00:00:00Z,NA,H,2013-02-23T00:00:00Z,NA,H,1,22,22,2013-02-02,2013-02-23,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1203,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-24,2013-07-22,23,171,NA,0,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-24T00:00:00Z,NA,H,2013-07-22T00:00:00Z,NA,H,23,171,149,2013-02-24,2013-07-22,0,0,DURD,149,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1203,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-24,2013-07-22,23,171,NA,0,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-24T00:00:00Z,NA,H,2013-07-22T00:00:00Z,NA,H,23,171,149,2013-02-24,2013-07-22,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1203,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-24,2013-07-22,23,171,NA,0,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-24T00:00:00Z,NA,H,2013-07-22T00:00:00Z,NA,H,23,171,149,2013-02-24,2013-07-22,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1203,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-24,2013-07-22,23,171,NA,0,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-24T00:00:00Z,NA,H,2013-07-22T00:00:00Z,NA,H,23,171,149,2013-02-24,2013-07-22,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1203,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-24,2013-07-22,23,171,NA,0,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-24T00:00:00Z,NA,H,2013-07-22T00:00:00Z,NA,H,23,171,149,2013-02-24,2013-07-22,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1203,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-23,2013-08-03,172,183,NA,0,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-07-23T00:00:00Z,NA,H,2013-08-03T00:00:00Z,NA,H,172,183,12,2013-07-23,2013-08-03,0,0,DURD,12,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1203,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-23,2013-08-03,172,183,NA,0,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-07-23T00:00:00Z,NA,H,2013-08-03T00:00:00Z,NA,H,172,183,12,2013-07-23,2013-08-03,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1203,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-23,2013-08-03,172,183,NA,0,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-07-23T00:00:00Z,NA,H,2013-08-03T00:00:00Z,NA,H,172,183,12,2013-07-23,2013-08-03,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1203,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-23,2013-08-03,172,183,NA,0,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-07-23T00:00:00Z,NA,H,2013-08-03T00:00:00Z,NA,H,172,183,12,2013-07-23,2013-08-03,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1203,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-23,2013-08-03,172,183,NA,0,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-07-23T00:00:00Z,NA,H,2013-08-03T00:00:00Z,NA,H,172,183,12,2013-07-23,2013-08-03,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-02T00:00:00Z,NA,NA,2013-08-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-02,2013-08-03,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-02T00:00:00Z,NA,NA,2013-08-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-02,2013-08-03,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-02T00:00:00Z,NA,NA,2013-08-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-02,2013-08-03,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-02T00:00:00Z,NA,NA,2013-08-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-02,2013-08-03,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-02T00:00:00Z,NA,NA,2013-08-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-02,2013-08-03,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-02T00:00:00Z,NA,NA,2013-08-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-02,2013-08-03,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-02T00:00:00Z,NA,NA,2013-08-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-02,2013-08-03,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-24T00:00:00Z,NA,NA,2013-08-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-24,2013-08-03,NA,NA,PDURD,161,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-24T00:00:00Z,NA,NA,2013-08-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-24,2013-08-03,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-24T00:00:00Z,NA,NA,2013-08-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-24,2013-08-03,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-24T00:00:00Z,NA,NA,2013-08-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-24,2013-08-03,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-24T00:00:00Z,NA,NA,2013-08-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-24,2013-08-03,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-24T00:00:00Z,NA,NA,2013-08-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-24,2013-08-03,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1203,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-02,2013-02-02T00:00:00Z,2013-08-03T23:59:59Z,2013-02-24T00:00:00Z,NA,NA,2013-08-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-24,2013-08-03,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1203,2013-02-02,2013-08-03,2013-02-02,2013-08-03,NA,2013-08-03T10:10,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-25,-8,Placebo,Placebo,H,H,2013-08-03,183,NA,2013-08-03,COMPLETED,NA,2013-02-02,NA,NA,NA,2013-08-03,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1211,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-15,2012-11-28,1,14,NA,54,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-15T00:00:00Z,NA,H,2012-11-28T00:00:00Z,NA,H,1,14,14,2012-11-15,2012-11-28,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-701-1211,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-15,2012-11-28,1,14,NA,54,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-15T00:00:00Z,NA,H,2012-11-28T00:00:00Z,NA,H,1,14,14,2012-11-15,2012-11-28,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-701-1211,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-15,2012-11-28,1,14,NA,54,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-15T00:00:00Z,NA,H,2012-11-28T00:00:00Z,NA,H,1,14,14,2012-11-15,2012-11-28,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-701-1211,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-15,2012-11-28,1,14,NA,54,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-15T00:00:00Z,NA,H,2012-11-28T00:00:00Z,NA,H,1,14,14,2012-11-15,2012-11-28,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-701-1211,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-15,2012-11-28,1,14,NA,54,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-15T00:00:00Z,NA,H,2012-11-28T00:00:00Z,NA,H,1,14,14,2012-11-15,2012-11-28,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-701-1211,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-29,2013-01-12,15,59,NA,54,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-29T00:00:00Z,NA,H,2013-01-12T00:00:00Z,NA,H,15,59,45,2012-11-29,2013-01-12,2430,2430,DURD,45,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-701-1211,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-29,2013-01-12,15,59,NA,54,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-29T00:00:00Z,NA,H,2013-01-12T00:00:00Z,NA,H,15,59,45,2012-11-29,2013-01-12,2430,2430,DOSE,2430,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-701-1211,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-29,2013-01-12,15,59,NA,54,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-29T00:00:00Z,NA,H,2013-01-12T00:00:00Z,NA,H,15,59,45,2012-11-29,2013-01-12,2430,2430,PLDOSE,2430,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-701-1211,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-29,2013-01-12,15,59,NA,54,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-29T00:00:00Z,NA,H,2013-01-12T00:00:00Z,NA,H,15,59,45,2012-11-29,2013-01-12,2430,2430,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-701-1211,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-29,2013-01-12,15,59,NA,54,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-29T00:00:00Z,NA,H,2013-01-12T00:00:00Z,NA,H,15,59,45,2012-11-29,2013-01-12,2430,2430,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-701-1211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-15T00:00:00Z,NA,NA,2013-01-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-15,2013-01-12,NA,NA,TDURD,59,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-701-1211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-15T00:00:00Z,NA,NA,2013-01-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-15,2013-01-12,NA,NA,TDOSE,3186,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-701-1211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-15T00:00:00Z,NA,NA,2013-01-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-15,2013-01-12,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-701-1211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-15T00:00:00Z,NA,NA,2013-01-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-15,2013-01-12,NA,NA,TPDOSE,3186,NA,OVERALL,Total planned dose (mg),11,NA,14,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-701-1211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-15T00:00:00Z,NA,NA,2013-01-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-15,2013-01-12,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-701-1211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-15T00:00:00Z,NA,NA,2013-01-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-15,2013-01-12,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-701-1211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-15T00:00:00Z,NA,NA,2013-01-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-15,2013-01-12,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-701-1211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-29T00:00:00Z,NA,NA,2013-01-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-29,2013-01-12,NA,NA,PDURD,45,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-701-1211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-29T00:00:00Z,NA,NA,2013-01-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-29,2013-01-12,NA,NA,PDOSE,2430,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-701-1211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-29T00:00:00Z,NA,NA,2013-01-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-29,2013-01-12,NA,NA,PPDOSE,2430,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-701-1211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-29T00:00:00Z,NA,NA,2013-01-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-29,2013-01-12,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-701-1211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-29T00:00:00Z,NA,NA,2013-01-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-29,2013-01-12,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-701-1211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-29T00:00:00Z,NA,NA,2013-01-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-29,2013-01-12,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-701-1211,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-15,2012-11-15T00:00:00Z,2013-01-12T23:59:59Z,2012-11-29T00:00:00Z,NA,NA,2013-01-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-29,2013-01-12,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1211,2012-11-15,2013-01-14,2012-11-15,2013-01-12,NA,2013-01-14,2013-01-14,Y,701,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-30,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-12,59,NA,2013-01-14,DISCONTINUED,NA,2012-11-15,2013-01-14,61,2,2013-01-14,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-701-1234,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-30,2013-04-21,1,23,NA,0,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-03-30T00:00:00Z,NA,H,2013-04-21T00:00:00Z,NA,H,1,23,23,2013-03-30,2013-04-21,0,0,DURD,23,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1234,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-30,2013-04-21,1,23,NA,0,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-03-30T00:00:00Z,NA,H,2013-04-21T00:00:00Z,NA,H,1,23,23,2013-03-30,2013-04-21,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1234,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-30,2013-04-21,1,23,NA,0,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-03-30T00:00:00Z,NA,H,2013-04-21T00:00:00Z,NA,H,1,23,23,2013-03-30,2013-04-21,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1234,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-30,2013-04-21,1,23,NA,0,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-03-30T00:00:00Z,NA,H,2013-04-21T00:00:00Z,NA,H,1,23,23,2013-03-30,2013-04-21,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1234,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-30,2013-04-21,1,23,NA,0,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-03-30T00:00:00Z,NA,H,2013-04-21T00:00:00Z,NA,H,1,23,23,2013-03-30,2013-04-21,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1234,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-22,2013-09-10,24,165,NA,0,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-04-22T00:00:00Z,NA,H,2013-09-10T00:00:00Z,NA,H,24,165,142,2013-04-22,2013-09-10,0,0,DURD,142,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1234,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-22,2013-09-10,24,165,NA,0,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-04-22T00:00:00Z,NA,H,2013-09-10T00:00:00Z,NA,H,24,165,142,2013-04-22,2013-09-10,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1234,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-22,2013-09-10,24,165,NA,0,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-04-22T00:00:00Z,NA,H,2013-09-10T00:00:00Z,NA,H,24,165,142,2013-04-22,2013-09-10,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1234,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-22,2013-09-10,24,165,NA,0,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-04-22T00:00:00Z,NA,H,2013-09-10T00:00:00Z,NA,H,24,165,142,2013-04-22,2013-09-10,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1234,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-22,2013-09-10,24,165,NA,0,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-04-22T00:00:00Z,NA,H,2013-09-10T00:00:00Z,NA,H,24,165,142,2013-04-22,2013-09-10,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1234,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-11,2013-09-22,166,177,NA,0,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-09-11T00:00:00Z,NA,H,2013-09-22T00:00:00Z,NA,H,166,177,12,2013-09-11,2013-09-22,0,0,DURD,12,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1234,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-11,2013-09-22,166,177,NA,0,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-09-11T00:00:00Z,NA,H,2013-09-22T00:00:00Z,NA,H,166,177,12,2013-09-11,2013-09-22,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1234,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-11,2013-09-22,166,177,NA,0,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-09-11T00:00:00Z,NA,H,2013-09-22T00:00:00Z,NA,H,166,177,12,2013-09-11,2013-09-22,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1234,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-11,2013-09-22,166,177,NA,0,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-09-11T00:00:00Z,NA,H,2013-09-22T00:00:00Z,NA,H,166,177,12,2013-09-11,2013-09-22,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1234,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-11,2013-09-22,166,177,NA,0,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-09-11T00:00:00Z,NA,H,2013-09-22T00:00:00Z,NA,H,166,177,12,2013-09-11,2013-09-22,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-03-30T00:00:00Z,NA,NA,2013-09-22T00:00:00Z,NA,NA,NA,NA,NA,2013-03-30,2013-09-22,NA,NA,TDURD,177,NA,OVERALL,Overall duration (days),7,>=90 days,16,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-03-30T00:00:00Z,NA,NA,2013-09-22T00:00:00Z,NA,NA,NA,NA,NA,2013-03-30,2013-09-22,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-03-30T00:00:00Z,NA,NA,2013-09-22T00:00:00Z,NA,NA,NA,NA,NA,2013-03-30,2013-09-22,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-03-30T00:00:00Z,NA,NA,2013-09-22T00:00:00Z,NA,NA,NA,NA,NA,2013-03-30,2013-09-22,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-03-30T00:00:00Z,NA,NA,2013-09-22T00:00:00Z,NA,NA,NA,NA,NA,2013-03-30,2013-09-22,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-03-30T00:00:00Z,NA,NA,2013-09-22T00:00:00Z,NA,NA,NA,NA,NA,2013-03-30,2013-09-22,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-03-30T00:00:00Z,NA,NA,2013-09-22T00:00:00Z,NA,NA,NA,NA,NA,2013-03-30,2013-09-22,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-04-22T00:00:00Z,NA,NA,2013-09-22T00:00:00Z,NA,NA,NA,NA,NA,2013-04-22,2013-09-22,NA,NA,PDURD,154,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-04-22T00:00:00Z,NA,NA,2013-09-22T00:00:00Z,NA,NA,NA,NA,NA,2013-04-22,2013-09-22,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-04-22T00:00:00Z,NA,NA,2013-09-22T00:00:00Z,NA,NA,NA,NA,NA,2013-04-22,2013-09-22,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-04-22T00:00:00Z,NA,NA,2013-09-22T00:00:00Z,NA,NA,NA,NA,NA,2013-04-22,2013-09-22,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-04-22T00:00:00Z,NA,NA,2013-09-22T00:00:00Z,NA,NA,NA,NA,NA,2013-04-22,2013-09-22,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-04-22T00:00:00Z,NA,NA,2013-09-22T00:00:00Z,NA,NA,NA,NA,NA,2013-04-22,2013-09-22,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1234,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-30,2013-03-30T00:00:00Z,2013-09-22T23:59:59Z,2013-04-22T00:00:00Z,NA,NA,2013-09-22T00:00:00Z,NA,NA,NA,NA,NA,2013-04-22,2013-09-22,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1234,2013-03-30,2013-09-22,2013-03-30,2013-09-22,NA,2013-09-22T09:25,NA,NA,701,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-10,Placebo,Placebo,H,H,2013-09-22,177,NA,2013-09-22,COMPLETED,NA,2013-03-30,NA,NA,NA,2013-09-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1239,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-11,2014-01-25,1,15,NA,54,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-11T00:00:00Z,NA,H,2014-01-25T00:00:00Z,NA,H,1,15,15,2014-01-11,2014-01-25,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1239,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-11,2014-01-25,1,15,NA,54,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-11T00:00:00Z,NA,H,2014-01-25T00:00:00Z,NA,H,1,15,15,2014-01-11,2014-01-25,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1239,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-11,2014-01-25,1,15,NA,54,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-11T00:00:00Z,NA,H,2014-01-25T00:00:00Z,NA,H,1,15,15,2014-01-11,2014-01-25,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1239,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-11,2014-01-25,1,15,NA,54,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-11T00:00:00Z,NA,H,2014-01-25T00:00:00Z,NA,H,1,15,15,2014-01-11,2014-01-25,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1239,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-11,2014-01-25,1,15,NA,54,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-11T00:00:00Z,NA,H,2014-01-25T00:00:00Z,NA,H,1,15,15,2014-01-11,2014-01-25,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1239,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-26,2014-06-27,16,168,NA,54,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-26T00:00:00Z,NA,H,2014-06-27T00:00:00Z,NA,H,16,168,153,2014-01-26,2014-06-27,12393,8262,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1239,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-26,2014-06-27,16,168,NA,54,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-26T00:00:00Z,NA,H,2014-06-27T00:00:00Z,NA,H,16,168,153,2014-01-26,2014-06-27,12393,8262,DOSE,12393,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1239,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-26,2014-06-27,16,168,NA,54,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-26T00:00:00Z,NA,H,2014-06-27T00:00:00Z,NA,H,16,168,153,2014-01-26,2014-06-27,12393,8262,PLDOSE,8262,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1239,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-26,2014-06-27,16,168,NA,54,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-26T00:00:00Z,NA,H,2014-06-27T00:00:00Z,NA,H,16,168,153,2014-01-26,2014-06-27,12393,8262,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1239,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-26,2014-06-27,16,168,NA,54,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-26T00:00:00Z,NA,H,2014-06-27T00:00:00Z,NA,H,16,168,153,2014-01-26,2014-06-27,12393,8262,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1239,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-28,2014-07-10,169,181,NA,54,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-06-28T00:00:00Z,NA,H,2014-07-10T00:00:00Z,NA,H,169,181,13,2014-06-28,2014-07-10,702,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1239,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-28,2014-07-10,169,181,NA,54,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-06-28T00:00:00Z,NA,H,2014-07-10T00:00:00Z,NA,H,169,181,13,2014-06-28,2014-07-10,702,702,DOSE,702,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1239,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-28,2014-07-10,169,181,NA,54,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-06-28T00:00:00Z,NA,H,2014-07-10T00:00:00Z,NA,H,169,181,13,2014-06-28,2014-07-10,702,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1239,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-28,2014-07-10,169,181,NA,54,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-06-28T00:00:00Z,NA,H,2014-07-10T00:00:00Z,NA,H,169,181,13,2014-06-28,2014-07-10,702,702,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1239,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-28,2014-07-10,169,181,NA,54,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-06-28T00:00:00Z,NA,H,2014-07-10T00:00:00Z,NA,H,169,181,13,2014-06-28,2014-07-10,702,702,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-11T00:00:00Z,NA,NA,2014-07-10T00:00:00Z,NA,NA,NA,NA,NA,2014-01-11,2014-07-10,NA,NA,TDURD,181,NA,OVERALL,Overall duration (days),7,>=90 days,16,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-11T00:00:00Z,NA,NA,2014-07-10T00:00:00Z,NA,NA,NA,NA,NA,2014-01-11,2014-07-10,NA,NA,TDOSE,13905,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-11T00:00:00Z,NA,NA,2014-07-10T00:00:00Z,NA,NA,NA,NA,NA,2014-01-11,2014-07-10,NA,NA,AVDDSE,76.8232044198895,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-11T00:00:00Z,NA,NA,2014-07-10T00:00:00Z,NA,NA,NA,NA,NA,2014-01-11,2014-07-10,NA,NA,TPDOSE,9774,NA,OVERALL,Total planned dose (mg),11,NA,19,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-11T00:00:00Z,NA,NA,2014-07-10T00:00:00Z,NA,NA,NA,NA,NA,2014-01-11,2014-07-10,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-11T00:00:00Z,NA,NA,2014-07-10T00:00:00Z,NA,NA,NA,NA,NA,2014-01-11,2014-07-10,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-11T00:00:00Z,NA,NA,2014-07-10T00:00:00Z,NA,NA,NA,NA,NA,2014-01-11,2014-07-10,NA,NA,TDOSINT,142.26519337016575,NA,OVERALL,Overall dose intensity (%),90,NA,22,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-26T00:00:00Z,NA,NA,2014-07-10T00:00:00Z,NA,NA,NA,NA,NA,2014-01-26,2014-07-10,NA,NA,PDURD,166,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-26T00:00:00Z,NA,NA,2014-07-10T00:00:00Z,NA,NA,NA,NA,NA,2014-01-26,2014-07-10,NA,NA,PDOSE,13095,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-26T00:00:00Z,NA,NA,2014-07-10T00:00:00Z,NA,NA,NA,NA,NA,2014-01-26,2014-07-10,NA,NA,PPDOSE,8964,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-26T00:00:00Z,NA,NA,2014-07-10T00:00:00Z,NA,NA,NA,NA,NA,2014-01-26,2014-07-10,NA,NA,PAVDDSE,78.8855421686747,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-26T00:00:00Z,NA,NA,2014-07-10T00:00:00Z,NA,NA,NA,NA,NA,2014-01-26,2014-07-10,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-26T00:00:00Z,NA,NA,2014-07-10T00:00:00Z,NA,NA,NA,NA,NA,2014-01-26,2014-07-10,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1239,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-07-10T23:59:59Z,2014-01-26T00:00:00Z,NA,NA,2014-07-10T00:00:00Z,NA,NA,NA,NA,NA,2014-01-26,2014-07-10,NA,NA,PDOSINT,146.08433734939757,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1239,2014-01-11,2014-07-11,2014-01-11,2014-07-10,NA,2014-07-11T15:40,NA,NA,701,56,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-28,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-10,181,NA,2014-07-11,COMPLETED,NA,2014-01-11,NA,NA,NA,2014-07-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1275,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-07,2014-02-22,1,16,NA,54,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-07T00:00:00Z,NA,H,2014-02-22T00:00:00Z,NA,H,1,16,16,2014-02-07,2014-02-22,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1275,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-07,2014-02-22,1,16,NA,54,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-07T00:00:00Z,NA,H,2014-02-22T00:00:00Z,NA,H,1,16,16,2014-02-07,2014-02-22,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1275,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-07,2014-02-22,1,16,NA,54,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-07T00:00:00Z,NA,H,2014-02-22T00:00:00Z,NA,H,1,16,16,2014-02-07,2014-02-22,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1275,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-07,2014-02-22,1,16,NA,54,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-07T00:00:00Z,NA,H,2014-02-22T00:00:00Z,NA,H,1,16,16,2014-02-07,2014-02-22,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1275,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-07,2014-02-22,1,16,NA,54,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-07T00:00:00Z,NA,H,2014-02-22T00:00:00Z,NA,H,1,16,16,2014-02-07,2014-02-22,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1275,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-23,2014-05-31,17,114,NA,54,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-23T00:00:00Z,NA,H,2014-05-31T00:00:00Z,NA,H,17,114,98,2014-02-23,2014-05-31,7938,5292,DURD,98,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1275,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-23,2014-05-31,17,114,NA,54,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-23T00:00:00Z,NA,H,2014-05-31T00:00:00Z,NA,H,17,114,98,2014-02-23,2014-05-31,7938,5292,DOSE,7938,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1275,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-23,2014-05-31,17,114,NA,54,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-23T00:00:00Z,NA,H,2014-05-31T00:00:00Z,NA,H,17,114,98,2014-02-23,2014-05-31,7938,5292,PLDOSE,5292,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1275,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-23,2014-05-31,17,114,NA,54,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-23T00:00:00Z,NA,H,2014-05-31T00:00:00Z,NA,H,17,114,98,2014-02-23,2014-05-31,7938,5292,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1275,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-23,2014-05-31,17,114,NA,54,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-23T00:00:00Z,NA,H,2014-05-31T00:00:00Z,NA,H,17,114,98,2014-02-23,2014-05-31,7938,5292,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-07T00:00:00Z,NA,NA,2014-05-31T00:00:00Z,NA,NA,NA,NA,NA,2014-02-07,2014-05-31,NA,NA,TDURD,114,NA,OVERALL,Overall duration (days),7,>=90 days,11,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-07T00:00:00Z,NA,NA,2014-05-31T00:00:00Z,NA,NA,NA,NA,NA,2014-02-07,2014-05-31,NA,NA,TDOSE,8802,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-07T00:00:00Z,NA,NA,2014-05-31T00:00:00Z,NA,NA,NA,NA,NA,2014-02-07,2014-05-31,NA,NA,AVDDSE,77.21052631578948,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-07T00:00:00Z,NA,NA,2014-05-31T00:00:00Z,NA,NA,NA,NA,NA,2014-02-07,2014-05-31,NA,NA,TPDOSE,6156,NA,OVERALL,Total planned dose (mg),11,NA,14,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-07T00:00:00Z,NA,NA,2014-05-31T00:00:00Z,NA,NA,NA,NA,NA,2014-02-07,2014-05-31,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-07T00:00:00Z,NA,NA,2014-05-31T00:00:00Z,NA,NA,NA,NA,NA,2014-02-07,2014-05-31,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-07T00:00:00Z,NA,NA,2014-05-31T00:00:00Z,NA,NA,NA,NA,NA,2014-02-07,2014-05-31,NA,NA,TDOSINT,142.98245614035088,NA,OVERALL,Overall dose intensity (%),90,NA,17,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-23T00:00:00Z,NA,NA,2014-05-31T00:00:00Z,NA,NA,NA,NA,NA,2014-02-23,2014-05-31,NA,NA,PDURD,98,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-23T00:00:00Z,NA,NA,2014-05-31T00:00:00Z,NA,NA,NA,NA,NA,2014-02-23,2014-05-31,NA,NA,PDOSE,7938,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-23T00:00:00Z,NA,NA,2014-05-31T00:00:00Z,NA,NA,NA,NA,NA,2014-02-23,2014-05-31,NA,NA,PPDOSE,5292,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-23T00:00:00Z,NA,NA,2014-05-31T00:00:00Z,NA,NA,NA,NA,NA,2014-02-23,2014-05-31,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-23T00:00:00Z,NA,NA,2014-05-31T00:00:00Z,NA,NA,NA,NA,NA,2014-02-23,2014-05-31,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-23T00:00:00Z,NA,NA,2014-05-31T00:00:00Z,NA,NA,NA,NA,NA,2014-02-23,2014-05-31,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1275,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-07,2014-02-07T00:00:00Z,2014-05-31T23:59:59Z,2014-02-23T00:00:00Z,NA,NA,2014-05-31T00:00:00Z,NA,NA,NA,NA,NA,2014-02-23,2014-05-31,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1275,2014-02-07,2014-06-14,2014-02-07,2014-05-31,NA,2014-06-14T12:35,NA,NA,701,61,YEARS,M,AMERICAN INDIAN OR ALASKA NATIVE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-25,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-31,114,NA,2014-06-14,DISCONTINUED,NA,2014-02-07,NA,NA,NA,2014-06-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1287,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-25,2014-02-11,1,18,NA,54,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-01-25T00:00:00Z,NA,H,2014-02-11T00:00:00Z,NA,H,1,18,18,2014-01-25,2014-02-11,972,972,DURD,18,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1287,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-25,2014-02-11,1,18,NA,54,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-01-25T00:00:00Z,NA,H,2014-02-11T00:00:00Z,NA,H,1,18,18,2014-01-25,2014-02-11,972,972,DOSE,972,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1287,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-25,2014-02-11,1,18,NA,54,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-01-25T00:00:00Z,NA,H,2014-02-11T00:00:00Z,NA,H,1,18,18,2014-01-25,2014-02-11,972,972,PLDOSE,972,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1287,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-25,2014-02-11,1,18,NA,54,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-01-25T00:00:00Z,NA,H,2014-02-11T00:00:00Z,NA,H,1,18,18,2014-01-25,2014-02-11,972,972,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1287,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-25,2014-02-11,1,18,NA,54,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-01-25T00:00:00Z,NA,H,2014-02-11T00:00:00Z,NA,H,1,18,18,2014-01-25,2014-02-11,972,972,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1287,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-12,2014-07-12,19,169,NA,54,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-02-12T00:00:00Z,NA,H,2014-07-12T00:00:00Z,NA,H,19,169,151,2014-02-12,2014-07-12,12231,8154,DURD,151,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1287,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-12,2014-07-12,19,169,NA,54,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-02-12T00:00:00Z,NA,H,2014-07-12T00:00:00Z,NA,H,19,169,151,2014-02-12,2014-07-12,12231,8154,DOSE,12231,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1287,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-12,2014-07-12,19,169,NA,54,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-02-12T00:00:00Z,NA,H,2014-07-12T00:00:00Z,NA,H,19,169,151,2014-02-12,2014-07-12,12231,8154,PLDOSE,8154,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1287,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-12,2014-07-12,19,169,NA,54,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-02-12T00:00:00Z,NA,H,2014-07-12T00:00:00Z,NA,H,19,169,151,2014-02-12,2014-07-12,12231,8154,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1287,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-12,2014-07-12,19,169,NA,54,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-02-12T00:00:00Z,NA,H,2014-07-12T00:00:00Z,NA,H,19,169,151,2014-02-12,2014-07-12,12231,8154,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1287,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-13,2014-07-26,170,183,NA,54,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-07-13T00:00:00Z,NA,H,2014-07-26T00:00:00Z,NA,H,170,183,14,2014-07-13,2014-07-26,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1287,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-13,2014-07-26,170,183,NA,54,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-07-13T00:00:00Z,NA,H,2014-07-26T00:00:00Z,NA,H,170,183,14,2014-07-13,2014-07-26,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1287,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-13,2014-07-26,170,183,NA,54,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-07-13T00:00:00Z,NA,H,2014-07-26T00:00:00Z,NA,H,170,183,14,2014-07-13,2014-07-26,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1287,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-13,2014-07-26,170,183,NA,54,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-07-13T00:00:00Z,NA,H,2014-07-26T00:00:00Z,NA,H,170,183,14,2014-07-13,2014-07-26,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1287,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-13,2014-07-26,170,183,NA,54,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-07-13T00:00:00Z,NA,H,2014-07-26T00:00:00Z,NA,H,170,183,14,2014-07-13,2014-07-26,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-01-25T00:00:00Z,NA,NA,2014-07-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-25,2014-07-26,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-01-25T00:00:00Z,NA,NA,2014-07-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-25,2014-07-26,NA,NA,TDOSE,13959,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-01-25T00:00:00Z,NA,NA,2014-07-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-25,2014-07-26,NA,NA,AVDDSE,76.27868852459017,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-01-25T00:00:00Z,NA,NA,2014-07-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-25,2014-07-26,NA,NA,TPDOSE,9882,NA,OVERALL,Total planned dose (mg),11,NA,19,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-01-25T00:00:00Z,NA,NA,2014-07-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-25,2014-07-26,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-01-25T00:00:00Z,NA,NA,2014-07-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-25,2014-07-26,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-01-25T00:00:00Z,NA,NA,2014-07-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-25,2014-07-26,NA,NA,TDOSINT,141.25683060109287,NA,OVERALL,Overall dose intensity (%),90,NA,22,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-02-12T00:00:00Z,NA,NA,2014-07-26T00:00:00Z,NA,NA,NA,NA,NA,2014-02-12,2014-07-26,NA,NA,PDURD,165,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-02-12T00:00:00Z,NA,NA,2014-07-26T00:00:00Z,NA,NA,NA,NA,NA,2014-02-12,2014-07-26,NA,NA,PDOSE,12987,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-02-12T00:00:00Z,NA,NA,2014-07-26T00:00:00Z,NA,NA,NA,NA,NA,2014-02-12,2014-07-26,NA,NA,PPDOSE,8910,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-02-12T00:00:00Z,NA,NA,2014-07-26T00:00:00Z,NA,NA,NA,NA,NA,2014-02-12,2014-07-26,NA,NA,PAVDDSE,78.7090909090909,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-02-12T00:00:00Z,NA,NA,2014-07-26T00:00:00Z,NA,NA,NA,NA,NA,2014-02-12,2014-07-26,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-02-12T00:00:00Z,NA,NA,2014-07-26T00:00:00Z,NA,NA,NA,NA,NA,2014-02-12,2014-07-26,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1287,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-25,2014-01-25T00:00:00Z,2014-07-26T23:59:59Z,2014-02-12T00:00:00Z,NA,NA,2014-07-26T00:00:00Z,NA,NA,NA,NA,NA,2014-02-12,2014-07-26,NA,NA,PDOSINT,145.75757575757575,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1287,2014-01-25,2014-07-26,2014-01-25,2014-07-26,NA,2014-07-26T13:15,NA,NA,701,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-26,183,NA,2014-07-26,COMPLETED,NA,2014-01-25,NA,NA,NA,2014-07-26,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1294,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-24,2013-04-10,1,18,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-03-24T00:00:00Z,NA,H,2013-04-10T00:00:00Z,NA,H,1,18,18,2013-03-24,2013-04-10,972,972,DURD,18,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1294,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-24,2013-04-10,1,18,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-03-24T00:00:00Z,NA,H,2013-04-10T00:00:00Z,NA,H,1,18,18,2013-03-24,2013-04-10,972,972,DOSE,972,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1294,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-24,2013-04-10,1,18,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-03-24T00:00:00Z,NA,H,2013-04-10T00:00:00Z,NA,H,1,18,18,2013-03-24,2013-04-10,972,972,PLDOSE,972,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1294,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-24,2013-04-10,1,18,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-03-24T00:00:00Z,NA,H,2013-04-10T00:00:00Z,NA,H,1,18,18,2013-03-24,2013-04-10,972,972,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1294,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-24,2013-04-10,1,18,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-03-24T00:00:00Z,NA,H,2013-04-10T00:00:00Z,NA,H,1,18,18,2013-03-24,2013-04-10,972,972,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1294,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-11,2013-06-14,19,83,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-04-11T00:00:00Z,NA,H,2013-06-14T00:00:00Z,NA,H,19,83,65,2013-04-11,2013-06-14,3510,3510,DURD,65,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1294,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-11,2013-06-14,19,83,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-04-11T00:00:00Z,NA,H,2013-06-14T00:00:00Z,NA,H,19,83,65,2013-04-11,2013-06-14,3510,3510,DOSE,3510,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1294,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-11,2013-06-14,19,83,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-04-11T00:00:00Z,NA,H,2013-06-14T00:00:00Z,NA,H,19,83,65,2013-04-11,2013-06-14,3510,3510,PLDOSE,3510,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1294,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-11,2013-06-14,19,83,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-04-11T00:00:00Z,NA,H,2013-06-14T00:00:00Z,NA,H,19,83,65,2013-04-11,2013-06-14,3510,3510,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1294,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-11,2013-06-14,19,83,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-04-11T00:00:00Z,NA,H,2013-06-14T00:00:00Z,NA,H,19,83,65,2013-04-11,2013-06-14,3510,3510,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-03-24T00:00:00Z,NA,NA,2013-06-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-24,2013-06-14,NA,NA,TDURD,83,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-03-24T00:00:00Z,NA,NA,2013-06-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-24,2013-06-14,NA,NA,TDOSE,4482,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-03-24T00:00:00Z,NA,NA,2013-06-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-24,2013-06-14,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-03-24T00:00:00Z,NA,NA,2013-06-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-24,2013-06-14,NA,NA,TPDOSE,4482,NA,OVERALL,Total planned dose (mg),11,NA,14,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-03-24T00:00:00Z,NA,NA,2013-06-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-24,2013-06-14,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-03-24T00:00:00Z,NA,NA,2013-06-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-24,2013-06-14,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-03-24T00:00:00Z,NA,NA,2013-06-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-24,2013-06-14,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-04-11T00:00:00Z,NA,NA,2013-06-14T00:00:00Z,NA,NA,NA,NA,NA,2013-04-11,2013-06-14,NA,NA,PDURD,65,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-04-11T00:00:00Z,NA,NA,2013-06-14T00:00:00Z,NA,NA,NA,NA,NA,2013-04-11,2013-06-14,NA,NA,PDOSE,3510,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-04-11T00:00:00Z,NA,NA,2013-06-14T00:00:00Z,NA,NA,NA,NA,NA,2013-04-11,2013-06-14,NA,NA,PPDOSE,3510,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-04-11T00:00:00Z,NA,NA,2013-06-14T00:00:00Z,NA,NA,NA,NA,NA,2013-04-11,2013-06-14,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-04-11T00:00:00Z,NA,NA,2013-06-14T00:00:00Z,NA,NA,NA,NA,NA,2013-04-11,2013-06-14,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-04-11T00:00:00Z,NA,NA,2013-06-14T00:00:00Z,NA,NA,NA,NA,NA,2013-04-11,2013-06-14,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1294,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-06-14T23:59:59Z,2013-04-11T00:00:00Z,NA,NA,2013-06-14T00:00:00Z,NA,NA,NA,NA,NA,2013-04-11,2013-06-14,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1294,2013-03-24,2013-06-14,2013-03-24,2013-06-14,NA,2013-10-08,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-14,83,NA,2013-06-14,DISCONTINUED,2013-10-08,2013-03-24,NA,NA,NA,2013-06-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1302,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-29,2013-09-15,1,18,NA,54,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-08-29T00:00:00Z,NA,H,2013-09-15T00:00:00Z,NA,H,1,18,18,2013-08-29,2013-09-15,972,972,DURD,18,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1302,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-29,2013-09-15,1,18,NA,54,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-08-29T00:00:00Z,NA,H,2013-09-15T00:00:00Z,NA,H,1,18,18,2013-08-29,2013-09-15,972,972,DOSE,972,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1302,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-29,2013-09-15,1,18,NA,54,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-08-29T00:00:00Z,NA,H,2013-09-15T00:00:00Z,NA,H,1,18,18,2013-08-29,2013-09-15,972,972,PLDOSE,972,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1302,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-29,2013-09-15,1,18,NA,54,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-08-29T00:00:00Z,NA,H,2013-09-15T00:00:00Z,NA,H,1,18,18,2013-08-29,2013-09-15,972,972,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1302,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-29,2013-09-15,1,18,NA,54,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-08-29T00:00:00Z,NA,H,2013-09-15T00:00:00Z,NA,H,1,18,18,2013-08-29,2013-09-15,972,972,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1302,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-16,2013-11-05,19,69,NA,54,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-09-16T00:00:00Z,NA,H,2013-11-05T00:00:00Z,NA,H,19,69,51,2013-09-16,2013-11-05,4131,2754,DURD,51,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1302,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-16,2013-11-05,19,69,NA,54,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-09-16T00:00:00Z,NA,H,2013-11-05T00:00:00Z,NA,H,19,69,51,2013-09-16,2013-11-05,4131,2754,DOSE,4131,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1302,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-16,2013-11-05,19,69,NA,54,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-09-16T00:00:00Z,NA,H,2013-11-05T00:00:00Z,NA,H,19,69,51,2013-09-16,2013-11-05,4131,2754,PLDOSE,2754,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1302,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-16,2013-11-05,19,69,NA,54,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-09-16T00:00:00Z,NA,H,2013-11-05T00:00:00Z,NA,H,19,69,51,2013-09-16,2013-11-05,4131,2754,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1302,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-16,2013-11-05,19,69,NA,54,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-09-16T00:00:00Z,NA,H,2013-11-05T00:00:00Z,NA,H,19,69,51,2013-09-16,2013-11-05,4131,2754,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-08-29T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-29,2013-11-05,NA,NA,TDURD,69,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-08-29T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-29,2013-11-05,NA,NA,TDOSE,5103,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-08-29T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-29,2013-11-05,NA,NA,AVDDSE,73.95652173913044,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-08-29T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-29,2013-11-05,NA,NA,TPDOSE,3726,NA,OVERALL,Total planned dose (mg),11,NA,14,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-08-29T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-29,2013-11-05,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-08-29T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-29,2013-11-05,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-08-29T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-29,2013-11-05,NA,NA,TDOSINT,136.95652173913044,NA,OVERALL,Overall dose intensity (%),90,NA,17,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-11-05,NA,NA,PDURD,51,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-11-05,NA,NA,PDOSE,4131,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-11-05,NA,NA,PPDOSE,2754,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-11-05,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-11-05,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-11-05,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1302,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-29,2013-08-29T00:00:00Z,2013-11-05T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-11-05,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1302,2013-08-29,2013-11-05,2013-08-29,2013-11-05,NA,2014-02-13,NA,NA,701,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-20,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-05,69,NA,2013-11-05,DISCONTINUED,2014-02-13,2013-08-29,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1317,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-05-22,2014-06-05,1,15,NA,54,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-05-22T00:00:00Z,NA,H,2014-06-05T00:00:00Z,NA,H,1,15,15,2014-05-22,2014-06-05,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1317,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-05-22,2014-06-05,1,15,NA,54,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-05-22T00:00:00Z,NA,H,2014-06-05T00:00:00Z,NA,H,1,15,15,2014-05-22,2014-06-05,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1317,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-05-22,2014-06-05,1,15,NA,54,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-05-22T00:00:00Z,NA,H,2014-06-05T00:00:00Z,NA,H,1,15,15,2014-05-22,2014-06-05,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1317,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-05-22,2014-06-05,1,15,NA,54,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-05-22T00:00:00Z,NA,H,2014-06-05T00:00:00Z,NA,H,1,15,15,2014-05-22,2014-06-05,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1317,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-05-22,2014-06-05,1,15,NA,54,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-05-22T00:00:00Z,NA,H,2014-06-05T00:00:00Z,NA,H,1,15,15,2014-05-22,2014-06-05,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1317,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-06-06,2014-11-06,16,169,NA,54,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-06-06T00:00:00Z,NA,H,2014-11-06T00:00:00Z,NA,H,16,169,154,2014-06-06,2014-11-06,8316,8316,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1317,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-06-06,2014-11-06,16,169,NA,54,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-06-06T00:00:00Z,NA,H,2014-11-06T00:00:00Z,NA,H,16,169,154,2014-06-06,2014-11-06,8316,8316,DOSE,8316,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1317,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-06-06,2014-11-06,16,169,NA,54,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-06-06T00:00:00Z,NA,H,2014-11-06T00:00:00Z,NA,H,16,169,154,2014-06-06,2014-11-06,8316,8316,PLDOSE,8316,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1317,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-06-06,2014-11-06,16,169,NA,54,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-06-06T00:00:00Z,NA,H,2014-11-06T00:00:00Z,NA,H,16,169,154,2014-06-06,2014-11-06,8316,8316,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1317,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-06-06,2014-11-06,16,169,NA,54,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-06-06T00:00:00Z,NA,H,2014-11-06T00:00:00Z,NA,H,16,169,154,2014-06-06,2014-11-06,8316,8316,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1317,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-11-07,2014-11-20,170,183,NA,54,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-11-07T00:00:00Z,NA,H,2014-11-20T00:00:00Z,NA,H,170,183,14,2014-11-07,2014-11-20,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1317,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-11-07,2014-11-20,170,183,NA,54,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-11-07T00:00:00Z,NA,H,2014-11-20T00:00:00Z,NA,H,170,183,14,2014-11-07,2014-11-20,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1317,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-11-07,2014-11-20,170,183,NA,54,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-11-07T00:00:00Z,NA,H,2014-11-20T00:00:00Z,NA,H,170,183,14,2014-11-07,2014-11-20,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1317,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-11-07,2014-11-20,170,183,NA,54,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-11-07T00:00:00Z,NA,H,2014-11-20T00:00:00Z,NA,H,170,183,14,2014-11-07,2014-11-20,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1317,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-11-07,2014-11-20,170,183,NA,54,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-11-07T00:00:00Z,NA,H,2014-11-20T00:00:00Z,NA,H,170,183,14,2014-11-07,2014-11-20,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-05-22T00:00:00Z,NA,NA,2014-11-20T00:00:00Z,NA,NA,NA,NA,NA,2014-05-22,2014-11-20,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-05-22T00:00:00Z,NA,NA,2014-11-20T00:00:00Z,NA,NA,NA,NA,NA,2014-05-22,2014-11-20,NA,NA,TDOSE,9882,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-05-22T00:00:00Z,NA,NA,2014-11-20T00:00:00Z,NA,NA,NA,NA,NA,2014-05-22,2014-11-20,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-05-22T00:00:00Z,NA,NA,2014-11-20T00:00:00Z,NA,NA,NA,NA,NA,2014-05-22,2014-11-20,NA,NA,TPDOSE,9882,NA,OVERALL,Total planned dose (mg),11,NA,19,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-05-22T00:00:00Z,NA,NA,2014-11-20T00:00:00Z,NA,NA,NA,NA,NA,2014-05-22,2014-11-20,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-05-22T00:00:00Z,NA,NA,2014-11-20T00:00:00Z,NA,NA,NA,NA,NA,2014-05-22,2014-11-20,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-05-22T00:00:00Z,NA,NA,2014-11-20T00:00:00Z,NA,NA,NA,NA,NA,2014-05-22,2014-11-20,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-06-06T00:00:00Z,NA,NA,2014-11-20T00:00:00Z,NA,NA,NA,NA,NA,2014-06-06,2014-11-20,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-06-06T00:00:00Z,NA,NA,2014-11-20T00:00:00Z,NA,NA,NA,NA,NA,2014-06-06,2014-11-20,NA,NA,PDOSE,9072,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-06-06T00:00:00Z,NA,NA,2014-11-20T00:00:00Z,NA,NA,NA,NA,NA,2014-06-06,2014-11-20,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-06-06T00:00:00Z,NA,NA,2014-11-20T00:00:00Z,NA,NA,NA,NA,NA,2014-06-06,2014-11-20,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-06-06T00:00:00Z,NA,NA,2014-11-20T00:00:00Z,NA,NA,NA,NA,NA,2014-06-06,2014-11-20,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-06-06T00:00:00Z,NA,NA,2014-11-20T00:00:00Z,NA,NA,NA,NA,NA,2014-06-06,2014-11-20,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1317,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-22,2014-05-22T00:00:00Z,2014-11-20T23:59:59Z,2014-06-06T00:00:00Z,NA,NA,2014-11-20T00:00:00Z,NA,NA,NA,NA,NA,2014-06-06,2014-11-20,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1317,2014-05-22,2014-11-20,2014-05-22,2014-11-20,NA,2014-11-20T11:54,NA,NA,701,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-10,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-11-20,183,NA,2014-11-20,COMPLETED,NA,2014-05-22,NA,NA,NA,2014-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1324,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-02,2012-10-16,1,15,NA,54,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-02T00:00:00Z,NA,H,2012-10-16T00:00:00Z,NA,H,1,15,15,2012-10-02,2012-10-16,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1324,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-02,2012-10-16,1,15,NA,54,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-02T00:00:00Z,NA,H,2012-10-16T00:00:00Z,NA,H,1,15,15,2012-10-02,2012-10-16,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1324,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-02,2012-10-16,1,15,NA,54,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-02T00:00:00Z,NA,H,2012-10-16T00:00:00Z,NA,H,1,15,15,2012-10-02,2012-10-16,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1324,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-02,2012-10-16,1,15,NA,54,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-02T00:00:00Z,NA,H,2012-10-16T00:00:00Z,NA,H,1,15,15,2012-10-02,2012-10-16,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1324,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-02,2012-10-16,1,15,NA,54,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-02T00:00:00Z,NA,H,2012-10-16T00:00:00Z,NA,H,1,15,15,2012-10-02,2012-10-16,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1324,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-17,2013-03-19,16,169,NA,54,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-17T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,16,169,154,2012-10-17,2013-03-19,8316,8316,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1324,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-17,2013-03-19,16,169,NA,54,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-17T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,16,169,154,2012-10-17,2013-03-19,8316,8316,DOSE,8316,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1324,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-17,2013-03-19,16,169,NA,54,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-17T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,16,169,154,2012-10-17,2013-03-19,8316,8316,PLDOSE,8316,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1324,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-17,2013-03-19,16,169,NA,54,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-17T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,16,169,154,2012-10-17,2013-03-19,8316,8316,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1324,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-17,2013-03-19,16,169,NA,54,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-17T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,16,169,154,2012-10-17,2013-03-19,8316,8316,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1324,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-20,2013-04-02,170,183,NA,54,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2013-03-20T00:00:00Z,NA,H,2013-04-02T00:00:00Z,NA,H,170,183,14,2013-03-20,2013-04-02,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1324,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-20,2013-04-02,170,183,NA,54,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2013-03-20T00:00:00Z,NA,H,2013-04-02T00:00:00Z,NA,H,170,183,14,2013-03-20,2013-04-02,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1324,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-20,2013-04-02,170,183,NA,54,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2013-03-20T00:00:00Z,NA,H,2013-04-02T00:00:00Z,NA,H,170,183,14,2013-03-20,2013-04-02,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1324,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-20,2013-04-02,170,183,NA,54,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2013-03-20T00:00:00Z,NA,H,2013-04-02T00:00:00Z,NA,H,170,183,14,2013-03-20,2013-04-02,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1324,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-20,2013-04-02,170,183,NA,54,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2013-03-20T00:00:00Z,NA,H,2013-04-02T00:00:00Z,NA,H,170,183,14,2013-03-20,2013-04-02,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2013-04-02T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2013-04-02,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2013-04-02T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2013-04-02,NA,NA,TDOSE,9882,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2013-04-02T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2013-04-02,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2013-04-02T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2013-04-02,NA,NA,TPDOSE,9882,NA,OVERALL,Total planned dose (mg),11,NA,19,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2013-04-02T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2013-04-02,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2013-04-02T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2013-04-02,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2013-04-02T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2013-04-02,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-17T00:00:00Z,NA,NA,2013-04-02T00:00:00Z,NA,NA,NA,NA,NA,2012-10-17,2013-04-02,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-17T00:00:00Z,NA,NA,2013-04-02T00:00:00Z,NA,NA,NA,NA,NA,2012-10-17,2013-04-02,NA,NA,PDOSE,9072,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-17T00:00:00Z,NA,NA,2013-04-02T00:00:00Z,NA,NA,NA,NA,NA,2012-10-17,2013-04-02,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-17T00:00:00Z,NA,NA,2013-04-02T00:00:00Z,NA,NA,NA,NA,NA,2012-10-17,2013-04-02,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-17T00:00:00Z,NA,NA,2013-04-02T00:00:00Z,NA,NA,NA,NA,NA,2012-10-17,2013-04-02,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-17T00:00:00Z,NA,NA,2013-04-02T00:00:00Z,NA,NA,NA,NA,NA,2012-10-17,2013-04-02,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1324,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2013-04-02T23:59:59Z,2012-10-17T00:00:00Z,NA,NA,2013-04-02T00:00:00Z,NA,NA,NA,NA,NA,2012-10-17,2013-04-02,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1324,2012-10-02,2013-04-02,2012-10-02,2013-04-02,NA,2013-04-02T11:35,NA,NA,701,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-02,183,NA,2013-04-02,COMPLETED,NA,2012-10-02,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1341,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-05,2013-01-18,1,14,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-05T00:00:00Z,NA,H,2013-01-18T00:00:00Z,NA,H,1,14,14,2013-01-05,2013-01-18,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1341,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-05,2013-01-18,1,14,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-05T00:00:00Z,NA,H,2013-01-18T00:00:00Z,NA,H,1,14,14,2013-01-05,2013-01-18,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1341,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-05,2013-01-18,1,14,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-05T00:00:00Z,NA,H,2013-01-18T00:00:00Z,NA,H,1,14,14,2013-01-05,2013-01-18,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1341,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-05,2013-01-18,1,14,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-05T00:00:00Z,NA,H,2013-01-18T00:00:00Z,NA,H,1,14,14,2013-01-05,2013-01-18,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1341,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-05,2013-01-18,1,14,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-05T00:00:00Z,NA,H,2013-01-18T00:00:00Z,NA,H,1,14,14,2013-01-05,2013-01-18,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1341,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-19,2013-01-26,15,22,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-19T00:00:00Z,NA,H,2013-01-26T00:00:00Z,NA,H,15,22,8,2013-01-19,2013-01-26,432,432,DURD,8,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1341,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-19,2013-01-26,15,22,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-19T00:00:00Z,NA,H,2013-01-26T00:00:00Z,NA,H,15,22,8,2013-01-19,2013-01-26,432,432,DOSE,432,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1341,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-19,2013-01-26,15,22,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-19T00:00:00Z,NA,H,2013-01-26T00:00:00Z,NA,H,15,22,8,2013-01-19,2013-01-26,432,432,PLDOSE,432,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1341,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-19,2013-01-26,15,22,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-19T00:00:00Z,NA,H,2013-01-26T00:00:00Z,NA,H,15,22,8,2013-01-19,2013-01-26,432,432,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1341,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-19,2013-01-26,15,22,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-19T00:00:00Z,NA,H,2013-01-26T00:00:00Z,NA,H,15,22,8,2013-01-19,2013-01-26,432,432,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-01-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-01-26,NA,NA,TDURD,22,NA,OVERALL,Overall duration (days),7,< 30 days,11,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-01-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-01-26,NA,NA,TDOSE,1188,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-01-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-01-26,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-01-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-01-26,NA,NA,TPDOSE,1188,NA,OVERALL,Total planned dose (mg),11,NA,14,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-01-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-01-26,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-01-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-01-26,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-01-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-01-26,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-01-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-01-26,NA,NA,PDURD,8,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-01-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-01-26,NA,NA,PDOSE,432,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-01-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-01-26,NA,NA,PPDOSE,432,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-01-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-01-26,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-01-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-01-26,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-01-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-01-26,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1341,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-01-26T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-01-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-01-26,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1341,2013-01-05,2013-02-07,2013-01-05,2013-01-26,NA,2013-02-21,NA,NA,701,51,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-22,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-26,22,NA,2013-02-07,DISCONTINUED,NA,2013-01-05,NA,NA,NA,2013-02-07,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1345,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-08,2013-10-24,1,17,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2013-10-24T00:00:00Z,NA,H,1,17,17,2013-10-08,2013-10-24,0,0,DURD,17,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1345,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-08,2013-10-24,1,17,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2013-10-24T00:00:00Z,NA,H,1,17,17,2013-10-08,2013-10-24,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1345,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-08,2013-10-24,1,17,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2013-10-24T00:00:00Z,NA,H,1,17,17,2013-10-08,2013-10-24,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1345,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-08,2013-10-24,1,17,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2013-10-24T00:00:00Z,NA,H,1,17,17,2013-10-08,2013-10-24,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1345,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-08,2013-10-24,1,17,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2013-10-24T00:00:00Z,NA,H,1,17,17,2013-10-08,2013-10-24,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1345,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-25,2014-03-18,18,162,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-25T00:00:00Z,NA,H,2014-03-18T00:00:00Z,NA,H,18,162,145,2013-10-25,2014-03-18,0,0,DURD,145,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1345,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-25,2014-03-18,18,162,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-25T00:00:00Z,NA,H,2014-03-18T00:00:00Z,NA,H,18,162,145,2013-10-25,2014-03-18,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1345,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-25,2014-03-18,18,162,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-25T00:00:00Z,NA,H,2014-03-18T00:00:00Z,NA,H,18,162,145,2013-10-25,2014-03-18,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1345,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-25,2014-03-18,18,162,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-25T00:00:00Z,NA,H,2014-03-18T00:00:00Z,NA,H,18,162,145,2013-10-25,2014-03-18,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1345,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-25,2014-03-18,18,162,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-25T00:00:00Z,NA,H,2014-03-18T00:00:00Z,NA,H,18,162,145,2013-10-25,2014-03-18,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-18,NA,NA,TDURD,162,NA,OVERALL,Overall duration (days),7,>=90 days,11,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-18,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-18,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-18,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-18,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-18,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-18,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2014-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2014-03-18,NA,NA,PDURD,145,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2014-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2014-03-18,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2014-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2014-03-18,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2014-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2014-03-18,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2014-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2014-03-18,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2014-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2014-03-18,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1345,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-03-18T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2014-03-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2014-03-18,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1345,2013-10-08,2014-03-18,2013-10-08,2014-03-18,NA,2014-03-18T14:12,NA,NA,701,63,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-01,-7,Placebo,Placebo,H,H,2014-03-18,162,NA,2014-03-18,DISCONTINUED,NA,2013-10-08,NA,NA,NA,2014-03-18,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1360,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-31,2013-08-05,1,6,NA,54,2013-07-31,2013-07-31T00:00:00Z,2013-08-05T23:59:59Z,2013-07-31T00:00:00Z,NA,H,2013-08-05T00:00:00Z,NA,H,1,6,6,2013-07-31,2013-08-05,324,324,DURD,6,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1360,2013-07-31,2013-08-14,2013-07-31,2013-08-05,NA,2014-02-11,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-24,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-05,6,NA,2013-08-14,DISCONTINUED,2014-02-11,2013-07-31,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1360,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-31,2013-08-05,1,6,NA,54,2013-07-31,2013-07-31T00:00:00Z,2013-08-05T23:59:59Z,2013-07-31T00:00:00Z,NA,H,2013-08-05T00:00:00Z,NA,H,1,6,6,2013-07-31,2013-08-05,324,324,DOSE,324,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1360,2013-07-31,2013-08-14,2013-07-31,2013-08-05,NA,2014-02-11,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-24,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-05,6,NA,2013-08-14,DISCONTINUED,2014-02-11,2013-07-31,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1360,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-31,2013-08-05,1,6,NA,54,2013-07-31,2013-07-31T00:00:00Z,2013-08-05T23:59:59Z,2013-07-31T00:00:00Z,NA,H,2013-08-05T00:00:00Z,NA,H,1,6,6,2013-07-31,2013-08-05,324,324,PLDOSE,324,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1360,2013-07-31,2013-08-14,2013-07-31,2013-08-05,NA,2014-02-11,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-24,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-05,6,NA,2013-08-14,DISCONTINUED,2014-02-11,2013-07-31,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1360,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-31,2013-08-05,1,6,NA,54,2013-07-31,2013-07-31T00:00:00Z,2013-08-05T23:59:59Z,2013-07-31T00:00:00Z,NA,H,2013-08-05T00:00:00Z,NA,H,1,6,6,2013-07-31,2013-08-05,324,324,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1360,2013-07-31,2013-08-14,2013-07-31,2013-08-05,NA,2014-02-11,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-24,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-05,6,NA,2013-08-14,DISCONTINUED,2014-02-11,2013-07-31,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1360,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-31,2013-08-05,1,6,NA,54,2013-07-31,2013-07-31T00:00:00Z,2013-08-05T23:59:59Z,2013-07-31T00:00:00Z,NA,H,2013-08-05T00:00:00Z,NA,H,1,6,6,2013-07-31,2013-08-05,324,324,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1360,2013-07-31,2013-08-14,2013-07-31,2013-08-05,NA,2014-02-11,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-24,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-05,6,NA,2013-08-14,DISCONTINUED,2014-02-11,2013-07-31,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1360,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-31,2013-07-31T00:00:00Z,2013-08-05T23:59:59Z,2013-07-31T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-31,2013-08-05,NA,NA,TDURD,6,NA,OVERALL,Overall duration (days),7,< 30 days,6,1360,2013-07-31,2013-08-14,2013-07-31,2013-08-05,NA,2014-02-11,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-24,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-05,6,NA,2013-08-14,DISCONTINUED,2014-02-11,2013-07-31,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1360,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-31,2013-07-31T00:00:00Z,2013-08-05T23:59:59Z,2013-07-31T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-31,2013-08-05,NA,NA,TDOSE,324,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1360,2013-07-31,2013-08-14,2013-07-31,2013-08-05,NA,2014-02-11,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-24,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-05,6,NA,2013-08-14,DISCONTINUED,2014-02-11,2013-07-31,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1360,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-31,2013-07-31T00:00:00Z,2013-08-05T23:59:59Z,2013-07-31T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-31,2013-08-05,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1360,2013-07-31,2013-08-14,2013-07-31,2013-08-05,NA,2014-02-11,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-24,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-05,6,NA,2013-08-14,DISCONTINUED,2014-02-11,2013-07-31,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1360,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-31,2013-07-31T00:00:00Z,2013-08-05T23:59:59Z,2013-07-31T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-31,2013-08-05,NA,NA,TPDOSE,324,NA,OVERALL,Total planned dose (mg),11,NA,9,1360,2013-07-31,2013-08-14,2013-07-31,2013-08-05,NA,2014-02-11,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-24,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-05,6,NA,2013-08-14,DISCONTINUED,2014-02-11,2013-07-31,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1360,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-31,2013-07-31T00:00:00Z,2013-08-05T23:59:59Z,2013-07-31T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-31,2013-08-05,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1360,2013-07-31,2013-08-14,2013-07-31,2013-08-05,NA,2014-02-11,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-24,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-05,6,NA,2013-08-14,DISCONTINUED,2014-02-11,2013-07-31,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1360,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-31,2013-07-31T00:00:00Z,2013-08-05T23:59:59Z,2013-07-31T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-31,2013-08-05,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1360,2013-07-31,2013-08-14,2013-07-31,2013-08-05,NA,2014-02-11,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-24,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-05,6,NA,2013-08-14,DISCONTINUED,2014-02-11,2013-07-31,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1360,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-31,2013-07-31T00:00:00Z,2013-08-05T23:59:59Z,2013-07-31T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-31,2013-08-05,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1360,2013-07-31,2013-08-14,2013-07-31,2013-08-05,NA,2014-02-11,NA,NA,701,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-24,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-05,6,NA,2013-08-14,DISCONTINUED,2014-02-11,2013-07-31,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1363,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-30,2013-06-12,1,14,NA,0,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-05-30T00:00:00Z,NA,H,2013-06-12T00:00:00Z,NA,H,1,14,14,2013-05-30,2013-06-12,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1363,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-30,2013-06-12,1,14,NA,0,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-05-30T00:00:00Z,NA,H,2013-06-12T00:00:00Z,NA,H,1,14,14,2013-05-30,2013-06-12,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1363,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-30,2013-06-12,1,14,NA,0,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-05-30T00:00:00Z,NA,H,2013-06-12T00:00:00Z,NA,H,1,14,14,2013-05-30,2013-06-12,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1363,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-30,2013-06-12,1,14,NA,0,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-05-30T00:00:00Z,NA,H,2013-06-12T00:00:00Z,NA,H,1,14,14,2013-05-30,2013-06-12,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1363,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-30,2013-06-12,1,14,NA,0,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-05-30T00:00:00Z,NA,H,2013-06-12T00:00:00Z,NA,H,1,14,14,2013-05-30,2013-06-12,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1363,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-13,2013-11-13,15,168,NA,0,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-06-13T00:00:00Z,NA,H,2013-11-13T00:00:00Z,NA,H,15,168,154,2013-06-13,2013-11-13,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1363,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-13,2013-11-13,15,168,NA,0,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-06-13T00:00:00Z,NA,H,2013-11-13T00:00:00Z,NA,H,15,168,154,2013-06-13,2013-11-13,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1363,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-13,2013-11-13,15,168,NA,0,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-06-13T00:00:00Z,NA,H,2013-11-13T00:00:00Z,NA,H,15,168,154,2013-06-13,2013-11-13,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1363,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-13,2013-11-13,15,168,NA,0,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-06-13T00:00:00Z,NA,H,2013-11-13T00:00:00Z,NA,H,15,168,154,2013-06-13,2013-11-13,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1363,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-13,2013-11-13,15,168,NA,0,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-06-13T00:00:00Z,NA,H,2013-11-13T00:00:00Z,NA,H,15,168,154,2013-06-13,2013-11-13,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1363,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-14,2013-11-27,169,182,NA,0,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-11-14T00:00:00Z,NA,H,2013-11-27T00:00:00Z,NA,H,169,182,14,2013-11-14,2013-11-27,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1363,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-14,2013-11-27,169,182,NA,0,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-11-14T00:00:00Z,NA,H,2013-11-27T00:00:00Z,NA,H,169,182,14,2013-11-14,2013-11-27,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1363,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-14,2013-11-27,169,182,NA,0,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-11-14T00:00:00Z,NA,H,2013-11-27T00:00:00Z,NA,H,169,182,14,2013-11-14,2013-11-27,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1363,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-14,2013-11-27,169,182,NA,0,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-11-14T00:00:00Z,NA,H,2013-11-27T00:00:00Z,NA,H,169,182,14,2013-11-14,2013-11-27,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1363,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-14,2013-11-27,169,182,NA,0,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-11-14T00:00:00Z,NA,H,2013-11-27T00:00:00Z,NA,H,169,182,14,2013-11-14,2013-11-27,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-05-30T00:00:00Z,NA,NA,2013-11-27T00:00:00Z,NA,NA,NA,NA,NA,2013-05-30,2013-11-27,NA,NA,TDURD,182,NA,OVERALL,Overall duration (days),7,>=90 days,16,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-05-30T00:00:00Z,NA,NA,2013-11-27T00:00:00Z,NA,NA,NA,NA,NA,2013-05-30,2013-11-27,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-05-30T00:00:00Z,NA,NA,2013-11-27T00:00:00Z,NA,NA,NA,NA,NA,2013-05-30,2013-11-27,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-05-30T00:00:00Z,NA,NA,2013-11-27T00:00:00Z,NA,NA,NA,NA,NA,2013-05-30,2013-11-27,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-05-30T00:00:00Z,NA,NA,2013-11-27T00:00:00Z,NA,NA,NA,NA,NA,2013-05-30,2013-11-27,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-05-30T00:00:00Z,NA,NA,2013-11-27T00:00:00Z,NA,NA,NA,NA,NA,2013-05-30,2013-11-27,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-05-30T00:00:00Z,NA,NA,2013-11-27T00:00:00Z,NA,NA,NA,NA,NA,2013-05-30,2013-11-27,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-06-13T00:00:00Z,NA,NA,2013-11-27T00:00:00Z,NA,NA,NA,NA,NA,2013-06-13,2013-11-27,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-06-13T00:00:00Z,NA,NA,2013-11-27T00:00:00Z,NA,NA,NA,NA,NA,2013-06-13,2013-11-27,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-06-13T00:00:00Z,NA,NA,2013-11-27T00:00:00Z,NA,NA,NA,NA,NA,2013-06-13,2013-11-27,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-06-13T00:00:00Z,NA,NA,2013-11-27T00:00:00Z,NA,NA,NA,NA,NA,2013-06-13,2013-11-27,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-06-13T00:00:00Z,NA,NA,2013-11-27T00:00:00Z,NA,NA,NA,NA,NA,2013-06-13,2013-11-27,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-06-13T00:00:00Z,NA,NA,2013-11-27T00:00:00Z,NA,NA,NA,NA,NA,2013-06-13,2013-11-27,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1363,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-30,2013-05-30T00:00:00Z,2013-11-27T23:59:59Z,2013-06-13T00:00:00Z,NA,NA,2013-11-27T00:00:00Z,NA,NA,NA,NA,NA,2013-06-13,2013-11-27,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1363,2013-05-30,2013-11-27,2013-05-30,2013-11-27,NA,2013-11-27T10:00,NA,NA,701,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-20,-10,Placebo,Placebo,H,H,2013-11-27,182,NA,2013-11-27,COMPLETED,NA,2013-05-30,NA,NA,NA,2013-11-27,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1383,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-04,2013-02-19,1,16,NA,54,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-04T00:00:00Z,NA,H,2013-02-19T00:00:00Z,NA,H,1,16,16,2013-02-04,2013-02-19,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1383,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-04,2013-02-19,1,16,NA,54,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-04T00:00:00Z,NA,H,2013-02-19T00:00:00Z,NA,H,1,16,16,2013-02-04,2013-02-19,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1383,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-04,2013-02-19,1,16,NA,54,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-04T00:00:00Z,NA,H,2013-02-19T00:00:00Z,NA,H,1,16,16,2013-02-04,2013-02-19,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1383,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-04,2013-02-19,1,16,NA,54,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-04T00:00:00Z,NA,H,2013-02-19T00:00:00Z,NA,H,1,16,16,2013-02-04,2013-02-19,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1383,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-04,2013-02-19,1,16,NA,54,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-04T00:00:00Z,NA,H,2013-02-19T00:00:00Z,NA,H,1,16,16,2013-02-04,2013-02-19,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1383,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-20,2013-07-30,17,177,NA,54,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-20T00:00:00Z,NA,H,2013-07-30T00:00:00Z,NA,H,17,177,161,2013-02-20,2013-07-30,13041,8694,DURD,161,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1383,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-20,2013-07-30,17,177,NA,54,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-20T00:00:00Z,NA,H,2013-07-30T00:00:00Z,NA,H,17,177,161,2013-02-20,2013-07-30,13041,8694,DOSE,13041,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1383,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-20,2013-07-30,17,177,NA,54,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-20T00:00:00Z,NA,H,2013-07-30T00:00:00Z,NA,H,17,177,161,2013-02-20,2013-07-30,13041,8694,PLDOSE,8694,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1383,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-20,2013-07-30,17,177,NA,54,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-20T00:00:00Z,NA,H,2013-07-30T00:00:00Z,NA,H,17,177,161,2013-02-20,2013-07-30,13041,8694,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1383,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-20,2013-07-30,17,177,NA,54,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-20T00:00:00Z,NA,H,2013-07-30T00:00:00Z,NA,H,17,177,161,2013-02-20,2013-07-30,13041,8694,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1383,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-31,2013-08-06,178,184,NA,54,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-07-31T00:00:00Z,NA,H,2013-08-06T00:00:00Z,NA,H,178,184,7,2013-07-31,2013-08-06,378,378,DURD,7,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1383,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-31,2013-08-06,178,184,NA,54,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-07-31T00:00:00Z,NA,H,2013-08-06T00:00:00Z,NA,H,178,184,7,2013-07-31,2013-08-06,378,378,DOSE,378,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1383,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-31,2013-08-06,178,184,NA,54,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-07-31T00:00:00Z,NA,H,2013-08-06T00:00:00Z,NA,H,178,184,7,2013-07-31,2013-08-06,378,378,PLDOSE,378,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1383,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-31,2013-08-06,178,184,NA,54,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-07-31T00:00:00Z,NA,H,2013-08-06T00:00:00Z,NA,H,178,184,7,2013-07-31,2013-08-06,378,378,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1383,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-31,2013-08-06,178,184,NA,54,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-07-31T00:00:00Z,NA,H,2013-08-06T00:00:00Z,NA,H,178,184,7,2013-07-31,2013-08-06,378,378,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-04T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-04,2013-08-06,NA,NA,TDURD,184,NA,OVERALL,Overall duration (days),7,>=90 days,16,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-04T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-04,2013-08-06,NA,NA,TDOSE,14283,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-04T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-04,2013-08-06,NA,NA,AVDDSE,77.625,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-04T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-04,2013-08-06,NA,NA,TPDOSE,9936,NA,OVERALL,Total planned dose (mg),11,NA,19,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-04T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-04,2013-08-06,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-04T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-04,2013-08-06,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-04T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-04,2013-08-06,NA,NA,TDOSINT,143.75,NA,OVERALL,Overall dose intensity (%),90,NA,22,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-08-06,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-08-06,NA,NA,PDOSE,13419,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-08-06,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-08-06,NA,NA,PAVDDSE,79.875,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-08-06,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-08-06,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1383,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-04,2013-02-04T00:00:00Z,2013-08-06T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-08-06,NA,NA,PDOSINT,147.91666666666669,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1383,2013-02-04,2013-08-06,2013-02-04,2013-08-06,NA,2013-08-06T12:00,NA,NA,701,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-22,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,184,NA,2013-08-06,COMPLETED,NA,2013-02-04,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1387,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-12,2014-03-25,1,14,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-03-25T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-25T00:00:00Z,NA,H,1,14,14,2014-03-12,2014-03-25,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1387,2014-03-12,2014-03-25,2014-03-12,2014-03-25,NA,2014-08-27,NA,NA,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-23,-17,Placebo,Placebo,H,H,2014-03-25,14,NA,2014-03-25,DISCONTINUED,2014-08-27,2014-03-12,NA,NA,NA,2014-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1387,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-12,2014-03-25,1,14,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-03-25T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-25T00:00:00Z,NA,H,1,14,14,2014-03-12,2014-03-25,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1387,2014-03-12,2014-03-25,2014-03-12,2014-03-25,NA,2014-08-27,NA,NA,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-23,-17,Placebo,Placebo,H,H,2014-03-25,14,NA,2014-03-25,DISCONTINUED,2014-08-27,2014-03-12,NA,NA,NA,2014-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1387,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-12,2014-03-25,1,14,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-03-25T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-25T00:00:00Z,NA,H,1,14,14,2014-03-12,2014-03-25,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1387,2014-03-12,2014-03-25,2014-03-12,2014-03-25,NA,2014-08-27,NA,NA,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-23,-17,Placebo,Placebo,H,H,2014-03-25,14,NA,2014-03-25,DISCONTINUED,2014-08-27,2014-03-12,NA,NA,NA,2014-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1387,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-12,2014-03-25,1,14,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-03-25T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-25T00:00:00Z,NA,H,1,14,14,2014-03-12,2014-03-25,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1387,2014-03-12,2014-03-25,2014-03-12,2014-03-25,NA,2014-08-27,NA,NA,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-23,-17,Placebo,Placebo,H,H,2014-03-25,14,NA,2014-03-25,DISCONTINUED,2014-08-27,2014-03-12,NA,NA,NA,2014-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1387,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-12,2014-03-25,1,14,NA,0,2014-03-12,2014-03-12T00:00:00Z,2014-03-25T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-25T00:00:00Z,NA,H,1,14,14,2014-03-12,2014-03-25,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1387,2014-03-12,2014-03-25,2014-03-12,2014-03-25,NA,2014-08-27,NA,NA,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-23,-17,Placebo,Placebo,H,H,2014-03-25,14,NA,2014-03-25,DISCONTINUED,2014-08-27,2014-03-12,NA,NA,NA,2014-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1387,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-03-25T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-03-25T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-03-25,NA,NA,TDURD,14,NA,OVERALL,Overall duration (days),7,< 30 days,6,1387,2014-03-12,2014-03-25,2014-03-12,2014-03-25,NA,2014-08-27,NA,NA,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-23,-17,Placebo,Placebo,H,H,2014-03-25,14,NA,2014-03-25,DISCONTINUED,2014-08-27,2014-03-12,NA,NA,NA,2014-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1387,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-03-25T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-03-25T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-03-25,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,7,1387,2014-03-12,2014-03-25,2014-03-12,2014-03-25,NA,2014-08-27,NA,NA,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-23,-17,Placebo,Placebo,H,H,2014-03-25,14,NA,2014-03-25,DISCONTINUED,2014-08-27,2014-03-12,NA,NA,NA,2014-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1387,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-03-25T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-03-25T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-03-25,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1387,2014-03-12,2014-03-25,2014-03-12,2014-03-25,NA,2014-08-27,NA,NA,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-23,-17,Placebo,Placebo,H,H,2014-03-25,14,NA,2014-03-25,DISCONTINUED,2014-08-27,2014-03-12,NA,NA,NA,2014-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1387,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-03-25T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-03-25T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-03-25,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,9,1387,2014-03-12,2014-03-25,2014-03-12,2014-03-25,NA,2014-08-27,NA,NA,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-23,-17,Placebo,Placebo,H,H,2014-03-25,14,NA,2014-03-25,DISCONTINUED,2014-08-27,2014-03-12,NA,NA,NA,2014-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1387,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-03-25T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-03-25T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-03-25,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1387,2014-03-12,2014-03-25,2014-03-12,2014-03-25,NA,2014-08-27,NA,NA,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-23,-17,Placebo,Placebo,H,H,2014-03-25,14,NA,2014-03-25,DISCONTINUED,2014-08-27,2014-03-12,NA,NA,NA,2014-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1387,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-03-25T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-03-25T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-03-25,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1387,2014-03-12,2014-03-25,2014-03-12,2014-03-25,NA,2014-08-27,NA,NA,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-23,-17,Placebo,Placebo,H,H,2014-03-25,14,NA,2014-03-25,DISCONTINUED,2014-08-27,2014-03-12,NA,NA,NA,2014-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1387,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-03-25T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-03-25T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-03-25,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,12,1387,2014-03-12,2014-03-25,2014-03-12,2014-03-25,NA,2014-08-27,NA,NA,701,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-23,-17,Placebo,Placebo,H,H,2014-03-25,14,NA,2014-03-25,DISCONTINUED,2014-08-27,2014-03-12,NA,NA,NA,2014-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1392,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-28,2012-11-11,1,15,NA,0,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,H,2012-11-11T00:00:00Z,NA,H,1,15,15,2012-10-28,2012-11-11,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1392,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-28,2012-11-11,1,15,NA,0,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,H,2012-11-11T00:00:00Z,NA,H,1,15,15,2012-10-28,2012-11-11,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1392,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-28,2012-11-11,1,15,NA,0,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,H,2012-11-11T00:00:00Z,NA,H,1,15,15,2012-10-28,2012-11-11,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1392,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-28,2012-11-11,1,15,NA,0,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,H,2012-11-11T00:00:00Z,NA,H,1,15,15,2012-10-28,2012-11-11,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1392,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-28,2012-11-11,1,15,NA,0,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,H,2012-11-11T00:00:00Z,NA,H,1,15,15,2012-10-28,2012-11-11,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1392,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-12,2013-04-15,16,170,NA,0,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-12T00:00:00Z,NA,H,2013-04-15T00:00:00Z,NA,H,16,170,155,2012-11-12,2013-04-15,0,0,DURD,155,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1392,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-12,2013-04-15,16,170,NA,0,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-12T00:00:00Z,NA,H,2013-04-15T00:00:00Z,NA,H,16,170,155,2012-11-12,2013-04-15,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1392,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-12,2013-04-15,16,170,NA,0,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-12T00:00:00Z,NA,H,2013-04-15T00:00:00Z,NA,H,16,170,155,2012-11-12,2013-04-15,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1392,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-12,2013-04-15,16,170,NA,0,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-12T00:00:00Z,NA,H,2013-04-15T00:00:00Z,NA,H,16,170,155,2012-11-12,2013-04-15,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1392,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-12,2013-04-15,16,170,NA,0,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-12T00:00:00Z,NA,H,2013-04-15T00:00:00Z,NA,H,16,170,155,2012-11-12,2013-04-15,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1392,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-16,2013-04-28,171,183,NA,0,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2013-04-16T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,171,183,13,2013-04-16,2013-04-28,0,0,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1392,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-16,2013-04-28,171,183,NA,0,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2013-04-16T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,171,183,13,2013-04-16,2013-04-28,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1392,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-16,2013-04-28,171,183,NA,0,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2013-04-16T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,171,183,13,2013-04-16,2013-04-28,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1392,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-16,2013-04-28,171,183,NA,0,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2013-04-16T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,171,183,13,2013-04-16,2013-04-28,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1392,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-16,2013-04-28,171,183,NA,0,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2013-04-16T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,171,183,13,2013-04-16,2013-04-28,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-28,2013-04-28,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-28,2013-04-28,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-28,2013-04-28,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-28,2013-04-28,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-28,2013-04-28,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-28,2013-04-28,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-10-28T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-28,2013-04-28,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-12T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-12,2013-04-28,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-12T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-12,2013-04-28,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-12T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-12,2013-04-28,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-12T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-12,2013-04-28,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-12T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-12,2013-04-28,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-12T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-12,2013-04-28,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1392,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-28,2012-10-28T00:00:00Z,2013-04-28T23:59:59Z,2012-11-12T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-12,2013-04-28,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1392,2012-10-28,2013-04-28,2012-10-28,2013-04-28,NA,2013-04-28T11:30,NA,NA,701,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-17,-11,Placebo,Placebo,H,H,2013-04-28,183,NA,2013-04-28,COMPLETED,NA,2012-10-28,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1415,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-23,2013-10-07,1,15,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-09-23T00:00:00Z,NA,H,2013-10-07T00:00:00Z,NA,H,1,15,15,2013-09-23,2013-10-07,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1415,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-23,2013-10-07,1,15,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-09-23T00:00:00Z,NA,H,2013-10-07T00:00:00Z,NA,H,1,15,15,2013-09-23,2013-10-07,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1415,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-23,2013-10-07,1,15,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-09-23T00:00:00Z,NA,H,2013-10-07T00:00:00Z,NA,H,1,15,15,2013-09-23,2013-10-07,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1415,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-23,2013-10-07,1,15,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-09-23T00:00:00Z,NA,H,2013-10-07T00:00:00Z,NA,H,1,15,15,2013-09-23,2013-10-07,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1415,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-23,2013-10-07,1,15,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-09-23T00:00:00Z,NA,H,2013-10-07T00:00:00Z,NA,H,1,15,15,2013-09-23,2013-10-07,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1415,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-08,2014-03-10,16,169,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2014-03-10T00:00:00Z,NA,H,16,169,154,2013-10-08,2014-03-10,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1415,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-08,2014-03-10,16,169,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2014-03-10T00:00:00Z,NA,H,16,169,154,2013-10-08,2014-03-10,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1415,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-08,2014-03-10,16,169,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2014-03-10T00:00:00Z,NA,H,16,169,154,2013-10-08,2014-03-10,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1415,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-08,2014-03-10,16,169,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2014-03-10T00:00:00Z,NA,H,16,169,154,2013-10-08,2014-03-10,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1415,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-08,2014-03-10,16,169,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2014-03-10T00:00:00Z,NA,H,16,169,154,2013-10-08,2014-03-10,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1415,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-11,2014-03-24,170,183,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2014-03-11T00:00:00Z,NA,H,2014-03-24T00:00:00Z,NA,H,170,183,14,2014-03-11,2014-03-24,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1415,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-11,2014-03-24,170,183,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2014-03-11T00:00:00Z,NA,H,2014-03-24T00:00:00Z,NA,H,170,183,14,2014-03-11,2014-03-24,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1415,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-11,2014-03-24,170,183,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2014-03-11T00:00:00Z,NA,H,2014-03-24T00:00:00Z,NA,H,170,183,14,2014-03-11,2014-03-24,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1415,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-11,2014-03-24,170,183,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2014-03-11T00:00:00Z,NA,H,2014-03-24T00:00:00Z,NA,H,170,183,14,2014-03-11,2014-03-24,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1415,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-11,2014-03-24,170,183,NA,0,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2014-03-11T00:00:00Z,NA,H,2014-03-24T00:00:00Z,NA,H,170,183,14,2014-03-11,2014-03-24,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1415,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-09-23T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-23,2014-03-24,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1415,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-09-23T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-23,2014-03-24,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1415,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-09-23T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-23,2014-03-24,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1415,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-09-23T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-23,2014-03-24,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1415,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-09-23T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-23,2014-03-24,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1415,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-09-23T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-23,2014-03-24,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1415,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-09-23T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-23,2014-03-24,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1415,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-24,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1415,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-24,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1415,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-24,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1415,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-24,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1415,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-24,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1415,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-24,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1415,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-23,2013-09-23T00:00:00Z,2014-03-24T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-24,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1415,2013-09-23,2014-03-24,2013-09-23,2014-03-24,NA,2014-03-24T12:34,NA,NA,701,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-8,Placebo,Placebo,H,H,2014-03-24,183,NA,2014-03-24,COMPLETED,NA,2013-09-23,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1429,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-19,2013-04-02,1,15,NA,54,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-03-19T00:00:00Z,NA,H,2013-04-02T00:00:00Z,NA,H,1,15,15,2013-03-19,2013-04-02,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1429,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-19,2013-04-02,1,15,NA,54,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-03-19T00:00:00Z,NA,H,2013-04-02T00:00:00Z,NA,H,1,15,15,2013-03-19,2013-04-02,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1429,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-19,2013-04-02,1,15,NA,54,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-03-19T00:00:00Z,NA,H,2013-04-02T00:00:00Z,NA,H,1,15,15,2013-03-19,2013-04-02,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1429,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-19,2013-04-02,1,15,NA,54,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-03-19T00:00:00Z,NA,H,2013-04-02T00:00:00Z,NA,H,1,15,15,2013-03-19,2013-04-02,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1429,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-19,2013-04-02,1,15,NA,54,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-03-19T00:00:00Z,NA,H,2013-04-02T00:00:00Z,NA,H,1,15,15,2013-03-19,2013-04-02,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1429,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-03,2013-04-30,16,43,NA,54,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-30T00:00:00Z,NA,H,16,43,28,2013-04-03,2013-04-30,1512,1512,DURD,28,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1429,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-03,2013-04-30,16,43,NA,54,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-30T00:00:00Z,NA,H,16,43,28,2013-04-03,2013-04-30,1512,1512,DOSE,1512,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1429,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-03,2013-04-30,16,43,NA,54,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-30T00:00:00Z,NA,H,16,43,28,2013-04-03,2013-04-30,1512,1512,PLDOSE,1512,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1429,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-03,2013-04-30,16,43,NA,54,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-30T00:00:00Z,NA,H,16,43,28,2013-04-03,2013-04-30,1512,1512,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1429,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-03,2013-04-30,16,43,NA,54,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-30T00:00:00Z,NA,H,16,43,28,2013-04-03,2013-04-30,1512,1512,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-03-19T00:00:00Z,NA,NA,2013-04-30T00:00:00Z,NA,NA,NA,NA,NA,2013-03-19,2013-04-30,NA,NA,TDURD,43,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-03-19T00:00:00Z,NA,NA,2013-04-30T00:00:00Z,NA,NA,NA,NA,NA,2013-03-19,2013-04-30,NA,NA,TDOSE,2322,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-03-19T00:00:00Z,NA,NA,2013-04-30T00:00:00Z,NA,NA,NA,NA,NA,2013-03-19,2013-04-30,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-03-19T00:00:00Z,NA,NA,2013-04-30T00:00:00Z,NA,NA,NA,NA,NA,2013-03-19,2013-04-30,NA,NA,TPDOSE,2322,NA,OVERALL,Total planned dose (mg),11,NA,14,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-03-19T00:00:00Z,NA,NA,2013-04-30T00:00:00Z,NA,NA,NA,NA,NA,2013-03-19,2013-04-30,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-03-19T00:00:00Z,NA,NA,2013-04-30T00:00:00Z,NA,NA,NA,NA,NA,2013-03-19,2013-04-30,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-03-19T00:00:00Z,NA,NA,2013-04-30T00:00:00Z,NA,NA,NA,NA,NA,2013-03-19,2013-04-30,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-04-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-04-30,NA,NA,PDURD,28,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-04-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-04-30,NA,NA,PDOSE,1512,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-04-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-04-30,NA,NA,PPDOSE,1512,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-04-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-04-30,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-04-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-04-30,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-04-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-04-30,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1429,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-19,2013-03-19T00:00:00Z,2013-04-30T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-04-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-04-30,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1429,2013-03-19,2013-04-30,2013-03-19,2013-04-30,NA,2013-04-30T12:22,NA,NA,701,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-30,43,NA,2013-04-30,DISCONTINUED,NA,2013-03-19,NA,NA,NA,2013-04-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1440,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-08,2013-08-23,1,16,NA,0,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-08T00:00:00Z,NA,H,2013-08-23T00:00:00Z,NA,H,1,16,16,2013-08-08,2013-08-23,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1440,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-08,2013-08-23,1,16,NA,0,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-08T00:00:00Z,NA,H,2013-08-23T00:00:00Z,NA,H,1,16,16,2013-08-08,2013-08-23,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1440,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-08,2013-08-23,1,16,NA,0,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-08T00:00:00Z,NA,H,2013-08-23T00:00:00Z,NA,H,1,16,16,2013-08-08,2013-08-23,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1440,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-08,2013-08-23,1,16,NA,0,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-08T00:00:00Z,NA,H,2013-08-23T00:00:00Z,NA,H,1,16,16,2013-08-08,2013-08-23,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1440,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-08,2013-08-23,1,16,NA,0,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-08T00:00:00Z,NA,H,2013-08-23T00:00:00Z,NA,H,1,16,16,2013-08-08,2013-08-23,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1440,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-24,2014-01-22,17,168,NA,0,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-24T00:00:00Z,NA,H,2014-01-22T00:00:00Z,NA,H,17,168,152,2013-08-24,2014-01-22,0,0,DURD,152,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1440,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-24,2014-01-22,17,168,NA,0,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-24T00:00:00Z,NA,H,2014-01-22T00:00:00Z,NA,H,17,168,152,2013-08-24,2014-01-22,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1440,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-24,2014-01-22,17,168,NA,0,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-24T00:00:00Z,NA,H,2014-01-22T00:00:00Z,NA,H,17,168,152,2013-08-24,2014-01-22,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1440,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-24,2014-01-22,17,168,NA,0,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-24T00:00:00Z,NA,H,2014-01-22T00:00:00Z,NA,H,17,168,152,2013-08-24,2014-01-22,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1440,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-24,2014-01-22,17,168,NA,0,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-24T00:00:00Z,NA,H,2014-01-22T00:00:00Z,NA,H,17,168,152,2013-08-24,2014-01-22,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1440,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-23,2014-02-05,169,182,NA,0,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2014-01-23T00:00:00Z,NA,H,2014-02-05T00:00:00Z,NA,H,169,182,14,2014-01-23,2014-02-05,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1440,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-23,2014-02-05,169,182,NA,0,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2014-01-23T00:00:00Z,NA,H,2014-02-05T00:00:00Z,NA,H,169,182,14,2014-01-23,2014-02-05,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1440,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-23,2014-02-05,169,182,NA,0,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2014-01-23T00:00:00Z,NA,H,2014-02-05T00:00:00Z,NA,H,169,182,14,2014-01-23,2014-02-05,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1440,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-23,2014-02-05,169,182,NA,0,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2014-01-23T00:00:00Z,NA,H,2014-02-05T00:00:00Z,NA,H,169,182,14,2014-01-23,2014-02-05,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1440,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-23,2014-02-05,169,182,NA,0,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2014-01-23T00:00:00Z,NA,H,2014-02-05T00:00:00Z,NA,H,169,182,14,2014-01-23,2014-02-05,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1440,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-08T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-08,2014-02-05,NA,NA,TDURD,182,NA,OVERALL,Overall duration (days),7,>=90 days,16,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1440,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-08T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-08,2014-02-05,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1440,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-08T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-08,2014-02-05,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1440,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-08T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-08,2014-02-05,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1440,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-08T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-08,2014-02-05,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1440,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-08T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-08,2014-02-05,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1440,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-08T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-08,2014-02-05,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1440,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-24T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-24,2014-02-05,NA,NA,PDURD,166,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1440,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-24T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-24,2014-02-05,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1440,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-24T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-24,2014-02-05,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1440,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-24T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-24,2014-02-05,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1440,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-24T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-24,2014-02-05,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1440,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-24T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-24,2014-02-05,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1440,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2014-02-05T23:59:59Z,2013-08-24T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-24,2014-02-05,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1440,2013-08-08,2014-02-05,2013-08-08,2014-02-05,NA,2014-02-05T11:25,NA,NA,701,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-24,-15,Placebo,Placebo,H,H,2014-02-05,182,NA,2014-02-05,COMPLETED,NA,2013-08-08,NA,NA,NA,2014-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1442,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-26,2013-11-09,1,15,NA,54,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-10-26T00:00:00Z,NA,H,2013-11-09T00:00:00Z,NA,H,1,15,15,2013-10-26,2013-11-09,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1442,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-26,2013-11-09,1,15,NA,54,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-10-26T00:00:00Z,NA,H,2013-11-09T00:00:00Z,NA,H,1,15,15,2013-10-26,2013-11-09,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1442,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-26,2013-11-09,1,15,NA,54,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-10-26T00:00:00Z,NA,H,2013-11-09T00:00:00Z,NA,H,1,15,15,2013-10-26,2013-11-09,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1442,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-26,2013-11-09,1,15,NA,54,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-10-26T00:00:00Z,NA,H,2013-11-09T00:00:00Z,NA,H,1,15,15,2013-10-26,2013-11-09,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1442,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-26,2013-11-09,1,15,NA,54,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-10-26T00:00:00Z,NA,H,2013-11-09T00:00:00Z,NA,H,1,15,15,2013-10-26,2013-11-09,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1442,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-10,2014-04-17,16,174,NA,54,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-11-10T00:00:00Z,NA,H,2014-04-17T00:00:00Z,NA,H,16,174,159,2013-11-10,2014-04-17,8586,8586,DURD,159,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1442,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-10,2014-04-17,16,174,NA,54,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-11-10T00:00:00Z,NA,H,2014-04-17T00:00:00Z,NA,H,16,174,159,2013-11-10,2014-04-17,8586,8586,DOSE,8586,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1442,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-10,2014-04-17,16,174,NA,54,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-11-10T00:00:00Z,NA,H,2014-04-17T00:00:00Z,NA,H,16,174,159,2013-11-10,2014-04-17,8586,8586,PLDOSE,8586,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1442,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-10,2014-04-17,16,174,NA,54,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-11-10T00:00:00Z,NA,H,2014-04-17T00:00:00Z,NA,H,16,174,159,2013-11-10,2014-04-17,8586,8586,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1442,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-10,2014-04-17,16,174,NA,54,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-11-10T00:00:00Z,NA,H,2014-04-17T00:00:00Z,NA,H,16,174,159,2013-11-10,2014-04-17,8586,8586,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1442,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-18,2014-04-26,175,183,NA,54,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2014-04-18T00:00:00Z,NA,H,2014-04-26T00:00:00Z,NA,H,175,183,9,2014-04-18,2014-04-26,486,486,DURD,9,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1442,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-18,2014-04-26,175,183,NA,54,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2014-04-18T00:00:00Z,NA,H,2014-04-26T00:00:00Z,NA,H,175,183,9,2014-04-18,2014-04-26,486,486,DOSE,486,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1442,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-18,2014-04-26,175,183,NA,54,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2014-04-18T00:00:00Z,NA,H,2014-04-26T00:00:00Z,NA,H,175,183,9,2014-04-18,2014-04-26,486,486,PLDOSE,486,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1442,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-18,2014-04-26,175,183,NA,54,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2014-04-18T00:00:00Z,NA,H,2014-04-26T00:00:00Z,NA,H,175,183,9,2014-04-18,2014-04-26,486,486,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1442,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-18,2014-04-26,175,183,NA,54,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2014-04-18T00:00:00Z,NA,H,2014-04-26T00:00:00Z,NA,H,175,183,9,2014-04-18,2014-04-26,486,486,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-10-26T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-10-26,2014-04-26,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-10-26T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-10-26,2014-04-26,NA,NA,TDOSE,9882,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-10-26T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-10-26,2014-04-26,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-10-26T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-10-26,2014-04-26,NA,NA,TPDOSE,9882,NA,OVERALL,Total planned dose (mg),11,NA,19,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-10-26T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-10-26,2014-04-26,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-10-26T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-10-26,2014-04-26,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-10-26T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-10-26,2014-04-26,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-11-10T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-11-10,2014-04-26,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-11-10T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-11-10,2014-04-26,NA,NA,PDOSE,9072,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-11-10T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-11-10,2014-04-26,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-11-10T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-11-10,2014-04-26,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-11-10T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-11-10,2014-04-26,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-11-10T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-11-10,2014-04-26,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1442,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-26,2013-10-26T00:00:00Z,2014-04-26T23:59:59Z,2013-11-10T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-11-10,2014-04-26,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1442,2013-10-26,2014-04-26,2013-10-26,2014-04-26,NA,2014-04-26T10:00,NA,NA,701,57,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-17,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-26,183,NA,2014-04-26,COMPLETED,NA,2013-10-26,NA,NA,NA,2014-04-26,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1444,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-05,2013-01-18,1,14,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-05T00:00:00Z,NA,H,2013-01-18T00:00:00Z,NA,H,1,14,14,2013-01-05,2013-01-18,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1444,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-05,2013-01-18,1,14,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-05T00:00:00Z,NA,H,2013-01-18T00:00:00Z,NA,H,1,14,14,2013-01-05,2013-01-18,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1444,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-05,2013-01-18,1,14,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-05T00:00:00Z,NA,H,2013-01-18T00:00:00Z,NA,H,1,14,14,2013-01-05,2013-01-18,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1444,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-05,2013-01-18,1,14,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-05T00:00:00Z,NA,H,2013-01-18T00:00:00Z,NA,H,1,14,14,2013-01-05,2013-01-18,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1444,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-05,2013-01-18,1,14,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-05T00:00:00Z,NA,H,2013-01-18T00:00:00Z,NA,H,1,14,14,2013-01-05,2013-01-18,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1444,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-19,2013-02-12,15,39,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-19T00:00:00Z,NA,H,2013-02-12T00:00:00Z,NA,H,15,39,25,2013-01-19,2013-02-12,2025,1350,DURD,25,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1444,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-19,2013-02-12,15,39,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-19T00:00:00Z,NA,H,2013-02-12T00:00:00Z,NA,H,15,39,25,2013-01-19,2013-02-12,2025,1350,DOSE,2025,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1444,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-19,2013-02-12,15,39,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-19T00:00:00Z,NA,H,2013-02-12T00:00:00Z,NA,H,15,39,25,2013-01-19,2013-02-12,2025,1350,PLDOSE,1350,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1444,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-19,2013-02-12,15,39,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-19T00:00:00Z,NA,H,2013-02-12T00:00:00Z,NA,H,15,39,25,2013-01-19,2013-02-12,2025,1350,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-701-1444,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-19,2013-02-12,15,39,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-19T00:00:00Z,NA,H,2013-02-12T00:00:00Z,NA,H,15,39,25,2013-01-19,2013-02-12,2025,1350,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-02-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-02-12,NA,NA,TDURD,39,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-02-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-02-12,NA,NA,TDOSE,2781,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-02-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-02-12,NA,NA,AVDDSE,71.3076923076923,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-02-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-02-12,NA,NA,TPDOSE,2106,NA,OVERALL,Total planned dose (mg),11,NA,14,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-02-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-02-12,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-02-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-02-12,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-02-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-02-12,NA,NA,TDOSINT,132.05128205128204,NA,OVERALL,Overall dose intensity (%),90,NA,17,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-02-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-02-12,NA,NA,PDURD,25,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-02-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-02-12,NA,NA,PDOSE,2025,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-02-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-02-12,NA,NA,PPDOSE,1350,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-02-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-02-12,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-02-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-02-12,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-02-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-02-12,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-701-1444,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-02-12T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-02-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-02-12,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1444,2013-01-05,2013-02-13,2013-01-05,2013-02-12,NA,2013-06-20,NA,NA,701,63,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-31,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-12,39,NA,2013-02-13,DISCONTINUED,2013-06-20,2013-01-05,NA,NA,NA,2013-02-13,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-702-1082,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-26,2013-08-08,1,14,NA,54,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-07-26T00:00:00Z,NA,H,2013-08-08T00:00:00Z,NA,H,1,14,14,2013-07-26,2013-08-08,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-702-1082,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-26,2013-08-08,1,14,NA,54,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-07-26T00:00:00Z,NA,H,2013-08-08T00:00:00Z,NA,H,1,14,14,2013-07-26,2013-08-08,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-702-1082,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-26,2013-08-08,1,14,NA,54,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-07-26T00:00:00Z,NA,H,2013-08-08T00:00:00Z,NA,H,1,14,14,2013-07-26,2013-08-08,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-702-1082,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-26,2013-08-08,1,14,NA,54,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-07-26T00:00:00Z,NA,H,2013-08-08T00:00:00Z,NA,H,1,14,14,2013-07-26,2013-08-08,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-702-1082,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-26,2013-08-08,1,14,NA,54,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-07-26T00:00:00Z,NA,H,2013-08-08T00:00:00Z,NA,H,1,14,14,2013-07-26,2013-08-08,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-702-1082,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-09,2013-10-13,15,80,NA,54,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-08-09T00:00:00Z,NA,H,2013-10-13T00:00:00Z,NA,H,15,80,66,2013-08-09,2013-10-13,3564,3564,DURD,66,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-702-1082,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-09,2013-10-13,15,80,NA,54,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-08-09T00:00:00Z,NA,H,2013-10-13T00:00:00Z,NA,H,15,80,66,2013-08-09,2013-10-13,3564,3564,DOSE,3564,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-702-1082,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-09,2013-10-13,15,80,NA,54,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-08-09T00:00:00Z,NA,H,2013-10-13T00:00:00Z,NA,H,15,80,66,2013-08-09,2013-10-13,3564,3564,PLDOSE,3564,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-702-1082,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-09,2013-10-13,15,80,NA,54,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-08-09T00:00:00Z,NA,H,2013-10-13T00:00:00Z,NA,H,15,80,66,2013-08-09,2013-10-13,3564,3564,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-702-1082,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-09,2013-10-13,15,80,NA,54,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-08-09T00:00:00Z,NA,H,2013-10-13T00:00:00Z,NA,H,15,80,66,2013-08-09,2013-10-13,3564,3564,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-702-1082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-07-26T00:00:00Z,NA,NA,2013-10-13T00:00:00Z,NA,NA,NA,NA,NA,2013-07-26,2013-10-13,NA,NA,TDURD,80,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-702-1082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-07-26T00:00:00Z,NA,NA,2013-10-13T00:00:00Z,NA,NA,NA,NA,NA,2013-07-26,2013-10-13,NA,NA,TDOSE,4320,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-702-1082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-07-26T00:00:00Z,NA,NA,2013-10-13T00:00:00Z,NA,NA,NA,NA,NA,2013-07-26,2013-10-13,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-702-1082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-07-26T00:00:00Z,NA,NA,2013-10-13T00:00:00Z,NA,NA,NA,NA,NA,2013-07-26,2013-10-13,NA,NA,TPDOSE,4320,NA,OVERALL,Total planned dose (mg),11,NA,14,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-702-1082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-07-26T00:00:00Z,NA,NA,2013-10-13T00:00:00Z,NA,NA,NA,NA,NA,2013-07-26,2013-10-13,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-702-1082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-07-26T00:00:00Z,NA,NA,2013-10-13T00:00:00Z,NA,NA,NA,NA,NA,2013-07-26,2013-10-13,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-702-1082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-07-26T00:00:00Z,NA,NA,2013-10-13T00:00:00Z,NA,NA,NA,NA,NA,2013-07-26,2013-10-13,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-702-1082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-08-09T00:00:00Z,NA,NA,2013-10-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-09,2013-10-13,NA,NA,PDURD,66,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-702-1082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-08-09T00:00:00Z,NA,NA,2013-10-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-09,2013-10-13,NA,NA,PDOSE,3564,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-702-1082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-08-09T00:00:00Z,NA,NA,2013-10-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-09,2013-10-13,NA,NA,PPDOSE,3564,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-702-1082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-08-09T00:00:00Z,NA,NA,2013-10-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-09,2013-10-13,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-702-1082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-08-09T00:00:00Z,NA,NA,2013-10-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-09,2013-10-13,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-702-1082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-08-09T00:00:00Z,NA,NA,2013-10-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-09,2013-10-13,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-702-1082,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-26,2013-07-26T00:00:00Z,2013-10-13T23:59:59Z,2013-08-09T00:00:00Z,NA,NA,2013-10-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-09,2013-10-13,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1082,2013-07-26,2013-11-17,2013-07-26,2013-10-13,NA,2013-11-17T12:20,NA,NA,702,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-03,-23,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-13,80,NA,2013-11-17,DISCONTINUED,NA,2013-07-26,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1042,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-02,2013-03-14,1,13,NA,0,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-02T00:00:00Z,NA,H,2013-03-14T00:00:00Z,NA,H,1,13,13,2013-03-02,2013-03-14,0,0,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1042,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-02,2013-03-14,1,13,NA,0,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-02T00:00:00Z,NA,H,2013-03-14T00:00:00Z,NA,H,1,13,13,2013-03-02,2013-03-14,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1042,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-02,2013-03-14,1,13,NA,0,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-02T00:00:00Z,NA,H,2013-03-14T00:00:00Z,NA,H,1,13,13,2013-03-02,2013-03-14,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1042,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-02,2013-03-14,1,13,NA,0,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-02T00:00:00Z,NA,H,2013-03-14T00:00:00Z,NA,H,1,13,13,2013-03-02,2013-03-14,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1042,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-02,2013-03-14,1,13,NA,0,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-02T00:00:00Z,NA,H,2013-03-14T00:00:00Z,NA,H,1,13,13,2013-03-02,2013-03-14,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1042,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-15,2013-08-09,14,161,NA,0,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-15T00:00:00Z,NA,H,2013-08-09T00:00:00Z,NA,H,14,161,148,2013-03-15,2013-08-09,0,0,DURD,148,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1042,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-15,2013-08-09,14,161,NA,0,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-15T00:00:00Z,NA,H,2013-08-09T00:00:00Z,NA,H,14,161,148,2013-03-15,2013-08-09,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1042,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-15,2013-08-09,14,161,NA,0,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-15T00:00:00Z,NA,H,2013-08-09T00:00:00Z,NA,H,14,161,148,2013-03-15,2013-08-09,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1042,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-15,2013-08-09,14,161,NA,0,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-15T00:00:00Z,NA,H,2013-08-09T00:00:00Z,NA,H,14,161,148,2013-03-15,2013-08-09,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1042,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-15,2013-08-09,14,161,NA,0,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-15T00:00:00Z,NA,H,2013-08-09T00:00:00Z,NA,H,14,161,148,2013-03-15,2013-08-09,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1042,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-10,2013-08-31,162,183,NA,0,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-08-10T00:00:00Z,NA,H,2013-08-31T00:00:00Z,NA,H,162,183,22,2013-08-10,2013-08-31,0,0,DURD,22,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1042,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-10,2013-08-31,162,183,NA,0,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-08-10T00:00:00Z,NA,H,2013-08-31T00:00:00Z,NA,H,162,183,22,2013-08-10,2013-08-31,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1042,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-10,2013-08-31,162,183,NA,0,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-08-10T00:00:00Z,NA,H,2013-08-31T00:00:00Z,NA,H,162,183,22,2013-08-10,2013-08-31,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1042,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-10,2013-08-31,162,183,NA,0,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-08-10T00:00:00Z,NA,H,2013-08-31T00:00:00Z,NA,H,162,183,22,2013-08-10,2013-08-31,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1042,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-10,2013-08-31,162,183,NA,0,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-08-10T00:00:00Z,NA,H,2013-08-31T00:00:00Z,NA,H,162,183,22,2013-08-10,2013-08-31,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-02T00:00:00Z,NA,NA,2013-08-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-02,2013-08-31,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-02T00:00:00Z,NA,NA,2013-08-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-02,2013-08-31,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-02T00:00:00Z,NA,NA,2013-08-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-02,2013-08-31,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-02T00:00:00Z,NA,NA,2013-08-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-02,2013-08-31,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-02T00:00:00Z,NA,NA,2013-08-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-02,2013-08-31,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-02T00:00:00Z,NA,NA,2013-08-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-02,2013-08-31,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-02T00:00:00Z,NA,NA,2013-08-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-02,2013-08-31,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-15T00:00:00Z,NA,NA,2013-08-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-15,2013-08-31,NA,NA,PDURD,170,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-15T00:00:00Z,NA,NA,2013-08-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-15,2013-08-31,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-15T00:00:00Z,NA,NA,2013-08-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-15,2013-08-31,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-15T00:00:00Z,NA,NA,2013-08-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-15,2013-08-31,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-15T00:00:00Z,NA,NA,2013-08-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-15,2013-08-31,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-15T00:00:00Z,NA,NA,2013-08-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-15,2013-08-31,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1042,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-02,2013-03-02T00:00:00Z,2013-08-31T23:59:59Z,2013-03-15T00:00:00Z,NA,NA,2013-08-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-15,2013-08-31,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1042,2013-03-02,2013-08-31,2013-03-02,2013-08-31,NA,2013-08-31T11:00,NA,NA,703,64,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-7,Placebo,Placebo,H,H,2013-08-31,183,NA,2013-08-31,COMPLETED,NA,2013-03-02,NA,NA,NA,2013-08-31,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1076,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-25,2013-11-06,1,13,NA,54,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-10-25T00:00:00Z,NA,H,2013-11-06T00:00:00Z,NA,H,1,13,13,2013-10-25,2013-11-06,702,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1076,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-25,2013-11-06,1,13,NA,54,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-10-25T00:00:00Z,NA,H,2013-11-06T00:00:00Z,NA,H,1,13,13,2013-10-25,2013-11-06,702,702,DOSE,702,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1076,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-25,2013-11-06,1,13,NA,54,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-10-25T00:00:00Z,NA,H,2013-11-06T00:00:00Z,NA,H,1,13,13,2013-10-25,2013-11-06,702,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1076,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-25,2013-11-06,1,13,NA,54,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-10-25T00:00:00Z,NA,H,2013-11-06T00:00:00Z,NA,H,1,13,13,2013-10-25,2013-11-06,702,702,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1076,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-25,2013-11-06,1,13,NA,54,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-10-25T00:00:00Z,NA,H,2013-11-06T00:00:00Z,NA,H,1,13,13,2013-10-25,2013-11-06,702,702,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1076,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-07,2013-12-24,14,61,NA,54,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-11-07T00:00:00Z,NA,H,2013-12-24T00:00:00Z,NA,H,14,61,48,2013-11-07,2013-12-24,3888,2592,DURD,48,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1076,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-07,2013-12-24,14,61,NA,54,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-11-07T00:00:00Z,NA,H,2013-12-24T00:00:00Z,NA,H,14,61,48,2013-11-07,2013-12-24,3888,2592,DOSE,3888,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1076,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-07,2013-12-24,14,61,NA,54,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-11-07T00:00:00Z,NA,H,2013-12-24T00:00:00Z,NA,H,14,61,48,2013-11-07,2013-12-24,3888,2592,PLDOSE,2592,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1076,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-07,2013-12-24,14,61,NA,54,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-11-07T00:00:00Z,NA,H,2013-12-24T00:00:00Z,NA,H,14,61,48,2013-11-07,2013-12-24,3888,2592,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1076,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-07,2013-12-24,14,61,NA,54,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-11-07T00:00:00Z,NA,H,2013-12-24T00:00:00Z,NA,H,14,61,48,2013-11-07,2013-12-24,3888,2592,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2013-12-24,NA,NA,TDURD,61,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2013-12-24,NA,NA,TDOSE,4590,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2013-12-24,NA,NA,AVDDSE,75.24590163934427,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2013-12-24,NA,NA,TPDOSE,3294,NA,OVERALL,Total planned dose (mg),11,NA,14,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2013-12-24,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2013-12-24,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2013-12-24,NA,NA,TDOSINT,139.34426229508196,NA,OVERALL,Overall dose intensity (%),90,NA,17,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-11-07T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-11-07,2013-12-24,NA,NA,PDURD,48,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-11-07T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-11-07,2013-12-24,NA,NA,PDOSE,3888,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-11-07T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-11-07,2013-12-24,NA,NA,PPDOSE,2592,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-11-07T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-11-07,2013-12-24,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-11-07T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-11-07,2013-12-24,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-11-07T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-11-07,2013-12-24,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1076,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2013-12-24T23:59:59Z,2013-11-07T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-11-07,2013-12-24,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1076,2013-10-25,2013-12-24,2013-10-25,2013-12-24,NA,2014-01-21,NA,NA,703,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-24,61,NA,2013-12-24,DISCONTINUED,NA,2013-10-25,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1086,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-02,2012-09-16,1,15,NA,54,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-02T00:00:00Z,NA,H,2012-09-16T00:00:00Z,NA,H,1,15,15,2012-09-02,2012-09-16,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1086,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-02,2012-09-16,1,15,NA,54,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-02T00:00:00Z,NA,H,2012-09-16T00:00:00Z,NA,H,1,15,15,2012-09-02,2012-09-16,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1086,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-02,2012-09-16,1,15,NA,54,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-02T00:00:00Z,NA,H,2012-09-16T00:00:00Z,NA,H,1,15,15,2012-09-02,2012-09-16,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1086,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-02,2012-09-16,1,15,NA,54,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-02T00:00:00Z,NA,H,2012-09-16T00:00:00Z,NA,H,1,15,15,2012-09-02,2012-09-16,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1086,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-02,2012-09-16,1,15,NA,54,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-02T00:00:00Z,NA,H,2012-09-16T00:00:00Z,NA,H,1,15,15,2012-09-02,2012-09-16,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1086,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-17,2012-12-04,16,94,NA,54,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-17T00:00:00Z,NA,H,2012-12-04T00:00:00Z,NA,H,16,94,79,2012-09-17,2012-12-04,4266,4266,DURD,79,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1086,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-17,2012-12-04,16,94,NA,54,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-17T00:00:00Z,NA,H,2012-12-04T00:00:00Z,NA,H,16,94,79,2012-09-17,2012-12-04,4266,4266,DOSE,4266,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1086,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-17,2012-12-04,16,94,NA,54,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-17T00:00:00Z,NA,H,2012-12-04T00:00:00Z,NA,H,16,94,79,2012-09-17,2012-12-04,4266,4266,PLDOSE,4266,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1086,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-17,2012-12-04,16,94,NA,54,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-17T00:00:00Z,NA,H,2012-12-04T00:00:00Z,NA,H,16,94,79,2012-09-17,2012-12-04,4266,4266,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1086,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-17,2012-12-04,16,94,NA,54,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-17T00:00:00Z,NA,H,2012-12-04T00:00:00Z,NA,H,16,94,79,2012-09-17,2012-12-04,4266,4266,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-02T00:00:00Z,NA,NA,2012-12-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-02,2012-12-04,NA,NA,TDURD,94,NA,OVERALL,Overall duration (days),7,>=90 days,11,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-02T00:00:00Z,NA,NA,2012-12-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-02,2012-12-04,NA,NA,TDOSE,5076,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-02T00:00:00Z,NA,NA,2012-12-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-02,2012-12-04,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-02T00:00:00Z,NA,NA,2012-12-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-02,2012-12-04,NA,NA,TPDOSE,5076,NA,OVERALL,Total planned dose (mg),11,NA,14,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-02T00:00:00Z,NA,NA,2012-12-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-02,2012-12-04,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-02T00:00:00Z,NA,NA,2012-12-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-02,2012-12-04,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-02T00:00:00Z,NA,NA,2012-12-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-02,2012-12-04,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-17T00:00:00Z,NA,NA,2012-12-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-17,2012-12-04,NA,NA,PDURD,79,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-17T00:00:00Z,NA,NA,2012-12-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-17,2012-12-04,NA,NA,PDOSE,4266,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-17T00:00:00Z,NA,NA,2012-12-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-17,2012-12-04,NA,NA,PPDOSE,4266,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-17T00:00:00Z,NA,NA,2012-12-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-17,2012-12-04,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-17T00:00:00Z,NA,NA,2012-12-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-17,2012-12-04,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-17T00:00:00Z,NA,NA,2012-12-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-17,2012-12-04,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1086,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-02,2012-09-02T00:00:00Z,2012-12-04T23:59:59Z,2012-09-17T00:00:00Z,NA,NA,2012-12-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-17,2012-12-04,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1086,2012-09-02,2012-12-24,2012-09-02,2012-12-04,NA,2013-03-26,NA,NA,703,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-22,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-12-04,94,NA,2012-12-24,DISCONTINUED,2013-03-26,2012-09-02,NA,NA,NA,2013-01-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1096,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-25,2013-02-09,1,16,NA,0,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-01-25T00:00:00Z,NA,H,2013-02-09T00:00:00Z,NA,H,1,16,16,2013-01-25,2013-02-09,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1096,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-25,2013-02-09,1,16,NA,0,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-01-25T00:00:00Z,NA,H,2013-02-09T00:00:00Z,NA,H,1,16,16,2013-01-25,2013-02-09,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1096,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-25,2013-02-09,1,16,NA,0,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-01-25T00:00:00Z,NA,H,2013-02-09T00:00:00Z,NA,H,1,16,16,2013-01-25,2013-02-09,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1096,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-25,2013-02-09,1,16,NA,0,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-01-25T00:00:00Z,NA,H,2013-02-09T00:00:00Z,NA,H,1,16,16,2013-01-25,2013-02-09,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1096,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-25,2013-02-09,1,16,NA,0,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-01-25T00:00:00Z,NA,H,2013-02-09T00:00:00Z,NA,H,1,16,16,2013-01-25,2013-02-09,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1096,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-10,2013-03-16,17,51,NA,0,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-02-10T00:00:00Z,NA,H,2013-03-16T00:00:00Z,NA,H,17,51,35,2013-02-10,2013-03-16,0,0,DURD,35,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1096,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-10,2013-03-16,17,51,NA,0,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-02-10T00:00:00Z,NA,H,2013-03-16T00:00:00Z,NA,H,17,51,35,2013-02-10,2013-03-16,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1096,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-10,2013-03-16,17,51,NA,0,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-02-10T00:00:00Z,NA,H,2013-03-16T00:00:00Z,NA,H,17,51,35,2013-02-10,2013-03-16,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1096,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-10,2013-03-16,17,51,NA,0,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-02-10T00:00:00Z,NA,H,2013-03-16T00:00:00Z,NA,H,17,51,35,2013-02-10,2013-03-16,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1096,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-10,2013-03-16,17,51,NA,0,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-02-10T00:00:00Z,NA,H,2013-03-16T00:00:00Z,NA,H,17,51,35,2013-02-10,2013-03-16,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-03-16,NA,NA,TDURD,51,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-03-16,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-03-16,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-03-16,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-03-16,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-03-16,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-03-16,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-02-10T00:00:00Z,NA,NA,2013-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-02-10,2013-03-16,NA,NA,PDURD,35,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-02-10T00:00:00Z,NA,NA,2013-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-02-10,2013-03-16,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-02-10T00:00:00Z,NA,NA,2013-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-02-10,2013-03-16,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-02-10T00:00:00Z,NA,NA,2013-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-02-10,2013-03-16,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-02-10T00:00:00Z,NA,NA,2013-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-02-10,2013-03-16,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-02-10T00:00:00Z,NA,NA,2013-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-02-10,2013-03-16,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1096,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-03-16T23:59:59Z,2013-02-10T00:00:00Z,NA,NA,2013-03-16T00:00:00Z,NA,NA,NA,NA,NA,2013-02-10,2013-03-16,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1096,2013-01-25,2013-03-29,2013-01-25,2013-03-16,NA,2013-03-29,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-19,-37,Placebo,Placebo,H,H,2013-03-16,51,NA,2013-03-29,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-03-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1100,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-13,2013-03-29,1,17,NA,0,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-13T00:00:00Z,NA,H,2013-03-29T00:00:00Z,NA,H,1,17,17,2013-03-13,2013-03-29,0,0,DURD,17,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1100,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-13,2013-03-29,1,17,NA,0,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-13T00:00:00Z,NA,H,2013-03-29T00:00:00Z,NA,H,1,17,17,2013-03-13,2013-03-29,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1100,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-13,2013-03-29,1,17,NA,0,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-13T00:00:00Z,NA,H,2013-03-29T00:00:00Z,NA,H,1,17,17,2013-03-13,2013-03-29,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1100,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-13,2013-03-29,1,17,NA,0,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-13T00:00:00Z,NA,H,2013-03-29T00:00:00Z,NA,H,1,17,17,2013-03-13,2013-03-29,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1100,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-13,2013-03-29,1,17,NA,0,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-13T00:00:00Z,NA,H,2013-03-29T00:00:00Z,NA,H,1,17,17,2013-03-13,2013-03-29,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1100,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-30,2013-08-28,18,169,NA,0,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-30T00:00:00Z,NA,H,2013-08-28T00:00:00Z,NA,H,18,169,152,2013-03-30,2013-08-28,0,0,DURD,152,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1100,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-30,2013-08-28,18,169,NA,0,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-30T00:00:00Z,NA,H,2013-08-28T00:00:00Z,NA,H,18,169,152,2013-03-30,2013-08-28,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1100,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-30,2013-08-28,18,169,NA,0,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-30T00:00:00Z,NA,H,2013-08-28T00:00:00Z,NA,H,18,169,152,2013-03-30,2013-08-28,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1100,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-30,2013-08-28,18,169,NA,0,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-30T00:00:00Z,NA,H,2013-08-28T00:00:00Z,NA,H,18,169,152,2013-03-30,2013-08-28,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1100,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-30,2013-08-28,18,169,NA,0,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-30T00:00:00Z,NA,H,2013-08-28T00:00:00Z,NA,H,18,169,152,2013-03-30,2013-08-28,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1100,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-29,2013-09-14,170,186,NA,0,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-08-29T00:00:00Z,NA,H,2013-09-14T00:00:00Z,NA,H,170,186,17,2013-08-29,2013-09-14,0,0,DURD,17,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1100,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-29,2013-09-14,170,186,NA,0,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-08-29T00:00:00Z,NA,H,2013-09-14T00:00:00Z,NA,H,170,186,17,2013-08-29,2013-09-14,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1100,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-29,2013-09-14,170,186,NA,0,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-08-29T00:00:00Z,NA,H,2013-09-14T00:00:00Z,NA,H,170,186,17,2013-08-29,2013-09-14,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1100,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-29,2013-09-14,170,186,NA,0,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-08-29T00:00:00Z,NA,H,2013-09-14T00:00:00Z,NA,H,170,186,17,2013-08-29,2013-09-14,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1100,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-29,2013-09-14,170,186,NA,0,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-08-29T00:00:00Z,NA,H,2013-09-14T00:00:00Z,NA,H,170,186,17,2013-08-29,2013-09-14,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-13T00:00:00Z,NA,NA,2013-09-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-13,2013-09-14,NA,NA,TDURD,186,NA,OVERALL,Overall duration (days),7,>=90 days,16,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-13T00:00:00Z,NA,NA,2013-09-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-13,2013-09-14,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-13T00:00:00Z,NA,NA,2013-09-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-13,2013-09-14,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-13T00:00:00Z,NA,NA,2013-09-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-13,2013-09-14,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-13T00:00:00Z,NA,NA,2013-09-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-13,2013-09-14,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-13T00:00:00Z,NA,NA,2013-09-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-13,2013-09-14,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-13T00:00:00Z,NA,NA,2013-09-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-13,2013-09-14,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-30T00:00:00Z,NA,NA,2013-09-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-30,2013-09-14,NA,NA,PDURD,169,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-30T00:00:00Z,NA,NA,2013-09-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-30,2013-09-14,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-30T00:00:00Z,NA,NA,2013-09-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-30,2013-09-14,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-30T00:00:00Z,NA,NA,2013-09-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-30,2013-09-14,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-30T00:00:00Z,NA,NA,2013-09-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-30,2013-09-14,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-30T00:00:00Z,NA,NA,2013-09-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-30,2013-09-14,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1100,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-13,2013-03-13T00:00:00Z,2013-09-14T23:59:59Z,2013-03-30T00:00:00Z,NA,NA,2013-09-14T00:00:00Z,NA,NA,NA,NA,NA,2013-03-30,2013-09-14,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1100,2013-03-13,2013-09-14,2013-03-13,2013-09-14,NA,2013-09-14T15:00,NA,NA,703,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-28,-13,Placebo,Placebo,H,H,2013-09-14,186,NA,2013-09-14,COMPLETED,NA,2013-03-13,NA,NA,NA,2013-09-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1119,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-20,2013-03-10,1,19,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-02-20T00:00:00Z,NA,H,2013-03-10T00:00:00Z,NA,H,1,19,19,2013-02-20,2013-03-10,1026,1026,DURD,19,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1119,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-20,2013-03-10,1,19,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-02-20T00:00:00Z,NA,H,2013-03-10T00:00:00Z,NA,H,1,19,19,2013-02-20,2013-03-10,1026,1026,DOSE,1026,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1119,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-20,2013-03-10,1,19,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-02-20T00:00:00Z,NA,H,2013-03-10T00:00:00Z,NA,H,1,19,19,2013-02-20,2013-03-10,1026,1026,PLDOSE,1026,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1119,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-20,2013-03-10,1,19,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-02-20T00:00:00Z,NA,H,2013-03-10T00:00:00Z,NA,H,1,19,19,2013-02-20,2013-03-10,1026,1026,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1119,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-20,2013-03-10,1,19,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-02-20T00:00:00Z,NA,H,2013-03-10T00:00:00Z,NA,H,1,19,19,2013-02-20,2013-03-10,1026,1026,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1119,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-11,2013-06-13,20,114,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-03-11T00:00:00Z,NA,H,2013-06-13T00:00:00Z,NA,H,20,114,95,2013-03-11,2013-06-13,5130,5130,DURD,95,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1119,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-11,2013-06-13,20,114,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-03-11T00:00:00Z,NA,H,2013-06-13T00:00:00Z,NA,H,20,114,95,2013-03-11,2013-06-13,5130,5130,DOSE,5130,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1119,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-11,2013-06-13,20,114,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-03-11T00:00:00Z,NA,H,2013-06-13T00:00:00Z,NA,H,20,114,95,2013-03-11,2013-06-13,5130,5130,PLDOSE,5130,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1119,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-11,2013-06-13,20,114,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-03-11T00:00:00Z,NA,H,2013-06-13T00:00:00Z,NA,H,20,114,95,2013-03-11,2013-06-13,5130,5130,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1119,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-11,2013-06-13,20,114,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-03-11T00:00:00Z,NA,H,2013-06-13T00:00:00Z,NA,H,20,114,95,2013-03-11,2013-06-13,5130,5130,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-06-13,NA,NA,TDURD,114,NA,OVERALL,Overall duration (days),7,>=90 days,11,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-06-13,NA,NA,TDOSE,6156,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-06-13,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-06-13,NA,NA,TPDOSE,6156,NA,OVERALL,Total planned dose (mg),11,NA,14,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-06-13,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-06-13,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-06-13,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-03-11T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-03-11,2013-06-13,NA,NA,PDURD,95,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-03-11T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-03-11,2013-06-13,NA,NA,PDOSE,5130,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-03-11T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-03-11,2013-06-13,NA,NA,PPDOSE,5130,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-03-11T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-03-11,2013-06-13,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-03-11T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-03-11,2013-06-13,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-03-11T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-03-11,2013-06-13,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1119,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-06-13T23:59:59Z,2013-03-11T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-03-11,2013-06-13,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1119,2013-02-20,2013-06-13,2013-02-20,2013-06-13,NA,2013-08-24,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-18,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-13,114,NA,2013-06-13,DISCONTINUED,2013-08-24,2013-02-20,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1175,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-20,2013-12-26,1,7,NA,0,2013-12-20,2013-12-20T00:00:00Z,2013-12-26T23:59:59Z,2013-12-20T00:00:00Z,NA,H,2013-12-26T00:00:00Z,NA,H,1,7,7,2013-12-20,2013-12-26,0,0,DURD,7,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1175,2013-12-20,2013-12-31,2013-12-20,2013-12-26,NA,2013-12-31T13:15,NA,NA,703,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-13,-7,Placebo,Placebo,H,H,2013-12-26,7,NA,2013-12-31,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2013-12-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1175,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-20,2013-12-26,1,7,NA,0,2013-12-20,2013-12-20T00:00:00Z,2013-12-26T23:59:59Z,2013-12-20T00:00:00Z,NA,H,2013-12-26T00:00:00Z,NA,H,1,7,7,2013-12-20,2013-12-26,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1175,2013-12-20,2013-12-31,2013-12-20,2013-12-26,NA,2013-12-31T13:15,NA,NA,703,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-13,-7,Placebo,Placebo,H,H,2013-12-26,7,NA,2013-12-31,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2013-12-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1175,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-20,2013-12-26,1,7,NA,0,2013-12-20,2013-12-20T00:00:00Z,2013-12-26T23:59:59Z,2013-12-20T00:00:00Z,NA,H,2013-12-26T00:00:00Z,NA,H,1,7,7,2013-12-20,2013-12-26,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1175,2013-12-20,2013-12-31,2013-12-20,2013-12-26,NA,2013-12-31T13:15,NA,NA,703,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-13,-7,Placebo,Placebo,H,H,2013-12-26,7,NA,2013-12-31,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2013-12-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1175,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-20,2013-12-26,1,7,NA,0,2013-12-20,2013-12-20T00:00:00Z,2013-12-26T23:59:59Z,2013-12-20T00:00:00Z,NA,H,2013-12-26T00:00:00Z,NA,H,1,7,7,2013-12-20,2013-12-26,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1175,2013-12-20,2013-12-31,2013-12-20,2013-12-26,NA,2013-12-31T13:15,NA,NA,703,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-13,-7,Placebo,Placebo,H,H,2013-12-26,7,NA,2013-12-31,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2013-12-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1175,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-20,2013-12-26,1,7,NA,0,2013-12-20,2013-12-20T00:00:00Z,2013-12-26T23:59:59Z,2013-12-20T00:00:00Z,NA,H,2013-12-26T00:00:00Z,NA,H,1,7,7,2013-12-20,2013-12-26,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1175,2013-12-20,2013-12-31,2013-12-20,2013-12-26,NA,2013-12-31T13:15,NA,NA,703,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-13,-7,Placebo,Placebo,H,H,2013-12-26,7,NA,2013-12-31,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2013-12-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1175,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2013-12-26T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2013-12-26T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2013-12-26,NA,NA,TDURD,7,NA,OVERALL,Overall duration (days),7,< 30 days,6,1175,2013-12-20,2013-12-31,2013-12-20,2013-12-26,NA,2013-12-31T13:15,NA,NA,703,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-13,-7,Placebo,Placebo,H,H,2013-12-26,7,NA,2013-12-31,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2013-12-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1175,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2013-12-26T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2013-12-26T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2013-12-26,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,7,1175,2013-12-20,2013-12-31,2013-12-20,2013-12-26,NA,2013-12-31T13:15,NA,NA,703,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-13,-7,Placebo,Placebo,H,H,2013-12-26,7,NA,2013-12-31,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2013-12-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1175,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2013-12-26T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2013-12-26T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2013-12-26,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1175,2013-12-20,2013-12-31,2013-12-20,2013-12-26,NA,2013-12-31T13:15,NA,NA,703,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-13,-7,Placebo,Placebo,H,H,2013-12-26,7,NA,2013-12-31,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2013-12-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1175,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2013-12-26T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2013-12-26T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2013-12-26,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,9,1175,2013-12-20,2013-12-31,2013-12-20,2013-12-26,NA,2013-12-31T13:15,NA,NA,703,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-13,-7,Placebo,Placebo,H,H,2013-12-26,7,NA,2013-12-31,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2013-12-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1175,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2013-12-26T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2013-12-26T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2013-12-26,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1175,2013-12-20,2013-12-31,2013-12-20,2013-12-26,NA,2013-12-31T13:15,NA,NA,703,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-13,-7,Placebo,Placebo,H,H,2013-12-26,7,NA,2013-12-31,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2013-12-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1175,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2013-12-26T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2013-12-26T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2013-12-26,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1175,2013-12-20,2013-12-31,2013-12-20,2013-12-26,NA,2013-12-31T13:15,NA,NA,703,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-13,-7,Placebo,Placebo,H,H,2013-12-26,7,NA,2013-12-31,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2013-12-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1175,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2013-12-26T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2013-12-26T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2013-12-26,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,12,1175,2013-12-20,2013-12-31,2013-12-20,2013-12-26,NA,2013-12-31T13:15,NA,NA,703,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-13,-7,Placebo,Placebo,H,H,2013-12-26,7,NA,2013-12-31,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2013-12-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1182,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-17,2013-10-31,1,15,NA,54,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2013-10-31T00:00:00Z,NA,H,1,15,15,2013-10-17,2013-10-31,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1182,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-17,2013-10-31,1,15,NA,54,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2013-10-31T00:00:00Z,NA,H,1,15,15,2013-10-17,2013-10-31,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1182,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-17,2013-10-31,1,15,NA,54,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2013-10-31T00:00:00Z,NA,H,1,15,15,2013-10-17,2013-10-31,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1182,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-17,2013-10-31,1,15,NA,54,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2013-10-31T00:00:00Z,NA,H,1,15,15,2013-10-17,2013-10-31,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1182,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-17,2013-10-31,1,15,NA,54,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2013-10-31T00:00:00Z,NA,H,1,15,15,2013-10-17,2013-10-31,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1182,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-01,2013-12-11,16,56,NA,54,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-11-01T00:00:00Z,NA,H,2013-12-11T00:00:00Z,NA,H,16,56,41,2013-11-01,2013-12-11,2214,2214,DURD,41,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1182,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-01,2013-12-11,16,56,NA,54,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-11-01T00:00:00Z,NA,H,2013-12-11T00:00:00Z,NA,H,16,56,41,2013-11-01,2013-12-11,2214,2214,DOSE,2214,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1182,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-01,2013-12-11,16,56,NA,54,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-11-01T00:00:00Z,NA,H,2013-12-11T00:00:00Z,NA,H,16,56,41,2013-11-01,2013-12-11,2214,2214,PLDOSE,2214,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1182,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-01,2013-12-11,16,56,NA,54,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-11-01T00:00:00Z,NA,H,2013-12-11T00:00:00Z,NA,H,16,56,41,2013-11-01,2013-12-11,2214,2214,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1182,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-01,2013-12-11,16,56,NA,54,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-11-01T00:00:00Z,NA,H,2013-12-11T00:00:00Z,NA,H,16,56,41,2013-11-01,2013-12-11,2214,2214,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2013-12-11T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2013-12-11,NA,NA,TDURD,56,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2013-12-11T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2013-12-11,NA,NA,TDOSE,3024,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2013-12-11T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2013-12-11,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2013-12-11T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2013-12-11,NA,NA,TPDOSE,3024,NA,OVERALL,Total planned dose (mg),11,NA,14,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2013-12-11T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2013-12-11,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2013-12-11T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2013-12-11,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2013-12-11T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2013-12-11,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-11-01T00:00:00Z,NA,NA,2013-12-11T00:00:00Z,NA,NA,NA,NA,NA,2013-11-01,2013-12-11,NA,NA,PDURD,41,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-11-01T00:00:00Z,NA,NA,2013-12-11T00:00:00Z,NA,NA,NA,NA,NA,2013-11-01,2013-12-11,NA,NA,PDOSE,2214,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-11-01T00:00:00Z,NA,NA,2013-12-11T00:00:00Z,NA,NA,NA,NA,NA,2013-11-01,2013-12-11,NA,NA,PPDOSE,2214,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-11-01T00:00:00Z,NA,NA,2013-12-11T00:00:00Z,NA,NA,NA,NA,NA,2013-11-01,2013-12-11,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-11-01T00:00:00Z,NA,NA,2013-12-11T00:00:00Z,NA,NA,NA,NA,NA,2013-11-01,2013-12-11,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-11-01T00:00:00Z,NA,NA,2013-12-11T00:00:00Z,NA,NA,NA,NA,NA,2013-11-01,2013-12-11,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1182,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-17,2013-10-17T00:00:00Z,2013-12-11T23:59:59Z,2013-11-01T00:00:00Z,NA,NA,2013-12-11T00:00:00Z,NA,NA,NA,NA,NA,2013-11-01,2013-12-11,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1182,2013-10-17,2013-12-12,2013-10-17,2013-12-11,NA,2014-01-14,NA,NA,703,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-08,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-11,56,NA,2013-12-12,DISCONTINUED,NA,2013-10-17,NA,NA,NA,2013-12-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1197,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-16,2013-06-29,1,14,NA,54,2013-06-16,2013-06-16T00:00:00Z,2013-06-29T23:59:59Z,2013-06-16T00:00:00Z,NA,H,2013-06-29T00:00:00Z,NA,H,1,14,14,2013-06-16,2013-06-29,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1197,2013-06-16,2013-07-22,2013-06-16,2013-06-29,NA,2013-07-22,NA,NA,703,76,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-01,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-29,14,NA,2013-07-22,DISCONTINUED,NA,2013-06-16,NA,NA,NA,2013-06-29,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1197,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-16,2013-06-29,1,14,NA,54,2013-06-16,2013-06-16T00:00:00Z,2013-06-29T23:59:59Z,2013-06-16T00:00:00Z,NA,H,2013-06-29T00:00:00Z,NA,H,1,14,14,2013-06-16,2013-06-29,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1197,2013-06-16,2013-07-22,2013-06-16,2013-06-29,NA,2013-07-22,NA,NA,703,76,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-01,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-29,14,NA,2013-07-22,DISCONTINUED,NA,2013-06-16,NA,NA,NA,2013-06-29,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1197,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-16,2013-06-29,1,14,NA,54,2013-06-16,2013-06-16T00:00:00Z,2013-06-29T23:59:59Z,2013-06-16T00:00:00Z,NA,H,2013-06-29T00:00:00Z,NA,H,1,14,14,2013-06-16,2013-06-29,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1197,2013-06-16,2013-07-22,2013-06-16,2013-06-29,NA,2013-07-22,NA,NA,703,76,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-01,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-29,14,NA,2013-07-22,DISCONTINUED,NA,2013-06-16,NA,NA,NA,2013-06-29,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1197,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-16,2013-06-29,1,14,NA,54,2013-06-16,2013-06-16T00:00:00Z,2013-06-29T23:59:59Z,2013-06-16T00:00:00Z,NA,H,2013-06-29T00:00:00Z,NA,H,1,14,14,2013-06-16,2013-06-29,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1197,2013-06-16,2013-07-22,2013-06-16,2013-06-29,NA,2013-07-22,NA,NA,703,76,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-01,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-29,14,NA,2013-07-22,DISCONTINUED,NA,2013-06-16,NA,NA,NA,2013-06-29,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1197,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-16,2013-06-29,1,14,NA,54,2013-06-16,2013-06-16T00:00:00Z,2013-06-29T23:59:59Z,2013-06-16T00:00:00Z,NA,H,2013-06-29T00:00:00Z,NA,H,1,14,14,2013-06-16,2013-06-29,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1197,2013-06-16,2013-07-22,2013-06-16,2013-06-29,NA,2013-07-22,NA,NA,703,76,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-01,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-29,14,NA,2013-07-22,DISCONTINUED,NA,2013-06-16,NA,NA,NA,2013-06-29,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1197,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-16,2013-06-16T00:00:00Z,2013-06-29T23:59:59Z,2013-06-16T00:00:00Z,NA,NA,2013-06-29T00:00:00Z,NA,NA,NA,NA,NA,2013-06-16,2013-06-29,NA,NA,TDURD,14,NA,OVERALL,Overall duration (days),7,< 30 days,6,1197,2013-06-16,2013-07-22,2013-06-16,2013-06-29,NA,2013-07-22,NA,NA,703,76,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-01,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-29,14,NA,2013-07-22,DISCONTINUED,NA,2013-06-16,NA,NA,NA,2013-06-29,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1197,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-16,2013-06-16T00:00:00Z,2013-06-29T23:59:59Z,2013-06-16T00:00:00Z,NA,NA,2013-06-29T00:00:00Z,NA,NA,NA,NA,NA,2013-06-16,2013-06-29,NA,NA,TDOSE,756,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1197,2013-06-16,2013-07-22,2013-06-16,2013-06-29,NA,2013-07-22,NA,NA,703,76,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-01,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-29,14,NA,2013-07-22,DISCONTINUED,NA,2013-06-16,NA,NA,NA,2013-06-29,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1197,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-16,2013-06-16T00:00:00Z,2013-06-29T23:59:59Z,2013-06-16T00:00:00Z,NA,NA,2013-06-29T00:00:00Z,NA,NA,NA,NA,NA,2013-06-16,2013-06-29,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1197,2013-06-16,2013-07-22,2013-06-16,2013-06-29,NA,2013-07-22,NA,NA,703,76,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-01,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-29,14,NA,2013-07-22,DISCONTINUED,NA,2013-06-16,NA,NA,NA,2013-06-29,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1197,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-16,2013-06-16T00:00:00Z,2013-06-29T23:59:59Z,2013-06-16T00:00:00Z,NA,NA,2013-06-29T00:00:00Z,NA,NA,NA,NA,NA,2013-06-16,2013-06-29,NA,NA,TPDOSE,756,NA,OVERALL,Total planned dose (mg),11,NA,9,1197,2013-06-16,2013-07-22,2013-06-16,2013-06-29,NA,2013-07-22,NA,NA,703,76,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-01,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-29,14,NA,2013-07-22,DISCONTINUED,NA,2013-06-16,NA,NA,NA,2013-06-29,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1197,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-16,2013-06-16T00:00:00Z,2013-06-29T23:59:59Z,2013-06-16T00:00:00Z,NA,NA,2013-06-29T00:00:00Z,NA,NA,NA,NA,NA,2013-06-16,2013-06-29,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1197,2013-06-16,2013-07-22,2013-06-16,2013-06-29,NA,2013-07-22,NA,NA,703,76,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-01,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-29,14,NA,2013-07-22,DISCONTINUED,NA,2013-06-16,NA,NA,NA,2013-06-29,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1197,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-16,2013-06-16T00:00:00Z,2013-06-29T23:59:59Z,2013-06-16T00:00:00Z,NA,NA,2013-06-29T00:00:00Z,NA,NA,NA,NA,NA,2013-06-16,2013-06-29,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1197,2013-06-16,2013-07-22,2013-06-16,2013-06-29,NA,2013-07-22,NA,NA,703,76,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-01,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-29,14,NA,2013-07-22,DISCONTINUED,NA,2013-06-16,NA,NA,NA,2013-06-29,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1197,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-16,2013-06-16T00:00:00Z,2013-06-29T23:59:59Z,2013-06-16T00:00:00Z,NA,NA,2013-06-29T00:00:00Z,NA,NA,NA,NA,NA,2013-06-16,2013-06-29,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1197,2013-06-16,2013-07-22,2013-06-16,2013-06-29,NA,2013-07-22,NA,NA,703,76,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-01,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-29,14,NA,2013-07-22,DISCONTINUED,NA,2013-06-16,NA,NA,NA,2013-06-29,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1210,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-16,2013-03-30,1,15,NA,0,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-16T00:00:00Z,NA,H,2013-03-30T00:00:00Z,NA,H,1,15,15,2013-03-16,2013-03-30,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1210,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-16,2013-03-30,1,15,NA,0,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-16T00:00:00Z,NA,H,2013-03-30T00:00:00Z,NA,H,1,15,15,2013-03-16,2013-03-30,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1210,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-16,2013-03-30,1,15,NA,0,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-16T00:00:00Z,NA,H,2013-03-30T00:00:00Z,NA,H,1,15,15,2013-03-16,2013-03-30,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1210,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-16,2013-03-30,1,15,NA,0,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-16T00:00:00Z,NA,H,2013-03-30T00:00:00Z,NA,H,1,15,15,2013-03-16,2013-03-30,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1210,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-16,2013-03-30,1,15,NA,0,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-16T00:00:00Z,NA,H,2013-03-30T00:00:00Z,NA,H,1,15,15,2013-03-16,2013-03-30,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1210,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-31,2013-08-24,16,162,NA,0,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-31T00:00:00Z,NA,H,2013-08-24T00:00:00Z,NA,H,16,162,147,2013-03-31,2013-08-24,0,0,DURD,147,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1210,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-31,2013-08-24,16,162,NA,0,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-31T00:00:00Z,NA,H,2013-08-24T00:00:00Z,NA,H,16,162,147,2013-03-31,2013-08-24,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1210,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-31,2013-08-24,16,162,NA,0,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-31T00:00:00Z,NA,H,2013-08-24T00:00:00Z,NA,H,16,162,147,2013-03-31,2013-08-24,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1210,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-31,2013-08-24,16,162,NA,0,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-31T00:00:00Z,NA,H,2013-08-24T00:00:00Z,NA,H,16,162,147,2013-03-31,2013-08-24,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1210,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-31,2013-08-24,16,162,NA,0,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-31T00:00:00Z,NA,H,2013-08-24T00:00:00Z,NA,H,16,162,147,2013-03-31,2013-08-24,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1210,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-25,2013-09-06,163,175,NA,0,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-08-25T00:00:00Z,NA,H,2013-09-06T00:00:00Z,NA,H,163,175,13,2013-08-25,2013-09-06,0,0,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1210,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-25,2013-09-06,163,175,NA,0,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-08-25T00:00:00Z,NA,H,2013-09-06T00:00:00Z,NA,H,163,175,13,2013-08-25,2013-09-06,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1210,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-25,2013-09-06,163,175,NA,0,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-08-25T00:00:00Z,NA,H,2013-09-06T00:00:00Z,NA,H,163,175,13,2013-08-25,2013-09-06,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1210,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-25,2013-09-06,163,175,NA,0,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-08-25T00:00:00Z,NA,H,2013-09-06T00:00:00Z,NA,H,163,175,13,2013-08-25,2013-09-06,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1210,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-25,2013-09-06,163,175,NA,0,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-08-25T00:00:00Z,NA,H,2013-09-06T00:00:00Z,NA,H,163,175,13,2013-08-25,2013-09-06,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1210,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-16T00:00:00Z,NA,NA,2013-09-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-16,2013-09-06,NA,NA,TDURD,175,NA,OVERALL,Overall duration (days),7,>=90 days,16,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1210,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-16T00:00:00Z,NA,NA,2013-09-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-16,2013-09-06,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1210,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-16T00:00:00Z,NA,NA,2013-09-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-16,2013-09-06,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1210,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-16T00:00:00Z,NA,NA,2013-09-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-16,2013-09-06,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1210,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-16T00:00:00Z,NA,NA,2013-09-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-16,2013-09-06,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1210,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-16T00:00:00Z,NA,NA,2013-09-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-16,2013-09-06,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1210,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-16T00:00:00Z,NA,NA,2013-09-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-16,2013-09-06,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1210,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-31T00:00:00Z,NA,NA,2013-09-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-31,2013-09-06,NA,NA,PDURD,160,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1210,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-31T00:00:00Z,NA,NA,2013-09-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-31,2013-09-06,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1210,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-31T00:00:00Z,NA,NA,2013-09-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-31,2013-09-06,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1210,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-31T00:00:00Z,NA,NA,2013-09-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-31,2013-09-06,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1210,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-31T00:00:00Z,NA,NA,2013-09-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-31,2013-09-06,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1210,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-31T00:00:00Z,NA,NA,2013-09-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-31,2013-09-06,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1210,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-16,2013-03-16T00:00:00Z,2013-09-06T23:59:59Z,2013-03-31T00:00:00Z,NA,NA,2013-09-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-31,2013-09-06,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1210,2013-03-16,2013-09-06,2013-03-16,2013-09-06,NA,2013-09-06T13:30,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-8,Placebo,Placebo,H,H,2013-09-06,175,NA,2013-09-06,COMPLETED,NA,2013-03-16,NA,NA,NA,2013-09-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1258,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-20,2012-08-01,1,13,NA,54,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-07-20T00:00:00Z,NA,H,2012-08-01T00:00:00Z,NA,H,1,13,13,2012-07-20,2012-08-01,702,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1258,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-20,2012-08-01,1,13,NA,54,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-07-20T00:00:00Z,NA,H,2012-08-01T00:00:00Z,NA,H,1,13,13,2012-07-20,2012-08-01,702,702,DOSE,702,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1258,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-20,2012-08-01,1,13,NA,54,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-07-20T00:00:00Z,NA,H,2012-08-01T00:00:00Z,NA,H,1,13,13,2012-07-20,2012-08-01,702,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1258,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-20,2012-08-01,1,13,NA,54,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-07-20T00:00:00Z,NA,H,2012-08-01T00:00:00Z,NA,H,1,13,13,2012-07-20,2012-08-01,702,702,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1258,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-20,2012-08-01,1,13,NA,54,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-07-20T00:00:00Z,NA,H,2012-08-01T00:00:00Z,NA,H,1,13,13,2012-07-20,2012-08-01,702,702,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1258,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-02,2012-12-31,14,165,NA,54,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-08-02T00:00:00Z,NA,H,2012-12-31T00:00:00Z,NA,H,14,165,152,2012-08-02,2012-12-31,12312,8208,DURD,152,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1258,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-02,2012-12-31,14,165,NA,54,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-08-02T00:00:00Z,NA,H,2012-12-31T00:00:00Z,NA,H,14,165,152,2012-08-02,2012-12-31,12312,8208,DOSE,12312,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1258,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-02,2012-12-31,14,165,NA,54,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-08-02T00:00:00Z,NA,H,2012-12-31T00:00:00Z,NA,H,14,165,152,2012-08-02,2012-12-31,12312,8208,PLDOSE,8208,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1258,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-02,2012-12-31,14,165,NA,54,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-08-02T00:00:00Z,NA,H,2012-12-31T00:00:00Z,NA,H,14,165,152,2012-08-02,2012-12-31,12312,8208,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1258,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-02,2012-12-31,14,165,NA,54,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-08-02T00:00:00Z,NA,H,2012-12-31T00:00:00Z,NA,H,14,165,152,2012-08-02,2012-12-31,12312,8208,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1258,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-01-01,2013-01-11,166,176,NA,54,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2013-01-01T00:00:00Z,NA,H,2013-01-11T00:00:00Z,NA,H,166,176,11,2013-01-01,2013-01-11,594,594,DURD,11,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1258,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-01-01,2013-01-11,166,176,NA,54,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2013-01-01T00:00:00Z,NA,H,2013-01-11T00:00:00Z,NA,H,166,176,11,2013-01-01,2013-01-11,594,594,DOSE,594,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1258,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-01-01,2013-01-11,166,176,NA,54,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2013-01-01T00:00:00Z,NA,H,2013-01-11T00:00:00Z,NA,H,166,176,11,2013-01-01,2013-01-11,594,594,PLDOSE,594,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1258,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-01-01,2013-01-11,166,176,NA,54,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2013-01-01T00:00:00Z,NA,H,2013-01-11T00:00:00Z,NA,H,166,176,11,2013-01-01,2013-01-11,594,594,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1258,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-01-01,2013-01-11,166,176,NA,54,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2013-01-01T00:00:00Z,NA,H,2013-01-11T00:00:00Z,NA,H,166,176,11,2013-01-01,2013-01-11,594,594,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-07-20T00:00:00Z,NA,NA,2013-01-11T00:00:00Z,NA,NA,NA,NA,NA,2012-07-20,2013-01-11,NA,NA,TDURD,176,NA,OVERALL,Overall duration (days),7,>=90 days,16,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-07-20T00:00:00Z,NA,NA,2013-01-11T00:00:00Z,NA,NA,NA,NA,NA,2012-07-20,2013-01-11,NA,NA,TDOSE,13608,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-07-20T00:00:00Z,NA,NA,2013-01-11T00:00:00Z,NA,NA,NA,NA,NA,2012-07-20,2013-01-11,NA,NA,AVDDSE,77.31818181818181,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-07-20T00:00:00Z,NA,NA,2013-01-11T00:00:00Z,NA,NA,NA,NA,NA,2012-07-20,2013-01-11,NA,NA,TPDOSE,9504,NA,OVERALL,Total planned dose (mg),11,NA,19,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-07-20T00:00:00Z,NA,NA,2013-01-11T00:00:00Z,NA,NA,NA,NA,NA,2012-07-20,2013-01-11,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-07-20T00:00:00Z,NA,NA,2013-01-11T00:00:00Z,NA,NA,NA,NA,NA,2012-07-20,2013-01-11,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-07-20T00:00:00Z,NA,NA,2013-01-11T00:00:00Z,NA,NA,NA,NA,NA,2012-07-20,2013-01-11,NA,NA,TDOSINT,143.1818181818182,NA,OVERALL,Overall dose intensity (%),90,NA,22,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-08-02T00:00:00Z,NA,NA,2013-01-11T00:00:00Z,NA,NA,NA,NA,NA,2012-08-02,2013-01-11,NA,NA,PDURD,163,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-08-02T00:00:00Z,NA,NA,2013-01-11T00:00:00Z,NA,NA,NA,NA,NA,2012-08-02,2013-01-11,NA,NA,PDOSE,12906,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-08-02T00:00:00Z,NA,NA,2013-01-11T00:00:00Z,NA,NA,NA,NA,NA,2012-08-02,2013-01-11,NA,NA,PPDOSE,8802,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-08-02T00:00:00Z,NA,NA,2013-01-11T00:00:00Z,NA,NA,NA,NA,NA,2012-08-02,2013-01-11,NA,NA,PAVDDSE,79.17791411042944,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-08-02T00:00:00Z,NA,NA,2013-01-11T00:00:00Z,NA,NA,NA,NA,NA,2012-08-02,2013-01-11,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-08-02T00:00:00Z,NA,NA,2013-01-11T00:00:00Z,NA,NA,NA,NA,NA,2012-08-02,2013-01-11,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1258,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-20,2012-07-20T00:00:00Z,2013-01-11T23:59:59Z,2012-08-02T00:00:00Z,NA,NA,2013-01-11T00:00:00Z,NA,NA,NA,NA,NA,2012-08-02,2013-01-11,NA,NA,PDOSINT,146.62576687116564,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1258,2012-07-20,2013-01-21,2012-07-20,2013-01-11,NA,2013-01-28,NA,NA,703,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-07-10,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-11,176,NA,2013-01-21,DISCONTINUED,NA,2012-07-20,NA,NA,NA,2013-01-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1279,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-13,2013-06-03,1,22,NA,54,2013-05-13,2013-05-13T00:00:00Z,2013-06-03T23:59:59Z,2013-05-13T00:00:00Z,NA,H,2013-06-03T00:00:00Z,NA,H,1,22,22,2013-05-13,2013-06-03,1188,1188,DURD,22,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1279,2013-05-13,2013-06-22,2013-05-13,2013-06-03,NA,2013-06-22,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-27,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-03,22,NA,2013-06-22,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-06-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1279,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-13,2013-06-03,1,22,NA,54,2013-05-13,2013-05-13T00:00:00Z,2013-06-03T23:59:59Z,2013-05-13T00:00:00Z,NA,H,2013-06-03T00:00:00Z,NA,H,1,22,22,2013-05-13,2013-06-03,1188,1188,DOSE,1188,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1279,2013-05-13,2013-06-22,2013-05-13,2013-06-03,NA,2013-06-22,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-27,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-03,22,NA,2013-06-22,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-06-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1279,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-13,2013-06-03,1,22,NA,54,2013-05-13,2013-05-13T00:00:00Z,2013-06-03T23:59:59Z,2013-05-13T00:00:00Z,NA,H,2013-06-03T00:00:00Z,NA,H,1,22,22,2013-05-13,2013-06-03,1188,1188,PLDOSE,1188,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1279,2013-05-13,2013-06-22,2013-05-13,2013-06-03,NA,2013-06-22,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-27,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-03,22,NA,2013-06-22,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-06-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1279,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-13,2013-06-03,1,22,NA,54,2013-05-13,2013-05-13T00:00:00Z,2013-06-03T23:59:59Z,2013-05-13T00:00:00Z,NA,H,2013-06-03T00:00:00Z,NA,H,1,22,22,2013-05-13,2013-06-03,1188,1188,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1279,2013-05-13,2013-06-22,2013-05-13,2013-06-03,NA,2013-06-22,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-27,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-03,22,NA,2013-06-22,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-06-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1279,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-13,2013-06-03,1,22,NA,54,2013-05-13,2013-05-13T00:00:00Z,2013-06-03T23:59:59Z,2013-05-13T00:00:00Z,NA,H,2013-06-03T00:00:00Z,NA,H,1,22,22,2013-05-13,2013-06-03,1188,1188,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1279,2013-05-13,2013-06-22,2013-05-13,2013-06-03,NA,2013-06-22,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-27,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-03,22,NA,2013-06-22,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-06-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1279,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-13,2013-05-13T00:00:00Z,2013-06-03T23:59:59Z,2013-05-13T00:00:00Z,NA,NA,2013-06-03T00:00:00Z,NA,NA,NA,NA,NA,2013-05-13,2013-06-03,NA,NA,TDURD,22,NA,OVERALL,Overall duration (days),7,< 30 days,6,1279,2013-05-13,2013-06-22,2013-05-13,2013-06-03,NA,2013-06-22,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-27,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-03,22,NA,2013-06-22,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-06-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1279,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-13,2013-05-13T00:00:00Z,2013-06-03T23:59:59Z,2013-05-13T00:00:00Z,NA,NA,2013-06-03T00:00:00Z,NA,NA,NA,NA,NA,2013-05-13,2013-06-03,NA,NA,TDOSE,1188,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1279,2013-05-13,2013-06-22,2013-05-13,2013-06-03,NA,2013-06-22,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-27,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-03,22,NA,2013-06-22,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-06-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1279,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-13,2013-05-13T00:00:00Z,2013-06-03T23:59:59Z,2013-05-13T00:00:00Z,NA,NA,2013-06-03T00:00:00Z,NA,NA,NA,NA,NA,2013-05-13,2013-06-03,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1279,2013-05-13,2013-06-22,2013-05-13,2013-06-03,NA,2013-06-22,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-27,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-03,22,NA,2013-06-22,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-06-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1279,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-13,2013-05-13T00:00:00Z,2013-06-03T23:59:59Z,2013-05-13T00:00:00Z,NA,NA,2013-06-03T00:00:00Z,NA,NA,NA,NA,NA,2013-05-13,2013-06-03,NA,NA,TPDOSE,1188,NA,OVERALL,Total planned dose (mg),11,NA,9,1279,2013-05-13,2013-06-22,2013-05-13,2013-06-03,NA,2013-06-22,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-27,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-03,22,NA,2013-06-22,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-06-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1279,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-13,2013-05-13T00:00:00Z,2013-06-03T23:59:59Z,2013-05-13T00:00:00Z,NA,NA,2013-06-03T00:00:00Z,NA,NA,NA,NA,NA,2013-05-13,2013-06-03,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1279,2013-05-13,2013-06-22,2013-05-13,2013-06-03,NA,2013-06-22,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-27,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-03,22,NA,2013-06-22,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-06-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1279,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-13,2013-05-13T00:00:00Z,2013-06-03T23:59:59Z,2013-05-13T00:00:00Z,NA,NA,2013-06-03T00:00:00Z,NA,NA,NA,NA,NA,2013-05-13,2013-06-03,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1279,2013-05-13,2013-06-22,2013-05-13,2013-06-03,NA,2013-06-22,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-27,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-03,22,NA,2013-06-22,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-06-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1279,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-13,2013-05-13T00:00:00Z,2013-06-03T23:59:59Z,2013-05-13T00:00:00Z,NA,NA,2013-06-03T00:00:00Z,NA,NA,NA,NA,NA,2013-05-13,2013-06-03,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1279,2013-05-13,2013-06-22,2013-05-13,2013-06-03,NA,2013-06-22,NA,NA,703,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-27,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-03,22,NA,2013-06-22,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-06-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1295,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-21,2013-12-05,1,15,NA,54,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-11-21T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,1,15,15,2013-11-21,2013-12-05,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1295,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-21,2013-12-05,1,15,NA,54,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-11-21T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,1,15,15,2013-11-21,2013-12-05,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1295,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-21,2013-12-05,1,15,NA,54,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-11-21T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,1,15,15,2013-11-21,2013-12-05,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1295,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-21,2013-12-05,1,15,NA,54,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-11-21T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,1,15,15,2013-11-21,2013-12-05,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1295,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-21,2013-12-05,1,15,NA,54,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-11-21T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,1,15,15,2013-11-21,2013-12-05,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1295,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-06,2014-04-19,16,150,NA,54,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-12-06T00:00:00Z,NA,H,2014-04-19T00:00:00Z,NA,H,16,150,135,2013-12-06,2014-04-19,10935,7290,DURD,135,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1295,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-06,2014-04-19,16,150,NA,54,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-12-06T00:00:00Z,NA,H,2014-04-19T00:00:00Z,NA,H,16,150,135,2013-12-06,2014-04-19,10935,7290,DOSE,10935,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1295,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-06,2014-04-19,16,150,NA,54,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-12-06T00:00:00Z,NA,H,2014-04-19T00:00:00Z,NA,H,16,150,135,2013-12-06,2014-04-19,10935,7290,PLDOSE,7290,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1295,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-06,2014-04-19,16,150,NA,54,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-12-06T00:00:00Z,NA,H,2014-04-19T00:00:00Z,NA,H,16,150,135,2013-12-06,2014-04-19,10935,7290,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1295,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-06,2014-04-19,16,150,NA,54,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-12-06T00:00:00Z,NA,H,2014-04-19T00:00:00Z,NA,H,16,150,135,2013-12-06,2014-04-19,10935,7290,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-11-21T00:00:00Z,NA,NA,2014-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-11-21,2014-04-19,NA,NA,TDURD,150,NA,OVERALL,Overall duration (days),7,>=90 days,11,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-11-21T00:00:00Z,NA,NA,2014-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-11-21,2014-04-19,NA,NA,TDOSE,11745,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-11-21T00:00:00Z,NA,NA,2014-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-11-21,2014-04-19,NA,NA,AVDDSE,78.3,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-11-21T00:00:00Z,NA,NA,2014-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-11-21,2014-04-19,NA,NA,TPDOSE,8100,NA,OVERALL,Total planned dose (mg),11,NA,14,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-11-21T00:00:00Z,NA,NA,2014-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-11-21,2014-04-19,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-11-21T00:00:00Z,NA,NA,2014-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-11-21,2014-04-19,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-11-21T00:00:00Z,NA,NA,2014-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-11-21,2014-04-19,NA,NA,TDOSINT,145,NA,OVERALL,Overall dose intensity (%),90,NA,17,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-12-06T00:00:00Z,NA,NA,2014-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-12-06,2014-04-19,NA,NA,PDURD,135,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-12-06T00:00:00Z,NA,NA,2014-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-12-06,2014-04-19,NA,NA,PDOSE,10935,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-12-06T00:00:00Z,NA,NA,2014-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-12-06,2014-04-19,NA,NA,PPDOSE,7290,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-12-06T00:00:00Z,NA,NA,2014-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-12-06,2014-04-19,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-12-06T00:00:00Z,NA,NA,2014-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-12-06,2014-04-19,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-12-06T00:00:00Z,NA,NA,2014-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-12-06,2014-04-19,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1295,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-21,2013-11-21T00:00:00Z,2014-04-19T23:59:59Z,2013-12-06T00:00:00Z,NA,NA,2014-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-12-06,2014-04-19,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1295,2013-11-21,2014-05-19,2013-11-21,2014-04-19,NA,2014-05-19T14:45,NA,NA,703,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-24,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-19,150,NA,2014-05-19,DISCONTINUED,NA,2013-11-21,NA,NA,NA,2014-05-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1299,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-12,2012-09-28,1,17,NA,0,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-12T00:00:00Z,NA,H,2012-09-28T00:00:00Z,NA,H,1,17,17,2012-09-12,2012-09-28,0,0,DURD,17,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1299,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-12,2012-09-28,1,17,NA,0,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-12T00:00:00Z,NA,H,2012-09-28T00:00:00Z,NA,H,1,17,17,2012-09-12,2012-09-28,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1299,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-12,2012-09-28,1,17,NA,0,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-12T00:00:00Z,NA,H,2012-09-28T00:00:00Z,NA,H,1,17,17,2012-09-12,2012-09-28,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1299,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-12,2012-09-28,1,17,NA,0,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-12T00:00:00Z,NA,H,2012-09-28T00:00:00Z,NA,H,1,17,17,2012-09-12,2012-09-28,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1299,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-12,2012-09-28,1,17,NA,0,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-12T00:00:00Z,NA,H,2012-09-28T00:00:00Z,NA,H,1,17,17,2012-09-12,2012-09-28,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1299,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-29,2013-03-01,18,171,NA,0,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-29T00:00:00Z,NA,H,2013-03-01T00:00:00Z,NA,H,18,171,154,2012-09-29,2013-03-01,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1299,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-29,2013-03-01,18,171,NA,0,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-29T00:00:00Z,NA,H,2013-03-01T00:00:00Z,NA,H,18,171,154,2012-09-29,2013-03-01,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1299,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-29,2013-03-01,18,171,NA,0,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-29T00:00:00Z,NA,H,2013-03-01T00:00:00Z,NA,H,18,171,154,2012-09-29,2013-03-01,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1299,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-29,2013-03-01,18,171,NA,0,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-29T00:00:00Z,NA,H,2013-03-01T00:00:00Z,NA,H,18,171,154,2012-09-29,2013-03-01,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1299,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-29,2013-03-01,18,171,NA,0,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-29T00:00:00Z,NA,H,2013-03-01T00:00:00Z,NA,H,18,171,154,2012-09-29,2013-03-01,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1299,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-02,2013-03-13,172,183,NA,0,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2013-03-02T00:00:00Z,NA,H,2013-03-13T00:00:00Z,NA,H,172,183,12,2013-03-02,2013-03-13,0,0,DURD,12,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1299,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-02,2013-03-13,172,183,NA,0,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2013-03-02T00:00:00Z,NA,H,2013-03-13T00:00:00Z,NA,H,172,183,12,2013-03-02,2013-03-13,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1299,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-02,2013-03-13,172,183,NA,0,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2013-03-02T00:00:00Z,NA,H,2013-03-13T00:00:00Z,NA,H,172,183,12,2013-03-02,2013-03-13,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1299,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-02,2013-03-13,172,183,NA,0,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2013-03-02T00:00:00Z,NA,H,2013-03-13T00:00:00Z,NA,H,172,183,12,2013-03-02,2013-03-13,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1299,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-02,2013-03-13,172,183,NA,0,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2013-03-02T00:00:00Z,NA,H,2013-03-13T00:00:00Z,NA,H,172,183,12,2013-03-02,2013-03-13,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-12T00:00:00Z,NA,NA,2013-03-13T00:00:00Z,NA,NA,NA,NA,NA,2012-09-12,2013-03-13,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-12T00:00:00Z,NA,NA,2013-03-13T00:00:00Z,NA,NA,NA,NA,NA,2012-09-12,2013-03-13,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-12T00:00:00Z,NA,NA,2013-03-13T00:00:00Z,NA,NA,NA,NA,NA,2012-09-12,2013-03-13,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-12T00:00:00Z,NA,NA,2013-03-13T00:00:00Z,NA,NA,NA,NA,NA,2012-09-12,2013-03-13,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-12T00:00:00Z,NA,NA,2013-03-13T00:00:00Z,NA,NA,NA,NA,NA,2012-09-12,2013-03-13,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-12T00:00:00Z,NA,NA,2013-03-13T00:00:00Z,NA,NA,NA,NA,NA,2012-09-12,2013-03-13,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-12T00:00:00Z,NA,NA,2013-03-13T00:00:00Z,NA,NA,NA,NA,NA,2012-09-12,2013-03-13,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-29T00:00:00Z,NA,NA,2013-03-13T00:00:00Z,NA,NA,NA,NA,NA,2012-09-29,2013-03-13,NA,NA,PDURD,166,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-29T00:00:00Z,NA,NA,2013-03-13T00:00:00Z,NA,NA,NA,NA,NA,2012-09-29,2013-03-13,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-29T00:00:00Z,NA,NA,2013-03-13T00:00:00Z,NA,NA,NA,NA,NA,2012-09-29,2013-03-13,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-29T00:00:00Z,NA,NA,2013-03-13T00:00:00Z,NA,NA,NA,NA,NA,2012-09-29,2013-03-13,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-29T00:00:00Z,NA,NA,2013-03-13T00:00:00Z,NA,NA,NA,NA,NA,2012-09-29,2013-03-13,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-29T00:00:00Z,NA,NA,2013-03-13T00:00:00Z,NA,NA,NA,NA,NA,2012-09-29,2013-03-13,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1299,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-12,2012-09-12T00:00:00Z,2013-03-13T23:59:59Z,2012-09-29T00:00:00Z,NA,NA,2013-03-13T00:00:00Z,NA,NA,NA,NA,NA,2012-09-29,2013-03-13,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1299,2012-09-12,2013-03-13,2012-09-12,2013-03-13,NA,2013-03-27,NA,NA,703,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-07,-5,Placebo,Placebo,H,H,2013-03-13,183,NA,2013-03-13,COMPLETED,NA,2012-09-12,NA,NA,NA,2013-03-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1335,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-17,2014-03-31,1,15,NA,54,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-03-17T00:00:00Z,NA,H,2014-03-31T00:00:00Z,NA,H,1,15,15,2014-03-17,2014-03-31,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1335,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-17,2014-03-31,1,15,NA,54,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-03-17T00:00:00Z,NA,H,2014-03-31T00:00:00Z,NA,H,1,15,15,2014-03-17,2014-03-31,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1335,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-17,2014-03-31,1,15,NA,54,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-03-17T00:00:00Z,NA,H,2014-03-31T00:00:00Z,NA,H,1,15,15,2014-03-17,2014-03-31,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1335,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-17,2014-03-31,1,15,NA,54,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-03-17T00:00:00Z,NA,H,2014-03-31T00:00:00Z,NA,H,1,15,15,2014-03-17,2014-03-31,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1335,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-17,2014-03-31,1,15,NA,54,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-03-17T00:00:00Z,NA,H,2014-03-31T00:00:00Z,NA,H,1,15,15,2014-03-17,2014-03-31,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1335,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-01,2014-05-07,16,52,NA,54,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-04-01T00:00:00Z,NA,H,2014-05-07T00:00:00Z,NA,H,16,52,37,2014-04-01,2014-05-07,2997,1998,DURD,37,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1335,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-01,2014-05-07,16,52,NA,54,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-04-01T00:00:00Z,NA,H,2014-05-07T00:00:00Z,NA,H,16,52,37,2014-04-01,2014-05-07,2997,1998,DOSE,2997,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1335,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-01,2014-05-07,16,52,NA,54,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-04-01T00:00:00Z,NA,H,2014-05-07T00:00:00Z,NA,H,16,52,37,2014-04-01,2014-05-07,2997,1998,PLDOSE,1998,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1335,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-01,2014-05-07,16,52,NA,54,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-04-01T00:00:00Z,NA,H,2014-05-07T00:00:00Z,NA,H,16,52,37,2014-04-01,2014-05-07,2997,1998,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1335,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-01,2014-05-07,16,52,NA,54,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-04-01T00:00:00Z,NA,H,2014-05-07T00:00:00Z,NA,H,16,52,37,2014-04-01,2014-05-07,2997,1998,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-03-17T00:00:00Z,NA,NA,2014-05-07T00:00:00Z,NA,NA,NA,NA,NA,2014-03-17,2014-05-07,NA,NA,TDURD,52,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-03-17T00:00:00Z,NA,NA,2014-05-07T00:00:00Z,NA,NA,NA,NA,NA,2014-03-17,2014-05-07,NA,NA,TDOSE,3807,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-03-17T00:00:00Z,NA,NA,2014-05-07T00:00:00Z,NA,NA,NA,NA,NA,2014-03-17,2014-05-07,NA,NA,AVDDSE,73.21153846153847,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-03-17T00:00:00Z,NA,NA,2014-05-07T00:00:00Z,NA,NA,NA,NA,NA,2014-03-17,2014-05-07,NA,NA,TPDOSE,2808,NA,OVERALL,Total planned dose (mg),11,NA,14,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-03-17T00:00:00Z,NA,NA,2014-05-07T00:00:00Z,NA,NA,NA,NA,NA,2014-03-17,2014-05-07,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-03-17T00:00:00Z,NA,NA,2014-05-07T00:00:00Z,NA,NA,NA,NA,NA,2014-03-17,2014-05-07,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-03-17T00:00:00Z,NA,NA,2014-05-07T00:00:00Z,NA,NA,NA,NA,NA,2014-03-17,2014-05-07,NA,NA,TDOSINT,135.5769230769231,NA,OVERALL,Overall dose intensity (%),90,NA,17,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-04-01T00:00:00Z,NA,NA,2014-05-07T00:00:00Z,NA,NA,NA,NA,NA,2014-04-01,2014-05-07,NA,NA,PDURD,37,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-04-01T00:00:00Z,NA,NA,2014-05-07T00:00:00Z,NA,NA,NA,NA,NA,2014-04-01,2014-05-07,NA,NA,PDOSE,2997,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-04-01T00:00:00Z,NA,NA,2014-05-07T00:00:00Z,NA,NA,NA,NA,NA,2014-04-01,2014-05-07,NA,NA,PPDOSE,1998,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-04-01T00:00:00Z,NA,NA,2014-05-07T00:00:00Z,NA,NA,NA,NA,NA,2014-04-01,2014-05-07,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-04-01T00:00:00Z,NA,NA,2014-05-07T00:00:00Z,NA,NA,NA,NA,NA,2014-04-01,2014-05-07,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-04-01T00:00:00Z,NA,NA,2014-05-07T00:00:00Z,NA,NA,NA,NA,NA,2014-04-01,2014-05-07,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1335,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-17,2014-03-17T00:00:00Z,2014-05-07T23:59:59Z,2014-04-01T00:00:00Z,NA,NA,2014-05-07T00:00:00Z,NA,NA,NA,NA,NA,2014-04-01,2014-05-07,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1335,2014-03-17,2014-05-24,2014-03-17,2014-05-07,NA,2014-05-24T12:15,NA,NA,703,67,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-28,-17,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-05-07,52,NA,2014-05-24,DISCONTINUED,NA,2014-03-17,NA,NA,NA,2014-05-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1379,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-22,2013-10-07,1,16,NA,54,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-09-22T00:00:00Z,NA,H,2013-10-07T00:00:00Z,NA,H,1,16,16,2013-09-22,2013-10-07,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1379,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-22,2013-10-07,1,16,NA,54,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-09-22T00:00:00Z,NA,H,2013-10-07T00:00:00Z,NA,H,1,16,16,2013-09-22,2013-10-07,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1379,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-22,2013-10-07,1,16,NA,54,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-09-22T00:00:00Z,NA,H,2013-10-07T00:00:00Z,NA,H,1,16,16,2013-09-22,2013-10-07,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1379,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-22,2013-10-07,1,16,NA,54,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-09-22T00:00:00Z,NA,H,2013-10-07T00:00:00Z,NA,H,1,16,16,2013-09-22,2013-10-07,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1379,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-22,2013-10-07,1,16,NA,54,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-09-22T00:00:00Z,NA,H,2013-10-07T00:00:00Z,NA,H,1,16,16,2013-09-22,2013-10-07,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1379,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-08,2014-03-08,17,168,NA,54,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,17,168,152,2013-10-08,2014-03-08,8208,8208,DURD,152,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1379,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-08,2014-03-08,17,168,NA,54,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,17,168,152,2013-10-08,2014-03-08,8208,8208,DOSE,8208,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1379,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-08,2014-03-08,17,168,NA,54,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,17,168,152,2013-10-08,2014-03-08,8208,8208,PLDOSE,8208,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1379,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-08,2014-03-08,17,168,NA,54,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,17,168,152,2013-10-08,2014-03-08,8208,8208,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1379,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-08,2014-03-08,17,168,NA,54,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,17,168,152,2013-10-08,2014-03-08,8208,8208,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1379,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-09,2014-03-21,169,181,NA,54,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2014-03-09T00:00:00Z,NA,H,2014-03-21T00:00:00Z,NA,H,169,181,13,2014-03-09,2014-03-21,702,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1379,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-09,2014-03-21,169,181,NA,54,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2014-03-09T00:00:00Z,NA,H,2014-03-21T00:00:00Z,NA,H,169,181,13,2014-03-09,2014-03-21,702,702,DOSE,702,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1379,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-09,2014-03-21,169,181,NA,54,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2014-03-09T00:00:00Z,NA,H,2014-03-21T00:00:00Z,NA,H,169,181,13,2014-03-09,2014-03-21,702,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1379,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-09,2014-03-21,169,181,NA,54,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2014-03-09T00:00:00Z,NA,H,2014-03-21T00:00:00Z,NA,H,169,181,13,2014-03-09,2014-03-21,702,702,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1379,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-09,2014-03-21,169,181,NA,54,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2014-03-09T00:00:00Z,NA,H,2014-03-21T00:00:00Z,NA,H,169,181,13,2014-03-09,2014-03-21,702,702,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-09-22T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2013-09-22,2014-03-21,NA,NA,TDURD,181,NA,OVERALL,Overall duration (days),7,>=90 days,16,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-09-22T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2013-09-22,2014-03-21,NA,NA,TDOSE,9774,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-09-22T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2013-09-22,2014-03-21,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-09-22T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2013-09-22,2014-03-21,NA,NA,TPDOSE,9774,NA,OVERALL,Total planned dose (mg),11,NA,19,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-09-22T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2013-09-22,2014-03-21,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-09-22T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2013-09-22,2014-03-21,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-09-22T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2013-09-22,2014-03-21,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-21,NA,NA,PDURD,165,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-21,NA,NA,PDOSE,8910,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-21,NA,NA,PPDOSE,8910,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-21,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-21,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-21,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1379,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-22,2013-09-22T00:00:00Z,2014-03-21T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-03-21,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1379,2013-09-22,2014-03-21,2013-09-22,2014-03-21,NA,2014-03-21T10:55,NA,NA,703,81,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-12,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-21,181,NA,2014-03-21,COMPLETED,NA,2013-09-22,NA,NA,NA,2014-03-21,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1403,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-12,2012-12-13,1,2,NA,54,2012-12-12,2012-12-12T00:00:00Z,2012-12-13T23:59:59Z,2012-12-12T00:00:00Z,NA,H,2012-12-13T00:00:00Z,NA,H,1,2,2,2012-12-12,2012-12-13,108,108,DURD,2,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2012-12-13,2,NA,2012-12-19,DISCONTINUED,NA,2012-12-12,NA,NA,NA,2012-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1403,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-12,2012-12-13,1,2,NA,54,2012-12-12,2012-12-12T00:00:00Z,2012-12-13T23:59:59Z,2012-12-12T00:00:00Z,NA,H,2012-12-13T00:00:00Z,NA,H,1,2,2,2012-12-12,2012-12-13,108,108,DOSE,108,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2012-12-13,2,NA,2012-12-19,DISCONTINUED,NA,2012-12-12,NA,NA,NA,2012-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1403,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-12,2012-12-13,1,2,NA,54,2012-12-12,2012-12-12T00:00:00Z,2012-12-13T23:59:59Z,2012-12-12T00:00:00Z,NA,H,2012-12-13T00:00:00Z,NA,H,1,2,2,2012-12-12,2012-12-13,108,108,PLDOSE,108,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2012-12-13,2,NA,2012-12-19,DISCONTINUED,NA,2012-12-12,NA,NA,NA,2012-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1403,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-12,2012-12-13,1,2,NA,54,2012-12-12,2012-12-12T00:00:00Z,2012-12-13T23:59:59Z,2012-12-12T00:00:00Z,NA,H,2012-12-13T00:00:00Z,NA,H,1,2,2,2012-12-12,2012-12-13,108,108,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2012-12-13,2,NA,2012-12-19,DISCONTINUED,NA,2012-12-12,NA,NA,NA,2012-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1403,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-12,2012-12-13,1,2,NA,54,2012-12-12,2012-12-12T00:00:00Z,2012-12-13T23:59:59Z,2012-12-12T00:00:00Z,NA,H,2012-12-13T00:00:00Z,NA,H,1,2,2,2012-12-12,2012-12-13,108,108,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2012-12-13,2,NA,2012-12-19,DISCONTINUED,NA,2012-12-12,NA,NA,NA,2012-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1403,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-12,2012-12-12T00:00:00Z,2012-12-13T23:59:59Z,2012-12-12T00:00:00Z,NA,NA,2012-12-13T00:00:00Z,NA,NA,NA,NA,NA,2012-12-12,2012-12-13,NA,NA,TDURD,2,NA,OVERALL,Overall duration (days),7,< 30 days,6,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2012-12-13,2,NA,2012-12-19,DISCONTINUED,NA,2012-12-12,NA,NA,NA,2012-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1403,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-12,2012-12-12T00:00:00Z,2012-12-13T23:59:59Z,2012-12-12T00:00:00Z,NA,NA,2012-12-13T00:00:00Z,NA,NA,NA,NA,NA,2012-12-12,2012-12-13,NA,NA,TDOSE,108,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2012-12-13,2,NA,2012-12-19,DISCONTINUED,NA,2012-12-12,NA,NA,NA,2012-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1403,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-12,2012-12-12T00:00:00Z,2012-12-13T23:59:59Z,2012-12-12T00:00:00Z,NA,NA,2012-12-13T00:00:00Z,NA,NA,NA,NA,NA,2012-12-12,2012-12-13,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2012-12-13,2,NA,2012-12-19,DISCONTINUED,NA,2012-12-12,NA,NA,NA,2012-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1403,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-12,2012-12-12T00:00:00Z,2012-12-13T23:59:59Z,2012-12-12T00:00:00Z,NA,NA,2012-12-13T00:00:00Z,NA,NA,NA,NA,NA,2012-12-12,2012-12-13,NA,NA,TPDOSE,108,NA,OVERALL,Total planned dose (mg),11,NA,9,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2012-12-13,2,NA,2012-12-19,DISCONTINUED,NA,2012-12-12,NA,NA,NA,2012-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1403,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-12,2012-12-12T00:00:00Z,2012-12-13T23:59:59Z,2012-12-12T00:00:00Z,NA,NA,2012-12-13T00:00:00Z,NA,NA,NA,NA,NA,2012-12-12,2012-12-13,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2012-12-13,2,NA,2012-12-19,DISCONTINUED,NA,2012-12-12,NA,NA,NA,2012-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1403,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-12,2012-12-12T00:00:00Z,2012-12-13T23:59:59Z,2012-12-12T00:00:00Z,NA,NA,2012-12-13T00:00:00Z,NA,NA,NA,NA,NA,2012-12-12,2012-12-13,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2012-12-13,2,NA,2012-12-19,DISCONTINUED,NA,2012-12-12,NA,NA,NA,2012-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1403,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-12,2012-12-12T00:00:00Z,2012-12-13T23:59:59Z,2012-12-12T00:00:00Z,NA,NA,2012-12-13T00:00:00Z,NA,NA,NA,NA,NA,2012-12-12,2012-12-13,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1403,2012-12-12,2012-12-19,2012-12-12,2012-12-13,NA,2013-01-08,NA,NA,703,67,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-05,-7,Xanomeline High Dose,Xanomeline Low Dose,H,H,2012-12-13,2,NA,2012-12-19,DISCONTINUED,NA,2012-12-12,NA,NA,NA,2012-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1439,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-12,2014-03-26,1,15,NA,54,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-26T00:00:00Z,NA,H,1,15,15,2014-03-12,2014-03-26,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1439,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-12,2014-03-26,1,15,NA,54,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-26T00:00:00Z,NA,H,1,15,15,2014-03-12,2014-03-26,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1439,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-12,2014-03-26,1,15,NA,54,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-26T00:00:00Z,NA,H,1,15,15,2014-03-12,2014-03-26,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1439,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-12,2014-03-26,1,15,NA,54,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-26T00:00:00Z,NA,H,1,15,15,2014-03-12,2014-03-26,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1439,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-12,2014-03-26,1,15,NA,54,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-12T00:00:00Z,NA,H,2014-03-26T00:00:00Z,NA,H,1,15,15,2014-03-12,2014-03-26,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1439,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-27,2014-08-28,16,170,NA,54,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-27T00:00:00Z,NA,H,2014-08-28T00:00:00Z,NA,H,16,170,155,2014-03-27,2014-08-28,12555,8370,DURD,155,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1439,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-27,2014-08-28,16,170,NA,54,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-27T00:00:00Z,NA,H,2014-08-28T00:00:00Z,NA,H,16,170,155,2014-03-27,2014-08-28,12555,8370,DOSE,12555,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1439,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-27,2014-08-28,16,170,NA,54,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-27T00:00:00Z,NA,H,2014-08-28T00:00:00Z,NA,H,16,170,155,2014-03-27,2014-08-28,12555,8370,PLDOSE,8370,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1439,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-27,2014-08-28,16,170,NA,54,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-27T00:00:00Z,NA,H,2014-08-28T00:00:00Z,NA,H,16,170,155,2014-03-27,2014-08-28,12555,8370,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1439,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-27,2014-08-28,16,170,NA,54,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-27T00:00:00Z,NA,H,2014-08-28T00:00:00Z,NA,H,16,170,155,2014-03-27,2014-08-28,12555,8370,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1439,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-29,2014-09-11,171,184,NA,54,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-08-29T00:00:00Z,NA,H,2014-09-11T00:00:00Z,NA,H,171,184,14,2014-08-29,2014-09-11,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1439,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-29,2014-09-11,171,184,NA,54,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-08-29T00:00:00Z,NA,H,2014-09-11T00:00:00Z,NA,H,171,184,14,2014-08-29,2014-09-11,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1439,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-29,2014-09-11,171,184,NA,54,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-08-29T00:00:00Z,NA,H,2014-09-11T00:00:00Z,NA,H,171,184,14,2014-08-29,2014-09-11,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1439,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-29,2014-09-11,171,184,NA,54,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-08-29T00:00:00Z,NA,H,2014-09-11T00:00:00Z,NA,H,171,184,14,2014-08-29,2014-09-11,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-703-1439,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-29,2014-09-11,171,184,NA,54,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-08-29T00:00:00Z,NA,H,2014-09-11T00:00:00Z,NA,H,171,184,14,2014-08-29,2014-09-11,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-09-11T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-09-11,NA,NA,TDURD,184,NA,OVERALL,Overall duration (days),7,>=90 days,16,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-09-11T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-09-11,NA,NA,TDOSE,14121,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-09-11T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-09-11,NA,NA,AVDDSE,76.7445652173913,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-09-11T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-09-11,NA,NA,TPDOSE,9936,NA,OVERALL,Total planned dose (mg),11,NA,19,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-09-11T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-09-11,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-09-11T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-09-11,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-12T00:00:00Z,NA,NA,2014-09-11T00:00:00Z,NA,NA,NA,NA,NA,2014-03-12,2014-09-11,NA,NA,TDOSINT,142.1195652173913,NA,OVERALL,Overall dose intensity (%),90,NA,22,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-27T00:00:00Z,NA,NA,2014-09-11T00:00:00Z,NA,NA,NA,NA,NA,2014-03-27,2014-09-11,NA,NA,PDURD,169,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-27T00:00:00Z,NA,NA,2014-09-11T00:00:00Z,NA,NA,NA,NA,NA,2014-03-27,2014-09-11,NA,NA,PDOSE,13311,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-27T00:00:00Z,NA,NA,2014-09-11T00:00:00Z,NA,NA,NA,NA,NA,2014-03-27,2014-09-11,NA,NA,PPDOSE,9126,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-27T00:00:00Z,NA,NA,2014-09-11T00:00:00Z,NA,NA,NA,NA,NA,2014-03-27,2014-09-11,NA,NA,PAVDDSE,78.76331360946746,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-27T00:00:00Z,NA,NA,2014-09-11T00:00:00Z,NA,NA,NA,NA,NA,2014-03-27,2014-09-11,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-27T00:00:00Z,NA,NA,2014-09-11T00:00:00Z,NA,NA,NA,NA,NA,2014-03-27,2014-09-11,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-703-1439,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-12,2014-03-12T00:00:00Z,2014-09-11T23:59:59Z,2014-03-27T00:00:00Z,NA,NA,2014-09-11T00:00:00Z,NA,NA,NA,NA,NA,2014-03-27,2014-09-11,NA,NA,PDOSINT,145.85798816568047,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1439,2014-03-12,2014-09-11,2014-03-12,2014-09-11,NA,2014-09-11T12:40,NA,NA,703,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-03-04,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-09-11,184,NA,2014-09-11,COMPLETED,NA,2014-03-12,NA,NA,NA,2014-09-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1008,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-13,2013-01-28,1,16,NA,54,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-13T00:00:00Z,NA,H,2013-01-28T00:00:00Z,NA,H,1,16,16,2013-01-13,2013-01-28,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1008,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-13,2013-01-28,1,16,NA,54,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-13T00:00:00Z,NA,H,2013-01-28T00:00:00Z,NA,H,1,16,16,2013-01-13,2013-01-28,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1008,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-13,2013-01-28,1,16,NA,54,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-13T00:00:00Z,NA,H,2013-01-28T00:00:00Z,NA,H,1,16,16,2013-01-13,2013-01-28,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1008,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-13,2013-01-28,1,16,NA,54,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-13T00:00:00Z,NA,H,2013-01-28T00:00:00Z,NA,H,1,16,16,2013-01-13,2013-01-28,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1008,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-13,2013-01-28,1,16,NA,54,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-13T00:00:00Z,NA,H,2013-01-28T00:00:00Z,NA,H,1,16,16,2013-01-13,2013-01-28,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1008,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-29,2013-02-21,17,40,NA,54,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-29T00:00:00Z,NA,H,2013-02-21T00:00:00Z,NA,H,17,40,24,2013-01-29,2013-02-21,1944,1296,DURD,24,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1008,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-29,2013-02-21,17,40,NA,54,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-29T00:00:00Z,NA,H,2013-02-21T00:00:00Z,NA,H,17,40,24,2013-01-29,2013-02-21,1944,1296,DOSE,1944,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1008,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-29,2013-02-21,17,40,NA,54,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-29T00:00:00Z,NA,H,2013-02-21T00:00:00Z,NA,H,17,40,24,2013-01-29,2013-02-21,1944,1296,PLDOSE,1296,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1008,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-29,2013-02-21,17,40,NA,54,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-29T00:00:00Z,NA,H,2013-02-21T00:00:00Z,NA,H,17,40,24,2013-01-29,2013-02-21,1944,1296,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1008,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-29,2013-02-21,17,40,NA,54,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-29T00:00:00Z,NA,H,2013-02-21T00:00:00Z,NA,H,17,40,24,2013-01-29,2013-02-21,1944,1296,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-13T00:00:00Z,NA,NA,2013-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-01-13,2013-02-21,NA,NA,TDURD,40,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-13T00:00:00Z,NA,NA,2013-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-01-13,2013-02-21,NA,NA,TDOSE,2808,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-13T00:00:00Z,NA,NA,2013-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-01-13,2013-02-21,NA,NA,AVDDSE,70.2,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-13T00:00:00Z,NA,NA,2013-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-01-13,2013-02-21,NA,NA,TPDOSE,2160,NA,OVERALL,Total planned dose (mg),11,NA,14,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-13T00:00:00Z,NA,NA,2013-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-01-13,2013-02-21,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-13T00:00:00Z,NA,NA,2013-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-01-13,2013-02-21,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-13T00:00:00Z,NA,NA,2013-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-01-13,2013-02-21,NA,NA,TDOSINT,130,NA,OVERALL,Overall dose intensity (%),90,NA,17,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-29T00:00:00Z,NA,NA,2013-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-01-29,2013-02-21,NA,NA,PDURD,24,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-29T00:00:00Z,NA,NA,2013-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-01-29,2013-02-21,NA,NA,PDOSE,1944,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-29T00:00:00Z,NA,NA,2013-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-01-29,2013-02-21,NA,NA,PPDOSE,1296,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-29T00:00:00Z,NA,NA,2013-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-01-29,2013-02-21,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-29T00:00:00Z,NA,NA,2013-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-01-29,2013-02-21,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-29T00:00:00Z,NA,NA,2013-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-01-29,2013-02-21,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1008,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-13,2013-01-13T00:00:00Z,2013-02-21T23:59:59Z,2013-01-29T00:00:00Z,NA,NA,2013-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-01-29,2013-02-21,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1008,2013-01-13,2013-02-25,2013-01-13,2013-02-21,NA,2013-02-25T11:00,NA,NA,704,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-06,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-21,40,NA,2013-02-25,DISCONTINUED,NA,2013-01-13,NA,NA,NA,2013-02-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1009,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-27,2013-09-14,1,19,NA,54,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-08-27T00:00:00Z,NA,H,2013-09-14T00:00:00Z,NA,H,1,19,19,2013-08-27,2013-09-14,1026,1026,DURD,19,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1009,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-27,2013-09-14,1,19,NA,54,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-08-27T00:00:00Z,NA,H,2013-09-14T00:00:00Z,NA,H,1,19,19,2013-08-27,2013-09-14,1026,1026,DOSE,1026,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1009,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-27,2013-09-14,1,19,NA,54,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-08-27T00:00:00Z,NA,H,2013-09-14T00:00:00Z,NA,H,1,19,19,2013-08-27,2013-09-14,1026,1026,PLDOSE,1026,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1009,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-27,2013-09-14,1,19,NA,54,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-08-27T00:00:00Z,NA,H,2013-09-14T00:00:00Z,NA,H,1,19,19,2013-08-27,2013-09-14,1026,1026,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1009,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-27,2013-09-14,1,19,NA,54,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-08-27T00:00:00Z,NA,H,2013-09-14T00:00:00Z,NA,H,1,19,19,2013-08-27,2013-09-14,1026,1026,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1009,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-15,2013-09-25,20,30,NA,54,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-09-15T00:00:00Z,NA,H,2013-09-25T00:00:00Z,NA,H,20,30,11,2013-09-15,2013-09-25,594,594,DURD,11,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1009,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-15,2013-09-25,20,30,NA,54,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-09-15T00:00:00Z,NA,H,2013-09-25T00:00:00Z,NA,H,20,30,11,2013-09-15,2013-09-25,594,594,DOSE,594,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1009,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-15,2013-09-25,20,30,NA,54,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-09-15T00:00:00Z,NA,H,2013-09-25T00:00:00Z,NA,H,20,30,11,2013-09-15,2013-09-25,594,594,PLDOSE,594,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1009,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-15,2013-09-25,20,30,NA,54,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-09-15T00:00:00Z,NA,H,2013-09-25T00:00:00Z,NA,H,20,30,11,2013-09-15,2013-09-25,594,594,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1009,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-15,2013-09-25,20,30,NA,54,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-09-15T00:00:00Z,NA,H,2013-09-25T00:00:00Z,NA,H,20,30,11,2013-09-15,2013-09-25,594,594,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-08-27T00:00:00Z,NA,NA,2013-09-25T00:00:00Z,NA,NA,NA,NA,NA,2013-08-27,2013-09-25,NA,NA,TDURD,30,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-08-27T00:00:00Z,NA,NA,2013-09-25T00:00:00Z,NA,NA,NA,NA,NA,2013-08-27,2013-09-25,NA,NA,TDOSE,1620,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-08-27T00:00:00Z,NA,NA,2013-09-25T00:00:00Z,NA,NA,NA,NA,NA,2013-08-27,2013-09-25,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-08-27T00:00:00Z,NA,NA,2013-09-25T00:00:00Z,NA,NA,NA,NA,NA,2013-08-27,2013-09-25,NA,NA,TPDOSE,1620,NA,OVERALL,Total planned dose (mg),11,NA,14,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-08-27T00:00:00Z,NA,NA,2013-09-25T00:00:00Z,NA,NA,NA,NA,NA,2013-08-27,2013-09-25,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-08-27T00:00:00Z,NA,NA,2013-09-25T00:00:00Z,NA,NA,NA,NA,NA,2013-08-27,2013-09-25,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-08-27T00:00:00Z,NA,NA,2013-09-25T00:00:00Z,NA,NA,NA,NA,NA,2013-08-27,2013-09-25,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-09-15T00:00:00Z,NA,NA,2013-09-25T00:00:00Z,NA,NA,NA,NA,NA,2013-09-15,2013-09-25,NA,NA,PDURD,11,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-09-15T00:00:00Z,NA,NA,2013-09-25T00:00:00Z,NA,NA,NA,NA,NA,2013-09-15,2013-09-25,NA,NA,PDOSE,594,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-09-15T00:00:00Z,NA,NA,2013-09-25T00:00:00Z,NA,NA,NA,NA,NA,2013-09-15,2013-09-25,NA,NA,PPDOSE,594,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-09-15T00:00:00Z,NA,NA,2013-09-25T00:00:00Z,NA,NA,NA,NA,NA,2013-09-15,2013-09-25,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-09-15T00:00:00Z,NA,NA,2013-09-25T00:00:00Z,NA,NA,NA,NA,NA,2013-09-15,2013-09-25,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-09-15T00:00:00Z,NA,NA,2013-09-25T00:00:00Z,NA,NA,NA,NA,NA,2013-09-15,2013-09-25,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1009,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-27,2013-08-27T00:00:00Z,2013-09-25T23:59:59Z,2013-09-15T00:00:00Z,NA,NA,2013-09-25T00:00:00Z,NA,NA,NA,NA,NA,2013-09-15,2013-09-25,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1009,2013-08-27,2013-10-02,2013-08-27,2013-09-25,NA,2013-10-02,NA,NA,704,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-25,30,NA,2013-10-02,DISCONTINUED,NA,2013-08-27,NA,NA,NA,2013-09-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1010,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-21,2014-03-08,1,16,NA,0,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-02-21T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,1,16,16,2014-02-21,2014-03-08,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1010,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-21,2014-03-08,1,16,NA,0,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-02-21T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,1,16,16,2014-02-21,2014-03-08,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1010,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-21,2014-03-08,1,16,NA,0,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-02-21T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,1,16,16,2014-02-21,2014-03-08,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1010,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-21,2014-03-08,1,16,NA,0,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-02-21T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,1,16,16,2014-02-21,2014-03-08,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1010,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-21,2014-03-08,1,16,NA,0,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-02-21T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,1,16,16,2014-02-21,2014-03-08,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1010,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-09,2014-07-08,17,138,NA,0,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-03-09T00:00:00Z,NA,H,2014-07-08T00:00:00Z,NA,H,17,138,122,2014-03-09,2014-07-08,0,0,DURD,122,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1010,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-09,2014-07-08,17,138,NA,0,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-03-09T00:00:00Z,NA,H,2014-07-08T00:00:00Z,NA,H,17,138,122,2014-03-09,2014-07-08,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1010,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-09,2014-07-08,17,138,NA,0,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-03-09T00:00:00Z,NA,H,2014-07-08T00:00:00Z,NA,H,17,138,122,2014-03-09,2014-07-08,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1010,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-09,2014-07-08,17,138,NA,0,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-03-09T00:00:00Z,NA,H,2014-07-08T00:00:00Z,NA,H,17,138,122,2014-03-09,2014-07-08,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1010,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-09,2014-07-08,17,138,NA,0,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-03-09T00:00:00Z,NA,H,2014-07-08T00:00:00Z,NA,H,17,138,122,2014-03-09,2014-07-08,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1010,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-02-21T00:00:00Z,NA,NA,2014-07-08T00:00:00Z,NA,NA,NA,NA,NA,2014-02-21,2014-07-08,NA,NA,TDURD,138,NA,OVERALL,Overall duration (days),7,>=90 days,11,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1010,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-02-21T00:00:00Z,NA,NA,2014-07-08T00:00:00Z,NA,NA,NA,NA,NA,2014-02-21,2014-07-08,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1010,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-02-21T00:00:00Z,NA,NA,2014-07-08T00:00:00Z,NA,NA,NA,NA,NA,2014-02-21,2014-07-08,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1010,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-02-21T00:00:00Z,NA,NA,2014-07-08T00:00:00Z,NA,NA,NA,NA,NA,2014-02-21,2014-07-08,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1010,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-02-21T00:00:00Z,NA,NA,2014-07-08T00:00:00Z,NA,NA,NA,NA,NA,2014-02-21,2014-07-08,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1010,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-02-21T00:00:00Z,NA,NA,2014-07-08T00:00:00Z,NA,NA,NA,NA,NA,2014-02-21,2014-07-08,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1010,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-02-21T00:00:00Z,NA,NA,2014-07-08T00:00:00Z,NA,NA,NA,NA,NA,2014-02-21,2014-07-08,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1010,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-03-09T00:00:00Z,NA,NA,2014-07-08T00:00:00Z,NA,NA,NA,NA,NA,2014-03-09,2014-07-08,NA,NA,PDURD,122,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1010,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-03-09T00:00:00Z,NA,NA,2014-07-08T00:00:00Z,NA,NA,NA,NA,NA,2014-03-09,2014-07-08,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1010,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-03-09T00:00:00Z,NA,NA,2014-07-08T00:00:00Z,NA,NA,NA,NA,NA,2014-03-09,2014-07-08,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1010,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-03-09T00:00:00Z,NA,NA,2014-07-08T00:00:00Z,NA,NA,NA,NA,NA,2014-03-09,2014-07-08,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1010,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-03-09T00:00:00Z,NA,NA,2014-07-08T00:00:00Z,NA,NA,NA,NA,NA,2014-03-09,2014-07-08,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1010,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-03-09T00:00:00Z,NA,NA,2014-07-08T00:00:00Z,NA,NA,NA,NA,NA,2014-03-09,2014-07-08,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1010,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-21,2014-02-21T00:00:00Z,2014-07-08T23:59:59Z,2014-03-09T00:00:00Z,NA,NA,2014-07-08T00:00:00Z,NA,NA,NA,NA,NA,2014-03-09,2014-07-08,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1010,2014-02-21,2014-07-09,2014-02-21,2014-07-08,NA,2014-07-09T11:00,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-08,-13,Placebo,Placebo,H,H,2014-07-08,138,NA,2014-07-09,DISCONTINUED,NA,2014-02-21,NA,NA,NA,2014-07-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1017,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-06,2013-10-19,1,14,NA,54,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-06T00:00:00Z,NA,H,2013-10-19T00:00:00Z,NA,H,1,14,14,2013-10-06,2013-10-19,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1017,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-06,2013-10-19,1,14,NA,54,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-06T00:00:00Z,NA,H,2013-10-19T00:00:00Z,NA,H,1,14,14,2013-10-06,2013-10-19,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1017,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-06,2013-10-19,1,14,NA,54,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-06T00:00:00Z,NA,H,2013-10-19T00:00:00Z,NA,H,1,14,14,2013-10-06,2013-10-19,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1017,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-06,2013-10-19,1,14,NA,54,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-06T00:00:00Z,NA,H,2013-10-19T00:00:00Z,NA,H,1,14,14,2013-10-06,2013-10-19,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1017,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-06,2013-10-19,1,14,NA,54,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-06T00:00:00Z,NA,H,2013-10-19T00:00:00Z,NA,H,1,14,14,2013-10-06,2013-10-19,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1017,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-20,2013-11-18,15,44,NA,54,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-20T00:00:00Z,NA,H,2013-11-18T00:00:00Z,NA,H,15,44,30,2013-10-20,2013-11-18,2430,1620,DURD,30,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1017,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-20,2013-11-18,15,44,NA,54,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-20T00:00:00Z,NA,H,2013-11-18T00:00:00Z,NA,H,15,44,30,2013-10-20,2013-11-18,2430,1620,DOSE,2430,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1017,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-20,2013-11-18,15,44,NA,54,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-20T00:00:00Z,NA,H,2013-11-18T00:00:00Z,NA,H,15,44,30,2013-10-20,2013-11-18,2430,1620,PLDOSE,1620,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1017,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-20,2013-11-18,15,44,NA,54,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-20T00:00:00Z,NA,H,2013-11-18T00:00:00Z,NA,H,15,44,30,2013-10-20,2013-11-18,2430,1620,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1017,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-20,2013-11-18,15,44,NA,54,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-20T00:00:00Z,NA,H,2013-11-18T00:00:00Z,NA,H,15,44,30,2013-10-20,2013-11-18,2430,1620,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-06T00:00:00Z,NA,NA,2013-11-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-06,2013-11-18,NA,NA,TDURD,44,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-06T00:00:00Z,NA,NA,2013-11-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-06,2013-11-18,NA,NA,TDOSE,3186,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-06T00:00:00Z,NA,NA,2013-11-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-06,2013-11-18,NA,NA,AVDDSE,72.4090909090909,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-06T00:00:00Z,NA,NA,2013-11-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-06,2013-11-18,NA,NA,TPDOSE,2376,NA,OVERALL,Total planned dose (mg),11,NA,14,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-06T00:00:00Z,NA,NA,2013-11-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-06,2013-11-18,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-06T00:00:00Z,NA,NA,2013-11-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-06,2013-11-18,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-06T00:00:00Z,NA,NA,2013-11-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-06,2013-11-18,NA,NA,TDOSINT,134.0909090909091,NA,OVERALL,Overall dose intensity (%),90,NA,17,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-20T00:00:00Z,NA,NA,2013-11-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-20,2013-11-18,NA,NA,PDURD,30,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-20T00:00:00Z,NA,NA,2013-11-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-20,2013-11-18,NA,NA,PDOSE,2430,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-20T00:00:00Z,NA,NA,2013-11-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-20,2013-11-18,NA,NA,PPDOSE,1620,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-20T00:00:00Z,NA,NA,2013-11-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-20,2013-11-18,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-20T00:00:00Z,NA,NA,2013-11-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-20,2013-11-18,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-20T00:00:00Z,NA,NA,2013-11-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-20,2013-11-18,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1017,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-06,2013-10-06T00:00:00Z,2013-11-18T23:59:59Z,2013-10-20T00:00:00Z,NA,NA,2013-11-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-20,2013-11-18,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1017,2013-10-06,2013-11-24,2013-10-06,2013-11-18,NA,2013-12-06,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-20,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-18,44,NA,2013-11-24,DISCONTINUED,NA,2013-10-06,NA,NA,NA,2013-11-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1025,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-27,2013-10-11,1,15,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-09-27T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,1,15,15,2013-09-27,2013-10-11,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1025,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-27,2013-10-11,1,15,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-09-27T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,1,15,15,2013-09-27,2013-10-11,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1025,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-27,2013-10-11,1,15,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-09-27T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,1,15,15,2013-09-27,2013-10-11,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1025,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-27,2013-10-11,1,15,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-09-27T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,1,15,15,2013-09-27,2013-10-11,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1025,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-27,2013-10-11,1,15,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-09-27T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,1,15,15,2013-09-27,2013-10-11,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1025,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-12,2013-10-24,16,28,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-10-12T00:00:00Z,NA,H,2013-10-24T00:00:00Z,NA,H,16,28,13,2013-10-12,2013-10-24,702,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1025,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-12,2013-10-24,16,28,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-10-12T00:00:00Z,NA,H,2013-10-24T00:00:00Z,NA,H,16,28,13,2013-10-12,2013-10-24,702,702,DOSE,702,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1025,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-12,2013-10-24,16,28,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-10-12T00:00:00Z,NA,H,2013-10-24T00:00:00Z,NA,H,16,28,13,2013-10-12,2013-10-24,702,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1025,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-12,2013-10-24,16,28,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-10-12T00:00:00Z,NA,H,2013-10-24T00:00:00Z,NA,H,16,28,13,2013-10-12,2013-10-24,702,702,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1025,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-12,2013-10-24,16,28,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-10-12T00:00:00Z,NA,H,2013-10-24T00:00:00Z,NA,H,16,28,13,2013-10-12,2013-10-24,702,702,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-09-27T00:00:00Z,NA,NA,2013-10-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-27,2013-10-24,NA,NA,TDURD,28,NA,OVERALL,Overall duration (days),7,< 30 days,11,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-09-27T00:00:00Z,NA,NA,2013-10-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-27,2013-10-24,NA,NA,TDOSE,1512,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-09-27T00:00:00Z,NA,NA,2013-10-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-27,2013-10-24,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-09-27T00:00:00Z,NA,NA,2013-10-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-27,2013-10-24,NA,NA,TPDOSE,1512,NA,OVERALL,Total planned dose (mg),11,NA,14,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-09-27T00:00:00Z,NA,NA,2013-10-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-27,2013-10-24,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-09-27T00:00:00Z,NA,NA,2013-10-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-27,2013-10-24,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-09-27T00:00:00Z,NA,NA,2013-10-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-27,2013-10-24,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2013-10-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2013-10-24,NA,NA,PDURD,13,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2013-10-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2013-10-24,NA,NA,PDOSE,702,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2013-10-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2013-10-24,NA,NA,PPDOSE,702,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2013-10-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2013-10-24,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2013-10-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2013-10-24,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2013-10-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2013-10-24,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1025,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-24T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2013-10-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2013-10-24,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1025,2013-09-27,2013-11-29,2013-09-27,2013-10-24,NA,2013-11-29T12:00,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-18,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-24,28,NA,2013-11-29,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1065,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-24,2013-11-07,1,15,NA,54,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-10-24T00:00:00Z,NA,H,2013-11-07T00:00:00Z,NA,H,1,15,15,2013-10-24,2013-11-07,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1065,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-24,2013-11-07,1,15,NA,54,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-10-24T00:00:00Z,NA,H,2013-11-07T00:00:00Z,NA,H,1,15,15,2013-10-24,2013-11-07,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1065,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-24,2013-11-07,1,15,NA,54,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-10-24T00:00:00Z,NA,H,2013-11-07T00:00:00Z,NA,H,1,15,15,2013-10-24,2013-11-07,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1065,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-24,2013-11-07,1,15,NA,54,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-10-24T00:00:00Z,NA,H,2013-11-07T00:00:00Z,NA,H,1,15,15,2013-10-24,2013-11-07,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1065,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-24,2013-11-07,1,15,NA,54,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-10-24T00:00:00Z,NA,H,2013-11-07T00:00:00Z,NA,H,1,15,15,2013-10-24,2013-11-07,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1065,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-08,2013-12-22,16,60,NA,54,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-11-08T00:00:00Z,NA,H,2013-12-22T00:00:00Z,NA,H,16,60,45,2013-11-08,2013-12-22,3645,2430,DURD,45,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1065,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-08,2013-12-22,16,60,NA,54,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-11-08T00:00:00Z,NA,H,2013-12-22T00:00:00Z,NA,H,16,60,45,2013-11-08,2013-12-22,3645,2430,DOSE,3645,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1065,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-08,2013-12-22,16,60,NA,54,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-11-08T00:00:00Z,NA,H,2013-12-22T00:00:00Z,NA,H,16,60,45,2013-11-08,2013-12-22,3645,2430,PLDOSE,2430,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1065,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-08,2013-12-22,16,60,NA,54,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-11-08T00:00:00Z,NA,H,2013-12-22T00:00:00Z,NA,H,16,60,45,2013-11-08,2013-12-22,3645,2430,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1065,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-08,2013-12-22,16,60,NA,54,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-11-08T00:00:00Z,NA,H,2013-12-22T00:00:00Z,NA,H,16,60,45,2013-11-08,2013-12-22,3645,2430,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-10-24T00:00:00Z,NA,NA,2013-12-22T00:00:00Z,NA,NA,NA,NA,NA,2013-10-24,2013-12-22,NA,NA,TDURD,60,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-10-24T00:00:00Z,NA,NA,2013-12-22T00:00:00Z,NA,NA,NA,NA,NA,2013-10-24,2013-12-22,NA,NA,TDOSE,4455,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-10-24T00:00:00Z,NA,NA,2013-12-22T00:00:00Z,NA,NA,NA,NA,NA,2013-10-24,2013-12-22,NA,NA,AVDDSE,74.25,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-10-24T00:00:00Z,NA,NA,2013-12-22T00:00:00Z,NA,NA,NA,NA,NA,2013-10-24,2013-12-22,NA,NA,TPDOSE,3240,NA,OVERALL,Total planned dose (mg),11,NA,14,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-10-24T00:00:00Z,NA,NA,2013-12-22T00:00:00Z,NA,NA,NA,NA,NA,2013-10-24,2013-12-22,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-10-24T00:00:00Z,NA,NA,2013-12-22T00:00:00Z,NA,NA,NA,NA,NA,2013-10-24,2013-12-22,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-10-24T00:00:00Z,NA,NA,2013-12-22T00:00:00Z,NA,NA,NA,NA,NA,2013-10-24,2013-12-22,NA,NA,TDOSINT,137.5,NA,OVERALL,Overall dose intensity (%),90,NA,17,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-11-08T00:00:00Z,NA,NA,2013-12-22T00:00:00Z,NA,NA,NA,NA,NA,2013-11-08,2013-12-22,NA,NA,PDURD,45,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-11-08T00:00:00Z,NA,NA,2013-12-22T00:00:00Z,NA,NA,NA,NA,NA,2013-11-08,2013-12-22,NA,NA,PDOSE,3645,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-11-08T00:00:00Z,NA,NA,2013-12-22T00:00:00Z,NA,NA,NA,NA,NA,2013-11-08,2013-12-22,NA,NA,PPDOSE,2430,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-11-08T00:00:00Z,NA,NA,2013-12-22T00:00:00Z,NA,NA,NA,NA,NA,2013-11-08,2013-12-22,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-11-08T00:00:00Z,NA,NA,2013-12-22T00:00:00Z,NA,NA,NA,NA,NA,2013-11-08,2013-12-22,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-11-08T00:00:00Z,NA,NA,2013-12-22T00:00:00Z,NA,NA,NA,NA,NA,2013-11-08,2013-12-22,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1065,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-24,2013-10-24T00:00:00Z,2013-12-22T23:59:59Z,2013-11-08T00:00:00Z,NA,NA,2013-12-22T00:00:00Z,NA,NA,NA,NA,NA,2013-11-08,2013-12-22,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1065,2013-10-24,2013-12-24,2013-10-24,2013-12-22,NA,2014-02-17,NA,NA,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-17,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-22,60,NA,2013-12-24,DISCONTINUED,NA,2013-10-24,NA,NA,NA,2013-12-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1074,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-22,2014-02-09,1,19,NA,54,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-01-22T00:00:00Z,NA,H,2014-02-09T00:00:00Z,NA,H,1,19,19,2014-01-22,2014-02-09,1026,1026,DURD,19,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1074,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-22,2014-02-09,1,19,NA,54,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-01-22T00:00:00Z,NA,H,2014-02-09T00:00:00Z,NA,H,1,19,19,2014-01-22,2014-02-09,1026,1026,DOSE,1026,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1074,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-22,2014-02-09,1,19,NA,54,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-01-22T00:00:00Z,NA,H,2014-02-09T00:00:00Z,NA,H,1,19,19,2014-01-22,2014-02-09,1026,1026,PLDOSE,1026,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1074,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-22,2014-02-09,1,19,NA,54,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-01-22T00:00:00Z,NA,H,2014-02-09T00:00:00Z,NA,H,1,19,19,2014-01-22,2014-02-09,1026,1026,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1074,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-22,2014-02-09,1,19,NA,54,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-01-22T00:00:00Z,NA,H,2014-02-09T00:00:00Z,NA,H,1,19,19,2014-01-22,2014-02-09,1026,1026,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1074,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-10,2014-03-20,20,58,NA,54,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-02-10T00:00:00Z,NA,H,2014-03-20T00:00:00Z,NA,H,20,58,39,2014-02-10,2014-03-20,3159,2106,DURD,39,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1074,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-10,2014-03-20,20,58,NA,54,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-02-10T00:00:00Z,NA,H,2014-03-20T00:00:00Z,NA,H,20,58,39,2014-02-10,2014-03-20,3159,2106,DOSE,3159,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1074,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-10,2014-03-20,20,58,NA,54,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-02-10T00:00:00Z,NA,H,2014-03-20T00:00:00Z,NA,H,20,58,39,2014-02-10,2014-03-20,3159,2106,PLDOSE,2106,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1074,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-10,2014-03-20,20,58,NA,54,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-02-10T00:00:00Z,NA,H,2014-03-20T00:00:00Z,NA,H,20,58,39,2014-02-10,2014-03-20,3159,2106,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1074,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-10,2014-03-20,20,58,NA,54,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-02-10T00:00:00Z,NA,H,2014-03-20T00:00:00Z,NA,H,20,58,39,2014-02-10,2014-03-20,3159,2106,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-01-22T00:00:00Z,NA,NA,2014-03-20T00:00:00Z,NA,NA,NA,NA,NA,2014-01-22,2014-03-20,NA,NA,TDURD,58,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-01-22T00:00:00Z,NA,NA,2014-03-20T00:00:00Z,NA,NA,NA,NA,NA,2014-01-22,2014-03-20,NA,NA,TDOSE,4185,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-01-22T00:00:00Z,NA,NA,2014-03-20T00:00:00Z,NA,NA,NA,NA,NA,2014-01-22,2014-03-20,NA,NA,AVDDSE,72.15517241379311,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-01-22T00:00:00Z,NA,NA,2014-03-20T00:00:00Z,NA,NA,NA,NA,NA,2014-01-22,2014-03-20,NA,NA,TPDOSE,3132,NA,OVERALL,Total planned dose (mg),11,NA,14,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-01-22T00:00:00Z,NA,NA,2014-03-20T00:00:00Z,NA,NA,NA,NA,NA,2014-01-22,2014-03-20,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-01-22T00:00:00Z,NA,NA,2014-03-20T00:00:00Z,NA,NA,NA,NA,NA,2014-01-22,2014-03-20,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-01-22T00:00:00Z,NA,NA,2014-03-20T00:00:00Z,NA,NA,NA,NA,NA,2014-01-22,2014-03-20,NA,NA,TDOSINT,133.6206896551724,NA,OVERALL,Overall dose intensity (%),90,NA,17,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-02-10T00:00:00Z,NA,NA,2014-03-20T00:00:00Z,NA,NA,NA,NA,NA,2014-02-10,2014-03-20,NA,NA,PDURD,39,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-02-10T00:00:00Z,NA,NA,2014-03-20T00:00:00Z,NA,NA,NA,NA,NA,2014-02-10,2014-03-20,NA,NA,PDOSE,3159,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-02-10T00:00:00Z,NA,NA,2014-03-20T00:00:00Z,NA,NA,NA,NA,NA,2014-02-10,2014-03-20,NA,NA,PPDOSE,2106,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-02-10T00:00:00Z,NA,NA,2014-03-20T00:00:00Z,NA,NA,NA,NA,NA,2014-02-10,2014-03-20,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-02-10T00:00:00Z,NA,NA,2014-03-20T00:00:00Z,NA,NA,NA,NA,NA,2014-02-10,2014-03-20,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-02-10T00:00:00Z,NA,NA,2014-03-20T00:00:00Z,NA,NA,NA,NA,NA,2014-02-10,2014-03-20,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1074,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-03-20T23:59:59Z,2014-02-10T00:00:00Z,NA,NA,2014-03-20T00:00:00Z,NA,NA,NA,NA,NA,2014-02-10,2014-03-20,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1074,2014-01-22,2014-03-31,2014-01-22,2014-03-20,NA,2014-03-31T10:30,NA,NA,704,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-19,-3,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-03-20,58,NA,2014-03-31,DISCONTINUED,NA,2014-01-22,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1093,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-15,2013-03-30,1,16,NA,54,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-15T00:00:00Z,NA,H,2013-03-30T00:00:00Z,NA,H,1,16,16,2013-03-15,2013-03-30,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1093,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-15,2013-03-30,1,16,NA,54,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-15T00:00:00Z,NA,H,2013-03-30T00:00:00Z,NA,H,1,16,16,2013-03-15,2013-03-30,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1093,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-15,2013-03-30,1,16,NA,54,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-15T00:00:00Z,NA,H,2013-03-30T00:00:00Z,NA,H,1,16,16,2013-03-15,2013-03-30,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1093,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-15,2013-03-30,1,16,NA,54,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-15T00:00:00Z,NA,H,2013-03-30T00:00:00Z,NA,H,1,16,16,2013-03-15,2013-03-30,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1093,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-15,2013-03-30,1,16,NA,54,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-15T00:00:00Z,NA,H,2013-03-30T00:00:00Z,NA,H,1,16,16,2013-03-15,2013-03-30,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1093,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-31,2013-06-17,17,95,NA,54,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-31T00:00:00Z,NA,H,2013-06-17T00:00:00Z,NA,H,17,95,79,2013-03-31,2013-06-17,6399,4266,DURD,79,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1093,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-31,2013-06-17,17,95,NA,54,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-31T00:00:00Z,NA,H,2013-06-17T00:00:00Z,NA,H,17,95,79,2013-03-31,2013-06-17,6399,4266,DOSE,6399,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1093,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-31,2013-06-17,17,95,NA,54,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-31T00:00:00Z,NA,H,2013-06-17T00:00:00Z,NA,H,17,95,79,2013-03-31,2013-06-17,6399,4266,PLDOSE,4266,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1093,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-31,2013-06-17,17,95,NA,54,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-31T00:00:00Z,NA,H,2013-06-17T00:00:00Z,NA,H,17,95,79,2013-03-31,2013-06-17,6399,4266,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1093,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-31,2013-06-17,17,95,NA,54,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-31T00:00:00Z,NA,H,2013-06-17T00:00:00Z,NA,H,17,95,79,2013-03-31,2013-06-17,6399,4266,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-15T00:00:00Z,NA,NA,2013-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-03-15,2013-06-17,NA,NA,TDURD,95,NA,OVERALL,Overall duration (days),7,>=90 days,11,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-15T00:00:00Z,NA,NA,2013-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-03-15,2013-06-17,NA,NA,TDOSE,7263,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-15T00:00:00Z,NA,NA,2013-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-03-15,2013-06-17,NA,NA,AVDDSE,76.45263157894736,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-15T00:00:00Z,NA,NA,2013-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-03-15,2013-06-17,NA,NA,TPDOSE,5130,NA,OVERALL,Total planned dose (mg),11,NA,14,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-15T00:00:00Z,NA,NA,2013-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-03-15,2013-06-17,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-15T00:00:00Z,NA,NA,2013-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-03-15,2013-06-17,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-15T00:00:00Z,NA,NA,2013-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-03-15,2013-06-17,NA,NA,TDOSINT,141.57894736842104,NA,OVERALL,Overall dose intensity (%),90,NA,17,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-31T00:00:00Z,NA,NA,2013-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-03-31,2013-06-17,NA,NA,PDURD,79,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-31T00:00:00Z,NA,NA,2013-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-03-31,2013-06-17,NA,NA,PDOSE,6399,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-31T00:00:00Z,NA,NA,2013-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-03-31,2013-06-17,NA,NA,PPDOSE,4266,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-31T00:00:00Z,NA,NA,2013-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-03-31,2013-06-17,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-31T00:00:00Z,NA,NA,2013-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-03-31,2013-06-17,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-31T00:00:00Z,NA,NA,2013-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-03-31,2013-06-17,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1093,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-15,2013-03-15T00:00:00Z,2013-06-17T23:59:59Z,2013-03-31T00:00:00Z,NA,NA,2013-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-03-31,2013-06-17,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1093,2013-03-15,2013-06-20,2013-03-15,2013-06-17,NA,2013-12-25,NA,NA,704,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-22,-21,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-17,95,NA,2013-06-20,DISCONTINUED,2013-12-25,2013-03-15,NA,NA,NA,2013-06-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1114,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-23,2013-02-03,1,12,NA,54,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-01-23T00:00:00Z,NA,H,2013-02-03T00:00:00Z,NA,H,1,12,12,2013-01-23,2013-02-03,648,648,DURD,12,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1114,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-23,2013-02-03,1,12,NA,54,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-01-23T00:00:00Z,NA,H,2013-02-03T00:00:00Z,NA,H,1,12,12,2013-01-23,2013-02-03,648,648,DOSE,648,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1114,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-23,2013-02-03,1,12,NA,54,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-01-23T00:00:00Z,NA,H,2013-02-03T00:00:00Z,NA,H,1,12,12,2013-01-23,2013-02-03,648,648,PLDOSE,648,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1114,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-23,2013-02-03,1,12,NA,54,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-01-23T00:00:00Z,NA,H,2013-02-03T00:00:00Z,NA,H,1,12,12,2013-01-23,2013-02-03,648,648,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1114,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-23,2013-02-03,1,12,NA,54,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-01-23T00:00:00Z,NA,H,2013-02-03T00:00:00Z,NA,H,1,12,12,2013-01-23,2013-02-03,648,648,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1114,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-04,2013-07-07,13,166,NA,54,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-02-04T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,13,166,154,2013-02-04,2013-07-07,8316,8316,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1114,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-04,2013-07-07,13,166,NA,54,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-02-04T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,13,166,154,2013-02-04,2013-07-07,8316,8316,DOSE,8316,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1114,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-04,2013-07-07,13,166,NA,54,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-02-04T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,13,166,154,2013-02-04,2013-07-07,8316,8316,PLDOSE,8316,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1114,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-04,2013-07-07,13,166,NA,54,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-02-04T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,13,166,154,2013-02-04,2013-07-07,8316,8316,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1114,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-04,2013-07-07,13,166,NA,54,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-02-04T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,13,166,154,2013-02-04,2013-07-07,8316,8316,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-01-23T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-01-23,2013-07-07,NA,NA,TDURD,166,NA,OVERALL,Overall duration (days),7,>=90 days,11,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-01-23T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-01-23,2013-07-07,NA,NA,TDOSE,8964,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-01-23T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-01-23,2013-07-07,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-01-23T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-01-23,2013-07-07,NA,NA,TPDOSE,8964,NA,OVERALL,Total planned dose (mg),11,NA,14,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-01-23T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-01-23,2013-07-07,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-01-23T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-01-23,2013-07-07,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-01-23T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-01-23,2013-07-07,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-02-04T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-04,2013-07-07,NA,NA,PDURD,154,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-02-04T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-04,2013-07-07,NA,NA,PDOSE,8316,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-02-04T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-04,2013-07-07,NA,NA,PPDOSE,8316,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-02-04T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-04,2013-07-07,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-02-04T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-04,2013-07-07,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-02-04T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-04,2013-07-07,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1114,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-23,2013-01-23T00:00:00Z,2013-07-07T23:59:59Z,2013-02-04T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-04,2013-07-07,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1114,2013-01-23,2013-07-08,2013-01-23,2013-07-07,NA,2013-07-08T09:56,NA,NA,704,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-09,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,166,NA,2013-07-08,DISCONTINUED,NA,2013-01-23,NA,NA,NA,2013-07-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1120,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-02,2013-12-15,1,14,NA,54,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-02T00:00:00Z,NA,H,2013-12-15T00:00:00Z,NA,H,1,14,14,2013-12-02,2013-12-15,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1120,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-02,2013-12-15,1,14,NA,54,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-02T00:00:00Z,NA,H,2013-12-15T00:00:00Z,NA,H,1,14,14,2013-12-02,2013-12-15,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1120,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-02,2013-12-15,1,14,NA,54,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-02T00:00:00Z,NA,H,2013-12-15T00:00:00Z,NA,H,1,14,14,2013-12-02,2013-12-15,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1120,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-02,2013-12-15,1,14,NA,54,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-02T00:00:00Z,NA,H,2013-12-15T00:00:00Z,NA,H,1,14,14,2013-12-02,2013-12-15,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1120,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-02,2013-12-15,1,14,NA,54,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-02T00:00:00Z,NA,H,2013-12-15T00:00:00Z,NA,H,1,14,14,2013-12-02,2013-12-15,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1120,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-16,2014-02-01,15,62,NA,54,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2014-02-01T00:00:00Z,NA,H,15,62,48,2013-12-16,2014-02-01,2592,2592,DURD,48,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1120,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-16,2014-02-01,15,62,NA,54,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2014-02-01T00:00:00Z,NA,H,15,62,48,2013-12-16,2014-02-01,2592,2592,DOSE,2592,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1120,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-16,2014-02-01,15,62,NA,54,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2014-02-01T00:00:00Z,NA,H,15,62,48,2013-12-16,2014-02-01,2592,2592,PLDOSE,2592,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1120,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-16,2014-02-01,15,62,NA,54,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2014-02-01T00:00:00Z,NA,H,15,62,48,2013-12-16,2014-02-01,2592,2592,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1120,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-16,2014-02-01,15,62,NA,54,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2014-02-01T00:00:00Z,NA,H,15,62,48,2013-12-16,2014-02-01,2592,2592,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1120,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-02T00:00:00Z,NA,NA,2014-02-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-02,2014-02-01,NA,NA,TDURD,62,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1120,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-02T00:00:00Z,NA,NA,2014-02-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-02,2014-02-01,NA,NA,TDOSE,3348,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1120,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-02T00:00:00Z,NA,NA,2014-02-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-02,2014-02-01,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1120,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-02T00:00:00Z,NA,NA,2014-02-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-02,2014-02-01,NA,NA,TPDOSE,3348,NA,OVERALL,Total planned dose (mg),11,NA,14,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1120,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-02T00:00:00Z,NA,NA,2014-02-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-02,2014-02-01,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1120,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-02T00:00:00Z,NA,NA,2014-02-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-02,2014-02-01,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1120,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-02T00:00:00Z,NA,NA,2014-02-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-02,2014-02-01,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1120,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-02-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-02-01,NA,NA,PDURD,48,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1120,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-02-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-02-01,NA,NA,PDOSE,2592,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1120,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-02-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-02-01,NA,NA,PPDOSE,2592,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1120,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-02-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-02-01,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1120,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-02-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-02-01,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1120,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-02-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-02-01,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1120,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-02,2013-12-02T00:00:00Z,2014-02-01T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-02-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-02-01,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1120,2013-12-02,2014-02-03,2013-12-02,2014-02-01,NA,2014-03-10,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-18,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-01,62,NA,2014-02-03,DISCONTINUED,NA,2013-12-02,NA,NA,NA,2014-02-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1127,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-02,2013-10-16,1,15,NA,0,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-02T00:00:00Z,NA,H,2013-10-16T00:00:00Z,NA,H,1,15,15,2013-10-02,2013-10-16,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1127,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-02,2013-10-16,1,15,NA,0,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-02T00:00:00Z,NA,H,2013-10-16T00:00:00Z,NA,H,1,15,15,2013-10-02,2013-10-16,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1127,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-02,2013-10-16,1,15,NA,0,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-02T00:00:00Z,NA,H,2013-10-16T00:00:00Z,NA,H,1,15,15,2013-10-02,2013-10-16,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1127,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-02,2013-10-16,1,15,NA,0,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-02T00:00:00Z,NA,H,2013-10-16T00:00:00Z,NA,H,1,15,15,2013-10-02,2013-10-16,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1127,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-02,2013-10-16,1,15,NA,0,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-02T00:00:00Z,NA,H,2013-10-16T00:00:00Z,NA,H,1,15,15,2013-10-02,2013-10-16,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1127,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-17,2014-03-17,16,167,NA,0,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2014-03-17T00:00:00Z,NA,H,16,167,152,2013-10-17,2014-03-17,0,0,DURD,152,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1127,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-17,2014-03-17,16,167,NA,0,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2014-03-17T00:00:00Z,NA,H,16,167,152,2013-10-17,2014-03-17,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1127,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-17,2014-03-17,16,167,NA,0,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2014-03-17T00:00:00Z,NA,H,16,167,152,2013-10-17,2014-03-17,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1127,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-17,2014-03-17,16,167,NA,0,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2014-03-17T00:00:00Z,NA,H,16,167,152,2013-10-17,2014-03-17,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1127,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-17,2014-03-17,16,167,NA,0,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2014-03-17T00:00:00Z,NA,H,16,167,152,2013-10-17,2014-03-17,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1127,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-18,2014-03-31,168,181,NA,0,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,H,2014-03-31T00:00:00Z,NA,H,168,181,14,2014-03-18,2014-03-31,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1127,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-18,2014-03-31,168,181,NA,0,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,H,2014-03-31T00:00:00Z,NA,H,168,181,14,2014-03-18,2014-03-31,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1127,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-18,2014-03-31,168,181,NA,0,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,H,2014-03-31T00:00:00Z,NA,H,168,181,14,2014-03-18,2014-03-31,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1127,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-18,2014-03-31,168,181,NA,0,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,H,2014-03-31T00:00:00Z,NA,H,168,181,14,2014-03-18,2014-03-31,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1127,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-18,2014-03-31,168,181,NA,0,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2014-03-18T00:00:00Z,NA,H,2014-03-31T00:00:00Z,NA,H,168,181,14,2014-03-18,2014-03-31,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-02T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-02,2014-03-31,NA,NA,TDURD,181,NA,OVERALL,Overall duration (days),7,>=90 days,16,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-02T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-02,2014-03-31,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-02T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-02,2014-03-31,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-02T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-02,2014-03-31,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-02T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-02,2014-03-31,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-02T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-02,2014-03-31,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-02T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-02,2014-03-31,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2014-03-31,NA,NA,PDURD,166,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2014-03-31,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2014-03-31,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2014-03-31,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2014-03-31,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2014-03-31,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1127,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-03-31T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2014-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2014-03-31,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1127,2013-10-02,2014-03-31,2013-10-02,2014-03-31,NA,2014-03-31T11:30,NA,NA,704,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-16,-16,Placebo,Placebo,H,H,2014-03-31,181,NA,2014-03-31,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1135,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-31,2013-11-14,1,15,NA,54,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-10-31T00:00:00Z,NA,H,2013-11-14T00:00:00Z,NA,H,1,15,15,2013-10-31,2013-11-14,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1135,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-31,2013-11-14,1,15,NA,54,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-10-31T00:00:00Z,NA,H,2013-11-14T00:00:00Z,NA,H,1,15,15,2013-10-31,2013-11-14,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1135,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-31,2013-11-14,1,15,NA,54,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-10-31T00:00:00Z,NA,H,2013-11-14T00:00:00Z,NA,H,1,15,15,2013-10-31,2013-11-14,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1135,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-31,2013-11-14,1,15,NA,54,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-10-31T00:00:00Z,NA,H,2013-11-14T00:00:00Z,NA,H,1,15,15,2013-10-31,2013-11-14,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1135,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-31,2013-11-14,1,15,NA,54,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-10-31T00:00:00Z,NA,H,2013-11-14T00:00:00Z,NA,H,1,15,15,2013-10-31,2013-11-14,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1135,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-15,2014-05-01,16,183,NA,54,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-11-15T00:00:00Z,NA,H,2014-05-01T00:00:00Z,NA,H,16,183,168,2013-11-15,2014-05-01,9072,9072,DURD,168,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1135,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-15,2014-05-01,16,183,NA,54,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-11-15T00:00:00Z,NA,H,2014-05-01T00:00:00Z,NA,H,16,183,168,2013-11-15,2014-05-01,9072,9072,DOSE,9072,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1135,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-15,2014-05-01,16,183,NA,54,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-11-15T00:00:00Z,NA,H,2014-05-01T00:00:00Z,NA,H,16,183,168,2013-11-15,2014-05-01,9072,9072,PLDOSE,9072,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1135,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-15,2014-05-01,16,183,NA,54,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-11-15T00:00:00Z,NA,H,2014-05-01T00:00:00Z,NA,H,16,183,168,2013-11-15,2014-05-01,9072,9072,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1135,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-15,2014-05-01,16,183,NA,54,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-11-15T00:00:00Z,NA,H,2014-05-01T00:00:00Z,NA,H,16,183,168,2013-11-15,2014-05-01,9072,9072,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1135,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-02,2014-05-16,184,198,NA,54,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2014-05-02T00:00:00Z,NA,H,2014-05-16T00:00:00Z,NA,H,184,198,15,2014-05-02,2014-05-16,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1135,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-02,2014-05-16,184,198,NA,54,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2014-05-02T00:00:00Z,NA,H,2014-05-16T00:00:00Z,NA,H,184,198,15,2014-05-02,2014-05-16,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1135,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-02,2014-05-16,184,198,NA,54,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2014-05-02T00:00:00Z,NA,H,2014-05-16T00:00:00Z,NA,H,184,198,15,2014-05-02,2014-05-16,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1135,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-02,2014-05-16,184,198,NA,54,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2014-05-02T00:00:00Z,NA,H,2014-05-16T00:00:00Z,NA,H,184,198,15,2014-05-02,2014-05-16,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1135,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-02,2014-05-16,184,198,NA,54,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2014-05-02T00:00:00Z,NA,H,2014-05-16T00:00:00Z,NA,H,184,198,15,2014-05-02,2014-05-16,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-10-31T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2013-10-31,2014-05-16,NA,NA,TDURD,198,NA,OVERALL,Overall duration (days),7,>=90 days,16,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-10-31T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2013-10-31,2014-05-16,NA,NA,TDOSE,10692,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-10-31T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2013-10-31,2014-05-16,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-10-31T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2013-10-31,2014-05-16,NA,NA,TPDOSE,10692,NA,OVERALL,Total planned dose (mg),11,NA,19,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-10-31T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2013-10-31,2014-05-16,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-10-31T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2013-10-31,2014-05-16,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-10-31T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2013-10-31,2014-05-16,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-11-15T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2013-11-15,2014-05-16,NA,NA,PDURD,183,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-11-15T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2013-11-15,2014-05-16,NA,NA,PDOSE,9882,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-11-15T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2013-11-15,2014-05-16,NA,NA,PPDOSE,9882,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-11-15T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2013-11-15,2014-05-16,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-11-15T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2013-11-15,2014-05-16,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-11-15T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2013-11-15,2014-05-16,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1135,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-31,2013-10-31T00:00:00Z,2014-05-16T23:59:59Z,2013-11-15T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2013-11-15,2014-05-16,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1135,2013-10-31,2014-05-16,2013-10-31,2014-05-16,NA,2014-05-16T09:45,NA,NA,704,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-23,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,198,NA,2014-05-16,COMPLETED,NA,2013-10-31,NA,NA,NA,2014-05-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1164,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-19,2012-10-04,1,16,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-09-19T00:00:00Z,NA,H,2012-10-04T00:00:00Z,NA,H,1,16,16,2012-09-19,2012-10-04,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1164,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-19,2012-10-04,1,16,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-09-19T00:00:00Z,NA,H,2012-10-04T00:00:00Z,NA,H,1,16,16,2012-09-19,2012-10-04,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1164,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-19,2012-10-04,1,16,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-09-19T00:00:00Z,NA,H,2012-10-04T00:00:00Z,NA,H,1,16,16,2012-09-19,2012-10-04,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1164,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-19,2012-10-04,1,16,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-09-19T00:00:00Z,NA,H,2012-10-04T00:00:00Z,NA,H,1,16,16,2012-09-19,2012-10-04,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1164,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-19,2012-10-04,1,16,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-09-19T00:00:00Z,NA,H,2012-10-04T00:00:00Z,NA,H,1,16,16,2012-09-19,2012-10-04,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1164,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-05,2013-03-17,17,180,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-10-05T00:00:00Z,NA,H,2013-03-17T00:00:00Z,NA,H,17,180,164,2012-10-05,2013-03-17,0,0,DURD,164,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1164,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-05,2013-03-17,17,180,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-10-05T00:00:00Z,NA,H,2013-03-17T00:00:00Z,NA,H,17,180,164,2012-10-05,2013-03-17,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1164,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-05,2013-03-17,17,180,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-10-05T00:00:00Z,NA,H,2013-03-17T00:00:00Z,NA,H,17,180,164,2012-10-05,2013-03-17,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1164,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-05,2013-03-17,17,180,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-10-05T00:00:00Z,NA,H,2013-03-17T00:00:00Z,NA,H,17,180,164,2012-10-05,2013-03-17,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1164,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-05,2013-03-17,17,180,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-10-05T00:00:00Z,NA,H,2013-03-17T00:00:00Z,NA,H,17,180,164,2012-10-05,2013-03-17,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1164,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-18,2013-04-04,181,198,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2013-03-18T00:00:00Z,NA,H,2013-04-04T00:00:00Z,NA,H,181,198,18,2013-03-18,2013-04-04,0,0,DURD,18,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1164,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-18,2013-04-04,181,198,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2013-03-18T00:00:00Z,NA,H,2013-04-04T00:00:00Z,NA,H,181,198,18,2013-03-18,2013-04-04,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1164,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-18,2013-04-04,181,198,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2013-03-18T00:00:00Z,NA,H,2013-04-04T00:00:00Z,NA,H,181,198,18,2013-03-18,2013-04-04,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1164,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-18,2013-04-04,181,198,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2013-03-18T00:00:00Z,NA,H,2013-04-04T00:00:00Z,NA,H,181,198,18,2013-03-18,2013-04-04,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1164,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-18,2013-04-04,181,198,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2013-03-18T00:00:00Z,NA,H,2013-04-04T00:00:00Z,NA,H,181,198,18,2013-03-18,2013-04-04,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2013-04-04,NA,NA,TDURD,198,NA,OVERALL,Overall duration (days),7,>=90 days,16,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2013-04-04,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2013-04-04,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2013-04-04,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2013-04-04,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2013-04-04,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2013-04-04,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-10-05T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2012-10-05,2013-04-04,NA,NA,PDURD,182,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-10-05T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2012-10-05,2013-04-04,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-10-05T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2012-10-05,2013-04-04,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-10-05T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2012-10-05,2013-04-04,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-10-05T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2012-10-05,2013-04-04,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-10-05T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2012-10-05,2013-04-04,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1164,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-04-04T23:59:59Z,2012-10-05T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2012-10-05,2013-04-04,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1164,2012-09-19,2013-04-04,2012-09-19,2013-04-04,NA,2013-04-04,NA,NA,704,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-11,-8,Placebo,Placebo,H,H,2013-04-04,198,NA,2013-04-04,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1218,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-19,2012-12-03,1,15,NA,54,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-11-19T00:00:00Z,NA,H,2012-12-03T00:00:00Z,NA,H,1,15,15,2012-11-19,2012-12-03,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1218,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-19,2012-12-03,1,15,NA,54,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-11-19T00:00:00Z,NA,H,2012-12-03T00:00:00Z,NA,H,1,15,15,2012-11-19,2012-12-03,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1218,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-19,2012-12-03,1,15,NA,54,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-11-19T00:00:00Z,NA,H,2012-12-03T00:00:00Z,NA,H,1,15,15,2012-11-19,2012-12-03,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1218,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-19,2012-12-03,1,15,NA,54,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-11-19T00:00:00Z,NA,H,2012-12-03T00:00:00Z,NA,H,1,15,15,2012-11-19,2012-12-03,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1218,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-19,2012-12-03,1,15,NA,54,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-11-19T00:00:00Z,NA,H,2012-12-03T00:00:00Z,NA,H,1,15,15,2012-11-19,2012-12-03,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1218,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-04,2013-05-13,16,176,NA,54,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-12-04T00:00:00Z,NA,H,2013-05-13T00:00:00Z,NA,H,16,176,161,2012-12-04,2013-05-13,8694,8694,DURD,161,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1218,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-04,2013-05-13,16,176,NA,54,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-12-04T00:00:00Z,NA,H,2013-05-13T00:00:00Z,NA,H,16,176,161,2012-12-04,2013-05-13,8694,8694,DOSE,8694,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1218,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-04,2013-05-13,16,176,NA,54,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-12-04T00:00:00Z,NA,H,2013-05-13T00:00:00Z,NA,H,16,176,161,2012-12-04,2013-05-13,8694,8694,PLDOSE,8694,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1218,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-04,2013-05-13,16,176,NA,54,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-12-04T00:00:00Z,NA,H,2013-05-13T00:00:00Z,NA,H,16,176,161,2012-12-04,2013-05-13,8694,8694,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1218,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-04,2013-05-13,16,176,NA,54,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-12-04T00:00:00Z,NA,H,2013-05-13T00:00:00Z,NA,H,16,176,161,2012-12-04,2013-05-13,8694,8694,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1218,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-14,2013-05-27,177,190,NA,54,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2013-05-14T00:00:00Z,NA,H,2013-05-27T00:00:00Z,NA,H,177,190,14,2013-05-14,2013-05-27,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1218,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-14,2013-05-27,177,190,NA,54,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2013-05-14T00:00:00Z,NA,H,2013-05-27T00:00:00Z,NA,H,177,190,14,2013-05-14,2013-05-27,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1218,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-14,2013-05-27,177,190,NA,54,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2013-05-14T00:00:00Z,NA,H,2013-05-27T00:00:00Z,NA,H,177,190,14,2013-05-14,2013-05-27,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1218,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-14,2013-05-27,177,190,NA,54,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2013-05-14T00:00:00Z,NA,H,2013-05-27T00:00:00Z,NA,H,177,190,14,2013-05-14,2013-05-27,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1218,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-14,2013-05-27,177,190,NA,54,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2013-05-14T00:00:00Z,NA,H,2013-05-27T00:00:00Z,NA,H,177,190,14,2013-05-14,2013-05-27,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-11-19T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-11-19,2013-05-27,NA,NA,TDURD,190,NA,OVERALL,Overall duration (days),7,>=90 days,16,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-11-19T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-11-19,2013-05-27,NA,NA,TDOSE,10260,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-11-19T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-11-19,2013-05-27,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-11-19T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-11-19,2013-05-27,NA,NA,TPDOSE,10260,NA,OVERALL,Total planned dose (mg),11,NA,19,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-11-19T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-11-19,2013-05-27,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-11-19T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-11-19,2013-05-27,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-11-19T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-11-19,2013-05-27,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-12-04T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-04,2013-05-27,NA,NA,PDURD,175,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-12-04T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-04,2013-05-27,NA,NA,PDOSE,9450,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-12-04T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-04,2013-05-27,NA,NA,PPDOSE,9450,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-12-04T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-04,2013-05-27,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-12-04T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-04,2013-05-27,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-12-04T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-04,2013-05-27,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1218,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-19,2012-11-19T00:00:00Z,2013-05-27T23:59:59Z,2012-12-04T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-04,2013-05-27,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1218,2012-11-19,2013-05-27,2012-11-19,2013-05-27,NA,2013-05-27T11:20,NA,NA,704,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-27,190,NA,2013-05-27,COMPLETED,NA,2012-11-19,NA,NA,NA,2013-05-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1233,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-21,2013-04-04,1,15,NA,0,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-03-21T00:00:00Z,NA,H,2013-04-04T00:00:00Z,NA,H,1,15,15,2013-03-21,2013-04-04,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1233,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-21,2013-04-04,1,15,NA,0,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-03-21T00:00:00Z,NA,H,2013-04-04T00:00:00Z,NA,H,1,15,15,2013-03-21,2013-04-04,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1233,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-21,2013-04-04,1,15,NA,0,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-03-21T00:00:00Z,NA,H,2013-04-04T00:00:00Z,NA,H,1,15,15,2013-03-21,2013-04-04,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1233,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-21,2013-04-04,1,15,NA,0,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-03-21T00:00:00Z,NA,H,2013-04-04T00:00:00Z,NA,H,1,15,15,2013-03-21,2013-04-04,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1233,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-21,2013-04-04,1,15,NA,0,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-03-21T00:00:00Z,NA,H,2013-04-04T00:00:00Z,NA,H,1,15,15,2013-03-21,2013-04-04,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1233,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-05,NA,16,NA,NA,0,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-04-05T00:00:00Z,NA,H,NA,NA,NA,16,NA,NA,2013-04-05,NA,NA,NA,DURD,NA,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1233,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-05,NA,16,NA,NA,0,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-04-05T00:00:00Z,NA,H,NA,NA,NA,16,NA,NA,2013-04-05,NA,NA,NA,DOSE,NA,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1233,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-05,NA,16,NA,NA,0,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-04-05T00:00:00Z,NA,H,NA,NA,NA,16,NA,NA,2013-04-05,NA,NA,NA,PLDOSE,NA,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1233,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-05,NA,16,NA,NA,0,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-04-05T00:00:00Z,NA,H,NA,NA,NA,16,NA,NA,2013-04-05,NA,NA,NA,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1233,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-05,NA,16,NA,NA,0,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-04-05T00:00:00Z,NA,H,NA,NA,NA,16,NA,NA,2013-04-05,NA,NA,NA,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-03-21T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-03-21,2013-04-04,NA,NA,TDURD,15,NA,OVERALL,Overall duration (days),7,< 30 days,11,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-03-21T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-03-21,2013-04-04,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-03-21T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-03-21,2013-04-04,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-03-21T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-03-21,2013-04-04,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-03-21T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-03-21,2013-04-04,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-03-21T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-03-21,2013-04-04,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-03-21T00:00:00Z,NA,NA,2013-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-03-21,2013-04-04,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-04-05T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-04-05,NA,NA,PDURD,0,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-04-05T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-04-05,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-04-05T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-04-05,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-04-05T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-04-05,NA,NA,PAVDDSE,NA,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-04-05T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-04-05,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-04-05T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-04-05,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1233,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-21,2013-03-21T00:00:00Z,2013-04-04T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-04-05T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-04-05,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1233,2013-03-21,2013-07-14,2013-03-21,2013-04-04,NA,2013-07-14,NA,NA,704,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-08,-13,Placebo,Placebo,H,H,2013-04-04,15,NA,2013-07-14,DISCONTINUED,NA,2013-03-21,NA,NA,NA,2013-07-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1241,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-25,2013-09-05,1,12,NA,54,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-08-25T00:00:00Z,NA,H,2013-09-05T00:00:00Z,NA,H,1,12,12,2013-08-25,2013-09-05,648,648,DURD,12,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1241,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-25,2013-09-05,1,12,NA,54,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-08-25T00:00:00Z,NA,H,2013-09-05T00:00:00Z,NA,H,1,12,12,2013-08-25,2013-09-05,648,648,DOSE,648,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1241,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-25,2013-09-05,1,12,NA,54,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-08-25T00:00:00Z,NA,H,2013-09-05T00:00:00Z,NA,H,1,12,12,2013-08-25,2013-09-05,648,648,PLDOSE,648,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1241,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-25,2013-09-05,1,12,NA,54,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-08-25T00:00:00Z,NA,H,2013-09-05T00:00:00Z,NA,H,1,12,12,2013-08-25,2013-09-05,648,648,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1241,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-25,2013-09-05,1,12,NA,54,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-08-25T00:00:00Z,NA,H,2013-09-05T00:00:00Z,NA,H,1,12,12,2013-08-25,2013-09-05,648,648,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1241,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-06,2013-10-09,13,46,NA,54,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-09-06T00:00:00Z,NA,H,2013-10-09T00:00:00Z,NA,H,13,46,34,2013-09-06,2013-10-09,2754,1836,DURD,34,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1241,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-06,2013-10-09,13,46,NA,54,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-09-06T00:00:00Z,NA,H,2013-10-09T00:00:00Z,NA,H,13,46,34,2013-09-06,2013-10-09,2754,1836,DOSE,2754,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1241,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-06,2013-10-09,13,46,NA,54,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-09-06T00:00:00Z,NA,H,2013-10-09T00:00:00Z,NA,H,13,46,34,2013-09-06,2013-10-09,2754,1836,PLDOSE,1836,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1241,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-06,2013-10-09,13,46,NA,54,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-09-06T00:00:00Z,NA,H,2013-10-09T00:00:00Z,NA,H,13,46,34,2013-09-06,2013-10-09,2754,1836,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1241,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-06,2013-10-09,13,46,NA,54,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-09-06T00:00:00Z,NA,H,2013-10-09T00:00:00Z,NA,H,13,46,34,2013-09-06,2013-10-09,2754,1836,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-08-25T00:00:00Z,NA,NA,2013-10-09T00:00:00Z,NA,NA,NA,NA,NA,2013-08-25,2013-10-09,NA,NA,TDURD,46,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-08-25T00:00:00Z,NA,NA,2013-10-09T00:00:00Z,NA,NA,NA,NA,NA,2013-08-25,2013-10-09,NA,NA,TDOSE,3402,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-08-25T00:00:00Z,NA,NA,2013-10-09T00:00:00Z,NA,NA,NA,NA,NA,2013-08-25,2013-10-09,NA,NA,AVDDSE,73.95652173913044,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-08-25T00:00:00Z,NA,NA,2013-10-09T00:00:00Z,NA,NA,NA,NA,NA,2013-08-25,2013-10-09,NA,NA,TPDOSE,2484,NA,OVERALL,Total planned dose (mg),11,NA,14,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-08-25T00:00:00Z,NA,NA,2013-10-09T00:00:00Z,NA,NA,NA,NA,NA,2013-08-25,2013-10-09,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-08-25T00:00:00Z,NA,NA,2013-10-09T00:00:00Z,NA,NA,NA,NA,NA,2013-08-25,2013-10-09,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-08-25T00:00:00Z,NA,NA,2013-10-09T00:00:00Z,NA,NA,NA,NA,NA,2013-08-25,2013-10-09,NA,NA,TDOSINT,136.95652173913044,NA,OVERALL,Overall dose intensity (%),90,NA,17,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2013-10-09T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2013-10-09,NA,NA,PDURD,34,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2013-10-09T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2013-10-09,NA,NA,PDOSE,2754,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2013-10-09T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2013-10-09,NA,NA,PPDOSE,1836,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2013-10-09T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2013-10-09,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2013-10-09T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2013-10-09,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2013-10-09T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2013-10-09,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1241,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-25,2013-08-25T00:00:00Z,2013-10-09T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2013-10-09T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2013-10-09,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1241,2013-08-25,2013-10-31,2013-08-25,2013-10-09,NA,2014-01-22,NA,NA,704,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-08-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-09,46,NA,2013-10-31,DISCONTINUED,NA,2013-08-25,NA,NA,NA,2013-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1260,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-08-30,2012-09-13,1,15,NA,0,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-08-30T00:00:00Z,NA,H,2012-09-13T00:00:00Z,NA,H,1,15,15,2012-08-30,2012-09-13,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1260,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-08-30,2012-09-13,1,15,NA,0,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-08-30T00:00:00Z,NA,H,2012-09-13T00:00:00Z,NA,H,1,15,15,2012-08-30,2012-09-13,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1260,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-08-30,2012-09-13,1,15,NA,0,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-08-30T00:00:00Z,NA,H,2012-09-13T00:00:00Z,NA,H,1,15,15,2012-08-30,2012-09-13,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1260,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-08-30,2012-09-13,1,15,NA,0,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-08-30T00:00:00Z,NA,H,2012-09-13T00:00:00Z,NA,H,1,15,15,2012-08-30,2012-09-13,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1260,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-08-30,2012-09-13,1,15,NA,0,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-08-30T00:00:00Z,NA,H,2012-09-13T00:00:00Z,NA,H,1,15,15,2012-08-30,2012-09-13,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1260,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-14,2012-11-04,16,67,NA,0,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-09-14T00:00:00Z,NA,H,2012-11-04T00:00:00Z,NA,H,16,67,52,2012-09-14,2012-11-04,0,0,DURD,52,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1260,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-14,2012-11-04,16,67,NA,0,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-09-14T00:00:00Z,NA,H,2012-11-04T00:00:00Z,NA,H,16,67,52,2012-09-14,2012-11-04,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1260,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-14,2012-11-04,16,67,NA,0,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-09-14T00:00:00Z,NA,H,2012-11-04T00:00:00Z,NA,H,16,67,52,2012-09-14,2012-11-04,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1260,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-14,2012-11-04,16,67,NA,0,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-09-14T00:00:00Z,NA,H,2012-11-04T00:00:00Z,NA,H,16,67,52,2012-09-14,2012-11-04,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1260,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-14,2012-11-04,16,67,NA,0,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-09-14T00:00:00Z,NA,H,2012-11-04T00:00:00Z,NA,H,16,67,52,2012-09-14,2012-11-04,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1260,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-08-30T00:00:00Z,NA,NA,2012-11-04T00:00:00Z,NA,NA,NA,NA,NA,2012-08-30,2012-11-04,NA,NA,TDURD,67,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1260,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-08-30T00:00:00Z,NA,NA,2012-11-04T00:00:00Z,NA,NA,NA,NA,NA,2012-08-30,2012-11-04,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1260,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-08-30T00:00:00Z,NA,NA,2012-11-04T00:00:00Z,NA,NA,NA,NA,NA,2012-08-30,2012-11-04,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1260,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-08-30T00:00:00Z,NA,NA,2012-11-04T00:00:00Z,NA,NA,NA,NA,NA,2012-08-30,2012-11-04,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1260,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-08-30T00:00:00Z,NA,NA,2012-11-04T00:00:00Z,NA,NA,NA,NA,NA,2012-08-30,2012-11-04,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1260,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-08-30T00:00:00Z,NA,NA,2012-11-04T00:00:00Z,NA,NA,NA,NA,NA,2012-08-30,2012-11-04,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1260,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-08-30T00:00:00Z,NA,NA,2012-11-04T00:00:00Z,NA,NA,NA,NA,NA,2012-08-30,2012-11-04,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1260,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-09-14T00:00:00Z,NA,NA,2012-11-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-14,2012-11-04,NA,NA,PDURD,52,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1260,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-09-14T00:00:00Z,NA,NA,2012-11-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-14,2012-11-04,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1260,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-09-14T00:00:00Z,NA,NA,2012-11-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-14,2012-11-04,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1260,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-09-14T00:00:00Z,NA,NA,2012-11-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-14,2012-11-04,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1260,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-09-14T00:00:00Z,NA,NA,2012-11-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-14,2012-11-04,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1260,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-09-14T00:00:00Z,NA,NA,2012-11-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-14,2012-11-04,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1260,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-08-30,2012-08-30T00:00:00Z,2012-11-04T23:59:59Z,2012-09-14T00:00:00Z,NA,NA,2012-11-04T00:00:00Z,NA,NA,NA,NA,NA,2012-09-14,2012-11-04,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1260,2012-08-30,2013-01-18,2012-08-30,2012-11-04,NA,2013-01-18,NA,NA,704,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-08-23,-7,Placebo,Placebo,H,H,2012-11-04,67,NA,2013-01-18,DISCONTINUED,NA,2012-08-30,NA,NA,NA,2012-11-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1266,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-13,2013-10-27,1,15,NA,54,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-13T00:00:00Z,NA,H,2013-10-27T00:00:00Z,NA,H,1,15,15,2013-10-13,2013-10-27,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1266,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-13,2013-10-27,1,15,NA,54,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-13T00:00:00Z,NA,H,2013-10-27T00:00:00Z,NA,H,1,15,15,2013-10-13,2013-10-27,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1266,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-13,2013-10-27,1,15,NA,54,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-13T00:00:00Z,NA,H,2013-10-27T00:00:00Z,NA,H,1,15,15,2013-10-13,2013-10-27,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1266,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-13,2013-10-27,1,15,NA,54,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-13T00:00:00Z,NA,H,2013-10-27T00:00:00Z,NA,H,1,15,15,2013-10-13,2013-10-27,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1266,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-13,2013-10-27,1,15,NA,54,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-13T00:00:00Z,NA,H,2013-10-27T00:00:00Z,NA,H,1,15,15,2013-10-13,2013-10-27,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1266,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-28,2013-12-06,16,55,NA,54,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-28T00:00:00Z,NA,H,2013-12-06T00:00:00Z,NA,H,16,55,40,2013-10-28,2013-12-06,3240,2160,DURD,40,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1266,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-28,2013-12-06,16,55,NA,54,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-28T00:00:00Z,NA,H,2013-12-06T00:00:00Z,NA,H,16,55,40,2013-10-28,2013-12-06,3240,2160,DOSE,3240,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1266,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-28,2013-12-06,16,55,NA,54,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-28T00:00:00Z,NA,H,2013-12-06T00:00:00Z,NA,H,16,55,40,2013-10-28,2013-12-06,3240,2160,PLDOSE,2160,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1266,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-28,2013-12-06,16,55,NA,54,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-28T00:00:00Z,NA,H,2013-12-06T00:00:00Z,NA,H,16,55,40,2013-10-28,2013-12-06,3240,2160,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1266,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-28,2013-12-06,16,55,NA,54,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-28T00:00:00Z,NA,H,2013-12-06T00:00:00Z,NA,H,16,55,40,2013-10-28,2013-12-06,3240,2160,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1266,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-13T00:00:00Z,NA,NA,2013-12-06T00:00:00Z,NA,NA,NA,NA,NA,2013-10-13,2013-12-06,NA,NA,TDURD,55,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1266,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-13T00:00:00Z,NA,NA,2013-12-06T00:00:00Z,NA,NA,NA,NA,NA,2013-10-13,2013-12-06,NA,NA,TDOSE,4050,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1266,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-13T00:00:00Z,NA,NA,2013-12-06T00:00:00Z,NA,NA,NA,NA,NA,2013-10-13,2013-12-06,NA,NA,AVDDSE,73.63636363636364,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1266,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-13T00:00:00Z,NA,NA,2013-12-06T00:00:00Z,NA,NA,NA,NA,NA,2013-10-13,2013-12-06,NA,NA,TPDOSE,2970,NA,OVERALL,Total planned dose (mg),11,NA,14,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1266,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-13T00:00:00Z,NA,NA,2013-12-06T00:00:00Z,NA,NA,NA,NA,NA,2013-10-13,2013-12-06,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1266,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-13T00:00:00Z,NA,NA,2013-12-06T00:00:00Z,NA,NA,NA,NA,NA,2013-10-13,2013-12-06,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1266,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-13T00:00:00Z,NA,NA,2013-12-06T00:00:00Z,NA,NA,NA,NA,NA,2013-10-13,2013-12-06,NA,NA,TDOSINT,136.36363636363635,NA,OVERALL,Overall dose intensity (%),90,NA,17,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1266,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-28T00:00:00Z,NA,NA,2013-12-06T00:00:00Z,NA,NA,NA,NA,NA,2013-10-28,2013-12-06,NA,NA,PDURD,40,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1266,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-28T00:00:00Z,NA,NA,2013-12-06T00:00:00Z,NA,NA,NA,NA,NA,2013-10-28,2013-12-06,NA,NA,PDOSE,3240,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1266,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-28T00:00:00Z,NA,NA,2013-12-06T00:00:00Z,NA,NA,NA,NA,NA,2013-10-28,2013-12-06,NA,NA,PPDOSE,2160,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1266,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-28T00:00:00Z,NA,NA,2013-12-06T00:00:00Z,NA,NA,NA,NA,NA,2013-10-28,2013-12-06,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1266,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-28T00:00:00Z,NA,NA,2013-12-06T00:00:00Z,NA,NA,NA,NA,NA,2013-10-28,2013-12-06,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1266,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-28T00:00:00Z,NA,NA,2013-12-06T00:00:00Z,NA,NA,NA,NA,NA,2013-10-28,2013-12-06,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1266,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-13,2013-10-13T00:00:00Z,2013-12-06T23:59:59Z,2013-10-28T00:00:00Z,NA,NA,2013-12-06T00:00:00Z,NA,NA,NA,NA,NA,2013-10-28,2013-12-06,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1266,2013-10-13,2013-12-06,2013-10-13,2013-12-06,NA,2014-01-03,NA,NA,704,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-05,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-06,55,NA,2013-12-06,DISCONTINUED,NA,2013-10-13,NA,NA,NA,2013-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1323,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-08,2013-07-23,1,16,NA,54,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-07-23T00:00:00Z,NA,H,1,16,16,2013-07-08,2013-07-23,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1323,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-08,2013-07-23,1,16,NA,54,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-07-23T00:00:00Z,NA,H,1,16,16,2013-07-08,2013-07-23,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1323,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-08,2013-07-23,1,16,NA,54,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-07-23T00:00:00Z,NA,H,1,16,16,2013-07-08,2013-07-23,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1323,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-08,2013-07-23,1,16,NA,54,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-07-23T00:00:00Z,NA,H,1,16,16,2013-07-08,2013-07-23,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1323,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-08,2013-07-23,1,16,NA,54,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-07-23T00:00:00Z,NA,H,1,16,16,2013-07-08,2013-07-23,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1323,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-24,2013-08-05,17,29,NA,54,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-24T00:00:00Z,NA,H,2013-08-05T00:00:00Z,NA,H,17,29,13,2013-07-24,2013-08-05,702,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1323,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-24,2013-08-05,17,29,NA,54,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-24T00:00:00Z,NA,H,2013-08-05T00:00:00Z,NA,H,17,29,13,2013-07-24,2013-08-05,702,702,DOSE,702,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1323,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-24,2013-08-05,17,29,NA,54,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-24T00:00:00Z,NA,H,2013-08-05T00:00:00Z,NA,H,17,29,13,2013-07-24,2013-08-05,702,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1323,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-24,2013-08-05,17,29,NA,54,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-24T00:00:00Z,NA,H,2013-08-05T00:00:00Z,NA,H,17,29,13,2013-07-24,2013-08-05,702,702,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1323,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-24,2013-08-05,17,29,NA,54,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-24T00:00:00Z,NA,H,2013-08-05T00:00:00Z,NA,H,17,29,13,2013-07-24,2013-08-05,702,702,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-08T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-08,2013-08-05,NA,NA,TDURD,29,NA,OVERALL,Overall duration (days),7,< 30 days,11,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-08T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-08,2013-08-05,NA,NA,TDOSE,1566,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-08T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-08,2013-08-05,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-08T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-08,2013-08-05,NA,NA,TPDOSE,1566,NA,OVERALL,Total planned dose (mg),11,NA,14,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-08T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-08,2013-08-05,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-08T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-08,2013-08-05,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-08T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-08,2013-08-05,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-24T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-24,2013-08-05,NA,NA,PDURD,13,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-24T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-24,2013-08-05,NA,NA,PDOSE,702,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-24T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-24,2013-08-05,NA,NA,PPDOSE,702,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-24T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-24,2013-08-05,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-24T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-24,2013-08-05,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-24T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-24,2013-08-05,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1323,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-08,2013-07-08T00:00:00Z,2013-08-05T23:59:59Z,2013-07-24T00:00:00Z,NA,NA,2013-08-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-24,2013-08-05,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1323,2013-07-08,2013-08-08,2013-07-08,2013-08-05,NA,2013-10-01,NA,NA,704,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-13,-25,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-05,29,NA,2013-08-08,DISCONTINUED,NA,2013-07-08,NA,NA,NA,2013-08-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1325,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-23,2014-05-07,1,15,NA,54,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-04-23T00:00:00Z,NA,H,2014-05-07T00:00:00Z,NA,H,1,15,15,2014-04-23,2014-05-07,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1325,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-23,2014-05-07,1,15,NA,54,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-04-23T00:00:00Z,NA,H,2014-05-07T00:00:00Z,NA,H,1,15,15,2014-04-23,2014-05-07,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1325,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-23,2014-05-07,1,15,NA,54,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-04-23T00:00:00Z,NA,H,2014-05-07T00:00:00Z,NA,H,1,15,15,2014-04-23,2014-05-07,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1325,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-23,2014-05-07,1,15,NA,54,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-04-23T00:00:00Z,NA,H,2014-05-07T00:00:00Z,NA,H,1,15,15,2014-04-23,2014-05-07,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1325,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-23,2014-05-07,1,15,NA,54,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-04-23T00:00:00Z,NA,H,2014-05-07T00:00:00Z,NA,H,1,15,15,2014-04-23,2014-05-07,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1325,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-08,2014-07-04,16,73,NA,54,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-05-08T00:00:00Z,NA,H,2014-07-04T00:00:00Z,NA,H,16,73,58,2014-05-08,2014-07-04,3132,3132,DURD,58,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1325,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-08,2014-07-04,16,73,NA,54,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-05-08T00:00:00Z,NA,H,2014-07-04T00:00:00Z,NA,H,16,73,58,2014-05-08,2014-07-04,3132,3132,DOSE,3132,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1325,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-08,2014-07-04,16,73,NA,54,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-05-08T00:00:00Z,NA,H,2014-07-04T00:00:00Z,NA,H,16,73,58,2014-05-08,2014-07-04,3132,3132,PLDOSE,3132,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1325,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-08,2014-07-04,16,73,NA,54,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-05-08T00:00:00Z,NA,H,2014-07-04T00:00:00Z,NA,H,16,73,58,2014-05-08,2014-07-04,3132,3132,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1325,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-08,2014-07-04,16,73,NA,54,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-05-08T00:00:00Z,NA,H,2014-07-04T00:00:00Z,NA,H,16,73,58,2014-05-08,2014-07-04,3132,3132,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-04-23T00:00:00Z,NA,NA,2014-07-04T00:00:00Z,NA,NA,NA,NA,NA,2014-04-23,2014-07-04,NA,NA,TDURD,73,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-04-23T00:00:00Z,NA,NA,2014-07-04T00:00:00Z,NA,NA,NA,NA,NA,2014-04-23,2014-07-04,NA,NA,TDOSE,3942,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-04-23T00:00:00Z,NA,NA,2014-07-04T00:00:00Z,NA,NA,NA,NA,NA,2014-04-23,2014-07-04,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-04-23T00:00:00Z,NA,NA,2014-07-04T00:00:00Z,NA,NA,NA,NA,NA,2014-04-23,2014-07-04,NA,NA,TPDOSE,3942,NA,OVERALL,Total planned dose (mg),11,NA,14,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-04-23T00:00:00Z,NA,NA,2014-07-04T00:00:00Z,NA,NA,NA,NA,NA,2014-04-23,2014-07-04,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-04-23T00:00:00Z,NA,NA,2014-07-04T00:00:00Z,NA,NA,NA,NA,NA,2014-04-23,2014-07-04,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-04-23T00:00:00Z,NA,NA,2014-07-04T00:00:00Z,NA,NA,NA,NA,NA,2014-04-23,2014-07-04,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-05-08T00:00:00Z,NA,NA,2014-07-04T00:00:00Z,NA,NA,NA,NA,NA,2014-05-08,2014-07-04,NA,NA,PDURD,58,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-05-08T00:00:00Z,NA,NA,2014-07-04T00:00:00Z,NA,NA,NA,NA,NA,2014-05-08,2014-07-04,NA,NA,PDOSE,3132,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-05-08T00:00:00Z,NA,NA,2014-07-04T00:00:00Z,NA,NA,NA,NA,NA,2014-05-08,2014-07-04,NA,NA,PPDOSE,3132,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-05-08T00:00:00Z,NA,NA,2014-07-04T00:00:00Z,NA,NA,NA,NA,NA,2014-05-08,2014-07-04,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-05-08T00:00:00Z,NA,NA,2014-07-04T00:00:00Z,NA,NA,NA,NA,NA,2014-05-08,2014-07-04,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-05-08T00:00:00Z,NA,NA,2014-07-04T00:00:00Z,NA,NA,NA,NA,NA,2014-05-08,2014-07-04,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1325,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-23,2014-04-23T00:00:00Z,2014-07-04T23:59:59Z,2014-05-08T00:00:00Z,NA,NA,2014-07-04T00:00:00Z,NA,NA,NA,NA,NA,2014-05-08,2014-07-04,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1325,2014-04-23,2014-08-06,2014-04-23,2014-07-04,NA,2014-08-06T13:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-04-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-04,73,NA,2014-08-06,DISCONTINUED,NA,2014-04-23,NA,NA,NA,2014-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1332,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-09,2013-12-23,1,15,NA,54,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-09T00:00:00Z,NA,H,2013-12-23T00:00:00Z,NA,H,1,15,15,2013-12-09,2013-12-23,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1332,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-09,2013-12-23,1,15,NA,54,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-09T00:00:00Z,NA,H,2013-12-23T00:00:00Z,NA,H,1,15,15,2013-12-09,2013-12-23,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1332,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-09,2013-12-23,1,15,NA,54,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-09T00:00:00Z,NA,H,2013-12-23T00:00:00Z,NA,H,1,15,15,2013-12-09,2013-12-23,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1332,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-09,2013-12-23,1,15,NA,54,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-09T00:00:00Z,NA,H,2013-12-23T00:00:00Z,NA,H,1,15,15,2013-12-09,2013-12-23,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1332,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-09,2013-12-23,1,15,NA,54,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-09T00:00:00Z,NA,H,2013-12-23T00:00:00Z,NA,H,1,15,15,2013-12-09,2013-12-23,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1332,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-24,2014-02-14,16,68,NA,54,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-24T00:00:00Z,NA,H,2014-02-14T00:00:00Z,NA,H,16,68,53,2013-12-24,2014-02-14,4293,2862,DURD,53,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1332,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-24,2014-02-14,16,68,NA,54,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-24T00:00:00Z,NA,H,2014-02-14T00:00:00Z,NA,H,16,68,53,2013-12-24,2014-02-14,4293,2862,DOSE,4293,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1332,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-24,2014-02-14,16,68,NA,54,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-24T00:00:00Z,NA,H,2014-02-14T00:00:00Z,NA,H,16,68,53,2013-12-24,2014-02-14,4293,2862,PLDOSE,2862,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1332,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-24,2014-02-14,16,68,NA,54,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-24T00:00:00Z,NA,H,2014-02-14T00:00:00Z,NA,H,16,68,53,2013-12-24,2014-02-14,4293,2862,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1332,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-24,2014-02-14,16,68,NA,54,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-24T00:00:00Z,NA,H,2014-02-14T00:00:00Z,NA,H,16,68,53,2013-12-24,2014-02-14,4293,2862,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1332,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-09T00:00:00Z,NA,NA,2014-02-14T00:00:00Z,NA,NA,NA,NA,NA,2013-12-09,2014-02-14,NA,NA,TDURD,68,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1332,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-09T00:00:00Z,NA,NA,2014-02-14T00:00:00Z,NA,NA,NA,NA,NA,2013-12-09,2014-02-14,NA,NA,TDOSE,5103,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1332,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-09T00:00:00Z,NA,NA,2014-02-14T00:00:00Z,NA,NA,NA,NA,NA,2013-12-09,2014-02-14,NA,NA,AVDDSE,75.04411764705883,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1332,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-09T00:00:00Z,NA,NA,2014-02-14T00:00:00Z,NA,NA,NA,NA,NA,2013-12-09,2014-02-14,NA,NA,TPDOSE,3672,NA,OVERALL,Total planned dose (mg),11,NA,14,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1332,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-09T00:00:00Z,NA,NA,2014-02-14T00:00:00Z,NA,NA,NA,NA,NA,2013-12-09,2014-02-14,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1332,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-09T00:00:00Z,NA,NA,2014-02-14T00:00:00Z,NA,NA,NA,NA,NA,2013-12-09,2014-02-14,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1332,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-09T00:00:00Z,NA,NA,2014-02-14T00:00:00Z,NA,NA,NA,NA,NA,2013-12-09,2014-02-14,NA,NA,TDOSINT,138.97058823529412,NA,OVERALL,Overall dose intensity (%),90,NA,17,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1332,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-24T00:00:00Z,NA,NA,2014-02-14T00:00:00Z,NA,NA,NA,NA,NA,2013-12-24,2014-02-14,NA,NA,PDURD,53,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1332,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-24T00:00:00Z,NA,NA,2014-02-14T00:00:00Z,NA,NA,NA,NA,NA,2013-12-24,2014-02-14,NA,NA,PDOSE,4293,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1332,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-24T00:00:00Z,NA,NA,2014-02-14T00:00:00Z,NA,NA,NA,NA,NA,2013-12-24,2014-02-14,NA,NA,PPDOSE,2862,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1332,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-24T00:00:00Z,NA,NA,2014-02-14T00:00:00Z,NA,NA,NA,NA,NA,2013-12-24,2014-02-14,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1332,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-24T00:00:00Z,NA,NA,2014-02-14T00:00:00Z,NA,NA,NA,NA,NA,2013-12-24,2014-02-14,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1332,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-24T00:00:00Z,NA,NA,2014-02-14T00:00:00Z,NA,NA,NA,NA,NA,2013-12-24,2014-02-14,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1332,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-09,2013-12-09T00:00:00Z,2014-02-14T23:59:59Z,2013-12-24T00:00:00Z,NA,NA,2014-02-14T00:00:00Z,NA,NA,NA,NA,NA,2013-12-24,2014-02-14,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1332,2013-12-09,2014-02-16,2013-12-09,2014-02-14,NA,2014-02-24,NA,NA,704,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-14,68,NA,2014-02-16,DISCONTINUED,NA,2013-12-09,NA,NA,NA,2014-02-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1351,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-12,2013-10-26,1,15,NA,0,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-12T00:00:00Z,NA,H,2013-10-26T00:00:00Z,NA,H,1,15,15,2013-10-12,2013-10-26,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1351,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-12,2013-10-26,1,15,NA,0,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-12T00:00:00Z,NA,H,2013-10-26T00:00:00Z,NA,H,1,15,15,2013-10-12,2013-10-26,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1351,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-12,2013-10-26,1,15,NA,0,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-12T00:00:00Z,NA,H,2013-10-26T00:00:00Z,NA,H,1,15,15,2013-10-12,2013-10-26,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1351,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-12,2013-10-26,1,15,NA,0,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-12T00:00:00Z,NA,H,2013-10-26T00:00:00Z,NA,H,1,15,15,2013-10-12,2013-10-26,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1351,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-12,2013-10-26,1,15,NA,0,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-12T00:00:00Z,NA,H,2013-10-26T00:00:00Z,NA,H,1,15,15,2013-10-12,2013-10-26,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1351,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-27,2014-04-04,16,175,NA,0,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-27T00:00:00Z,NA,H,2014-04-04T00:00:00Z,NA,H,16,175,160,2013-10-27,2014-04-04,0,0,DURD,160,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1351,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-27,2014-04-04,16,175,NA,0,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-27T00:00:00Z,NA,H,2014-04-04T00:00:00Z,NA,H,16,175,160,2013-10-27,2014-04-04,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1351,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-27,2014-04-04,16,175,NA,0,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-27T00:00:00Z,NA,H,2014-04-04T00:00:00Z,NA,H,16,175,160,2013-10-27,2014-04-04,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1351,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-27,2014-04-04,16,175,NA,0,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-27T00:00:00Z,NA,H,2014-04-04T00:00:00Z,NA,H,16,175,160,2013-10-27,2014-04-04,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1351,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-27,2014-04-04,16,175,NA,0,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-27T00:00:00Z,NA,H,2014-04-04T00:00:00Z,NA,H,16,175,160,2013-10-27,2014-04-04,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1351,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-05,2014-04-18,176,189,NA,0,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2014-04-05T00:00:00Z,NA,H,2014-04-18T00:00:00Z,NA,H,176,189,14,2014-04-05,2014-04-18,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1351,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-05,2014-04-18,176,189,NA,0,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2014-04-05T00:00:00Z,NA,H,2014-04-18T00:00:00Z,NA,H,176,189,14,2014-04-05,2014-04-18,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1351,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-05,2014-04-18,176,189,NA,0,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2014-04-05T00:00:00Z,NA,H,2014-04-18T00:00:00Z,NA,H,176,189,14,2014-04-05,2014-04-18,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1351,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-05,2014-04-18,176,189,NA,0,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2014-04-05T00:00:00Z,NA,H,2014-04-18T00:00:00Z,NA,H,176,189,14,2014-04-05,2014-04-18,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1351,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-05,2014-04-18,176,189,NA,0,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2014-04-05T00:00:00Z,NA,H,2014-04-18T00:00:00Z,NA,H,176,189,14,2014-04-05,2014-04-18,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2014-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2014-04-18,NA,NA,TDURD,189,NA,OVERALL,Overall duration (days),7,>=90 days,16,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2014-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2014-04-18,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2014-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2014-04-18,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2014-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2014-04-18,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2014-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2014-04-18,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2014-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2014-04-18,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2014-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2014-04-18,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-27T00:00:00Z,NA,NA,2014-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-27,2014-04-18,NA,NA,PDURD,174,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-27T00:00:00Z,NA,NA,2014-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-27,2014-04-18,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-27T00:00:00Z,NA,NA,2014-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-27,2014-04-18,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-27T00:00:00Z,NA,NA,2014-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-27,2014-04-18,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-27T00:00:00Z,NA,NA,2014-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-27,2014-04-18,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-27T00:00:00Z,NA,NA,2014-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-27,2014-04-18,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1351,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-12,2013-10-12T00:00:00Z,2014-04-18T23:59:59Z,2013-10-27T00:00:00Z,NA,NA,2014-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-10-27,2014-04-18,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1351,2013-10-12,2014-04-18,2013-10-12,2014-04-18,NA,2014-04-18T10:30,NA,NA,704,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-26,-16,Placebo,Placebo,H,H,2014-04-18,189,NA,2014-04-18,COMPLETED,NA,2013-10-12,NA,NA,NA,2014-04-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1388,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-07,2012-12-21,1,15,NA,0,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-07T00:00:00Z,NA,H,2012-12-21T00:00:00Z,NA,H,1,15,15,2012-12-07,2012-12-21,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1388,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-07,2012-12-21,1,15,NA,0,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-07T00:00:00Z,NA,H,2012-12-21T00:00:00Z,NA,H,1,15,15,2012-12-07,2012-12-21,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1388,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-07,2012-12-21,1,15,NA,0,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-07T00:00:00Z,NA,H,2012-12-21T00:00:00Z,NA,H,1,15,15,2012-12-07,2012-12-21,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1388,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-07,2012-12-21,1,15,NA,0,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-07T00:00:00Z,NA,H,2012-12-21T00:00:00Z,NA,H,1,15,15,2012-12-07,2012-12-21,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1388,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-07,2012-12-21,1,15,NA,0,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-07T00:00:00Z,NA,H,2012-12-21T00:00:00Z,NA,H,1,15,15,2012-12-07,2012-12-21,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1388,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-22,2013-05-23,16,168,NA,0,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-22T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,16,168,153,2012-12-22,2013-05-23,0,0,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1388,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-22,2013-05-23,16,168,NA,0,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-22T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,16,168,153,2012-12-22,2013-05-23,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1388,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-22,2013-05-23,16,168,NA,0,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-22T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,16,168,153,2012-12-22,2013-05-23,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1388,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-22,2013-05-23,16,168,NA,0,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-22T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,16,168,153,2012-12-22,2013-05-23,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1388,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-22,2013-05-23,16,168,NA,0,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-22T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,16,168,153,2012-12-22,2013-05-23,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1388,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-24,2013-06-11,169,187,NA,0,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2013-05-24T00:00:00Z,NA,H,2013-06-11T00:00:00Z,NA,H,169,187,19,2013-05-24,2013-06-11,0,0,DURD,19,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1388,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-24,2013-06-11,169,187,NA,0,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2013-05-24T00:00:00Z,NA,H,2013-06-11T00:00:00Z,NA,H,169,187,19,2013-05-24,2013-06-11,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1388,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-24,2013-06-11,169,187,NA,0,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2013-05-24T00:00:00Z,NA,H,2013-06-11T00:00:00Z,NA,H,169,187,19,2013-05-24,2013-06-11,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1388,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-24,2013-06-11,169,187,NA,0,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2013-05-24T00:00:00Z,NA,H,2013-06-11T00:00:00Z,NA,H,169,187,19,2013-05-24,2013-06-11,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1388,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-24,2013-06-11,169,187,NA,0,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2013-05-24T00:00:00Z,NA,H,2013-06-11T00:00:00Z,NA,H,169,187,19,2013-05-24,2013-06-11,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-07T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-07,2013-06-11,NA,NA,TDURD,187,NA,OVERALL,Overall duration (days),7,>=90 days,16,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-07T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-07,2013-06-11,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-07T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-07,2013-06-11,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-07T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-07,2013-06-11,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-07T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-07,2013-06-11,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-07T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-07,2013-06-11,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-07T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-07,2013-06-11,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-22T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-22,2013-06-11,NA,NA,PDURD,172,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-22T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-22,2013-06-11,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-22T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-22,2013-06-11,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-22T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-22,2013-06-11,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-22T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-22,2013-06-11,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-22T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-22,2013-06-11,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1388,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-11T23:59:59Z,2012-12-22T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-22,2013-06-11,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1388,2012-12-07,2013-06-19,2012-12-07,2013-06-11,NA,2013-06-19T12:30,NA,NA,704,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-28,-9,Placebo,Placebo,H,H,2013-06-11,187,NA,2013-06-19,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1435,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-17,2012-12-01,1,15,NA,0,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-11-17T00:00:00Z,NA,H,2012-12-01T00:00:00Z,NA,H,1,15,15,2012-11-17,2012-12-01,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1435,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-17,2012-12-01,1,15,NA,0,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-11-17T00:00:00Z,NA,H,2012-12-01T00:00:00Z,NA,H,1,15,15,2012-11-17,2012-12-01,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1435,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-17,2012-12-01,1,15,NA,0,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-11-17T00:00:00Z,NA,H,2012-12-01T00:00:00Z,NA,H,1,15,15,2012-11-17,2012-12-01,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1435,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-17,2012-12-01,1,15,NA,0,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-11-17T00:00:00Z,NA,H,2012-12-01T00:00:00Z,NA,H,1,15,15,2012-11-17,2012-12-01,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1435,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-17,2012-12-01,1,15,NA,0,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-11-17T00:00:00Z,NA,H,2012-12-01T00:00:00Z,NA,H,1,15,15,2012-11-17,2012-12-01,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1435,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-02,2013-01-09,16,54,NA,0,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-12-02T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,16,54,39,2012-12-02,2013-01-09,0,0,DURD,39,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1435,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-02,2013-01-09,16,54,NA,0,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-12-02T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,16,54,39,2012-12-02,2013-01-09,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1435,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-02,2013-01-09,16,54,NA,0,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-12-02T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,16,54,39,2012-12-02,2013-01-09,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1435,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-02,2013-01-09,16,54,NA,0,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-12-02T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,16,54,39,2012-12-02,2013-01-09,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1435,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-02,2013-01-09,16,54,NA,0,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-12-02T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,16,54,39,2012-12-02,2013-01-09,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-11-17T00:00:00Z,NA,NA,2013-01-09T00:00:00Z,NA,NA,NA,NA,NA,2012-11-17,2013-01-09,NA,NA,TDURD,54,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-11-17T00:00:00Z,NA,NA,2013-01-09T00:00:00Z,NA,NA,NA,NA,NA,2012-11-17,2013-01-09,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-11-17T00:00:00Z,NA,NA,2013-01-09T00:00:00Z,NA,NA,NA,NA,NA,2012-11-17,2013-01-09,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-11-17T00:00:00Z,NA,NA,2013-01-09T00:00:00Z,NA,NA,NA,NA,NA,2012-11-17,2013-01-09,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-11-17T00:00:00Z,NA,NA,2013-01-09T00:00:00Z,NA,NA,NA,NA,NA,2012-11-17,2013-01-09,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-11-17T00:00:00Z,NA,NA,2013-01-09T00:00:00Z,NA,NA,NA,NA,NA,2012-11-17,2013-01-09,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-11-17T00:00:00Z,NA,NA,2013-01-09T00:00:00Z,NA,NA,NA,NA,NA,2012-11-17,2013-01-09,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-12-02T00:00:00Z,NA,NA,2013-01-09T00:00:00Z,NA,NA,NA,NA,NA,2012-12-02,2013-01-09,NA,NA,PDURD,39,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-12-02T00:00:00Z,NA,NA,2013-01-09T00:00:00Z,NA,NA,NA,NA,NA,2012-12-02,2013-01-09,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-12-02T00:00:00Z,NA,NA,2013-01-09T00:00:00Z,NA,NA,NA,NA,NA,2012-12-02,2013-01-09,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-12-02T00:00:00Z,NA,NA,2013-01-09T00:00:00Z,NA,NA,NA,NA,NA,2012-12-02,2013-01-09,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-12-02T00:00:00Z,NA,NA,2013-01-09T00:00:00Z,NA,NA,NA,NA,NA,2012-12-02,2013-01-09,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-12-02T00:00:00Z,NA,NA,2013-01-09T00:00:00Z,NA,NA,NA,NA,NA,2012-12-02,2013-01-09,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-704-1435,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-17,2012-11-17T00:00:00Z,2013-01-09T23:59:59Z,2012-12-02T00:00:00Z,NA,NA,2013-01-09T00:00:00Z,NA,NA,NA,NA,NA,2012-12-02,2013-01-09,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1435,2012-11-17,2013-01-12,2012-11-17,2013-01-09,NA,2013-01-12T12:00,NA,NA,704,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-01,-16,Placebo,Placebo,H,H,2013-01-09,54,NA,2013-01-12,DISCONTINUED,NA,2012-11-17,NA,NA,NA,2013-01-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-704-1445,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-05-11,2014-05-25,1,15,NA,0,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-11T00:00:00Z,NA,H,2014-05-25T00:00:00Z,NA,H,1,15,15,2014-05-11,2014-05-25,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-704-1445,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-05-11,2014-05-25,1,15,NA,0,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-11T00:00:00Z,NA,H,2014-05-25T00:00:00Z,NA,H,1,15,15,2014-05-11,2014-05-25,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-704-1445,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-05-11,2014-05-25,1,15,NA,0,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-11T00:00:00Z,NA,H,2014-05-25T00:00:00Z,NA,H,1,15,15,2014-05-11,2014-05-25,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-704-1445,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-05-11,2014-05-25,1,15,NA,0,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-11T00:00:00Z,NA,H,2014-05-25T00:00:00Z,NA,H,1,15,15,2014-05-11,2014-05-25,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-704-1445,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-05-11,2014-05-25,1,15,NA,0,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-11T00:00:00Z,NA,H,2014-05-25T00:00:00Z,NA,H,1,15,15,2014-05-11,2014-05-25,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-704-1445,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-26,2014-11-01,16,175,NA,0,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-26T00:00:00Z,NA,H,2014-11-01T00:00:00Z,NA,H,16,175,160,2014-05-26,2014-11-01,0,0,DURD,160,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-704-1445,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-26,2014-11-01,16,175,NA,0,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-26T00:00:00Z,NA,H,2014-11-01T00:00:00Z,NA,H,16,175,160,2014-05-26,2014-11-01,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-704-1445,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-26,2014-11-01,16,175,NA,0,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-26T00:00:00Z,NA,H,2014-11-01T00:00:00Z,NA,H,16,175,160,2014-05-26,2014-11-01,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-704-1445,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-26,2014-11-01,16,175,NA,0,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-26T00:00:00Z,NA,H,2014-11-01T00:00:00Z,NA,H,16,175,160,2014-05-26,2014-11-01,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-704-1445,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-26,2014-11-01,16,175,NA,0,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-26T00:00:00Z,NA,H,2014-11-01T00:00:00Z,NA,H,16,175,160,2014-05-26,2014-11-01,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-704-1445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-11T00:00:00Z,NA,NA,2014-11-01T00:00:00Z,NA,NA,NA,NA,NA,2014-05-11,2014-11-01,NA,NA,TDURD,175,NA,OVERALL,Overall duration (days),7,>=90 days,11,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-704-1445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-11T00:00:00Z,NA,NA,2014-11-01T00:00:00Z,NA,NA,NA,NA,NA,2014-05-11,2014-11-01,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-704-1445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-11T00:00:00Z,NA,NA,2014-11-01T00:00:00Z,NA,NA,NA,NA,NA,2014-05-11,2014-11-01,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-704-1445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-11T00:00:00Z,NA,NA,2014-11-01T00:00:00Z,NA,NA,NA,NA,NA,2014-05-11,2014-11-01,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-704-1445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-11T00:00:00Z,NA,NA,2014-11-01T00:00:00Z,NA,NA,NA,NA,NA,2014-05-11,2014-11-01,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-704-1445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-11T00:00:00Z,NA,NA,2014-11-01T00:00:00Z,NA,NA,NA,NA,NA,2014-05-11,2014-11-01,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-704-1445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-11T00:00:00Z,NA,NA,2014-11-01T00:00:00Z,NA,NA,NA,NA,NA,2014-05-11,2014-11-01,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-704-1445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-26T00:00:00Z,NA,NA,2014-11-01T00:00:00Z,NA,NA,NA,NA,NA,2014-05-26,2014-11-01,NA,NA,PDURD,160,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-704-1445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-26T00:00:00Z,NA,NA,2014-11-01T00:00:00Z,NA,NA,NA,NA,NA,2014-05-26,2014-11-01,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-704-1445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-26T00:00:00Z,NA,NA,2014-11-01T00:00:00Z,NA,NA,NA,NA,NA,2014-05-26,2014-11-01,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-704-1445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-26T00:00:00Z,NA,NA,2014-11-01T00:00:00Z,NA,NA,NA,NA,NA,2014-05-26,2014-11-01,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-704-1445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-26T00:00:00Z,NA,NA,2014-11-01T00:00:00Z,NA,NA,NA,NA,NA,2014-05-26,2014-11-01,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-704-1445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-26T00:00:00Z,NA,NA,2014-11-01T00:00:00Z,NA,NA,NA,NA,NA,2014-05-26,2014-11-01,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,NA,01-704-1445,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-11,2014-05-11T00:00:00Z,2014-11-01T23:59:59Z,2014-05-26T00:00:00Z,NA,NA,2014-11-01T00:00:00Z,NA,NA,NA,NA,NA,2014-05-26,2014-11-01,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1445,2014-05-11,2014-11-01,2014-05-11,2014-11-01,NA,2014-11-01,2014-11-01,Y,704,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-05-01,-10,Placebo,Placebo,H,H,2014-11-01,175,NA,2014-11-01,DISCONTINUED,NA,2014-05-11,2014-11-01,175,0,2014-11-01,>=65,Y,White,"NA",<= 30,Y,NA,NA
CDISCPILOT01,EX,01-705-1018,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-05,NA,1,NA,NA,0,2013-07-05,2013-07-05T00:00:00Z,NA,2013-07-05T00:00:00Z,NA,H,NA,NA,NA,1,NA,NA,2013-07-05,NA,NA,NA,DURD,NA,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1018,2013-07-05,2013-07-12,2013-07-05,NA,NA,2013-07-12,NA,NA,705,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-30,-5,Placebo,Placebo,H,NA,NA,NA,NA,2013-07-12,DISCONTINUED,NA,2013-07-05,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1018,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-05,NA,1,NA,NA,0,2013-07-05,2013-07-05T00:00:00Z,NA,2013-07-05T00:00:00Z,NA,H,NA,NA,NA,1,NA,NA,2013-07-05,NA,NA,NA,DOSE,NA,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1018,2013-07-05,2013-07-12,2013-07-05,NA,NA,2013-07-12,NA,NA,705,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-30,-5,Placebo,Placebo,H,NA,NA,NA,NA,2013-07-12,DISCONTINUED,NA,2013-07-05,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1018,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-05,NA,1,NA,NA,0,2013-07-05,2013-07-05T00:00:00Z,NA,2013-07-05T00:00:00Z,NA,H,NA,NA,NA,1,NA,NA,2013-07-05,NA,NA,NA,PLDOSE,NA,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1018,2013-07-05,2013-07-12,2013-07-05,NA,NA,2013-07-12,NA,NA,705,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-30,-5,Placebo,Placebo,H,NA,NA,NA,NA,2013-07-12,DISCONTINUED,NA,2013-07-05,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1018,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-05,NA,1,NA,NA,0,2013-07-05,2013-07-05T00:00:00Z,NA,2013-07-05T00:00:00Z,NA,H,NA,NA,NA,1,NA,NA,2013-07-05,NA,NA,NA,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1018,2013-07-05,2013-07-12,2013-07-05,NA,NA,2013-07-12,NA,NA,705,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-30,-5,Placebo,Placebo,H,NA,NA,NA,NA,2013-07-12,DISCONTINUED,NA,2013-07-05,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1018,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-05,NA,1,NA,NA,0,2013-07-05,2013-07-05T00:00:00Z,NA,2013-07-05T00:00:00Z,NA,H,NA,NA,NA,1,NA,NA,2013-07-05,NA,NA,NA,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1018,2013-07-05,2013-07-12,2013-07-05,NA,NA,2013-07-12,NA,NA,705,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-30,-5,Placebo,Placebo,H,NA,NA,NA,NA,2013-07-12,DISCONTINUED,NA,2013-07-05,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1018,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-05,2013-07-05T00:00:00Z,NA,2013-07-05T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-05,2013-07-05,NA,NA,TDURD,0,NA,OVERALL,Overall duration (days),7,< 30 days,6,1018,2013-07-05,2013-07-12,2013-07-05,NA,NA,2013-07-12,NA,NA,705,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-30,-5,Placebo,Placebo,H,NA,NA,NA,NA,2013-07-12,DISCONTINUED,NA,2013-07-05,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1018,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-05,2013-07-05T00:00:00Z,NA,2013-07-05T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-05,2013-07-05,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,7,1018,2013-07-05,2013-07-12,2013-07-05,NA,NA,2013-07-12,NA,NA,705,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-30,-5,Placebo,Placebo,H,NA,NA,NA,NA,2013-07-12,DISCONTINUED,NA,2013-07-05,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1018,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-05,2013-07-05T00:00:00Z,NA,2013-07-05T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-05,2013-07-05,NA,NA,AVDDSE,NA,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1018,2013-07-05,2013-07-12,2013-07-05,NA,NA,2013-07-12,NA,NA,705,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-30,-5,Placebo,Placebo,H,NA,NA,NA,NA,2013-07-12,DISCONTINUED,NA,2013-07-05,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1018,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-05,2013-07-05T00:00:00Z,NA,2013-07-05T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-05,2013-07-05,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,9,1018,2013-07-05,2013-07-12,2013-07-05,NA,NA,2013-07-12,NA,NA,705,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-30,-5,Placebo,Placebo,H,NA,NA,NA,NA,2013-07-12,DISCONTINUED,NA,2013-07-05,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1018,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-05,2013-07-05T00:00:00Z,NA,2013-07-05T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-05,2013-07-05,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1018,2013-07-05,2013-07-12,2013-07-05,NA,NA,2013-07-12,NA,NA,705,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-30,-5,Placebo,Placebo,H,NA,NA,NA,NA,2013-07-12,DISCONTINUED,NA,2013-07-05,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1018,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-05,2013-07-05T00:00:00Z,NA,2013-07-05T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-05,2013-07-05,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1018,2013-07-05,2013-07-12,2013-07-05,NA,NA,2013-07-12,NA,NA,705,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-30,-5,Placebo,Placebo,H,NA,NA,NA,NA,2013-07-12,DISCONTINUED,NA,2013-07-05,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1018,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-05,2013-07-05T00:00:00Z,NA,2013-07-05T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-07-05,2013-07-05,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,12,1018,2013-07-05,2013-07-12,2013-07-05,NA,NA,2013-07-12,NA,NA,705,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-30,-5,Placebo,Placebo,H,NA,NA,NA,NA,2013-07-12,DISCONTINUED,NA,2013-07-05,NA,NA,NA,2013-06-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1031,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-27,2013-12-18,1,22,NA,54,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-11-27T00:00:00Z,NA,H,2013-12-18T00:00:00Z,NA,H,1,22,22,2013-11-27,2013-12-18,1188,1188,DURD,22,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1031,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-27,2013-12-18,1,22,NA,54,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-11-27T00:00:00Z,NA,H,2013-12-18T00:00:00Z,NA,H,1,22,22,2013-11-27,2013-12-18,1188,1188,DOSE,1188,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1031,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-27,2013-12-18,1,22,NA,54,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-11-27T00:00:00Z,NA,H,2013-12-18T00:00:00Z,NA,H,1,22,22,2013-11-27,2013-12-18,1188,1188,PLDOSE,1188,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1031,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-27,2013-12-18,1,22,NA,54,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-11-27T00:00:00Z,NA,H,2013-12-18T00:00:00Z,NA,H,1,22,22,2013-11-27,2013-12-18,1188,1188,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1031,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-27,2013-12-18,1,22,NA,54,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-11-27T00:00:00Z,NA,H,2013-12-18T00:00:00Z,NA,H,1,22,22,2013-11-27,2013-12-18,1188,1188,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1031,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-19,NA,23,NA,NA,54,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-12-19T00:00:00Z,NA,H,NA,NA,NA,23,NA,NA,2013-12-19,NA,NA,NA,DURD,NA,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1031,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-19,NA,23,NA,NA,54,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-12-19T00:00:00Z,NA,H,NA,NA,NA,23,NA,NA,2013-12-19,NA,NA,NA,DOSE,NA,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1031,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-19,NA,23,NA,NA,54,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-12-19T00:00:00Z,NA,H,NA,NA,NA,23,NA,NA,2013-12-19,NA,NA,NA,PLDOSE,NA,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1031,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-19,NA,23,NA,NA,54,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-12-19T00:00:00Z,NA,H,NA,NA,NA,23,NA,NA,2013-12-19,NA,NA,NA,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1031,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-19,NA,23,NA,NA,54,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-12-19T00:00:00Z,NA,H,NA,NA,NA,23,NA,NA,2013-12-19,NA,NA,NA,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-11-27T00:00:00Z,NA,NA,2013-12-18T00:00:00Z,NA,NA,NA,NA,NA,2013-11-27,2013-12-18,NA,NA,TDURD,22,NA,OVERALL,Overall duration (days),7,< 30 days,11,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-11-27T00:00:00Z,NA,NA,2013-12-18T00:00:00Z,NA,NA,NA,NA,NA,2013-11-27,2013-12-18,NA,NA,TDOSE,1188,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-11-27T00:00:00Z,NA,NA,2013-12-18T00:00:00Z,NA,NA,NA,NA,NA,2013-11-27,2013-12-18,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-11-27T00:00:00Z,NA,NA,2013-12-18T00:00:00Z,NA,NA,NA,NA,NA,2013-11-27,2013-12-18,NA,NA,TPDOSE,1188,NA,OVERALL,Total planned dose (mg),11,NA,14,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-11-27T00:00:00Z,NA,NA,2013-12-18T00:00:00Z,NA,NA,NA,NA,NA,2013-11-27,2013-12-18,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-11-27T00:00:00Z,NA,NA,2013-12-18T00:00:00Z,NA,NA,NA,NA,NA,2013-11-27,2013-12-18,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-11-27T00:00:00Z,NA,NA,2013-12-18T00:00:00Z,NA,NA,NA,NA,NA,2013-11-27,2013-12-18,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-12-19T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-12-19,2013-12-19,NA,NA,PDURD,0,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-12-19T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-12-19,2013-12-19,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-12-19T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-12-19,2013-12-19,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-12-19T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-12-19,2013-12-19,NA,NA,PAVDDSE,NA,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-12-19T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-12-19,2013-12-19,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-12-19T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-12-19,2013-12-19,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1031,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-27,2013-11-27T00:00:00Z,2013-12-18T23:59:59Z,2013-12-19T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-12-19,2013-12-19,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1031,2013-11-27,2014-05-11,2013-11-27,2013-12-18,NA,2014-05-11T09:55,NA,NA,705,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-17,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-18,22,NA,2014-05-11,DISCONTINUED,NA,2013-11-27,NA,NA,NA,2014-05-11,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1059,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-05,2013-08-19,1,15,NA,0,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-05T00:00:00Z,NA,H,2013-08-19T00:00:00Z,NA,H,1,15,15,2013-08-05,2013-08-19,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1059,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-05,2013-08-19,1,15,NA,0,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-05T00:00:00Z,NA,H,2013-08-19T00:00:00Z,NA,H,1,15,15,2013-08-05,2013-08-19,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1059,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-05,2013-08-19,1,15,NA,0,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-05T00:00:00Z,NA,H,2013-08-19T00:00:00Z,NA,H,1,15,15,2013-08-05,2013-08-19,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1059,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-05,2013-08-19,1,15,NA,0,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-05T00:00:00Z,NA,H,2013-08-19T00:00:00Z,NA,H,1,15,15,2013-08-05,2013-08-19,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1059,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-05,2013-08-19,1,15,NA,0,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-05T00:00:00Z,NA,H,2013-08-19T00:00:00Z,NA,H,1,15,15,2013-08-05,2013-08-19,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1059,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-20,2013-12-05,16,123,NA,0,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-20T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,16,123,108,2013-08-20,2013-12-05,0,0,DURD,108,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1059,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-20,2013-12-05,16,123,NA,0,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-20T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,16,123,108,2013-08-20,2013-12-05,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1059,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-20,2013-12-05,16,123,NA,0,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-20T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,16,123,108,2013-08-20,2013-12-05,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1059,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-20,2013-12-05,16,123,NA,0,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-20T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,16,123,108,2013-08-20,2013-12-05,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1059,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-20,2013-12-05,16,123,NA,0,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-20T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,16,123,108,2013-08-20,2013-12-05,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-05T00:00:00Z,NA,NA,2013-12-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-05,2013-12-05,NA,NA,TDURD,123,NA,OVERALL,Overall duration (days),7,>=90 days,11,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-05T00:00:00Z,NA,NA,2013-12-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-05,2013-12-05,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-05T00:00:00Z,NA,NA,2013-12-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-05,2013-12-05,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-05T00:00:00Z,NA,NA,2013-12-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-05,2013-12-05,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-05T00:00:00Z,NA,NA,2013-12-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-05,2013-12-05,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-05T00:00:00Z,NA,NA,2013-12-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-05,2013-12-05,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-05T00:00:00Z,NA,NA,2013-12-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-05,2013-12-05,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-20T00:00:00Z,NA,NA,2013-12-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-20,2013-12-05,NA,NA,PDURD,108,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-20T00:00:00Z,NA,NA,2013-12-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-20,2013-12-05,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-20T00:00:00Z,NA,NA,2013-12-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-20,2013-12-05,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-20T00:00:00Z,NA,NA,2013-12-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-20,2013-12-05,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-20T00:00:00Z,NA,NA,2013-12-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-20,2013-12-05,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-20T00:00:00Z,NA,NA,2013-12-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-20,2013-12-05,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1059,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2013-12-05T23:59:59Z,2013-08-20T00:00:00Z,NA,NA,2013-12-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-20,2013-12-05,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1059,2013-08-05,2013-12-05,2013-08-05,2013-12-05,NA,2014-02-06,NA,NA,705,66,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-02,-3,Placebo,Placebo,H,H,2013-12-05,123,NA,2013-12-05,DISCONTINUED,2014-02-06,2013-08-05,NA,NA,NA,2013-12-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1186,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-08,2014-01-23,1,16,NA,0,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-08T00:00:00Z,NA,H,2014-01-23T00:00:00Z,NA,H,1,16,16,2014-01-08,2014-01-23,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1186,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-08,2014-01-23,1,16,NA,0,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-08T00:00:00Z,NA,H,2014-01-23T00:00:00Z,NA,H,1,16,16,2014-01-08,2014-01-23,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1186,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-08,2014-01-23,1,16,NA,0,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-08T00:00:00Z,NA,H,2014-01-23T00:00:00Z,NA,H,1,16,16,2014-01-08,2014-01-23,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1186,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-08,2014-01-23,1,16,NA,0,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-08T00:00:00Z,NA,H,2014-01-23T00:00:00Z,NA,H,1,16,16,2014-01-08,2014-01-23,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1186,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-08,2014-01-23,1,16,NA,0,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-08T00:00:00Z,NA,H,2014-01-23T00:00:00Z,NA,H,1,16,16,2014-01-08,2014-01-23,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1186,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-24,2014-01-26,17,19,NA,0,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-24T00:00:00Z,NA,H,2014-01-26T00:00:00Z,NA,H,17,19,3,2014-01-24,2014-01-26,0,0,DURD,3,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1186,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-24,2014-01-26,17,19,NA,0,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-24T00:00:00Z,NA,H,2014-01-26T00:00:00Z,NA,H,17,19,3,2014-01-24,2014-01-26,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1186,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-24,2014-01-26,17,19,NA,0,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-24T00:00:00Z,NA,H,2014-01-26T00:00:00Z,NA,H,17,19,3,2014-01-24,2014-01-26,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1186,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-24,2014-01-26,17,19,NA,0,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-24T00:00:00Z,NA,H,2014-01-26T00:00:00Z,NA,H,17,19,3,2014-01-24,2014-01-26,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1186,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-24,2014-01-26,17,19,NA,0,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-24T00:00:00Z,NA,H,2014-01-26T00:00:00Z,NA,H,17,19,3,2014-01-24,2014-01-26,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-08T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-08,2014-01-26,NA,NA,TDURD,19,NA,OVERALL,Overall duration (days),7,< 30 days,11,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-08T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-08,2014-01-26,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-08T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-08,2014-01-26,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-08T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-08,2014-01-26,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-08T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-08,2014-01-26,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-08T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-08,2014-01-26,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-08T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-08,2014-01-26,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-24T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-24,2014-01-26,NA,NA,PDURD,3,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-24T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-24,2014-01-26,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-24T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-24,2014-01-26,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-24T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-24,2014-01-26,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-24T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-24,2014-01-26,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-24T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-24,2014-01-26,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1186,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-08,2014-01-08T00:00:00Z,2014-01-26T23:59:59Z,2014-01-24T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-24,2014-01-26,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1186,2014-01-08,2014-02-07,2014-01-08,2014-01-26,NA,2014-02-07T15:20,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-03,-5,Placebo,Placebo,H,H,2014-01-26,19,NA,2014-02-07,DISCONTINUED,NA,2014-01-08,NA,NA,NA,2014-02-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1199,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-16,2013-09-28,1,13,NA,54,2013-09-16,2013-09-16T00:00:00Z,2013-09-28T23:59:59Z,2013-09-16T00:00:00Z,NA,H,2013-09-28T00:00:00Z,NA,H,1,13,13,2013-09-16,2013-09-28,702,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1199,2013-09-16,2013-09-29,2013-09-16,2013-09-28,NA,2013-09-29T10:30,NA,NA,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-11,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-28,13,NA,2013-09-29,DISCONTINUED,NA,2013-09-16,NA,NA,NA,2013-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1199,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-16,2013-09-28,1,13,NA,54,2013-09-16,2013-09-16T00:00:00Z,2013-09-28T23:59:59Z,2013-09-16T00:00:00Z,NA,H,2013-09-28T00:00:00Z,NA,H,1,13,13,2013-09-16,2013-09-28,702,702,DOSE,702,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1199,2013-09-16,2013-09-29,2013-09-16,2013-09-28,NA,2013-09-29T10:30,NA,NA,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-11,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-28,13,NA,2013-09-29,DISCONTINUED,NA,2013-09-16,NA,NA,NA,2013-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1199,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-16,2013-09-28,1,13,NA,54,2013-09-16,2013-09-16T00:00:00Z,2013-09-28T23:59:59Z,2013-09-16T00:00:00Z,NA,H,2013-09-28T00:00:00Z,NA,H,1,13,13,2013-09-16,2013-09-28,702,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1199,2013-09-16,2013-09-29,2013-09-16,2013-09-28,NA,2013-09-29T10:30,NA,NA,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-11,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-28,13,NA,2013-09-29,DISCONTINUED,NA,2013-09-16,NA,NA,NA,2013-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1199,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-16,2013-09-28,1,13,NA,54,2013-09-16,2013-09-16T00:00:00Z,2013-09-28T23:59:59Z,2013-09-16T00:00:00Z,NA,H,2013-09-28T00:00:00Z,NA,H,1,13,13,2013-09-16,2013-09-28,702,702,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1199,2013-09-16,2013-09-29,2013-09-16,2013-09-28,NA,2013-09-29T10:30,NA,NA,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-11,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-28,13,NA,2013-09-29,DISCONTINUED,NA,2013-09-16,NA,NA,NA,2013-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1199,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-16,2013-09-28,1,13,NA,54,2013-09-16,2013-09-16T00:00:00Z,2013-09-28T23:59:59Z,2013-09-16T00:00:00Z,NA,H,2013-09-28T00:00:00Z,NA,H,1,13,13,2013-09-16,2013-09-28,702,702,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1199,2013-09-16,2013-09-29,2013-09-16,2013-09-28,NA,2013-09-29T10:30,NA,NA,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-11,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-28,13,NA,2013-09-29,DISCONTINUED,NA,2013-09-16,NA,NA,NA,2013-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1199,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-09-28T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-09-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-09-28,NA,NA,TDURD,13,NA,OVERALL,Overall duration (days),7,< 30 days,6,1199,2013-09-16,2013-09-29,2013-09-16,2013-09-28,NA,2013-09-29T10:30,NA,NA,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-11,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-28,13,NA,2013-09-29,DISCONTINUED,NA,2013-09-16,NA,NA,NA,2013-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1199,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-09-28T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-09-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-09-28,NA,NA,TDOSE,702,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1199,2013-09-16,2013-09-29,2013-09-16,2013-09-28,NA,2013-09-29T10:30,NA,NA,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-11,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-28,13,NA,2013-09-29,DISCONTINUED,NA,2013-09-16,NA,NA,NA,2013-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1199,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-09-28T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-09-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-09-28,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1199,2013-09-16,2013-09-29,2013-09-16,2013-09-28,NA,2013-09-29T10:30,NA,NA,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-11,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-28,13,NA,2013-09-29,DISCONTINUED,NA,2013-09-16,NA,NA,NA,2013-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1199,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-09-28T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-09-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-09-28,NA,NA,TPDOSE,702,NA,OVERALL,Total planned dose (mg),11,NA,9,1199,2013-09-16,2013-09-29,2013-09-16,2013-09-28,NA,2013-09-29T10:30,NA,NA,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-11,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-28,13,NA,2013-09-29,DISCONTINUED,NA,2013-09-16,NA,NA,NA,2013-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1199,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-09-28T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-09-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-09-28,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1199,2013-09-16,2013-09-29,2013-09-16,2013-09-28,NA,2013-09-29T10:30,NA,NA,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-11,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-28,13,NA,2013-09-29,DISCONTINUED,NA,2013-09-16,NA,NA,NA,2013-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1199,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-09-28T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-09-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-09-28,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1199,2013-09-16,2013-09-29,2013-09-16,2013-09-28,NA,2013-09-29T10:30,NA,NA,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-11,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-28,13,NA,2013-09-29,DISCONTINUED,NA,2013-09-16,NA,NA,NA,2013-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1199,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-09-28T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-09-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-09-28,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1199,2013-09-16,2013-09-29,2013-09-16,2013-09-28,NA,2013-09-29T10:30,NA,NA,705,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-11,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-09-28,13,NA,2013-09-29,DISCONTINUED,NA,2013-09-16,NA,NA,NA,2013-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1280,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-17,2014-01-31,1,15,NA,54,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-01-17T00:00:00Z,NA,H,2014-01-31T00:00:00Z,NA,H,1,15,15,2014-01-17,2014-01-31,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1280,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-17,2014-01-31,1,15,NA,54,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-01-17T00:00:00Z,NA,H,2014-01-31T00:00:00Z,NA,H,1,15,15,2014-01-17,2014-01-31,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1280,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-17,2014-01-31,1,15,NA,54,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-01-17T00:00:00Z,NA,H,2014-01-31T00:00:00Z,NA,H,1,15,15,2014-01-17,2014-01-31,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1280,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-17,2014-01-31,1,15,NA,54,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-01-17T00:00:00Z,NA,H,2014-01-31T00:00:00Z,NA,H,1,15,15,2014-01-17,2014-01-31,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1280,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-17,2014-01-31,1,15,NA,54,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-01-17T00:00:00Z,NA,H,2014-01-31T00:00:00Z,NA,H,1,15,15,2014-01-17,2014-01-31,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1280,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-01,2014-07-11,16,176,NA,54,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-02-01T00:00:00Z,NA,H,2014-07-11T00:00:00Z,NA,H,16,176,161,2014-02-01,2014-07-11,13041,8694,DURD,161,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1280,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-01,2014-07-11,16,176,NA,54,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-02-01T00:00:00Z,NA,H,2014-07-11T00:00:00Z,NA,H,16,176,161,2014-02-01,2014-07-11,13041,8694,DOSE,13041,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1280,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-01,2014-07-11,16,176,NA,54,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-02-01T00:00:00Z,NA,H,2014-07-11T00:00:00Z,NA,H,16,176,161,2014-02-01,2014-07-11,13041,8694,PLDOSE,8694,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1280,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-01,2014-07-11,16,176,NA,54,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-02-01T00:00:00Z,NA,H,2014-07-11T00:00:00Z,NA,H,16,176,161,2014-02-01,2014-07-11,13041,8694,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1280,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-01,2014-07-11,16,176,NA,54,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-02-01T00:00:00Z,NA,H,2014-07-11T00:00:00Z,NA,H,16,176,161,2014-02-01,2014-07-11,13041,8694,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1280,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-12,2014-07-25,177,190,NA,54,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-07-12T00:00:00Z,NA,H,2014-07-25T00:00:00Z,NA,H,177,190,14,2014-07-12,2014-07-25,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1280,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-12,2014-07-25,177,190,NA,54,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-07-12T00:00:00Z,NA,H,2014-07-25T00:00:00Z,NA,H,177,190,14,2014-07-12,2014-07-25,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1280,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-12,2014-07-25,177,190,NA,54,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-07-12T00:00:00Z,NA,H,2014-07-25T00:00:00Z,NA,H,177,190,14,2014-07-12,2014-07-25,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1280,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-12,2014-07-25,177,190,NA,54,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-07-12T00:00:00Z,NA,H,2014-07-25T00:00:00Z,NA,H,177,190,14,2014-07-12,2014-07-25,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1280,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-12,2014-07-25,177,190,NA,54,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-07-12T00:00:00Z,NA,H,2014-07-25T00:00:00Z,NA,H,177,190,14,2014-07-12,2014-07-25,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-01-17T00:00:00Z,NA,NA,2014-07-25T00:00:00Z,NA,NA,NA,NA,NA,2014-01-17,2014-07-25,NA,NA,TDURD,190,NA,OVERALL,Overall duration (days),7,>=90 days,16,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-01-17T00:00:00Z,NA,NA,2014-07-25T00:00:00Z,NA,NA,NA,NA,NA,2014-01-17,2014-07-25,NA,NA,TDOSE,14607,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-01-17T00:00:00Z,NA,NA,2014-07-25T00:00:00Z,NA,NA,NA,NA,NA,2014-01-17,2014-07-25,NA,NA,AVDDSE,76.87894736842105,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-01-17T00:00:00Z,NA,NA,2014-07-25T00:00:00Z,NA,NA,NA,NA,NA,2014-01-17,2014-07-25,NA,NA,TPDOSE,10260,NA,OVERALL,Total planned dose (mg),11,NA,19,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-01-17T00:00:00Z,NA,NA,2014-07-25T00:00:00Z,NA,NA,NA,NA,NA,2014-01-17,2014-07-25,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-01-17T00:00:00Z,NA,NA,2014-07-25T00:00:00Z,NA,NA,NA,NA,NA,2014-01-17,2014-07-25,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-01-17T00:00:00Z,NA,NA,2014-07-25T00:00:00Z,NA,NA,NA,NA,NA,2014-01-17,2014-07-25,NA,NA,TDOSINT,142.3684210526316,NA,OVERALL,Overall dose intensity (%),90,NA,22,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-02-01T00:00:00Z,NA,NA,2014-07-25T00:00:00Z,NA,NA,NA,NA,NA,2014-02-01,2014-07-25,NA,NA,PDURD,175,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-02-01T00:00:00Z,NA,NA,2014-07-25T00:00:00Z,NA,NA,NA,NA,NA,2014-02-01,2014-07-25,NA,NA,PDOSE,13797,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-02-01T00:00:00Z,NA,NA,2014-07-25T00:00:00Z,NA,NA,NA,NA,NA,2014-02-01,2014-07-25,NA,NA,PPDOSE,9450,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-02-01T00:00:00Z,NA,NA,2014-07-25T00:00:00Z,NA,NA,NA,NA,NA,2014-02-01,2014-07-25,NA,NA,PAVDDSE,78.84,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-02-01T00:00:00Z,NA,NA,2014-07-25T00:00:00Z,NA,NA,NA,NA,NA,2014-02-01,2014-07-25,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-02-01T00:00:00Z,NA,NA,2014-07-25T00:00:00Z,NA,NA,NA,NA,NA,2014-02-01,2014-07-25,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1280,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-17,2014-01-17T00:00:00Z,2014-07-25T23:59:59Z,2014-02-01T00:00:00Z,NA,NA,2014-07-25T00:00:00Z,NA,NA,NA,NA,NA,2014-02-01,2014-07-25,NA,NA,PDOSINT,146,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1280,2014-01-17,2014-07-25,2014-01-17,2014-07-25,NA,2014-07-25,NA,NA,705,56,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-11,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-25,190,NA,2014-07-25,COMPLETED,NA,2014-01-17,NA,NA,NA,2014-07-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1281,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-28,2013-12-15,1,18,NA,54,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-11-28T00:00:00Z,NA,H,2013-12-15T00:00:00Z,NA,H,1,18,18,2013-11-28,2013-12-15,972,972,DURD,18,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1281,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-28,2013-12-15,1,18,NA,54,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-11-28T00:00:00Z,NA,H,2013-12-15T00:00:00Z,NA,H,1,18,18,2013-11-28,2013-12-15,972,972,DOSE,972,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1281,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-28,2013-12-15,1,18,NA,54,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-11-28T00:00:00Z,NA,H,2013-12-15T00:00:00Z,NA,H,1,18,18,2013-11-28,2013-12-15,972,972,PLDOSE,972,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1281,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-28,2013-12-15,1,18,NA,54,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-11-28T00:00:00Z,NA,H,2013-12-15T00:00:00Z,NA,H,1,18,18,2013-11-28,2013-12-15,972,972,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1281,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-28,2013-12-15,1,18,NA,54,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-11-28T00:00:00Z,NA,H,2013-12-15T00:00:00Z,NA,H,1,18,18,2013-11-28,2013-12-15,972,972,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1281,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-16,2014-02-27,19,92,NA,54,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2014-02-27T00:00:00Z,NA,H,19,92,74,2013-12-16,2014-02-27,5994,3996,DURD,74,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1281,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-16,2014-02-27,19,92,NA,54,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2014-02-27T00:00:00Z,NA,H,19,92,74,2013-12-16,2014-02-27,5994,3996,DOSE,5994,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1281,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-16,2014-02-27,19,92,NA,54,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2014-02-27T00:00:00Z,NA,H,19,92,74,2013-12-16,2014-02-27,5994,3996,PLDOSE,3996,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1281,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-16,2014-02-27,19,92,NA,54,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2014-02-27T00:00:00Z,NA,H,19,92,74,2013-12-16,2014-02-27,5994,3996,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1281,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-16,2014-02-27,19,92,NA,54,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2014-02-27T00:00:00Z,NA,H,19,92,74,2013-12-16,2014-02-27,5994,3996,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-11-28T00:00:00Z,NA,NA,2014-02-27T00:00:00Z,NA,NA,NA,NA,NA,2013-11-28,2014-02-27,NA,NA,TDURD,92,NA,OVERALL,Overall duration (days),7,>=90 days,11,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-11-28T00:00:00Z,NA,NA,2014-02-27T00:00:00Z,NA,NA,NA,NA,NA,2013-11-28,2014-02-27,NA,NA,TDOSE,6966,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-11-28T00:00:00Z,NA,NA,2014-02-27T00:00:00Z,NA,NA,NA,NA,NA,2013-11-28,2014-02-27,NA,NA,AVDDSE,75.71739130434783,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-11-28T00:00:00Z,NA,NA,2014-02-27T00:00:00Z,NA,NA,NA,NA,NA,2013-11-28,2014-02-27,NA,NA,TPDOSE,4968,NA,OVERALL,Total planned dose (mg),11,NA,14,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-11-28T00:00:00Z,NA,NA,2014-02-27T00:00:00Z,NA,NA,NA,NA,NA,2013-11-28,2014-02-27,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-11-28T00:00:00Z,NA,NA,2014-02-27T00:00:00Z,NA,NA,NA,NA,NA,2013-11-28,2014-02-27,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-11-28T00:00:00Z,NA,NA,2014-02-27T00:00:00Z,NA,NA,NA,NA,NA,2013-11-28,2014-02-27,NA,NA,TDOSINT,140.2173913043478,NA,OVERALL,Overall dose intensity (%),90,NA,17,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-02-27T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-02-27,NA,NA,PDURD,74,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-02-27T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-02-27,NA,NA,PDOSE,5994,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-02-27T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-02-27,NA,NA,PPDOSE,3996,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-02-27T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-02-27,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-02-27T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-02-27,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-02-27T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-02-27,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1281,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-28,2013-11-28T00:00:00Z,2014-02-27T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-02-27T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-02-27,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1281,2013-11-28,2014-03-17,2013-11-28,2014-02-27,NA,2014-04-20,NA,NA,705,73,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-26,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-02-27,92,NA,2014-03-17,DISCONTINUED,NA,2013-11-28,NA,NA,NA,2014-03-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1282,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-26,2013-01-09,1,15,NA,0,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2012-12-26T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,1,15,15,2012-12-26,2013-01-09,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1282,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-26,2013-01-09,1,15,NA,0,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2012-12-26T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,1,15,15,2012-12-26,2013-01-09,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1282,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-26,2013-01-09,1,15,NA,0,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2012-12-26T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,1,15,15,2012-12-26,2013-01-09,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1282,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-26,2013-01-09,1,15,NA,0,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2012-12-26T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,1,15,15,2012-12-26,2013-01-09,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1282,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-26,2013-01-09,1,15,NA,0,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2012-12-26T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,1,15,15,2012-12-26,2013-01-09,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1282,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-10,2013-06-11,16,168,NA,0,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-01-10T00:00:00Z,NA,H,2013-06-11T00:00:00Z,NA,H,16,168,153,2013-01-10,2013-06-11,0,0,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1282,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-10,2013-06-11,16,168,NA,0,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-01-10T00:00:00Z,NA,H,2013-06-11T00:00:00Z,NA,H,16,168,153,2013-01-10,2013-06-11,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1282,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-10,2013-06-11,16,168,NA,0,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-01-10T00:00:00Z,NA,H,2013-06-11T00:00:00Z,NA,H,16,168,153,2013-01-10,2013-06-11,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1282,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-10,2013-06-11,16,168,NA,0,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-01-10T00:00:00Z,NA,H,2013-06-11T00:00:00Z,NA,H,16,168,153,2013-01-10,2013-06-11,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1282,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-10,2013-06-11,16,168,NA,0,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-01-10T00:00:00Z,NA,H,2013-06-11T00:00:00Z,NA,H,16,168,153,2013-01-10,2013-06-11,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1282,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-12,2013-06-24,169,181,NA,0,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-06-12T00:00:00Z,NA,H,2013-06-24T00:00:00Z,NA,H,169,181,13,2013-06-12,2013-06-24,0,0,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1282,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-12,2013-06-24,169,181,NA,0,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-06-12T00:00:00Z,NA,H,2013-06-24T00:00:00Z,NA,H,169,181,13,2013-06-12,2013-06-24,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1282,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-12,2013-06-24,169,181,NA,0,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-06-12T00:00:00Z,NA,H,2013-06-24T00:00:00Z,NA,H,169,181,13,2013-06-12,2013-06-24,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1282,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-12,2013-06-24,169,181,NA,0,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-06-12T00:00:00Z,NA,H,2013-06-24T00:00:00Z,NA,H,169,181,13,2013-06-12,2013-06-24,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1282,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-12,2013-06-24,169,181,NA,0,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-06-12T00:00:00Z,NA,H,2013-06-24T00:00:00Z,NA,H,169,181,13,2013-06-12,2013-06-24,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2012-12-26T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-26,2013-06-24,NA,NA,TDURD,181,NA,OVERALL,Overall duration (days),7,>=90 days,16,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2012-12-26T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-26,2013-06-24,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2012-12-26T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-26,2013-06-24,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2012-12-26T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-26,2013-06-24,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2012-12-26T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-26,2013-06-24,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2012-12-26T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-26,2013-06-24,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2012-12-26T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-26,2013-06-24,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-06-24,NA,NA,PDURD,166,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-06-24,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-06-24,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-06-24,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-06-24,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-06-24,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1282,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-06-24T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-06-24,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1282,2012-12-26,2013-06-24,2012-12-26,2013-06-24,NA,2013-06-24T15:25,NA,NA,705,70,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-23,-3,Placebo,Placebo,H,H,2013-06-24,181,NA,2013-06-24,COMPLETED,NA,2012-12-26,NA,NA,NA,2013-06-24,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1292,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-14,2013-10-29,1,16,NA,54,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-14T00:00:00Z,NA,H,2013-10-29T00:00:00Z,NA,H,1,16,16,2013-10-14,2013-10-29,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1292,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-14,2013-10-29,1,16,NA,54,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-14T00:00:00Z,NA,H,2013-10-29T00:00:00Z,NA,H,1,16,16,2013-10-14,2013-10-29,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1292,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-14,2013-10-29,1,16,NA,54,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-14T00:00:00Z,NA,H,2013-10-29T00:00:00Z,NA,H,1,16,16,2013-10-14,2013-10-29,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1292,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-14,2013-10-29,1,16,NA,54,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-14T00:00:00Z,NA,H,2013-10-29T00:00:00Z,NA,H,1,16,16,2013-10-14,2013-10-29,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1292,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-14,2013-10-29,1,16,NA,54,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-14T00:00:00Z,NA,H,2013-10-29T00:00:00Z,NA,H,1,16,16,2013-10-14,2013-10-29,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1292,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-30,2014-04-28,17,197,NA,54,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-30T00:00:00Z,NA,H,2014-04-28T00:00:00Z,NA,H,17,197,181,2013-10-30,2014-04-28,9774,9774,DURD,181,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1292,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-30,2014-04-28,17,197,NA,54,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-30T00:00:00Z,NA,H,2014-04-28T00:00:00Z,NA,H,17,197,181,2013-10-30,2014-04-28,9774,9774,DOSE,9774,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1292,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-30,2014-04-28,17,197,NA,54,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-30T00:00:00Z,NA,H,2014-04-28T00:00:00Z,NA,H,17,197,181,2013-10-30,2014-04-28,9774,9774,PLDOSE,9774,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1292,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-30,2014-04-28,17,197,NA,54,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-30T00:00:00Z,NA,H,2014-04-28T00:00:00Z,NA,H,17,197,181,2013-10-30,2014-04-28,9774,9774,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1292,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-30,2014-04-28,17,197,NA,54,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-30T00:00:00Z,NA,H,2014-04-28T00:00:00Z,NA,H,17,197,181,2013-10-30,2014-04-28,9774,9774,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1292,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-29,2014-05-13,198,212,NA,54,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2014-04-29T00:00:00Z,NA,H,2014-05-13T00:00:00Z,NA,H,198,212,15,2014-04-29,2014-05-13,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1292,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-29,2014-05-13,198,212,NA,54,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2014-04-29T00:00:00Z,NA,H,2014-05-13T00:00:00Z,NA,H,198,212,15,2014-04-29,2014-05-13,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1292,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-29,2014-05-13,198,212,NA,54,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2014-04-29T00:00:00Z,NA,H,2014-05-13T00:00:00Z,NA,H,198,212,15,2014-04-29,2014-05-13,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1292,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-29,2014-05-13,198,212,NA,54,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2014-04-29T00:00:00Z,NA,H,2014-05-13T00:00:00Z,NA,H,198,212,15,2014-04-29,2014-05-13,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1292,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-29,2014-05-13,198,212,NA,54,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2014-04-29T00:00:00Z,NA,H,2014-05-13T00:00:00Z,NA,H,198,212,15,2014-04-29,2014-05-13,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1292,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-14T00:00:00Z,NA,NA,2014-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-14,2014-05-13,NA,NA,TDURD,212,NA,OVERALL,Overall duration (days),7,>=90 days,16,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1292,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-14T00:00:00Z,NA,NA,2014-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-14,2014-05-13,NA,NA,TDOSE,11448,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1292,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-14T00:00:00Z,NA,NA,2014-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-14,2014-05-13,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1292,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-14T00:00:00Z,NA,NA,2014-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-14,2014-05-13,NA,NA,TPDOSE,11448,NA,OVERALL,Total planned dose (mg),11,NA,19,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1292,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-14T00:00:00Z,NA,NA,2014-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-14,2014-05-13,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1292,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-14T00:00:00Z,NA,NA,2014-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-14,2014-05-13,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1292,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-14T00:00:00Z,NA,NA,2014-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-14,2014-05-13,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1292,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-30T00:00:00Z,NA,NA,2014-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-30,2014-05-13,NA,NA,PDURD,196,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1292,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-30T00:00:00Z,NA,NA,2014-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-30,2014-05-13,NA,NA,PDOSE,10584,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1292,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-30T00:00:00Z,NA,NA,2014-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-30,2014-05-13,NA,NA,PPDOSE,10584,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1292,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-30T00:00:00Z,NA,NA,2014-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-30,2014-05-13,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1292,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-30T00:00:00Z,NA,NA,2014-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-30,2014-05-13,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1292,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-30T00:00:00Z,NA,NA,2014-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-30,2014-05-13,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1292,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-14,2013-10-14T00:00:00Z,2014-05-13T23:59:59Z,2013-10-30T00:00:00Z,NA,NA,2014-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-30,2014-05-13,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1292,2013-10-14,2014-05-14,2013-10-14,2014-05-13,NA,2014-05-14T13:33,NA,NA,705,60,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-10-11,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-13,212,NA,2014-05-14,COMPLETED,NA,2013-10-14,NA,NA,NA,2014-05-14,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1303,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-16,2013-12-30,1,15,NA,54,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2013-12-30T00:00:00Z,NA,H,1,15,15,2013-12-16,2013-12-30,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1303,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-16,2013-12-30,1,15,NA,54,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2013-12-30T00:00:00Z,NA,H,1,15,15,2013-12-16,2013-12-30,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1303,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-16,2013-12-30,1,15,NA,54,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2013-12-30T00:00:00Z,NA,H,1,15,15,2013-12-16,2013-12-30,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1303,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-16,2013-12-30,1,15,NA,54,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2013-12-30T00:00:00Z,NA,H,1,15,15,2013-12-16,2013-12-30,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1303,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-16,2013-12-30,1,15,NA,54,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2013-12-30T00:00:00Z,NA,H,1,15,15,2013-12-16,2013-12-30,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1303,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-31,NA,16,NA,NA,54,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-31T00:00:00Z,NA,H,NA,NA,NA,16,NA,NA,2013-12-31,NA,NA,NA,DURD,NA,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1303,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-31,NA,16,NA,NA,54,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-31T00:00:00Z,NA,H,NA,NA,NA,16,NA,NA,2013-12-31,NA,NA,NA,DOSE,NA,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1303,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-31,NA,16,NA,NA,54,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-31T00:00:00Z,NA,H,NA,NA,NA,16,NA,NA,2013-12-31,NA,NA,NA,PLDOSE,NA,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1303,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-31,NA,16,NA,NA,54,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-31T00:00:00Z,NA,H,NA,NA,NA,16,NA,NA,2013-12-31,NA,NA,NA,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1303,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-31,NA,16,NA,NA,54,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-31T00:00:00Z,NA,H,NA,NA,NA,16,NA,NA,2013-12-31,NA,NA,NA,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2013-12-30T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2013-12-30,NA,NA,TDURD,15,NA,OVERALL,Overall duration (days),7,< 30 days,11,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2013-12-30T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2013-12-30,NA,NA,TDOSE,810,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2013-12-30T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2013-12-30,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2013-12-30T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2013-12-30,NA,NA,TPDOSE,810,NA,OVERALL,Total planned dose (mg),11,NA,14,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2013-12-30T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2013-12-30,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2013-12-30T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2013-12-30,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2013-12-30T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2013-12-30,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-31T00:00:00Z,NA,NA,2013-12-31T00:00:00Z,NA,NA,NA,NA,NA,2013-12-31,2013-12-31,NA,NA,PDURD,0,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-31T00:00:00Z,NA,NA,2013-12-31T00:00:00Z,NA,NA,NA,NA,NA,2013-12-31,2013-12-31,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-31T00:00:00Z,NA,NA,2013-12-31T00:00:00Z,NA,NA,NA,NA,NA,2013-12-31,2013-12-31,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-31T00:00:00Z,NA,NA,2013-12-31T00:00:00Z,NA,NA,NA,NA,NA,2013-12-31,2013-12-31,NA,NA,PAVDDSE,NA,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-31T00:00:00Z,NA,NA,2013-12-31T00:00:00Z,NA,NA,NA,NA,NA,2013-12-31,2013-12-31,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-31T00:00:00Z,NA,NA,2013-12-31T00:00:00Z,NA,NA,NA,NA,NA,2013-12-31,2013-12-31,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1303,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2013-12-30T23:59:59Z,2013-12-31T00:00:00Z,NA,NA,2013-12-31T00:00:00Z,NA,NA,NA,NA,NA,2013-12-31,2013-12-31,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1303,2013-12-16,2014-06-02,2013-12-16,2013-12-30,NA,2014-06-02,NA,NA,705,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-30,15,NA,2014-06-02,DISCONTINUED,NA,2013-12-16,NA,NA,NA,2014-04-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1310,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-02,2013-11-22,1,21,NA,54,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-02T00:00:00Z,NA,H,2013-11-22T00:00:00Z,NA,H,1,21,21,2013-11-02,2013-11-22,1134,1134,DURD,21,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1310,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-02,2013-11-22,1,21,NA,54,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-02T00:00:00Z,NA,H,2013-11-22T00:00:00Z,NA,H,1,21,21,2013-11-02,2013-11-22,1134,1134,DOSE,1134,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1310,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-02,2013-11-22,1,21,NA,54,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-02T00:00:00Z,NA,H,2013-11-22T00:00:00Z,NA,H,1,21,21,2013-11-02,2013-11-22,1134,1134,PLDOSE,1134,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1310,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-02,2013-11-22,1,21,NA,54,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-02T00:00:00Z,NA,H,2013-11-22T00:00:00Z,NA,H,1,21,21,2013-11-02,2013-11-22,1134,1134,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1310,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-02,2013-11-22,1,21,NA,54,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-02T00:00:00Z,NA,H,2013-11-22T00:00:00Z,NA,H,1,21,21,2013-11-02,2013-11-22,1134,1134,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1310,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-23,2014-01-23,22,83,NA,54,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-23T00:00:00Z,NA,H,2014-01-23T00:00:00Z,NA,H,22,83,62,2013-11-23,2014-01-23,5022,3348,DURD,62,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1310,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-23,2014-01-23,22,83,NA,54,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-23T00:00:00Z,NA,H,2014-01-23T00:00:00Z,NA,H,22,83,62,2013-11-23,2014-01-23,5022,3348,DOSE,5022,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1310,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-23,2014-01-23,22,83,NA,54,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-23T00:00:00Z,NA,H,2014-01-23T00:00:00Z,NA,H,22,83,62,2013-11-23,2014-01-23,5022,3348,PLDOSE,3348,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1310,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-23,2014-01-23,22,83,NA,54,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-23T00:00:00Z,NA,H,2014-01-23T00:00:00Z,NA,H,22,83,62,2013-11-23,2014-01-23,5022,3348,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1310,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-23,2014-01-23,22,83,NA,54,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-23T00:00:00Z,NA,H,2014-01-23T00:00:00Z,NA,H,22,83,62,2013-11-23,2014-01-23,5022,3348,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1310,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-02T00:00:00Z,NA,NA,2014-01-23T00:00:00Z,NA,NA,NA,NA,NA,2013-11-02,2014-01-23,NA,NA,TDURD,83,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1310,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-02T00:00:00Z,NA,NA,2014-01-23T00:00:00Z,NA,NA,NA,NA,NA,2013-11-02,2014-01-23,NA,NA,TDOSE,6156,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1310,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-02T00:00:00Z,NA,NA,2014-01-23T00:00:00Z,NA,NA,NA,NA,NA,2013-11-02,2014-01-23,NA,NA,AVDDSE,74.16867469879519,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1310,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-02T00:00:00Z,NA,NA,2014-01-23T00:00:00Z,NA,NA,NA,NA,NA,2013-11-02,2014-01-23,NA,NA,TPDOSE,4482,NA,OVERALL,Total planned dose (mg),11,NA,14,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1310,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-02T00:00:00Z,NA,NA,2014-01-23T00:00:00Z,NA,NA,NA,NA,NA,2013-11-02,2014-01-23,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1310,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-02T00:00:00Z,NA,NA,2014-01-23T00:00:00Z,NA,NA,NA,NA,NA,2013-11-02,2014-01-23,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1310,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-02T00:00:00Z,NA,NA,2014-01-23T00:00:00Z,NA,NA,NA,NA,NA,2013-11-02,2014-01-23,NA,NA,TDOSINT,137.34939759036143,NA,OVERALL,Overall dose intensity (%),90,NA,17,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1310,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-23T00:00:00Z,NA,NA,2014-01-23T00:00:00Z,NA,NA,NA,NA,NA,2013-11-23,2014-01-23,NA,NA,PDURD,62,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1310,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-23T00:00:00Z,NA,NA,2014-01-23T00:00:00Z,NA,NA,NA,NA,NA,2013-11-23,2014-01-23,NA,NA,PDOSE,5022,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1310,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-23T00:00:00Z,NA,NA,2014-01-23T00:00:00Z,NA,NA,NA,NA,NA,2013-11-23,2014-01-23,NA,NA,PPDOSE,3348,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1310,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-23T00:00:00Z,NA,NA,2014-01-23T00:00:00Z,NA,NA,NA,NA,NA,2013-11-23,2014-01-23,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1310,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-23T00:00:00Z,NA,NA,2014-01-23T00:00:00Z,NA,NA,NA,NA,NA,2013-11-23,2014-01-23,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1310,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-23T00:00:00Z,NA,NA,2014-01-23T00:00:00Z,NA,NA,NA,NA,NA,2013-11-23,2014-01-23,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1310,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-02,2013-11-02T00:00:00Z,2014-01-23T23:59:59Z,2013-11-23T00:00:00Z,NA,NA,2014-01-23T00:00:00Z,NA,NA,NA,NA,NA,2013-11-23,2014-01-23,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1310,2013-11-02,2014-01-23,2013-11-02,2014-01-23,NA,2014-02-24,NA,NA,705,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-26,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-23,83,NA,2014-01-23,DISCONTINUED,NA,2013-11-02,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1349,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-10,2013-03-24,1,15,NA,0,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-10T00:00:00Z,NA,H,2013-03-24T00:00:00Z,NA,H,1,15,15,2013-03-10,2013-03-24,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1349,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-10,2013-03-24,1,15,NA,0,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-10T00:00:00Z,NA,H,2013-03-24T00:00:00Z,NA,H,1,15,15,2013-03-10,2013-03-24,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1349,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-10,2013-03-24,1,15,NA,0,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-10T00:00:00Z,NA,H,2013-03-24T00:00:00Z,NA,H,1,15,15,2013-03-10,2013-03-24,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1349,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-10,2013-03-24,1,15,NA,0,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-10T00:00:00Z,NA,H,2013-03-24T00:00:00Z,NA,H,1,15,15,2013-03-10,2013-03-24,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1349,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-10,2013-03-24,1,15,NA,0,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-10T00:00:00Z,NA,H,2013-03-24T00:00:00Z,NA,H,1,15,15,2013-03-10,2013-03-24,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1349,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-25,2013-08-25,16,169,NA,0,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-25T00:00:00Z,NA,H,2013-08-25T00:00:00Z,NA,H,16,169,154,2013-03-25,2013-08-25,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1349,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-25,2013-08-25,16,169,NA,0,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-25T00:00:00Z,NA,H,2013-08-25T00:00:00Z,NA,H,16,169,154,2013-03-25,2013-08-25,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1349,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-25,2013-08-25,16,169,NA,0,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-25T00:00:00Z,NA,H,2013-08-25T00:00:00Z,NA,H,16,169,154,2013-03-25,2013-08-25,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1349,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-25,2013-08-25,16,169,NA,0,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-25T00:00:00Z,NA,H,2013-08-25T00:00:00Z,NA,H,16,169,154,2013-03-25,2013-08-25,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1349,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-25,2013-08-25,16,169,NA,0,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-25T00:00:00Z,NA,H,2013-08-25T00:00:00Z,NA,H,16,169,154,2013-03-25,2013-08-25,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1349,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-26,2013-09-08,170,183,NA,0,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-08-26T00:00:00Z,NA,H,2013-09-08T00:00:00Z,NA,H,170,183,14,2013-08-26,2013-09-08,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1349,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-26,2013-09-08,170,183,NA,0,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-08-26T00:00:00Z,NA,H,2013-09-08T00:00:00Z,NA,H,170,183,14,2013-08-26,2013-09-08,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1349,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-26,2013-09-08,170,183,NA,0,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-08-26T00:00:00Z,NA,H,2013-09-08T00:00:00Z,NA,H,170,183,14,2013-08-26,2013-09-08,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1349,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-26,2013-09-08,170,183,NA,0,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-08-26T00:00:00Z,NA,H,2013-09-08T00:00:00Z,NA,H,170,183,14,2013-08-26,2013-09-08,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1349,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-26,2013-09-08,170,183,NA,0,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-08-26T00:00:00Z,NA,H,2013-09-08T00:00:00Z,NA,H,170,183,14,2013-08-26,2013-09-08,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-10T00:00:00Z,NA,NA,2013-09-08T00:00:00Z,NA,NA,NA,NA,NA,2013-03-10,2013-09-08,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-10T00:00:00Z,NA,NA,2013-09-08T00:00:00Z,NA,NA,NA,NA,NA,2013-03-10,2013-09-08,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-10T00:00:00Z,NA,NA,2013-09-08T00:00:00Z,NA,NA,NA,NA,NA,2013-03-10,2013-09-08,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-10T00:00:00Z,NA,NA,2013-09-08T00:00:00Z,NA,NA,NA,NA,NA,2013-03-10,2013-09-08,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-10T00:00:00Z,NA,NA,2013-09-08T00:00:00Z,NA,NA,NA,NA,NA,2013-03-10,2013-09-08,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-10T00:00:00Z,NA,NA,2013-09-08T00:00:00Z,NA,NA,NA,NA,NA,2013-03-10,2013-09-08,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-10T00:00:00Z,NA,NA,2013-09-08T00:00:00Z,NA,NA,NA,NA,NA,2013-03-10,2013-09-08,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-25T00:00:00Z,NA,NA,2013-09-08T00:00:00Z,NA,NA,NA,NA,NA,2013-03-25,2013-09-08,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-25T00:00:00Z,NA,NA,2013-09-08T00:00:00Z,NA,NA,NA,NA,NA,2013-03-25,2013-09-08,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-25T00:00:00Z,NA,NA,2013-09-08T00:00:00Z,NA,NA,NA,NA,NA,2013-03-25,2013-09-08,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-25T00:00:00Z,NA,NA,2013-09-08T00:00:00Z,NA,NA,NA,NA,NA,2013-03-25,2013-09-08,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-25T00:00:00Z,NA,NA,2013-09-08T00:00:00Z,NA,NA,NA,NA,NA,2013-03-25,2013-09-08,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-25T00:00:00Z,NA,NA,2013-09-08T00:00:00Z,NA,NA,NA,NA,NA,2013-03-25,2013-09-08,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1349,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-10,2013-03-10T00:00:00Z,2013-09-08T23:59:59Z,2013-03-25T00:00:00Z,NA,NA,2013-09-08T00:00:00Z,NA,NA,NA,NA,NA,2013-03-25,2013-09-08,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1349,2013-03-10,2013-09-08,2013-03-10,2013-09-08,NA,2013-09-08T10:10,NA,NA,705,86,YEARS,F,WHITE,HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-24,-14,Placebo,Placebo,H,H,2013-09-08,183,NA,2013-09-08,COMPLETED,NA,2013-03-10,NA,NA,NA,2013-09-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1377,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-04,2014-01-25,1,22,NA,54,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-04T00:00:00Z,NA,H,2014-01-25T00:00:00Z,NA,H,1,22,22,2014-01-04,2014-01-25,1188,1188,DURD,22,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1377,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-04,2014-01-25,1,22,NA,54,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-04T00:00:00Z,NA,H,2014-01-25T00:00:00Z,NA,H,1,22,22,2014-01-04,2014-01-25,1188,1188,DOSE,1188,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1377,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-04,2014-01-25,1,22,NA,54,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-04T00:00:00Z,NA,H,2014-01-25T00:00:00Z,NA,H,1,22,22,2014-01-04,2014-01-25,1188,1188,PLDOSE,1188,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1377,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-04,2014-01-25,1,22,NA,54,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-04T00:00:00Z,NA,H,2014-01-25T00:00:00Z,NA,H,1,22,22,2014-01-04,2014-01-25,1188,1188,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1377,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-04,2014-01-25,1,22,NA,54,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-04T00:00:00Z,NA,H,2014-01-25T00:00:00Z,NA,H,1,22,22,2014-01-04,2014-01-25,1188,1188,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1377,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-26,NA,23,NA,NA,54,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-26T00:00:00Z,NA,H,NA,NA,NA,23,NA,NA,2014-01-26,NA,NA,NA,DURD,NA,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1377,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-26,NA,23,NA,NA,54,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-26T00:00:00Z,NA,H,NA,NA,NA,23,NA,NA,2014-01-26,NA,NA,NA,DOSE,NA,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1377,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-26,NA,23,NA,NA,54,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-26T00:00:00Z,NA,H,NA,NA,NA,23,NA,NA,2014-01-26,NA,NA,NA,PLDOSE,NA,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1377,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-26,NA,23,NA,NA,54,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-26T00:00:00Z,NA,H,NA,NA,NA,23,NA,NA,2014-01-26,NA,NA,NA,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1377,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-26,NA,23,NA,NA,54,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-26T00:00:00Z,NA,H,NA,NA,NA,23,NA,NA,2014-01-26,NA,NA,NA,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-04T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2014-01-04,2014-01-25,NA,NA,TDURD,22,NA,OVERALL,Overall duration (days),7,< 30 days,11,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-04T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2014-01-04,2014-01-25,NA,NA,TDOSE,1188,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-04T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2014-01-04,2014-01-25,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-04T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2014-01-04,2014-01-25,NA,NA,TPDOSE,1188,NA,OVERALL,Total planned dose (mg),11,NA,14,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-04T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2014-01-04,2014-01-25,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-04T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2014-01-04,2014-01-25,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-04T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2014-01-04,2014-01-25,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-26T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-26,2014-01-26,NA,NA,PDURD,0,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-26T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-26,2014-01-26,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-26T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-26,2014-01-26,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-26T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-26,2014-01-26,NA,NA,PAVDDSE,NA,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-26T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-26,2014-01-26,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-26T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-26,2014-01-26,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1377,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-04,2014-01-04T00:00:00Z,2014-01-25T23:59:59Z,2014-01-26T00:00:00Z,NA,NA,2014-01-26T00:00:00Z,NA,NA,NA,NA,NA,2014-01-26,2014-01-26,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1377,2014-01-04,2014-03-07,2014-01-04,2014-01-25,NA,2014-03-07,NA,NA,705,63,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-29,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-25,22,NA,2014-03-07,DISCONTINUED,NA,2014-01-04,NA,NA,NA,2014-02-07,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1382,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-13,NA,1,NA,NA,54,2013-05-13,2013-05-13T00:00:00Z,NA,2013-05-13T00:00:00Z,NA,H,NA,NA,NA,1,NA,NA,2013-05-13,NA,NA,NA,DURD,NA,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1382,2013-05-13,2013-05-13,2013-05-13,NA,NA,2013-05-13,NA,NA,705,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-09,-4,Xanomeline High Dose,Xanomeline Low Dose,H,NA,NA,NA,NA,2013-05-13,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1382,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-13,NA,1,NA,NA,54,2013-05-13,2013-05-13T00:00:00Z,NA,2013-05-13T00:00:00Z,NA,H,NA,NA,NA,1,NA,NA,2013-05-13,NA,NA,NA,DOSE,NA,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1382,2013-05-13,2013-05-13,2013-05-13,NA,NA,2013-05-13,NA,NA,705,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-09,-4,Xanomeline High Dose,Xanomeline Low Dose,H,NA,NA,NA,NA,2013-05-13,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1382,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-13,NA,1,NA,NA,54,2013-05-13,2013-05-13T00:00:00Z,NA,2013-05-13T00:00:00Z,NA,H,NA,NA,NA,1,NA,NA,2013-05-13,NA,NA,NA,PLDOSE,NA,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1382,2013-05-13,2013-05-13,2013-05-13,NA,NA,2013-05-13,NA,NA,705,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-09,-4,Xanomeline High Dose,Xanomeline Low Dose,H,NA,NA,NA,NA,2013-05-13,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1382,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-13,NA,1,NA,NA,54,2013-05-13,2013-05-13T00:00:00Z,NA,2013-05-13T00:00:00Z,NA,H,NA,NA,NA,1,NA,NA,2013-05-13,NA,NA,NA,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1382,2013-05-13,2013-05-13,2013-05-13,NA,NA,2013-05-13,NA,NA,705,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-09,-4,Xanomeline High Dose,Xanomeline Low Dose,H,NA,NA,NA,NA,2013-05-13,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1382,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-13,NA,1,NA,NA,54,2013-05-13,2013-05-13T00:00:00Z,NA,2013-05-13T00:00:00Z,NA,H,NA,NA,NA,1,NA,NA,2013-05-13,NA,NA,NA,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1382,2013-05-13,2013-05-13,2013-05-13,NA,NA,2013-05-13,NA,NA,705,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-09,-4,Xanomeline High Dose,Xanomeline Low Dose,H,NA,NA,NA,NA,2013-05-13,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1382,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-13,2013-05-13T00:00:00Z,NA,2013-05-13T00:00:00Z,NA,NA,2013-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-05-13,2013-05-13,NA,NA,TDURD,0,NA,OVERALL,Overall duration (days),7,< 30 days,6,1382,2013-05-13,2013-05-13,2013-05-13,NA,NA,2013-05-13,NA,NA,705,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-09,-4,Xanomeline High Dose,Xanomeline Low Dose,H,NA,NA,NA,NA,2013-05-13,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1382,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-13,2013-05-13T00:00:00Z,NA,2013-05-13T00:00:00Z,NA,NA,2013-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-05-13,2013-05-13,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,7,1382,2013-05-13,2013-05-13,2013-05-13,NA,NA,2013-05-13,NA,NA,705,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-09,-4,Xanomeline High Dose,Xanomeline Low Dose,H,NA,NA,NA,NA,2013-05-13,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1382,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-13,2013-05-13T00:00:00Z,NA,2013-05-13T00:00:00Z,NA,NA,2013-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-05-13,2013-05-13,NA,NA,AVDDSE,NA,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1382,2013-05-13,2013-05-13,2013-05-13,NA,NA,2013-05-13,NA,NA,705,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-09,-4,Xanomeline High Dose,Xanomeline Low Dose,H,NA,NA,NA,NA,2013-05-13,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1382,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-13,2013-05-13T00:00:00Z,NA,2013-05-13T00:00:00Z,NA,NA,2013-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-05-13,2013-05-13,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,9,1382,2013-05-13,2013-05-13,2013-05-13,NA,NA,2013-05-13,NA,NA,705,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-09,-4,Xanomeline High Dose,Xanomeline Low Dose,H,NA,NA,NA,NA,2013-05-13,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1382,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-13,2013-05-13T00:00:00Z,NA,2013-05-13T00:00:00Z,NA,NA,2013-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-05-13,2013-05-13,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1382,2013-05-13,2013-05-13,2013-05-13,NA,NA,2013-05-13,NA,NA,705,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-09,-4,Xanomeline High Dose,Xanomeline Low Dose,H,NA,NA,NA,NA,2013-05-13,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1382,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-13,2013-05-13T00:00:00Z,NA,2013-05-13T00:00:00Z,NA,NA,2013-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-05-13,2013-05-13,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1382,2013-05-13,2013-05-13,2013-05-13,NA,NA,2013-05-13,NA,NA,705,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-09,-4,Xanomeline High Dose,Xanomeline Low Dose,H,NA,NA,NA,NA,2013-05-13,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1382,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-13,2013-05-13T00:00:00Z,NA,2013-05-13T00:00:00Z,NA,NA,2013-05-13T00:00:00Z,NA,NA,NA,NA,NA,2013-05-13,2013-05-13,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,12,1382,2013-05-13,2013-05-13,2013-05-13,NA,NA,2013-05-13,NA,NA,705,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-09,-4,Xanomeline High Dose,Xanomeline Low Dose,H,NA,NA,NA,NA,2013-05-13,DISCONTINUED,NA,2013-05-13,NA,NA,NA,2013-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1393,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-07,2012-09-27,1,21,NA,54,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-07T00:00:00Z,NA,H,2012-09-27T00:00:00Z,NA,H,1,21,21,2012-09-07,2012-09-27,1134,1134,DURD,21,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1393,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-07,2012-09-27,1,21,NA,54,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-07T00:00:00Z,NA,H,2012-09-27T00:00:00Z,NA,H,1,21,21,2012-09-07,2012-09-27,1134,1134,DOSE,1134,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1393,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-07,2012-09-27,1,21,NA,54,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-07T00:00:00Z,NA,H,2012-09-27T00:00:00Z,NA,H,1,21,21,2012-09-07,2012-09-27,1134,1134,PLDOSE,1134,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1393,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-07,2012-09-27,1,21,NA,54,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-07T00:00:00Z,NA,H,2012-09-27T00:00:00Z,NA,H,1,21,21,2012-09-07,2012-09-27,1134,1134,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1393,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-07,2012-09-27,1,21,NA,54,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-07T00:00:00Z,NA,H,2012-09-27T00:00:00Z,NA,H,1,21,21,2012-09-07,2012-09-27,1134,1134,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1393,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-28,2013-02-01,22,148,NA,54,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-28T00:00:00Z,NA,H,2013-02-01T00:00:00Z,NA,H,22,148,127,2012-09-28,2013-02-01,6858,6858,DURD,127,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1393,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-28,2013-02-01,22,148,NA,54,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-28T00:00:00Z,NA,H,2013-02-01T00:00:00Z,NA,H,22,148,127,2012-09-28,2013-02-01,6858,6858,DOSE,6858,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1393,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-28,2013-02-01,22,148,NA,54,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-28T00:00:00Z,NA,H,2013-02-01T00:00:00Z,NA,H,22,148,127,2012-09-28,2013-02-01,6858,6858,PLDOSE,6858,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1393,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-28,2013-02-01,22,148,NA,54,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-28T00:00:00Z,NA,H,2013-02-01T00:00:00Z,NA,H,22,148,127,2012-09-28,2013-02-01,6858,6858,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1393,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-28,2013-02-01,22,148,NA,54,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-28T00:00:00Z,NA,H,2013-02-01T00:00:00Z,NA,H,22,148,127,2012-09-28,2013-02-01,6858,6858,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-07T00:00:00Z,NA,NA,2013-02-01T00:00:00Z,NA,NA,NA,NA,NA,2012-09-07,2013-02-01,NA,NA,TDURD,148,NA,OVERALL,Overall duration (days),7,>=90 days,11,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-07T00:00:00Z,NA,NA,2013-02-01T00:00:00Z,NA,NA,NA,NA,NA,2012-09-07,2013-02-01,NA,NA,TDOSE,7992,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-07T00:00:00Z,NA,NA,2013-02-01T00:00:00Z,NA,NA,NA,NA,NA,2012-09-07,2013-02-01,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-07T00:00:00Z,NA,NA,2013-02-01T00:00:00Z,NA,NA,NA,NA,NA,2012-09-07,2013-02-01,NA,NA,TPDOSE,7992,NA,OVERALL,Total planned dose (mg),11,NA,14,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-07T00:00:00Z,NA,NA,2013-02-01T00:00:00Z,NA,NA,NA,NA,NA,2012-09-07,2013-02-01,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-07T00:00:00Z,NA,NA,2013-02-01T00:00:00Z,NA,NA,NA,NA,NA,2012-09-07,2013-02-01,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-07T00:00:00Z,NA,NA,2013-02-01T00:00:00Z,NA,NA,NA,NA,NA,2012-09-07,2013-02-01,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-28T00:00:00Z,NA,NA,2013-02-01T00:00:00Z,NA,NA,NA,NA,NA,2012-09-28,2013-02-01,NA,NA,PDURD,127,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-28T00:00:00Z,NA,NA,2013-02-01T00:00:00Z,NA,NA,NA,NA,NA,2012-09-28,2013-02-01,NA,NA,PDOSE,6858,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-28T00:00:00Z,NA,NA,2013-02-01T00:00:00Z,NA,NA,NA,NA,NA,2012-09-28,2013-02-01,NA,NA,PPDOSE,6858,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-28T00:00:00Z,NA,NA,2013-02-01T00:00:00Z,NA,NA,NA,NA,NA,2012-09-28,2013-02-01,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-28T00:00:00Z,NA,NA,2013-02-01T00:00:00Z,NA,NA,NA,NA,NA,2012-09-28,2013-02-01,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-28T00:00:00Z,NA,NA,2013-02-01T00:00:00Z,NA,NA,NA,NA,NA,2012-09-28,2013-02-01,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1393,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-07,2012-09-07T00:00:00Z,2013-02-01T23:59:59Z,2012-09-28T00:00:00Z,NA,NA,2013-02-01T00:00:00Z,NA,NA,NA,NA,NA,2012-09-28,2013-02-01,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1393,2012-09-07,2013-02-20,2012-09-07,2013-02-01,NA,2013-04-25,NA,NA,705,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-5,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-01,148,NA,2013-02-20,DISCONTINUED,NA,2012-09-07,NA,NA,NA,2013-02-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1431,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-23,2013-07-07,1,15,NA,54,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-06-23T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,1,15,15,2013-06-23,2013-07-07,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1431,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-23,2013-07-07,1,15,NA,54,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-06-23T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,1,15,15,2013-06-23,2013-07-07,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1431,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-23,2013-07-07,1,15,NA,54,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-06-23T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,1,15,15,2013-06-23,2013-07-07,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1431,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-23,2013-07-07,1,15,NA,54,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-06-23T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,1,15,15,2013-06-23,2013-07-07,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1431,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-23,2013-07-07,1,15,NA,54,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-06-23T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,1,15,15,2013-06-23,2013-07-07,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1431,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-08,2013-12-05,16,166,NA,54,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,16,166,151,2013-07-08,2013-12-05,8154,8154,DURD,151,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1431,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-08,2013-12-05,16,166,NA,54,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,16,166,151,2013-07-08,2013-12-05,8154,8154,DOSE,8154,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1431,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-08,2013-12-05,16,166,NA,54,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,16,166,151,2013-07-08,2013-12-05,8154,8154,PLDOSE,8154,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1431,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-08,2013-12-05,16,166,NA,54,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,16,166,151,2013-07-08,2013-12-05,8154,8154,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1431,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-08,2013-12-05,16,166,NA,54,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,16,166,151,2013-07-08,2013-12-05,8154,8154,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1431,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-06,2013-12-19,167,180,NA,54,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-12-06T00:00:00Z,NA,H,2013-12-19T00:00:00Z,NA,H,167,180,14,2013-12-06,2013-12-19,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1431,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-06,2013-12-19,167,180,NA,54,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-12-06T00:00:00Z,NA,H,2013-12-19T00:00:00Z,NA,H,167,180,14,2013-12-06,2013-12-19,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1431,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-06,2013-12-19,167,180,NA,54,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-12-06T00:00:00Z,NA,H,2013-12-19T00:00:00Z,NA,H,167,180,14,2013-12-06,2013-12-19,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1431,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-06,2013-12-19,167,180,NA,54,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-12-06T00:00:00Z,NA,H,2013-12-19T00:00:00Z,NA,H,167,180,14,2013-12-06,2013-12-19,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-705-1431,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-06,2013-12-19,167,180,NA,54,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-12-06T00:00:00Z,NA,H,2013-12-19T00:00:00Z,NA,H,167,180,14,2013-12-06,2013-12-19,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-06-23T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-06-23,2013-12-19,NA,NA,TDURD,180,NA,OVERALL,Overall duration (days),7,>=90 days,16,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-06-23T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-06-23,2013-12-19,NA,NA,TDOSE,9720,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-06-23T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-06-23,2013-12-19,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-06-23T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-06-23,2013-12-19,NA,NA,TPDOSE,9720,NA,OVERALL,Total planned dose (mg),11,NA,19,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-06-23T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-06-23,2013-12-19,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-06-23T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-06-23,2013-12-19,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-06-23T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-06-23,2013-12-19,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-07-08T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-07-08,2013-12-19,NA,NA,PDURD,165,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-07-08T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-07-08,2013-12-19,NA,NA,PDOSE,8910,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-07-08T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-07-08,2013-12-19,NA,NA,PPDOSE,8910,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-07-08T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-07-08,2013-12-19,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-07-08T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-07-08,2013-12-19,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-07-08T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-07-08,2013-12-19,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-705-1431,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-23,2013-06-23T00:00:00Z,2013-12-19T23:59:59Z,2013-07-08T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-07-08,2013-12-19,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1431,2013-06-23,2013-12-19,2013-06-23,2013-12-19,NA,2013-12-19T10:05,NA,NA,705,68,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-16,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-19,180,NA,2013-12-19,COMPLETED,NA,2013-06-23,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1041,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-31,2014-01-14,1,15,NA,0,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2013-12-31T00:00:00Z,NA,H,2014-01-14T00:00:00Z,NA,H,1,15,15,2013-12-31,2014-01-14,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1041,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-31,2014-01-14,1,15,NA,0,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2013-12-31T00:00:00Z,NA,H,2014-01-14T00:00:00Z,NA,H,1,15,15,2013-12-31,2014-01-14,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1041,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-31,2014-01-14,1,15,NA,0,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2013-12-31T00:00:00Z,NA,H,2014-01-14T00:00:00Z,NA,H,1,15,15,2013-12-31,2014-01-14,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1041,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-31,2014-01-14,1,15,NA,0,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2013-12-31T00:00:00Z,NA,H,2014-01-14T00:00:00Z,NA,H,1,15,15,2013-12-31,2014-01-14,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1041,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-31,2014-01-14,1,15,NA,0,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2013-12-31T00:00:00Z,NA,H,2014-01-14T00:00:00Z,NA,H,1,15,15,2013-12-31,2014-01-14,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1041,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-15,2014-07-15,16,197,NA,0,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-01-15T00:00:00Z,NA,H,2014-07-15T00:00:00Z,NA,H,16,197,182,2014-01-15,2014-07-15,0,0,DURD,182,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1041,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-15,2014-07-15,16,197,NA,0,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-01-15T00:00:00Z,NA,H,2014-07-15T00:00:00Z,NA,H,16,197,182,2014-01-15,2014-07-15,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1041,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-15,2014-07-15,16,197,NA,0,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-01-15T00:00:00Z,NA,H,2014-07-15T00:00:00Z,NA,H,16,197,182,2014-01-15,2014-07-15,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1041,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-15,2014-07-15,16,197,NA,0,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-01-15T00:00:00Z,NA,H,2014-07-15T00:00:00Z,NA,H,16,197,182,2014-01-15,2014-07-15,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1041,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-15,2014-07-15,16,197,NA,0,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-01-15T00:00:00Z,NA,H,2014-07-15T00:00:00Z,NA,H,16,197,182,2014-01-15,2014-07-15,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1041,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-16,2014-07-28,198,210,NA,0,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-07-16T00:00:00Z,NA,H,2014-07-28T00:00:00Z,NA,H,198,210,13,2014-07-16,2014-07-28,0,0,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1041,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-16,2014-07-28,198,210,NA,0,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-07-16T00:00:00Z,NA,H,2014-07-28T00:00:00Z,NA,H,198,210,13,2014-07-16,2014-07-28,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1041,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-16,2014-07-28,198,210,NA,0,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-07-16T00:00:00Z,NA,H,2014-07-28T00:00:00Z,NA,H,198,210,13,2014-07-16,2014-07-28,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1041,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-16,2014-07-28,198,210,NA,0,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-07-16T00:00:00Z,NA,H,2014-07-28T00:00:00Z,NA,H,198,210,13,2014-07-16,2014-07-28,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1041,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-16,2014-07-28,198,210,NA,0,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-07-16T00:00:00Z,NA,H,2014-07-28T00:00:00Z,NA,H,198,210,13,2014-07-16,2014-07-28,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2013-12-31T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2013-12-31,2014-07-28,NA,NA,TDURD,210,NA,OVERALL,Overall duration (days),7,>=90 days,16,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2013-12-31T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2013-12-31,2014-07-28,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2013-12-31T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2013-12-31,2014-07-28,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2013-12-31T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2013-12-31,2014-07-28,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2013-12-31T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2013-12-31,2014-07-28,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2013-12-31T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2013-12-31,2014-07-28,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2013-12-31T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2013-12-31,2014-07-28,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-01-15T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-15,2014-07-28,NA,NA,PDURD,195,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-01-15T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-15,2014-07-28,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-01-15T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-15,2014-07-28,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-01-15T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-15,2014-07-28,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-01-15T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-15,2014-07-28,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-01-15T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-15,2014-07-28,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1041,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-31,2013-12-31T00:00:00Z,2014-07-28T23:59:59Z,2014-01-15T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-15,2014-07-28,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1041,2013-12-31,2014-07-29,2013-12-31,2014-07-28,NA,2014-07-29T13:45,NA,NA,706,64,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-21,-10,Placebo,Placebo,H,H,2014-07-28,210,NA,2014-07-29,COMPLETED,NA,2013-12-31,NA,NA,NA,2014-07-29,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1049,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-14,2013-05-28,1,15,NA,54,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-14T00:00:00Z,NA,H,2013-05-28T00:00:00Z,NA,H,1,15,15,2013-05-14,2013-05-28,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1049,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-14,2013-05-28,1,15,NA,54,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-14T00:00:00Z,NA,H,2013-05-28T00:00:00Z,NA,H,1,15,15,2013-05-14,2013-05-28,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1049,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-14,2013-05-28,1,15,NA,54,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-14T00:00:00Z,NA,H,2013-05-28T00:00:00Z,NA,H,1,15,15,2013-05-14,2013-05-28,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1049,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-14,2013-05-28,1,15,NA,54,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-14T00:00:00Z,NA,H,2013-05-28T00:00:00Z,NA,H,1,15,15,2013-05-14,2013-05-28,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1049,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-14,2013-05-28,1,15,NA,54,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-14T00:00:00Z,NA,H,2013-05-28T00:00:00Z,NA,H,1,15,15,2013-05-14,2013-05-28,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1049,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-29,2013-06-18,16,36,NA,54,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-29T00:00:00Z,NA,H,2013-06-18T00:00:00Z,NA,H,16,36,21,2013-05-29,2013-06-18,1701,1134,DURD,21,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1049,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-29,2013-06-18,16,36,NA,54,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-29T00:00:00Z,NA,H,2013-06-18T00:00:00Z,NA,H,16,36,21,2013-05-29,2013-06-18,1701,1134,DOSE,1701,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1049,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-29,2013-06-18,16,36,NA,54,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-29T00:00:00Z,NA,H,2013-06-18T00:00:00Z,NA,H,16,36,21,2013-05-29,2013-06-18,1701,1134,PLDOSE,1134,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1049,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-29,2013-06-18,16,36,NA,54,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-29T00:00:00Z,NA,H,2013-06-18T00:00:00Z,NA,H,16,36,21,2013-05-29,2013-06-18,1701,1134,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1049,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-29,2013-06-18,16,36,NA,54,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-29T00:00:00Z,NA,H,2013-06-18T00:00:00Z,NA,H,16,36,21,2013-05-29,2013-06-18,1701,1134,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-14T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-14,2013-06-18,NA,NA,TDURD,36,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-14T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-14,2013-06-18,NA,NA,TDOSE,2511,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-14T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-14,2013-06-18,NA,NA,AVDDSE,69.75,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-14T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-14,2013-06-18,NA,NA,TPDOSE,1944,NA,OVERALL,Total planned dose (mg),11,NA,14,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-14T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-14,2013-06-18,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-14T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-14,2013-06-18,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-14T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-14,2013-06-18,NA,NA,TDOSINT,129.16666666666669,NA,OVERALL,Overall dose intensity (%),90,NA,17,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-29T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-29,2013-06-18,NA,NA,PDURD,21,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-29T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-29,2013-06-18,NA,NA,PDOSE,1701,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-29T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-29,2013-06-18,NA,NA,PPDOSE,1134,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-29T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-29,2013-06-18,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-29T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-29,2013-06-18,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-29T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-29,2013-06-18,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1049,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-14,2013-05-14T00:00:00Z,2013-06-18T23:59:59Z,2013-05-29T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-29,2013-06-18,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1049,2013-05-14,2013-06-25,2013-05-14,2013-06-18,NA,2013-11-26,NA,NA,706,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-30,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,36,NA,2013-06-25,DISCONTINUED,2013-11-26,2013-05-14,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1384,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-15,2012-09-24,1,10,NA,54,2012-09-15,2012-09-15T00:00:00Z,2012-09-24T23:59:59Z,2012-09-15T00:00:00Z,NA,H,2012-09-24T00:00:00Z,NA,H,1,10,10,2012-09-15,2012-09-24,540,540,DURD,10,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-24,10,NA,2012-09-29,DISCONTINUED,2013-06-22,2012-09-15,NA,NA,NA,2012-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1384,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-15,2012-09-24,1,10,NA,54,2012-09-15,2012-09-15T00:00:00Z,2012-09-24T23:59:59Z,2012-09-15T00:00:00Z,NA,H,2012-09-24T00:00:00Z,NA,H,1,10,10,2012-09-15,2012-09-24,540,540,DOSE,540,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-24,10,NA,2012-09-29,DISCONTINUED,2013-06-22,2012-09-15,NA,NA,NA,2012-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1384,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-15,2012-09-24,1,10,NA,54,2012-09-15,2012-09-15T00:00:00Z,2012-09-24T23:59:59Z,2012-09-15T00:00:00Z,NA,H,2012-09-24T00:00:00Z,NA,H,1,10,10,2012-09-15,2012-09-24,540,540,PLDOSE,540,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-24,10,NA,2012-09-29,DISCONTINUED,2013-06-22,2012-09-15,NA,NA,NA,2012-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1384,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-15,2012-09-24,1,10,NA,54,2012-09-15,2012-09-15T00:00:00Z,2012-09-24T23:59:59Z,2012-09-15T00:00:00Z,NA,H,2012-09-24T00:00:00Z,NA,H,1,10,10,2012-09-15,2012-09-24,540,540,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-24,10,NA,2012-09-29,DISCONTINUED,2013-06-22,2012-09-15,NA,NA,NA,2012-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-706-1384,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-15,2012-09-24,1,10,NA,54,2012-09-15,2012-09-15T00:00:00Z,2012-09-24T23:59:59Z,2012-09-15T00:00:00Z,NA,H,2012-09-24T00:00:00Z,NA,H,1,10,10,2012-09-15,2012-09-24,540,540,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-24,10,NA,2012-09-29,DISCONTINUED,2013-06-22,2012-09-15,NA,NA,NA,2012-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1384,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-15,2012-09-15T00:00:00Z,2012-09-24T23:59:59Z,2012-09-15T00:00:00Z,NA,NA,2012-09-24T00:00:00Z,NA,NA,NA,NA,NA,2012-09-15,2012-09-24,NA,NA,TDURD,10,NA,OVERALL,Overall duration (days),7,< 30 days,6,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-24,10,NA,2012-09-29,DISCONTINUED,2013-06-22,2012-09-15,NA,NA,NA,2012-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1384,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-15,2012-09-15T00:00:00Z,2012-09-24T23:59:59Z,2012-09-15T00:00:00Z,NA,NA,2012-09-24T00:00:00Z,NA,NA,NA,NA,NA,2012-09-15,2012-09-24,NA,NA,TDOSE,540,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-24,10,NA,2012-09-29,DISCONTINUED,2013-06-22,2012-09-15,NA,NA,NA,2012-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1384,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-15,2012-09-15T00:00:00Z,2012-09-24T23:59:59Z,2012-09-15T00:00:00Z,NA,NA,2012-09-24T00:00:00Z,NA,NA,NA,NA,NA,2012-09-15,2012-09-24,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-24,10,NA,2012-09-29,DISCONTINUED,2013-06-22,2012-09-15,NA,NA,NA,2012-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1384,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-15,2012-09-15T00:00:00Z,2012-09-24T23:59:59Z,2012-09-15T00:00:00Z,NA,NA,2012-09-24T00:00:00Z,NA,NA,NA,NA,NA,2012-09-15,2012-09-24,NA,NA,TPDOSE,540,NA,OVERALL,Total planned dose (mg),11,NA,9,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-24,10,NA,2012-09-29,DISCONTINUED,2013-06-22,2012-09-15,NA,NA,NA,2012-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1384,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-15,2012-09-15T00:00:00Z,2012-09-24T23:59:59Z,2012-09-15T00:00:00Z,NA,NA,2012-09-24T00:00:00Z,NA,NA,NA,NA,NA,2012-09-15,2012-09-24,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-24,10,NA,2012-09-29,DISCONTINUED,2013-06-22,2012-09-15,NA,NA,NA,2012-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1384,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-15,2012-09-15T00:00:00Z,2012-09-24T23:59:59Z,2012-09-15T00:00:00Z,NA,NA,2012-09-24T00:00:00Z,NA,NA,NA,NA,NA,2012-09-15,2012-09-24,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-24,10,NA,2012-09-29,DISCONTINUED,2013-06-22,2012-09-15,NA,NA,NA,2012-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-706-1384,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-15,2012-09-15T00:00:00Z,2012-09-24T23:59:59Z,2012-09-15T00:00:00Z,NA,NA,2012-09-24T00:00:00Z,NA,NA,NA,NA,NA,2012-09-15,2012-09-24,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1384,2012-09-15,2012-09-29,2012-09-15,2012-09-24,NA,2013-06-22,NA,NA,706,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-08-25,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-09-24,10,NA,2012-09-29,DISCONTINUED,2013-06-22,2012-09-15,NA,NA,NA,2012-09-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1037,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-20,2013-12-24,1,5,NA,54,2013-12-20,2013-12-20T00:00:00Z,2013-12-24T23:59:59Z,2013-12-20T00:00:00Z,NA,H,2013-12-24T00:00:00Z,NA,H,1,5,5,2013-12-20,2013-12-24,270,270,DURD,5,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1037,2013-12-20,2014-01-08,2013-12-20,2013-12-24,NA,2014-01-08T12:40,NA,NA,707,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-12,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-24,5,NA,2014-01-08,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1037,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-20,2013-12-24,1,5,NA,54,2013-12-20,2013-12-20T00:00:00Z,2013-12-24T23:59:59Z,2013-12-20T00:00:00Z,NA,H,2013-12-24T00:00:00Z,NA,H,1,5,5,2013-12-20,2013-12-24,270,270,DOSE,270,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1037,2013-12-20,2014-01-08,2013-12-20,2013-12-24,NA,2014-01-08T12:40,NA,NA,707,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-12,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-24,5,NA,2014-01-08,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1037,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-20,2013-12-24,1,5,NA,54,2013-12-20,2013-12-20T00:00:00Z,2013-12-24T23:59:59Z,2013-12-20T00:00:00Z,NA,H,2013-12-24T00:00:00Z,NA,H,1,5,5,2013-12-20,2013-12-24,270,270,PLDOSE,270,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1037,2013-12-20,2014-01-08,2013-12-20,2013-12-24,NA,2014-01-08T12:40,NA,NA,707,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-12,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-24,5,NA,2014-01-08,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1037,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-20,2013-12-24,1,5,NA,54,2013-12-20,2013-12-20T00:00:00Z,2013-12-24T23:59:59Z,2013-12-20T00:00:00Z,NA,H,2013-12-24T00:00:00Z,NA,H,1,5,5,2013-12-20,2013-12-24,270,270,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1037,2013-12-20,2014-01-08,2013-12-20,2013-12-24,NA,2014-01-08T12:40,NA,NA,707,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-12,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-24,5,NA,2014-01-08,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1037,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-20,2013-12-24,1,5,NA,54,2013-12-20,2013-12-20T00:00:00Z,2013-12-24T23:59:59Z,2013-12-20T00:00:00Z,NA,H,2013-12-24T00:00:00Z,NA,H,1,5,5,2013-12-20,2013-12-24,270,270,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1037,2013-12-20,2014-01-08,2013-12-20,2013-12-24,NA,2014-01-08T12:40,NA,NA,707,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-12,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-24,5,NA,2014-01-08,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1037,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2013-12-24T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2013-12-24,NA,NA,TDURD,5,NA,OVERALL,Overall duration (days),7,< 30 days,6,1037,2013-12-20,2014-01-08,2013-12-20,2013-12-24,NA,2014-01-08T12:40,NA,NA,707,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-12,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-24,5,NA,2014-01-08,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1037,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2013-12-24T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2013-12-24,NA,NA,TDOSE,270,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1037,2013-12-20,2014-01-08,2013-12-20,2013-12-24,NA,2014-01-08T12:40,NA,NA,707,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-12,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-24,5,NA,2014-01-08,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1037,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2013-12-24T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2013-12-24,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1037,2013-12-20,2014-01-08,2013-12-20,2013-12-24,NA,2014-01-08T12:40,NA,NA,707,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-12,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-24,5,NA,2014-01-08,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1037,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2013-12-24T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2013-12-24,NA,NA,TPDOSE,270,NA,OVERALL,Total planned dose (mg),11,NA,9,1037,2013-12-20,2014-01-08,2013-12-20,2013-12-24,NA,2014-01-08T12:40,NA,NA,707,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-12,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-24,5,NA,2014-01-08,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1037,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2013-12-24T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2013-12-24,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1037,2013-12-20,2014-01-08,2013-12-20,2013-12-24,NA,2014-01-08T12:40,NA,NA,707,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-12,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-24,5,NA,2014-01-08,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1037,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2013-12-24T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2013-12-24,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1037,2013-12-20,2014-01-08,2013-12-20,2013-12-24,NA,2014-01-08T12:40,NA,NA,707,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-12,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-24,5,NA,2014-01-08,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1037,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2013-12-24T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2013-12-24T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2013-12-24,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1037,2013-12-20,2014-01-08,2013-12-20,2013-12-24,NA,2014-01-08T12:40,NA,NA,707,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-12,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-24,5,NA,2014-01-08,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1206,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-28,2013-11-12,1,16,NA,0,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-10-28T00:00:00Z,NA,H,2013-11-12T00:00:00Z,NA,H,1,16,16,2013-10-28,2013-11-12,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1206,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-28,2013-11-12,1,16,NA,0,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-10-28T00:00:00Z,NA,H,2013-11-12T00:00:00Z,NA,H,1,16,16,2013-10-28,2013-11-12,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1206,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-28,2013-11-12,1,16,NA,0,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-10-28T00:00:00Z,NA,H,2013-11-12T00:00:00Z,NA,H,1,16,16,2013-10-28,2013-11-12,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1206,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-28,2013-11-12,1,16,NA,0,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-10-28T00:00:00Z,NA,H,2013-11-12T00:00:00Z,NA,H,1,16,16,2013-10-28,2013-11-12,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1206,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-28,2013-11-12,1,16,NA,0,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-10-28T00:00:00Z,NA,H,2013-11-12T00:00:00Z,NA,H,1,16,16,2013-10-28,2013-11-12,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1206,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-13,2014-04-13,17,168,NA,0,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-11-13T00:00:00Z,NA,H,2014-04-13T00:00:00Z,NA,H,17,168,152,2013-11-13,2014-04-13,0,0,DURD,152,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1206,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-13,2014-04-13,17,168,NA,0,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-11-13T00:00:00Z,NA,H,2014-04-13T00:00:00Z,NA,H,17,168,152,2013-11-13,2014-04-13,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1206,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-13,2014-04-13,17,168,NA,0,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-11-13T00:00:00Z,NA,H,2014-04-13T00:00:00Z,NA,H,17,168,152,2013-11-13,2014-04-13,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1206,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-13,2014-04-13,17,168,NA,0,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-11-13T00:00:00Z,NA,H,2014-04-13T00:00:00Z,NA,H,17,168,152,2013-11-13,2014-04-13,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1206,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-13,2014-04-13,17,168,NA,0,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-11-13T00:00:00Z,NA,H,2014-04-13T00:00:00Z,NA,H,17,168,152,2013-11-13,2014-04-13,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1206,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-14,2014-04-26,169,181,NA,0,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2014-04-14T00:00:00Z,NA,H,2014-04-26T00:00:00Z,NA,H,169,181,13,2014-04-14,2014-04-26,0,0,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1206,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-14,2014-04-26,169,181,NA,0,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2014-04-14T00:00:00Z,NA,H,2014-04-26T00:00:00Z,NA,H,169,181,13,2014-04-14,2014-04-26,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1206,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-14,2014-04-26,169,181,NA,0,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2014-04-14T00:00:00Z,NA,H,2014-04-26T00:00:00Z,NA,H,169,181,13,2014-04-14,2014-04-26,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1206,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-14,2014-04-26,169,181,NA,0,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2014-04-14T00:00:00Z,NA,H,2014-04-26T00:00:00Z,NA,H,169,181,13,2014-04-14,2014-04-26,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-707-1206,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-14,2014-04-26,169,181,NA,0,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2014-04-14T00:00:00Z,NA,H,2014-04-26T00:00:00Z,NA,H,169,181,13,2014-04-14,2014-04-26,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-10-28T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-10-28,2014-04-26,NA,NA,TDURD,181,NA,OVERALL,Overall duration (days),7,>=90 days,16,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-10-28T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-10-28,2014-04-26,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-10-28T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-10-28,2014-04-26,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-10-28T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-10-28,2014-04-26,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-10-28T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-10-28,2014-04-26,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-10-28T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-10-28,2014-04-26,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-10-28T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-10-28,2014-04-26,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-11-13T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-11-13,2014-04-26,NA,NA,PDURD,165,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-11-13T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-11-13,2014-04-26,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-11-13T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-11-13,2014-04-26,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-11-13T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-11-13,2014-04-26,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-11-13T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-11-13,2014-04-26,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-11-13T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-11-13,2014-04-26,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-707-1206,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-28,2013-10-28T00:00:00Z,2014-04-26T23:59:59Z,2013-11-13T00:00:00Z,NA,NA,2014-04-26T00:00:00Z,NA,NA,NA,NA,NA,2013-11-13,2014-04-26,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1206,2013-10-28,2014-04-27,2013-10-28,2014-04-26,NA,2014-04-27T08:00,NA,NA,707,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-20,-8,Placebo,Placebo,H,H,2014-04-26,181,NA,2014-04-27,COMPLETED,NA,2013-10-28,NA,NA,NA,2014-04-27,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1019,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-20,2014-01-01,1,13,NA,54,2013-12-20,2013-12-20T00:00:00Z,2014-01-01T23:59:59Z,2013-12-20T00:00:00Z,NA,H,2014-01-01T00:00:00Z,NA,H,1,13,13,2013-12-20,2014-01-01,702,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-01,13,NA,2014-01-23,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1019,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-20,2014-01-01,1,13,NA,54,2013-12-20,2013-12-20T00:00:00Z,2014-01-01T23:59:59Z,2013-12-20T00:00:00Z,NA,H,2014-01-01T00:00:00Z,NA,H,1,13,13,2013-12-20,2014-01-01,702,702,DOSE,702,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-01,13,NA,2014-01-23,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1019,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-20,2014-01-01,1,13,NA,54,2013-12-20,2013-12-20T00:00:00Z,2014-01-01T23:59:59Z,2013-12-20T00:00:00Z,NA,H,2014-01-01T00:00:00Z,NA,H,1,13,13,2013-12-20,2014-01-01,702,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-01,13,NA,2014-01-23,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1019,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-20,2014-01-01,1,13,NA,54,2013-12-20,2013-12-20T00:00:00Z,2014-01-01T23:59:59Z,2013-12-20T00:00:00Z,NA,H,2014-01-01T00:00:00Z,NA,H,1,13,13,2013-12-20,2014-01-01,702,702,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-01,13,NA,2014-01-23,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1019,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-20,2014-01-01,1,13,NA,54,2013-12-20,2013-12-20T00:00:00Z,2014-01-01T23:59:59Z,2013-12-20T00:00:00Z,NA,H,2014-01-01T00:00:00Z,NA,H,1,13,13,2013-12-20,2014-01-01,702,702,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-01,13,NA,2014-01-23,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1019,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2014-01-01T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2014-01-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2014-01-01,NA,NA,TDURD,13,NA,OVERALL,Overall duration (days),7,< 30 days,6,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-01,13,NA,2014-01-23,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1019,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2014-01-01T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2014-01-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2014-01-01,NA,NA,TDOSE,702,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-01,13,NA,2014-01-23,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1019,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2014-01-01T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2014-01-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2014-01-01,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-01,13,NA,2014-01-23,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1019,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2014-01-01T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2014-01-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2014-01-01,NA,NA,TPDOSE,702,NA,OVERALL,Total planned dose (mg),11,NA,9,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-01,13,NA,2014-01-23,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1019,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2014-01-01T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2014-01-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2014-01-01,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-01,13,NA,2014-01-23,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1019,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2014-01-01T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2014-01-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2014-01-01,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-01,13,NA,2014-01-23,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1019,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-20,2013-12-20T00:00:00Z,2014-01-01T23:59:59Z,2013-12-20T00:00:00Z,NA,NA,2014-01-01T00:00:00Z,NA,NA,NA,NA,NA,2013-12-20,2014-01-01,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1019,2013-12-20,2014-01-23,2013-12-20,2014-01-01,NA,2014-01-23T10:10,NA,NA,708,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-10,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-01,13,NA,2014-01-23,DISCONTINUED,NA,2013-12-20,NA,NA,NA,2014-01-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1032,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-09,2013-02-23,1,15,NA,54,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-09T00:00:00Z,NA,H,2013-02-23T00:00:00Z,NA,H,1,15,15,2013-02-09,2013-02-23,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1032,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-09,2013-02-23,1,15,NA,54,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-09T00:00:00Z,NA,H,2013-02-23T00:00:00Z,NA,H,1,15,15,2013-02-09,2013-02-23,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1032,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-09,2013-02-23,1,15,NA,54,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-09T00:00:00Z,NA,H,2013-02-23T00:00:00Z,NA,H,1,15,15,2013-02-09,2013-02-23,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1032,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-09,2013-02-23,1,15,NA,54,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-09T00:00:00Z,NA,H,2013-02-23T00:00:00Z,NA,H,1,15,15,2013-02-09,2013-02-23,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1032,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-09,2013-02-23,1,15,NA,54,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-09T00:00:00Z,NA,H,2013-02-23T00:00:00Z,NA,H,1,15,15,2013-02-09,2013-02-23,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1032,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-24,2013-03-01,16,21,NA,54,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-24T00:00:00Z,NA,H,2013-03-01T00:00:00Z,NA,H,16,21,6,2013-02-24,2013-03-01,324,324,DURD,6,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1032,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-24,2013-03-01,16,21,NA,54,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-24T00:00:00Z,NA,H,2013-03-01T00:00:00Z,NA,H,16,21,6,2013-02-24,2013-03-01,324,324,DOSE,324,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1032,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-24,2013-03-01,16,21,NA,54,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-24T00:00:00Z,NA,H,2013-03-01T00:00:00Z,NA,H,16,21,6,2013-02-24,2013-03-01,324,324,PLDOSE,324,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1032,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-24,2013-03-01,16,21,NA,54,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-24T00:00:00Z,NA,H,2013-03-01T00:00:00Z,NA,H,16,21,6,2013-02-24,2013-03-01,324,324,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1032,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-24,2013-03-01,16,21,NA,54,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-24T00:00:00Z,NA,H,2013-03-01T00:00:00Z,NA,H,16,21,6,2013-02-24,2013-03-01,324,324,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-03-01,NA,NA,TDURD,21,NA,OVERALL,Overall duration (days),7,< 30 days,11,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-03-01,NA,NA,TDOSE,1134,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-03-01,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-03-01,NA,NA,TPDOSE,1134,NA,OVERALL,Total planned dose (mg),11,NA,14,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-03-01,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-03-01,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-03-01,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-24T00:00:00Z,NA,NA,2013-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-02-24,2013-03-01,NA,NA,PDURD,6,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-24T00:00:00Z,NA,NA,2013-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-02-24,2013-03-01,NA,NA,PDOSE,324,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-24T00:00:00Z,NA,NA,2013-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-02-24,2013-03-01,NA,NA,PPDOSE,324,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-24T00:00:00Z,NA,NA,2013-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-02-24,2013-03-01,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-24T00:00:00Z,NA,NA,2013-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-02-24,2013-03-01,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-24T00:00:00Z,NA,NA,2013-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-02-24,2013-03-01,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1032,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-03-01T23:59:59Z,2013-02-24T00:00:00Z,NA,NA,2013-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-02-24,2013-03-01,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1032,2013-02-09,2013-03-09,2013-02-09,2013-03-01,NA,2013-03-09T10:45,NA,NA,708,62,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-01,21,NA,2013-03-09,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-03-09,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1084,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-09,2013-05-23,1,15,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-09T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,1,15,15,2013-05-09,2013-05-23,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1084,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-09,2013-05-23,1,15,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-09T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,1,15,15,2013-05-09,2013-05-23,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1084,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-09,2013-05-23,1,15,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-09T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,1,15,15,2013-05-09,2013-05-23,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1084,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-09,2013-05-23,1,15,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-09T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,1,15,15,2013-05-09,2013-05-23,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1084,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-09,2013-05-23,1,15,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-09T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,1,15,15,2013-05-09,2013-05-23,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1084,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-24,2013-10-28,16,173,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-24T00:00:00Z,NA,H,2013-10-28T00:00:00Z,NA,H,16,173,158,2013-05-24,2013-10-28,8532,8532,DURD,158,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1084,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-24,2013-10-28,16,173,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-24T00:00:00Z,NA,H,2013-10-28T00:00:00Z,NA,H,16,173,158,2013-05-24,2013-10-28,8532,8532,DOSE,8532,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1084,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-24,2013-10-28,16,173,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-24T00:00:00Z,NA,H,2013-10-28T00:00:00Z,NA,H,16,173,158,2013-05-24,2013-10-28,8532,8532,PLDOSE,8532,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1084,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-24,2013-10-28,16,173,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-24T00:00:00Z,NA,H,2013-10-28T00:00:00Z,NA,H,16,173,158,2013-05-24,2013-10-28,8532,8532,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1084,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-24,2013-10-28,16,173,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-24T00:00:00Z,NA,H,2013-10-28T00:00:00Z,NA,H,16,173,158,2013-05-24,2013-10-28,8532,8532,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1084,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-29,2013-11-11,174,187,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-10-29T00:00:00Z,NA,H,2013-11-11T00:00:00Z,NA,H,174,187,14,2013-10-29,2013-11-11,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1084,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-29,2013-11-11,174,187,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-10-29T00:00:00Z,NA,H,2013-11-11T00:00:00Z,NA,H,174,187,14,2013-10-29,2013-11-11,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1084,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-29,2013-11-11,174,187,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-10-29T00:00:00Z,NA,H,2013-11-11T00:00:00Z,NA,H,174,187,14,2013-10-29,2013-11-11,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1084,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-29,2013-11-11,174,187,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-10-29T00:00:00Z,NA,H,2013-11-11T00:00:00Z,NA,H,174,187,14,2013-10-29,2013-11-11,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1084,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-29,2013-11-11,174,187,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-10-29T00:00:00Z,NA,H,2013-11-11T00:00:00Z,NA,H,174,187,14,2013-10-29,2013-11-11,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-11-11T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-11-11,NA,NA,TDURD,187,NA,OVERALL,Overall duration (days),7,>=90 days,16,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-11-11T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-11-11,NA,NA,TDOSE,10098,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-11-11T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-11-11,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-11-11T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-11-11,NA,NA,TPDOSE,10098,NA,OVERALL,Total planned dose (mg),11,NA,19,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-11-11T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-11-11,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-11-11T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-11-11,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-11-11T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-11-11,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-24T00:00:00Z,NA,NA,2013-11-11T00:00:00Z,NA,NA,NA,NA,NA,2013-05-24,2013-11-11,NA,NA,PDURD,172,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-24T00:00:00Z,NA,NA,2013-11-11T00:00:00Z,NA,NA,NA,NA,NA,2013-05-24,2013-11-11,NA,NA,PDOSE,9288,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-24T00:00:00Z,NA,NA,2013-11-11T00:00:00Z,NA,NA,NA,NA,NA,2013-05-24,2013-11-11,NA,NA,PPDOSE,9288,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-24T00:00:00Z,NA,NA,2013-11-11T00:00:00Z,NA,NA,NA,NA,NA,2013-05-24,2013-11-11,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-24T00:00:00Z,NA,NA,2013-11-11T00:00:00Z,NA,NA,NA,NA,NA,2013-05-24,2013-11-11,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-24T00:00:00Z,NA,NA,2013-11-11T00:00:00Z,NA,NA,NA,NA,NA,2013-05-24,2013-11-11,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1084,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-11-11T23:59:59Z,2013-05-24T00:00:00Z,NA,NA,2013-11-11T00:00:00Z,NA,NA,NA,NA,NA,2013-05-24,2013-11-11,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1084,2013-05-09,2013-11-11,2013-05-09,2013-11-11,NA,2013-11-11T10:00,NA,NA,708,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-01,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-11-11,187,NA,2013-11-11,COMPLETED,NA,2013-05-09,NA,NA,NA,2013-11-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1087,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-22,2012-11-05,1,15,NA,0,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-10-22T00:00:00Z,NA,H,2012-11-05T00:00:00Z,NA,H,1,15,15,2012-10-22,2012-11-05,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1087,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-22,2012-11-05,1,15,NA,0,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-10-22T00:00:00Z,NA,H,2012-11-05T00:00:00Z,NA,H,1,15,15,2012-10-22,2012-11-05,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1087,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-22,2012-11-05,1,15,NA,0,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-10-22T00:00:00Z,NA,H,2012-11-05T00:00:00Z,NA,H,1,15,15,2012-10-22,2012-11-05,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1087,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-22,2012-11-05,1,15,NA,0,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-10-22T00:00:00Z,NA,H,2012-11-05T00:00:00Z,NA,H,1,15,15,2012-10-22,2012-11-05,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1087,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-22,2012-11-05,1,15,NA,0,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-10-22T00:00:00Z,NA,H,2012-11-05T00:00:00Z,NA,H,1,15,15,2012-10-22,2012-11-05,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1087,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-06,2013-04-10,16,171,NA,0,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-11-06T00:00:00Z,NA,H,2013-04-10T00:00:00Z,NA,H,16,171,156,2012-11-06,2013-04-10,0,0,DURD,156,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1087,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-06,2013-04-10,16,171,NA,0,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-11-06T00:00:00Z,NA,H,2013-04-10T00:00:00Z,NA,H,16,171,156,2012-11-06,2013-04-10,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1087,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-06,2013-04-10,16,171,NA,0,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-11-06T00:00:00Z,NA,H,2013-04-10T00:00:00Z,NA,H,16,171,156,2012-11-06,2013-04-10,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1087,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-06,2013-04-10,16,171,NA,0,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-11-06T00:00:00Z,NA,H,2013-04-10T00:00:00Z,NA,H,16,171,156,2012-11-06,2013-04-10,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1087,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-06,2013-04-10,16,171,NA,0,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-11-06T00:00:00Z,NA,H,2013-04-10T00:00:00Z,NA,H,16,171,156,2012-11-06,2013-04-10,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1087,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-11,2013-04-28,172,189,NA,0,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2013-04-11T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,172,189,18,2013-04-11,2013-04-28,0,0,DURD,18,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1087,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-11,2013-04-28,172,189,NA,0,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2013-04-11T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,172,189,18,2013-04-11,2013-04-28,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1087,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-11,2013-04-28,172,189,NA,0,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2013-04-11T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,172,189,18,2013-04-11,2013-04-28,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1087,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-11,2013-04-28,172,189,NA,0,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2013-04-11T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,172,189,18,2013-04-11,2013-04-28,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1087,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-11,2013-04-28,172,189,NA,0,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2013-04-11T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,172,189,18,2013-04-11,2013-04-28,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-10-22T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-22,2013-04-28,NA,NA,TDURD,189,NA,OVERALL,Overall duration (days),7,>=90 days,16,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-10-22T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-22,2013-04-28,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-10-22T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-22,2013-04-28,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-10-22T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-22,2013-04-28,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-10-22T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-22,2013-04-28,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-10-22T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-22,2013-04-28,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-10-22T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-10-22,2013-04-28,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-11-06T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-06,2013-04-28,NA,NA,PDURD,174,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-11-06T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-06,2013-04-28,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-11-06T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-06,2013-04-28,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-11-06T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-06,2013-04-28,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-11-06T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-06,2013-04-28,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-11-06T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-06,2013-04-28,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1087,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-22,2012-10-22T00:00:00Z,2013-04-28T23:59:59Z,2012-11-06T00:00:00Z,NA,NA,2013-04-28T00:00:00Z,NA,NA,NA,NA,NA,2012-11-06,2013-04-28,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1087,2012-10-22,2013-04-28,2012-10-22,2013-04-28,NA,2013-04-28T12:40,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-10-06,-16,Placebo,Placebo,H,H,2013-04-28,189,NA,2013-04-28,COMPLETED,NA,2012-10-22,NA,NA,NA,2013-04-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1158,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-08,2014-02-26,1,19,NA,0,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-08T00:00:00Z,NA,H,2014-02-26T00:00:00Z,NA,H,1,19,19,2014-02-08,2014-02-26,0,0,DURD,19,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1158,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-08,2014-02-26,1,19,NA,0,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-08T00:00:00Z,NA,H,2014-02-26T00:00:00Z,NA,H,1,19,19,2014-02-08,2014-02-26,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1158,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-08,2014-02-26,1,19,NA,0,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-08T00:00:00Z,NA,H,2014-02-26T00:00:00Z,NA,H,1,19,19,2014-02-08,2014-02-26,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1158,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-08,2014-02-26,1,19,NA,0,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-08T00:00:00Z,NA,H,2014-02-26T00:00:00Z,NA,H,1,19,19,2014-02-08,2014-02-26,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1158,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-08,2014-02-26,1,19,NA,0,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-08T00:00:00Z,NA,H,2014-02-26T00:00:00Z,NA,H,1,19,19,2014-02-08,2014-02-26,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1158,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-27,2014-03-21,20,42,NA,0,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-27T00:00:00Z,NA,H,2014-03-21T00:00:00Z,NA,H,20,42,23,2014-02-27,2014-03-21,0,0,DURD,23,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1158,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-27,2014-03-21,20,42,NA,0,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-27T00:00:00Z,NA,H,2014-03-21T00:00:00Z,NA,H,20,42,23,2014-02-27,2014-03-21,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1158,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-27,2014-03-21,20,42,NA,0,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-27T00:00:00Z,NA,H,2014-03-21T00:00:00Z,NA,H,20,42,23,2014-02-27,2014-03-21,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1158,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-27,2014-03-21,20,42,NA,0,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-27T00:00:00Z,NA,H,2014-03-21T00:00:00Z,NA,H,20,42,23,2014-02-27,2014-03-21,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1158,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-27,2014-03-21,20,42,NA,0,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-27T00:00:00Z,NA,H,2014-03-21T00:00:00Z,NA,H,20,42,23,2014-02-27,2014-03-21,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-08T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-08,2014-03-21,NA,NA,TDURD,42,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-08T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-08,2014-03-21,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-08T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-08,2014-03-21,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-08T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-08,2014-03-21,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-08T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-08,2014-03-21,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-08T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-08,2014-03-21,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-08T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-08,2014-03-21,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-27T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-27,2014-03-21,NA,NA,PDURD,23,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-27T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-27,2014-03-21,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-27T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-27,2014-03-21,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-27T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-27,2014-03-21,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-27T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-27,2014-03-21,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-27T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-27,2014-03-21,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1158,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-08,2014-02-08T00:00:00Z,2014-03-21T23:59:59Z,2014-02-27T00:00:00Z,NA,NA,2014-03-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-27,2014-03-21,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1158,2014-02-08,2014-03-22,2014-02-08,2014-03-21,NA,2014-03-22T11:15,NA,NA,708,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-01,-7,Placebo,Placebo,H,H,2014-03-21,42,NA,2014-03-22,DISCONTINUED,NA,2014-02-08,NA,NA,NA,2014-03-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1171,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-06,2012-12-18,1,13,NA,0,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-06T00:00:00Z,NA,H,2012-12-18T00:00:00Z,NA,H,1,13,13,2012-12-06,2012-12-18,0,0,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1171,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-06,2012-12-18,1,13,NA,0,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-06T00:00:00Z,NA,H,2012-12-18T00:00:00Z,NA,H,1,13,13,2012-12-06,2012-12-18,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1171,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-06,2012-12-18,1,13,NA,0,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-06T00:00:00Z,NA,H,2012-12-18T00:00:00Z,NA,H,1,13,13,2012-12-06,2012-12-18,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1171,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-06,2012-12-18,1,13,NA,0,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-06T00:00:00Z,NA,H,2012-12-18T00:00:00Z,NA,H,1,13,13,2012-12-06,2012-12-18,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1171,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-06,2012-12-18,1,13,NA,0,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-06T00:00:00Z,NA,H,2012-12-18T00:00:00Z,NA,H,1,13,13,2012-12-06,2012-12-18,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1171,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-19,2013-05-20,14,166,NA,0,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-19T00:00:00Z,NA,H,2013-05-20T00:00:00Z,NA,H,14,166,153,2012-12-19,2013-05-20,0,0,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1171,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-19,2013-05-20,14,166,NA,0,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-19T00:00:00Z,NA,H,2013-05-20T00:00:00Z,NA,H,14,166,153,2012-12-19,2013-05-20,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1171,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-19,2013-05-20,14,166,NA,0,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-19T00:00:00Z,NA,H,2013-05-20T00:00:00Z,NA,H,14,166,153,2012-12-19,2013-05-20,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1171,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-19,2013-05-20,14,166,NA,0,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-19T00:00:00Z,NA,H,2013-05-20T00:00:00Z,NA,H,14,166,153,2012-12-19,2013-05-20,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1171,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-19,2013-05-20,14,166,NA,0,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-19T00:00:00Z,NA,H,2013-05-20T00:00:00Z,NA,H,14,166,153,2012-12-19,2013-05-20,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1171,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-21,2013-06-04,167,181,NA,0,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2013-05-21T00:00:00Z,NA,H,2013-06-04T00:00:00Z,NA,H,167,181,15,2013-05-21,2013-06-04,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1171,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-21,2013-06-04,167,181,NA,0,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2013-05-21T00:00:00Z,NA,H,2013-06-04T00:00:00Z,NA,H,167,181,15,2013-05-21,2013-06-04,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1171,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-21,2013-06-04,167,181,NA,0,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2013-05-21T00:00:00Z,NA,H,2013-06-04T00:00:00Z,NA,H,167,181,15,2013-05-21,2013-06-04,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1171,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-21,2013-06-04,167,181,NA,0,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2013-05-21T00:00:00Z,NA,H,2013-06-04T00:00:00Z,NA,H,167,181,15,2013-05-21,2013-06-04,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1171,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-21,2013-06-04,167,181,NA,0,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2013-05-21T00:00:00Z,NA,H,2013-06-04T00:00:00Z,NA,H,167,181,15,2013-05-21,2013-06-04,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-06T00:00:00Z,NA,NA,2013-06-04T00:00:00Z,NA,NA,NA,NA,NA,2012-12-06,2013-06-04,NA,NA,TDURD,181,NA,OVERALL,Overall duration (days),7,>=90 days,16,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-06T00:00:00Z,NA,NA,2013-06-04T00:00:00Z,NA,NA,NA,NA,NA,2012-12-06,2013-06-04,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-06T00:00:00Z,NA,NA,2013-06-04T00:00:00Z,NA,NA,NA,NA,NA,2012-12-06,2013-06-04,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-06T00:00:00Z,NA,NA,2013-06-04T00:00:00Z,NA,NA,NA,NA,NA,2012-12-06,2013-06-04,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-06T00:00:00Z,NA,NA,2013-06-04T00:00:00Z,NA,NA,NA,NA,NA,2012-12-06,2013-06-04,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-06T00:00:00Z,NA,NA,2013-06-04T00:00:00Z,NA,NA,NA,NA,NA,2012-12-06,2013-06-04,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-06T00:00:00Z,NA,NA,2013-06-04T00:00:00Z,NA,NA,NA,NA,NA,2012-12-06,2013-06-04,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-19T00:00:00Z,NA,NA,2013-06-04T00:00:00Z,NA,NA,NA,NA,NA,2012-12-19,2013-06-04,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-19T00:00:00Z,NA,NA,2013-06-04T00:00:00Z,NA,NA,NA,NA,NA,2012-12-19,2013-06-04,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-19T00:00:00Z,NA,NA,2013-06-04T00:00:00Z,NA,NA,NA,NA,NA,2012-12-19,2013-06-04,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-19T00:00:00Z,NA,NA,2013-06-04T00:00:00Z,NA,NA,NA,NA,NA,2012-12-19,2013-06-04,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-19T00:00:00Z,NA,NA,2013-06-04T00:00:00Z,NA,NA,NA,NA,NA,2012-12-19,2013-06-04,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-19T00:00:00Z,NA,NA,2013-06-04T00:00:00Z,NA,NA,NA,NA,NA,2012-12-19,2013-06-04,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1171,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-06,2012-12-06T00:00:00Z,2013-06-04T23:59:59Z,2012-12-19T00:00:00Z,NA,NA,2013-06-04T00:00:00Z,NA,NA,NA,NA,NA,2012-12-19,2013-06-04,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1171,2012-12-06,2013-06-04,2012-12-06,2013-06-04,NA,2013-06-04,NA,NA,708,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-25,-11,Placebo,Placebo,H,H,2013-06-04,181,NA,2013-06-04,COMPLETED,NA,2012-12-06,NA,NA,NA,2013-06-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1178,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-29,2014-01-18,1,21,NA,54,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2013-12-29T00:00:00Z,NA,H,2014-01-18T00:00:00Z,NA,H,1,21,21,2013-12-29,2014-01-18,1134,1134,DURD,21,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1178,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-29,2014-01-18,1,21,NA,54,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2013-12-29T00:00:00Z,NA,H,2014-01-18T00:00:00Z,NA,H,1,21,21,2013-12-29,2014-01-18,1134,1134,DOSE,1134,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1178,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-29,2014-01-18,1,21,NA,54,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2013-12-29T00:00:00Z,NA,H,2014-01-18T00:00:00Z,NA,H,1,21,21,2013-12-29,2014-01-18,1134,1134,PLDOSE,1134,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1178,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-29,2014-01-18,1,21,NA,54,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2013-12-29T00:00:00Z,NA,H,2014-01-18T00:00:00Z,NA,H,1,21,21,2013-12-29,2014-01-18,1134,1134,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1178,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-29,2014-01-18,1,21,NA,54,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2013-12-29T00:00:00Z,NA,H,2014-01-18T00:00:00Z,NA,H,1,21,21,2013-12-29,2014-01-18,1134,1134,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1178,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-19,2014-04-06,22,99,NA,54,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2014-01-19T00:00:00Z,NA,H,2014-04-06T00:00:00Z,NA,H,22,99,78,2014-01-19,2014-04-06,6318,4212,DURD,78,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1178,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-19,2014-04-06,22,99,NA,54,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2014-01-19T00:00:00Z,NA,H,2014-04-06T00:00:00Z,NA,H,22,99,78,2014-01-19,2014-04-06,6318,4212,DOSE,6318,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1178,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-19,2014-04-06,22,99,NA,54,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2014-01-19T00:00:00Z,NA,H,2014-04-06T00:00:00Z,NA,H,22,99,78,2014-01-19,2014-04-06,6318,4212,PLDOSE,4212,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1178,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-19,2014-04-06,22,99,NA,54,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2014-01-19T00:00:00Z,NA,H,2014-04-06T00:00:00Z,NA,H,22,99,78,2014-01-19,2014-04-06,6318,4212,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1178,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-19,2014-04-06,22,99,NA,54,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2014-01-19T00:00:00Z,NA,H,2014-04-06T00:00:00Z,NA,H,22,99,78,2014-01-19,2014-04-06,6318,4212,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1178,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2013-12-29T00:00:00Z,NA,NA,2014-04-06T00:00:00Z,NA,NA,NA,NA,NA,2013-12-29,2014-04-06,NA,NA,TDURD,99,NA,OVERALL,Overall duration (days),7,>=90 days,11,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1178,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2013-12-29T00:00:00Z,NA,NA,2014-04-06T00:00:00Z,NA,NA,NA,NA,NA,2013-12-29,2014-04-06,NA,NA,TDOSE,7452,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1178,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2013-12-29T00:00:00Z,NA,NA,2014-04-06T00:00:00Z,NA,NA,NA,NA,NA,2013-12-29,2014-04-06,NA,NA,AVDDSE,75.27272727272727,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1178,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2013-12-29T00:00:00Z,NA,NA,2014-04-06T00:00:00Z,NA,NA,NA,NA,NA,2013-12-29,2014-04-06,NA,NA,TPDOSE,5346,NA,OVERALL,Total planned dose (mg),11,NA,14,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1178,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2013-12-29T00:00:00Z,NA,NA,2014-04-06T00:00:00Z,NA,NA,NA,NA,NA,2013-12-29,2014-04-06,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1178,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2013-12-29T00:00:00Z,NA,NA,2014-04-06T00:00:00Z,NA,NA,NA,NA,NA,2013-12-29,2014-04-06,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1178,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2013-12-29T00:00:00Z,NA,NA,2014-04-06T00:00:00Z,NA,NA,NA,NA,NA,2013-12-29,2014-04-06,NA,NA,TDOSINT,139.3939393939394,NA,OVERALL,Overall dose intensity (%),90,NA,17,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1178,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2014-01-19T00:00:00Z,NA,NA,2014-04-06T00:00:00Z,NA,NA,NA,NA,NA,2014-01-19,2014-04-06,NA,NA,PDURD,78,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1178,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2014-01-19T00:00:00Z,NA,NA,2014-04-06T00:00:00Z,NA,NA,NA,NA,NA,2014-01-19,2014-04-06,NA,NA,PDOSE,6318,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1178,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2014-01-19T00:00:00Z,NA,NA,2014-04-06T00:00:00Z,NA,NA,NA,NA,NA,2014-01-19,2014-04-06,NA,NA,PPDOSE,4212,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1178,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2014-01-19T00:00:00Z,NA,NA,2014-04-06T00:00:00Z,NA,NA,NA,NA,NA,2014-01-19,2014-04-06,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1178,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2014-01-19T00:00:00Z,NA,NA,2014-04-06T00:00:00Z,NA,NA,NA,NA,NA,2014-01-19,2014-04-06,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1178,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2014-01-19T00:00:00Z,NA,NA,2014-04-06T00:00:00Z,NA,NA,NA,NA,NA,2014-01-19,2014-04-06,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1178,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-29,2013-12-29T00:00:00Z,2014-04-06T23:59:59Z,2014-01-19T00:00:00Z,NA,NA,2014-04-06T00:00:00Z,NA,NA,NA,NA,NA,2014-01-19,2014-04-06,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1178,2013-12-29,2014-04-06,2013-12-29,2014-04-06,NA,2014-04-06T08:50,NA,NA,708,77,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-13,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-06,99,NA,2014-04-06,DISCONTINUED,NA,2013-12-29,NA,NA,NA,2014-04-06,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1213,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-09,2013-02-22,1,14,NA,54,2013-02-09,2013-02-09T00:00:00Z,2013-02-22T23:59:59Z,2013-02-09T00:00:00Z,NA,H,2013-02-22T00:00:00Z,NA,H,1,14,14,2013-02-09,2013-02-22,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1213,2013-02-09,2013-02-26,2013-02-09,2013-02-22,NA,2013-02-26,NA,NA,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-01,-8,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-22,14,NA,2013-02-26,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-02-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1213,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-09,2013-02-22,1,14,NA,54,2013-02-09,2013-02-09T00:00:00Z,2013-02-22T23:59:59Z,2013-02-09T00:00:00Z,NA,H,2013-02-22T00:00:00Z,NA,H,1,14,14,2013-02-09,2013-02-22,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1213,2013-02-09,2013-02-26,2013-02-09,2013-02-22,NA,2013-02-26,NA,NA,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-01,-8,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-22,14,NA,2013-02-26,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-02-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1213,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-09,2013-02-22,1,14,NA,54,2013-02-09,2013-02-09T00:00:00Z,2013-02-22T23:59:59Z,2013-02-09T00:00:00Z,NA,H,2013-02-22T00:00:00Z,NA,H,1,14,14,2013-02-09,2013-02-22,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1213,2013-02-09,2013-02-26,2013-02-09,2013-02-22,NA,2013-02-26,NA,NA,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-01,-8,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-22,14,NA,2013-02-26,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-02-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1213,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-09,2013-02-22,1,14,NA,54,2013-02-09,2013-02-09T00:00:00Z,2013-02-22T23:59:59Z,2013-02-09T00:00:00Z,NA,H,2013-02-22T00:00:00Z,NA,H,1,14,14,2013-02-09,2013-02-22,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1213,2013-02-09,2013-02-26,2013-02-09,2013-02-22,NA,2013-02-26,NA,NA,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-01,-8,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-22,14,NA,2013-02-26,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-02-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1213,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-09,2013-02-22,1,14,NA,54,2013-02-09,2013-02-09T00:00:00Z,2013-02-22T23:59:59Z,2013-02-09T00:00:00Z,NA,H,2013-02-22T00:00:00Z,NA,H,1,14,14,2013-02-09,2013-02-22,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1213,2013-02-09,2013-02-26,2013-02-09,2013-02-22,NA,2013-02-26,NA,NA,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-01,-8,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-22,14,NA,2013-02-26,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-02-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1213,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-02-22T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-02-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-02-22,NA,NA,TDURD,14,NA,OVERALL,Overall duration (days),7,< 30 days,6,1213,2013-02-09,2013-02-26,2013-02-09,2013-02-22,NA,2013-02-26,NA,NA,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-01,-8,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-22,14,NA,2013-02-26,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-02-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1213,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-02-22T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-02-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-02-22,NA,NA,TDOSE,756,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1213,2013-02-09,2013-02-26,2013-02-09,2013-02-22,NA,2013-02-26,NA,NA,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-01,-8,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-22,14,NA,2013-02-26,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-02-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1213,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-02-22T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-02-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-02-22,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1213,2013-02-09,2013-02-26,2013-02-09,2013-02-22,NA,2013-02-26,NA,NA,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-01,-8,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-22,14,NA,2013-02-26,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-02-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1213,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-02-22T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-02-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-02-22,NA,NA,TPDOSE,756,NA,OVERALL,Total planned dose (mg),11,NA,9,1213,2013-02-09,2013-02-26,2013-02-09,2013-02-22,NA,2013-02-26,NA,NA,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-01,-8,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-22,14,NA,2013-02-26,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-02-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1213,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-02-22T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-02-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-02-22,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1213,2013-02-09,2013-02-26,2013-02-09,2013-02-22,NA,2013-02-26,NA,NA,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-01,-8,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-22,14,NA,2013-02-26,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-02-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1213,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-02-22T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-02-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-02-22,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1213,2013-02-09,2013-02-26,2013-02-09,2013-02-22,NA,2013-02-26,NA,NA,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-01,-8,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-22,14,NA,2013-02-26,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-02-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1213,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-09,2013-02-09T00:00:00Z,2013-02-22T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-02-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-02-22,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1213,2013-02-09,2013-02-26,2013-02-09,2013-02-22,NA,2013-02-26,NA,NA,708,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-01,-8,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-22,14,NA,2013-02-26,DISCONTINUED,NA,2013-02-09,NA,NA,NA,2013-02-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1216,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-24,2012-11-08,1,16,NA,54,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-10-24T00:00:00Z,NA,H,2012-11-08T00:00:00Z,NA,H,1,16,16,2012-10-24,2012-11-08,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1216,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-24,2012-11-08,1,16,NA,54,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-10-24T00:00:00Z,NA,H,2012-11-08T00:00:00Z,NA,H,1,16,16,2012-10-24,2012-11-08,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1216,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-24,2012-11-08,1,16,NA,54,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-10-24T00:00:00Z,NA,H,2012-11-08T00:00:00Z,NA,H,1,16,16,2012-10-24,2012-11-08,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1216,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-24,2012-11-08,1,16,NA,54,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-10-24T00:00:00Z,NA,H,2012-11-08T00:00:00Z,NA,H,1,16,16,2012-10-24,2012-11-08,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1216,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-24,2012-11-08,1,16,NA,54,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-10-24T00:00:00Z,NA,H,2012-11-08T00:00:00Z,NA,H,1,16,16,2012-10-24,2012-11-08,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1216,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-09,2012-11-29,17,37,NA,54,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-11-09T00:00:00Z,NA,H,2012-11-29T00:00:00Z,NA,H,17,37,21,2012-11-09,2012-11-29,1701,1134,DURD,21,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1216,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-09,2012-11-29,17,37,NA,54,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-11-09T00:00:00Z,NA,H,2012-11-29T00:00:00Z,NA,H,17,37,21,2012-11-09,2012-11-29,1701,1134,DOSE,1701,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1216,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-09,2012-11-29,17,37,NA,54,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-11-09T00:00:00Z,NA,H,2012-11-29T00:00:00Z,NA,H,17,37,21,2012-11-09,2012-11-29,1701,1134,PLDOSE,1134,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1216,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-09,2012-11-29,17,37,NA,54,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-11-09T00:00:00Z,NA,H,2012-11-29T00:00:00Z,NA,H,17,37,21,2012-11-09,2012-11-29,1701,1134,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1216,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-09,2012-11-29,17,37,NA,54,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-11-09T00:00:00Z,NA,H,2012-11-29T00:00:00Z,NA,H,17,37,21,2012-11-09,2012-11-29,1701,1134,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-10-24T00:00:00Z,NA,NA,2012-11-29T00:00:00Z,NA,NA,NA,NA,NA,2012-10-24,2012-11-29,NA,NA,TDURD,37,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-10-24T00:00:00Z,NA,NA,2012-11-29T00:00:00Z,NA,NA,NA,NA,NA,2012-10-24,2012-11-29,NA,NA,TDOSE,2565,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-10-24T00:00:00Z,NA,NA,2012-11-29T00:00:00Z,NA,NA,NA,NA,NA,2012-10-24,2012-11-29,NA,NA,AVDDSE,69.32432432432432,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-10-24T00:00:00Z,NA,NA,2012-11-29T00:00:00Z,NA,NA,NA,NA,NA,2012-10-24,2012-11-29,NA,NA,TPDOSE,1998,NA,OVERALL,Total planned dose (mg),11,NA,14,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-10-24T00:00:00Z,NA,NA,2012-11-29T00:00:00Z,NA,NA,NA,NA,NA,2012-10-24,2012-11-29,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-10-24T00:00:00Z,NA,NA,2012-11-29T00:00:00Z,NA,NA,NA,NA,NA,2012-10-24,2012-11-29,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-10-24T00:00:00Z,NA,NA,2012-11-29T00:00:00Z,NA,NA,NA,NA,NA,2012-10-24,2012-11-29,NA,NA,TDOSINT,128.3783783783784,NA,OVERALL,Overall dose intensity (%),90,NA,17,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-11-09T00:00:00Z,NA,NA,2012-11-29T00:00:00Z,NA,NA,NA,NA,NA,2012-11-09,2012-11-29,NA,NA,PDURD,21,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-11-09T00:00:00Z,NA,NA,2012-11-29T00:00:00Z,NA,NA,NA,NA,NA,2012-11-09,2012-11-29,NA,NA,PDOSE,1701,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-11-09T00:00:00Z,NA,NA,2012-11-29T00:00:00Z,NA,NA,NA,NA,NA,2012-11-09,2012-11-29,NA,NA,PPDOSE,1134,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-11-09T00:00:00Z,NA,NA,2012-11-29T00:00:00Z,NA,NA,NA,NA,NA,2012-11-09,2012-11-29,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-11-09T00:00:00Z,NA,NA,2012-11-29T00:00:00Z,NA,NA,NA,NA,NA,2012-11-09,2012-11-29,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-11-09T00:00:00Z,NA,NA,2012-11-29T00:00:00Z,NA,NA,NA,NA,NA,2012-11-09,2012-11-29,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1216,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-24,2012-10-24T00:00:00Z,2012-11-29T23:59:59Z,2012-11-09T00:00:00Z,NA,NA,2012-11-29T00:00:00Z,NA,NA,NA,NA,NA,2012-11-09,2012-11-29,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1216,2012-10-24,2012-12-06,2012-10-24,2012-11-29,NA,2013-01-09,NA,NA,708,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-14,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-11-29,37,NA,2012-12-06,DISCONTINUED,NA,2012-10-24,NA,NA,NA,2012-12-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1236,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-21,2013-09-21,1,1,NA,54,2013-09-21,2013-09-21T00:00:00Z,2013-09-21T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-09-21T00:00:00Z,NA,H,1,1,1,2013-09-21,2013-09-21,54,54,DURD,1,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1236,2013-09-21,2013-09-26,2013-09-21,2013-09-21,NA,2013-09-26,NA,NA,708,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-08,-13,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-09-21,1,NA,2013-09-26,DISCONTINUED,NA,2013-09-21,NA,NA,NA,2013-09-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1236,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-21,2013-09-21,1,1,NA,54,2013-09-21,2013-09-21T00:00:00Z,2013-09-21T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-09-21T00:00:00Z,NA,H,1,1,1,2013-09-21,2013-09-21,54,54,DOSE,54,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1236,2013-09-21,2013-09-26,2013-09-21,2013-09-21,NA,2013-09-26,NA,NA,708,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-08,-13,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-09-21,1,NA,2013-09-26,DISCONTINUED,NA,2013-09-21,NA,NA,NA,2013-09-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1236,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-21,2013-09-21,1,1,NA,54,2013-09-21,2013-09-21T00:00:00Z,2013-09-21T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-09-21T00:00:00Z,NA,H,1,1,1,2013-09-21,2013-09-21,54,54,PLDOSE,54,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1236,2013-09-21,2013-09-26,2013-09-21,2013-09-21,NA,2013-09-26,NA,NA,708,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-08,-13,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-09-21,1,NA,2013-09-26,DISCONTINUED,NA,2013-09-21,NA,NA,NA,2013-09-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1236,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-21,2013-09-21,1,1,NA,54,2013-09-21,2013-09-21T00:00:00Z,2013-09-21T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-09-21T00:00:00Z,NA,H,1,1,1,2013-09-21,2013-09-21,54,54,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1236,2013-09-21,2013-09-26,2013-09-21,2013-09-21,NA,2013-09-26,NA,NA,708,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-08,-13,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-09-21,1,NA,2013-09-26,DISCONTINUED,NA,2013-09-21,NA,NA,NA,2013-09-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1236,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-21,2013-09-21,1,1,NA,54,2013-09-21,2013-09-21T00:00:00Z,2013-09-21T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-09-21T00:00:00Z,NA,H,1,1,1,2013-09-21,2013-09-21,54,54,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1236,2013-09-21,2013-09-26,2013-09-21,2013-09-21,NA,2013-09-26,NA,NA,708,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-08,-13,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-09-21,1,NA,2013-09-26,DISCONTINUED,NA,2013-09-21,NA,NA,NA,2013-09-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1236,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-09-21T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2013-09-21T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2013-09-21,NA,NA,TDURD,1,NA,OVERALL,Overall duration (days),7,< 30 days,6,1236,2013-09-21,2013-09-26,2013-09-21,2013-09-21,NA,2013-09-26,NA,NA,708,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-08,-13,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-09-21,1,NA,2013-09-26,DISCONTINUED,NA,2013-09-21,NA,NA,NA,2013-09-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1236,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-09-21T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2013-09-21T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2013-09-21,NA,NA,TDOSE,54,NA,OVERALL,Total dose administered (mg),8,< 100 mg,7,1236,2013-09-21,2013-09-26,2013-09-21,2013-09-21,NA,2013-09-26,NA,NA,708,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-08,-13,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-09-21,1,NA,2013-09-26,DISCONTINUED,NA,2013-09-21,NA,NA,NA,2013-09-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1236,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-09-21T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2013-09-21T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2013-09-21,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1236,2013-09-21,2013-09-26,2013-09-21,2013-09-21,NA,2013-09-26,NA,NA,708,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-08,-13,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-09-21,1,NA,2013-09-26,DISCONTINUED,NA,2013-09-21,NA,NA,NA,2013-09-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1236,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-09-21T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2013-09-21T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2013-09-21,NA,NA,TPDOSE,54,NA,OVERALL,Total planned dose (mg),11,NA,9,1236,2013-09-21,2013-09-26,2013-09-21,2013-09-21,NA,2013-09-26,NA,NA,708,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-08,-13,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-09-21,1,NA,2013-09-26,DISCONTINUED,NA,2013-09-21,NA,NA,NA,2013-09-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1236,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-09-21T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2013-09-21T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2013-09-21,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1236,2013-09-21,2013-09-26,2013-09-21,2013-09-21,NA,2013-09-26,NA,NA,708,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-08,-13,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-09-21,1,NA,2013-09-26,DISCONTINUED,NA,2013-09-21,NA,NA,NA,2013-09-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1236,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-09-21T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2013-09-21T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2013-09-21,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1236,2013-09-21,2013-09-26,2013-09-21,2013-09-21,NA,2013-09-26,NA,NA,708,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-08,-13,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-09-21,1,NA,2013-09-26,DISCONTINUED,NA,2013-09-21,NA,NA,NA,2013-09-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1236,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-09-21T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2013-09-21T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2013-09-21,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1236,2013-09-21,2013-09-26,2013-09-21,2013-09-21,NA,2013-09-26,NA,NA,708,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-08,-13,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-09-21,1,NA,2013-09-26,DISCONTINUED,NA,2013-09-21,NA,NA,NA,2013-09-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1253,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-07,2013-05-21,1,15,NA,0,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-07T00:00:00Z,NA,H,2013-05-21T00:00:00Z,NA,H,1,15,15,2013-05-07,2013-05-21,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1253,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-07,2013-05-21,1,15,NA,0,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-07T00:00:00Z,NA,H,2013-05-21T00:00:00Z,NA,H,1,15,15,2013-05-07,2013-05-21,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1253,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-07,2013-05-21,1,15,NA,0,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-07T00:00:00Z,NA,H,2013-05-21T00:00:00Z,NA,H,1,15,15,2013-05-07,2013-05-21,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1253,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-07,2013-05-21,1,15,NA,0,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-07T00:00:00Z,NA,H,2013-05-21T00:00:00Z,NA,H,1,15,15,2013-05-07,2013-05-21,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1253,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-07,2013-05-21,1,15,NA,0,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-07T00:00:00Z,NA,H,2013-05-21T00:00:00Z,NA,H,1,15,15,2013-05-07,2013-05-21,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1253,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-22,2013-10-27,16,174,NA,0,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-22T00:00:00Z,NA,H,2013-10-27T00:00:00Z,NA,H,16,174,159,2013-05-22,2013-10-27,0,0,DURD,159,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1253,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-22,2013-10-27,16,174,NA,0,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-22T00:00:00Z,NA,H,2013-10-27T00:00:00Z,NA,H,16,174,159,2013-05-22,2013-10-27,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1253,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-22,2013-10-27,16,174,NA,0,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-22T00:00:00Z,NA,H,2013-10-27T00:00:00Z,NA,H,16,174,159,2013-05-22,2013-10-27,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1253,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-22,2013-10-27,16,174,NA,0,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-22T00:00:00Z,NA,H,2013-10-27T00:00:00Z,NA,H,16,174,159,2013-05-22,2013-10-27,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1253,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-22,2013-10-27,16,174,NA,0,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-22T00:00:00Z,NA,H,2013-10-27T00:00:00Z,NA,H,16,174,159,2013-05-22,2013-10-27,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1253,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-28,2013-11-05,175,183,NA,0,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-10-28T00:00:00Z,NA,H,2013-11-05T00:00:00Z,NA,H,175,183,9,2013-10-28,2013-11-05,0,0,DURD,9,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1253,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-28,2013-11-05,175,183,NA,0,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-10-28T00:00:00Z,NA,H,2013-11-05T00:00:00Z,NA,H,175,183,9,2013-10-28,2013-11-05,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1253,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-28,2013-11-05,175,183,NA,0,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-10-28T00:00:00Z,NA,H,2013-11-05T00:00:00Z,NA,H,175,183,9,2013-10-28,2013-11-05,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1253,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-28,2013-11-05,175,183,NA,0,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-10-28T00:00:00Z,NA,H,2013-11-05T00:00:00Z,NA,H,175,183,9,2013-10-28,2013-11-05,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1253,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-28,2013-11-05,175,183,NA,0,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-10-28T00:00:00Z,NA,H,2013-11-05T00:00:00Z,NA,H,175,183,9,2013-10-28,2013-11-05,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-07T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-05-07,2013-11-05,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-07T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-05-07,2013-11-05,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-07T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-05-07,2013-11-05,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-07T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-05-07,2013-11-05,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-07T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-05-07,2013-11-05,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-07T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-05-07,2013-11-05,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-07T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-05-07,2013-11-05,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-22T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-05-22,2013-11-05,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-22T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-05-22,2013-11-05,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-22T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-05-22,2013-11-05,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-22T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-05-22,2013-11-05,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-22T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-05-22,2013-11-05,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-22T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-05-22,2013-11-05,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1253,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-07,2013-05-07T00:00:00Z,2013-11-05T23:59:59Z,2013-05-22T00:00:00Z,NA,NA,2013-11-05T00:00:00Z,NA,NA,NA,NA,NA,2013-05-22,2013-11-05,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1253,2013-05-07,2013-11-05,2013-05-07,2013-11-05,NA,2013-11-05,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-26,-11,Placebo,Placebo,H,H,2013-11-05,183,NA,2013-11-05,COMPLETED,NA,2013-05-07,NA,NA,NA,2013-11-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1272,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-06,2013-02-21,1,16,NA,54,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-06T00:00:00Z,NA,H,2013-02-21T00:00:00Z,NA,H,1,16,16,2013-02-06,2013-02-21,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1272,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-06,2013-02-21,1,16,NA,54,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-06T00:00:00Z,NA,H,2013-02-21T00:00:00Z,NA,H,1,16,16,2013-02-06,2013-02-21,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1272,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-06,2013-02-21,1,16,NA,54,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-06T00:00:00Z,NA,H,2013-02-21T00:00:00Z,NA,H,1,16,16,2013-02-06,2013-02-21,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1272,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-06,2013-02-21,1,16,NA,54,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-06T00:00:00Z,NA,H,2013-02-21T00:00:00Z,NA,H,1,16,16,2013-02-06,2013-02-21,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1272,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-06,2013-02-21,1,16,NA,54,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-06T00:00:00Z,NA,H,2013-02-21T00:00:00Z,NA,H,1,16,16,2013-02-06,2013-02-21,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1272,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-22,2013-03-22,17,45,NA,54,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-22T00:00:00Z,NA,H,2013-03-22T00:00:00Z,NA,H,17,45,29,2013-02-22,2013-03-22,1566,1566,DURD,29,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1272,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-22,2013-03-22,17,45,NA,54,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-22T00:00:00Z,NA,H,2013-03-22T00:00:00Z,NA,H,17,45,29,2013-02-22,2013-03-22,1566,1566,DOSE,1566,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1272,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-22,2013-03-22,17,45,NA,54,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-22T00:00:00Z,NA,H,2013-03-22T00:00:00Z,NA,H,17,45,29,2013-02-22,2013-03-22,1566,1566,PLDOSE,1566,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1272,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-22,2013-03-22,17,45,NA,54,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-22T00:00:00Z,NA,H,2013-03-22T00:00:00Z,NA,H,17,45,29,2013-02-22,2013-03-22,1566,1566,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1272,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-22,2013-03-22,17,45,NA,54,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-22T00:00:00Z,NA,H,2013-03-22T00:00:00Z,NA,H,17,45,29,2013-02-22,2013-03-22,1566,1566,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1272,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-06T00:00:00Z,NA,NA,2013-03-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-06,2013-03-22,NA,NA,TDURD,45,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1272,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-06T00:00:00Z,NA,NA,2013-03-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-06,2013-03-22,NA,NA,TDOSE,2430,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1272,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-06T00:00:00Z,NA,NA,2013-03-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-06,2013-03-22,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1272,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-06T00:00:00Z,NA,NA,2013-03-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-06,2013-03-22,NA,NA,TPDOSE,2430,NA,OVERALL,Total planned dose (mg),11,NA,14,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1272,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-06T00:00:00Z,NA,NA,2013-03-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-06,2013-03-22,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1272,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-06T00:00:00Z,NA,NA,2013-03-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-06,2013-03-22,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1272,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-06T00:00:00Z,NA,NA,2013-03-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-06,2013-03-22,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1272,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-22T00:00:00Z,NA,NA,2013-03-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-22,2013-03-22,NA,NA,PDURD,29,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1272,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-22T00:00:00Z,NA,NA,2013-03-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-22,2013-03-22,NA,NA,PDOSE,1566,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1272,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-22T00:00:00Z,NA,NA,2013-03-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-22,2013-03-22,NA,NA,PPDOSE,1566,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1272,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-22T00:00:00Z,NA,NA,2013-03-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-22,2013-03-22,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1272,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-22T00:00:00Z,NA,NA,2013-03-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-22,2013-03-22,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1272,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-22T00:00:00Z,NA,NA,2013-03-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-22,2013-03-22,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1272,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-06,2013-02-06T00:00:00Z,2013-03-22T23:59:59Z,2013-02-22T00:00:00Z,NA,NA,2013-03-22T00:00:00Z,NA,NA,NA,NA,NA,2013-02-22,2013-03-22,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1272,2013-02-06,2013-04-04,2013-02-06,2013-03-22,NA,2013-04-04T11:05,NA,NA,708,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-22,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-22,45,NA,2013-04-04,DISCONTINUED,NA,2013-02-06,NA,NA,NA,2013-04-04,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1286,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-10,2013-09-23,1,14,NA,0,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-10T00:00:00Z,NA,H,2013-09-23T00:00:00Z,NA,H,1,14,14,2013-09-10,2013-09-23,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1286,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-10,2013-09-23,1,14,NA,0,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-10T00:00:00Z,NA,H,2013-09-23T00:00:00Z,NA,H,1,14,14,2013-09-10,2013-09-23,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1286,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-10,2013-09-23,1,14,NA,0,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-10T00:00:00Z,NA,H,2013-09-23T00:00:00Z,NA,H,1,14,14,2013-09-10,2013-09-23,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1286,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-10,2013-09-23,1,14,NA,0,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-10T00:00:00Z,NA,H,2013-09-23T00:00:00Z,NA,H,1,14,14,2013-09-10,2013-09-23,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1286,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-10,2013-09-23,1,14,NA,0,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-10T00:00:00Z,NA,H,2013-09-23T00:00:00Z,NA,H,1,14,14,2013-09-10,2013-09-23,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1286,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-24,2014-02-23,15,167,NA,0,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-24T00:00:00Z,NA,H,2014-02-23T00:00:00Z,NA,H,15,167,153,2013-09-24,2014-02-23,0,0,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1286,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-24,2014-02-23,15,167,NA,0,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-24T00:00:00Z,NA,H,2014-02-23T00:00:00Z,NA,H,15,167,153,2013-09-24,2014-02-23,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1286,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-24,2014-02-23,15,167,NA,0,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-24T00:00:00Z,NA,H,2014-02-23T00:00:00Z,NA,H,15,167,153,2013-09-24,2014-02-23,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1286,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-24,2014-02-23,15,167,NA,0,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-24T00:00:00Z,NA,H,2014-02-23T00:00:00Z,NA,H,15,167,153,2013-09-24,2014-02-23,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1286,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-24,2014-02-23,15,167,NA,0,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-24T00:00:00Z,NA,H,2014-02-23T00:00:00Z,NA,H,15,167,153,2013-09-24,2014-02-23,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1286,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-24,2014-03-08,168,180,NA,0,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2014-02-24T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,168,180,13,2014-02-24,2014-03-08,0,0,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1286,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-24,2014-03-08,168,180,NA,0,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2014-02-24T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,168,180,13,2014-02-24,2014-03-08,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1286,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-24,2014-03-08,168,180,NA,0,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2014-02-24T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,168,180,13,2014-02-24,2014-03-08,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1286,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-24,2014-03-08,168,180,NA,0,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2014-02-24T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,168,180,13,2014-02-24,2014-03-08,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1286,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-24,2014-03-08,168,180,NA,0,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2014-02-24T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,168,180,13,2014-02-24,2014-03-08,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-10T00:00:00Z,NA,NA,2014-03-08T00:00:00Z,NA,NA,NA,NA,NA,2013-09-10,2014-03-08,NA,NA,TDURD,180,NA,OVERALL,Overall duration (days),7,>=90 days,16,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-10T00:00:00Z,NA,NA,2014-03-08T00:00:00Z,NA,NA,NA,NA,NA,2013-09-10,2014-03-08,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-10T00:00:00Z,NA,NA,2014-03-08T00:00:00Z,NA,NA,NA,NA,NA,2013-09-10,2014-03-08,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-10T00:00:00Z,NA,NA,2014-03-08T00:00:00Z,NA,NA,NA,NA,NA,2013-09-10,2014-03-08,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-10T00:00:00Z,NA,NA,2014-03-08T00:00:00Z,NA,NA,NA,NA,NA,2013-09-10,2014-03-08,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-10T00:00:00Z,NA,NA,2014-03-08T00:00:00Z,NA,NA,NA,NA,NA,2013-09-10,2014-03-08,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-10T00:00:00Z,NA,NA,2014-03-08T00:00:00Z,NA,NA,NA,NA,NA,2013-09-10,2014-03-08,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-24T00:00:00Z,NA,NA,2014-03-08T00:00:00Z,NA,NA,NA,NA,NA,2013-09-24,2014-03-08,NA,NA,PDURD,166,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-24T00:00:00Z,NA,NA,2014-03-08T00:00:00Z,NA,NA,NA,NA,NA,2013-09-24,2014-03-08,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-24T00:00:00Z,NA,NA,2014-03-08T00:00:00Z,NA,NA,NA,NA,NA,2013-09-24,2014-03-08,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-24T00:00:00Z,NA,NA,2014-03-08T00:00:00Z,NA,NA,NA,NA,NA,2013-09-24,2014-03-08,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-24T00:00:00Z,NA,NA,2014-03-08T00:00:00Z,NA,NA,NA,NA,NA,2013-09-24,2014-03-08,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-24T00:00:00Z,NA,NA,2014-03-08T00:00:00Z,NA,NA,NA,NA,NA,2013-09-24,2014-03-08,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1286,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-10,2013-09-10T00:00:00Z,2014-03-08T23:59:59Z,2013-09-24T00:00:00Z,NA,NA,2014-03-08T00:00:00Z,NA,NA,NA,NA,NA,2013-09-24,2014-03-08,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1286,2013-09-10,2014-03-08,2013-09-10,2014-03-08,NA,2014-03-08T09:50,NA,NA,708,80,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-25,-16,Placebo,Placebo,H,H,2014-03-08,180,NA,2014-03-08,COMPLETED,NA,2013-09-10,NA,NA,NA,2014-03-08,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1296,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-14,2013-06-27,1,14,NA,0,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-14T00:00:00Z,NA,H,2013-06-27T00:00:00Z,NA,H,1,14,14,2013-06-14,2013-06-27,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1296,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-14,2013-06-27,1,14,NA,0,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-14T00:00:00Z,NA,H,2013-06-27T00:00:00Z,NA,H,1,14,14,2013-06-14,2013-06-27,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1296,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-14,2013-06-27,1,14,NA,0,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-14T00:00:00Z,NA,H,2013-06-27T00:00:00Z,NA,H,1,14,14,2013-06-14,2013-06-27,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1296,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-14,2013-06-27,1,14,NA,0,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-14T00:00:00Z,NA,H,2013-06-27T00:00:00Z,NA,H,1,14,14,2013-06-14,2013-06-27,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1296,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-14,2013-06-27,1,14,NA,0,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-14T00:00:00Z,NA,H,2013-06-27T00:00:00Z,NA,H,1,14,14,2013-06-14,2013-06-27,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1296,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-28,2013-11-27,15,167,NA,0,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-28T00:00:00Z,NA,H,2013-11-27T00:00:00Z,NA,H,15,167,153,2013-06-28,2013-11-27,0,0,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1296,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-28,2013-11-27,15,167,NA,0,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-28T00:00:00Z,NA,H,2013-11-27T00:00:00Z,NA,H,15,167,153,2013-06-28,2013-11-27,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1296,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-28,2013-11-27,15,167,NA,0,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-28T00:00:00Z,NA,H,2013-11-27T00:00:00Z,NA,H,15,167,153,2013-06-28,2013-11-27,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1296,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-28,2013-11-27,15,167,NA,0,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-28T00:00:00Z,NA,H,2013-11-27T00:00:00Z,NA,H,15,167,153,2013-06-28,2013-11-27,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1296,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-28,2013-11-27,15,167,NA,0,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-28T00:00:00Z,NA,H,2013-11-27T00:00:00Z,NA,H,15,167,153,2013-06-28,2013-11-27,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1296,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-28,2013-12-12,168,182,NA,0,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-11-28T00:00:00Z,NA,H,2013-12-12T00:00:00Z,NA,H,168,182,15,2013-11-28,2013-12-12,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1296,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-28,2013-12-12,168,182,NA,0,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-11-28T00:00:00Z,NA,H,2013-12-12T00:00:00Z,NA,H,168,182,15,2013-11-28,2013-12-12,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1296,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-28,2013-12-12,168,182,NA,0,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-11-28T00:00:00Z,NA,H,2013-12-12T00:00:00Z,NA,H,168,182,15,2013-11-28,2013-12-12,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1296,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-28,2013-12-12,168,182,NA,0,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-11-28T00:00:00Z,NA,H,2013-12-12T00:00:00Z,NA,H,168,182,15,2013-11-28,2013-12-12,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1296,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-28,2013-12-12,168,182,NA,0,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-11-28T00:00:00Z,NA,H,2013-12-12T00:00:00Z,NA,H,168,182,15,2013-11-28,2013-12-12,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-14T00:00:00Z,NA,NA,2013-12-12T00:00:00Z,NA,NA,NA,NA,NA,2013-06-14,2013-12-12,NA,NA,TDURD,182,NA,OVERALL,Overall duration (days),7,>=90 days,16,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-14T00:00:00Z,NA,NA,2013-12-12T00:00:00Z,NA,NA,NA,NA,NA,2013-06-14,2013-12-12,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-14T00:00:00Z,NA,NA,2013-12-12T00:00:00Z,NA,NA,NA,NA,NA,2013-06-14,2013-12-12,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-14T00:00:00Z,NA,NA,2013-12-12T00:00:00Z,NA,NA,NA,NA,NA,2013-06-14,2013-12-12,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-14T00:00:00Z,NA,NA,2013-12-12T00:00:00Z,NA,NA,NA,NA,NA,2013-06-14,2013-12-12,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-14T00:00:00Z,NA,NA,2013-12-12T00:00:00Z,NA,NA,NA,NA,NA,2013-06-14,2013-12-12,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-14T00:00:00Z,NA,NA,2013-12-12T00:00:00Z,NA,NA,NA,NA,NA,2013-06-14,2013-12-12,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-28T00:00:00Z,NA,NA,2013-12-12T00:00:00Z,NA,NA,NA,NA,NA,2013-06-28,2013-12-12,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-28T00:00:00Z,NA,NA,2013-12-12T00:00:00Z,NA,NA,NA,NA,NA,2013-06-28,2013-12-12,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-28T00:00:00Z,NA,NA,2013-12-12T00:00:00Z,NA,NA,NA,NA,NA,2013-06-28,2013-12-12,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-28T00:00:00Z,NA,NA,2013-12-12T00:00:00Z,NA,NA,NA,NA,NA,2013-06-28,2013-12-12,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-28T00:00:00Z,NA,NA,2013-12-12T00:00:00Z,NA,NA,NA,NA,NA,2013-06-28,2013-12-12,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-28T00:00:00Z,NA,NA,2013-12-12T00:00:00Z,NA,NA,NA,NA,NA,2013-06-28,2013-12-12,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1296,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-14,2013-06-14T00:00:00Z,2013-12-12T23:59:59Z,2013-06-28T00:00:00Z,NA,NA,2013-12-12T00:00:00Z,NA,NA,NA,NA,NA,2013-06-28,2013-12-12,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1296,2013-06-14,2013-12-12,2013-06-14,2013-12-12,NA,2013-12-12T09:30,NA,NA,708,57,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-07,-7,Placebo,Placebo,H,H,2013-12-12,182,NA,2013-12-12,COMPLETED,NA,2013-06-14,NA,NA,NA,2013-12-12,18-64,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1297,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-25,2013-02-08,1,15,NA,54,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-01-25T00:00:00Z,NA,H,2013-02-08T00:00:00Z,NA,H,1,15,15,2013-01-25,2013-02-08,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1297,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-25,2013-02-08,1,15,NA,54,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-01-25T00:00:00Z,NA,H,2013-02-08T00:00:00Z,NA,H,1,15,15,2013-01-25,2013-02-08,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1297,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-25,2013-02-08,1,15,NA,54,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-01-25T00:00:00Z,NA,H,2013-02-08T00:00:00Z,NA,H,1,15,15,2013-01-25,2013-02-08,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1297,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-25,2013-02-08,1,15,NA,54,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-01-25T00:00:00Z,NA,H,2013-02-08T00:00:00Z,NA,H,1,15,15,2013-01-25,2013-02-08,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1297,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-25,2013-02-08,1,15,NA,54,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-01-25T00:00:00Z,NA,H,2013-02-08T00:00:00Z,NA,H,1,15,15,2013-01-25,2013-02-08,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1297,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-09,2013-05-03,16,99,NA,54,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-02-09T00:00:00Z,NA,H,2013-05-03T00:00:00Z,NA,H,16,99,84,2013-02-09,2013-05-03,4536,4536,DURD,84,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1297,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-09,2013-05-03,16,99,NA,54,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-02-09T00:00:00Z,NA,H,2013-05-03T00:00:00Z,NA,H,16,99,84,2013-02-09,2013-05-03,4536,4536,DOSE,4536,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1297,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-09,2013-05-03,16,99,NA,54,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-02-09T00:00:00Z,NA,H,2013-05-03T00:00:00Z,NA,H,16,99,84,2013-02-09,2013-05-03,4536,4536,PLDOSE,4536,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1297,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-09,2013-05-03,16,99,NA,54,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-02-09T00:00:00Z,NA,H,2013-05-03T00:00:00Z,NA,H,16,99,84,2013-02-09,2013-05-03,4536,4536,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1297,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-09,2013-05-03,16,99,NA,54,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-02-09T00:00:00Z,NA,H,2013-05-03T00:00:00Z,NA,H,16,99,84,2013-02-09,2013-05-03,4536,4536,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-05-03T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-05-03,NA,NA,TDURD,99,NA,OVERALL,Overall duration (days),7,>=90 days,11,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-05-03T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-05-03,NA,NA,TDOSE,5346,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-05-03T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-05-03,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-05-03T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-05-03,NA,NA,TPDOSE,5346,NA,OVERALL,Total planned dose (mg),11,NA,14,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-05-03T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-05-03,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-05-03T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-05-03,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-05-03T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-05-03,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-05-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-05-03,NA,NA,PDURD,84,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-05-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-05-03,NA,NA,PDOSE,4536,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-05-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-05-03,NA,NA,PPDOSE,4536,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-05-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-05-03,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-05-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-05-03,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-05-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-05-03,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1297,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-25,2013-01-25T00:00:00Z,2013-05-03T23:59:59Z,2013-02-09T00:00:00Z,NA,NA,2013-05-03T00:00:00Z,NA,NA,NA,NA,NA,2013-02-09,2013-05-03,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1297,2013-01-25,2013-05-08,2013-01-25,2013-05-03,NA,2013-06-07,NA,NA,708,61,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-15,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-03,99,NA,2013-05-08,DISCONTINUED,NA,2013-01-25,NA,NA,NA,2013-05-08,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1316,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-23,2013-09-05,1,14,NA,0,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-08-23T00:00:00Z,NA,H,2013-09-05T00:00:00Z,NA,H,1,14,14,2013-08-23,2013-09-05,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1316,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-23,2013-09-05,1,14,NA,0,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-08-23T00:00:00Z,NA,H,2013-09-05T00:00:00Z,NA,H,1,14,14,2013-08-23,2013-09-05,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1316,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-23,2013-09-05,1,14,NA,0,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-08-23T00:00:00Z,NA,H,2013-09-05T00:00:00Z,NA,H,1,14,14,2013-08-23,2013-09-05,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1316,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-23,2013-09-05,1,14,NA,0,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-08-23T00:00:00Z,NA,H,2013-09-05T00:00:00Z,NA,H,1,14,14,2013-08-23,2013-09-05,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1316,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-23,2013-09-05,1,14,NA,0,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-08-23T00:00:00Z,NA,H,2013-09-05T00:00:00Z,NA,H,1,14,14,2013-08-23,2013-09-05,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1316,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-06,2014-02-15,15,177,NA,0,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-09-06T00:00:00Z,NA,H,2014-02-15T00:00:00Z,NA,H,15,177,163,2013-09-06,2014-02-15,0,0,DURD,163,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1316,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-06,2014-02-15,15,177,NA,0,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-09-06T00:00:00Z,NA,H,2014-02-15T00:00:00Z,NA,H,15,177,163,2013-09-06,2014-02-15,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1316,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-06,2014-02-15,15,177,NA,0,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-09-06T00:00:00Z,NA,H,2014-02-15T00:00:00Z,NA,H,15,177,163,2013-09-06,2014-02-15,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1316,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-06,2014-02-15,15,177,NA,0,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-09-06T00:00:00Z,NA,H,2014-02-15T00:00:00Z,NA,H,15,177,163,2013-09-06,2014-02-15,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1316,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-06,2014-02-15,15,177,NA,0,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-09-06T00:00:00Z,NA,H,2014-02-15T00:00:00Z,NA,H,15,177,163,2013-09-06,2014-02-15,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1316,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-16,2014-03-01,178,191,NA,0,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2014-02-16T00:00:00Z,NA,H,2014-03-01T00:00:00Z,NA,H,178,191,14,2014-02-16,2014-03-01,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1316,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-16,2014-03-01,178,191,NA,0,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2014-02-16T00:00:00Z,NA,H,2014-03-01T00:00:00Z,NA,H,178,191,14,2014-02-16,2014-03-01,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1316,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-16,2014-03-01,178,191,NA,0,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2014-02-16T00:00:00Z,NA,H,2014-03-01T00:00:00Z,NA,H,178,191,14,2014-02-16,2014-03-01,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1316,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-16,2014-03-01,178,191,NA,0,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2014-02-16T00:00:00Z,NA,H,2014-03-01T00:00:00Z,NA,H,178,191,14,2014-02-16,2014-03-01,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1316,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-16,2014-03-01,178,191,NA,0,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2014-02-16T00:00:00Z,NA,H,2014-03-01T00:00:00Z,NA,H,178,191,14,2014-02-16,2014-03-01,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2014-03-01,NA,NA,TDURD,191,NA,OVERALL,Overall duration (days),7,>=90 days,16,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2014-03-01,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2014-03-01,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2014-03-01,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2014-03-01,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2014-03-01,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2014-03-01,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2014-03-01,NA,NA,PDURD,177,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2014-03-01,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2014-03-01,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2014-03-01,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2014-03-01,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2014-03-01,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1316,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-23,2013-08-23T00:00:00Z,2014-03-01T23:59:59Z,2013-09-06T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2013-09-06,2014-03-01,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1316,2013-08-23,2014-03-01,2013-08-23,2014-03-01,NA,2014-03-01T10:25,NA,NA,708,74,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-15,-8,Placebo,Placebo,H,H,2014-03-01,191,NA,2014-03-01,COMPLETED,NA,2013-08-23,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1336,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-07,2012-12-21,1,15,NA,54,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-07T00:00:00Z,NA,H,2012-12-21T00:00:00Z,NA,H,1,15,15,2012-12-07,2012-12-21,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1336,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-07,2012-12-21,1,15,NA,54,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-07T00:00:00Z,NA,H,2012-12-21T00:00:00Z,NA,H,1,15,15,2012-12-07,2012-12-21,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1336,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-07,2012-12-21,1,15,NA,54,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-07T00:00:00Z,NA,H,2012-12-21T00:00:00Z,NA,H,1,15,15,2012-12-07,2012-12-21,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1336,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-07,2012-12-21,1,15,NA,54,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-07T00:00:00Z,NA,H,2012-12-21T00:00:00Z,NA,H,1,15,15,2012-12-07,2012-12-21,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1336,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-07,2012-12-21,1,15,NA,54,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-07T00:00:00Z,NA,H,2012-12-21T00:00:00Z,NA,H,1,15,15,2012-12-07,2012-12-21,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1336,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-22,2013-05-22,16,167,NA,54,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-22T00:00:00Z,NA,H,2013-05-22T00:00:00Z,NA,H,16,167,152,2012-12-22,2013-05-22,12312,8208,DURD,152,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1336,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-22,2013-05-22,16,167,NA,54,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-22T00:00:00Z,NA,H,2013-05-22T00:00:00Z,NA,H,16,167,152,2012-12-22,2013-05-22,12312,8208,DOSE,12312,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1336,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-22,2013-05-22,16,167,NA,54,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-22T00:00:00Z,NA,H,2013-05-22T00:00:00Z,NA,H,16,167,152,2012-12-22,2013-05-22,12312,8208,PLDOSE,8208,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1336,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-22,2013-05-22,16,167,NA,54,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-22T00:00:00Z,NA,H,2013-05-22T00:00:00Z,NA,H,16,167,152,2012-12-22,2013-05-22,12312,8208,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1336,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-22,2013-05-22,16,167,NA,54,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-22T00:00:00Z,NA,H,2013-05-22T00:00:00Z,NA,H,16,167,152,2012-12-22,2013-05-22,12312,8208,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1336,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-23,2013-06-05,168,181,NA,54,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2013-05-23T00:00:00Z,NA,H,2013-06-05T00:00:00Z,NA,H,168,181,14,2013-05-23,2013-06-05,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1336,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-23,2013-06-05,168,181,NA,54,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2013-05-23T00:00:00Z,NA,H,2013-06-05T00:00:00Z,NA,H,168,181,14,2013-05-23,2013-06-05,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1336,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-23,2013-06-05,168,181,NA,54,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2013-05-23T00:00:00Z,NA,H,2013-06-05T00:00:00Z,NA,H,168,181,14,2013-05-23,2013-06-05,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1336,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-23,2013-06-05,168,181,NA,54,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2013-05-23T00:00:00Z,NA,H,2013-06-05T00:00:00Z,NA,H,168,181,14,2013-05-23,2013-06-05,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1336,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-23,2013-06-05,168,181,NA,54,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2013-05-23T00:00:00Z,NA,H,2013-06-05T00:00:00Z,NA,H,168,181,14,2013-05-23,2013-06-05,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-07T00:00:00Z,NA,NA,2013-06-05T00:00:00Z,NA,NA,NA,NA,NA,2012-12-07,2013-06-05,NA,NA,TDURD,181,NA,OVERALL,Overall duration (days),7,>=90 days,16,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-07T00:00:00Z,NA,NA,2013-06-05T00:00:00Z,NA,NA,NA,NA,NA,2012-12-07,2013-06-05,NA,NA,TDOSE,13878,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-07T00:00:00Z,NA,NA,2013-06-05T00:00:00Z,NA,NA,NA,NA,NA,2012-12-07,2013-06-05,NA,NA,AVDDSE,76.67403314917127,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-07T00:00:00Z,NA,NA,2013-06-05T00:00:00Z,NA,NA,NA,NA,NA,2012-12-07,2013-06-05,NA,NA,TPDOSE,9774,NA,OVERALL,Total planned dose (mg),11,NA,19,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-07T00:00:00Z,NA,NA,2013-06-05T00:00:00Z,NA,NA,NA,NA,NA,2012-12-07,2013-06-05,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-07T00:00:00Z,NA,NA,2013-06-05T00:00:00Z,NA,NA,NA,NA,NA,2012-12-07,2013-06-05,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-07T00:00:00Z,NA,NA,2013-06-05T00:00:00Z,NA,NA,NA,NA,NA,2012-12-07,2013-06-05,NA,NA,TDOSINT,141.9889502762431,NA,OVERALL,Overall dose intensity (%),90,NA,22,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-22T00:00:00Z,NA,NA,2013-06-05T00:00:00Z,NA,NA,NA,NA,NA,2012-12-22,2013-06-05,NA,NA,PDURD,166,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-22T00:00:00Z,NA,NA,2013-06-05T00:00:00Z,NA,NA,NA,NA,NA,2012-12-22,2013-06-05,NA,NA,PDOSE,13068,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-22T00:00:00Z,NA,NA,2013-06-05T00:00:00Z,NA,NA,NA,NA,NA,2012-12-22,2013-06-05,NA,NA,PPDOSE,8964,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-22T00:00:00Z,NA,NA,2013-06-05T00:00:00Z,NA,NA,NA,NA,NA,2012-12-22,2013-06-05,NA,NA,PAVDDSE,78.72289156626506,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-22T00:00:00Z,NA,NA,2013-06-05T00:00:00Z,NA,NA,NA,NA,NA,2012-12-22,2013-06-05,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-22T00:00:00Z,NA,NA,2013-06-05T00:00:00Z,NA,NA,NA,NA,NA,2012-12-22,2013-06-05,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1336,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-07,2012-12-07T00:00:00Z,2013-06-05T23:59:59Z,2012-12-22T00:00:00Z,NA,NA,2013-06-05T00:00:00Z,NA,NA,NA,NA,NA,2012-12-22,2013-06-05,NA,NA,PDOSINT,145.78313253012047,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1336,2012-12-07,2013-06-05,2012-12-07,2013-06-05,NA,2013-07-05,NA,NA,708,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-21,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-05,181,NA,2013-06-05,COMPLETED,NA,2012-12-07,NA,NA,NA,2013-06-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1342,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-29,2013-01-12,1,15,NA,0,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2012-12-29T00:00:00Z,NA,H,2013-01-12T00:00:00Z,NA,H,1,15,15,2012-12-29,2013-01-12,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1342,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-29,2013-01-12,1,15,NA,0,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2012-12-29T00:00:00Z,NA,H,2013-01-12T00:00:00Z,NA,H,1,15,15,2012-12-29,2013-01-12,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1342,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-29,2013-01-12,1,15,NA,0,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2012-12-29T00:00:00Z,NA,H,2013-01-12T00:00:00Z,NA,H,1,15,15,2012-12-29,2013-01-12,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1342,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-29,2013-01-12,1,15,NA,0,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2012-12-29T00:00:00Z,NA,H,2013-01-12T00:00:00Z,NA,H,1,15,15,2012-12-29,2013-01-12,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1342,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-29,2013-01-12,1,15,NA,0,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2012-12-29T00:00:00Z,NA,H,2013-01-12T00:00:00Z,NA,H,1,15,15,2012-12-29,2013-01-12,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1342,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-13,2013-06-15,16,169,NA,0,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-01-13T00:00:00Z,NA,H,2013-06-15T00:00:00Z,NA,H,16,169,154,2013-01-13,2013-06-15,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1342,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-13,2013-06-15,16,169,NA,0,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-01-13T00:00:00Z,NA,H,2013-06-15T00:00:00Z,NA,H,16,169,154,2013-01-13,2013-06-15,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1342,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-13,2013-06-15,16,169,NA,0,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-01-13T00:00:00Z,NA,H,2013-06-15T00:00:00Z,NA,H,16,169,154,2013-01-13,2013-06-15,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1342,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-13,2013-06-15,16,169,NA,0,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-01-13T00:00:00Z,NA,H,2013-06-15T00:00:00Z,NA,H,16,169,154,2013-01-13,2013-06-15,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1342,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-13,2013-06-15,16,169,NA,0,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-01-13T00:00:00Z,NA,H,2013-06-15T00:00:00Z,NA,H,16,169,154,2013-01-13,2013-06-15,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1342,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-16,2013-06-28,170,182,NA,0,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-06-16T00:00:00Z,NA,H,2013-06-28T00:00:00Z,NA,H,170,182,13,2013-06-16,2013-06-28,0,0,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1342,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-16,2013-06-28,170,182,NA,0,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-06-16T00:00:00Z,NA,H,2013-06-28T00:00:00Z,NA,H,170,182,13,2013-06-16,2013-06-28,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1342,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-16,2013-06-28,170,182,NA,0,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-06-16T00:00:00Z,NA,H,2013-06-28T00:00:00Z,NA,H,170,182,13,2013-06-16,2013-06-28,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1342,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-16,2013-06-28,170,182,NA,0,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-06-16T00:00:00Z,NA,H,2013-06-28T00:00:00Z,NA,H,170,182,13,2013-06-16,2013-06-28,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1342,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-16,2013-06-28,170,182,NA,0,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-06-16T00:00:00Z,NA,H,2013-06-28T00:00:00Z,NA,H,170,182,13,2013-06-16,2013-06-28,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2012-12-29T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2012-12-29,2013-06-28,NA,NA,TDURD,182,NA,OVERALL,Overall duration (days),7,>=90 days,16,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2012-12-29T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2012-12-29,2013-06-28,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2012-12-29T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2012-12-29,2013-06-28,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2012-12-29T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2012-12-29,2013-06-28,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2012-12-29T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2012-12-29,2013-06-28,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2012-12-29T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2012-12-29,2013-06-28,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2012-12-29T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2012-12-29,2013-06-28,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-01-13T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-01-13,2013-06-28,NA,NA,PDURD,167,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-01-13T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-01-13,2013-06-28,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-01-13T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-01-13,2013-06-28,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-01-13T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-01-13,2013-06-28,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-01-13T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-01-13,2013-06-28,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-01-13T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-01-13,2013-06-28,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1342,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-29,2012-12-29T00:00:00Z,2013-06-28T23:59:59Z,2013-01-13T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-01-13,2013-06-28,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1342,2012-12-29,2013-06-28,2012-12-29,2013-06-28,NA,2013-06-28T09:40,NA,NA,708,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-21,-8,Placebo,Placebo,H,H,2013-06-28,182,NA,2013-06-28,COMPLETED,NA,2012-12-29,NA,NA,NA,2013-06-28,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1347,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-20,2013-05-04,1,15,NA,54,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-04-20T00:00:00Z,NA,H,2013-05-04T00:00:00Z,NA,H,1,15,15,2013-04-20,2013-05-04,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1347,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-20,2013-05-04,1,15,NA,54,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-04-20T00:00:00Z,NA,H,2013-05-04T00:00:00Z,NA,H,1,15,15,2013-04-20,2013-05-04,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1347,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-20,2013-05-04,1,15,NA,54,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-04-20T00:00:00Z,NA,H,2013-05-04T00:00:00Z,NA,H,1,15,15,2013-04-20,2013-05-04,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1347,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-20,2013-05-04,1,15,NA,54,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-04-20T00:00:00Z,NA,H,2013-05-04T00:00:00Z,NA,H,1,15,15,2013-04-20,2013-05-04,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1347,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-20,2013-05-04,1,15,NA,54,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-04-20T00:00:00Z,NA,H,2013-05-04T00:00:00Z,NA,H,1,15,15,2013-04-20,2013-05-04,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1347,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-05,2013-06-18,16,60,NA,54,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-05-05T00:00:00Z,NA,H,2013-06-18T00:00:00Z,NA,H,16,60,45,2013-05-05,2013-06-18,3645,2430,DURD,45,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1347,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-05,2013-06-18,16,60,NA,54,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-05-05T00:00:00Z,NA,H,2013-06-18T00:00:00Z,NA,H,16,60,45,2013-05-05,2013-06-18,3645,2430,DOSE,3645,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1347,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-05,2013-06-18,16,60,NA,54,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-05-05T00:00:00Z,NA,H,2013-06-18T00:00:00Z,NA,H,16,60,45,2013-05-05,2013-06-18,3645,2430,PLDOSE,2430,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1347,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-05,2013-06-18,16,60,NA,54,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-05-05T00:00:00Z,NA,H,2013-06-18T00:00:00Z,NA,H,16,60,45,2013-05-05,2013-06-18,3645,2430,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1347,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-05,2013-06-18,16,60,NA,54,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-05-05T00:00:00Z,NA,H,2013-06-18T00:00:00Z,NA,H,16,60,45,2013-05-05,2013-06-18,3645,2430,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-04-20T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-04-20,2013-06-18,NA,NA,TDURD,60,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-04-20T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-04-20,2013-06-18,NA,NA,TDOSE,4455,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-04-20T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-04-20,2013-06-18,NA,NA,AVDDSE,74.25,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-04-20T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-04-20,2013-06-18,NA,NA,TPDOSE,3240,NA,OVERALL,Total planned dose (mg),11,NA,14,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-04-20T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-04-20,2013-06-18,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-04-20T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-04-20,2013-06-18,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-04-20T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-04-20,2013-06-18,NA,NA,TDOSINT,137.5,NA,OVERALL,Overall dose intensity (%),90,NA,17,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-05-05T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-05,2013-06-18,NA,NA,PDURD,45,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-05-05T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-05,2013-06-18,NA,NA,PDOSE,3645,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-05-05T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-05,2013-06-18,NA,NA,PPDOSE,2430,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-05-05T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-05,2013-06-18,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-05-05T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-05,2013-06-18,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-05-05T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-05,2013-06-18,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1347,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-20,2013-04-20T00:00:00Z,2013-06-18T23:59:59Z,2013-05-05T00:00:00Z,NA,NA,2013-06-18T00:00:00Z,NA,NA,NA,NA,NA,2013-05-05,2013-06-18,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1347,2013-04-20,2013-06-18,2013-04-20,2013-06-18,NA,2013-08-02,NA,NA,708,61,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-18,60,NA,2013-06-18,DISCONTINUED,NA,2013-04-20,NA,NA,NA,2013-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1348,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-05,2013-08-19,1,15,NA,54,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-05T00:00:00Z,NA,H,2013-08-19T00:00:00Z,NA,H,1,15,15,2013-08-05,2013-08-19,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1348,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-05,2013-08-19,1,15,NA,54,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-05T00:00:00Z,NA,H,2013-08-19T00:00:00Z,NA,H,1,15,15,2013-08-05,2013-08-19,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1348,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-05,2013-08-19,1,15,NA,54,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-05T00:00:00Z,NA,H,2013-08-19T00:00:00Z,NA,H,1,15,15,2013-08-05,2013-08-19,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1348,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-05,2013-08-19,1,15,NA,54,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-05T00:00:00Z,NA,H,2013-08-19T00:00:00Z,NA,H,1,15,15,2013-08-05,2013-08-19,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1348,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-05,2013-08-19,1,15,NA,54,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-05T00:00:00Z,NA,H,2013-08-19T00:00:00Z,NA,H,1,15,15,2013-08-05,2013-08-19,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1348,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-20,2014-02-03,16,183,NA,54,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-20T00:00:00Z,NA,H,2014-02-03T00:00:00Z,NA,H,16,183,168,2013-08-20,2014-02-03,9072,9072,DURD,168,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1348,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-20,2014-02-03,16,183,NA,54,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-20T00:00:00Z,NA,H,2014-02-03T00:00:00Z,NA,H,16,183,168,2013-08-20,2014-02-03,9072,9072,DOSE,9072,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1348,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-20,2014-02-03,16,183,NA,54,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-20T00:00:00Z,NA,H,2014-02-03T00:00:00Z,NA,H,16,183,168,2013-08-20,2014-02-03,9072,9072,PLDOSE,9072,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1348,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-20,2014-02-03,16,183,NA,54,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-20T00:00:00Z,NA,H,2014-02-03T00:00:00Z,NA,H,16,183,168,2013-08-20,2014-02-03,9072,9072,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1348,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-20,2014-02-03,16,183,NA,54,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-20T00:00:00Z,NA,H,2014-02-03T00:00:00Z,NA,H,16,183,168,2013-08-20,2014-02-03,9072,9072,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1348,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-04,2014-02-13,184,193,NA,54,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2014-02-04T00:00:00Z,NA,H,2014-02-13T00:00:00Z,NA,H,184,193,10,2014-02-04,2014-02-13,540,540,DURD,10,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1348,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-04,2014-02-13,184,193,NA,54,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2014-02-04T00:00:00Z,NA,H,2014-02-13T00:00:00Z,NA,H,184,193,10,2014-02-04,2014-02-13,540,540,DOSE,540,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1348,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-04,2014-02-13,184,193,NA,54,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2014-02-04T00:00:00Z,NA,H,2014-02-13T00:00:00Z,NA,H,184,193,10,2014-02-04,2014-02-13,540,540,PLDOSE,540,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1348,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-04,2014-02-13,184,193,NA,54,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2014-02-04T00:00:00Z,NA,H,2014-02-13T00:00:00Z,NA,H,184,193,10,2014-02-04,2014-02-13,540,540,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1348,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-04,2014-02-13,184,193,NA,54,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2014-02-04T00:00:00Z,NA,H,2014-02-13T00:00:00Z,NA,H,184,193,10,2014-02-04,2014-02-13,540,540,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-05T00:00:00Z,NA,NA,2014-02-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-05,2014-02-13,NA,NA,TDURD,193,NA,OVERALL,Overall duration (days),7,>=90 days,16,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-05T00:00:00Z,NA,NA,2014-02-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-05,2014-02-13,NA,NA,TDOSE,10422,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-05T00:00:00Z,NA,NA,2014-02-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-05,2014-02-13,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-05T00:00:00Z,NA,NA,2014-02-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-05,2014-02-13,NA,NA,TPDOSE,10422,NA,OVERALL,Total planned dose (mg),11,NA,19,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-05T00:00:00Z,NA,NA,2014-02-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-05,2014-02-13,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-05T00:00:00Z,NA,NA,2014-02-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-05,2014-02-13,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-05T00:00:00Z,NA,NA,2014-02-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-05,2014-02-13,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-20T00:00:00Z,NA,NA,2014-02-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-20,2014-02-13,NA,NA,PDURD,178,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-20T00:00:00Z,NA,NA,2014-02-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-20,2014-02-13,NA,NA,PDOSE,9612,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-20T00:00:00Z,NA,NA,2014-02-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-20,2014-02-13,NA,NA,PPDOSE,9612,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-20T00:00:00Z,NA,NA,2014-02-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-20,2014-02-13,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-20T00:00:00Z,NA,NA,2014-02-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-20,2014-02-13,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-20T00:00:00Z,NA,NA,2014-02-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-20,2014-02-13,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1348,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-05,2013-08-05T00:00:00Z,2014-02-13T23:59:59Z,2013-08-20T00:00:00Z,NA,NA,2014-02-13T00:00:00Z,NA,NA,NA,NA,NA,2013-08-20,2014-02-13,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1348,2013-08-05,2014-02-13,2013-08-05,2014-02-13,NA,2014-02-13T10:25,NA,NA,708,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-28,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-02-13,193,NA,2014-02-13,COMPLETED,NA,2013-08-05,NA,NA,NA,2014-02-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1353,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-04,2013-07-18,1,15,NA,54,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-04T00:00:00Z,NA,H,2013-07-18T00:00:00Z,NA,H,1,15,15,2013-07-04,2013-07-18,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1353,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-04,2013-07-18,1,15,NA,54,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-04T00:00:00Z,NA,H,2013-07-18T00:00:00Z,NA,H,1,15,15,2013-07-04,2013-07-18,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1353,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-04,2013-07-18,1,15,NA,54,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-04T00:00:00Z,NA,H,2013-07-18T00:00:00Z,NA,H,1,15,15,2013-07-04,2013-07-18,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1353,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-04,2013-07-18,1,15,NA,54,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-04T00:00:00Z,NA,H,2013-07-18T00:00:00Z,NA,H,1,15,15,2013-07-04,2013-07-18,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1353,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-04,2013-07-18,1,15,NA,54,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-04T00:00:00Z,NA,H,2013-07-18T00:00:00Z,NA,H,1,15,15,2013-07-04,2013-07-18,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1353,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-19,2013-08-28,16,56,NA,54,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-19T00:00:00Z,NA,H,2013-08-28T00:00:00Z,NA,H,16,56,41,2013-07-19,2013-08-28,2214,2214,DURD,41,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1353,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-19,2013-08-28,16,56,NA,54,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-19T00:00:00Z,NA,H,2013-08-28T00:00:00Z,NA,H,16,56,41,2013-07-19,2013-08-28,2214,2214,DOSE,2214,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1353,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-19,2013-08-28,16,56,NA,54,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-19T00:00:00Z,NA,H,2013-08-28T00:00:00Z,NA,H,16,56,41,2013-07-19,2013-08-28,2214,2214,PLDOSE,2214,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1353,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-19,2013-08-28,16,56,NA,54,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-19T00:00:00Z,NA,H,2013-08-28T00:00:00Z,NA,H,16,56,41,2013-07-19,2013-08-28,2214,2214,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1353,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-19,2013-08-28,16,56,NA,54,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-19T00:00:00Z,NA,H,2013-08-28T00:00:00Z,NA,H,16,56,41,2013-07-19,2013-08-28,2214,2214,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-04T00:00:00Z,NA,NA,2013-08-28T00:00:00Z,NA,NA,NA,NA,NA,2013-07-04,2013-08-28,NA,NA,TDURD,56,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-04T00:00:00Z,NA,NA,2013-08-28T00:00:00Z,NA,NA,NA,NA,NA,2013-07-04,2013-08-28,NA,NA,TDOSE,3024,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-04T00:00:00Z,NA,NA,2013-08-28T00:00:00Z,NA,NA,NA,NA,NA,2013-07-04,2013-08-28,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-04T00:00:00Z,NA,NA,2013-08-28T00:00:00Z,NA,NA,NA,NA,NA,2013-07-04,2013-08-28,NA,NA,TPDOSE,3024,NA,OVERALL,Total planned dose (mg),11,NA,14,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-04T00:00:00Z,NA,NA,2013-08-28T00:00:00Z,NA,NA,NA,NA,NA,2013-07-04,2013-08-28,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-04T00:00:00Z,NA,NA,2013-08-28T00:00:00Z,NA,NA,NA,NA,NA,2013-07-04,2013-08-28,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-04T00:00:00Z,NA,NA,2013-08-28T00:00:00Z,NA,NA,NA,NA,NA,2013-07-04,2013-08-28,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2013-08-28T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2013-08-28,NA,NA,PDURD,41,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2013-08-28T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2013-08-28,NA,NA,PDOSE,2214,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2013-08-28T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2013-08-28,NA,NA,PPDOSE,2214,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2013-08-28T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2013-08-28,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2013-08-28T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2013-08-28,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2013-08-28T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2013-08-28,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1353,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2013-08-28T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2013-08-28T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2013-08-28,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1353,2013-07-04,2013-09-10,2013-07-04,2013-08-28,NA,2013-09-10T13:15,NA,NA,708,87,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-17,-17,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-28,56,NA,2013-09-10,DISCONTINUED,NA,2013-07-04,NA,NA,NA,2013-09-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1372,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-12,2013-04-19,1,8,NA,54,2013-04-12,2013-04-12T00:00:00Z,2013-04-19T23:59:59Z,2013-04-12T00:00:00Z,NA,H,2013-04-19T00:00:00Z,NA,H,1,8,8,2013-04-12,2013-04-19,432,432,DURD,8,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1372,2013-04-12,2013-05-10,2013-04-12,2013-04-19,NA,2013-05-10,NA,NA,708,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-03,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-04-19,8,NA,2013-05-10,DISCONTINUED,NA,2013-04-12,NA,NA,NA,2013-04-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1372,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-12,2013-04-19,1,8,NA,54,2013-04-12,2013-04-12T00:00:00Z,2013-04-19T23:59:59Z,2013-04-12T00:00:00Z,NA,H,2013-04-19T00:00:00Z,NA,H,1,8,8,2013-04-12,2013-04-19,432,432,DOSE,432,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1372,2013-04-12,2013-05-10,2013-04-12,2013-04-19,NA,2013-05-10,NA,NA,708,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-03,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-04-19,8,NA,2013-05-10,DISCONTINUED,NA,2013-04-12,NA,NA,NA,2013-04-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1372,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-12,2013-04-19,1,8,NA,54,2013-04-12,2013-04-12T00:00:00Z,2013-04-19T23:59:59Z,2013-04-12T00:00:00Z,NA,H,2013-04-19T00:00:00Z,NA,H,1,8,8,2013-04-12,2013-04-19,432,432,PLDOSE,432,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1372,2013-04-12,2013-05-10,2013-04-12,2013-04-19,NA,2013-05-10,NA,NA,708,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-03,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-04-19,8,NA,2013-05-10,DISCONTINUED,NA,2013-04-12,NA,NA,NA,2013-04-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1372,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-12,2013-04-19,1,8,NA,54,2013-04-12,2013-04-12T00:00:00Z,2013-04-19T23:59:59Z,2013-04-12T00:00:00Z,NA,H,2013-04-19T00:00:00Z,NA,H,1,8,8,2013-04-12,2013-04-19,432,432,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1372,2013-04-12,2013-05-10,2013-04-12,2013-04-19,NA,2013-05-10,NA,NA,708,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-03,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-04-19,8,NA,2013-05-10,DISCONTINUED,NA,2013-04-12,NA,NA,NA,2013-04-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1372,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-12,2013-04-19,1,8,NA,54,2013-04-12,2013-04-12T00:00:00Z,2013-04-19T23:59:59Z,2013-04-12T00:00:00Z,NA,H,2013-04-19T00:00:00Z,NA,H,1,8,8,2013-04-12,2013-04-19,432,432,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1372,2013-04-12,2013-05-10,2013-04-12,2013-04-19,NA,2013-05-10,NA,NA,708,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-03,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-04-19,8,NA,2013-05-10,DISCONTINUED,NA,2013-04-12,NA,NA,NA,2013-04-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1372,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-12,2013-04-12T00:00:00Z,2013-04-19T23:59:59Z,2013-04-12T00:00:00Z,NA,NA,2013-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-04-12,2013-04-19,NA,NA,TDURD,8,NA,OVERALL,Overall duration (days),7,< 30 days,6,1372,2013-04-12,2013-05-10,2013-04-12,2013-04-19,NA,2013-05-10,NA,NA,708,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-03,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-04-19,8,NA,2013-05-10,DISCONTINUED,NA,2013-04-12,NA,NA,NA,2013-04-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1372,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-12,2013-04-12T00:00:00Z,2013-04-19T23:59:59Z,2013-04-12T00:00:00Z,NA,NA,2013-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-04-12,2013-04-19,NA,NA,TDOSE,432,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1372,2013-04-12,2013-05-10,2013-04-12,2013-04-19,NA,2013-05-10,NA,NA,708,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-03,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-04-19,8,NA,2013-05-10,DISCONTINUED,NA,2013-04-12,NA,NA,NA,2013-04-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1372,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-12,2013-04-12T00:00:00Z,2013-04-19T23:59:59Z,2013-04-12T00:00:00Z,NA,NA,2013-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-04-12,2013-04-19,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1372,2013-04-12,2013-05-10,2013-04-12,2013-04-19,NA,2013-05-10,NA,NA,708,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-03,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-04-19,8,NA,2013-05-10,DISCONTINUED,NA,2013-04-12,NA,NA,NA,2013-04-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1372,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-12,2013-04-12T00:00:00Z,2013-04-19T23:59:59Z,2013-04-12T00:00:00Z,NA,NA,2013-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-04-12,2013-04-19,NA,NA,TPDOSE,432,NA,OVERALL,Total planned dose (mg),11,NA,9,1372,2013-04-12,2013-05-10,2013-04-12,2013-04-19,NA,2013-05-10,NA,NA,708,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-03,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-04-19,8,NA,2013-05-10,DISCONTINUED,NA,2013-04-12,NA,NA,NA,2013-04-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1372,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-12,2013-04-12T00:00:00Z,2013-04-19T23:59:59Z,2013-04-12T00:00:00Z,NA,NA,2013-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-04-12,2013-04-19,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1372,2013-04-12,2013-05-10,2013-04-12,2013-04-19,NA,2013-05-10,NA,NA,708,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-03,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-04-19,8,NA,2013-05-10,DISCONTINUED,NA,2013-04-12,NA,NA,NA,2013-04-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1372,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-12,2013-04-12T00:00:00Z,2013-04-19T23:59:59Z,2013-04-12T00:00:00Z,NA,NA,2013-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-04-12,2013-04-19,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1372,2013-04-12,2013-05-10,2013-04-12,2013-04-19,NA,2013-05-10,NA,NA,708,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-03,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-04-19,8,NA,2013-05-10,DISCONTINUED,NA,2013-04-12,NA,NA,NA,2013-04-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1372,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-12,2013-04-12T00:00:00Z,2013-04-19T23:59:59Z,2013-04-12T00:00:00Z,NA,NA,2013-04-19T00:00:00Z,NA,NA,NA,NA,NA,2013-04-12,2013-04-19,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1372,2013-04-12,2013-05-10,2013-04-12,2013-04-19,NA,2013-05-10,NA,NA,708,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-03,-9,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-04-19,8,NA,2013-05-10,DISCONTINUED,NA,2013-04-12,NA,NA,NA,2013-04-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1378,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-03,2013-09-21,1,19,NA,0,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-03T00:00:00Z,NA,H,2013-09-21T00:00:00Z,NA,H,1,19,19,2013-09-03,2013-09-21,0,0,DURD,19,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1378,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-03,2013-09-21,1,19,NA,0,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-03T00:00:00Z,NA,H,2013-09-21T00:00:00Z,NA,H,1,19,19,2013-09-03,2013-09-21,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1378,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-03,2013-09-21,1,19,NA,0,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-03T00:00:00Z,NA,H,2013-09-21T00:00:00Z,NA,H,1,19,19,2013-09-03,2013-09-21,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1378,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-03,2013-09-21,1,19,NA,0,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-03T00:00:00Z,NA,H,2013-09-21T00:00:00Z,NA,H,1,19,19,2013-09-03,2013-09-21,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1378,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-03,2013-09-21,1,19,NA,0,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-03T00:00:00Z,NA,H,2013-09-21T00:00:00Z,NA,H,1,19,19,2013-09-03,2013-09-21,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1378,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-22,2014-01-28,20,148,NA,0,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-22T00:00:00Z,NA,H,2014-01-28T00:00:00Z,NA,H,20,148,129,2013-09-22,2014-01-28,0,0,DURD,129,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1378,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-22,2014-01-28,20,148,NA,0,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-22T00:00:00Z,NA,H,2014-01-28T00:00:00Z,NA,H,20,148,129,2013-09-22,2014-01-28,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1378,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-22,2014-01-28,20,148,NA,0,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-22T00:00:00Z,NA,H,2014-01-28T00:00:00Z,NA,H,20,148,129,2013-09-22,2014-01-28,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1378,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-22,2014-01-28,20,148,NA,0,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-22T00:00:00Z,NA,H,2014-01-28T00:00:00Z,NA,H,20,148,129,2013-09-22,2014-01-28,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1378,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-22,2014-01-28,20,148,NA,0,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-22T00:00:00Z,NA,H,2014-01-28T00:00:00Z,NA,H,20,148,129,2013-09-22,2014-01-28,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-03T00:00:00Z,NA,NA,2014-01-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-03,2014-01-28,NA,NA,TDURD,148,NA,OVERALL,Overall duration (days),7,>=90 days,11,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-03T00:00:00Z,NA,NA,2014-01-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-03,2014-01-28,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-03T00:00:00Z,NA,NA,2014-01-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-03,2014-01-28,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-03T00:00:00Z,NA,NA,2014-01-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-03,2014-01-28,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-03T00:00:00Z,NA,NA,2014-01-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-03,2014-01-28,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-03T00:00:00Z,NA,NA,2014-01-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-03,2014-01-28,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-03T00:00:00Z,NA,NA,2014-01-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-03,2014-01-28,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-22T00:00:00Z,NA,NA,2014-01-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-22,2014-01-28,NA,NA,PDURD,129,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-22T00:00:00Z,NA,NA,2014-01-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-22,2014-01-28,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-22T00:00:00Z,NA,NA,2014-01-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-22,2014-01-28,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-22T00:00:00Z,NA,NA,2014-01-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-22,2014-01-28,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-22T00:00:00Z,NA,NA,2014-01-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-22,2014-01-28,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-22T00:00:00Z,NA,NA,2014-01-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-22,2014-01-28,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1378,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-03,2013-09-03T00:00:00Z,2014-01-28T23:59:59Z,2013-09-22T00:00:00Z,NA,NA,2014-01-28T00:00:00Z,NA,NA,NA,NA,NA,2013-09-22,2014-01-28,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1378,2013-09-03,2014-01-28,2013-09-03,2014-01-28,NA,2014-01-28T13:00,NA,NA,708,67,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-24,-10,Placebo,Placebo,H,H,2014-01-28,148,NA,2014-01-28,DISCONTINUED,NA,2013-09-03,NA,NA,NA,2014-01-28,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1406,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-26,2014-01-09,1,15,NA,54,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2013-12-26T00:00:00Z,NA,H,2014-01-09T00:00:00Z,NA,H,1,15,15,2013-12-26,2014-01-09,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1406,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-26,2014-01-09,1,15,NA,54,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2013-12-26T00:00:00Z,NA,H,2014-01-09T00:00:00Z,NA,H,1,15,15,2013-12-26,2014-01-09,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1406,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-26,2014-01-09,1,15,NA,54,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2013-12-26T00:00:00Z,NA,H,2014-01-09T00:00:00Z,NA,H,1,15,15,2013-12-26,2014-01-09,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1406,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-26,2014-01-09,1,15,NA,54,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2013-12-26T00:00:00Z,NA,H,2014-01-09T00:00:00Z,NA,H,1,15,15,2013-12-26,2014-01-09,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1406,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-26,2014-01-09,1,15,NA,54,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2013-12-26T00:00:00Z,NA,H,2014-01-09T00:00:00Z,NA,H,1,15,15,2013-12-26,2014-01-09,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1406,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-10,2014-06-16,16,173,NA,54,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-01-10T00:00:00Z,NA,H,2014-06-16T00:00:00Z,NA,H,16,173,158,2014-01-10,2014-06-16,12798,8532,DURD,158,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1406,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-10,2014-06-16,16,173,NA,54,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-01-10T00:00:00Z,NA,H,2014-06-16T00:00:00Z,NA,H,16,173,158,2014-01-10,2014-06-16,12798,8532,DOSE,12798,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1406,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-10,2014-06-16,16,173,NA,54,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-01-10T00:00:00Z,NA,H,2014-06-16T00:00:00Z,NA,H,16,173,158,2014-01-10,2014-06-16,12798,8532,PLDOSE,8532,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1406,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-10,2014-06-16,16,173,NA,54,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-01-10T00:00:00Z,NA,H,2014-06-16T00:00:00Z,NA,H,16,173,158,2014-01-10,2014-06-16,12798,8532,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1406,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-10,2014-06-16,16,173,NA,54,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-01-10T00:00:00Z,NA,H,2014-06-16T00:00:00Z,NA,H,16,173,158,2014-01-10,2014-06-16,12798,8532,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1406,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-17,2014-07-02,174,189,NA,54,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-06-17T00:00:00Z,NA,H,2014-07-02T00:00:00Z,NA,H,174,189,16,2014-06-17,2014-07-02,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1406,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-17,2014-07-02,174,189,NA,54,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-06-17T00:00:00Z,NA,H,2014-07-02T00:00:00Z,NA,H,174,189,16,2014-06-17,2014-07-02,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1406,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-17,2014-07-02,174,189,NA,54,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-06-17T00:00:00Z,NA,H,2014-07-02T00:00:00Z,NA,H,174,189,16,2014-06-17,2014-07-02,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1406,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-17,2014-07-02,174,189,NA,54,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-06-17T00:00:00Z,NA,H,2014-07-02T00:00:00Z,NA,H,174,189,16,2014-06-17,2014-07-02,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1406,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-17,2014-07-02,174,189,NA,54,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-06-17T00:00:00Z,NA,H,2014-07-02T00:00:00Z,NA,H,174,189,16,2014-06-17,2014-07-02,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2013-12-26T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2013-12-26,2014-07-02,NA,NA,TDURD,189,NA,OVERALL,Overall duration (days),7,>=90 days,16,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2013-12-26T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2013-12-26,2014-07-02,NA,NA,TDOSE,14472,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2013-12-26T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2013-12-26,2014-07-02,NA,NA,AVDDSE,76.57142857142857,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2013-12-26T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2013-12-26,2014-07-02,NA,NA,TPDOSE,10206,NA,OVERALL,Total planned dose (mg),11,NA,19,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2013-12-26T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2013-12-26,2014-07-02,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2013-12-26T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2013-12-26,2014-07-02,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2013-12-26T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2013-12-26,2014-07-02,NA,NA,TDOSINT,141.7989417989418,NA,OVERALL,Overall dose intensity (%),90,NA,22,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-01-10T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-10,2014-07-02,NA,NA,PDURD,174,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-01-10T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-10,2014-07-02,NA,NA,PDOSE,13662,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-01-10T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-10,2014-07-02,NA,NA,PPDOSE,9396,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-01-10T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-10,2014-07-02,NA,NA,PAVDDSE,78.51724137931035,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-01-10T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-10,2014-07-02,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-01-10T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-10,2014-07-02,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1406,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-26,2013-12-26T00:00:00Z,2014-07-02T23:59:59Z,2014-01-10T00:00:00Z,NA,NA,2014-07-02T00:00:00Z,NA,NA,NA,NA,NA,2014-01-10,2014-07-02,NA,NA,PDOSINT,145.4022988505747,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1406,2013-12-26,2014-07-02,2013-12-26,2014-07-02,NA,2014-07-02T13:45,NA,NA,708,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-06,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-02,189,NA,2014-07-02,COMPLETED,NA,2013-12-26,NA,NA,NA,2014-07-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1428,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-09,2013-11-23,1,15,NA,54,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-09T00:00:00Z,NA,H,2013-11-23T00:00:00Z,NA,H,1,15,15,2013-11-09,2013-11-23,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1428,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-09,2013-11-23,1,15,NA,54,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-09T00:00:00Z,NA,H,2013-11-23T00:00:00Z,NA,H,1,15,15,2013-11-09,2013-11-23,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1428,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-09,2013-11-23,1,15,NA,54,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-09T00:00:00Z,NA,H,2013-11-23T00:00:00Z,NA,H,1,15,15,2013-11-09,2013-11-23,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1428,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-09,2013-11-23,1,15,NA,54,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-09T00:00:00Z,NA,H,2013-11-23T00:00:00Z,NA,H,1,15,15,2013-11-09,2013-11-23,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1428,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-09,2013-11-23,1,15,NA,54,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-09T00:00:00Z,NA,H,2013-11-23T00:00:00Z,NA,H,1,15,15,2013-11-09,2013-11-23,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1428,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-24,2013-12-14,16,36,NA,54,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-24T00:00:00Z,NA,H,2013-12-14T00:00:00Z,NA,H,16,36,21,2013-11-24,2013-12-14,1134,1134,DURD,21,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1428,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-24,2013-12-14,16,36,NA,54,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-24T00:00:00Z,NA,H,2013-12-14T00:00:00Z,NA,H,16,36,21,2013-11-24,2013-12-14,1134,1134,DOSE,1134,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1428,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-24,2013-12-14,16,36,NA,54,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-24T00:00:00Z,NA,H,2013-12-14T00:00:00Z,NA,H,16,36,21,2013-11-24,2013-12-14,1134,1134,PLDOSE,1134,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1428,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-24,2013-12-14,16,36,NA,54,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-24T00:00:00Z,NA,H,2013-12-14T00:00:00Z,NA,H,16,36,21,2013-11-24,2013-12-14,1134,1134,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-708-1428,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-24,2013-12-14,16,36,NA,54,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-24T00:00:00Z,NA,H,2013-12-14T00:00:00Z,NA,H,16,36,21,2013-11-24,2013-12-14,1134,1134,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1428,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-09T00:00:00Z,NA,NA,2013-12-14T00:00:00Z,NA,NA,NA,NA,NA,2013-11-09,2013-12-14,NA,NA,TDURD,36,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1428,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-09T00:00:00Z,NA,NA,2013-12-14T00:00:00Z,NA,NA,NA,NA,NA,2013-11-09,2013-12-14,NA,NA,TDOSE,1944,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1428,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-09T00:00:00Z,NA,NA,2013-12-14T00:00:00Z,NA,NA,NA,NA,NA,2013-11-09,2013-12-14,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1428,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-09T00:00:00Z,NA,NA,2013-12-14T00:00:00Z,NA,NA,NA,NA,NA,2013-11-09,2013-12-14,NA,NA,TPDOSE,1944,NA,OVERALL,Total planned dose (mg),11,NA,14,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1428,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-09T00:00:00Z,NA,NA,2013-12-14T00:00:00Z,NA,NA,NA,NA,NA,2013-11-09,2013-12-14,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1428,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-09T00:00:00Z,NA,NA,2013-12-14T00:00:00Z,NA,NA,NA,NA,NA,2013-11-09,2013-12-14,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1428,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-09T00:00:00Z,NA,NA,2013-12-14T00:00:00Z,NA,NA,NA,NA,NA,2013-11-09,2013-12-14,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1428,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-24T00:00:00Z,NA,NA,2013-12-14T00:00:00Z,NA,NA,NA,NA,NA,2013-11-24,2013-12-14,NA,NA,PDURD,21,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1428,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-24T00:00:00Z,NA,NA,2013-12-14T00:00:00Z,NA,NA,NA,NA,NA,2013-11-24,2013-12-14,NA,NA,PDOSE,1134,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1428,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-24T00:00:00Z,NA,NA,2013-12-14T00:00:00Z,NA,NA,NA,NA,NA,2013-11-24,2013-12-14,NA,NA,PPDOSE,1134,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1428,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-24T00:00:00Z,NA,NA,2013-12-14T00:00:00Z,NA,NA,NA,NA,NA,2013-11-24,2013-12-14,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1428,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-24T00:00:00Z,NA,NA,2013-12-14T00:00:00Z,NA,NA,NA,NA,NA,2013-11-24,2013-12-14,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1428,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-24T00:00:00Z,NA,NA,2013-12-14T00:00:00Z,NA,NA,NA,NA,NA,2013-11-24,2013-12-14,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-708-1428,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-09,2013-11-09T00:00:00Z,2013-12-14T23:59:59Z,2013-11-24T00:00:00Z,NA,NA,2013-12-14T00:00:00Z,NA,NA,NA,NA,NA,2013-11-24,2013-12-14,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1428,2013-11-09,2014-01-31,2013-11-09,2013-12-14,NA,2014-01-31T11:10,NA,NA,708,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-11-02,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-12-14,36,NA,2014-01-31,DISCONTINUED,NA,2013-11-09,NA,NA,NA,2014-01-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1001,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-08,2013-10-22,1,15,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2013-10-22T00:00:00Z,NA,H,1,15,15,2013-10-08,2013-10-22,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1001,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-08,2013-10-22,1,15,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2013-10-22T00:00:00Z,NA,H,1,15,15,2013-10-08,2013-10-22,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1001,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-08,2013-10-22,1,15,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2013-10-22T00:00:00Z,NA,H,1,15,15,2013-10-08,2013-10-22,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1001,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-08,2013-10-22,1,15,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2013-10-22T00:00:00Z,NA,H,1,15,15,2013-10-08,2013-10-22,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1001,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-08,2013-10-22,1,15,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-08T00:00:00Z,NA,H,2013-10-22T00:00:00Z,NA,H,1,15,15,2013-10-08,2013-10-22,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1001,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-23,2014-03-17,16,161,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-23T00:00:00Z,NA,H,2014-03-17T00:00:00Z,NA,H,16,161,146,2013-10-23,2014-03-17,0,0,DURD,146,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1001,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-23,2014-03-17,16,161,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-23T00:00:00Z,NA,H,2014-03-17T00:00:00Z,NA,H,16,161,146,2013-10-23,2014-03-17,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1001,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-23,2014-03-17,16,161,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-23T00:00:00Z,NA,H,2014-03-17T00:00:00Z,NA,H,16,161,146,2013-10-23,2014-03-17,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1001,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-23,2014-03-17,16,161,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-23T00:00:00Z,NA,H,2014-03-17T00:00:00Z,NA,H,16,161,146,2013-10-23,2014-03-17,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1001,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-23,2014-03-17,16,161,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-23T00:00:00Z,NA,H,2014-03-17T00:00:00Z,NA,H,16,161,146,2013-10-23,2014-03-17,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1001,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-18,2014-04-08,162,183,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2014-03-18T00:00:00Z,NA,H,2014-04-08T00:00:00Z,NA,H,162,183,22,2014-03-18,2014-04-08,0,0,DURD,22,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1001,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-18,2014-04-08,162,183,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2014-03-18T00:00:00Z,NA,H,2014-04-08T00:00:00Z,NA,H,162,183,22,2014-03-18,2014-04-08,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1001,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-18,2014-04-08,162,183,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2014-03-18T00:00:00Z,NA,H,2014-04-08T00:00:00Z,NA,H,162,183,22,2014-03-18,2014-04-08,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1001,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-18,2014-04-08,162,183,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2014-03-18T00:00:00Z,NA,H,2014-04-08T00:00:00Z,NA,H,162,183,22,2014-03-18,2014-04-08,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1001,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-18,2014-04-08,162,183,NA,0,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2014-03-18T00:00:00Z,NA,H,2014-04-08T00:00:00Z,NA,H,162,183,22,2014-03-18,2014-04-08,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1001,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-04-08T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-04-08,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1001,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-04-08T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-04-08,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1001,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-04-08T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-04-08,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1001,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-04-08T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-04-08,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1001,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-04-08T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-04-08,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1001,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-04-08T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-04-08,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1001,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-08T00:00:00Z,NA,NA,2014-04-08T00:00:00Z,NA,NA,NA,NA,NA,2013-10-08,2014-04-08,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1001,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-23T00:00:00Z,NA,NA,2014-04-08T00:00:00Z,NA,NA,NA,NA,NA,2013-10-23,2014-04-08,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1001,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-23T00:00:00Z,NA,NA,2014-04-08T00:00:00Z,NA,NA,NA,NA,NA,2013-10-23,2014-04-08,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1001,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-23T00:00:00Z,NA,NA,2014-04-08T00:00:00Z,NA,NA,NA,NA,NA,2013-10-23,2014-04-08,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1001,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-23T00:00:00Z,NA,NA,2014-04-08T00:00:00Z,NA,NA,NA,NA,NA,2013-10-23,2014-04-08,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1001,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-23T00:00:00Z,NA,NA,2014-04-08T00:00:00Z,NA,NA,NA,NA,NA,2013-10-23,2014-04-08,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1001,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-23T00:00:00Z,NA,NA,2014-04-08T00:00:00Z,NA,NA,NA,NA,NA,2013-10-23,2014-04-08,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1001,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-08,2013-10-08T00:00:00Z,2014-04-08T23:59:59Z,2013-10-23T00:00:00Z,NA,NA,2014-04-08T00:00:00Z,NA,NA,NA,NA,NA,2013-10-23,2014-04-08,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1001,2013-10-08,2014-04-08,2013-10-08,2014-04-08,NA,2014-04-08,NA,NA,709,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-20,-18,Placebo,Placebo,H,H,2014-04-08,183,NA,2014-04-08,COMPLETED,NA,2013-10-08,NA,NA,NA,2014-04-08,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1007,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-31,2012-08-18,1,19,NA,54,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-07-31T00:00:00Z,NA,H,2012-08-18T00:00:00Z,NA,H,1,19,19,2012-07-31,2012-08-18,1026,1026,DURD,19,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1007,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-31,2012-08-18,1,19,NA,54,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-07-31T00:00:00Z,NA,H,2012-08-18T00:00:00Z,NA,H,1,19,19,2012-07-31,2012-08-18,1026,1026,DOSE,1026,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1007,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-31,2012-08-18,1,19,NA,54,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-07-31T00:00:00Z,NA,H,2012-08-18T00:00:00Z,NA,H,1,19,19,2012-07-31,2012-08-18,1026,1026,PLDOSE,1026,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1007,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-31,2012-08-18,1,19,NA,54,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-07-31T00:00:00Z,NA,H,2012-08-18T00:00:00Z,NA,H,1,19,19,2012-07-31,2012-08-18,1026,1026,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1007,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-31,2012-08-18,1,19,NA,54,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-07-31T00:00:00Z,NA,H,2012-08-18T00:00:00Z,NA,H,1,19,19,2012-07-31,2012-08-18,1026,1026,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1007,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-19,2012-08-28,20,29,NA,54,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-08-19T00:00:00Z,NA,H,2012-08-28T00:00:00Z,NA,H,20,29,10,2012-08-19,2012-08-28,540,540,DURD,10,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1007,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-19,2012-08-28,20,29,NA,54,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-08-19T00:00:00Z,NA,H,2012-08-28T00:00:00Z,NA,H,20,29,10,2012-08-19,2012-08-28,540,540,DOSE,540,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1007,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-19,2012-08-28,20,29,NA,54,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-08-19T00:00:00Z,NA,H,2012-08-28T00:00:00Z,NA,H,20,29,10,2012-08-19,2012-08-28,540,540,PLDOSE,540,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1007,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-19,2012-08-28,20,29,NA,54,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-08-19T00:00:00Z,NA,H,2012-08-28T00:00:00Z,NA,H,20,29,10,2012-08-19,2012-08-28,540,540,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1007,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-19,2012-08-28,20,29,NA,54,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-08-19T00:00:00Z,NA,H,2012-08-28T00:00:00Z,NA,H,20,29,10,2012-08-19,2012-08-28,540,540,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-07-31T00:00:00Z,NA,NA,2012-08-28T00:00:00Z,NA,NA,NA,NA,NA,2012-07-31,2012-08-28,NA,NA,TDURD,29,NA,OVERALL,Overall duration (days),7,< 30 days,11,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-07-31T00:00:00Z,NA,NA,2012-08-28T00:00:00Z,NA,NA,NA,NA,NA,2012-07-31,2012-08-28,NA,NA,TDOSE,1566,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-07-31T00:00:00Z,NA,NA,2012-08-28T00:00:00Z,NA,NA,NA,NA,NA,2012-07-31,2012-08-28,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-07-31T00:00:00Z,NA,NA,2012-08-28T00:00:00Z,NA,NA,NA,NA,NA,2012-07-31,2012-08-28,NA,NA,TPDOSE,1566,NA,OVERALL,Total planned dose (mg),11,NA,14,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-07-31T00:00:00Z,NA,NA,2012-08-28T00:00:00Z,NA,NA,NA,NA,NA,2012-07-31,2012-08-28,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-07-31T00:00:00Z,NA,NA,2012-08-28T00:00:00Z,NA,NA,NA,NA,NA,2012-07-31,2012-08-28,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-07-31T00:00:00Z,NA,NA,2012-08-28T00:00:00Z,NA,NA,NA,NA,NA,2012-07-31,2012-08-28,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-08-19T00:00:00Z,NA,NA,2012-08-28T00:00:00Z,NA,NA,NA,NA,NA,2012-08-19,2012-08-28,NA,NA,PDURD,10,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-08-19T00:00:00Z,NA,NA,2012-08-28T00:00:00Z,NA,NA,NA,NA,NA,2012-08-19,2012-08-28,NA,NA,PDOSE,540,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-08-19T00:00:00Z,NA,NA,2012-08-28T00:00:00Z,NA,NA,NA,NA,NA,2012-08-19,2012-08-28,NA,NA,PPDOSE,540,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-08-19T00:00:00Z,NA,NA,2012-08-28T00:00:00Z,NA,NA,NA,NA,NA,2012-08-19,2012-08-28,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-08-19T00:00:00Z,NA,NA,2012-08-28T00:00:00Z,NA,NA,NA,NA,NA,2012-08-19,2012-08-28,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-08-19T00:00:00Z,NA,NA,2012-08-28T00:00:00Z,NA,NA,NA,NA,NA,2012-08-19,2012-08-28,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1007,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-31,2012-07-31T00:00:00Z,2012-08-28T23:59:59Z,2012-08-19T00:00:00Z,NA,NA,2012-08-28T00:00:00Z,NA,NA,NA,NA,NA,2012-08-19,2012-08-28,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1007,2012-07-31,2012-09-01,2012-07-31,2012-08-28,NA,2012-09-07,NA,NA,709,54,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-07-21,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-08-28,29,NA,2012-09-01,DISCONTINUED,NA,2012-07-31,NA,NA,NA,2012-09-01,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1020,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-01,2012-12-15,1,15,NA,54,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-01T00:00:00Z,NA,H,2012-12-15T00:00:00Z,NA,H,1,15,15,2012-12-01,2012-12-15,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1020,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-01,2012-12-15,1,15,NA,54,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-01T00:00:00Z,NA,H,2012-12-15T00:00:00Z,NA,H,1,15,15,2012-12-01,2012-12-15,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1020,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-01,2012-12-15,1,15,NA,54,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-01T00:00:00Z,NA,H,2012-12-15T00:00:00Z,NA,H,1,15,15,2012-12-01,2012-12-15,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1020,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-01,2012-12-15,1,15,NA,54,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-01T00:00:00Z,NA,H,2012-12-15T00:00:00Z,NA,H,1,15,15,2012-12-01,2012-12-15,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1020,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-01,2012-12-15,1,15,NA,54,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-01T00:00:00Z,NA,H,2012-12-15T00:00:00Z,NA,H,1,15,15,2012-12-01,2012-12-15,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1020,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-16,2013-05-18,16,169,NA,54,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-16T00:00:00Z,NA,H,2013-05-18T00:00:00Z,NA,H,16,169,154,2012-12-16,2013-05-18,8316,8316,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1020,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-16,2013-05-18,16,169,NA,54,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-16T00:00:00Z,NA,H,2013-05-18T00:00:00Z,NA,H,16,169,154,2012-12-16,2013-05-18,8316,8316,DOSE,8316,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1020,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-16,2013-05-18,16,169,NA,54,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-16T00:00:00Z,NA,H,2013-05-18T00:00:00Z,NA,H,16,169,154,2012-12-16,2013-05-18,8316,8316,PLDOSE,8316,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1020,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-16,2013-05-18,16,169,NA,54,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-16T00:00:00Z,NA,H,2013-05-18T00:00:00Z,NA,H,16,169,154,2012-12-16,2013-05-18,8316,8316,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1020,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-16,2013-05-18,16,169,NA,54,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-16T00:00:00Z,NA,H,2013-05-18T00:00:00Z,NA,H,16,169,154,2012-12-16,2013-05-18,8316,8316,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1020,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-19,2013-06-01,170,183,NA,54,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2013-05-19T00:00:00Z,NA,H,2013-06-01T00:00:00Z,NA,H,170,183,14,2013-05-19,2013-06-01,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1020,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-19,2013-06-01,170,183,NA,54,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2013-05-19T00:00:00Z,NA,H,2013-06-01T00:00:00Z,NA,H,170,183,14,2013-05-19,2013-06-01,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1020,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-19,2013-06-01,170,183,NA,54,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2013-05-19T00:00:00Z,NA,H,2013-06-01T00:00:00Z,NA,H,170,183,14,2013-05-19,2013-06-01,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1020,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-19,2013-06-01,170,183,NA,54,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2013-05-19T00:00:00Z,NA,H,2013-06-01T00:00:00Z,NA,H,170,183,14,2013-05-19,2013-06-01,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1020,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-19,2013-06-01,170,183,NA,54,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2013-05-19T00:00:00Z,NA,H,2013-06-01T00:00:00Z,NA,H,170,183,14,2013-05-19,2013-06-01,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1020,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-01T00:00:00Z,NA,NA,2013-06-01T00:00:00Z,NA,NA,NA,NA,NA,2012-12-01,2013-06-01,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1020,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-01T00:00:00Z,NA,NA,2013-06-01T00:00:00Z,NA,NA,NA,NA,NA,2012-12-01,2013-06-01,NA,NA,TDOSE,9882,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1020,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-01T00:00:00Z,NA,NA,2013-06-01T00:00:00Z,NA,NA,NA,NA,NA,2012-12-01,2013-06-01,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1020,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-01T00:00:00Z,NA,NA,2013-06-01T00:00:00Z,NA,NA,NA,NA,NA,2012-12-01,2013-06-01,NA,NA,TPDOSE,9882,NA,OVERALL,Total planned dose (mg),11,NA,19,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1020,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-01T00:00:00Z,NA,NA,2013-06-01T00:00:00Z,NA,NA,NA,NA,NA,2012-12-01,2013-06-01,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1020,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-01T00:00:00Z,NA,NA,2013-06-01T00:00:00Z,NA,NA,NA,NA,NA,2012-12-01,2013-06-01,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1020,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-01T00:00:00Z,NA,NA,2013-06-01T00:00:00Z,NA,NA,NA,NA,NA,2012-12-01,2013-06-01,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1020,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-16T00:00:00Z,NA,NA,2013-06-01T00:00:00Z,NA,NA,NA,NA,NA,2012-12-16,2013-06-01,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1020,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-16T00:00:00Z,NA,NA,2013-06-01T00:00:00Z,NA,NA,NA,NA,NA,2012-12-16,2013-06-01,NA,NA,PDOSE,9072,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1020,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-16T00:00:00Z,NA,NA,2013-06-01T00:00:00Z,NA,NA,NA,NA,NA,2012-12-16,2013-06-01,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1020,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-16T00:00:00Z,NA,NA,2013-06-01T00:00:00Z,NA,NA,NA,NA,NA,2012-12-16,2013-06-01,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1020,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-16T00:00:00Z,NA,NA,2013-06-01T00:00:00Z,NA,NA,NA,NA,NA,2012-12-16,2013-06-01,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1020,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-16T00:00:00Z,NA,NA,2013-06-01T00:00:00Z,NA,NA,NA,NA,NA,2012-12-16,2013-06-01,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1020,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-01,2012-12-01T00:00:00Z,2013-06-01T23:59:59Z,2012-12-16T00:00:00Z,NA,NA,2013-06-01T00:00:00Z,NA,NA,NA,NA,NA,2012-12-16,2013-06-01,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1020,2012-12-01,2013-06-01,2012-12-01,2013-06-01,NA,2013-06-01T10:40,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-22,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-01,183,NA,2013-06-01,COMPLETED,NA,2012-12-01,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1029,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-25,2013-01-09,1,16,NA,54,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2012-12-25T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,1,16,16,2012-12-25,2013-01-09,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1029,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-25,2013-01-09,1,16,NA,54,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2012-12-25T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,1,16,16,2012-12-25,2013-01-09,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1029,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-25,2013-01-09,1,16,NA,54,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2012-12-25T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,1,16,16,2012-12-25,2013-01-09,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1029,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-25,2013-01-09,1,16,NA,54,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2012-12-25T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,1,16,16,2012-12-25,2013-01-09,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1029,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-25,2013-01-09,1,16,NA,54,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2012-12-25T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,1,16,16,2012-12-25,2013-01-09,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1029,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-10,2013-06-12,17,170,NA,54,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-01-10T00:00:00Z,NA,H,2013-06-12T00:00:00Z,NA,H,17,170,154,2013-01-10,2013-06-12,12474,8316,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1029,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-10,2013-06-12,17,170,NA,54,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-01-10T00:00:00Z,NA,H,2013-06-12T00:00:00Z,NA,H,17,170,154,2013-01-10,2013-06-12,12474,8316,DOSE,12474,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1029,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-10,2013-06-12,17,170,NA,54,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-01-10T00:00:00Z,NA,H,2013-06-12T00:00:00Z,NA,H,17,170,154,2013-01-10,2013-06-12,12474,8316,PLDOSE,8316,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1029,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-10,2013-06-12,17,170,NA,54,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-01-10T00:00:00Z,NA,H,2013-06-12T00:00:00Z,NA,H,17,170,154,2013-01-10,2013-06-12,12474,8316,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1029,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-10,2013-06-12,17,170,NA,54,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-01-10T00:00:00Z,NA,H,2013-06-12T00:00:00Z,NA,H,17,170,154,2013-01-10,2013-06-12,12474,8316,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1029,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-13,2013-06-26,171,184,NA,54,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-06-13T00:00:00Z,NA,H,2013-06-26T00:00:00Z,NA,H,171,184,14,2013-06-13,2013-06-26,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1029,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-13,2013-06-26,171,184,NA,54,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-06-13T00:00:00Z,NA,H,2013-06-26T00:00:00Z,NA,H,171,184,14,2013-06-13,2013-06-26,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1029,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-13,2013-06-26,171,184,NA,54,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-06-13T00:00:00Z,NA,H,2013-06-26T00:00:00Z,NA,H,171,184,14,2013-06-13,2013-06-26,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1029,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-13,2013-06-26,171,184,NA,54,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-06-13T00:00:00Z,NA,H,2013-06-26T00:00:00Z,NA,H,171,184,14,2013-06-13,2013-06-26,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1029,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-13,2013-06-26,171,184,NA,54,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-06-13T00:00:00Z,NA,H,2013-06-26T00:00:00Z,NA,H,171,184,14,2013-06-13,2013-06-26,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2012-12-25T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2012-12-25,2013-06-26,NA,NA,TDURD,184,NA,OVERALL,Overall duration (days),7,>=90 days,16,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2012-12-25T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2012-12-25,2013-06-26,NA,NA,TDOSE,14094,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2012-12-25T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2012-12-25,2013-06-26,NA,NA,AVDDSE,76.59782608695652,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2012-12-25T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2012-12-25,2013-06-26,NA,NA,TPDOSE,9936,NA,OVERALL,Total planned dose (mg),11,NA,19,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2012-12-25T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2012-12-25,2013-06-26,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2012-12-25T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2012-12-25,2013-06-26,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2012-12-25T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2012-12-25,2013-06-26,NA,NA,TDOSINT,141.84782608695653,NA,OVERALL,Overall dose intensity (%),90,NA,22,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-06-26,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-06-26,NA,NA,PDOSE,13230,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-06-26,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-06-26,NA,NA,PAVDDSE,78.75,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-06-26,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-06-26,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1029,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-25,2012-12-25T00:00:00Z,2013-06-26T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-06-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-06-26,NA,NA,PDOSINT,145.83333333333331,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1029,2012-12-25,2013-06-26,2012-12-25,2013-06-26,NA,2013-06-26T10:58,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-10,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-06-26,184,NA,2013-06-26,COMPLETED,NA,2012-12-25,NA,NA,NA,2013-06-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1081,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-18,2014-02-01,1,15,NA,54,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-01-18T00:00:00Z,NA,H,2014-02-01T00:00:00Z,NA,H,1,15,15,2014-01-18,2014-02-01,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1081,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-18,2014-02-01,1,15,NA,54,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-01-18T00:00:00Z,NA,H,2014-02-01T00:00:00Z,NA,H,1,15,15,2014-01-18,2014-02-01,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1081,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-18,2014-02-01,1,15,NA,54,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-01-18T00:00:00Z,NA,H,2014-02-01T00:00:00Z,NA,H,1,15,15,2014-01-18,2014-02-01,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1081,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-18,2014-02-01,1,15,NA,54,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-01-18T00:00:00Z,NA,H,2014-02-01T00:00:00Z,NA,H,1,15,15,2014-01-18,2014-02-01,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1081,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-18,2014-02-01,1,15,NA,54,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-01-18T00:00:00Z,NA,H,2014-02-01T00:00:00Z,NA,H,1,15,15,2014-01-18,2014-02-01,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1081,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-02,2014-04-27,16,100,NA,54,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-02-02T00:00:00Z,NA,H,2014-04-27T00:00:00Z,NA,H,16,100,85,2014-02-02,2014-04-27,4590,4590,DURD,85,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1081,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-02,2014-04-27,16,100,NA,54,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-02-02T00:00:00Z,NA,H,2014-04-27T00:00:00Z,NA,H,16,100,85,2014-02-02,2014-04-27,4590,4590,DOSE,4590,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1081,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-02,2014-04-27,16,100,NA,54,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-02-02T00:00:00Z,NA,H,2014-04-27T00:00:00Z,NA,H,16,100,85,2014-02-02,2014-04-27,4590,4590,PLDOSE,4590,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1081,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-02,2014-04-27,16,100,NA,54,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-02-02T00:00:00Z,NA,H,2014-04-27T00:00:00Z,NA,H,16,100,85,2014-02-02,2014-04-27,4590,4590,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1081,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-02,2014-04-27,16,100,NA,54,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-02-02T00:00:00Z,NA,H,2014-04-27T00:00:00Z,NA,H,16,100,85,2014-02-02,2014-04-27,4590,4590,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-01-18T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-01-18,2014-04-27,NA,NA,TDURD,100,NA,OVERALL,Overall duration (days),7,>=90 days,11,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-01-18T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-01-18,2014-04-27,NA,NA,TDOSE,5400,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-01-18T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-01-18,2014-04-27,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-01-18T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-01-18,2014-04-27,NA,NA,TPDOSE,5400,NA,OVERALL,Total planned dose (mg),11,NA,14,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-01-18T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-01-18,2014-04-27,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-01-18T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-01-18,2014-04-27,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-01-18T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-01-18,2014-04-27,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-02-02T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-02-02,2014-04-27,NA,NA,PDURD,85,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-02-02T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-02-02,2014-04-27,NA,NA,PDOSE,4590,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-02-02T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-02-02,2014-04-27,NA,NA,PPDOSE,4590,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-02-02T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-02-02,2014-04-27,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-02-02T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-02-02,2014-04-27,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-02-02T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-02-02,2014-04-27,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1081,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-18,2014-01-18T00:00:00Z,2014-04-27T23:59:59Z,2014-02-02T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-02-02,2014-04-27,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1081,2014-01-18,2014-05-10,2014-01-18,2014-04-27,NA,2014-05-10T11:15,NA,NA,709,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-09,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,100,NA,2014-05-10,DISCONTINUED,NA,2014-01-18,NA,NA,NA,2014-05-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1088,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-12,2014-04-26,1,15,NA,0,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-12T00:00:00Z,NA,H,2014-04-26T00:00:00Z,NA,H,1,15,15,2014-04-12,2014-04-26,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1088,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-12,2014-04-26,1,15,NA,0,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-12T00:00:00Z,NA,H,2014-04-26T00:00:00Z,NA,H,1,15,15,2014-04-12,2014-04-26,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1088,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-12,2014-04-26,1,15,NA,0,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-12T00:00:00Z,NA,H,2014-04-26T00:00:00Z,NA,H,1,15,15,2014-04-12,2014-04-26,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1088,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-12,2014-04-26,1,15,NA,0,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-12T00:00:00Z,NA,H,2014-04-26T00:00:00Z,NA,H,1,15,15,2014-04-12,2014-04-26,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1088,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-12,2014-04-26,1,15,NA,0,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-12T00:00:00Z,NA,H,2014-04-26T00:00:00Z,NA,H,1,15,15,2014-04-12,2014-04-26,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1088,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-27,2014-09-27,16,169,NA,0,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-27T00:00:00Z,NA,H,2014-09-27T00:00:00Z,NA,H,16,169,154,2014-04-27,2014-09-27,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1088,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-27,2014-09-27,16,169,NA,0,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-27T00:00:00Z,NA,H,2014-09-27T00:00:00Z,NA,H,16,169,154,2014-04-27,2014-09-27,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1088,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-27,2014-09-27,16,169,NA,0,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-27T00:00:00Z,NA,H,2014-09-27T00:00:00Z,NA,H,16,169,154,2014-04-27,2014-09-27,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1088,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-27,2014-09-27,16,169,NA,0,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-27T00:00:00Z,NA,H,2014-09-27T00:00:00Z,NA,H,16,169,154,2014-04-27,2014-09-27,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1088,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-27,2014-09-27,16,169,NA,0,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-27T00:00:00Z,NA,H,2014-09-27T00:00:00Z,NA,H,16,169,154,2014-04-27,2014-09-27,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1088,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-09-28,2014-10-09,170,181,NA,0,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-09-28T00:00:00Z,NA,H,2014-10-09T00:00:00Z,NA,H,170,181,12,2014-09-28,2014-10-09,0,0,DURD,12,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1088,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-09-28,2014-10-09,170,181,NA,0,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-09-28T00:00:00Z,NA,H,2014-10-09T00:00:00Z,NA,H,170,181,12,2014-09-28,2014-10-09,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1088,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-09-28,2014-10-09,170,181,NA,0,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-09-28T00:00:00Z,NA,H,2014-10-09T00:00:00Z,NA,H,170,181,12,2014-09-28,2014-10-09,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1088,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-09-28,2014-10-09,170,181,NA,0,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-09-28T00:00:00Z,NA,H,2014-10-09T00:00:00Z,NA,H,170,181,12,2014-09-28,2014-10-09,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1088,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-09-28,2014-10-09,170,181,NA,0,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-09-28T00:00:00Z,NA,H,2014-10-09T00:00:00Z,NA,H,170,181,12,2014-09-28,2014-10-09,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-12T00:00:00Z,NA,NA,2014-10-09T00:00:00Z,NA,NA,NA,NA,NA,2014-04-12,2014-10-09,NA,NA,TDURD,181,NA,OVERALL,Overall duration (days),7,>=90 days,16,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-12T00:00:00Z,NA,NA,2014-10-09T00:00:00Z,NA,NA,NA,NA,NA,2014-04-12,2014-10-09,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-12T00:00:00Z,NA,NA,2014-10-09T00:00:00Z,NA,NA,NA,NA,NA,2014-04-12,2014-10-09,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-12T00:00:00Z,NA,NA,2014-10-09T00:00:00Z,NA,NA,NA,NA,NA,2014-04-12,2014-10-09,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-12T00:00:00Z,NA,NA,2014-10-09T00:00:00Z,NA,NA,NA,NA,NA,2014-04-12,2014-10-09,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-12T00:00:00Z,NA,NA,2014-10-09T00:00:00Z,NA,NA,NA,NA,NA,2014-04-12,2014-10-09,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-12T00:00:00Z,NA,NA,2014-10-09T00:00:00Z,NA,NA,NA,NA,NA,2014-04-12,2014-10-09,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-27T00:00:00Z,NA,NA,2014-10-09T00:00:00Z,NA,NA,NA,NA,NA,2014-04-27,2014-10-09,NA,NA,PDURD,166,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-27T00:00:00Z,NA,NA,2014-10-09T00:00:00Z,NA,NA,NA,NA,NA,2014-04-27,2014-10-09,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-27T00:00:00Z,NA,NA,2014-10-09T00:00:00Z,NA,NA,NA,NA,NA,2014-04-27,2014-10-09,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-27T00:00:00Z,NA,NA,2014-10-09T00:00:00Z,NA,NA,NA,NA,NA,2014-04-27,2014-10-09,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-27T00:00:00Z,NA,NA,2014-10-09T00:00:00Z,NA,NA,NA,NA,NA,2014-04-27,2014-10-09,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-27T00:00:00Z,NA,NA,2014-10-09T00:00:00Z,NA,NA,NA,NA,NA,2014-04-27,2014-10-09,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1088,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-12,2014-04-12T00:00:00Z,2014-10-09T23:59:59Z,2014-04-27T00:00:00Z,NA,NA,2014-10-09T00:00:00Z,NA,NA,NA,NA,NA,2014-04-27,2014-10-09,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1088,2014-04-12,2014-10-09,2014-04-12,2014-10-09,NA,2014-10-09T13:25,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-30,-13,Placebo,Placebo,H,H,2014-10-09,181,NA,2014-10-09,COMPLETED,NA,2014-04-12,NA,NA,NA,2014-10-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1099,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-25,2013-11-12,1,19,NA,54,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-10-25T00:00:00Z,NA,H,2013-11-12T00:00:00Z,NA,H,1,19,19,2013-10-25,2013-11-12,1026,1026,DURD,19,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1099,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-25,2013-11-12,1,19,NA,54,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-10-25T00:00:00Z,NA,H,2013-11-12T00:00:00Z,NA,H,1,19,19,2013-10-25,2013-11-12,1026,1026,DOSE,1026,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1099,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-25,2013-11-12,1,19,NA,54,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-10-25T00:00:00Z,NA,H,2013-11-12T00:00:00Z,NA,H,1,19,19,2013-10-25,2013-11-12,1026,1026,PLDOSE,1026,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1099,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-25,2013-11-12,1,19,NA,54,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-10-25T00:00:00Z,NA,H,2013-11-12T00:00:00Z,NA,H,1,19,19,2013-10-25,2013-11-12,1026,1026,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1099,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-25,2013-11-12,1,19,NA,54,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-10-25T00:00:00Z,NA,H,2013-11-12T00:00:00Z,NA,H,1,19,19,2013-10-25,2013-11-12,1026,1026,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1099,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-13,2014-04-11,20,169,NA,54,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-11-13T00:00:00Z,NA,H,2014-04-11T00:00:00Z,NA,H,20,169,150,2013-11-13,2014-04-11,12150,8100,DURD,150,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1099,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-13,2014-04-11,20,169,NA,54,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-11-13T00:00:00Z,NA,H,2014-04-11T00:00:00Z,NA,H,20,169,150,2013-11-13,2014-04-11,12150,8100,DOSE,12150,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1099,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-13,2014-04-11,20,169,NA,54,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-11-13T00:00:00Z,NA,H,2014-04-11T00:00:00Z,NA,H,20,169,150,2013-11-13,2014-04-11,12150,8100,PLDOSE,8100,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1099,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-13,2014-04-11,20,169,NA,54,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-11-13T00:00:00Z,NA,H,2014-04-11T00:00:00Z,NA,H,20,169,150,2013-11-13,2014-04-11,12150,8100,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1099,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-13,2014-04-11,20,169,NA,54,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-11-13T00:00:00Z,NA,H,2014-04-11T00:00:00Z,NA,H,20,169,150,2013-11-13,2014-04-11,12150,8100,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1099,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-12,2014-04-25,170,183,NA,54,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2014-04-12T00:00:00Z,NA,H,2014-04-25T00:00:00Z,NA,H,170,183,14,2014-04-12,2014-04-25,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1099,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-12,2014-04-25,170,183,NA,54,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2014-04-12T00:00:00Z,NA,H,2014-04-25T00:00:00Z,NA,H,170,183,14,2014-04-12,2014-04-25,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1099,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-12,2014-04-25,170,183,NA,54,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2014-04-12T00:00:00Z,NA,H,2014-04-25T00:00:00Z,NA,H,170,183,14,2014-04-12,2014-04-25,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1099,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-12,2014-04-25,170,183,NA,54,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2014-04-12T00:00:00Z,NA,H,2014-04-25T00:00:00Z,NA,H,170,183,14,2014-04-12,2014-04-25,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1099,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-12,2014-04-25,170,183,NA,54,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2014-04-12T00:00:00Z,NA,H,2014-04-25T00:00:00Z,NA,H,170,183,14,2014-04-12,2014-04-25,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2014-04-25T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2014-04-25,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2014-04-25T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2014-04-25,NA,NA,TDOSE,13932,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2014-04-25T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2014-04-25,NA,NA,AVDDSE,76.1311475409836,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2014-04-25T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2014-04-25,NA,NA,TPDOSE,9882,NA,OVERALL,Total planned dose (mg),11,NA,19,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2014-04-25T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2014-04-25,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2014-04-25T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2014-04-25,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-10-25T00:00:00Z,NA,NA,2014-04-25T00:00:00Z,NA,NA,NA,NA,NA,2013-10-25,2014-04-25,NA,NA,TDOSINT,140.98360655737704,NA,OVERALL,Overall dose intensity (%),90,NA,22,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-11-13T00:00:00Z,NA,NA,2014-04-25T00:00:00Z,NA,NA,NA,NA,NA,2013-11-13,2014-04-25,NA,NA,PDURD,164,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-11-13T00:00:00Z,NA,NA,2014-04-25T00:00:00Z,NA,NA,NA,NA,NA,2013-11-13,2014-04-25,NA,NA,PDOSE,12906,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-11-13T00:00:00Z,NA,NA,2014-04-25T00:00:00Z,NA,NA,NA,NA,NA,2013-11-13,2014-04-25,NA,NA,PPDOSE,8856,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-11-13T00:00:00Z,NA,NA,2014-04-25T00:00:00Z,NA,NA,NA,NA,NA,2013-11-13,2014-04-25,NA,NA,PAVDDSE,78.6951219512195,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-11-13T00:00:00Z,NA,NA,2014-04-25T00:00:00Z,NA,NA,NA,NA,NA,2013-11-13,2014-04-25,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-11-13T00:00:00Z,NA,NA,2014-04-25T00:00:00Z,NA,NA,NA,NA,NA,2013-11-13,2014-04-25,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1099,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-25,2013-10-25T00:00:00Z,2014-04-25T23:59:59Z,2013-11-13T00:00:00Z,NA,NA,2014-04-25T00:00:00Z,NA,NA,NA,NA,NA,2013-11-13,2014-04-25,NA,NA,PDOSINT,145.73170731707316,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1099,2013-10-25,2014-04-25,2013-10-25,2014-04-25,NA,2014-04-25T09:10,NA,NA,709,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-14,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-25,183,NA,2014-04-25,COMPLETED,NA,2013-10-25,NA,NA,NA,2014-04-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1102,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-15,2013-01-31,1,17,NA,54,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-01-15T00:00:00Z,NA,H,2013-01-31T00:00:00Z,NA,H,1,17,17,2013-01-15,2013-01-31,918,918,DURD,17,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1102,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-15,2013-01-31,1,17,NA,54,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-01-15T00:00:00Z,NA,H,2013-01-31T00:00:00Z,NA,H,1,17,17,2013-01-15,2013-01-31,918,918,DOSE,918,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1102,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-15,2013-01-31,1,17,NA,54,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-01-15T00:00:00Z,NA,H,2013-01-31T00:00:00Z,NA,H,1,17,17,2013-01-15,2013-01-31,918,918,PLDOSE,918,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1102,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-15,2013-01-31,1,17,NA,54,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-01-15T00:00:00Z,NA,H,2013-01-31T00:00:00Z,NA,H,1,17,17,2013-01-15,2013-01-31,918,918,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1102,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-15,2013-01-31,1,17,NA,54,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-01-15T00:00:00Z,NA,H,2013-01-31T00:00:00Z,NA,H,1,17,17,2013-01-15,2013-01-31,918,918,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1102,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-01,2013-03-27,18,72,NA,54,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-02-01T00:00:00Z,NA,H,2013-03-27T00:00:00Z,NA,H,18,72,55,2013-02-01,2013-03-27,2970,2970,DURD,55,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1102,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-01,2013-03-27,18,72,NA,54,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-02-01T00:00:00Z,NA,H,2013-03-27T00:00:00Z,NA,H,18,72,55,2013-02-01,2013-03-27,2970,2970,DOSE,2970,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1102,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-01,2013-03-27,18,72,NA,54,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-02-01T00:00:00Z,NA,H,2013-03-27T00:00:00Z,NA,H,18,72,55,2013-02-01,2013-03-27,2970,2970,PLDOSE,2970,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1102,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-01,2013-03-27,18,72,NA,54,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-02-01T00:00:00Z,NA,H,2013-03-27T00:00:00Z,NA,H,18,72,55,2013-02-01,2013-03-27,2970,2970,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1102,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-01,2013-03-27,18,72,NA,54,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-02-01T00:00:00Z,NA,H,2013-03-27T00:00:00Z,NA,H,18,72,55,2013-02-01,2013-03-27,2970,2970,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-01-15T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2013-01-15,2013-03-27,NA,NA,TDURD,72,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-01-15T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2013-01-15,2013-03-27,NA,NA,TDOSE,3888,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-01-15T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2013-01-15,2013-03-27,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-01-15T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2013-01-15,2013-03-27,NA,NA,TPDOSE,3888,NA,OVERALL,Total planned dose (mg),11,NA,14,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-01-15T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2013-01-15,2013-03-27,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-01-15T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2013-01-15,2013-03-27,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-01-15T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2013-01-15,2013-03-27,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-03-27,NA,NA,PDURD,55,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-03-27,NA,NA,PDOSE,2970,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-03-27,NA,NA,PPDOSE,2970,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-03-27,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-03-27,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-03-27,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1102,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-15,2013-01-15T00:00:00Z,2013-03-27T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-03-27,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1102,2013-01-15,2013-03-31,2013-01-15,2013-03-27,NA,2013-05-12,NA,NA,709,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-07,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,72,NA,2013-03-31,DISCONTINUED,NA,2013-01-15,NA,NA,NA,2013-03-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1168,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-02,2013-08-17,1,16,NA,54,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-02T00:00:00Z,NA,H,2013-08-17T00:00:00Z,NA,H,1,16,16,2013-08-02,2013-08-17,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1168,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-02,2013-08-17,1,16,NA,54,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-02T00:00:00Z,NA,H,2013-08-17T00:00:00Z,NA,H,1,16,16,2013-08-02,2013-08-17,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1168,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-02,2013-08-17,1,16,NA,54,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-02T00:00:00Z,NA,H,2013-08-17T00:00:00Z,NA,H,1,16,16,2013-08-02,2013-08-17,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1168,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-02,2013-08-17,1,16,NA,54,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-02T00:00:00Z,NA,H,2013-08-17T00:00:00Z,NA,H,1,16,16,2013-08-02,2013-08-17,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1168,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-02,2013-08-17,1,16,NA,54,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-02T00:00:00Z,NA,H,2013-08-17T00:00:00Z,NA,H,1,16,16,2013-08-02,2013-08-17,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1168,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-18,2013-09-26,17,56,NA,54,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-18T00:00:00Z,NA,H,2013-09-26T00:00:00Z,NA,H,17,56,40,2013-08-18,2013-09-26,3240,2160,DURD,40,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1168,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-18,2013-09-26,17,56,NA,54,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-18T00:00:00Z,NA,H,2013-09-26T00:00:00Z,NA,H,17,56,40,2013-08-18,2013-09-26,3240,2160,DOSE,3240,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1168,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-18,2013-09-26,17,56,NA,54,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-18T00:00:00Z,NA,H,2013-09-26T00:00:00Z,NA,H,17,56,40,2013-08-18,2013-09-26,3240,2160,PLDOSE,2160,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1168,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-18,2013-09-26,17,56,NA,54,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-18T00:00:00Z,NA,H,2013-09-26T00:00:00Z,NA,H,17,56,40,2013-08-18,2013-09-26,3240,2160,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1168,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-18,2013-09-26,17,56,NA,54,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-18T00:00:00Z,NA,H,2013-09-26T00:00:00Z,NA,H,17,56,40,2013-08-18,2013-09-26,3240,2160,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-02T00:00:00Z,NA,NA,2013-09-26T00:00:00Z,NA,NA,NA,NA,NA,2013-08-02,2013-09-26,NA,NA,TDURD,56,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-02T00:00:00Z,NA,NA,2013-09-26T00:00:00Z,NA,NA,NA,NA,NA,2013-08-02,2013-09-26,NA,NA,TDOSE,4104,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-02T00:00:00Z,NA,NA,2013-09-26T00:00:00Z,NA,NA,NA,NA,NA,2013-08-02,2013-09-26,NA,NA,AVDDSE,73.28571428571429,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-02T00:00:00Z,NA,NA,2013-09-26T00:00:00Z,NA,NA,NA,NA,NA,2013-08-02,2013-09-26,NA,NA,TPDOSE,3024,NA,OVERALL,Total planned dose (mg),11,NA,14,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-02T00:00:00Z,NA,NA,2013-09-26T00:00:00Z,NA,NA,NA,NA,NA,2013-08-02,2013-09-26,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-02T00:00:00Z,NA,NA,2013-09-26T00:00:00Z,NA,NA,NA,NA,NA,2013-08-02,2013-09-26,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-02T00:00:00Z,NA,NA,2013-09-26T00:00:00Z,NA,NA,NA,NA,NA,2013-08-02,2013-09-26,NA,NA,TDOSINT,135.71428571428572,NA,OVERALL,Overall dose intensity (%),90,NA,17,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-18T00:00:00Z,NA,NA,2013-09-26T00:00:00Z,NA,NA,NA,NA,NA,2013-08-18,2013-09-26,NA,NA,PDURD,40,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-18T00:00:00Z,NA,NA,2013-09-26T00:00:00Z,NA,NA,NA,NA,NA,2013-08-18,2013-09-26,NA,NA,PDOSE,3240,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-18T00:00:00Z,NA,NA,2013-09-26T00:00:00Z,NA,NA,NA,NA,NA,2013-08-18,2013-09-26,NA,NA,PPDOSE,2160,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-18T00:00:00Z,NA,NA,2013-09-26T00:00:00Z,NA,NA,NA,NA,NA,2013-08-18,2013-09-26,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-18T00:00:00Z,NA,NA,2013-09-26T00:00:00Z,NA,NA,NA,NA,NA,2013-08-18,2013-09-26,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-18T00:00:00Z,NA,NA,2013-09-26T00:00:00Z,NA,NA,NA,NA,NA,2013-08-18,2013-09-26,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1168,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-02,2013-08-02T00:00:00Z,2013-09-26T23:59:59Z,2013-08-18T00:00:00Z,NA,NA,2013-09-26T00:00:00Z,NA,NA,NA,NA,NA,2013-08-18,2013-09-26,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1168,2013-08-02,2013-09-27,2013-08-02,2013-09-26,NA,2013-11-01,NA,NA,709,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-07-25,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-09-26,56,NA,2013-09-27,DISCONTINUED,NA,2013-08-02,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1217,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-04,2013-03-19,1,16,NA,54,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-04T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,1,16,16,2013-03-04,2013-03-19,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1217,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-04,2013-03-19,1,16,NA,54,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-04T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,1,16,16,2013-03-04,2013-03-19,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1217,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-04,2013-03-19,1,16,NA,54,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-04T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,1,16,16,2013-03-04,2013-03-19,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1217,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-04,2013-03-19,1,16,NA,54,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-04T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,1,16,16,2013-03-04,2013-03-19,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1217,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-04,2013-03-19,1,16,NA,54,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-04T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,1,16,16,2013-03-04,2013-03-19,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1217,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-20,2013-06-11,17,100,NA,54,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-20T00:00:00Z,NA,H,2013-06-11T00:00:00Z,NA,H,17,100,84,2013-03-20,2013-06-11,4536,4536,DURD,84,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1217,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-20,2013-06-11,17,100,NA,54,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-20T00:00:00Z,NA,H,2013-06-11T00:00:00Z,NA,H,17,100,84,2013-03-20,2013-06-11,4536,4536,DOSE,4536,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1217,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-20,2013-06-11,17,100,NA,54,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-20T00:00:00Z,NA,H,2013-06-11T00:00:00Z,NA,H,17,100,84,2013-03-20,2013-06-11,4536,4536,PLDOSE,4536,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1217,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-20,2013-06-11,17,100,NA,54,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-20T00:00:00Z,NA,H,2013-06-11T00:00:00Z,NA,H,17,100,84,2013-03-20,2013-06-11,4536,4536,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1217,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-20,2013-06-11,17,100,NA,54,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-20T00:00:00Z,NA,H,2013-06-11T00:00:00Z,NA,H,17,100,84,2013-03-20,2013-06-11,4536,4536,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-06-11,NA,NA,TDURD,100,NA,OVERALL,Overall duration (days),7,>=90 days,11,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-06-11,NA,NA,TDOSE,5400,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-06-11,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-06-11,NA,NA,TPDOSE,5400,NA,OVERALL,Total planned dose (mg),11,NA,14,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-06-11,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-06-11,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-06-11,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-20T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2013-03-20,2013-06-11,NA,NA,PDURD,84,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-20T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2013-03-20,2013-06-11,NA,NA,PDOSE,4536,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-20T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2013-03-20,2013-06-11,NA,NA,PPDOSE,4536,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-20T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2013-03-20,2013-06-11,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-20T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2013-03-20,2013-06-11,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-20T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2013-03-20,2013-06-11,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1217,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-04,2013-03-04T00:00:00Z,2013-06-11T23:59:59Z,2013-03-20T00:00:00Z,NA,NA,2013-06-11T00:00:00Z,NA,NA,NA,NA,NA,2013-03-20,2013-06-11,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1217,2013-03-04,2013-06-25,2013-03-04,2013-06-11,NA,2013-06-25T10:35,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-16,-16,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-11,100,NA,2013-06-25,DISCONTINUED,NA,2013-03-04,NA,NA,NA,2013-06-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1238,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-15,2013-05-29,1,15,NA,54,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-15T00:00:00Z,NA,H,2013-05-29T00:00:00Z,NA,H,1,15,15,2013-05-15,2013-05-29,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1238,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-15,2013-05-29,1,15,NA,54,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-15T00:00:00Z,NA,H,2013-05-29T00:00:00Z,NA,H,1,15,15,2013-05-15,2013-05-29,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1238,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-15,2013-05-29,1,15,NA,54,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-15T00:00:00Z,NA,H,2013-05-29T00:00:00Z,NA,H,1,15,15,2013-05-15,2013-05-29,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1238,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-15,2013-05-29,1,15,NA,54,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-15T00:00:00Z,NA,H,2013-05-29T00:00:00Z,NA,H,1,15,15,2013-05-15,2013-05-29,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1238,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-15,2013-05-29,1,15,NA,54,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-15T00:00:00Z,NA,H,2013-05-29T00:00:00Z,NA,H,1,15,15,2013-05-15,2013-05-29,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1238,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-30,2013-08-06,16,84,NA,54,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-30T00:00:00Z,NA,H,2013-08-06T00:00:00Z,NA,H,16,84,69,2013-05-30,2013-08-06,5589,3726,DURD,69,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1238,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-30,2013-08-06,16,84,NA,54,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-30T00:00:00Z,NA,H,2013-08-06T00:00:00Z,NA,H,16,84,69,2013-05-30,2013-08-06,5589,3726,DOSE,5589,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1238,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-30,2013-08-06,16,84,NA,54,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-30T00:00:00Z,NA,H,2013-08-06T00:00:00Z,NA,H,16,84,69,2013-05-30,2013-08-06,5589,3726,PLDOSE,3726,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1238,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-30,2013-08-06,16,84,NA,54,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-30T00:00:00Z,NA,H,2013-08-06T00:00:00Z,NA,H,16,84,69,2013-05-30,2013-08-06,5589,3726,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1238,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-30,2013-08-06,16,84,NA,54,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-30T00:00:00Z,NA,H,2013-08-06T00:00:00Z,NA,H,16,84,69,2013-05-30,2013-08-06,5589,3726,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-15T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-05-15,2013-08-06,NA,NA,TDURD,84,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-15T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-05-15,2013-08-06,NA,NA,TDOSE,6399,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-15T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-05-15,2013-08-06,NA,NA,AVDDSE,76.17857142857143,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-15T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-05-15,2013-08-06,NA,NA,TPDOSE,4536,NA,OVERALL,Total planned dose (mg),11,NA,14,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-15T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-05-15,2013-08-06,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-15T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-05-15,2013-08-06,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-15T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-05-15,2013-08-06,NA,NA,TDOSINT,141.07142857142858,NA,OVERALL,Overall dose intensity (%),90,NA,17,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-30T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-05-30,2013-08-06,NA,NA,PDURD,69,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-30T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-05-30,2013-08-06,NA,NA,PDOSE,5589,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-30T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-05-30,2013-08-06,NA,NA,PPDOSE,3726,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-30T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-05-30,2013-08-06,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-30T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-05-30,2013-08-06,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-30T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-05-30,2013-08-06,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1238,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-15,2013-05-15T00:00:00Z,2013-08-06T23:59:59Z,2013-05-30T00:00:00Z,NA,NA,2013-08-06T00:00:00Z,NA,NA,NA,NA,NA,2013-05-30,2013-08-06,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1238,2013-05-15,2013-08-07,2013-05-15,2013-08-06,NA,2013-08-13,NA,NA,709,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-02,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-06,84,NA,2013-08-07,DISCONTINUED,NA,2013-05-15,NA,NA,NA,2013-08-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1259,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-26,2013-02-10,1,16,NA,0,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-01-26T00:00:00Z,NA,H,2013-02-10T00:00:00Z,NA,H,1,16,16,2013-01-26,2013-02-10,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1259,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-26,2013-02-10,1,16,NA,0,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-01-26T00:00:00Z,NA,H,2013-02-10T00:00:00Z,NA,H,1,16,16,2013-01-26,2013-02-10,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1259,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-26,2013-02-10,1,16,NA,0,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-01-26T00:00:00Z,NA,H,2013-02-10T00:00:00Z,NA,H,1,16,16,2013-01-26,2013-02-10,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1259,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-26,2013-02-10,1,16,NA,0,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-01-26T00:00:00Z,NA,H,2013-02-10T00:00:00Z,NA,H,1,16,16,2013-01-26,2013-02-10,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1259,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-26,2013-02-10,1,16,NA,0,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-01-26T00:00:00Z,NA,H,2013-02-10T00:00:00Z,NA,H,1,16,16,2013-01-26,2013-02-10,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1259,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-11,2013-06-13,17,139,NA,0,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-02-11T00:00:00Z,NA,H,2013-06-13T00:00:00Z,NA,H,17,139,123,2013-02-11,2013-06-13,0,0,DURD,123,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1259,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-11,2013-06-13,17,139,NA,0,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-02-11T00:00:00Z,NA,H,2013-06-13T00:00:00Z,NA,H,17,139,123,2013-02-11,2013-06-13,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1259,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-11,2013-06-13,17,139,NA,0,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-02-11T00:00:00Z,NA,H,2013-06-13T00:00:00Z,NA,H,17,139,123,2013-02-11,2013-06-13,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1259,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-11,2013-06-13,17,139,NA,0,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-02-11T00:00:00Z,NA,H,2013-06-13T00:00:00Z,NA,H,17,139,123,2013-02-11,2013-06-13,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1259,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-11,2013-06-13,17,139,NA,0,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-02-11T00:00:00Z,NA,H,2013-06-13T00:00:00Z,NA,H,17,139,123,2013-02-11,2013-06-13,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-01-26T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-01-26,2013-06-13,NA,NA,TDURD,139,NA,OVERALL,Overall duration (days),7,>=90 days,11,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-01-26T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-01-26,2013-06-13,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-01-26T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-01-26,2013-06-13,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-01-26T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-01-26,2013-06-13,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-01-26T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-01-26,2013-06-13,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-01-26T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-01-26,2013-06-13,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-01-26T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-01-26,2013-06-13,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-02-11T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-02-11,2013-06-13,NA,NA,PDURD,123,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-02-11T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-02-11,2013-06-13,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-02-11T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-02-11,2013-06-13,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-02-11T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-02-11,2013-06-13,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-02-11T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-02-11,2013-06-13,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-02-11T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-02-11,2013-06-13,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1259,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-26,2013-01-26T00:00:00Z,2013-06-13T23:59:59Z,2013-02-11T00:00:00Z,NA,NA,2013-06-13T00:00:00Z,NA,NA,NA,NA,NA,2013-02-11,2013-06-13,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1259,2013-01-26,2013-06-13,2013-01-26,2013-06-13,NA,2013-06-13T12:23,NA,NA,709,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-13,-13,Placebo,Placebo,H,H,2013-06-13,139,NA,2013-06-13,DISCONTINUED,NA,2013-01-26,NA,NA,NA,2013-06-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1285,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-24,2013-04-08,1,16,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-03-24T00:00:00Z,NA,H,2013-04-08T00:00:00Z,NA,H,1,16,16,2013-03-24,2013-04-08,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1285,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-24,2013-04-08,1,16,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-03-24T00:00:00Z,NA,H,2013-04-08T00:00:00Z,NA,H,1,16,16,2013-03-24,2013-04-08,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1285,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-24,2013-04-08,1,16,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-03-24T00:00:00Z,NA,H,2013-04-08T00:00:00Z,NA,H,1,16,16,2013-03-24,2013-04-08,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1285,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-24,2013-04-08,1,16,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-03-24T00:00:00Z,NA,H,2013-04-08T00:00:00Z,NA,H,1,16,16,2013-03-24,2013-04-08,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1285,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-24,2013-04-08,1,16,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-03-24T00:00:00Z,NA,H,2013-04-08T00:00:00Z,NA,H,1,16,16,2013-03-24,2013-04-08,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1285,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-09,2013-05-23,17,61,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-09T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,17,61,45,2013-04-09,2013-05-23,2430,2430,DURD,45,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1285,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-09,2013-05-23,17,61,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-09T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,17,61,45,2013-04-09,2013-05-23,2430,2430,DOSE,2430,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1285,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-09,2013-05-23,17,61,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-09T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,17,61,45,2013-04-09,2013-05-23,2430,2430,PLDOSE,2430,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1285,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-09,2013-05-23,17,61,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-09T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,17,61,45,2013-04-09,2013-05-23,2430,2430,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1285,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-09,2013-05-23,17,61,NA,54,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-09T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,17,61,45,2013-04-09,2013-05-23,2430,2430,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-03-24T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-03-24,2013-05-23,NA,NA,TDURD,61,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-03-24T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-03-24,2013-05-23,NA,NA,TDOSE,3294,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-03-24T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-03-24,2013-05-23,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-03-24T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-03-24,2013-05-23,NA,NA,TPDOSE,3294,NA,OVERALL,Total planned dose (mg),11,NA,14,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-03-24T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-03-24,2013-05-23,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-03-24T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-03-24,2013-05-23,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-03-24T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-03-24,2013-05-23,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-09T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-09,2013-05-23,NA,NA,PDURD,45,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-09T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-09,2013-05-23,NA,NA,PDOSE,2430,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-09T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-09,2013-05-23,NA,NA,PPDOSE,2430,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-09T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-09,2013-05-23,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-09T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-09,2013-05-23,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-09T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-09,2013-05-23,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1285,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-24,2013-03-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-09T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-09,2013-05-23,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1285,2013-03-24,2013-05-31,2013-03-24,2013-05-23,NA,2013-05-31T13:15,NA,NA,709,87,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-17,-7,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-23,61,NA,2013-05-31,DISCONTINUED,NA,2013-03-24,NA,NA,NA,2013-05-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1301,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-19,2013-08-02,1,15,NA,0,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-07-19T00:00:00Z,NA,H,2013-08-02T00:00:00Z,NA,H,1,15,15,2013-07-19,2013-08-02,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1301,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-19,2013-08-02,1,15,NA,0,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-07-19T00:00:00Z,NA,H,2013-08-02T00:00:00Z,NA,H,1,15,15,2013-07-19,2013-08-02,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1301,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-19,2013-08-02,1,15,NA,0,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-07-19T00:00:00Z,NA,H,2013-08-02T00:00:00Z,NA,H,1,15,15,2013-07-19,2013-08-02,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1301,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-19,2013-08-02,1,15,NA,0,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-07-19T00:00:00Z,NA,H,2013-08-02T00:00:00Z,NA,H,1,15,15,2013-07-19,2013-08-02,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1301,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-19,2013-08-02,1,15,NA,0,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-07-19T00:00:00Z,NA,H,2013-08-02T00:00:00Z,NA,H,1,15,15,2013-07-19,2013-08-02,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1301,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-03,2014-01-04,16,170,NA,0,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-08-03T00:00:00Z,NA,H,2014-01-04T00:00:00Z,NA,H,16,170,155,2013-08-03,2014-01-04,0,0,DURD,155,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1301,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-03,2014-01-04,16,170,NA,0,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-08-03T00:00:00Z,NA,H,2014-01-04T00:00:00Z,NA,H,16,170,155,2013-08-03,2014-01-04,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1301,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-03,2014-01-04,16,170,NA,0,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-08-03T00:00:00Z,NA,H,2014-01-04T00:00:00Z,NA,H,16,170,155,2013-08-03,2014-01-04,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1301,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-03,2014-01-04,16,170,NA,0,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-08-03T00:00:00Z,NA,H,2014-01-04T00:00:00Z,NA,H,16,170,155,2013-08-03,2014-01-04,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1301,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-03,2014-01-04,16,170,NA,0,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-08-03T00:00:00Z,NA,H,2014-01-04T00:00:00Z,NA,H,16,170,155,2013-08-03,2014-01-04,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1301,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-05,2014-01-17,171,183,NA,0,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2014-01-05T00:00:00Z,NA,H,2014-01-17T00:00:00Z,NA,H,171,183,13,2014-01-05,2014-01-17,0,0,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1301,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-05,2014-01-17,171,183,NA,0,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2014-01-05T00:00:00Z,NA,H,2014-01-17T00:00:00Z,NA,H,171,183,13,2014-01-05,2014-01-17,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1301,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-05,2014-01-17,171,183,NA,0,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2014-01-05T00:00:00Z,NA,H,2014-01-17T00:00:00Z,NA,H,171,183,13,2014-01-05,2014-01-17,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1301,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-05,2014-01-17,171,183,NA,0,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2014-01-05T00:00:00Z,NA,H,2014-01-17T00:00:00Z,NA,H,171,183,13,2014-01-05,2014-01-17,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1301,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-05,2014-01-17,171,183,NA,0,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2014-01-05T00:00:00Z,NA,H,2014-01-17T00:00:00Z,NA,H,171,183,13,2014-01-05,2014-01-17,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2014-01-17T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2014-01-17,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2014-01-17T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2014-01-17,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2014-01-17T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2014-01-17,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2014-01-17T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2014-01-17,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2014-01-17T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2014-01-17,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2014-01-17T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2014-01-17,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-07-19T00:00:00Z,NA,NA,2014-01-17T00:00:00Z,NA,NA,NA,NA,NA,2013-07-19,2014-01-17,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-08-03T00:00:00Z,NA,NA,2014-01-17T00:00:00Z,NA,NA,NA,NA,NA,2013-08-03,2014-01-17,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-08-03T00:00:00Z,NA,NA,2014-01-17T00:00:00Z,NA,NA,NA,NA,NA,2013-08-03,2014-01-17,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-08-03T00:00:00Z,NA,NA,2014-01-17T00:00:00Z,NA,NA,NA,NA,NA,2013-08-03,2014-01-17,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-08-03T00:00:00Z,NA,NA,2014-01-17T00:00:00Z,NA,NA,NA,NA,NA,2013-08-03,2014-01-17,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-08-03T00:00:00Z,NA,NA,2014-01-17T00:00:00Z,NA,NA,NA,NA,NA,2013-08-03,2014-01-17,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-08-03T00:00:00Z,NA,NA,2014-01-17T00:00:00Z,NA,NA,NA,NA,NA,2013-08-03,2014-01-17,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1301,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-19,2013-07-19T00:00:00Z,2014-01-17T23:59:59Z,2013-08-03T00:00:00Z,NA,NA,2014-01-17T00:00:00Z,NA,NA,NA,NA,NA,2013-08-03,2014-01-17,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1301,2013-07-19,2014-01-17,2013-07-19,2014-01-17,NA,2014-01-17T10:07,NA,NA,709,62,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-14,-5,Placebo,Placebo,H,H,2014-01-17,183,NA,2014-01-17,COMPLETED,NA,2013-07-19,NA,NA,NA,2014-01-17,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1306,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-03,2014-02-19,1,17,NA,0,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-03T00:00:00Z,NA,H,2014-02-19T00:00:00Z,NA,H,1,17,17,2014-02-03,2014-02-19,0,0,DURD,17,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1306,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-03,2014-02-19,1,17,NA,0,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-03T00:00:00Z,NA,H,2014-02-19T00:00:00Z,NA,H,1,17,17,2014-02-03,2014-02-19,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1306,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-03,2014-02-19,1,17,NA,0,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-03T00:00:00Z,NA,H,2014-02-19T00:00:00Z,NA,H,1,17,17,2014-02-03,2014-02-19,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1306,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-03,2014-02-19,1,17,NA,0,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-03T00:00:00Z,NA,H,2014-02-19T00:00:00Z,NA,H,1,17,17,2014-02-03,2014-02-19,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1306,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-03,2014-02-19,1,17,NA,0,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-03T00:00:00Z,NA,H,2014-02-19T00:00:00Z,NA,H,1,17,17,2014-02-03,2014-02-19,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1306,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-20,2014-06-16,18,134,NA,0,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-20T00:00:00Z,NA,H,2014-06-16T00:00:00Z,NA,H,18,134,117,2014-02-20,2014-06-16,0,0,DURD,117,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1306,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-20,2014-06-16,18,134,NA,0,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-20T00:00:00Z,NA,H,2014-06-16T00:00:00Z,NA,H,18,134,117,2014-02-20,2014-06-16,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1306,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-20,2014-06-16,18,134,NA,0,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-20T00:00:00Z,NA,H,2014-06-16T00:00:00Z,NA,H,18,134,117,2014-02-20,2014-06-16,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1306,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-20,2014-06-16,18,134,NA,0,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-20T00:00:00Z,NA,H,2014-06-16T00:00:00Z,NA,H,18,134,117,2014-02-20,2014-06-16,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1306,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-20,2014-06-16,18,134,NA,0,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-20T00:00:00Z,NA,H,2014-06-16T00:00:00Z,NA,H,18,134,117,2014-02-20,2014-06-16,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-03T00:00:00Z,NA,NA,2014-06-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-03,2014-06-16,NA,NA,TDURD,134,NA,OVERALL,Overall duration (days),7,>=90 days,11,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-03T00:00:00Z,NA,NA,2014-06-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-03,2014-06-16,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-03T00:00:00Z,NA,NA,2014-06-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-03,2014-06-16,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-03T00:00:00Z,NA,NA,2014-06-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-03,2014-06-16,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-03T00:00:00Z,NA,NA,2014-06-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-03,2014-06-16,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-03T00:00:00Z,NA,NA,2014-06-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-03,2014-06-16,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-03T00:00:00Z,NA,NA,2014-06-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-03,2014-06-16,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-20T00:00:00Z,NA,NA,2014-06-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-20,2014-06-16,NA,NA,PDURD,117,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-20T00:00:00Z,NA,NA,2014-06-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-20,2014-06-16,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-20T00:00:00Z,NA,NA,2014-06-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-20,2014-06-16,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-20T00:00:00Z,NA,NA,2014-06-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-20,2014-06-16,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-20T00:00:00Z,NA,NA,2014-06-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-20,2014-06-16,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-20T00:00:00Z,NA,NA,2014-06-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-20,2014-06-16,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1306,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-03,2014-02-03T00:00:00Z,2014-06-16T23:59:59Z,2014-02-20T00:00:00Z,NA,NA,2014-06-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-20,2014-06-16,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1306,2014-02-03,2014-06-25,2014-02-03,2014-06-16,NA,2014-06-25T10:45,NA,NA,709,60,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-19,-15,Placebo,Placebo,H,H,2014-06-16,134,NA,2014-06-25,DISCONTINUED,NA,2014-02-03,NA,NA,NA,2014-06-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1309,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-19,2013-07-01,1,13,NA,54,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-06-19T00:00:00Z,NA,H,2013-07-01T00:00:00Z,NA,H,1,13,13,2013-06-19,2013-07-01,702,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1309,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-19,2013-07-01,1,13,NA,54,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-06-19T00:00:00Z,NA,H,2013-07-01T00:00:00Z,NA,H,1,13,13,2013-06-19,2013-07-01,702,702,DOSE,702,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1309,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-19,2013-07-01,1,13,NA,54,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-06-19T00:00:00Z,NA,H,2013-07-01T00:00:00Z,NA,H,1,13,13,2013-06-19,2013-07-01,702,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1309,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-19,2013-07-01,1,13,NA,54,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-06-19T00:00:00Z,NA,H,2013-07-01T00:00:00Z,NA,H,1,13,13,2013-06-19,2013-07-01,702,702,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1309,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-19,2013-07-01,1,13,NA,54,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-06-19T00:00:00Z,NA,H,2013-07-01T00:00:00Z,NA,H,1,13,13,2013-06-19,2013-07-01,702,702,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1309,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-02,2013-12-05,14,170,NA,54,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-07-02T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,14,170,157,2013-07-02,2013-12-05,12717,8478,DURD,157,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1309,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-02,2013-12-05,14,170,NA,54,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-07-02T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,14,170,157,2013-07-02,2013-12-05,12717,8478,DOSE,12717,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1309,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-02,2013-12-05,14,170,NA,54,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-07-02T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,14,170,157,2013-07-02,2013-12-05,12717,8478,PLDOSE,8478,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1309,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-02,2013-12-05,14,170,NA,54,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-07-02T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,14,170,157,2013-07-02,2013-12-05,12717,8478,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1309,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-02,2013-12-05,14,170,NA,54,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-07-02T00:00:00Z,NA,H,2013-12-05T00:00:00Z,NA,H,14,170,157,2013-07-02,2013-12-05,12717,8478,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1309,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-06,2013-12-19,171,184,NA,54,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-12-06T00:00:00Z,NA,H,2013-12-19T00:00:00Z,NA,H,171,184,14,2013-12-06,2013-12-19,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1309,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-06,2013-12-19,171,184,NA,54,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-12-06T00:00:00Z,NA,H,2013-12-19T00:00:00Z,NA,H,171,184,14,2013-12-06,2013-12-19,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1309,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-06,2013-12-19,171,184,NA,54,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-12-06T00:00:00Z,NA,H,2013-12-19T00:00:00Z,NA,H,171,184,14,2013-12-06,2013-12-19,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1309,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-06,2013-12-19,171,184,NA,54,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-12-06T00:00:00Z,NA,H,2013-12-19T00:00:00Z,NA,H,171,184,14,2013-12-06,2013-12-19,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1309,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-06,2013-12-19,171,184,NA,54,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-12-06T00:00:00Z,NA,H,2013-12-19T00:00:00Z,NA,H,171,184,14,2013-12-06,2013-12-19,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1309,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-06-19T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-06-19,2013-12-19,NA,NA,TDURD,184,NA,OVERALL,Overall duration (days),7,>=90 days,16,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1309,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-06-19T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-06-19,2013-12-19,NA,NA,TDOSE,14175,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1309,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-06-19T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-06-19,2013-12-19,NA,NA,AVDDSE,77.03804347826087,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1309,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-06-19T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-06-19,2013-12-19,NA,NA,TPDOSE,9936,NA,OVERALL,Total planned dose (mg),11,NA,19,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1309,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-06-19T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-06-19,2013-12-19,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1309,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-06-19T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-06-19,2013-12-19,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1309,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-06-19T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-06-19,2013-12-19,NA,NA,TDOSINT,142.66304347826087,NA,OVERALL,Overall dose intensity (%),90,NA,22,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1309,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-07-02T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-07-02,2013-12-19,NA,NA,PDURD,171,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1309,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-07-02T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-07-02,2013-12-19,NA,NA,PDOSE,13473,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1309,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-07-02T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-07-02,2013-12-19,NA,NA,PPDOSE,9234,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1309,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-07-02T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-07-02,2013-12-19,NA,NA,PAVDDSE,78.78947368421052,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1309,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-07-02T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-07-02,2013-12-19,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1309,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-07-02T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-07-02,2013-12-19,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1309,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-19,2013-06-19T00:00:00Z,2013-12-19T23:59:59Z,2013-07-02T00:00:00Z,NA,NA,2013-12-19T00:00:00Z,NA,NA,NA,NA,NA,2013-07-02,2013-12-19,NA,NA,PDOSINT,145.906432748538,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1309,2013-06-19,2013-12-19,2013-06-19,2013-12-19,NA,2013-12-19T10:35,NA,NA,709,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-09,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-12-19,184,NA,2013-12-19,COMPLETED,NA,2013-06-19,NA,NA,NA,2013-12-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1312,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-20,2014-05-10,1,21,NA,0,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-04-20T00:00:00Z,NA,H,2014-05-10T00:00:00Z,NA,H,1,21,21,2014-04-20,2014-05-10,0,0,DURD,21,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1312,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-20,2014-05-10,1,21,NA,0,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-04-20T00:00:00Z,NA,H,2014-05-10T00:00:00Z,NA,H,1,21,21,2014-04-20,2014-05-10,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1312,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-20,2014-05-10,1,21,NA,0,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-04-20T00:00:00Z,NA,H,2014-05-10T00:00:00Z,NA,H,1,21,21,2014-04-20,2014-05-10,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1312,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-20,2014-05-10,1,21,NA,0,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-04-20T00:00:00Z,NA,H,2014-05-10T00:00:00Z,NA,H,1,21,21,2014-04-20,2014-05-10,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1312,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-20,2014-05-10,1,21,NA,0,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-04-20T00:00:00Z,NA,H,2014-05-10T00:00:00Z,NA,H,1,21,21,2014-04-20,2014-05-10,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1312,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-11,2014-10-05,22,169,NA,0,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-05-11T00:00:00Z,NA,H,2014-10-05T00:00:00Z,NA,H,22,169,148,2014-05-11,2014-10-05,0,0,DURD,148,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1312,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-11,2014-10-05,22,169,NA,0,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-05-11T00:00:00Z,NA,H,2014-10-05T00:00:00Z,NA,H,22,169,148,2014-05-11,2014-10-05,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1312,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-11,2014-10-05,22,169,NA,0,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-05-11T00:00:00Z,NA,H,2014-10-05T00:00:00Z,NA,H,22,169,148,2014-05-11,2014-10-05,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1312,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-11,2014-10-05,22,169,NA,0,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-05-11T00:00:00Z,NA,H,2014-10-05T00:00:00Z,NA,H,22,169,148,2014-05-11,2014-10-05,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1312,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-11,2014-10-05,22,169,NA,0,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-05-11T00:00:00Z,NA,H,2014-10-05T00:00:00Z,NA,H,22,169,148,2014-05-11,2014-10-05,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1312,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-10-06,2014-10-19,170,183,NA,0,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-10-06T00:00:00Z,NA,H,2014-10-19T00:00:00Z,NA,H,170,183,14,2014-10-06,2014-10-19,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1312,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-10-06,2014-10-19,170,183,NA,0,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-10-06T00:00:00Z,NA,H,2014-10-19T00:00:00Z,NA,H,170,183,14,2014-10-06,2014-10-19,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1312,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-10-06,2014-10-19,170,183,NA,0,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-10-06T00:00:00Z,NA,H,2014-10-19T00:00:00Z,NA,H,170,183,14,2014-10-06,2014-10-19,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1312,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-10-06,2014-10-19,170,183,NA,0,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-10-06T00:00:00Z,NA,H,2014-10-19T00:00:00Z,NA,H,170,183,14,2014-10-06,2014-10-19,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1312,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-10-06,2014-10-19,170,183,NA,0,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-10-06T00:00:00Z,NA,H,2014-10-19T00:00:00Z,NA,H,170,183,14,2014-10-06,2014-10-19,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-04-20T00:00:00Z,NA,NA,2014-10-19T00:00:00Z,NA,NA,NA,NA,NA,2014-04-20,2014-10-19,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-04-20T00:00:00Z,NA,NA,2014-10-19T00:00:00Z,NA,NA,NA,NA,NA,2014-04-20,2014-10-19,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-04-20T00:00:00Z,NA,NA,2014-10-19T00:00:00Z,NA,NA,NA,NA,NA,2014-04-20,2014-10-19,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-04-20T00:00:00Z,NA,NA,2014-10-19T00:00:00Z,NA,NA,NA,NA,NA,2014-04-20,2014-10-19,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-04-20T00:00:00Z,NA,NA,2014-10-19T00:00:00Z,NA,NA,NA,NA,NA,2014-04-20,2014-10-19,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-04-20T00:00:00Z,NA,NA,2014-10-19T00:00:00Z,NA,NA,NA,NA,NA,2014-04-20,2014-10-19,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-04-20T00:00:00Z,NA,NA,2014-10-19T00:00:00Z,NA,NA,NA,NA,NA,2014-04-20,2014-10-19,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-05-11T00:00:00Z,NA,NA,2014-10-19T00:00:00Z,NA,NA,NA,NA,NA,2014-05-11,2014-10-19,NA,NA,PDURD,162,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-05-11T00:00:00Z,NA,NA,2014-10-19T00:00:00Z,NA,NA,NA,NA,NA,2014-05-11,2014-10-19,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-05-11T00:00:00Z,NA,NA,2014-10-19T00:00:00Z,NA,NA,NA,NA,NA,2014-05-11,2014-10-19,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-05-11T00:00:00Z,NA,NA,2014-10-19T00:00:00Z,NA,NA,NA,NA,NA,2014-05-11,2014-10-19,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-05-11T00:00:00Z,NA,NA,2014-10-19T00:00:00Z,NA,NA,NA,NA,NA,2014-05-11,2014-10-19,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-05-11T00:00:00Z,NA,NA,2014-10-19T00:00:00Z,NA,NA,NA,NA,NA,2014-05-11,2014-10-19,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1312,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-20,2014-04-20T00:00:00Z,2014-10-19T23:59:59Z,2014-05-11T00:00:00Z,NA,NA,2014-10-19T00:00:00Z,NA,NA,NA,NA,NA,2014-05-11,2014-10-19,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1312,2014-04-20,2014-10-19,2014-04-20,2014-10-19,NA,2014-10-19T10:00,NA,NA,709,68,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-13,-7,Placebo,Placebo,H,H,2014-10-19,183,NA,2014-10-19,COMPLETED,NA,2014-04-20,NA,NA,NA,2014-10-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1326,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-05,2013-04-18,1,14,NA,54,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-05T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,1,14,14,2013-04-05,2013-04-18,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1326,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-05,2013-04-18,1,14,NA,54,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-05T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,1,14,14,2013-04-05,2013-04-18,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1326,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-05,2013-04-18,1,14,NA,54,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-05T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,1,14,14,2013-04-05,2013-04-18,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1326,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-05,2013-04-18,1,14,NA,54,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-05T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,1,14,14,2013-04-05,2013-04-18,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1326,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-05,2013-04-18,1,14,NA,54,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-05T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,1,14,14,2013-04-05,2013-04-18,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1326,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-19,2013-09-20,15,169,NA,54,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,H,2013-09-20T00:00:00Z,NA,H,15,169,155,2013-04-19,2013-09-20,8370,8370,DURD,155,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1326,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-19,2013-09-20,15,169,NA,54,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,H,2013-09-20T00:00:00Z,NA,H,15,169,155,2013-04-19,2013-09-20,8370,8370,DOSE,8370,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1326,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-19,2013-09-20,15,169,NA,54,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,H,2013-09-20T00:00:00Z,NA,H,15,169,155,2013-04-19,2013-09-20,8370,8370,PLDOSE,8370,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1326,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-19,2013-09-20,15,169,NA,54,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,H,2013-09-20T00:00:00Z,NA,H,15,169,155,2013-04-19,2013-09-20,8370,8370,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1326,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-19,2013-09-20,15,169,NA,54,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,H,2013-09-20T00:00:00Z,NA,H,15,169,155,2013-04-19,2013-09-20,8370,8370,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1326,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-21,2013-10-02,170,181,NA,54,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-10-02T00:00:00Z,NA,H,170,181,12,2013-09-21,2013-10-02,648,648,DURD,12,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1326,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-21,2013-10-02,170,181,NA,54,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-10-02T00:00:00Z,NA,H,170,181,12,2013-09-21,2013-10-02,648,648,DOSE,648,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1326,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-21,2013-10-02,170,181,NA,54,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-10-02T00:00:00Z,NA,H,170,181,12,2013-09-21,2013-10-02,648,648,PLDOSE,648,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1326,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-21,2013-10-02,170,181,NA,54,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-10-02T00:00:00Z,NA,H,170,181,12,2013-09-21,2013-10-02,648,648,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1326,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-21,2013-10-02,170,181,NA,54,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-10-02T00:00:00Z,NA,H,170,181,12,2013-09-21,2013-10-02,648,648,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1326,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-10-02,NA,NA,TDURD,181,NA,OVERALL,Overall duration (days),7,>=90 days,16,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1326,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-10-02,NA,NA,TDOSE,9774,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1326,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-10-02,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1326,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-10-02,NA,NA,TPDOSE,9774,NA,OVERALL,Total planned dose (mg),11,NA,19,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1326,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-10-02,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1326,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-10-02,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1326,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-10-02,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1326,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-19,2013-10-02,NA,NA,PDURD,167,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1326,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-19,2013-10-02,NA,NA,PDOSE,9018,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1326,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-19,2013-10-02,NA,NA,PPDOSE,9018,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1326,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-19,2013-10-02,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1326,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-19,2013-10-02,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1326,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-19,2013-10-02,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1326,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-19,2013-10-02,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1326,2013-04-05,2013-10-02,2013-04-05,2013-10-02,NA,2013-10-02T09:40,NA,NA,709,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-21,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-02,181,NA,2013-10-02,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1329,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-15,2013-08-25,1,11,NA,54,2013-08-15,2013-08-15T00:00:00Z,2013-08-25T23:59:59Z,2013-08-15T00:00:00Z,NA,H,2013-08-25T00:00:00Z,NA,H,1,11,11,2013-08-15,2013-08-25,594,594,DURD,11,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1329,2013-08-15,2013-08-29,2013-08-15,2013-08-25,NA,2013-08-29T10:35,NA,NA,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-01,-14,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-25,11,NA,2013-08-29,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1329,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-15,2013-08-25,1,11,NA,54,2013-08-15,2013-08-15T00:00:00Z,2013-08-25T23:59:59Z,2013-08-15T00:00:00Z,NA,H,2013-08-25T00:00:00Z,NA,H,1,11,11,2013-08-15,2013-08-25,594,594,DOSE,594,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1329,2013-08-15,2013-08-29,2013-08-15,2013-08-25,NA,2013-08-29T10:35,NA,NA,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-01,-14,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-25,11,NA,2013-08-29,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1329,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-15,2013-08-25,1,11,NA,54,2013-08-15,2013-08-15T00:00:00Z,2013-08-25T23:59:59Z,2013-08-15T00:00:00Z,NA,H,2013-08-25T00:00:00Z,NA,H,1,11,11,2013-08-15,2013-08-25,594,594,PLDOSE,594,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1329,2013-08-15,2013-08-29,2013-08-15,2013-08-25,NA,2013-08-29T10:35,NA,NA,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-01,-14,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-25,11,NA,2013-08-29,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1329,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-15,2013-08-25,1,11,NA,54,2013-08-15,2013-08-15T00:00:00Z,2013-08-25T23:59:59Z,2013-08-15T00:00:00Z,NA,H,2013-08-25T00:00:00Z,NA,H,1,11,11,2013-08-15,2013-08-25,594,594,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1329,2013-08-15,2013-08-29,2013-08-15,2013-08-25,NA,2013-08-29T10:35,NA,NA,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-01,-14,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-25,11,NA,2013-08-29,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1329,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-15,2013-08-25,1,11,NA,54,2013-08-15,2013-08-15T00:00:00Z,2013-08-25T23:59:59Z,2013-08-15T00:00:00Z,NA,H,2013-08-25T00:00:00Z,NA,H,1,11,11,2013-08-15,2013-08-25,594,594,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1329,2013-08-15,2013-08-29,2013-08-15,2013-08-25,NA,2013-08-29T10:35,NA,NA,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-01,-14,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-25,11,NA,2013-08-29,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1329,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-15,2013-08-15T00:00:00Z,2013-08-25T23:59:59Z,2013-08-15T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-08-15,2013-08-25,NA,NA,TDURD,11,NA,OVERALL,Overall duration (days),7,< 30 days,6,1329,2013-08-15,2013-08-29,2013-08-15,2013-08-25,NA,2013-08-29T10:35,NA,NA,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-01,-14,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-25,11,NA,2013-08-29,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1329,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-15,2013-08-15T00:00:00Z,2013-08-25T23:59:59Z,2013-08-15T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-08-15,2013-08-25,NA,NA,TDOSE,594,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1329,2013-08-15,2013-08-29,2013-08-15,2013-08-25,NA,2013-08-29T10:35,NA,NA,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-01,-14,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-25,11,NA,2013-08-29,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1329,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-15,2013-08-15T00:00:00Z,2013-08-25T23:59:59Z,2013-08-15T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-08-15,2013-08-25,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1329,2013-08-15,2013-08-29,2013-08-15,2013-08-25,NA,2013-08-29T10:35,NA,NA,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-01,-14,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-25,11,NA,2013-08-29,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1329,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-15,2013-08-15T00:00:00Z,2013-08-25T23:59:59Z,2013-08-15T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-08-15,2013-08-25,NA,NA,TPDOSE,594,NA,OVERALL,Total planned dose (mg),11,NA,9,1329,2013-08-15,2013-08-29,2013-08-15,2013-08-25,NA,2013-08-29T10:35,NA,NA,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-01,-14,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-25,11,NA,2013-08-29,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1329,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-15,2013-08-15T00:00:00Z,2013-08-25T23:59:59Z,2013-08-15T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-08-15,2013-08-25,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1329,2013-08-15,2013-08-29,2013-08-15,2013-08-25,NA,2013-08-29T10:35,NA,NA,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-01,-14,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-25,11,NA,2013-08-29,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1329,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-15,2013-08-15T00:00:00Z,2013-08-25T23:59:59Z,2013-08-15T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-08-15,2013-08-25,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1329,2013-08-15,2013-08-29,2013-08-15,2013-08-25,NA,2013-08-29T10:35,NA,NA,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-01,-14,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-25,11,NA,2013-08-29,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1329,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-15,2013-08-15T00:00:00Z,2013-08-25T23:59:59Z,2013-08-15T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-08-15,2013-08-25,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1329,2013-08-15,2013-08-29,2013-08-15,2013-08-25,NA,2013-08-29T10:35,NA,NA,709,70,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-01,-14,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-25,11,NA,2013-08-29,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1339,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-23,2013-01-05,1,14,NA,0,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2012-12-23T00:00:00Z,NA,H,2013-01-05T00:00:00Z,NA,H,1,14,14,2012-12-23,2013-01-05,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1339,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-23,2013-01-05,1,14,NA,0,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2012-12-23T00:00:00Z,NA,H,2013-01-05T00:00:00Z,NA,H,1,14,14,2012-12-23,2013-01-05,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1339,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-23,2013-01-05,1,14,NA,0,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2012-12-23T00:00:00Z,NA,H,2013-01-05T00:00:00Z,NA,H,1,14,14,2012-12-23,2013-01-05,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1339,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-23,2013-01-05,1,14,NA,0,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2012-12-23T00:00:00Z,NA,H,2013-01-05T00:00:00Z,NA,H,1,14,14,2012-12-23,2013-01-05,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1339,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-23,2013-01-05,1,14,NA,0,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2012-12-23T00:00:00Z,NA,H,2013-01-05T00:00:00Z,NA,H,1,14,14,2012-12-23,2013-01-05,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1339,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-06,2013-06-08,15,168,NA,0,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-01-06T00:00:00Z,NA,H,2013-06-08T00:00:00Z,NA,H,15,168,154,2013-01-06,2013-06-08,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1339,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-06,2013-06-08,15,168,NA,0,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-01-06T00:00:00Z,NA,H,2013-06-08T00:00:00Z,NA,H,15,168,154,2013-01-06,2013-06-08,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1339,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-06,2013-06-08,15,168,NA,0,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-01-06T00:00:00Z,NA,H,2013-06-08T00:00:00Z,NA,H,15,168,154,2013-01-06,2013-06-08,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1339,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-06,2013-06-08,15,168,NA,0,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-01-06T00:00:00Z,NA,H,2013-06-08T00:00:00Z,NA,H,15,168,154,2013-01-06,2013-06-08,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1339,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-06,2013-06-08,15,168,NA,0,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-01-06T00:00:00Z,NA,H,2013-06-08T00:00:00Z,NA,H,15,168,154,2013-01-06,2013-06-08,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1339,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-09,2013-06-24,169,184,NA,0,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-06-09T00:00:00Z,NA,H,2013-06-24T00:00:00Z,NA,H,169,184,16,2013-06-09,2013-06-24,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1339,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-09,2013-06-24,169,184,NA,0,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-06-09T00:00:00Z,NA,H,2013-06-24T00:00:00Z,NA,H,169,184,16,2013-06-09,2013-06-24,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1339,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-09,2013-06-24,169,184,NA,0,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-06-09T00:00:00Z,NA,H,2013-06-24T00:00:00Z,NA,H,169,184,16,2013-06-09,2013-06-24,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1339,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-09,2013-06-24,169,184,NA,0,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-06-09T00:00:00Z,NA,H,2013-06-24T00:00:00Z,NA,H,169,184,16,2013-06-09,2013-06-24,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1339,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-09,2013-06-24,169,184,NA,0,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-06-09T00:00:00Z,NA,H,2013-06-24T00:00:00Z,NA,H,169,184,16,2013-06-09,2013-06-24,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2012-12-23T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-23,2013-06-24,NA,NA,TDURD,184,NA,OVERALL,Overall duration (days),7,>=90 days,16,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2012-12-23T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-23,2013-06-24,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2012-12-23T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-23,2013-06-24,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2012-12-23T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-23,2013-06-24,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2012-12-23T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-23,2013-06-24,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2012-12-23T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-23,2013-06-24,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2012-12-23T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-23,2013-06-24,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-01-06T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-06,2013-06-24,NA,NA,PDURD,170,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-01-06T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-06,2013-06-24,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-01-06T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-06,2013-06-24,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-01-06T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-06,2013-06-24,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-01-06T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-06,2013-06-24,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-01-06T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-06,2013-06-24,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1339,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-23,2012-12-23T00:00:00Z,2013-06-24T23:59:59Z,2013-01-06T00:00:00Z,NA,NA,2013-06-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-06,2013-06-24,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1339,2012-12-23,2013-06-24,2012-12-23,2013-06-24,NA,2013-06-24T10:10,NA,NA,709,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-15,-8,Placebo,Placebo,H,H,2013-06-24,184,NA,2013-06-24,COMPLETED,NA,2012-12-23,NA,NA,NA,2013-06-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1424,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-03,2013-03-07,1,5,NA,54,2013-03-03,2013-03-03T00:00:00Z,2013-03-07T23:59:59Z,2013-03-03T00:00:00Z,NA,H,2013-03-07T00:00:00Z,NA,H,1,5,5,2013-03-03,2013-03-07,270,270,DURD,5,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1424,2013-03-03,2013-03-08,2013-03-03,2013-03-07,NA,2013-03-17,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-15,-16,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-03-07,5,NA,2013-03-08,DISCONTINUED,NA,2013-03-03,NA,NA,NA,2013-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1424,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-03,2013-03-07,1,5,NA,54,2013-03-03,2013-03-03T00:00:00Z,2013-03-07T23:59:59Z,2013-03-03T00:00:00Z,NA,H,2013-03-07T00:00:00Z,NA,H,1,5,5,2013-03-03,2013-03-07,270,270,DOSE,270,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1424,2013-03-03,2013-03-08,2013-03-03,2013-03-07,NA,2013-03-17,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-15,-16,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-03-07,5,NA,2013-03-08,DISCONTINUED,NA,2013-03-03,NA,NA,NA,2013-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1424,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-03,2013-03-07,1,5,NA,54,2013-03-03,2013-03-03T00:00:00Z,2013-03-07T23:59:59Z,2013-03-03T00:00:00Z,NA,H,2013-03-07T00:00:00Z,NA,H,1,5,5,2013-03-03,2013-03-07,270,270,PLDOSE,270,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1424,2013-03-03,2013-03-08,2013-03-03,2013-03-07,NA,2013-03-17,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-15,-16,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-03-07,5,NA,2013-03-08,DISCONTINUED,NA,2013-03-03,NA,NA,NA,2013-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1424,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-03,2013-03-07,1,5,NA,54,2013-03-03,2013-03-03T00:00:00Z,2013-03-07T23:59:59Z,2013-03-03T00:00:00Z,NA,H,2013-03-07T00:00:00Z,NA,H,1,5,5,2013-03-03,2013-03-07,270,270,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1424,2013-03-03,2013-03-08,2013-03-03,2013-03-07,NA,2013-03-17,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-15,-16,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-03-07,5,NA,2013-03-08,DISCONTINUED,NA,2013-03-03,NA,NA,NA,2013-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-709-1424,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-03-03,2013-03-07,1,5,NA,54,2013-03-03,2013-03-03T00:00:00Z,2013-03-07T23:59:59Z,2013-03-03T00:00:00Z,NA,H,2013-03-07T00:00:00Z,NA,H,1,5,5,2013-03-03,2013-03-07,270,270,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1424,2013-03-03,2013-03-08,2013-03-03,2013-03-07,NA,2013-03-17,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-15,-16,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-03-07,5,NA,2013-03-08,DISCONTINUED,NA,2013-03-03,NA,NA,NA,2013-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1424,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-03,2013-03-03T00:00:00Z,2013-03-07T23:59:59Z,2013-03-03T00:00:00Z,NA,NA,2013-03-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-03,2013-03-07,NA,NA,TDURD,5,NA,OVERALL,Overall duration (days),7,< 30 days,6,1424,2013-03-03,2013-03-08,2013-03-03,2013-03-07,NA,2013-03-17,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-15,-16,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-03-07,5,NA,2013-03-08,DISCONTINUED,NA,2013-03-03,NA,NA,NA,2013-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1424,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-03,2013-03-03T00:00:00Z,2013-03-07T23:59:59Z,2013-03-03T00:00:00Z,NA,NA,2013-03-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-03,2013-03-07,NA,NA,TDOSE,270,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1424,2013-03-03,2013-03-08,2013-03-03,2013-03-07,NA,2013-03-17,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-15,-16,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-03-07,5,NA,2013-03-08,DISCONTINUED,NA,2013-03-03,NA,NA,NA,2013-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1424,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-03,2013-03-03T00:00:00Z,2013-03-07T23:59:59Z,2013-03-03T00:00:00Z,NA,NA,2013-03-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-03,2013-03-07,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1424,2013-03-03,2013-03-08,2013-03-03,2013-03-07,NA,2013-03-17,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-15,-16,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-03-07,5,NA,2013-03-08,DISCONTINUED,NA,2013-03-03,NA,NA,NA,2013-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1424,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-03,2013-03-03T00:00:00Z,2013-03-07T23:59:59Z,2013-03-03T00:00:00Z,NA,NA,2013-03-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-03,2013-03-07,NA,NA,TPDOSE,270,NA,OVERALL,Total planned dose (mg),11,NA,9,1424,2013-03-03,2013-03-08,2013-03-03,2013-03-07,NA,2013-03-17,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-15,-16,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-03-07,5,NA,2013-03-08,DISCONTINUED,NA,2013-03-03,NA,NA,NA,2013-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1424,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-03,2013-03-03T00:00:00Z,2013-03-07T23:59:59Z,2013-03-03T00:00:00Z,NA,NA,2013-03-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-03,2013-03-07,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1424,2013-03-03,2013-03-08,2013-03-03,2013-03-07,NA,2013-03-17,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-15,-16,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-03-07,5,NA,2013-03-08,DISCONTINUED,NA,2013-03-03,NA,NA,NA,2013-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1424,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-03,2013-03-03T00:00:00Z,2013-03-07T23:59:59Z,2013-03-03T00:00:00Z,NA,NA,2013-03-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-03,2013-03-07,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1424,2013-03-03,2013-03-08,2013-03-03,2013-03-07,NA,2013-03-17,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-15,-16,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-03-07,5,NA,2013-03-08,DISCONTINUED,NA,2013-03-03,NA,NA,NA,2013-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-709-1424,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-03-03,2013-03-03T00:00:00Z,2013-03-07T23:59:59Z,2013-03-03T00:00:00Z,NA,NA,2013-03-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-03,2013-03-07,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1424,2013-03-03,2013-03-08,2013-03-03,2013-03-07,NA,2013-03-17,NA,NA,709,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-15,-16,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-03-07,5,NA,2013-03-08,DISCONTINUED,NA,2013-03-03,NA,NA,NA,2013-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1002,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-14,2014-01-18,1,5,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-01-18T23:59:59Z,2014-01-14T00:00:00Z,NA,H,2014-01-18T00:00:00Z,NA,H,1,5,5,2014-01-14,2014-01-18,270,270,DURD,5,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1002,2014-01-14,2014-01-18,2014-01-14,2014-01-18,NA,2014-01-20,NA,NA,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-30,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-18,5,NA,2014-01-18,DISCONTINUED,NA,2014-01-14,NA,NA,NA,2014-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1002,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-14,2014-01-18,1,5,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-01-18T23:59:59Z,2014-01-14T00:00:00Z,NA,H,2014-01-18T00:00:00Z,NA,H,1,5,5,2014-01-14,2014-01-18,270,270,DOSE,270,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1002,2014-01-14,2014-01-18,2014-01-14,2014-01-18,NA,2014-01-20,NA,NA,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-30,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-18,5,NA,2014-01-18,DISCONTINUED,NA,2014-01-14,NA,NA,NA,2014-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1002,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-14,2014-01-18,1,5,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-01-18T23:59:59Z,2014-01-14T00:00:00Z,NA,H,2014-01-18T00:00:00Z,NA,H,1,5,5,2014-01-14,2014-01-18,270,270,PLDOSE,270,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1002,2014-01-14,2014-01-18,2014-01-14,2014-01-18,NA,2014-01-20,NA,NA,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-30,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-18,5,NA,2014-01-18,DISCONTINUED,NA,2014-01-14,NA,NA,NA,2014-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1002,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-14,2014-01-18,1,5,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-01-18T23:59:59Z,2014-01-14T00:00:00Z,NA,H,2014-01-18T00:00:00Z,NA,H,1,5,5,2014-01-14,2014-01-18,270,270,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1002,2014-01-14,2014-01-18,2014-01-14,2014-01-18,NA,2014-01-20,NA,NA,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-30,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-18,5,NA,2014-01-18,DISCONTINUED,NA,2014-01-14,NA,NA,NA,2014-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1002,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-14,2014-01-18,1,5,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-01-18T23:59:59Z,2014-01-14T00:00:00Z,NA,H,2014-01-18T00:00:00Z,NA,H,1,5,5,2014-01-14,2014-01-18,270,270,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1002,2014-01-14,2014-01-18,2014-01-14,2014-01-18,NA,2014-01-20,NA,NA,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-30,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-18,5,NA,2014-01-18,DISCONTINUED,NA,2014-01-14,NA,NA,NA,2014-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1002,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-01-18T23:59:59Z,2014-01-14T00:00:00Z,NA,NA,2014-01-18T00:00:00Z,NA,NA,NA,NA,NA,2014-01-14,2014-01-18,NA,NA,TDURD,5,NA,OVERALL,Overall duration (days),7,< 30 days,6,1002,2014-01-14,2014-01-18,2014-01-14,2014-01-18,NA,2014-01-20,NA,NA,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-30,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-18,5,NA,2014-01-18,DISCONTINUED,NA,2014-01-14,NA,NA,NA,2014-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1002,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-01-18T23:59:59Z,2014-01-14T00:00:00Z,NA,NA,2014-01-18T00:00:00Z,NA,NA,NA,NA,NA,2014-01-14,2014-01-18,NA,NA,TDOSE,270,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1002,2014-01-14,2014-01-18,2014-01-14,2014-01-18,NA,2014-01-20,NA,NA,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-30,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-18,5,NA,2014-01-18,DISCONTINUED,NA,2014-01-14,NA,NA,NA,2014-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1002,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-01-18T23:59:59Z,2014-01-14T00:00:00Z,NA,NA,2014-01-18T00:00:00Z,NA,NA,NA,NA,NA,2014-01-14,2014-01-18,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1002,2014-01-14,2014-01-18,2014-01-14,2014-01-18,NA,2014-01-20,NA,NA,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-30,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-18,5,NA,2014-01-18,DISCONTINUED,NA,2014-01-14,NA,NA,NA,2014-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1002,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-01-18T23:59:59Z,2014-01-14T00:00:00Z,NA,NA,2014-01-18T00:00:00Z,NA,NA,NA,NA,NA,2014-01-14,2014-01-18,NA,NA,TPDOSE,270,NA,OVERALL,Total planned dose (mg),11,NA,9,1002,2014-01-14,2014-01-18,2014-01-14,2014-01-18,NA,2014-01-20,NA,NA,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-30,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-18,5,NA,2014-01-18,DISCONTINUED,NA,2014-01-14,NA,NA,NA,2014-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1002,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-01-18T23:59:59Z,2014-01-14T00:00:00Z,NA,NA,2014-01-18T00:00:00Z,NA,NA,NA,NA,NA,2014-01-14,2014-01-18,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1002,2014-01-14,2014-01-18,2014-01-14,2014-01-18,NA,2014-01-20,NA,NA,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-30,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-18,5,NA,2014-01-18,DISCONTINUED,NA,2014-01-14,NA,NA,NA,2014-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1002,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-01-18T23:59:59Z,2014-01-14T00:00:00Z,NA,NA,2014-01-18T00:00:00Z,NA,NA,NA,NA,NA,2014-01-14,2014-01-18,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1002,2014-01-14,2014-01-18,2014-01-14,2014-01-18,NA,2014-01-20,NA,NA,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-30,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-18,5,NA,2014-01-18,DISCONTINUED,NA,2014-01-14,NA,NA,NA,2014-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1002,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-01-18T23:59:59Z,2014-01-14T00:00:00Z,NA,NA,2014-01-18T00:00:00Z,NA,NA,NA,NA,NA,2014-01-14,2014-01-18,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1002,2014-01-14,2014-01-18,2014-01-14,2014-01-18,NA,2014-01-20,NA,NA,710,88,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-30,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-18,5,NA,2014-01-18,DISCONTINUED,NA,2014-01-14,NA,NA,NA,2014-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1006,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-10,2013-02-22,1,13,NA,54,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-10T00:00:00Z,NA,H,2013-02-22T00:00:00Z,NA,H,1,13,13,2013-02-10,2013-02-22,702,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1006,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-10,2013-02-22,1,13,NA,54,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-10T00:00:00Z,NA,H,2013-02-22T00:00:00Z,NA,H,1,13,13,2013-02-10,2013-02-22,702,702,DOSE,702,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1006,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-10,2013-02-22,1,13,NA,54,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-10T00:00:00Z,NA,H,2013-02-22T00:00:00Z,NA,H,1,13,13,2013-02-10,2013-02-22,702,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1006,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-10,2013-02-22,1,13,NA,54,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-10T00:00:00Z,NA,H,2013-02-22T00:00:00Z,NA,H,1,13,13,2013-02-10,2013-02-22,702,702,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1006,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-10,2013-02-22,1,13,NA,54,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-10T00:00:00Z,NA,H,2013-02-22T00:00:00Z,NA,H,1,13,13,2013-02-10,2013-02-22,702,702,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1006,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-23,2013-07-27,14,168,NA,54,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-23T00:00:00Z,NA,H,2013-07-27T00:00:00Z,NA,H,14,168,155,2013-02-23,2013-07-27,12555,8370,DURD,155,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1006,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-23,2013-07-27,14,168,NA,54,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-23T00:00:00Z,NA,H,2013-07-27T00:00:00Z,NA,H,14,168,155,2013-02-23,2013-07-27,12555,8370,DOSE,12555,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1006,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-23,2013-07-27,14,168,NA,54,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-23T00:00:00Z,NA,H,2013-07-27T00:00:00Z,NA,H,14,168,155,2013-02-23,2013-07-27,12555,8370,PLDOSE,8370,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1006,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-23,2013-07-27,14,168,NA,54,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-23T00:00:00Z,NA,H,2013-07-27T00:00:00Z,NA,H,14,168,155,2013-02-23,2013-07-27,12555,8370,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1006,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-23,2013-07-27,14,168,NA,54,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-23T00:00:00Z,NA,H,2013-07-27T00:00:00Z,NA,H,14,168,155,2013-02-23,2013-07-27,12555,8370,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1006,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-28,2013-08-09,169,181,NA,54,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-07-28T00:00:00Z,NA,H,2013-08-09T00:00:00Z,NA,H,169,181,13,2013-07-28,2013-08-09,702,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1006,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-28,2013-08-09,169,181,NA,54,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-07-28T00:00:00Z,NA,H,2013-08-09T00:00:00Z,NA,H,169,181,13,2013-07-28,2013-08-09,702,702,DOSE,702,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1006,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-28,2013-08-09,169,181,NA,54,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-07-28T00:00:00Z,NA,H,2013-08-09T00:00:00Z,NA,H,169,181,13,2013-07-28,2013-08-09,702,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1006,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-28,2013-08-09,169,181,NA,54,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-07-28T00:00:00Z,NA,H,2013-08-09T00:00:00Z,NA,H,169,181,13,2013-07-28,2013-08-09,702,702,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1006,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-28,2013-08-09,169,181,NA,54,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-07-28T00:00:00Z,NA,H,2013-08-09T00:00:00Z,NA,H,169,181,13,2013-07-28,2013-08-09,702,702,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-10T00:00:00Z,NA,NA,2013-08-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-10,2013-08-09,NA,NA,TDURD,181,NA,OVERALL,Overall duration (days),7,>=90 days,16,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-10T00:00:00Z,NA,NA,2013-08-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-10,2013-08-09,NA,NA,TDOSE,13959,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-10T00:00:00Z,NA,NA,2013-08-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-10,2013-08-09,NA,NA,AVDDSE,77.12154696132596,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-10T00:00:00Z,NA,NA,2013-08-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-10,2013-08-09,NA,NA,TPDOSE,9774,NA,OVERALL,Total planned dose (mg),11,NA,19,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-10T00:00:00Z,NA,NA,2013-08-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-10,2013-08-09,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-10T00:00:00Z,NA,NA,2013-08-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-10,2013-08-09,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-10T00:00:00Z,NA,NA,2013-08-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-10,2013-08-09,NA,NA,TDOSINT,142.81767955801106,NA,OVERALL,Overall dose intensity (%),90,NA,22,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-23T00:00:00Z,NA,NA,2013-08-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-23,2013-08-09,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-23T00:00:00Z,NA,NA,2013-08-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-23,2013-08-09,NA,NA,PDOSE,13257,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-23T00:00:00Z,NA,NA,2013-08-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-23,2013-08-09,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-23T00:00:00Z,NA,NA,2013-08-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-23,2013-08-09,NA,NA,PAVDDSE,78.91071428571429,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-23T00:00:00Z,NA,NA,2013-08-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-23,2013-08-09,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-23T00:00:00Z,NA,NA,2013-08-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-23,2013-08-09,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1006,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-10,2013-02-10T00:00:00Z,2013-08-09T23:59:59Z,2013-02-23T00:00:00Z,NA,NA,2013-08-09T00:00:00Z,NA,NA,NA,NA,NA,2013-02-23,2013-08-09,NA,NA,PDOSINT,146.13095238095238,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1006,2013-02-10,2013-08-10,2013-02-10,2013-08-09,NA,2013-08-10T10:10,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-27,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-09,181,NA,2013-08-10,COMPLETED,NA,2013-02-10,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1021,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-27,2013-10-11,1,15,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-09-27T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,1,15,15,2013-09-27,2013-10-11,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1021,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-27,2013-10-11,1,15,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-09-27T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,1,15,15,2013-09-27,2013-10-11,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1021,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-27,2013-10-11,1,15,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-09-27T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,1,15,15,2013-09-27,2013-10-11,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1021,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-27,2013-10-11,1,15,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-09-27T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,1,15,15,2013-09-27,2013-10-11,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1021,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-27,2013-10-11,1,15,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-09-27T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,1,15,15,2013-09-27,2013-10-11,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1021,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-12,2013-10-29,16,33,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-10-12T00:00:00Z,NA,H,2013-10-29T00:00:00Z,NA,H,16,33,18,2013-10-12,2013-10-29,1458,972,DURD,18,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1021,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-12,2013-10-29,16,33,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-10-12T00:00:00Z,NA,H,2013-10-29T00:00:00Z,NA,H,16,33,18,2013-10-12,2013-10-29,1458,972,DOSE,1458,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1021,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-12,2013-10-29,16,33,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-10-12T00:00:00Z,NA,H,2013-10-29T00:00:00Z,NA,H,16,33,18,2013-10-12,2013-10-29,1458,972,PLDOSE,972,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1021,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-12,2013-10-29,16,33,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-10-12T00:00:00Z,NA,H,2013-10-29T00:00:00Z,NA,H,16,33,18,2013-10-12,2013-10-29,1458,972,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1021,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-12,2013-10-29,16,33,NA,54,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-10-12T00:00:00Z,NA,H,2013-10-29T00:00:00Z,NA,H,16,33,18,2013-10-12,2013-10-29,1458,972,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-09-27T00:00:00Z,NA,NA,2013-10-29T00:00:00Z,NA,NA,NA,NA,NA,2013-09-27,2013-10-29,NA,NA,TDURD,33,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-09-27T00:00:00Z,NA,NA,2013-10-29T00:00:00Z,NA,NA,NA,NA,NA,2013-09-27,2013-10-29,NA,NA,TDOSE,2268,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-09-27T00:00:00Z,NA,NA,2013-10-29T00:00:00Z,NA,NA,NA,NA,NA,2013-09-27,2013-10-29,NA,NA,AVDDSE,68.72727272727273,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-09-27T00:00:00Z,NA,NA,2013-10-29T00:00:00Z,NA,NA,NA,NA,NA,2013-09-27,2013-10-29,NA,NA,TPDOSE,1782,NA,OVERALL,Total planned dose (mg),11,NA,14,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-09-27T00:00:00Z,NA,NA,2013-10-29T00:00:00Z,NA,NA,NA,NA,NA,2013-09-27,2013-10-29,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-09-27T00:00:00Z,NA,NA,2013-10-29T00:00:00Z,NA,NA,NA,NA,NA,2013-09-27,2013-10-29,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-09-27T00:00:00Z,NA,NA,2013-10-29T00:00:00Z,NA,NA,NA,NA,NA,2013-09-27,2013-10-29,NA,NA,TDOSINT,127.27272727272727,NA,OVERALL,Overall dose intensity (%),90,NA,17,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2013-10-29T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2013-10-29,NA,NA,PDURD,18,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2013-10-29T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2013-10-29,NA,NA,PDOSE,1458,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2013-10-29T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2013-10-29,NA,NA,PPDOSE,972,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2013-10-29T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2013-10-29,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2013-10-29T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2013-10-29,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2013-10-29T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2013-10-29,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1021,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-27,2013-09-27T00:00:00Z,2013-10-29T23:59:59Z,2013-10-12T00:00:00Z,NA,NA,2013-10-29T00:00:00Z,NA,NA,NA,NA,NA,2013-10-12,2013-10-29,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1021,2013-09-27,2013-11-12,2013-09-27,2013-10-29,NA,2013-11-22,NA,NA,710,79,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-09-19,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-29,33,NA,2013-11-12,DISCONTINUED,NA,2013-09-27,NA,NA,NA,2013-11-12,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1027,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-28,2014-03-14,1,15,NA,0,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-02-28T00:00:00Z,NA,H,2014-03-14T00:00:00Z,NA,H,1,15,15,2014-02-28,2014-03-14,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1027,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-28,2014-03-14,1,15,NA,0,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-02-28T00:00:00Z,NA,H,2014-03-14T00:00:00Z,NA,H,1,15,15,2014-02-28,2014-03-14,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1027,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-28,2014-03-14,1,15,NA,0,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-02-28T00:00:00Z,NA,H,2014-03-14T00:00:00Z,NA,H,1,15,15,2014-02-28,2014-03-14,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1027,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-28,2014-03-14,1,15,NA,0,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-02-28T00:00:00Z,NA,H,2014-03-14T00:00:00Z,NA,H,1,15,15,2014-02-28,2014-03-14,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1027,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-28,2014-03-14,1,15,NA,0,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-02-28T00:00:00Z,NA,H,2014-03-14T00:00:00Z,NA,H,1,15,15,2014-02-28,2014-03-14,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1027,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-15,2014-08-19,16,173,NA,0,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-03-15T00:00:00Z,NA,H,2014-08-19T00:00:00Z,NA,H,16,173,158,2014-03-15,2014-08-19,0,0,DURD,158,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1027,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-15,2014-08-19,16,173,NA,0,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-03-15T00:00:00Z,NA,H,2014-08-19T00:00:00Z,NA,H,16,173,158,2014-03-15,2014-08-19,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1027,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-15,2014-08-19,16,173,NA,0,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-03-15T00:00:00Z,NA,H,2014-08-19T00:00:00Z,NA,H,16,173,158,2014-03-15,2014-08-19,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1027,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-15,2014-08-19,16,173,NA,0,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-03-15T00:00:00Z,NA,H,2014-08-19T00:00:00Z,NA,H,16,173,158,2014-03-15,2014-08-19,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1027,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-03-15,2014-08-19,16,173,NA,0,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-03-15T00:00:00Z,NA,H,2014-08-19T00:00:00Z,NA,H,16,173,158,2014-03-15,2014-08-19,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1027,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-20,2014-08-29,174,183,NA,0,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-08-20T00:00:00Z,NA,H,2014-08-29T00:00:00Z,NA,H,174,183,10,2014-08-20,2014-08-29,0,0,DURD,10,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1027,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-20,2014-08-29,174,183,NA,0,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-08-20T00:00:00Z,NA,H,2014-08-29T00:00:00Z,NA,H,174,183,10,2014-08-20,2014-08-29,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1027,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-20,2014-08-29,174,183,NA,0,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-08-20T00:00:00Z,NA,H,2014-08-29T00:00:00Z,NA,H,174,183,10,2014-08-20,2014-08-29,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1027,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-20,2014-08-29,174,183,NA,0,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-08-20T00:00:00Z,NA,H,2014-08-29T00:00:00Z,NA,H,174,183,10,2014-08-20,2014-08-29,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1027,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-20,2014-08-29,174,183,NA,0,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-08-20T00:00:00Z,NA,H,2014-08-29T00:00:00Z,NA,H,174,183,10,2014-08-20,2014-08-29,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-02-28T00:00:00Z,NA,NA,2014-08-29T00:00:00Z,NA,NA,NA,NA,NA,2014-02-28,2014-08-29,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-02-28T00:00:00Z,NA,NA,2014-08-29T00:00:00Z,NA,NA,NA,NA,NA,2014-02-28,2014-08-29,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-02-28T00:00:00Z,NA,NA,2014-08-29T00:00:00Z,NA,NA,NA,NA,NA,2014-02-28,2014-08-29,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-02-28T00:00:00Z,NA,NA,2014-08-29T00:00:00Z,NA,NA,NA,NA,NA,2014-02-28,2014-08-29,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-02-28T00:00:00Z,NA,NA,2014-08-29T00:00:00Z,NA,NA,NA,NA,NA,2014-02-28,2014-08-29,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-02-28T00:00:00Z,NA,NA,2014-08-29T00:00:00Z,NA,NA,NA,NA,NA,2014-02-28,2014-08-29,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-02-28T00:00:00Z,NA,NA,2014-08-29T00:00:00Z,NA,NA,NA,NA,NA,2014-02-28,2014-08-29,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-03-15T00:00:00Z,NA,NA,2014-08-29T00:00:00Z,NA,NA,NA,NA,NA,2014-03-15,2014-08-29,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-03-15T00:00:00Z,NA,NA,2014-08-29T00:00:00Z,NA,NA,NA,NA,NA,2014-03-15,2014-08-29,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-03-15T00:00:00Z,NA,NA,2014-08-29T00:00:00Z,NA,NA,NA,NA,NA,2014-03-15,2014-08-29,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-03-15T00:00:00Z,NA,NA,2014-08-29T00:00:00Z,NA,NA,NA,NA,NA,2014-03-15,2014-08-29,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-03-15T00:00:00Z,NA,NA,2014-08-29T00:00:00Z,NA,NA,NA,NA,NA,2014-03-15,2014-08-29,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-03-15T00:00:00Z,NA,NA,2014-08-29T00:00:00Z,NA,NA,NA,NA,NA,2014-03-15,2014-08-29,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1027,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-28,2014-02-28T00:00:00Z,2014-08-29T23:59:59Z,2014-03-15T00:00:00Z,NA,NA,2014-08-29T00:00:00Z,NA,NA,NA,NA,NA,2014-03-15,2014-08-29,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1027,2014-02-28,2014-08-29,2014-02-28,2014-08-29,NA,2014-08-29T11:05,NA,NA,710,83,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-02-03,-25,Placebo,Placebo,H,H,2014-08-29,183,NA,2014-08-29,COMPLETED,NA,2014-02-28,NA,NA,NA,2014-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1045,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-03,2013-06-17,1,15,NA,54,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-03T00:00:00Z,NA,H,2013-06-17T00:00:00Z,NA,H,1,15,15,2013-06-03,2013-06-17,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1045,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-03,2013-06-17,1,15,NA,54,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-03T00:00:00Z,NA,H,2013-06-17T00:00:00Z,NA,H,1,15,15,2013-06-03,2013-06-17,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1045,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-03,2013-06-17,1,15,NA,54,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-03T00:00:00Z,NA,H,2013-06-17T00:00:00Z,NA,H,1,15,15,2013-06-03,2013-06-17,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1045,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-03,2013-06-17,1,15,NA,54,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-03T00:00:00Z,NA,H,2013-06-17T00:00:00Z,NA,H,1,15,15,2013-06-03,2013-06-17,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1045,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-03,2013-06-17,1,15,NA,54,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-03T00:00:00Z,NA,H,2013-06-17T00:00:00Z,NA,H,1,15,15,2013-06-03,2013-06-17,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1045,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-18,2013-08-13,16,72,NA,54,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-18T00:00:00Z,NA,H,2013-08-13T00:00:00Z,NA,H,16,72,57,2013-06-18,2013-08-13,3078,3078,DURD,57,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1045,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-18,2013-08-13,16,72,NA,54,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-18T00:00:00Z,NA,H,2013-08-13T00:00:00Z,NA,H,16,72,57,2013-06-18,2013-08-13,3078,3078,DOSE,3078,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1045,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-18,2013-08-13,16,72,NA,54,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-18T00:00:00Z,NA,H,2013-08-13T00:00:00Z,NA,H,16,72,57,2013-06-18,2013-08-13,3078,3078,PLDOSE,3078,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1045,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-18,2013-08-13,16,72,NA,54,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-18T00:00:00Z,NA,H,2013-08-13T00:00:00Z,NA,H,16,72,57,2013-06-18,2013-08-13,3078,3078,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1045,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-18,2013-08-13,16,72,NA,54,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-18T00:00:00Z,NA,H,2013-08-13T00:00:00Z,NA,H,16,72,57,2013-06-18,2013-08-13,3078,3078,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-03T00:00:00Z,NA,NA,2013-08-13T00:00:00Z,NA,NA,NA,NA,NA,2013-06-03,2013-08-13,NA,NA,TDURD,72,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-03T00:00:00Z,NA,NA,2013-08-13T00:00:00Z,NA,NA,NA,NA,NA,2013-06-03,2013-08-13,NA,NA,TDOSE,3888,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-03T00:00:00Z,NA,NA,2013-08-13T00:00:00Z,NA,NA,NA,NA,NA,2013-06-03,2013-08-13,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-03T00:00:00Z,NA,NA,2013-08-13T00:00:00Z,NA,NA,NA,NA,NA,2013-06-03,2013-08-13,NA,NA,TPDOSE,3888,NA,OVERALL,Total planned dose (mg),11,NA,14,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-03T00:00:00Z,NA,NA,2013-08-13T00:00:00Z,NA,NA,NA,NA,NA,2013-06-03,2013-08-13,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-03T00:00:00Z,NA,NA,2013-08-13T00:00:00Z,NA,NA,NA,NA,NA,2013-06-03,2013-08-13,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-03T00:00:00Z,NA,NA,2013-08-13T00:00:00Z,NA,NA,NA,NA,NA,2013-06-03,2013-08-13,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-18T00:00:00Z,NA,NA,2013-08-13T00:00:00Z,NA,NA,NA,NA,NA,2013-06-18,2013-08-13,NA,NA,PDURD,57,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-18T00:00:00Z,NA,NA,2013-08-13T00:00:00Z,NA,NA,NA,NA,NA,2013-06-18,2013-08-13,NA,NA,PDOSE,3078,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-18T00:00:00Z,NA,NA,2013-08-13T00:00:00Z,NA,NA,NA,NA,NA,2013-06-18,2013-08-13,NA,NA,PPDOSE,3078,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-18T00:00:00Z,NA,NA,2013-08-13T00:00:00Z,NA,NA,NA,NA,NA,2013-06-18,2013-08-13,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-18T00:00:00Z,NA,NA,2013-08-13T00:00:00Z,NA,NA,NA,NA,NA,2013-06-18,2013-08-13,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-18T00:00:00Z,NA,NA,2013-08-13T00:00:00Z,NA,NA,NA,NA,NA,2013-06-18,2013-08-13,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1045,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-03,2013-06-03T00:00:00Z,2013-08-13T23:59:59Z,2013-06-18T00:00:00Z,NA,NA,2013-08-13T00:00:00Z,NA,NA,NA,NA,NA,2013-06-18,2013-08-13,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1045,2013-06-03,2013-08-17,2013-06-03,2013-08-13,NA,2013-09-08,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-20,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-13,72,NA,2013-08-17,DISCONTINUED,NA,2013-06-03,NA,NA,NA,2013-08-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1053,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-26,2013-01-09,1,15,NA,54,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2012-12-26T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,1,15,15,2012-12-26,2013-01-09,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1053,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-26,2013-01-09,1,15,NA,54,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2012-12-26T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,1,15,15,2012-12-26,2013-01-09,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1053,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-26,2013-01-09,1,15,NA,54,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2012-12-26T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,1,15,15,2012-12-26,2013-01-09,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1053,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-26,2013-01-09,1,15,NA,54,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2012-12-26T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,1,15,15,2012-12-26,2013-01-09,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1053,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-26,2013-01-09,1,15,NA,54,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2012-12-26T00:00:00Z,NA,H,2013-01-09T00:00:00Z,NA,H,1,15,15,2012-12-26,2013-01-09,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1053,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-10,2013-02-10,16,47,NA,54,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2013-01-10T00:00:00Z,NA,H,2013-02-10T00:00:00Z,NA,H,16,47,32,2013-01-10,2013-02-10,1728,1728,DURD,32,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1053,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-10,2013-02-10,16,47,NA,54,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2013-01-10T00:00:00Z,NA,H,2013-02-10T00:00:00Z,NA,H,16,47,32,2013-01-10,2013-02-10,1728,1728,DOSE,1728,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1053,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-10,2013-02-10,16,47,NA,54,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2013-01-10T00:00:00Z,NA,H,2013-02-10T00:00:00Z,NA,H,16,47,32,2013-01-10,2013-02-10,1728,1728,PLDOSE,1728,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1053,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-10,2013-02-10,16,47,NA,54,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2013-01-10T00:00:00Z,NA,H,2013-02-10T00:00:00Z,NA,H,16,47,32,2013-01-10,2013-02-10,1728,1728,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1053,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-10,2013-02-10,16,47,NA,54,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2013-01-10T00:00:00Z,NA,H,2013-02-10T00:00:00Z,NA,H,16,47,32,2013-01-10,2013-02-10,1728,1728,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2012-12-26T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-12-26,2013-02-10,NA,NA,TDURD,47,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2012-12-26T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-12-26,2013-02-10,NA,NA,TDOSE,2538,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2012-12-26T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-12-26,2013-02-10,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2012-12-26T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-12-26,2013-02-10,NA,NA,TPDOSE,2538,NA,OVERALL,Total planned dose (mg),11,NA,14,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2012-12-26T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-12-26,2013-02-10,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2012-12-26T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-12-26,2013-02-10,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2012-12-26T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-12-26,2013-02-10,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-02-10,NA,NA,PDURD,32,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-02-10,NA,NA,PDOSE,1728,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-02-10,NA,NA,PPDOSE,1728,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-02-10,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-02-10,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-02-10,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1053,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-26,2012-12-26T00:00:00Z,2013-02-10T23:59:59Z,2013-01-10T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2013-01-10,2013-02-10,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1053,2012-12-26,2013-02-15,2012-12-26,2013-02-10,NA,2013-02-26T13:25,NA,NA,710,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-15,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-10,47,NA,2013-02-15,DISCONTINUED,NA,2012-12-26,NA,NA,NA,2013-02-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1060,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-01,2013-01-15,1,15,NA,0,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-01T00:00:00Z,NA,H,2013-01-15T00:00:00Z,NA,H,1,15,15,2013-01-01,2013-01-15,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1060,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-01,2013-01-15,1,15,NA,0,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-01T00:00:00Z,NA,H,2013-01-15T00:00:00Z,NA,H,1,15,15,2013-01-01,2013-01-15,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1060,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-01,2013-01-15,1,15,NA,0,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-01T00:00:00Z,NA,H,2013-01-15T00:00:00Z,NA,H,1,15,15,2013-01-01,2013-01-15,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1060,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-01,2013-01-15,1,15,NA,0,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-01T00:00:00Z,NA,H,2013-01-15T00:00:00Z,NA,H,1,15,15,2013-01-01,2013-01-15,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1060,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-01,2013-01-15,1,15,NA,0,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-01T00:00:00Z,NA,H,2013-01-15T00:00:00Z,NA,H,1,15,15,2013-01-01,2013-01-15,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1060,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-16,2013-06-21,16,172,NA,0,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-16T00:00:00Z,NA,H,2013-06-21T00:00:00Z,NA,H,16,172,157,2013-01-16,2013-06-21,0,0,DURD,157,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1060,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-16,2013-06-21,16,172,NA,0,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-16T00:00:00Z,NA,H,2013-06-21T00:00:00Z,NA,H,16,172,157,2013-01-16,2013-06-21,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1060,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-16,2013-06-21,16,172,NA,0,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-16T00:00:00Z,NA,H,2013-06-21T00:00:00Z,NA,H,16,172,157,2013-01-16,2013-06-21,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1060,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-16,2013-06-21,16,172,NA,0,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-16T00:00:00Z,NA,H,2013-06-21T00:00:00Z,NA,H,16,172,157,2013-01-16,2013-06-21,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1060,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-16,2013-06-21,16,172,NA,0,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-16T00:00:00Z,NA,H,2013-06-21T00:00:00Z,NA,H,16,172,157,2013-01-16,2013-06-21,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1060,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-22,2013-07-05,173,186,NA,0,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-06-22T00:00:00Z,NA,H,2013-07-05T00:00:00Z,NA,H,173,186,14,2013-06-22,2013-07-05,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1060,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-22,2013-07-05,173,186,NA,0,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-06-22T00:00:00Z,NA,H,2013-07-05T00:00:00Z,NA,H,173,186,14,2013-06-22,2013-07-05,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1060,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-22,2013-07-05,173,186,NA,0,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-06-22T00:00:00Z,NA,H,2013-07-05T00:00:00Z,NA,H,173,186,14,2013-06-22,2013-07-05,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1060,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-22,2013-07-05,173,186,NA,0,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-06-22T00:00:00Z,NA,H,2013-07-05T00:00:00Z,NA,H,173,186,14,2013-06-22,2013-07-05,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1060,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-22,2013-07-05,173,186,NA,0,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-06-22T00:00:00Z,NA,H,2013-07-05T00:00:00Z,NA,H,173,186,14,2013-06-22,2013-07-05,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1060,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-01T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-01,2013-07-05,NA,NA,TDURD,186,NA,OVERALL,Overall duration (days),7,>=90 days,16,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1060,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-01T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-01,2013-07-05,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1060,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-01T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-01,2013-07-05,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1060,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-01T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-01,2013-07-05,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1060,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-01T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-01,2013-07-05,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1060,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-01T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-01,2013-07-05,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1060,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-01T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-01,2013-07-05,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1060,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-16T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-16,2013-07-05,NA,NA,PDURD,171,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1060,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-16T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-16,2013-07-05,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1060,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-16T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-16,2013-07-05,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1060,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-16T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-16,2013-07-05,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1060,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-16T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-16,2013-07-05,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1060,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-16T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-16,2013-07-05,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1060,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-01,2013-01-01T00:00:00Z,2013-07-05T23:59:59Z,2013-01-16T00:00:00Z,NA,NA,2013-07-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-16,2013-07-05,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1060,2013-01-01,2013-07-05,2013-01-01,2013-07-05,NA,2013-07-05T14:40,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-12-24,-8,Placebo,Placebo,H,H,2013-07-05,186,NA,2013-07-05,COMPLETED,NA,2013-01-01,NA,NA,NA,2013-07-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1070,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-08,2012-09-22,1,15,NA,54,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-08T00:00:00Z,NA,H,2012-09-22T00:00:00Z,NA,H,1,15,15,2012-09-08,2012-09-22,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1070,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-08,2012-09-22,1,15,NA,54,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-08T00:00:00Z,NA,H,2012-09-22T00:00:00Z,NA,H,1,15,15,2012-09-08,2012-09-22,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1070,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-08,2012-09-22,1,15,NA,54,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-08T00:00:00Z,NA,H,2012-09-22T00:00:00Z,NA,H,1,15,15,2012-09-08,2012-09-22,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1070,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-08,2012-09-22,1,15,NA,54,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-08T00:00:00Z,NA,H,2012-09-22T00:00:00Z,NA,H,1,15,15,2012-09-08,2012-09-22,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1070,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-08,2012-09-22,1,15,NA,54,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-08T00:00:00Z,NA,H,2012-09-22T00:00:00Z,NA,H,1,15,15,2012-09-08,2012-09-22,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1070,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-23,2013-01-22,16,137,NA,54,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-23T00:00:00Z,NA,H,2013-01-22T00:00:00Z,NA,H,16,137,122,2012-09-23,2013-01-22,9882,6588,DURD,122,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1070,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-23,2013-01-22,16,137,NA,54,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-23T00:00:00Z,NA,H,2013-01-22T00:00:00Z,NA,H,16,137,122,2012-09-23,2013-01-22,9882,6588,DOSE,9882,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1070,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-23,2013-01-22,16,137,NA,54,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-23T00:00:00Z,NA,H,2013-01-22T00:00:00Z,NA,H,16,137,122,2012-09-23,2013-01-22,9882,6588,PLDOSE,6588,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1070,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-23,2013-01-22,16,137,NA,54,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-23T00:00:00Z,NA,H,2013-01-22T00:00:00Z,NA,H,16,137,122,2012-09-23,2013-01-22,9882,6588,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1070,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-09-23,2013-01-22,16,137,NA,54,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-23T00:00:00Z,NA,H,2013-01-22T00:00:00Z,NA,H,16,137,122,2012-09-23,2013-01-22,9882,6588,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-08T00:00:00Z,NA,NA,2013-01-22T00:00:00Z,NA,NA,NA,NA,NA,2012-09-08,2013-01-22,NA,NA,TDURD,137,NA,OVERALL,Overall duration (days),7,>=90 days,11,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-08T00:00:00Z,NA,NA,2013-01-22T00:00:00Z,NA,NA,NA,NA,NA,2012-09-08,2013-01-22,NA,NA,TDOSE,10692,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-08T00:00:00Z,NA,NA,2013-01-22T00:00:00Z,NA,NA,NA,NA,NA,2012-09-08,2013-01-22,NA,NA,AVDDSE,78.04379562043796,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-08T00:00:00Z,NA,NA,2013-01-22T00:00:00Z,NA,NA,NA,NA,NA,2012-09-08,2013-01-22,NA,NA,TPDOSE,7398,NA,OVERALL,Total planned dose (mg),11,NA,14,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-08T00:00:00Z,NA,NA,2013-01-22T00:00:00Z,NA,NA,NA,NA,NA,2012-09-08,2013-01-22,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-08T00:00:00Z,NA,NA,2013-01-22T00:00:00Z,NA,NA,NA,NA,NA,2012-09-08,2013-01-22,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-08T00:00:00Z,NA,NA,2013-01-22T00:00:00Z,NA,NA,NA,NA,NA,2012-09-08,2013-01-22,NA,NA,TDOSINT,144.52554744525548,NA,OVERALL,Overall dose intensity (%),90,NA,17,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-23T00:00:00Z,NA,NA,2013-01-22T00:00:00Z,NA,NA,NA,NA,NA,2012-09-23,2013-01-22,NA,NA,PDURD,122,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-23T00:00:00Z,NA,NA,2013-01-22T00:00:00Z,NA,NA,NA,NA,NA,2012-09-23,2013-01-22,NA,NA,PDOSE,9882,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-23T00:00:00Z,NA,NA,2013-01-22T00:00:00Z,NA,NA,NA,NA,NA,2012-09-23,2013-01-22,NA,NA,PPDOSE,6588,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-23T00:00:00Z,NA,NA,2013-01-22T00:00:00Z,NA,NA,NA,NA,NA,2012-09-23,2013-01-22,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-23T00:00:00Z,NA,NA,2013-01-22T00:00:00Z,NA,NA,NA,NA,NA,2012-09-23,2013-01-22,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-23T00:00:00Z,NA,NA,2013-01-22T00:00:00Z,NA,NA,NA,NA,NA,2012-09-23,2013-01-22,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1070,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-08,2012-09-08T00:00:00Z,2013-01-22T23:59:59Z,2012-09-23T00:00:00Z,NA,NA,2013-01-22T00:00:00Z,NA,NA,NA,NA,NA,2012-09-23,2013-01-22,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1070,2012-09-08,2013-02-23,2012-09-08,2013-01-22,NA,2013-07-04,NA,NA,710,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-08-28,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-01-22,137,NA,2013-02-23,DISCONTINUED,NA,2012-09-08,NA,NA,NA,2013-02-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1077,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-17,2013-12-01,1,15,NA,0,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-11-17T00:00:00Z,NA,H,2013-12-01T00:00:00Z,NA,H,1,15,15,2013-11-17,2013-12-01,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1077,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-17,2013-12-01,1,15,NA,0,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-11-17T00:00:00Z,NA,H,2013-12-01T00:00:00Z,NA,H,1,15,15,2013-11-17,2013-12-01,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1077,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-17,2013-12-01,1,15,NA,0,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-11-17T00:00:00Z,NA,H,2013-12-01T00:00:00Z,NA,H,1,15,15,2013-11-17,2013-12-01,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1077,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-17,2013-12-01,1,15,NA,0,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-11-17T00:00:00Z,NA,H,2013-12-01T00:00:00Z,NA,H,1,15,15,2013-11-17,2013-12-01,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1077,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-17,2013-12-01,1,15,NA,0,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-11-17T00:00:00Z,NA,H,2013-12-01T00:00:00Z,NA,H,1,15,15,2013-11-17,2013-12-01,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1077,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-02,2014-05-03,16,168,NA,0,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-12-02T00:00:00Z,NA,H,2014-05-03T00:00:00Z,NA,H,16,168,153,2013-12-02,2014-05-03,0,0,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1077,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-02,2014-05-03,16,168,NA,0,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-12-02T00:00:00Z,NA,H,2014-05-03T00:00:00Z,NA,H,16,168,153,2013-12-02,2014-05-03,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1077,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-02,2014-05-03,16,168,NA,0,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-12-02T00:00:00Z,NA,H,2014-05-03T00:00:00Z,NA,H,16,168,153,2013-12-02,2014-05-03,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1077,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-02,2014-05-03,16,168,NA,0,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-12-02T00:00:00Z,NA,H,2014-05-03T00:00:00Z,NA,H,16,168,153,2013-12-02,2014-05-03,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1077,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-02,2014-05-03,16,168,NA,0,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-12-02T00:00:00Z,NA,H,2014-05-03T00:00:00Z,NA,H,16,168,153,2013-12-02,2014-05-03,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1077,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-04,2014-05-18,169,183,NA,0,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2014-05-04T00:00:00Z,NA,H,2014-05-18T00:00:00Z,NA,H,169,183,15,2014-05-04,2014-05-18,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1077,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-04,2014-05-18,169,183,NA,0,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2014-05-04T00:00:00Z,NA,H,2014-05-18T00:00:00Z,NA,H,169,183,15,2014-05-04,2014-05-18,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1077,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-04,2014-05-18,169,183,NA,0,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2014-05-04T00:00:00Z,NA,H,2014-05-18T00:00:00Z,NA,H,169,183,15,2014-05-04,2014-05-18,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1077,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-04,2014-05-18,169,183,NA,0,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2014-05-04T00:00:00Z,NA,H,2014-05-18T00:00:00Z,NA,H,169,183,15,2014-05-04,2014-05-18,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1077,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-04,2014-05-18,169,183,NA,0,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2014-05-04T00:00:00Z,NA,H,2014-05-18T00:00:00Z,NA,H,169,183,15,2014-05-04,2014-05-18,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-11-17T00:00:00Z,NA,NA,2014-05-18T00:00:00Z,NA,NA,NA,NA,NA,2013-11-17,2014-05-18,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-11-17T00:00:00Z,NA,NA,2014-05-18T00:00:00Z,NA,NA,NA,NA,NA,2013-11-17,2014-05-18,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-11-17T00:00:00Z,NA,NA,2014-05-18T00:00:00Z,NA,NA,NA,NA,NA,2013-11-17,2014-05-18,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-11-17T00:00:00Z,NA,NA,2014-05-18T00:00:00Z,NA,NA,NA,NA,NA,2013-11-17,2014-05-18,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-11-17T00:00:00Z,NA,NA,2014-05-18T00:00:00Z,NA,NA,NA,NA,NA,2013-11-17,2014-05-18,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-11-17T00:00:00Z,NA,NA,2014-05-18T00:00:00Z,NA,NA,NA,NA,NA,2013-11-17,2014-05-18,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-11-17T00:00:00Z,NA,NA,2014-05-18T00:00:00Z,NA,NA,NA,NA,NA,2013-11-17,2014-05-18,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-12-02T00:00:00Z,NA,NA,2014-05-18T00:00:00Z,NA,NA,NA,NA,NA,2013-12-02,2014-05-18,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-12-02T00:00:00Z,NA,NA,2014-05-18T00:00:00Z,NA,NA,NA,NA,NA,2013-12-02,2014-05-18,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-12-02T00:00:00Z,NA,NA,2014-05-18T00:00:00Z,NA,NA,NA,NA,NA,2013-12-02,2014-05-18,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-12-02T00:00:00Z,NA,NA,2014-05-18T00:00:00Z,NA,NA,NA,NA,NA,2013-12-02,2014-05-18,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-12-02T00:00:00Z,NA,NA,2014-05-18T00:00:00Z,NA,NA,NA,NA,NA,2013-12-02,2014-05-18,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-12-02T00:00:00Z,NA,NA,2014-05-18T00:00:00Z,NA,NA,NA,NA,NA,2013-12-02,2014-05-18,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1077,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-17,2013-11-17T00:00:00Z,2014-05-18T23:59:59Z,2013-12-02T00:00:00Z,NA,NA,2014-05-18T00:00:00Z,NA,NA,NA,NA,NA,2013-12-02,2014-05-18,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1077,2013-11-17,2014-05-18,2013-11-17,2014-05-18,NA,2014-05-18T09:50,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-03,-14,Placebo,Placebo,H,H,2014-05-18,183,NA,2014-05-18,COMPLETED,NA,2013-11-17,NA,NA,NA,2014-05-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1078,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-17,2013-10-06,1,20,NA,0,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-09-17T00:00:00Z,NA,H,2013-10-06T00:00:00Z,NA,H,1,20,20,2013-09-17,2013-10-06,0,0,DURD,20,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1078,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-17,2013-10-06,1,20,NA,0,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-09-17T00:00:00Z,NA,H,2013-10-06T00:00:00Z,NA,H,1,20,20,2013-09-17,2013-10-06,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1078,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-17,2013-10-06,1,20,NA,0,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-09-17T00:00:00Z,NA,H,2013-10-06T00:00:00Z,NA,H,1,20,20,2013-09-17,2013-10-06,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1078,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-17,2013-10-06,1,20,NA,0,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-09-17T00:00:00Z,NA,H,2013-10-06T00:00:00Z,NA,H,1,20,20,2013-09-17,2013-10-06,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1078,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-17,2013-10-06,1,20,NA,0,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-09-17T00:00:00Z,NA,H,2013-10-06T00:00:00Z,NA,H,1,20,20,2013-09-17,2013-10-06,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1078,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-07,2014-03-08,21,173,NA,0,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-10-07T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,21,173,153,2013-10-07,2014-03-08,0,0,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1078,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-07,2014-03-08,21,173,NA,0,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-10-07T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,21,173,153,2013-10-07,2014-03-08,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1078,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-07,2014-03-08,21,173,NA,0,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-10-07T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,21,173,153,2013-10-07,2014-03-08,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1078,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-07,2014-03-08,21,173,NA,0,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-10-07T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,21,173,153,2013-10-07,2014-03-08,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1078,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-07,2014-03-08,21,173,NA,0,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-10-07T00:00:00Z,NA,H,2014-03-08T00:00:00Z,NA,H,21,173,153,2013-10-07,2014-03-08,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1078,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-09,2014-03-23,174,188,NA,0,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2014-03-09T00:00:00Z,NA,H,2014-03-23T00:00:00Z,NA,H,174,188,15,2014-03-09,2014-03-23,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1078,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-09,2014-03-23,174,188,NA,0,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2014-03-09T00:00:00Z,NA,H,2014-03-23T00:00:00Z,NA,H,174,188,15,2014-03-09,2014-03-23,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1078,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-09,2014-03-23,174,188,NA,0,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2014-03-09T00:00:00Z,NA,H,2014-03-23T00:00:00Z,NA,H,174,188,15,2014-03-09,2014-03-23,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1078,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-09,2014-03-23,174,188,NA,0,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2014-03-09T00:00:00Z,NA,H,2014-03-23T00:00:00Z,NA,H,174,188,15,2014-03-09,2014-03-23,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1078,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-09,2014-03-23,174,188,NA,0,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2014-03-09T00:00:00Z,NA,H,2014-03-23T00:00:00Z,NA,H,174,188,15,2014-03-09,2014-03-23,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-09-17T00:00:00Z,NA,NA,2014-03-23T00:00:00Z,NA,NA,NA,NA,NA,2013-09-17,2014-03-23,NA,NA,TDURD,188,NA,OVERALL,Overall duration (days),7,>=90 days,16,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-09-17T00:00:00Z,NA,NA,2014-03-23T00:00:00Z,NA,NA,NA,NA,NA,2013-09-17,2014-03-23,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-09-17T00:00:00Z,NA,NA,2014-03-23T00:00:00Z,NA,NA,NA,NA,NA,2013-09-17,2014-03-23,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-09-17T00:00:00Z,NA,NA,2014-03-23T00:00:00Z,NA,NA,NA,NA,NA,2013-09-17,2014-03-23,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-09-17T00:00:00Z,NA,NA,2014-03-23T00:00:00Z,NA,NA,NA,NA,NA,2013-09-17,2014-03-23,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-09-17T00:00:00Z,NA,NA,2014-03-23T00:00:00Z,NA,NA,NA,NA,NA,2013-09-17,2014-03-23,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-09-17T00:00:00Z,NA,NA,2014-03-23T00:00:00Z,NA,NA,NA,NA,NA,2013-09-17,2014-03-23,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-10-07T00:00:00Z,NA,NA,2014-03-23T00:00:00Z,NA,NA,NA,NA,NA,2013-10-07,2014-03-23,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-10-07T00:00:00Z,NA,NA,2014-03-23T00:00:00Z,NA,NA,NA,NA,NA,2013-10-07,2014-03-23,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-10-07T00:00:00Z,NA,NA,2014-03-23T00:00:00Z,NA,NA,NA,NA,NA,2013-10-07,2014-03-23,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-10-07T00:00:00Z,NA,NA,2014-03-23T00:00:00Z,NA,NA,NA,NA,NA,2013-10-07,2014-03-23,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-10-07T00:00:00Z,NA,NA,2014-03-23T00:00:00Z,NA,NA,NA,NA,NA,2013-10-07,2014-03-23,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-10-07T00:00:00Z,NA,NA,2014-03-23T00:00:00Z,NA,NA,NA,NA,NA,2013-10-07,2014-03-23,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1078,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-17,2013-09-17T00:00:00Z,2014-03-23T23:59:59Z,2013-10-07T00:00:00Z,NA,NA,2014-03-23T00:00:00Z,NA,NA,NA,NA,NA,2013-10-07,2014-03-23,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1078,2013-09-17,2014-03-23,2013-09-17,2014-03-23,NA,2014-03-23T16:00,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-06,-11,Placebo,Placebo,H,H,2014-03-23,188,NA,2014-03-23,COMPLETED,NA,2013-09-17,NA,NA,NA,2014-03-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1083,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-22,2013-08-01,1,11,NA,0,2013-07-22,2013-07-22T00:00:00Z,2013-08-01T23:59:59Z,2013-07-22T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,1,11,11,2013-07-22,2013-08-01,0,0,DURD,11,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1083,2013-07-22,2013-08-03,2013-07-22,2013-08-01,NA,2013-08-03,2013-08-02,Y,710,89,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-09,-13,Placebo,Placebo,H,H,2013-08-01,11,NA,2013-08-02,DISCONTINUED,NA,2013-07-22,2013-08-02,12,1,2013-08-02,>=65,Y,White,"NA",<= 30,Y,NA,Y
CDISCPILOT01,EX,01-710-1083,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-22,2013-08-01,1,11,NA,0,2013-07-22,2013-07-22T00:00:00Z,2013-08-01T23:59:59Z,2013-07-22T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,1,11,11,2013-07-22,2013-08-01,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1083,2013-07-22,2013-08-03,2013-07-22,2013-08-01,NA,2013-08-03,2013-08-02,Y,710,89,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-09,-13,Placebo,Placebo,H,H,2013-08-01,11,NA,2013-08-02,DISCONTINUED,NA,2013-07-22,2013-08-02,12,1,2013-08-02,>=65,Y,White,"NA",<= 30,Y,NA,Y
CDISCPILOT01,EX,01-710-1083,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-22,2013-08-01,1,11,NA,0,2013-07-22,2013-07-22T00:00:00Z,2013-08-01T23:59:59Z,2013-07-22T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,1,11,11,2013-07-22,2013-08-01,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1083,2013-07-22,2013-08-03,2013-07-22,2013-08-01,NA,2013-08-03,2013-08-02,Y,710,89,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-09,-13,Placebo,Placebo,H,H,2013-08-01,11,NA,2013-08-02,DISCONTINUED,NA,2013-07-22,2013-08-02,12,1,2013-08-02,>=65,Y,White,"NA",<= 30,Y,NA,Y
CDISCPILOT01,EX,01-710-1083,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-22,2013-08-01,1,11,NA,0,2013-07-22,2013-07-22T00:00:00Z,2013-08-01T23:59:59Z,2013-07-22T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,1,11,11,2013-07-22,2013-08-01,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1083,2013-07-22,2013-08-03,2013-07-22,2013-08-01,NA,2013-08-03,2013-08-02,Y,710,89,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-09,-13,Placebo,Placebo,H,H,2013-08-01,11,NA,2013-08-02,DISCONTINUED,NA,2013-07-22,2013-08-02,12,1,2013-08-02,>=65,Y,White,"NA",<= 30,Y,NA,Y
CDISCPILOT01,EX,01-710-1083,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-22,2013-08-01,1,11,NA,0,2013-07-22,2013-07-22T00:00:00Z,2013-08-01T23:59:59Z,2013-07-22T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,1,11,11,2013-07-22,2013-08-01,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1083,2013-07-22,2013-08-03,2013-07-22,2013-08-01,NA,2013-08-03,2013-08-02,Y,710,89,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-09,-13,Placebo,Placebo,H,H,2013-08-01,11,NA,2013-08-02,DISCONTINUED,NA,2013-07-22,2013-08-02,12,1,2013-08-02,>=65,Y,White,"NA",<= 30,Y,NA,Y
CDISCPILOT01,NA,01-710-1083,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-22,2013-07-22T00:00:00Z,2013-08-01T23:59:59Z,2013-07-22T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-07-22,2013-08-01,NA,NA,TDURD,11,NA,OVERALL,Overall duration (days),7,< 30 days,6,1083,2013-07-22,2013-08-03,2013-07-22,2013-08-01,NA,2013-08-03,2013-08-02,Y,710,89,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-09,-13,Placebo,Placebo,H,H,2013-08-01,11,NA,2013-08-02,DISCONTINUED,NA,2013-07-22,2013-08-02,12,1,2013-08-02,>=65,Y,White,"NA",<= 30,Y,NA,Y
CDISCPILOT01,NA,01-710-1083,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-22,2013-07-22T00:00:00Z,2013-08-01T23:59:59Z,2013-07-22T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-07-22,2013-08-01,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,7,1083,2013-07-22,2013-08-03,2013-07-22,2013-08-01,NA,2013-08-03,2013-08-02,Y,710,89,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-09,-13,Placebo,Placebo,H,H,2013-08-01,11,NA,2013-08-02,DISCONTINUED,NA,2013-07-22,2013-08-02,12,1,2013-08-02,>=65,Y,White,"NA",<= 30,Y,NA,Y
CDISCPILOT01,NA,01-710-1083,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-22,2013-07-22T00:00:00Z,2013-08-01T23:59:59Z,2013-07-22T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-07-22,2013-08-01,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1083,2013-07-22,2013-08-03,2013-07-22,2013-08-01,NA,2013-08-03,2013-08-02,Y,710,89,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-09,-13,Placebo,Placebo,H,H,2013-08-01,11,NA,2013-08-02,DISCONTINUED,NA,2013-07-22,2013-08-02,12,1,2013-08-02,>=65,Y,White,"NA",<= 30,Y,NA,Y
CDISCPILOT01,NA,01-710-1083,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-22,2013-07-22T00:00:00Z,2013-08-01T23:59:59Z,2013-07-22T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-07-22,2013-08-01,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,9,1083,2013-07-22,2013-08-03,2013-07-22,2013-08-01,NA,2013-08-03,2013-08-02,Y,710,89,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-09,-13,Placebo,Placebo,H,H,2013-08-01,11,NA,2013-08-02,DISCONTINUED,NA,2013-07-22,2013-08-02,12,1,2013-08-02,>=65,Y,White,"NA",<= 30,Y,NA,Y
CDISCPILOT01,NA,01-710-1083,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-22,2013-07-22T00:00:00Z,2013-08-01T23:59:59Z,2013-07-22T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-07-22,2013-08-01,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1083,2013-07-22,2013-08-03,2013-07-22,2013-08-01,NA,2013-08-03,2013-08-02,Y,710,89,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-09,-13,Placebo,Placebo,H,H,2013-08-01,11,NA,2013-08-02,DISCONTINUED,NA,2013-07-22,2013-08-02,12,1,2013-08-02,>=65,Y,White,"NA",<= 30,Y,NA,Y
CDISCPILOT01,NA,01-710-1083,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-22,2013-07-22T00:00:00Z,2013-08-01T23:59:59Z,2013-07-22T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-07-22,2013-08-01,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1083,2013-07-22,2013-08-03,2013-07-22,2013-08-01,NA,2013-08-03,2013-08-02,Y,710,89,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-09,-13,Placebo,Placebo,H,H,2013-08-01,11,NA,2013-08-02,DISCONTINUED,NA,2013-07-22,2013-08-02,12,1,2013-08-02,>=65,Y,White,"NA",<= 30,Y,NA,Y
CDISCPILOT01,NA,01-710-1083,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-22,2013-07-22T00:00:00Z,2013-08-01T23:59:59Z,2013-07-22T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-07-22,2013-08-01,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,12,1083,2013-07-22,2013-08-03,2013-07-22,2013-08-01,NA,2013-08-03,2013-08-02,Y,710,89,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-09,-13,Placebo,Placebo,H,H,2013-08-01,11,NA,2013-08-02,DISCONTINUED,NA,2013-07-22,2013-08-02,12,1,2013-08-02,>=65,Y,White,"NA",<= 30,Y,NA,Y
CDISCPILOT01,EX,01-710-1137,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-11,2013-10-25,1,15,NA,54,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-11T00:00:00Z,NA,H,2013-10-25T00:00:00Z,NA,H,1,15,15,2013-10-11,2013-10-25,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1137,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-11,2013-10-25,1,15,NA,54,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-11T00:00:00Z,NA,H,2013-10-25T00:00:00Z,NA,H,1,15,15,2013-10-11,2013-10-25,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1137,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-11,2013-10-25,1,15,NA,54,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-11T00:00:00Z,NA,H,2013-10-25T00:00:00Z,NA,H,1,15,15,2013-10-11,2013-10-25,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1137,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-11,2013-10-25,1,15,NA,54,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-11T00:00:00Z,NA,H,2013-10-25T00:00:00Z,NA,H,1,15,15,2013-10-11,2013-10-25,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1137,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-11,2013-10-25,1,15,NA,54,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-11T00:00:00Z,NA,H,2013-10-25T00:00:00Z,NA,H,1,15,15,2013-10-11,2013-10-25,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1137,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-26,2013-11-13,16,34,NA,54,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-26T00:00:00Z,NA,H,2013-11-13T00:00:00Z,NA,H,16,34,19,2013-10-26,2013-11-13,1539,1026,DURD,19,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1137,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-26,2013-11-13,16,34,NA,54,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-26T00:00:00Z,NA,H,2013-11-13T00:00:00Z,NA,H,16,34,19,2013-10-26,2013-11-13,1539,1026,DOSE,1539,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1137,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-26,2013-11-13,16,34,NA,54,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-26T00:00:00Z,NA,H,2013-11-13T00:00:00Z,NA,H,16,34,19,2013-10-26,2013-11-13,1539,1026,PLDOSE,1026,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1137,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-26,2013-11-13,16,34,NA,54,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-26T00:00:00Z,NA,H,2013-11-13T00:00:00Z,NA,H,16,34,19,2013-10-26,2013-11-13,1539,1026,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1137,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-26,2013-11-13,16,34,NA,54,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-26T00:00:00Z,NA,H,2013-11-13T00:00:00Z,NA,H,16,34,19,2013-10-26,2013-11-13,1539,1026,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-11T00:00:00Z,NA,NA,2013-11-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-11,2013-11-13,NA,NA,TDURD,34,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-11T00:00:00Z,NA,NA,2013-11-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-11,2013-11-13,NA,NA,TDOSE,2349,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-11T00:00:00Z,NA,NA,2013-11-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-11,2013-11-13,NA,NA,AVDDSE,69.08823529411765,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-11T00:00:00Z,NA,NA,2013-11-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-11,2013-11-13,NA,NA,TPDOSE,1836,NA,OVERALL,Total planned dose (mg),11,NA,14,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-11T00:00:00Z,NA,NA,2013-11-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-11,2013-11-13,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-11T00:00:00Z,NA,NA,2013-11-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-11,2013-11-13,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-11T00:00:00Z,NA,NA,2013-11-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-11,2013-11-13,NA,NA,TDOSINT,127.94117647058823,NA,OVERALL,Overall dose intensity (%),90,NA,17,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-26T00:00:00Z,NA,NA,2013-11-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-26,2013-11-13,NA,NA,PDURD,19,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-26T00:00:00Z,NA,NA,2013-11-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-26,2013-11-13,NA,NA,PDOSE,1539,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-26T00:00:00Z,NA,NA,2013-11-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-26,2013-11-13,NA,NA,PPDOSE,1026,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-26T00:00:00Z,NA,NA,2013-11-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-26,2013-11-13,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-26T00:00:00Z,NA,NA,2013-11-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-26,2013-11-13,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-26T00:00:00Z,NA,NA,2013-11-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-26,2013-11-13,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1137,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-11,2013-10-11T00:00:00Z,2013-11-13T23:59:59Z,2013-10-26T00:00:00Z,NA,NA,2013-11-13T00:00:00Z,NA,NA,NA,NA,NA,2013-10-26,2013-11-13,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1137,2013-10-11,2013-11-13,2013-10-11,2013-11-13,NA,2013-11-25,NA,NA,710,79,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-10-03,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-13,34,NA,2013-11-13,DISCONTINUED,NA,2013-10-11,NA,NA,NA,2013-11-13,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1142,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-02,2012-10-16,1,15,NA,54,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-02T00:00:00Z,NA,H,2012-10-16T00:00:00Z,NA,H,1,15,15,2012-10-02,2012-10-16,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1142,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-02,2012-10-16,1,15,NA,54,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-02T00:00:00Z,NA,H,2012-10-16T00:00:00Z,NA,H,1,15,15,2012-10-02,2012-10-16,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1142,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-02,2012-10-16,1,15,NA,54,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-02T00:00:00Z,NA,H,2012-10-16T00:00:00Z,NA,H,1,15,15,2012-10-02,2012-10-16,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1142,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-02,2012-10-16,1,15,NA,54,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-02T00:00:00Z,NA,H,2012-10-16T00:00:00Z,NA,H,1,15,15,2012-10-02,2012-10-16,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1142,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-02,2012-10-16,1,15,NA,54,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-02T00:00:00Z,NA,H,2012-10-16T00:00:00Z,NA,H,1,15,15,2012-10-02,2012-10-16,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1142,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-17,2012-10-20,16,19,NA,54,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-17T00:00:00Z,NA,H,2012-10-20T00:00:00Z,NA,H,16,19,4,2012-10-17,2012-10-20,324,216,DURD,4,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1142,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-17,2012-10-20,16,19,NA,54,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-17T00:00:00Z,NA,H,2012-10-20T00:00:00Z,NA,H,16,19,4,2012-10-17,2012-10-20,324,216,DOSE,324,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1142,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-17,2012-10-20,16,19,NA,54,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-17T00:00:00Z,NA,H,2012-10-20T00:00:00Z,NA,H,16,19,4,2012-10-17,2012-10-20,324,216,PLDOSE,216,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1142,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-17,2012-10-20,16,19,NA,54,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-17T00:00:00Z,NA,H,2012-10-20T00:00:00Z,NA,H,16,19,4,2012-10-17,2012-10-20,324,216,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1142,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-17,2012-10-20,16,19,NA,54,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-17T00:00:00Z,NA,H,2012-10-20T00:00:00Z,NA,H,16,19,4,2012-10-17,2012-10-20,324,216,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2012-10-20T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2012-10-20,NA,NA,TDURD,19,NA,OVERALL,Overall duration (days),7,< 30 days,11,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2012-10-20T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2012-10-20,NA,NA,TDOSE,1134,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2012-10-20T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2012-10-20,NA,NA,AVDDSE,59.68421052631579,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2012-10-20T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2012-10-20,NA,NA,TPDOSE,1026,NA,OVERALL,Total planned dose (mg),11,NA,14,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2012-10-20T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2012-10-20,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2012-10-20T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2012-10-20,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2012-10-20T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2012-10-20,NA,NA,TDOSINT,110.5263157894737,NA,OVERALL,Overall dose intensity (%),90,NA,17,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-17T00:00:00Z,NA,NA,2012-10-20T00:00:00Z,NA,NA,NA,NA,NA,2012-10-17,2012-10-20,NA,NA,PDURD,4,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-17T00:00:00Z,NA,NA,2012-10-20T00:00:00Z,NA,NA,NA,NA,NA,2012-10-17,2012-10-20,NA,NA,PDOSE,324,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-17T00:00:00Z,NA,NA,2012-10-20T00:00:00Z,NA,NA,NA,NA,NA,2012-10-17,2012-10-20,NA,NA,PPDOSE,216,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-17T00:00:00Z,NA,NA,2012-10-20T00:00:00Z,NA,NA,NA,NA,NA,2012-10-17,2012-10-20,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-17T00:00:00Z,NA,NA,2012-10-20T00:00:00Z,NA,NA,NA,NA,NA,2012-10-17,2012-10-20,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-17T00:00:00Z,NA,NA,2012-10-20T00:00:00Z,NA,NA,NA,NA,NA,2012-10-17,2012-10-20,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1142,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-02,2012-10-02T00:00:00Z,2012-10-20T23:59:59Z,2012-10-17T00:00:00Z,NA,NA,2012-10-20T00:00:00Z,NA,NA,NA,NA,NA,2012-10-17,2012-10-20,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1142,2012-10-02,2012-10-23,2012-10-02,2012-10-20,NA,2012-10-28,NA,NA,710,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-09-12,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2012-10-20,19,NA,2012-10-23,DISCONTINUED,NA,2012-10-02,NA,NA,NA,2012-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1154,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-29,2014-04-12,1,15,NA,54,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-03-29T00:00:00Z,NA,H,2014-04-12T00:00:00Z,NA,H,1,15,15,2014-03-29,2014-04-12,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1154,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-29,2014-04-12,1,15,NA,54,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-03-29T00:00:00Z,NA,H,2014-04-12T00:00:00Z,NA,H,1,15,15,2014-03-29,2014-04-12,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1154,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-29,2014-04-12,1,15,NA,54,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-03-29T00:00:00Z,NA,H,2014-04-12T00:00:00Z,NA,H,1,15,15,2014-03-29,2014-04-12,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1154,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-29,2014-04-12,1,15,NA,54,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-03-29T00:00:00Z,NA,H,2014-04-12T00:00:00Z,NA,H,1,15,15,2014-03-29,2014-04-12,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1154,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-29,2014-04-12,1,15,NA,54,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-03-29T00:00:00Z,NA,H,2014-04-12T00:00:00Z,NA,H,1,15,15,2014-03-29,2014-04-12,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1154,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-13,2014-04-27,16,30,NA,54,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-04-13T00:00:00Z,NA,H,2014-04-27T00:00:00Z,NA,H,16,30,15,2014-04-13,2014-04-27,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1154,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-13,2014-04-27,16,30,NA,54,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-04-13T00:00:00Z,NA,H,2014-04-27T00:00:00Z,NA,H,16,30,15,2014-04-13,2014-04-27,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1154,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-13,2014-04-27,16,30,NA,54,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-04-13T00:00:00Z,NA,H,2014-04-27T00:00:00Z,NA,H,16,30,15,2014-04-13,2014-04-27,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1154,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-13,2014-04-27,16,30,NA,54,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-04-13T00:00:00Z,NA,H,2014-04-27T00:00:00Z,NA,H,16,30,15,2014-04-13,2014-04-27,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1154,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-13,2014-04-27,16,30,NA,54,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-04-13T00:00:00Z,NA,H,2014-04-27T00:00:00Z,NA,H,16,30,15,2014-04-13,2014-04-27,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-03-29T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-03-29,2014-04-27,NA,NA,TDURD,30,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-03-29T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-03-29,2014-04-27,NA,NA,TDOSE,1620,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-03-29T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-03-29,2014-04-27,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-03-29T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-03-29,2014-04-27,NA,NA,TPDOSE,1620,NA,OVERALL,Total planned dose (mg),11,NA,14,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-03-29T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-03-29,2014-04-27,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-03-29T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-03-29,2014-04-27,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-03-29T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-03-29,2014-04-27,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-04-13T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-04-13,2014-04-27,NA,NA,PDURD,15,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-04-13T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-04-13,2014-04-27,NA,NA,PDOSE,810,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-04-13T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-04-13,2014-04-27,NA,NA,PPDOSE,810,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-04-13T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-04-13,2014-04-27,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-04-13T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-04-13,2014-04-27,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-04-13T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-04-13,2014-04-27,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1154,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-29,2014-03-29T00:00:00Z,2014-04-27T23:59:59Z,2014-04-13T00:00:00Z,NA,NA,2014-04-27T00:00:00Z,NA,NA,NA,NA,NA,2014-04-13,2014-04-27,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1154,2014-03-29,2014-05-09,2014-03-29,2014-04-27,NA,2014-06-13,NA,NA,710,84,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-08,-21,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-27,30,NA,2014-05-09,DISCONTINUED,NA,2014-03-29,NA,NA,NA,2014-05-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1166,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-30,2012-12-14,1,15,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-11-30T00:00:00Z,NA,H,2012-12-14T00:00:00Z,NA,H,1,15,15,2012-11-30,2012-12-14,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1166,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-30,2012-12-14,1,15,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-11-30T00:00:00Z,NA,H,2012-12-14T00:00:00Z,NA,H,1,15,15,2012-11-30,2012-12-14,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1166,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-30,2012-12-14,1,15,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-11-30T00:00:00Z,NA,H,2012-12-14T00:00:00Z,NA,H,1,15,15,2012-11-30,2012-12-14,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1166,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-30,2012-12-14,1,15,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-11-30T00:00:00Z,NA,H,2012-12-14T00:00:00Z,NA,H,1,15,15,2012-11-30,2012-12-14,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1166,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-30,2012-12-14,1,15,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-11-30T00:00:00Z,NA,H,2012-12-14T00:00:00Z,NA,H,1,15,15,2012-11-30,2012-12-14,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1166,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-15,2013-03-19,16,110,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-12-15T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,16,110,95,2012-12-15,2013-03-19,5130,5130,DURD,95,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1166,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-15,2013-03-19,16,110,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-12-15T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,16,110,95,2012-12-15,2013-03-19,5130,5130,DOSE,5130,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1166,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-15,2013-03-19,16,110,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-12-15T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,16,110,95,2012-12-15,2013-03-19,5130,5130,PLDOSE,5130,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1166,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-15,2013-03-19,16,110,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-12-15T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,16,110,95,2012-12-15,2013-03-19,5130,5130,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1166,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-15,2013-03-19,16,110,NA,54,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-12-15T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,16,110,95,2012-12-15,2013-03-19,5130,5130,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-11-30T00:00:00Z,NA,NA,2013-03-19T00:00:00Z,NA,NA,NA,NA,NA,2012-11-30,2013-03-19,NA,NA,TDURD,110,NA,OVERALL,Overall duration (days),7,>=90 days,11,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-11-30T00:00:00Z,NA,NA,2013-03-19T00:00:00Z,NA,NA,NA,NA,NA,2012-11-30,2013-03-19,NA,NA,TDOSE,5940,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-11-30T00:00:00Z,NA,NA,2013-03-19T00:00:00Z,NA,NA,NA,NA,NA,2012-11-30,2013-03-19,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-11-30T00:00:00Z,NA,NA,2013-03-19T00:00:00Z,NA,NA,NA,NA,NA,2012-11-30,2013-03-19,NA,NA,TPDOSE,5940,NA,OVERALL,Total planned dose (mg),11,NA,14,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-11-30T00:00:00Z,NA,NA,2013-03-19T00:00:00Z,NA,NA,NA,NA,NA,2012-11-30,2013-03-19,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-11-30T00:00:00Z,NA,NA,2013-03-19T00:00:00Z,NA,NA,NA,NA,NA,2012-11-30,2013-03-19,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-11-30T00:00:00Z,NA,NA,2013-03-19T00:00:00Z,NA,NA,NA,NA,NA,2012-11-30,2013-03-19,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-12-15T00:00:00Z,NA,NA,2013-03-19T00:00:00Z,NA,NA,NA,NA,NA,2012-12-15,2013-03-19,NA,NA,PDURD,95,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-12-15T00:00:00Z,NA,NA,2013-03-19T00:00:00Z,NA,NA,NA,NA,NA,2012-12-15,2013-03-19,NA,NA,PDOSE,5130,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-12-15T00:00:00Z,NA,NA,2013-03-19T00:00:00Z,NA,NA,NA,NA,NA,2012-12-15,2013-03-19,NA,NA,PPDOSE,5130,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-12-15T00:00:00Z,NA,NA,2013-03-19T00:00:00Z,NA,NA,NA,NA,NA,2012-12-15,2013-03-19,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-12-15T00:00:00Z,NA,NA,2013-03-19T00:00:00Z,NA,NA,NA,NA,NA,2012-12-15,2013-03-19,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-12-15T00:00:00Z,NA,NA,2013-03-19T00:00:00Z,NA,NA,NA,NA,NA,2012-12-15,2013-03-19,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1166,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-30,2012-11-30T00:00:00Z,2013-03-19T23:59:59Z,2012-12-15T00:00:00Z,NA,NA,2013-03-19T00:00:00Z,NA,NA,NA,NA,NA,2012-12-15,2013-03-19,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1166,2012-11-30,2013-03-30,2012-11-30,2013-03-19,NA,2013-05-22,NA,NA,710,81,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-11-10,-20,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-19,110,NA,2013-03-30,DISCONTINUED,NA,2012-11-30,NA,NA,NA,2013-03-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1183,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-16,2013-11-30,1,15,NA,0,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-11-16T00:00:00Z,NA,H,2013-11-30T00:00:00Z,NA,H,1,15,15,2013-11-16,2013-11-30,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1183,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-16,2013-11-30,1,15,NA,0,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-11-16T00:00:00Z,NA,H,2013-11-30T00:00:00Z,NA,H,1,15,15,2013-11-16,2013-11-30,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1183,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-16,2013-11-30,1,15,NA,0,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-11-16T00:00:00Z,NA,H,2013-11-30T00:00:00Z,NA,H,1,15,15,2013-11-16,2013-11-30,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1183,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-16,2013-11-30,1,15,NA,0,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-11-16T00:00:00Z,NA,H,2013-11-30T00:00:00Z,NA,H,1,15,15,2013-11-16,2013-11-30,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1183,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-11-16,2013-11-30,1,15,NA,0,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-11-16T00:00:00Z,NA,H,2013-11-30T00:00:00Z,NA,H,1,15,15,2013-11-16,2013-11-30,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1183,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-01,2014-05-03,16,169,NA,0,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-12-01T00:00:00Z,NA,H,2014-05-03T00:00:00Z,NA,H,16,169,154,2013-12-01,2014-05-03,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1183,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-01,2014-05-03,16,169,NA,0,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-12-01T00:00:00Z,NA,H,2014-05-03T00:00:00Z,NA,H,16,169,154,2013-12-01,2014-05-03,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1183,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-01,2014-05-03,16,169,NA,0,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-12-01T00:00:00Z,NA,H,2014-05-03T00:00:00Z,NA,H,16,169,154,2013-12-01,2014-05-03,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1183,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-01,2014-05-03,16,169,NA,0,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-12-01T00:00:00Z,NA,H,2014-05-03T00:00:00Z,NA,H,16,169,154,2013-12-01,2014-05-03,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1183,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-01,2014-05-03,16,169,NA,0,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-12-01T00:00:00Z,NA,H,2014-05-03T00:00:00Z,NA,H,16,169,154,2013-12-01,2014-05-03,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1183,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-04,2014-05-17,170,183,NA,0,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2014-05-04T00:00:00Z,NA,H,2014-05-17T00:00:00Z,NA,H,170,183,14,2014-05-04,2014-05-17,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1183,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-04,2014-05-17,170,183,NA,0,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2014-05-04T00:00:00Z,NA,H,2014-05-17T00:00:00Z,NA,H,170,183,14,2014-05-04,2014-05-17,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1183,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-04,2014-05-17,170,183,NA,0,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2014-05-04T00:00:00Z,NA,H,2014-05-17T00:00:00Z,NA,H,170,183,14,2014-05-04,2014-05-17,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1183,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-04,2014-05-17,170,183,NA,0,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2014-05-04T00:00:00Z,NA,H,2014-05-17T00:00:00Z,NA,H,170,183,14,2014-05-04,2014-05-17,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1183,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-04,2014-05-17,170,183,NA,0,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2014-05-04T00:00:00Z,NA,H,2014-05-17T00:00:00Z,NA,H,170,183,14,2014-05-04,2014-05-17,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-11-16T00:00:00Z,NA,NA,2014-05-17T00:00:00Z,NA,NA,NA,NA,NA,2013-11-16,2014-05-17,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-11-16T00:00:00Z,NA,NA,2014-05-17T00:00:00Z,NA,NA,NA,NA,NA,2013-11-16,2014-05-17,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-11-16T00:00:00Z,NA,NA,2014-05-17T00:00:00Z,NA,NA,NA,NA,NA,2013-11-16,2014-05-17,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-11-16T00:00:00Z,NA,NA,2014-05-17T00:00:00Z,NA,NA,NA,NA,NA,2013-11-16,2014-05-17,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-11-16T00:00:00Z,NA,NA,2014-05-17T00:00:00Z,NA,NA,NA,NA,NA,2013-11-16,2014-05-17,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-11-16T00:00:00Z,NA,NA,2014-05-17T00:00:00Z,NA,NA,NA,NA,NA,2013-11-16,2014-05-17,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-11-16T00:00:00Z,NA,NA,2014-05-17T00:00:00Z,NA,NA,NA,NA,NA,2013-11-16,2014-05-17,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-12-01T00:00:00Z,NA,NA,2014-05-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-01,2014-05-17,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-12-01T00:00:00Z,NA,NA,2014-05-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-01,2014-05-17,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-12-01T00:00:00Z,NA,NA,2014-05-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-01,2014-05-17,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-12-01T00:00:00Z,NA,NA,2014-05-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-01,2014-05-17,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-12-01T00:00:00Z,NA,NA,2014-05-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-01,2014-05-17,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-12-01T00:00:00Z,NA,NA,2014-05-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-01,2014-05-17,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1183,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-11-16,2013-11-16T00:00:00Z,2014-05-17T23:59:59Z,2013-12-01T00:00:00Z,NA,NA,2014-05-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-01,2014-05-17,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1183,2013-11-16,2014-05-17,2013-11-16,2014-05-17,NA,2014-05-17T11:55,NA,NA,710,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-24,-23,Placebo,Placebo,H,H,2014-05-17,183,NA,2014-05-17,COMPLETED,NA,2013-11-16,NA,NA,NA,2014-05-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1187,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-10,2012-11-24,1,15,NA,54,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-10T00:00:00Z,NA,H,2012-11-24T00:00:00Z,NA,H,1,15,15,2012-11-10,2012-11-24,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1187,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-10,2012-11-24,1,15,NA,54,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-10T00:00:00Z,NA,H,2012-11-24T00:00:00Z,NA,H,1,15,15,2012-11-10,2012-11-24,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1187,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-10,2012-11-24,1,15,NA,54,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-10T00:00:00Z,NA,H,2012-11-24T00:00:00Z,NA,H,1,15,15,2012-11-10,2012-11-24,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1187,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-10,2012-11-24,1,15,NA,54,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-10T00:00:00Z,NA,H,2012-11-24T00:00:00Z,NA,H,1,15,15,2012-11-10,2012-11-24,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1187,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-10,2012-11-24,1,15,NA,54,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-10T00:00:00Z,NA,H,2012-11-24T00:00:00Z,NA,H,1,15,15,2012-11-10,2012-11-24,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1187,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-25,2013-04-28,16,170,NA,54,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-25T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,16,170,155,2012-11-25,2013-04-28,12555,8370,DURD,155,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1187,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-25,2013-04-28,16,170,NA,54,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-25T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,16,170,155,2012-11-25,2013-04-28,12555,8370,DOSE,12555,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1187,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-25,2013-04-28,16,170,NA,54,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-25T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,16,170,155,2012-11-25,2013-04-28,12555,8370,PLDOSE,8370,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1187,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-25,2013-04-28,16,170,NA,54,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-25T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,16,170,155,2012-11-25,2013-04-28,12555,8370,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1187,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-25,2013-04-28,16,170,NA,54,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-25T00:00:00Z,NA,H,2013-04-28T00:00:00Z,NA,H,16,170,155,2012-11-25,2013-04-28,12555,8370,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1187,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-29,2013-05-12,171,184,NA,54,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2013-04-29T00:00:00Z,NA,H,2013-05-12T00:00:00Z,NA,H,171,184,14,2013-04-29,2013-05-12,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1187,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-29,2013-05-12,171,184,NA,54,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2013-04-29T00:00:00Z,NA,H,2013-05-12T00:00:00Z,NA,H,171,184,14,2013-04-29,2013-05-12,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1187,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-29,2013-05-12,171,184,NA,54,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2013-04-29T00:00:00Z,NA,H,2013-05-12T00:00:00Z,NA,H,171,184,14,2013-04-29,2013-05-12,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1187,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-29,2013-05-12,171,184,NA,54,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2013-04-29T00:00:00Z,NA,H,2013-05-12T00:00:00Z,NA,H,171,184,14,2013-04-29,2013-05-12,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1187,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-29,2013-05-12,171,184,NA,54,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2013-04-29T00:00:00Z,NA,H,2013-05-12T00:00:00Z,NA,H,171,184,14,2013-04-29,2013-05-12,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-10T00:00:00Z,NA,NA,2013-05-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-10,2013-05-12,NA,NA,TDURD,184,NA,OVERALL,Overall duration (days),7,>=90 days,16,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-10T00:00:00Z,NA,NA,2013-05-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-10,2013-05-12,NA,NA,TDOSE,14121,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-10T00:00:00Z,NA,NA,2013-05-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-10,2013-05-12,NA,NA,AVDDSE,76.7445652173913,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-10T00:00:00Z,NA,NA,2013-05-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-10,2013-05-12,NA,NA,TPDOSE,9936,NA,OVERALL,Total planned dose (mg),11,NA,19,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-10T00:00:00Z,NA,NA,2013-05-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-10,2013-05-12,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-10T00:00:00Z,NA,NA,2013-05-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-10,2013-05-12,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-10T00:00:00Z,NA,NA,2013-05-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-10,2013-05-12,NA,NA,TDOSINT,142.1195652173913,NA,OVERALL,Overall dose intensity (%),90,NA,22,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-25T00:00:00Z,NA,NA,2013-05-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-25,2013-05-12,NA,NA,PDURD,169,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-25T00:00:00Z,NA,NA,2013-05-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-25,2013-05-12,NA,NA,PDOSE,13311,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-25T00:00:00Z,NA,NA,2013-05-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-25,2013-05-12,NA,NA,PPDOSE,9126,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-25T00:00:00Z,NA,NA,2013-05-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-25,2013-05-12,NA,NA,PAVDDSE,78.76331360946746,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-25T00:00:00Z,NA,NA,2013-05-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-25,2013-05-12,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-25T00:00:00Z,NA,NA,2013-05-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-25,2013-05-12,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1187,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-10,2012-11-10T00:00:00Z,2013-05-12T23:59:59Z,2012-11-25T00:00:00Z,NA,NA,2013-05-12T00:00:00Z,NA,NA,NA,NA,NA,2012-11-25,2013-05-12,NA,NA,PDOSINT,145.85798816568047,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1187,2012-11-10,2013-05-12,2012-11-10,2013-05-12,NA,2013-05-12T11:05,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-26,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-12,184,NA,2013-05-12,COMPLETED,NA,2012-11-10,NA,NA,NA,2013-05-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1235,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-26,2012-10-10,1,15,NA,54,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-09-26T00:00:00Z,NA,H,2012-10-10T00:00:00Z,NA,H,1,15,15,2012-09-26,2012-10-10,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1235,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-26,2012-10-10,1,15,NA,54,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-09-26T00:00:00Z,NA,H,2012-10-10T00:00:00Z,NA,H,1,15,15,2012-09-26,2012-10-10,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1235,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-26,2012-10-10,1,15,NA,54,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-09-26T00:00:00Z,NA,H,2012-10-10T00:00:00Z,NA,H,1,15,15,2012-09-26,2012-10-10,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1235,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-26,2012-10-10,1,15,NA,54,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-09-26T00:00:00Z,NA,H,2012-10-10T00:00:00Z,NA,H,1,15,15,2012-09-26,2012-10-10,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1235,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-26,2012-10-10,1,15,NA,54,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-09-26T00:00:00Z,NA,H,2012-10-10T00:00:00Z,NA,H,1,15,15,2012-09-26,2012-10-10,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1235,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-11,2013-03-13,16,169,NA,54,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-10-11T00:00:00Z,NA,H,2013-03-13T00:00:00Z,NA,H,16,169,154,2012-10-11,2013-03-13,8316,8316,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1235,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-11,2013-03-13,16,169,NA,54,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-10-11T00:00:00Z,NA,H,2013-03-13T00:00:00Z,NA,H,16,169,154,2012-10-11,2013-03-13,8316,8316,DOSE,8316,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1235,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-11,2013-03-13,16,169,NA,54,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-10-11T00:00:00Z,NA,H,2013-03-13T00:00:00Z,NA,H,16,169,154,2012-10-11,2013-03-13,8316,8316,PLDOSE,8316,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1235,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-11,2013-03-13,16,169,NA,54,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-10-11T00:00:00Z,NA,H,2013-03-13T00:00:00Z,NA,H,16,169,154,2012-10-11,2013-03-13,8316,8316,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1235,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-11,2013-03-13,16,169,NA,54,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-10-11T00:00:00Z,NA,H,2013-03-13T00:00:00Z,NA,H,16,169,154,2012-10-11,2013-03-13,8316,8316,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1235,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-14,2013-03-27,170,183,NA,54,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2013-03-14T00:00:00Z,NA,H,2013-03-27T00:00:00Z,NA,H,170,183,14,2013-03-14,2013-03-27,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1235,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-14,2013-03-27,170,183,NA,54,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2013-03-14T00:00:00Z,NA,H,2013-03-27T00:00:00Z,NA,H,170,183,14,2013-03-14,2013-03-27,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1235,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-14,2013-03-27,170,183,NA,54,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2013-03-14T00:00:00Z,NA,H,2013-03-27T00:00:00Z,NA,H,170,183,14,2013-03-14,2013-03-27,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1235,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-14,2013-03-27,170,183,NA,54,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2013-03-14T00:00:00Z,NA,H,2013-03-27T00:00:00Z,NA,H,170,183,14,2013-03-14,2013-03-27,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1235,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-14,2013-03-27,170,183,NA,54,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2013-03-14T00:00:00Z,NA,H,2013-03-27T00:00:00Z,NA,H,170,183,14,2013-03-14,2013-03-27,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-09-26T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2012-09-26,2013-03-27,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-09-26T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2012-09-26,2013-03-27,NA,NA,TDOSE,9882,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-09-26T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2012-09-26,2013-03-27,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-09-26T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2012-09-26,2013-03-27,NA,NA,TPDOSE,9882,NA,OVERALL,Total planned dose (mg),11,NA,19,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-09-26T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2012-09-26,2013-03-27,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-09-26T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2012-09-26,2013-03-27,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-09-26T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2012-09-26,2013-03-27,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-10-11T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-11,2013-03-27,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-10-11T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-11,2013-03-27,NA,NA,PDOSE,9072,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-10-11T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-11,2013-03-27,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-10-11T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-11,2013-03-27,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-10-11T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-11,2013-03-27,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-10-11T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-11,2013-03-27,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1235,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-26,2012-09-26T00:00:00Z,2013-03-27T23:59:59Z,2012-10-11T00:00:00Z,NA,NA,2013-03-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-11,2013-03-27,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1235,2012-09-26,2013-03-27,2012-09-26,2013-03-27,NA,2013-03-27T09:35,NA,NA,710,56,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-13,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-03-27,183,NA,2013-03-27,COMPLETED,NA,2012-09-26,NA,NA,NA,2013-03-27,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1249,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-28,2014-01-11,1,15,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2013-12-28T00:00:00Z,NA,H,2014-01-11T00:00:00Z,NA,H,1,15,15,2013-12-28,2014-01-11,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1249,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-28,2014-01-11,1,15,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2013-12-28T00:00:00Z,NA,H,2014-01-11T00:00:00Z,NA,H,1,15,15,2013-12-28,2014-01-11,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1249,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-28,2014-01-11,1,15,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2013-12-28T00:00:00Z,NA,H,2014-01-11T00:00:00Z,NA,H,1,15,15,2013-12-28,2014-01-11,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1249,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-28,2014-01-11,1,15,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2013-12-28T00:00:00Z,NA,H,2014-01-11T00:00:00Z,NA,H,1,15,15,2013-12-28,2014-01-11,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1249,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-28,2014-01-11,1,15,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2013-12-28T00:00:00Z,NA,H,2014-01-11T00:00:00Z,NA,H,1,15,15,2013-12-28,2014-01-11,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1249,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-12,2014-06-14,16,169,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-01-12T00:00:00Z,NA,H,2014-06-14T00:00:00Z,NA,H,16,169,154,2014-01-12,2014-06-14,12474,8316,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1249,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-12,2014-06-14,16,169,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-01-12T00:00:00Z,NA,H,2014-06-14T00:00:00Z,NA,H,16,169,154,2014-01-12,2014-06-14,12474,8316,DOSE,12474,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1249,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-12,2014-06-14,16,169,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-01-12T00:00:00Z,NA,H,2014-06-14T00:00:00Z,NA,H,16,169,154,2014-01-12,2014-06-14,12474,8316,PLDOSE,8316,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1249,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-12,2014-06-14,16,169,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-01-12T00:00:00Z,NA,H,2014-06-14T00:00:00Z,NA,H,16,169,154,2014-01-12,2014-06-14,12474,8316,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1249,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-12,2014-06-14,16,169,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-01-12T00:00:00Z,NA,H,2014-06-14T00:00:00Z,NA,H,16,169,154,2014-01-12,2014-06-14,12474,8316,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1249,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-15,2014-06-28,170,183,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-06-15T00:00:00Z,NA,H,2014-06-28T00:00:00Z,NA,H,170,183,14,2014-06-15,2014-06-28,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1249,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-15,2014-06-28,170,183,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-06-15T00:00:00Z,NA,H,2014-06-28T00:00:00Z,NA,H,170,183,14,2014-06-15,2014-06-28,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1249,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-15,2014-06-28,170,183,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-06-15T00:00:00Z,NA,H,2014-06-28T00:00:00Z,NA,H,170,183,14,2014-06-15,2014-06-28,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1249,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-15,2014-06-28,170,183,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-06-15T00:00:00Z,NA,H,2014-06-28T00:00:00Z,NA,H,170,183,14,2014-06-15,2014-06-28,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1249,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-15,2014-06-28,170,183,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-06-15T00:00:00Z,NA,H,2014-06-28T00:00:00Z,NA,H,170,183,14,2014-06-15,2014-06-28,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-06-28,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-06-28,NA,NA,TDOSE,14040,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-06-28,NA,NA,AVDDSE,76.72131147540983,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-06-28,NA,NA,TPDOSE,9882,NA,OVERALL,Total planned dose (mg),11,NA,19,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-06-28,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-06-28,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-06-28,NA,NA,TDOSINT,142.07650273224044,NA,OVERALL,Overall dose intensity (%),90,NA,22,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-01-12T00:00:00Z,NA,NA,2014-06-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-12,2014-06-28,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-01-12T00:00:00Z,NA,NA,2014-06-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-12,2014-06-28,NA,NA,PDOSE,13230,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-01-12T00:00:00Z,NA,NA,2014-06-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-12,2014-06-28,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-01-12T00:00:00Z,NA,NA,2014-06-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-12,2014-06-28,NA,NA,PAVDDSE,78.75,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-01-12T00:00:00Z,NA,NA,2014-06-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-12,2014-06-28,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-01-12T00:00:00Z,NA,NA,2014-06-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-12,2014-06-28,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1249,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-06-28T23:59:59Z,2014-01-12T00:00:00Z,NA,NA,2014-06-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-12,2014-06-28,NA,NA,PDOSINT,145.83333333333331,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1249,2013-12-28,2014-06-28,2013-12-28,2014-06-28,NA,2014-06-28T11:05,NA,NA,710,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-19,-9,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-28,183,NA,2014-06-28,COMPLETED,NA,2013-12-28,NA,NA,NA,2014-06-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1264,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-13,2013-06-27,1,15,NA,0,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-13T00:00:00Z,NA,H,2013-06-27T00:00:00Z,NA,H,1,15,15,2013-06-13,2013-06-27,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1264,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-13,2013-06-27,1,15,NA,0,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-13T00:00:00Z,NA,H,2013-06-27T00:00:00Z,NA,H,1,15,15,2013-06-13,2013-06-27,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1264,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-13,2013-06-27,1,15,NA,0,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-13T00:00:00Z,NA,H,2013-06-27T00:00:00Z,NA,H,1,15,15,2013-06-13,2013-06-27,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1264,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-13,2013-06-27,1,15,NA,0,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-13T00:00:00Z,NA,H,2013-06-27T00:00:00Z,NA,H,1,15,15,2013-06-13,2013-06-27,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1264,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-13,2013-06-27,1,15,NA,0,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-13T00:00:00Z,NA,H,2013-06-27T00:00:00Z,NA,H,1,15,15,2013-06-13,2013-06-27,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1264,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-28,2013-10-11,16,121,NA,0,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-28T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,16,121,106,2013-06-28,2013-10-11,0,0,DURD,106,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1264,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-28,2013-10-11,16,121,NA,0,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-28T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,16,121,106,2013-06-28,2013-10-11,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1264,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-28,2013-10-11,16,121,NA,0,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-28T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,16,121,106,2013-06-28,2013-10-11,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1264,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-28,2013-10-11,16,121,NA,0,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-28T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,16,121,106,2013-06-28,2013-10-11,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1264,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-28,2013-10-11,16,121,NA,0,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-28T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,16,121,106,2013-06-28,2013-10-11,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-13T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-06-13,2013-10-11,NA,NA,TDURD,121,NA,OVERALL,Overall duration (days),7,>=90 days,11,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-13T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-06-13,2013-10-11,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-13T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-06-13,2013-10-11,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-13T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-06-13,2013-10-11,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-13T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-06-13,2013-10-11,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-13T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-06-13,2013-10-11,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-13T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-06-13,2013-10-11,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-28T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-06-28,2013-10-11,NA,NA,PDURD,106,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-28T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-06-28,2013-10-11,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-28T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-06-28,2013-10-11,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-28T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-06-28,2013-10-11,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-28T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-06-28,2013-10-11,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-28T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-06-28,2013-10-11,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1264,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-13,2013-06-13T00:00:00Z,2013-10-11T23:59:59Z,2013-06-28T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-06-28,2013-10-11,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1264,2013-06-13,2013-10-12,2013-06-13,2013-10-11,NA,2013-11-05,NA,NA,710,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-06-02,-11,Placebo,Placebo,H,H,2013-10-11,121,NA,2013-10-12,DISCONTINUED,NA,2013-06-13,NA,NA,NA,2013-10-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1270,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-12,2014-03-01,1,18,NA,54,2014-02-12,2014-02-12T00:00:00Z,2014-03-01T23:59:59Z,2014-02-12T00:00:00Z,NA,H,2014-03-01T00:00:00Z,NA,H,1,18,18,2014-02-12,2014-03-01,972,972,DURD,18,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1270,2014-02-12,2014-03-01,2014-02-12,2014-03-01,NA,2014-03-26,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-02-01,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-01,18,NA,2014-03-01,DISCONTINUED,NA,2014-02-12,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1270,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-12,2014-03-01,1,18,NA,54,2014-02-12,2014-02-12T00:00:00Z,2014-03-01T23:59:59Z,2014-02-12T00:00:00Z,NA,H,2014-03-01T00:00:00Z,NA,H,1,18,18,2014-02-12,2014-03-01,972,972,DOSE,972,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1270,2014-02-12,2014-03-01,2014-02-12,2014-03-01,NA,2014-03-26,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-02-01,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-01,18,NA,2014-03-01,DISCONTINUED,NA,2014-02-12,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1270,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-12,2014-03-01,1,18,NA,54,2014-02-12,2014-02-12T00:00:00Z,2014-03-01T23:59:59Z,2014-02-12T00:00:00Z,NA,H,2014-03-01T00:00:00Z,NA,H,1,18,18,2014-02-12,2014-03-01,972,972,PLDOSE,972,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1270,2014-02-12,2014-03-01,2014-02-12,2014-03-01,NA,2014-03-26,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-02-01,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-01,18,NA,2014-03-01,DISCONTINUED,NA,2014-02-12,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1270,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-12,2014-03-01,1,18,NA,54,2014-02-12,2014-02-12T00:00:00Z,2014-03-01T23:59:59Z,2014-02-12T00:00:00Z,NA,H,2014-03-01T00:00:00Z,NA,H,1,18,18,2014-02-12,2014-03-01,972,972,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1270,2014-02-12,2014-03-01,2014-02-12,2014-03-01,NA,2014-03-26,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-02-01,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-01,18,NA,2014-03-01,DISCONTINUED,NA,2014-02-12,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1270,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-12,2014-03-01,1,18,NA,54,2014-02-12,2014-02-12T00:00:00Z,2014-03-01T23:59:59Z,2014-02-12T00:00:00Z,NA,H,2014-03-01T00:00:00Z,NA,H,1,18,18,2014-02-12,2014-03-01,972,972,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1270,2014-02-12,2014-03-01,2014-02-12,2014-03-01,NA,2014-03-26,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-02-01,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-01,18,NA,2014-03-01,DISCONTINUED,NA,2014-02-12,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1270,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-12,2014-02-12T00:00:00Z,2014-03-01T23:59:59Z,2014-02-12T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2014-02-12,2014-03-01,NA,NA,TDURD,18,NA,OVERALL,Overall duration (days),7,< 30 days,6,1270,2014-02-12,2014-03-01,2014-02-12,2014-03-01,NA,2014-03-26,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-02-01,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-01,18,NA,2014-03-01,DISCONTINUED,NA,2014-02-12,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1270,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-12,2014-02-12T00:00:00Z,2014-03-01T23:59:59Z,2014-02-12T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2014-02-12,2014-03-01,NA,NA,TDOSE,972,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1270,2014-02-12,2014-03-01,2014-02-12,2014-03-01,NA,2014-03-26,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-02-01,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-01,18,NA,2014-03-01,DISCONTINUED,NA,2014-02-12,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1270,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-12,2014-02-12T00:00:00Z,2014-03-01T23:59:59Z,2014-02-12T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2014-02-12,2014-03-01,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1270,2014-02-12,2014-03-01,2014-02-12,2014-03-01,NA,2014-03-26,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-02-01,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-01,18,NA,2014-03-01,DISCONTINUED,NA,2014-02-12,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1270,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-12,2014-02-12T00:00:00Z,2014-03-01T23:59:59Z,2014-02-12T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2014-02-12,2014-03-01,NA,NA,TPDOSE,972,NA,OVERALL,Total planned dose (mg),11,NA,9,1270,2014-02-12,2014-03-01,2014-02-12,2014-03-01,NA,2014-03-26,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-02-01,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-01,18,NA,2014-03-01,DISCONTINUED,NA,2014-02-12,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1270,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-12,2014-02-12T00:00:00Z,2014-03-01T23:59:59Z,2014-02-12T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2014-02-12,2014-03-01,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1270,2014-02-12,2014-03-01,2014-02-12,2014-03-01,NA,2014-03-26,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-02-01,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-01,18,NA,2014-03-01,DISCONTINUED,NA,2014-02-12,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1270,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-12,2014-02-12T00:00:00Z,2014-03-01T23:59:59Z,2014-02-12T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2014-02-12,2014-03-01,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1270,2014-02-12,2014-03-01,2014-02-12,2014-03-01,NA,2014-03-26,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-02-01,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-01,18,NA,2014-03-01,DISCONTINUED,NA,2014-02-12,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1270,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-12,2014-02-12T00:00:00Z,2014-03-01T23:59:59Z,2014-02-12T00:00:00Z,NA,NA,2014-03-01T00:00:00Z,NA,NA,NA,NA,NA,2014-02-12,2014-03-01,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1270,2014-02-12,2014-03-01,2014-02-12,2014-03-01,NA,2014-03-26,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-02-01,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-01,18,NA,2014-03-01,DISCONTINUED,NA,2014-02-12,NA,NA,NA,2014-03-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1271,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-27,2012-10-12,1,16,NA,0,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-09-27T00:00:00Z,NA,H,2012-10-12T00:00:00Z,NA,H,1,16,16,2012-09-27,2012-10-12,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1271,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-27,2012-10-12,1,16,NA,0,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-09-27T00:00:00Z,NA,H,2012-10-12T00:00:00Z,NA,H,1,16,16,2012-09-27,2012-10-12,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1271,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-27,2012-10-12,1,16,NA,0,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-09-27T00:00:00Z,NA,H,2012-10-12T00:00:00Z,NA,H,1,16,16,2012-09-27,2012-10-12,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1271,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-27,2012-10-12,1,16,NA,0,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-09-27T00:00:00Z,NA,H,2012-10-12T00:00:00Z,NA,H,1,16,16,2012-09-27,2012-10-12,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1271,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-27,2012-10-12,1,16,NA,0,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-09-27T00:00:00Z,NA,H,2012-10-12T00:00:00Z,NA,H,1,16,16,2012-09-27,2012-10-12,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1271,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-13,2012-11-21,17,56,NA,0,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-10-13T00:00:00Z,NA,H,2012-11-21T00:00:00Z,NA,H,17,56,40,2012-10-13,2012-11-21,0,0,DURD,40,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1271,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-13,2012-11-21,17,56,NA,0,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-10-13T00:00:00Z,NA,H,2012-11-21T00:00:00Z,NA,H,17,56,40,2012-10-13,2012-11-21,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1271,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-13,2012-11-21,17,56,NA,0,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-10-13T00:00:00Z,NA,H,2012-11-21T00:00:00Z,NA,H,17,56,40,2012-10-13,2012-11-21,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1271,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-13,2012-11-21,17,56,NA,0,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-10-13T00:00:00Z,NA,H,2012-11-21T00:00:00Z,NA,H,17,56,40,2012-10-13,2012-11-21,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1271,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-13,2012-11-21,17,56,NA,0,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-10-13T00:00:00Z,NA,H,2012-11-21T00:00:00Z,NA,H,17,56,40,2012-10-13,2012-11-21,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-09-27T00:00:00Z,NA,NA,2012-11-21T00:00:00Z,NA,NA,NA,NA,NA,2012-09-27,2012-11-21,NA,NA,TDURD,56,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-09-27T00:00:00Z,NA,NA,2012-11-21T00:00:00Z,NA,NA,NA,NA,NA,2012-09-27,2012-11-21,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-09-27T00:00:00Z,NA,NA,2012-11-21T00:00:00Z,NA,NA,NA,NA,NA,2012-09-27,2012-11-21,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-09-27T00:00:00Z,NA,NA,2012-11-21T00:00:00Z,NA,NA,NA,NA,NA,2012-09-27,2012-11-21,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-09-27T00:00:00Z,NA,NA,2012-11-21T00:00:00Z,NA,NA,NA,NA,NA,2012-09-27,2012-11-21,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-09-27T00:00:00Z,NA,NA,2012-11-21T00:00:00Z,NA,NA,NA,NA,NA,2012-09-27,2012-11-21,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-09-27T00:00:00Z,NA,NA,2012-11-21T00:00:00Z,NA,NA,NA,NA,NA,2012-09-27,2012-11-21,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-10-13T00:00:00Z,NA,NA,2012-11-21T00:00:00Z,NA,NA,NA,NA,NA,2012-10-13,2012-11-21,NA,NA,PDURD,40,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-10-13T00:00:00Z,NA,NA,2012-11-21T00:00:00Z,NA,NA,NA,NA,NA,2012-10-13,2012-11-21,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-10-13T00:00:00Z,NA,NA,2012-11-21T00:00:00Z,NA,NA,NA,NA,NA,2012-10-13,2012-11-21,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-10-13T00:00:00Z,NA,NA,2012-11-21T00:00:00Z,NA,NA,NA,NA,NA,2012-10-13,2012-11-21,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-10-13T00:00:00Z,NA,NA,2012-11-21T00:00:00Z,NA,NA,NA,NA,NA,2012-10-13,2012-11-21,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-10-13T00:00:00Z,NA,NA,2012-11-21T00:00:00Z,NA,NA,NA,NA,NA,2012-10-13,2012-11-21,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1271,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-27,2012-09-27T00:00:00Z,2012-11-21T23:59:59Z,2012-10-13T00:00:00Z,NA,NA,2012-11-21T00:00:00Z,NA,NA,NA,NA,NA,2012-10-13,2012-11-21,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1271,2012-09-27,2012-12-02,2012-09-27,2012-11-21,NA,2012-12-09,NA,NA,710,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-04,-23,Placebo,Placebo,H,H,2012-11-21,56,NA,2012-12-02,DISCONTINUED,NA,2012-09-27,NA,NA,NA,2012-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1278,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-24,2013-01-07,1,15,NA,54,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2012-12-24T00:00:00Z,NA,H,2013-01-07T00:00:00Z,NA,H,1,15,15,2012-12-24,2013-01-07,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1278,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-24,2013-01-07,1,15,NA,54,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2012-12-24T00:00:00Z,NA,H,2013-01-07T00:00:00Z,NA,H,1,15,15,2012-12-24,2013-01-07,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1278,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-24,2013-01-07,1,15,NA,54,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2012-12-24T00:00:00Z,NA,H,2013-01-07T00:00:00Z,NA,H,1,15,15,2012-12-24,2013-01-07,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1278,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-24,2013-01-07,1,15,NA,54,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2012-12-24T00:00:00Z,NA,H,2013-01-07T00:00:00Z,NA,H,1,15,15,2012-12-24,2013-01-07,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1278,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-24,2013-01-07,1,15,NA,54,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2012-12-24T00:00:00Z,NA,H,2013-01-07T00:00:00Z,NA,H,1,15,15,2012-12-24,2013-01-07,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1278,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-08,2013-02-26,16,65,NA,54,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2013-01-08T00:00:00Z,NA,H,2013-02-26T00:00:00Z,NA,H,16,65,50,2013-01-08,2013-02-26,4050,2700,DURD,50,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1278,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-08,2013-02-26,16,65,NA,54,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2013-01-08T00:00:00Z,NA,H,2013-02-26T00:00:00Z,NA,H,16,65,50,2013-01-08,2013-02-26,4050,2700,DOSE,4050,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1278,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-08,2013-02-26,16,65,NA,54,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2013-01-08T00:00:00Z,NA,H,2013-02-26T00:00:00Z,NA,H,16,65,50,2013-01-08,2013-02-26,4050,2700,PLDOSE,2700,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1278,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-08,2013-02-26,16,65,NA,54,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2013-01-08T00:00:00Z,NA,H,2013-02-26T00:00:00Z,NA,H,16,65,50,2013-01-08,2013-02-26,4050,2700,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1278,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-08,2013-02-26,16,65,NA,54,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2013-01-08T00:00:00Z,NA,H,2013-02-26T00:00:00Z,NA,H,16,65,50,2013-01-08,2013-02-26,4050,2700,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1278,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2012-12-24T00:00:00Z,NA,NA,2013-02-26T00:00:00Z,NA,NA,NA,NA,NA,2012-12-24,2013-02-26,NA,NA,TDURD,65,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1278,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2012-12-24T00:00:00Z,NA,NA,2013-02-26T00:00:00Z,NA,NA,NA,NA,NA,2012-12-24,2013-02-26,NA,NA,TDOSE,4860,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1278,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2012-12-24T00:00:00Z,NA,NA,2013-02-26T00:00:00Z,NA,NA,NA,NA,NA,2012-12-24,2013-02-26,NA,NA,AVDDSE,74.76923076923077,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1278,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2012-12-24T00:00:00Z,NA,NA,2013-02-26T00:00:00Z,NA,NA,NA,NA,NA,2012-12-24,2013-02-26,NA,NA,TPDOSE,3510,NA,OVERALL,Total planned dose (mg),11,NA,14,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1278,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2012-12-24T00:00:00Z,NA,NA,2013-02-26T00:00:00Z,NA,NA,NA,NA,NA,2012-12-24,2013-02-26,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1278,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2012-12-24T00:00:00Z,NA,NA,2013-02-26T00:00:00Z,NA,NA,NA,NA,NA,2012-12-24,2013-02-26,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1278,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2012-12-24T00:00:00Z,NA,NA,2013-02-26T00:00:00Z,NA,NA,NA,NA,NA,2012-12-24,2013-02-26,NA,NA,TDOSINT,138.46153846153845,NA,OVERALL,Overall dose intensity (%),90,NA,17,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1278,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2013-01-08T00:00:00Z,NA,NA,2013-02-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-08,2013-02-26,NA,NA,PDURD,50,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1278,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2013-01-08T00:00:00Z,NA,NA,2013-02-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-08,2013-02-26,NA,NA,PDOSE,4050,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1278,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2013-01-08T00:00:00Z,NA,NA,2013-02-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-08,2013-02-26,NA,NA,PPDOSE,2700,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1278,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2013-01-08T00:00:00Z,NA,NA,2013-02-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-08,2013-02-26,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1278,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2013-01-08T00:00:00Z,NA,NA,2013-02-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-08,2013-02-26,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1278,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2013-01-08T00:00:00Z,NA,NA,2013-02-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-08,2013-02-26,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1278,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-24,2012-12-24T00:00:00Z,2013-02-26T23:59:59Z,2013-01-08T00:00:00Z,NA,NA,2013-02-26T00:00:00Z,NA,NA,NA,NA,NA,2013-01-08,2013-02-26,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1278,2012-12-24,2013-03-03,2012-12-24,2013-02-26,NA,2013-03-10,NA,NA,710,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-26,65,NA,2013-03-03,DISCONTINUED,NA,2012-12-24,NA,NA,NA,2013-03-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1300,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-15,2012-12-30,1,16,NA,54,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-15T00:00:00Z,NA,H,2012-12-30T00:00:00Z,NA,H,1,16,16,2012-12-15,2012-12-30,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1300,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-15,2012-12-30,1,16,NA,54,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-15T00:00:00Z,NA,H,2012-12-30T00:00:00Z,NA,H,1,16,16,2012-12-15,2012-12-30,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1300,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-15,2012-12-30,1,16,NA,54,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-15T00:00:00Z,NA,H,2012-12-30T00:00:00Z,NA,H,1,16,16,2012-12-15,2012-12-30,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1300,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-15,2012-12-30,1,16,NA,54,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-15T00:00:00Z,NA,H,2012-12-30T00:00:00Z,NA,H,1,16,16,2012-12-15,2012-12-30,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1300,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-15,2012-12-30,1,16,NA,54,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-15T00:00:00Z,NA,H,2012-12-30T00:00:00Z,NA,H,1,16,16,2012-12-15,2012-12-30,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1300,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-31,2013-02-15,17,63,NA,54,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-31T00:00:00Z,NA,H,2013-02-15T00:00:00Z,NA,H,17,63,47,2012-12-31,2013-02-15,2538,2538,DURD,47,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1300,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-31,2013-02-15,17,63,NA,54,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-31T00:00:00Z,NA,H,2013-02-15T00:00:00Z,NA,H,17,63,47,2012-12-31,2013-02-15,2538,2538,DOSE,2538,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1300,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-31,2013-02-15,17,63,NA,54,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-31T00:00:00Z,NA,H,2013-02-15T00:00:00Z,NA,H,17,63,47,2012-12-31,2013-02-15,2538,2538,PLDOSE,2538,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1300,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-31,2013-02-15,17,63,NA,54,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-31T00:00:00Z,NA,H,2013-02-15T00:00:00Z,NA,H,17,63,47,2012-12-31,2013-02-15,2538,2538,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1300,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-31,2013-02-15,17,63,NA,54,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-31T00:00:00Z,NA,H,2013-02-15T00:00:00Z,NA,H,17,63,47,2012-12-31,2013-02-15,2538,2538,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-15T00:00:00Z,NA,NA,2013-02-15T00:00:00Z,NA,NA,NA,NA,NA,2012-12-15,2013-02-15,NA,NA,TDURD,63,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-15T00:00:00Z,NA,NA,2013-02-15T00:00:00Z,NA,NA,NA,NA,NA,2012-12-15,2013-02-15,NA,NA,TDOSE,3402,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-15T00:00:00Z,NA,NA,2013-02-15T00:00:00Z,NA,NA,NA,NA,NA,2012-12-15,2013-02-15,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-15T00:00:00Z,NA,NA,2013-02-15T00:00:00Z,NA,NA,NA,NA,NA,2012-12-15,2013-02-15,NA,NA,TPDOSE,3402,NA,OVERALL,Total planned dose (mg),11,NA,14,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-15T00:00:00Z,NA,NA,2013-02-15T00:00:00Z,NA,NA,NA,NA,NA,2012-12-15,2013-02-15,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-15T00:00:00Z,NA,NA,2013-02-15T00:00:00Z,NA,NA,NA,NA,NA,2012-12-15,2013-02-15,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-15T00:00:00Z,NA,NA,2013-02-15T00:00:00Z,NA,NA,NA,NA,NA,2012-12-15,2013-02-15,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-31T00:00:00Z,NA,NA,2013-02-15T00:00:00Z,NA,NA,NA,NA,NA,2012-12-31,2013-02-15,NA,NA,PDURD,47,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-31T00:00:00Z,NA,NA,2013-02-15T00:00:00Z,NA,NA,NA,NA,NA,2012-12-31,2013-02-15,NA,NA,PDOSE,2538,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-31T00:00:00Z,NA,NA,2013-02-15T00:00:00Z,NA,NA,NA,NA,NA,2012-12-31,2013-02-15,NA,NA,PPDOSE,2538,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-31T00:00:00Z,NA,NA,2013-02-15T00:00:00Z,NA,NA,NA,NA,NA,2012-12-31,2013-02-15,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-31T00:00:00Z,NA,NA,2013-02-15T00:00:00Z,NA,NA,NA,NA,NA,2012-12-31,2013-02-15,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-31T00:00:00Z,NA,NA,2013-02-15T00:00:00Z,NA,NA,NA,NA,NA,2012-12-31,2013-02-15,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1300,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-15,2012-12-15T00:00:00Z,2013-02-15T23:59:59Z,2012-12-31T00:00:00Z,NA,NA,2013-02-15T00:00:00Z,NA,NA,NA,NA,NA,2012-12-31,2013-02-15,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1300,2012-12-15,2013-02-19,2012-12-15,2013-02-15,NA,2013-03-19,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-04,-11,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-15,63,NA,2013-02-19,DISCONTINUED,NA,2012-12-15,NA,NA,NA,2013-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1314,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-24,2013-05-09,1,16,NA,0,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-24T00:00:00Z,NA,H,2013-05-09T00:00:00Z,NA,H,1,16,16,2013-04-24,2013-05-09,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1314,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-24,2013-05-09,1,16,NA,0,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-24T00:00:00Z,NA,H,2013-05-09T00:00:00Z,NA,H,1,16,16,2013-04-24,2013-05-09,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1314,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-24,2013-05-09,1,16,NA,0,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-24T00:00:00Z,NA,H,2013-05-09T00:00:00Z,NA,H,1,16,16,2013-04-24,2013-05-09,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1314,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-24,2013-05-09,1,16,NA,0,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-24T00:00:00Z,NA,H,2013-05-09T00:00:00Z,NA,H,1,16,16,2013-04-24,2013-05-09,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1314,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-24,2013-05-09,1,16,NA,0,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-24T00:00:00Z,NA,H,2013-05-09T00:00:00Z,NA,H,1,16,16,2013-04-24,2013-05-09,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1314,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-10,2013-05-23,17,30,NA,0,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-05-10T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,17,30,14,2013-05-10,2013-05-23,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1314,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-10,2013-05-23,17,30,NA,0,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-05-10T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,17,30,14,2013-05-10,2013-05-23,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1314,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-10,2013-05-23,17,30,NA,0,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-05-10T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,17,30,14,2013-05-10,2013-05-23,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1314,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-10,2013-05-23,17,30,NA,0,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-05-10T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,17,30,14,2013-05-10,2013-05-23,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1314,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-10,2013-05-23,17,30,NA,0,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-05-10T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,17,30,14,2013-05-10,2013-05-23,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-24T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-24,2013-05-23,NA,NA,TDURD,30,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-24T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-24,2013-05-23,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-24T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-24,2013-05-23,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-24T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-24,2013-05-23,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-24T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-24,2013-05-23,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-24T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-24,2013-05-23,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-04-24T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-24,2013-05-23,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-05-10T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-05-10,2013-05-23,NA,NA,PDURD,14,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-05-10T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-05-10,2013-05-23,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-05-10T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-05-10,2013-05-23,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-05-10T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-05-10,2013-05-23,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-05-10T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-05-10,2013-05-23,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-05-10T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-05-10,2013-05-23,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1314,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-24,2013-04-24T00:00:00Z,2013-05-23T23:59:59Z,2013-05-10T00:00:00Z,NA,NA,2013-05-23T00:00:00Z,NA,NA,NA,NA,NA,2013-05-10,2013-05-23,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1314,2013-04-24,2013-05-25,2013-04-24,2013-05-23,NA,2013-05-25,NA,NA,710,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-21,-3,Placebo,Placebo,H,H,2013-05-23,30,NA,2013-05-25,DISCONTINUED,NA,2013-04-24,NA,NA,NA,2013-05-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1315,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-27,2013-03-13,1,15,NA,0,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-02-27T00:00:00Z,NA,H,2013-03-13T00:00:00Z,NA,H,1,15,15,2013-02-27,2013-03-13,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1315,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-27,2013-03-13,1,15,NA,0,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-02-27T00:00:00Z,NA,H,2013-03-13T00:00:00Z,NA,H,1,15,15,2013-02-27,2013-03-13,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1315,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-27,2013-03-13,1,15,NA,0,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-02-27T00:00:00Z,NA,H,2013-03-13T00:00:00Z,NA,H,1,15,15,2013-02-27,2013-03-13,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1315,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-27,2013-03-13,1,15,NA,0,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-02-27T00:00:00Z,NA,H,2013-03-13T00:00:00Z,NA,H,1,15,15,2013-02-27,2013-03-13,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1315,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-27,2013-03-13,1,15,NA,0,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-02-27T00:00:00Z,NA,H,2013-03-13T00:00:00Z,NA,H,1,15,15,2013-02-27,2013-03-13,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1315,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-14,2013-07-06,16,130,NA,0,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-03-14T00:00:00Z,NA,H,2013-07-06T00:00:00Z,NA,H,16,130,115,2013-03-14,2013-07-06,0,0,DURD,115,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1315,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-14,2013-07-06,16,130,NA,0,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-03-14T00:00:00Z,NA,H,2013-07-06T00:00:00Z,NA,H,16,130,115,2013-03-14,2013-07-06,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1315,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-14,2013-07-06,16,130,NA,0,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-03-14T00:00:00Z,NA,H,2013-07-06T00:00:00Z,NA,H,16,130,115,2013-03-14,2013-07-06,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1315,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-14,2013-07-06,16,130,NA,0,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-03-14T00:00:00Z,NA,H,2013-07-06T00:00:00Z,NA,H,16,130,115,2013-03-14,2013-07-06,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1315,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-14,2013-07-06,16,130,NA,0,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-03-14T00:00:00Z,NA,H,2013-07-06T00:00:00Z,NA,H,16,130,115,2013-03-14,2013-07-06,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-02-27T00:00:00Z,NA,NA,2013-07-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-27,2013-07-06,NA,NA,TDURD,130,NA,OVERALL,Overall duration (days),7,>=90 days,11,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-02-27T00:00:00Z,NA,NA,2013-07-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-27,2013-07-06,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-02-27T00:00:00Z,NA,NA,2013-07-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-27,2013-07-06,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-02-27T00:00:00Z,NA,NA,2013-07-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-27,2013-07-06,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-02-27T00:00:00Z,NA,NA,2013-07-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-27,2013-07-06,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-02-27T00:00:00Z,NA,NA,2013-07-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-27,2013-07-06,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-02-27T00:00:00Z,NA,NA,2013-07-06T00:00:00Z,NA,NA,NA,NA,NA,2013-02-27,2013-07-06,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-03-14T00:00:00Z,NA,NA,2013-07-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-14,2013-07-06,NA,NA,PDURD,115,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-03-14T00:00:00Z,NA,NA,2013-07-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-14,2013-07-06,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-03-14T00:00:00Z,NA,NA,2013-07-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-14,2013-07-06,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-03-14T00:00:00Z,NA,NA,2013-07-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-14,2013-07-06,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-03-14T00:00:00Z,NA,NA,2013-07-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-14,2013-07-06,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-03-14T00:00:00Z,NA,NA,2013-07-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-14,2013-07-06,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1315,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-27,2013-02-27T00:00:00Z,2013-07-06T23:59:59Z,2013-03-14T00:00:00Z,NA,NA,2013-07-06T00:00:00Z,NA,NA,NA,NA,NA,2013-03-14,2013-07-06,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1315,2013-02-27,2013-07-16,2013-02-27,2013-07-06,NA,2013-09-02,NA,NA,710,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-15,Placebo,Placebo,H,H,2013-07-06,130,NA,2013-07-16,DISCONTINUED,NA,2013-02-27,NA,NA,NA,2013-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1354,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-11,2012-11-25,1,15,NA,54,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-11T00:00:00Z,NA,H,2012-11-25T00:00:00Z,NA,H,1,15,15,2012-11-11,2012-11-25,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1354,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-11,2012-11-25,1,15,NA,54,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-11T00:00:00Z,NA,H,2012-11-25T00:00:00Z,NA,H,1,15,15,2012-11-11,2012-11-25,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1354,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-11,2012-11-25,1,15,NA,54,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-11T00:00:00Z,NA,H,2012-11-25T00:00:00Z,NA,H,1,15,15,2012-11-11,2012-11-25,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1354,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-11,2012-11-25,1,15,NA,54,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-11T00:00:00Z,NA,H,2012-11-25T00:00:00Z,NA,H,1,15,15,2012-11-11,2012-11-25,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1354,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-11,2012-11-25,1,15,NA,54,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-11T00:00:00Z,NA,H,2012-11-25T00:00:00Z,NA,H,1,15,15,2012-11-11,2012-11-25,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1354,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-26,2013-04-21,16,162,NA,54,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-26T00:00:00Z,NA,H,2013-04-21T00:00:00Z,NA,H,16,162,147,2012-11-26,2013-04-21,11907,7938,DURD,147,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1354,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-26,2013-04-21,16,162,NA,54,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-26T00:00:00Z,NA,H,2013-04-21T00:00:00Z,NA,H,16,162,147,2012-11-26,2013-04-21,11907,7938,DOSE,11907,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1354,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-26,2013-04-21,16,162,NA,54,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-26T00:00:00Z,NA,H,2013-04-21T00:00:00Z,NA,H,16,162,147,2012-11-26,2013-04-21,11907,7938,PLDOSE,7938,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1354,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-26,2013-04-21,16,162,NA,54,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-26T00:00:00Z,NA,H,2013-04-21T00:00:00Z,NA,H,16,162,147,2012-11-26,2013-04-21,11907,7938,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1354,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-26,2013-04-21,16,162,NA,54,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-26T00:00:00Z,NA,H,2013-04-21T00:00:00Z,NA,H,16,162,147,2012-11-26,2013-04-21,11907,7938,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1354,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-22,2013-05-01,163,172,NA,54,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2013-04-22T00:00:00Z,NA,H,2013-05-01T00:00:00Z,NA,H,163,172,10,2013-04-22,2013-05-01,540,540,DURD,10,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1354,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-22,2013-05-01,163,172,NA,54,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2013-04-22T00:00:00Z,NA,H,2013-05-01T00:00:00Z,NA,H,163,172,10,2013-04-22,2013-05-01,540,540,DOSE,540,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1354,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-22,2013-05-01,163,172,NA,54,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2013-04-22T00:00:00Z,NA,H,2013-05-01T00:00:00Z,NA,H,163,172,10,2013-04-22,2013-05-01,540,540,PLDOSE,540,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1354,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-22,2013-05-01,163,172,NA,54,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2013-04-22T00:00:00Z,NA,H,2013-05-01T00:00:00Z,NA,H,163,172,10,2013-04-22,2013-05-01,540,540,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1354,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-22,2013-05-01,163,172,NA,54,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2013-04-22T00:00:00Z,NA,H,2013-05-01T00:00:00Z,NA,H,163,172,10,2013-04-22,2013-05-01,540,540,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-11T00:00:00Z,NA,NA,2013-05-01T00:00:00Z,NA,NA,NA,NA,NA,2012-11-11,2013-05-01,NA,NA,TDURD,172,NA,OVERALL,Overall duration (days),7,>=90 days,16,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-11T00:00:00Z,NA,NA,2013-05-01T00:00:00Z,NA,NA,NA,NA,NA,2012-11-11,2013-05-01,NA,NA,TDOSE,13257,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-11T00:00:00Z,NA,NA,2013-05-01T00:00:00Z,NA,NA,NA,NA,NA,2012-11-11,2013-05-01,NA,NA,AVDDSE,77.07558139534883,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-11T00:00:00Z,NA,NA,2013-05-01T00:00:00Z,NA,NA,NA,NA,NA,2012-11-11,2013-05-01,NA,NA,TPDOSE,9288,NA,OVERALL,Total planned dose (mg),11,NA,19,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-11T00:00:00Z,NA,NA,2013-05-01T00:00:00Z,NA,NA,NA,NA,NA,2012-11-11,2013-05-01,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-11T00:00:00Z,NA,NA,2013-05-01T00:00:00Z,NA,NA,NA,NA,NA,2012-11-11,2013-05-01,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-11T00:00:00Z,NA,NA,2013-05-01T00:00:00Z,NA,NA,NA,NA,NA,2012-11-11,2013-05-01,NA,NA,TDOSINT,142.7325581395349,NA,OVERALL,Overall dose intensity (%),90,NA,22,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-26T00:00:00Z,NA,NA,2013-05-01T00:00:00Z,NA,NA,NA,NA,NA,2012-11-26,2013-05-01,NA,NA,PDURD,157,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-26T00:00:00Z,NA,NA,2013-05-01T00:00:00Z,NA,NA,NA,NA,NA,2012-11-26,2013-05-01,NA,NA,PDOSE,12447,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-26T00:00:00Z,NA,NA,2013-05-01T00:00:00Z,NA,NA,NA,NA,NA,2012-11-26,2013-05-01,NA,NA,PPDOSE,8478,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-26T00:00:00Z,NA,NA,2013-05-01T00:00:00Z,NA,NA,NA,NA,NA,2012-11-26,2013-05-01,NA,NA,PAVDDSE,79.28025477707007,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-26T00:00:00Z,NA,NA,2013-05-01T00:00:00Z,NA,NA,NA,NA,NA,2012-11-26,2013-05-01,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-26T00:00:00Z,NA,NA,2013-05-01T00:00:00Z,NA,NA,NA,NA,NA,2012-11-26,2013-05-01,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1354,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-11,2012-11-11T00:00:00Z,2013-05-01T23:59:59Z,2012-11-26T00:00:00Z,NA,NA,2013-05-01T00:00:00Z,NA,NA,NA,NA,NA,2012-11-26,2013-05-01,NA,NA,PDOSINT,146.81528662420382,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1354,2012-11-11,2013-05-01,2012-11-11,2013-05-01,NA,2013-05-01T14:05,NA,NA,710,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-29,-13,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-01,172,NA,2013-05-01,COMPLETED,NA,2012-11-11,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1358,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-17,2012-10-01,1,15,NA,54,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-09-17T00:00:00Z,NA,H,2012-10-01T00:00:00Z,NA,H,1,15,15,2012-09-17,2012-10-01,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1358,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-17,2012-10-01,1,15,NA,54,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-09-17T00:00:00Z,NA,H,2012-10-01T00:00:00Z,NA,H,1,15,15,2012-09-17,2012-10-01,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1358,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-17,2012-10-01,1,15,NA,54,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-09-17T00:00:00Z,NA,H,2012-10-01T00:00:00Z,NA,H,1,15,15,2012-09-17,2012-10-01,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1358,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-17,2012-10-01,1,15,NA,54,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-09-17T00:00:00Z,NA,H,2012-10-01T00:00:00Z,NA,H,1,15,15,2012-09-17,2012-10-01,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1358,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-17,2012-10-01,1,15,NA,54,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-09-17T00:00:00Z,NA,H,2012-10-01T00:00:00Z,NA,H,1,15,15,2012-09-17,2012-10-01,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1358,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-02,2013-02-09,16,146,NA,54,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-10-02T00:00:00Z,NA,H,2013-02-09T00:00:00Z,NA,H,16,146,131,2012-10-02,2013-02-09,7074,7074,DURD,131,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1358,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-02,2013-02-09,16,146,NA,54,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-10-02T00:00:00Z,NA,H,2013-02-09T00:00:00Z,NA,H,16,146,131,2012-10-02,2013-02-09,7074,7074,DOSE,7074,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1358,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-02,2013-02-09,16,146,NA,54,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-10-02T00:00:00Z,NA,H,2013-02-09T00:00:00Z,NA,H,16,146,131,2012-10-02,2013-02-09,7074,7074,PLDOSE,7074,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1358,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-02,2013-02-09,16,146,NA,54,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-10-02T00:00:00Z,NA,H,2013-02-09T00:00:00Z,NA,H,16,146,131,2012-10-02,2013-02-09,7074,7074,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1358,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-02,2013-02-09,16,146,NA,54,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-10-02T00:00:00Z,NA,H,2013-02-09T00:00:00Z,NA,H,16,146,131,2012-10-02,2013-02-09,7074,7074,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-09-17T00:00:00Z,NA,NA,2013-02-09T00:00:00Z,NA,NA,NA,NA,NA,2012-09-17,2013-02-09,NA,NA,TDURD,146,NA,OVERALL,Overall duration (days),7,>=90 days,11,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-09-17T00:00:00Z,NA,NA,2013-02-09T00:00:00Z,NA,NA,NA,NA,NA,2012-09-17,2013-02-09,NA,NA,TDOSE,7884,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-09-17T00:00:00Z,NA,NA,2013-02-09T00:00:00Z,NA,NA,NA,NA,NA,2012-09-17,2013-02-09,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-09-17T00:00:00Z,NA,NA,2013-02-09T00:00:00Z,NA,NA,NA,NA,NA,2012-09-17,2013-02-09,NA,NA,TPDOSE,7884,NA,OVERALL,Total planned dose (mg),11,NA,14,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-09-17T00:00:00Z,NA,NA,2013-02-09T00:00:00Z,NA,NA,NA,NA,NA,2012-09-17,2013-02-09,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-09-17T00:00:00Z,NA,NA,2013-02-09T00:00:00Z,NA,NA,NA,NA,NA,2012-09-17,2013-02-09,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-09-17T00:00:00Z,NA,NA,2013-02-09T00:00:00Z,NA,NA,NA,NA,NA,2012-09-17,2013-02-09,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2013-02-09T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2013-02-09,NA,NA,PDURD,131,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2013-02-09T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2013-02-09,NA,NA,PDOSE,7074,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2013-02-09T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2013-02-09,NA,NA,PPDOSE,7074,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2013-02-09T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2013-02-09,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2013-02-09T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2013-02-09,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2013-02-09T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2013-02-09,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1358,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-17,2012-09-17T00:00:00Z,2013-02-09T23:59:59Z,2012-10-02T00:00:00Z,NA,NA,2013-02-09T00:00:00Z,NA,NA,NA,NA,NA,2012-10-02,2013-02-09,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1358,2012-09-17,2013-03-12,2012-09-17,2013-02-09,NA,2013-03-12,NA,NA,710,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-02,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-09,146,NA,2013-03-12,DISCONTINUED,NA,2012-09-17,NA,NA,NA,2013-02-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1368,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-23,2013-11-06,1,15,NA,0,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-10-23T00:00:00Z,NA,H,2013-11-06T00:00:00Z,NA,H,1,15,15,2013-10-23,2013-11-06,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1368,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-23,2013-11-06,1,15,NA,0,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-10-23T00:00:00Z,NA,H,2013-11-06T00:00:00Z,NA,H,1,15,15,2013-10-23,2013-11-06,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1368,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-23,2013-11-06,1,15,NA,0,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-10-23T00:00:00Z,NA,H,2013-11-06T00:00:00Z,NA,H,1,15,15,2013-10-23,2013-11-06,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1368,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-23,2013-11-06,1,15,NA,0,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-10-23T00:00:00Z,NA,H,2013-11-06T00:00:00Z,NA,H,1,15,15,2013-10-23,2013-11-06,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1368,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-23,2013-11-06,1,15,NA,0,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-10-23T00:00:00Z,NA,H,2013-11-06T00:00:00Z,NA,H,1,15,15,2013-10-23,2013-11-06,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1368,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-07,2014-04-09,16,169,NA,0,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-11-07T00:00:00Z,NA,H,2014-04-09T00:00:00Z,NA,H,16,169,154,2013-11-07,2014-04-09,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1368,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-07,2014-04-09,16,169,NA,0,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-11-07T00:00:00Z,NA,H,2014-04-09T00:00:00Z,NA,H,16,169,154,2013-11-07,2014-04-09,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1368,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-07,2014-04-09,16,169,NA,0,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-11-07T00:00:00Z,NA,H,2014-04-09T00:00:00Z,NA,H,16,169,154,2013-11-07,2014-04-09,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1368,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-07,2014-04-09,16,169,NA,0,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-11-07T00:00:00Z,NA,H,2014-04-09T00:00:00Z,NA,H,16,169,154,2013-11-07,2014-04-09,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1368,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-11-07,2014-04-09,16,169,NA,0,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-11-07T00:00:00Z,NA,H,2014-04-09T00:00:00Z,NA,H,16,169,154,2013-11-07,2014-04-09,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1368,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-10,2014-04-24,170,184,NA,0,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2014-04-10T00:00:00Z,NA,H,2014-04-24T00:00:00Z,NA,H,170,184,15,2014-04-10,2014-04-24,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1368,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-10,2014-04-24,170,184,NA,0,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2014-04-10T00:00:00Z,NA,H,2014-04-24T00:00:00Z,NA,H,170,184,15,2014-04-10,2014-04-24,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1368,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-10,2014-04-24,170,184,NA,0,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2014-04-10T00:00:00Z,NA,H,2014-04-24T00:00:00Z,NA,H,170,184,15,2014-04-10,2014-04-24,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1368,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-10,2014-04-24,170,184,NA,0,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2014-04-10T00:00:00Z,NA,H,2014-04-24T00:00:00Z,NA,H,170,184,15,2014-04-10,2014-04-24,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1368,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-04-10,2014-04-24,170,184,NA,0,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2014-04-10T00:00:00Z,NA,H,2014-04-24T00:00:00Z,NA,H,170,184,15,2014-04-10,2014-04-24,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-10-23T00:00:00Z,NA,NA,2014-04-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-23,2014-04-24,NA,NA,TDURD,184,NA,OVERALL,Overall duration (days),7,>=90 days,16,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-10-23T00:00:00Z,NA,NA,2014-04-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-23,2014-04-24,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-10-23T00:00:00Z,NA,NA,2014-04-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-23,2014-04-24,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-10-23T00:00:00Z,NA,NA,2014-04-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-23,2014-04-24,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-10-23T00:00:00Z,NA,NA,2014-04-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-23,2014-04-24,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-10-23T00:00:00Z,NA,NA,2014-04-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-23,2014-04-24,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-10-23T00:00:00Z,NA,NA,2014-04-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-23,2014-04-24,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-11-07T00:00:00Z,NA,NA,2014-04-24T00:00:00Z,NA,NA,NA,NA,NA,2013-11-07,2014-04-24,NA,NA,PDURD,169,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-11-07T00:00:00Z,NA,NA,2014-04-24T00:00:00Z,NA,NA,NA,NA,NA,2013-11-07,2014-04-24,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-11-07T00:00:00Z,NA,NA,2014-04-24T00:00:00Z,NA,NA,NA,NA,NA,2013-11-07,2014-04-24,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-11-07T00:00:00Z,NA,NA,2014-04-24T00:00:00Z,NA,NA,NA,NA,NA,2013-11-07,2014-04-24,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-11-07T00:00:00Z,NA,NA,2014-04-24T00:00:00Z,NA,NA,NA,NA,NA,2013-11-07,2014-04-24,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-11-07T00:00:00Z,NA,NA,2014-04-24T00:00:00Z,NA,NA,NA,NA,NA,2013-11-07,2014-04-24,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1368,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-23,2013-10-23T00:00:00Z,2014-04-24T23:59:59Z,2013-11-07T00:00:00Z,NA,NA,2014-04-24T00:00:00Z,NA,NA,NA,NA,NA,2013-11-07,2014-04-24,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1368,2013-10-23,2014-04-24,2013-10-23,2014-04-24,NA,2014-04-24T10:10,NA,NA,710,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-10-21,-2,Placebo,Placebo,H,H,2014-04-24,184,NA,2014-04-24,COMPLETED,NA,2013-10-23,NA,NA,NA,2014-04-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1385,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-29,2012-11-12,1,15,NA,54,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-10-29T00:00:00Z,NA,H,2012-11-12T00:00:00Z,NA,H,1,15,15,2012-10-29,2012-11-12,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1385,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-29,2012-11-12,1,15,NA,54,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-10-29T00:00:00Z,NA,H,2012-11-12T00:00:00Z,NA,H,1,15,15,2012-10-29,2012-11-12,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1385,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-29,2012-11-12,1,15,NA,54,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-10-29T00:00:00Z,NA,H,2012-11-12T00:00:00Z,NA,H,1,15,15,2012-10-29,2012-11-12,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1385,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-29,2012-11-12,1,15,NA,54,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-10-29T00:00:00Z,NA,H,2012-11-12T00:00:00Z,NA,H,1,15,15,2012-10-29,2012-11-12,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1385,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-29,2012-11-12,1,15,NA,54,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-10-29T00:00:00Z,NA,H,2012-11-12T00:00:00Z,NA,H,1,15,15,2012-10-29,2012-11-12,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1385,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-13,2013-02-18,16,113,NA,54,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-11-13T00:00:00Z,NA,H,2013-02-18T00:00:00Z,NA,H,16,113,98,2012-11-13,2013-02-18,5292,5292,DURD,98,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1385,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-13,2013-02-18,16,113,NA,54,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-11-13T00:00:00Z,NA,H,2013-02-18T00:00:00Z,NA,H,16,113,98,2012-11-13,2013-02-18,5292,5292,DOSE,5292,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1385,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-13,2013-02-18,16,113,NA,54,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-11-13T00:00:00Z,NA,H,2013-02-18T00:00:00Z,NA,H,16,113,98,2012-11-13,2013-02-18,5292,5292,PLDOSE,5292,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1385,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-13,2013-02-18,16,113,NA,54,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-11-13T00:00:00Z,NA,H,2013-02-18T00:00:00Z,NA,H,16,113,98,2012-11-13,2013-02-18,5292,5292,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1385,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-13,2013-02-18,16,113,NA,54,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-11-13T00:00:00Z,NA,H,2013-02-18T00:00:00Z,NA,H,16,113,98,2012-11-13,2013-02-18,5292,5292,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-10-29T00:00:00Z,NA,NA,2013-02-18T00:00:00Z,NA,NA,NA,NA,NA,2012-10-29,2013-02-18,NA,NA,TDURD,113,NA,OVERALL,Overall duration (days),7,>=90 days,11,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-10-29T00:00:00Z,NA,NA,2013-02-18T00:00:00Z,NA,NA,NA,NA,NA,2012-10-29,2013-02-18,NA,NA,TDOSE,6102,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-10-29T00:00:00Z,NA,NA,2013-02-18T00:00:00Z,NA,NA,NA,NA,NA,2012-10-29,2013-02-18,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-10-29T00:00:00Z,NA,NA,2013-02-18T00:00:00Z,NA,NA,NA,NA,NA,2012-10-29,2013-02-18,NA,NA,TPDOSE,6102,NA,OVERALL,Total planned dose (mg),11,NA,14,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-10-29T00:00:00Z,NA,NA,2013-02-18T00:00:00Z,NA,NA,NA,NA,NA,2012-10-29,2013-02-18,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-10-29T00:00:00Z,NA,NA,2013-02-18T00:00:00Z,NA,NA,NA,NA,NA,2012-10-29,2013-02-18,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-10-29T00:00:00Z,NA,NA,2013-02-18T00:00:00Z,NA,NA,NA,NA,NA,2012-10-29,2013-02-18,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-11-13T00:00:00Z,NA,NA,2013-02-18T00:00:00Z,NA,NA,NA,NA,NA,2012-11-13,2013-02-18,NA,NA,PDURD,98,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-11-13T00:00:00Z,NA,NA,2013-02-18T00:00:00Z,NA,NA,NA,NA,NA,2012-11-13,2013-02-18,NA,NA,PDOSE,5292,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-11-13T00:00:00Z,NA,NA,2013-02-18T00:00:00Z,NA,NA,NA,NA,NA,2012-11-13,2013-02-18,NA,NA,PPDOSE,5292,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-11-13T00:00:00Z,NA,NA,2013-02-18T00:00:00Z,NA,NA,NA,NA,NA,2012-11-13,2013-02-18,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-11-13T00:00:00Z,NA,NA,2013-02-18T00:00:00Z,NA,NA,NA,NA,NA,2012-11-13,2013-02-18,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-11-13T00:00:00Z,NA,NA,2013-02-18T00:00:00Z,NA,NA,NA,NA,NA,2012-11-13,2013-02-18,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1385,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-29,2012-10-29T00:00:00Z,2013-02-18T23:59:59Z,2012-11-13T00:00:00Z,NA,NA,2013-02-18T00:00:00Z,NA,NA,NA,NA,NA,2012-11-13,2013-02-18,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1385,2012-10-29,2013-02-18,2012-10-29,2013-02-18,NA,2013-02-24,NA,NA,710,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-10-21,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-02-18,113,NA,2013-02-18,DISCONTINUED,NA,2012-10-29,NA,NA,NA,2013-02-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1408,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-05,2013-01-24,1,20,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-05T00:00:00Z,NA,H,2013-01-24T00:00:00Z,NA,H,1,20,20,2013-01-05,2013-01-24,1080,1080,DURD,20,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1408,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-05,2013-01-24,1,20,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-05T00:00:00Z,NA,H,2013-01-24T00:00:00Z,NA,H,1,20,20,2013-01-05,2013-01-24,1080,1080,DOSE,1080,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1408,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-05,2013-01-24,1,20,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-05T00:00:00Z,NA,H,2013-01-24T00:00:00Z,NA,H,1,20,20,2013-01-05,2013-01-24,1080,1080,PLDOSE,1080,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1408,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-05,2013-01-24,1,20,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-05T00:00:00Z,NA,H,2013-01-24T00:00:00Z,NA,H,1,20,20,2013-01-05,2013-01-24,1080,1080,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1408,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-05,2013-01-24,1,20,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-05T00:00:00Z,NA,H,2013-01-24T00:00:00Z,NA,H,1,20,20,2013-01-05,2013-01-24,1080,1080,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1408,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-25,2013-06-28,21,175,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-25T00:00:00Z,NA,H,2013-06-28T00:00:00Z,NA,H,21,175,155,2013-01-25,2013-06-28,12555,8370,DURD,155,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1408,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-25,2013-06-28,21,175,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-25T00:00:00Z,NA,H,2013-06-28T00:00:00Z,NA,H,21,175,155,2013-01-25,2013-06-28,12555,8370,DOSE,12555,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1408,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-25,2013-06-28,21,175,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-25T00:00:00Z,NA,H,2013-06-28T00:00:00Z,NA,H,21,175,155,2013-01-25,2013-06-28,12555,8370,PLDOSE,8370,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1408,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-25,2013-06-28,21,175,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-25T00:00:00Z,NA,H,2013-06-28T00:00:00Z,NA,H,21,175,155,2013-01-25,2013-06-28,12555,8370,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1408,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-25,2013-06-28,21,175,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-25T00:00:00Z,NA,H,2013-06-28T00:00:00Z,NA,H,21,175,155,2013-01-25,2013-06-28,12555,8370,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1408,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-29,2013-07-12,176,189,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-06-29T00:00:00Z,NA,H,2013-07-12T00:00:00Z,NA,H,176,189,14,2013-06-29,2013-07-12,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1408,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-29,2013-07-12,176,189,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-06-29T00:00:00Z,NA,H,2013-07-12T00:00:00Z,NA,H,176,189,14,2013-06-29,2013-07-12,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1408,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-29,2013-07-12,176,189,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-06-29T00:00:00Z,NA,H,2013-07-12T00:00:00Z,NA,H,176,189,14,2013-06-29,2013-07-12,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1408,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-29,2013-07-12,176,189,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-06-29T00:00:00Z,NA,H,2013-07-12T00:00:00Z,NA,H,176,189,14,2013-06-29,2013-07-12,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-710-1408,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-06-29,2013-07-12,176,189,NA,54,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-06-29T00:00:00Z,NA,H,2013-07-12T00:00:00Z,NA,H,176,189,14,2013-06-29,2013-07-12,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-07-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-07-12,NA,NA,TDURD,189,NA,OVERALL,Overall duration (days),7,>=90 days,16,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-07-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-07-12,NA,NA,TDOSE,14391,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-07-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-07-12,NA,NA,AVDDSE,76.14285714285714,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-07-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-07-12,NA,NA,TPDOSE,10206,NA,OVERALL,Total planned dose (mg),11,NA,19,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-07-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-07-12,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-07-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-07-12,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-05T00:00:00Z,NA,NA,2013-07-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-05,2013-07-12,NA,NA,TDOSINT,141.005291005291,NA,OVERALL,Overall dose intensity (%),90,NA,22,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-07-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-07-12,NA,NA,PDURD,169,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-07-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-07-12,NA,NA,PDOSE,13311,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-07-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-07-12,NA,NA,PPDOSE,9126,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-07-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-07-12,NA,NA,PAVDDSE,78.76331360946746,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-07-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-07-12,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-07-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-07-12,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-710-1408,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-05,2013-01-05T00:00:00Z,2013-07-12T23:59:59Z,2013-01-25T00:00:00Z,NA,NA,2013-07-12T00:00:00Z,NA,NA,NA,NA,NA,2013-01-25,2013-07-12,NA,NA,PDOSINT,145.85798816568047,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1408,2013-01-05,2013-07-12,2013-01-05,2013-07-12,NA,2013-07-12T14:35,NA,NA,710,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-26,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-12,189,NA,2013-07-12,COMPLETED,NA,2013-01-05,NA,NA,NA,2013-07-12,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1012,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-03,2013-04-17,1,15,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-17T00:00:00Z,NA,H,1,15,15,2013-04-03,2013-04-17,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1012,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-03,2013-04-17,1,15,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-17T00:00:00Z,NA,H,1,15,15,2013-04-03,2013-04-17,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1012,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-03,2013-04-17,1,15,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-17T00:00:00Z,NA,H,1,15,15,2013-04-03,2013-04-17,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1012,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-03,2013-04-17,1,15,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-17T00:00:00Z,NA,H,1,15,15,2013-04-03,2013-04-17,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1012,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-03,2013-04-17,1,15,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-17T00:00:00Z,NA,H,1,15,15,2013-04-03,2013-04-17,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1012,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-18,2013-04-29,16,27,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-18T00:00:00Z,NA,H,2013-04-29T00:00:00Z,NA,H,16,27,12,2013-04-18,2013-04-29,972,648,DURD,12,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1012,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-18,2013-04-29,16,27,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-18T00:00:00Z,NA,H,2013-04-29T00:00:00Z,NA,H,16,27,12,2013-04-18,2013-04-29,972,648,DOSE,972,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1012,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-18,2013-04-29,16,27,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-18T00:00:00Z,NA,H,2013-04-29T00:00:00Z,NA,H,16,27,12,2013-04-18,2013-04-29,972,648,PLDOSE,648,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1012,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-18,2013-04-29,16,27,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-18T00:00:00Z,NA,H,2013-04-29T00:00:00Z,NA,H,16,27,12,2013-04-18,2013-04-29,972,648,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1012,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-18,2013-04-29,16,27,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-18T00:00:00Z,NA,H,2013-04-29T00:00:00Z,NA,H,16,27,12,2013-04-18,2013-04-29,972,648,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1012,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-04-29T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-04-29,NA,NA,TDURD,27,NA,OVERALL,Overall duration (days),7,< 30 days,11,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1012,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-04-29T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-04-29,NA,NA,TDOSE,1782,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1012,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-04-29T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-04-29,NA,NA,AVDDSE,66,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1012,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-04-29T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-04-29,NA,NA,TPDOSE,1458,NA,OVERALL,Total planned dose (mg),11,NA,14,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1012,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-04-29T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-04-29,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1012,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-04-29T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-04-29,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1012,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-04-29T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-04-29,NA,NA,TDOSINT,122.22222222222223,NA,OVERALL,Overall dose intensity (%),90,NA,17,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1012,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-18T00:00:00Z,NA,NA,2013-04-29T00:00:00Z,NA,NA,NA,NA,NA,2013-04-18,2013-04-29,NA,NA,PDURD,12,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1012,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-18T00:00:00Z,NA,NA,2013-04-29T00:00:00Z,NA,NA,NA,NA,NA,2013-04-18,2013-04-29,NA,NA,PDOSE,972,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1012,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-18T00:00:00Z,NA,NA,2013-04-29T00:00:00Z,NA,NA,NA,NA,NA,2013-04-18,2013-04-29,NA,NA,PPDOSE,648,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1012,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-18T00:00:00Z,NA,NA,2013-04-29T00:00:00Z,NA,NA,NA,NA,NA,2013-04-18,2013-04-29,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1012,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-18T00:00:00Z,NA,NA,2013-04-29T00:00:00Z,NA,NA,NA,NA,NA,2013-04-18,2013-04-29,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1012,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-18T00:00:00Z,NA,NA,2013-04-29T00:00:00Z,NA,NA,NA,NA,NA,2013-04-18,2013-04-29,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1012,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-04-29T23:59:59Z,2013-04-18T00:00:00Z,NA,NA,2013-04-29T00:00:00Z,NA,NA,NA,NA,NA,2013-04-18,2013-04-29,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1012,2013-04-03,2013-05-02,2013-04-03,2013-04-29,NA,2013-09-18,NA,NA,711,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-03-20,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-29,27,NA,2013-05-02,DISCONTINUED,2013-09-18,2013-04-03,NA,NA,NA,2013-05-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1036,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-29,2012-08-12,1,15,NA,0,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-07-29T00:00:00Z,NA,H,2012-08-12T00:00:00Z,NA,H,1,15,15,2012-07-29,2012-08-12,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1036,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-29,2012-08-12,1,15,NA,0,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-07-29T00:00:00Z,NA,H,2012-08-12T00:00:00Z,NA,H,1,15,15,2012-07-29,2012-08-12,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1036,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-29,2012-08-12,1,15,NA,0,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-07-29T00:00:00Z,NA,H,2012-08-12T00:00:00Z,NA,H,1,15,15,2012-07-29,2012-08-12,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1036,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-29,2012-08-12,1,15,NA,0,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-07-29T00:00:00Z,NA,H,2012-08-12T00:00:00Z,NA,H,1,15,15,2012-07-29,2012-08-12,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1036,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-29,2012-08-12,1,15,NA,0,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-07-29T00:00:00Z,NA,H,2012-08-12T00:00:00Z,NA,H,1,15,15,2012-07-29,2012-08-12,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1036,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-13,2013-01-13,16,169,NA,0,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-08-13T00:00:00Z,NA,H,2013-01-13T00:00:00Z,NA,H,16,169,154,2012-08-13,2013-01-13,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1036,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-13,2013-01-13,16,169,NA,0,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-08-13T00:00:00Z,NA,H,2013-01-13T00:00:00Z,NA,H,16,169,154,2012-08-13,2013-01-13,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1036,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-13,2013-01-13,16,169,NA,0,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-08-13T00:00:00Z,NA,H,2013-01-13T00:00:00Z,NA,H,16,169,154,2012-08-13,2013-01-13,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1036,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-13,2013-01-13,16,169,NA,0,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-08-13T00:00:00Z,NA,H,2013-01-13T00:00:00Z,NA,H,16,169,154,2012-08-13,2013-01-13,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1036,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-08-13,2013-01-13,16,169,NA,0,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-08-13T00:00:00Z,NA,H,2013-01-13T00:00:00Z,NA,H,16,169,154,2012-08-13,2013-01-13,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1036,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-01-14,2013-02-10,170,197,NA,0,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2013-01-14T00:00:00Z,NA,H,2013-02-10T00:00:00Z,NA,H,170,197,28,2013-01-14,2013-02-10,0,0,DURD,28,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1036,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-01-14,2013-02-10,170,197,NA,0,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2013-01-14T00:00:00Z,NA,H,2013-02-10T00:00:00Z,NA,H,170,197,28,2013-01-14,2013-02-10,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1036,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-01-14,2013-02-10,170,197,NA,0,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2013-01-14T00:00:00Z,NA,H,2013-02-10T00:00:00Z,NA,H,170,197,28,2013-01-14,2013-02-10,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1036,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-01-14,2013-02-10,170,197,NA,0,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2013-01-14T00:00:00Z,NA,H,2013-02-10T00:00:00Z,NA,H,170,197,28,2013-01-14,2013-02-10,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1036,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-01-14,2013-02-10,170,197,NA,0,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2013-01-14T00:00:00Z,NA,H,2013-02-10T00:00:00Z,NA,H,170,197,28,2013-01-14,2013-02-10,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-07-29T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-07-29,2013-02-10,NA,NA,TDURD,197,NA,OVERALL,Overall duration (days),7,>=90 days,16,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-07-29T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-07-29,2013-02-10,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-07-29T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-07-29,2013-02-10,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-07-29T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-07-29,2013-02-10,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-07-29T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-07-29,2013-02-10,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-07-29T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-07-29,2013-02-10,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-07-29T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-07-29,2013-02-10,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-08-13T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-08-13,2013-02-10,NA,NA,PDURD,182,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-08-13T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-08-13,2013-02-10,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-08-13T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-08-13,2013-02-10,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-08-13T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-08-13,2013-02-10,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-08-13T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-08-13,2013-02-10,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-08-13T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-08-13,2013-02-10,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1036,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-29,2012-07-29T00:00:00Z,2013-02-10T23:59:59Z,2012-08-13T00:00:00Z,NA,NA,2013-02-10T00:00:00Z,NA,NA,NA,NA,NA,2012-08-13,2013-02-10,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1036,2012-07-29,2013-02-10,2012-07-29,2013-02-10,NA,2013-02-10T10:25,NA,NA,711,70,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-20,-9,Placebo,Placebo,H,H,2013-02-10,197,NA,2013-02-10,COMPLETED,NA,2012-07-29,NA,NA,NA,2013-02-10,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1143,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-03,2013-04-17,1,15,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-17T00:00:00Z,NA,H,1,15,15,2013-04-03,2013-04-17,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1143,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-03,2013-04-17,1,15,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-17T00:00:00Z,NA,H,1,15,15,2013-04-03,2013-04-17,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1143,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-03,2013-04-17,1,15,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-17T00:00:00Z,NA,H,1,15,15,2013-04-03,2013-04-17,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1143,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-03,2013-04-17,1,15,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-17T00:00:00Z,NA,H,1,15,15,2013-04-03,2013-04-17,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1143,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-03,2013-04-17,1,15,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-17T00:00:00Z,NA,H,1,15,15,2013-04-03,2013-04-17,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1143,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-18,2013-05-30,16,58,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-18T00:00:00Z,NA,H,2013-05-30T00:00:00Z,NA,H,16,58,43,2013-04-18,2013-05-30,2322,2322,DURD,43,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1143,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-18,2013-05-30,16,58,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-18T00:00:00Z,NA,H,2013-05-30T00:00:00Z,NA,H,16,58,43,2013-04-18,2013-05-30,2322,2322,DOSE,2322,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1143,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-18,2013-05-30,16,58,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-18T00:00:00Z,NA,H,2013-05-30T00:00:00Z,NA,H,16,58,43,2013-04-18,2013-05-30,2322,2322,PLDOSE,2322,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1143,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-18,2013-05-30,16,58,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-18T00:00:00Z,NA,H,2013-05-30T00:00:00Z,NA,H,16,58,43,2013-04-18,2013-05-30,2322,2322,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1143,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-18,2013-05-30,16,58,NA,54,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-18T00:00:00Z,NA,H,2013-05-30T00:00:00Z,NA,H,16,58,43,2013-04-18,2013-05-30,2322,2322,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-05-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-05-30,NA,NA,TDURD,58,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-05-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-05-30,NA,NA,TDOSE,3132,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-05-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-05-30,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-05-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-05-30,NA,NA,TPDOSE,3132,NA,OVERALL,Total planned dose (mg),11,NA,14,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-05-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-05-30,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-05-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-05-30,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-05-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-05-30,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-18T00:00:00Z,NA,NA,2013-05-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-18,2013-05-30,NA,NA,PDURD,43,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-18T00:00:00Z,NA,NA,2013-05-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-18,2013-05-30,NA,NA,PDOSE,2322,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-18T00:00:00Z,NA,NA,2013-05-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-18,2013-05-30,NA,NA,PPDOSE,2322,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-18T00:00:00Z,NA,NA,2013-05-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-18,2013-05-30,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-18T00:00:00Z,NA,NA,2013-05-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-18,2013-05-30,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-18T00:00:00Z,NA,NA,2013-05-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-18,2013-05-30,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1143,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-05-30T23:59:59Z,2013-04-18T00:00:00Z,NA,NA,2013-05-30T00:00:00Z,NA,NA,NA,NA,NA,2013-04-18,2013-05-30,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1143,2013-04-03,2013-06-01,2013-04-03,2013-05-30,NA,2013-09-22,NA,NA,711,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-03-30,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-30,58,NA,2013-06-01,DISCONTINUED,2013-09-22,2013-04-03,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1433,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-27,2013-02-05,1,10,NA,54,2013-01-27,2013-01-27T00:00:00Z,2013-02-05T23:59:59Z,2013-01-27T00:00:00Z,NA,H,2013-02-05T00:00:00Z,NA,H,1,10,10,2013-01-27,2013-02-05,540,540,DURD,10,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1433,2013-01-27,2013-02-06,2013-01-27,2013-02-05,NA,2013-02-06T10:52,NA,NA,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-05,10,NA,2013-02-06,DISCONTINUED,NA,2013-01-27,NA,NA,NA,2013-02-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1433,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-27,2013-02-05,1,10,NA,54,2013-01-27,2013-01-27T00:00:00Z,2013-02-05T23:59:59Z,2013-01-27T00:00:00Z,NA,H,2013-02-05T00:00:00Z,NA,H,1,10,10,2013-01-27,2013-02-05,540,540,DOSE,540,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1433,2013-01-27,2013-02-06,2013-01-27,2013-02-05,NA,2013-02-06T10:52,NA,NA,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-05,10,NA,2013-02-06,DISCONTINUED,NA,2013-01-27,NA,NA,NA,2013-02-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1433,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-27,2013-02-05,1,10,NA,54,2013-01-27,2013-01-27T00:00:00Z,2013-02-05T23:59:59Z,2013-01-27T00:00:00Z,NA,H,2013-02-05T00:00:00Z,NA,H,1,10,10,2013-01-27,2013-02-05,540,540,PLDOSE,540,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1433,2013-01-27,2013-02-06,2013-01-27,2013-02-05,NA,2013-02-06T10:52,NA,NA,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-05,10,NA,2013-02-06,DISCONTINUED,NA,2013-01-27,NA,NA,NA,2013-02-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1433,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-27,2013-02-05,1,10,NA,54,2013-01-27,2013-01-27T00:00:00Z,2013-02-05T23:59:59Z,2013-01-27T00:00:00Z,NA,H,2013-02-05T00:00:00Z,NA,H,1,10,10,2013-01-27,2013-02-05,540,540,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1433,2013-01-27,2013-02-06,2013-01-27,2013-02-05,NA,2013-02-06T10:52,NA,NA,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-05,10,NA,2013-02-06,DISCONTINUED,NA,2013-01-27,NA,NA,NA,2013-02-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-711-1433,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-27,2013-02-05,1,10,NA,54,2013-01-27,2013-01-27T00:00:00Z,2013-02-05T23:59:59Z,2013-01-27T00:00:00Z,NA,H,2013-02-05T00:00:00Z,NA,H,1,10,10,2013-01-27,2013-02-05,540,540,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1433,2013-01-27,2013-02-06,2013-01-27,2013-02-05,NA,2013-02-06T10:52,NA,NA,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-05,10,NA,2013-02-06,DISCONTINUED,NA,2013-01-27,NA,NA,NA,2013-02-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1433,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-27,2013-01-27T00:00:00Z,2013-02-05T23:59:59Z,2013-01-27T00:00:00Z,NA,NA,2013-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-27,2013-02-05,NA,NA,TDURD,10,NA,OVERALL,Overall duration (days),7,< 30 days,6,1433,2013-01-27,2013-02-06,2013-01-27,2013-02-05,NA,2013-02-06T10:52,NA,NA,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-05,10,NA,2013-02-06,DISCONTINUED,NA,2013-01-27,NA,NA,NA,2013-02-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1433,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-27,2013-01-27T00:00:00Z,2013-02-05T23:59:59Z,2013-01-27T00:00:00Z,NA,NA,2013-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-27,2013-02-05,NA,NA,TDOSE,540,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1433,2013-01-27,2013-02-06,2013-01-27,2013-02-05,NA,2013-02-06T10:52,NA,NA,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-05,10,NA,2013-02-06,DISCONTINUED,NA,2013-01-27,NA,NA,NA,2013-02-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1433,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-27,2013-01-27T00:00:00Z,2013-02-05T23:59:59Z,2013-01-27T00:00:00Z,NA,NA,2013-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-27,2013-02-05,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1433,2013-01-27,2013-02-06,2013-01-27,2013-02-05,NA,2013-02-06T10:52,NA,NA,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-05,10,NA,2013-02-06,DISCONTINUED,NA,2013-01-27,NA,NA,NA,2013-02-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1433,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-27,2013-01-27T00:00:00Z,2013-02-05T23:59:59Z,2013-01-27T00:00:00Z,NA,NA,2013-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-27,2013-02-05,NA,NA,TPDOSE,540,NA,OVERALL,Total planned dose (mg),11,NA,9,1433,2013-01-27,2013-02-06,2013-01-27,2013-02-05,NA,2013-02-06T10:52,NA,NA,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-05,10,NA,2013-02-06,DISCONTINUED,NA,2013-01-27,NA,NA,NA,2013-02-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1433,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-27,2013-01-27T00:00:00Z,2013-02-05T23:59:59Z,2013-01-27T00:00:00Z,NA,NA,2013-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-27,2013-02-05,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1433,2013-01-27,2013-02-06,2013-01-27,2013-02-05,NA,2013-02-06T10:52,NA,NA,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-05,10,NA,2013-02-06,DISCONTINUED,NA,2013-01-27,NA,NA,NA,2013-02-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1433,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-27,2013-01-27T00:00:00Z,2013-02-05T23:59:59Z,2013-01-27T00:00:00Z,NA,NA,2013-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-27,2013-02-05,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1433,2013-01-27,2013-02-06,2013-01-27,2013-02-05,NA,2013-02-06T10:52,NA,NA,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-05,10,NA,2013-02-06,DISCONTINUED,NA,2013-01-27,NA,NA,NA,2013-02-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-711-1433,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-27,2013-01-27T00:00:00Z,2013-02-05T23:59:59Z,2013-01-27T00:00:00Z,NA,NA,2013-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-01-27,2013-02-05,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1433,2013-01-27,2013-02-06,2013-01-27,2013-02-05,NA,2013-02-06T10:52,NA,NA,711,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-02-05,10,NA,2013-02-06,DISCONTINUED,NA,2013-01-27,NA,NA,NA,2013-02-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1043,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-15,2013-09-30,1,16,NA,54,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-09-15T00:00:00Z,NA,H,2013-09-30T00:00:00Z,NA,H,1,16,16,2013-09-15,2013-09-30,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1043,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-15,2013-09-30,1,16,NA,54,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-09-15T00:00:00Z,NA,H,2013-09-30T00:00:00Z,NA,H,1,16,16,2013-09-15,2013-09-30,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1043,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-15,2013-09-30,1,16,NA,54,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-09-15T00:00:00Z,NA,H,2013-09-30T00:00:00Z,NA,H,1,16,16,2013-09-15,2013-09-30,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1043,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-15,2013-09-30,1,16,NA,54,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-09-15T00:00:00Z,NA,H,2013-09-30T00:00:00Z,NA,H,1,16,16,2013-09-15,2013-09-30,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1043,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-15,2013-09-30,1,16,NA,54,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-09-15T00:00:00Z,NA,H,2013-09-30T00:00:00Z,NA,H,1,16,16,2013-09-15,2013-09-30,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1043,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-01,2014-02-28,17,167,NA,54,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-10-01T00:00:00Z,NA,H,2014-02-28T00:00:00Z,NA,H,17,167,151,2013-10-01,2014-02-28,8154,8154,DURD,151,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1043,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-01,2014-02-28,17,167,NA,54,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-10-01T00:00:00Z,NA,H,2014-02-28T00:00:00Z,NA,H,17,167,151,2013-10-01,2014-02-28,8154,8154,DOSE,8154,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1043,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-01,2014-02-28,17,167,NA,54,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-10-01T00:00:00Z,NA,H,2014-02-28T00:00:00Z,NA,H,17,167,151,2013-10-01,2014-02-28,8154,8154,PLDOSE,8154,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1043,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-01,2014-02-28,17,167,NA,54,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-10-01T00:00:00Z,NA,H,2014-02-28T00:00:00Z,NA,H,17,167,151,2013-10-01,2014-02-28,8154,8154,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1043,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-01,2014-02-28,17,167,NA,54,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-10-01T00:00:00Z,NA,H,2014-02-28T00:00:00Z,NA,H,17,167,151,2013-10-01,2014-02-28,8154,8154,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1043,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-01,2014-03-24,168,191,NA,54,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2014-03-01T00:00:00Z,NA,H,2014-03-24T00:00:00Z,NA,H,168,191,24,2014-03-01,2014-03-24,1296,1296,DURD,24,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1043,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-01,2014-03-24,168,191,NA,54,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2014-03-01T00:00:00Z,NA,H,2014-03-24T00:00:00Z,NA,H,168,191,24,2014-03-01,2014-03-24,1296,1296,DOSE,1296,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1043,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-01,2014-03-24,168,191,NA,54,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2014-03-01T00:00:00Z,NA,H,2014-03-24T00:00:00Z,NA,H,168,191,24,2014-03-01,2014-03-24,1296,1296,PLDOSE,1296,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1043,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-01,2014-03-24,168,191,NA,54,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2014-03-01T00:00:00Z,NA,H,2014-03-24T00:00:00Z,NA,H,168,191,24,2014-03-01,2014-03-24,1296,1296,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1043,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-01,2014-03-24,168,191,NA,54,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2014-03-01T00:00:00Z,NA,H,2014-03-24T00:00:00Z,NA,H,168,191,24,2014-03-01,2014-03-24,1296,1296,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-09-15T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-15,2014-03-24,NA,NA,TDURD,191,NA,OVERALL,Overall duration (days),7,>=90 days,16,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-09-15T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-15,2014-03-24,NA,NA,TDOSE,10314,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-09-15T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-15,2014-03-24,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-09-15T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-15,2014-03-24,NA,NA,TPDOSE,10314,NA,OVERALL,Total planned dose (mg),11,NA,19,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-09-15T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-15,2014-03-24,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-09-15T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-15,2014-03-24,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-09-15T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-09-15,2014-03-24,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-10-01T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-01,2014-03-24,NA,NA,PDURD,175,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-10-01T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-01,2014-03-24,NA,NA,PDOSE,9450,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-10-01T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-01,2014-03-24,NA,NA,PPDOSE,9450,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-10-01T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-01,2014-03-24,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-10-01T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-01,2014-03-24,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-10-01T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-01,2014-03-24,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1043,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-15,2013-09-15T00:00:00Z,2014-03-24T23:59:59Z,2013-10-01T00:00:00Z,NA,NA,2014-03-24T00:00:00Z,NA,NA,NA,NA,NA,2013-10-01,2014-03-24,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1043,2013-09-15,2014-03-24,2013-09-15,2014-03-24,NA,2014-03-24T14:30,NA,NA,713,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-17,-29,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-24,191,NA,2014-03-24,COMPLETED,NA,2013-09-15,NA,NA,NA,2014-03-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1073,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-30,2014-04-14,1,16,NA,54,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-03-30T00:00:00Z,NA,H,2014-04-14T00:00:00Z,NA,H,1,16,16,2014-03-30,2014-04-14,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1073,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-30,2014-04-14,1,16,NA,54,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-03-30T00:00:00Z,NA,H,2014-04-14T00:00:00Z,NA,H,1,16,16,2014-03-30,2014-04-14,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1073,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-30,2014-04-14,1,16,NA,54,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-03-30T00:00:00Z,NA,H,2014-04-14T00:00:00Z,NA,H,1,16,16,2014-03-30,2014-04-14,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1073,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-30,2014-04-14,1,16,NA,54,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-03-30T00:00:00Z,NA,H,2014-04-14T00:00:00Z,NA,H,1,16,16,2014-03-30,2014-04-14,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1073,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-30,2014-04-14,1,16,NA,54,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-03-30T00:00:00Z,NA,H,2014-04-14T00:00:00Z,NA,H,1,16,16,2014-03-30,2014-04-14,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1073,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-15,2014-09-21,17,176,NA,54,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-04-15T00:00:00Z,NA,H,2014-09-21T00:00:00Z,NA,H,17,176,160,2014-04-15,2014-09-21,8640,8640,DURD,160,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1073,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-15,2014-09-21,17,176,NA,54,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-04-15T00:00:00Z,NA,H,2014-09-21T00:00:00Z,NA,H,17,176,160,2014-04-15,2014-09-21,8640,8640,DOSE,8640,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1073,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-15,2014-09-21,17,176,NA,54,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-04-15T00:00:00Z,NA,H,2014-09-21T00:00:00Z,NA,H,17,176,160,2014-04-15,2014-09-21,8640,8640,PLDOSE,8640,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1073,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-15,2014-09-21,17,176,NA,54,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-04-15T00:00:00Z,NA,H,2014-09-21T00:00:00Z,NA,H,17,176,160,2014-04-15,2014-09-21,8640,8640,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1073,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-15,2014-09-21,17,176,NA,54,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-04-15T00:00:00Z,NA,H,2014-09-21T00:00:00Z,NA,H,17,176,160,2014-04-15,2014-09-21,8640,8640,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1073,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-09-22,2014-10-05,177,190,NA,54,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-09-22T00:00:00Z,NA,H,2014-10-05T00:00:00Z,NA,H,177,190,14,2014-09-22,2014-10-05,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1073,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-09-22,2014-10-05,177,190,NA,54,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-09-22T00:00:00Z,NA,H,2014-10-05T00:00:00Z,NA,H,177,190,14,2014-09-22,2014-10-05,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1073,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-09-22,2014-10-05,177,190,NA,54,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-09-22T00:00:00Z,NA,H,2014-10-05T00:00:00Z,NA,H,177,190,14,2014-09-22,2014-10-05,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1073,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-09-22,2014-10-05,177,190,NA,54,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-09-22T00:00:00Z,NA,H,2014-10-05T00:00:00Z,NA,H,177,190,14,2014-09-22,2014-10-05,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1073,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-09-22,2014-10-05,177,190,NA,54,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-09-22T00:00:00Z,NA,H,2014-10-05T00:00:00Z,NA,H,177,190,14,2014-09-22,2014-10-05,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-03-30T00:00:00Z,NA,NA,2014-10-05T00:00:00Z,NA,NA,NA,NA,NA,2014-03-30,2014-10-05,NA,NA,TDURD,190,NA,OVERALL,Overall duration (days),7,>=90 days,16,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-03-30T00:00:00Z,NA,NA,2014-10-05T00:00:00Z,NA,NA,NA,NA,NA,2014-03-30,2014-10-05,NA,NA,TDOSE,10260,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-03-30T00:00:00Z,NA,NA,2014-10-05T00:00:00Z,NA,NA,NA,NA,NA,2014-03-30,2014-10-05,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-03-30T00:00:00Z,NA,NA,2014-10-05T00:00:00Z,NA,NA,NA,NA,NA,2014-03-30,2014-10-05,NA,NA,TPDOSE,10260,NA,OVERALL,Total planned dose (mg),11,NA,19,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-03-30T00:00:00Z,NA,NA,2014-10-05T00:00:00Z,NA,NA,NA,NA,NA,2014-03-30,2014-10-05,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-03-30T00:00:00Z,NA,NA,2014-10-05T00:00:00Z,NA,NA,NA,NA,NA,2014-03-30,2014-10-05,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-03-30T00:00:00Z,NA,NA,2014-10-05T00:00:00Z,NA,NA,NA,NA,NA,2014-03-30,2014-10-05,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-04-15T00:00:00Z,NA,NA,2014-10-05T00:00:00Z,NA,NA,NA,NA,NA,2014-04-15,2014-10-05,NA,NA,PDURD,174,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-04-15T00:00:00Z,NA,NA,2014-10-05T00:00:00Z,NA,NA,NA,NA,NA,2014-04-15,2014-10-05,NA,NA,PDOSE,9396,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-04-15T00:00:00Z,NA,NA,2014-10-05T00:00:00Z,NA,NA,NA,NA,NA,2014-04-15,2014-10-05,NA,NA,PPDOSE,9396,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-04-15T00:00:00Z,NA,NA,2014-10-05T00:00:00Z,NA,NA,NA,NA,NA,2014-04-15,2014-10-05,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-04-15T00:00:00Z,NA,NA,2014-10-05T00:00:00Z,NA,NA,NA,NA,NA,2014-04-15,2014-10-05,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-04-15T00:00:00Z,NA,NA,2014-10-05T00:00:00Z,NA,NA,NA,NA,NA,2014-04-15,2014-10-05,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1073,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-30,2014-03-30T00:00:00Z,2014-10-05T23:59:59Z,2014-04-15T00:00:00Z,NA,NA,2014-10-05T00:00:00Z,NA,NA,NA,NA,NA,2014-04-15,2014-10-05,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1073,2014-03-30,2014-10-05,2014-03-30,2014-10-05,NA,2014-10-05T10:30,NA,NA,713,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-15,-15,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-10-05,190,NA,2014-10-05,COMPLETED,NA,2014-03-30,NA,NA,NA,2014-10-05,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1106,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-31,2012-11-15,1,16,NA,54,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-10-31T00:00:00Z,NA,H,2012-11-15T00:00:00Z,NA,H,1,16,16,2012-10-31,2012-11-15,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1106,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-31,2012-11-15,1,16,NA,54,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-10-31T00:00:00Z,NA,H,2012-11-15T00:00:00Z,NA,H,1,16,16,2012-10-31,2012-11-15,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1106,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-31,2012-11-15,1,16,NA,54,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-10-31T00:00:00Z,NA,H,2012-11-15T00:00:00Z,NA,H,1,16,16,2012-10-31,2012-11-15,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1106,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-31,2012-11-15,1,16,NA,54,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-10-31T00:00:00Z,NA,H,2012-11-15T00:00:00Z,NA,H,1,16,16,2012-10-31,2012-11-15,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1106,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-31,2012-11-15,1,16,NA,54,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-10-31T00:00:00Z,NA,H,2012-11-15T00:00:00Z,NA,H,1,16,16,2012-10-31,2012-11-15,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1106,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-16,2013-04-22,17,174,NA,54,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-11-16T00:00:00Z,NA,H,2013-04-22T00:00:00Z,NA,H,17,174,158,2012-11-16,2013-04-22,12798,8532,DURD,158,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1106,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-16,2013-04-22,17,174,NA,54,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-11-16T00:00:00Z,NA,H,2013-04-22T00:00:00Z,NA,H,17,174,158,2012-11-16,2013-04-22,12798,8532,DOSE,12798,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1106,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-16,2013-04-22,17,174,NA,54,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-11-16T00:00:00Z,NA,H,2013-04-22T00:00:00Z,NA,H,17,174,158,2012-11-16,2013-04-22,12798,8532,PLDOSE,8532,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1106,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-16,2013-04-22,17,174,NA,54,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-11-16T00:00:00Z,NA,H,2013-04-22T00:00:00Z,NA,H,17,174,158,2012-11-16,2013-04-22,12798,8532,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1106,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-11-16,2013-04-22,17,174,NA,54,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-11-16T00:00:00Z,NA,H,2013-04-22T00:00:00Z,NA,H,17,174,158,2012-11-16,2013-04-22,12798,8532,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1106,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-23,2013-05-06,175,188,NA,54,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2013-04-23T00:00:00Z,NA,H,2013-05-06T00:00:00Z,NA,H,175,188,14,2013-04-23,2013-05-06,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1106,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-23,2013-05-06,175,188,NA,54,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2013-04-23T00:00:00Z,NA,H,2013-05-06T00:00:00Z,NA,H,175,188,14,2013-04-23,2013-05-06,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1106,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-23,2013-05-06,175,188,NA,54,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2013-04-23T00:00:00Z,NA,H,2013-05-06T00:00:00Z,NA,H,175,188,14,2013-04-23,2013-05-06,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1106,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-23,2013-05-06,175,188,NA,54,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2013-04-23T00:00:00Z,NA,H,2013-05-06T00:00:00Z,NA,H,175,188,14,2013-04-23,2013-05-06,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1106,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-04-23,2013-05-06,175,188,NA,54,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2013-04-23T00:00:00Z,NA,H,2013-05-06T00:00:00Z,NA,H,175,188,14,2013-04-23,2013-05-06,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-10-31T00:00:00Z,NA,NA,2013-05-06T00:00:00Z,NA,NA,NA,NA,NA,2012-10-31,2013-05-06,NA,NA,TDURD,188,NA,OVERALL,Overall duration (days),7,>=90 days,16,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-10-31T00:00:00Z,NA,NA,2013-05-06T00:00:00Z,NA,NA,NA,NA,NA,2012-10-31,2013-05-06,NA,NA,TDOSE,14418,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-10-31T00:00:00Z,NA,NA,2013-05-06T00:00:00Z,NA,NA,NA,NA,NA,2012-10-31,2013-05-06,NA,NA,AVDDSE,76.69148936170212,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-10-31T00:00:00Z,NA,NA,2013-05-06T00:00:00Z,NA,NA,NA,NA,NA,2012-10-31,2013-05-06,NA,NA,TPDOSE,10152,NA,OVERALL,Total planned dose (mg),11,NA,19,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-10-31T00:00:00Z,NA,NA,2013-05-06T00:00:00Z,NA,NA,NA,NA,NA,2012-10-31,2013-05-06,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-10-31T00:00:00Z,NA,NA,2013-05-06T00:00:00Z,NA,NA,NA,NA,NA,2012-10-31,2013-05-06,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-10-31T00:00:00Z,NA,NA,2013-05-06T00:00:00Z,NA,NA,NA,NA,NA,2012-10-31,2013-05-06,NA,NA,TDOSINT,142.0212765957447,NA,OVERALL,Overall dose intensity (%),90,NA,22,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-11-16T00:00:00Z,NA,NA,2013-05-06T00:00:00Z,NA,NA,NA,NA,NA,2012-11-16,2013-05-06,NA,NA,PDURD,172,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-11-16T00:00:00Z,NA,NA,2013-05-06T00:00:00Z,NA,NA,NA,NA,NA,2012-11-16,2013-05-06,NA,NA,PDOSE,13554,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-11-16T00:00:00Z,NA,NA,2013-05-06T00:00:00Z,NA,NA,NA,NA,NA,2012-11-16,2013-05-06,NA,NA,PPDOSE,9288,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-11-16T00:00:00Z,NA,NA,2013-05-06T00:00:00Z,NA,NA,NA,NA,NA,2012-11-16,2013-05-06,NA,NA,PAVDDSE,78.80232558139535,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-11-16T00:00:00Z,NA,NA,2013-05-06T00:00:00Z,NA,NA,NA,NA,NA,2012-11-16,2013-05-06,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-11-16T00:00:00Z,NA,NA,2013-05-06T00:00:00Z,NA,NA,NA,NA,NA,2012-11-16,2013-05-06,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1106,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-31,2012-10-31T00:00:00Z,2013-05-06T23:59:59Z,2012-11-16T00:00:00Z,NA,NA,2013-05-06T00:00:00Z,NA,NA,NA,NA,NA,2012-11-16,2013-05-06,NA,NA,PDOSINT,145.93023255813952,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1106,2012-10-31,2013-05-06,2012-10-31,2013-05-06,NA,2013-05-06T11:25,NA,NA,713,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-03,-28,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-05-06,188,NA,2013-05-06,COMPLETED,NA,2012-10-31,NA,NA,NA,2013-05-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1141,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-31,2013-06-14,1,15,NA,54,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-05-31T00:00:00Z,NA,H,2013-06-14T00:00:00Z,NA,H,1,15,15,2013-05-31,2013-06-14,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1141,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-31,2013-06-14,1,15,NA,54,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-05-31T00:00:00Z,NA,H,2013-06-14T00:00:00Z,NA,H,1,15,15,2013-05-31,2013-06-14,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1141,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-31,2013-06-14,1,15,NA,54,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-05-31T00:00:00Z,NA,H,2013-06-14T00:00:00Z,NA,H,1,15,15,2013-05-31,2013-06-14,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1141,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-31,2013-06-14,1,15,NA,54,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-05-31T00:00:00Z,NA,H,2013-06-14T00:00:00Z,NA,H,1,15,15,2013-05-31,2013-06-14,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1141,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-31,2013-06-14,1,15,NA,54,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-05-31T00:00:00Z,NA,H,2013-06-14T00:00:00Z,NA,H,1,15,15,2013-05-31,2013-06-14,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1141,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-15,2013-07-01,16,32,NA,54,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-06-15T00:00:00Z,NA,H,2013-07-01T00:00:00Z,NA,H,16,32,17,2013-06-15,2013-07-01,1377,918,DURD,17,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1141,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-15,2013-07-01,16,32,NA,54,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-06-15T00:00:00Z,NA,H,2013-07-01T00:00:00Z,NA,H,16,32,17,2013-06-15,2013-07-01,1377,918,DOSE,1377,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1141,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-15,2013-07-01,16,32,NA,54,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-06-15T00:00:00Z,NA,H,2013-07-01T00:00:00Z,NA,H,16,32,17,2013-06-15,2013-07-01,1377,918,PLDOSE,918,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1141,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-15,2013-07-01,16,32,NA,54,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-06-15T00:00:00Z,NA,H,2013-07-01T00:00:00Z,NA,H,16,32,17,2013-06-15,2013-07-01,1377,918,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1141,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-15,2013-07-01,16,32,NA,54,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-06-15T00:00:00Z,NA,H,2013-07-01T00:00:00Z,NA,H,16,32,17,2013-06-15,2013-07-01,1377,918,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-05-31T00:00:00Z,NA,NA,2013-07-01T00:00:00Z,NA,NA,NA,NA,NA,2013-05-31,2013-07-01,NA,NA,TDURD,32,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-05-31T00:00:00Z,NA,NA,2013-07-01T00:00:00Z,NA,NA,NA,NA,NA,2013-05-31,2013-07-01,NA,NA,TDOSE,2187,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-05-31T00:00:00Z,NA,NA,2013-07-01T00:00:00Z,NA,NA,NA,NA,NA,2013-05-31,2013-07-01,NA,NA,AVDDSE,68.34375,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-05-31T00:00:00Z,NA,NA,2013-07-01T00:00:00Z,NA,NA,NA,NA,NA,2013-05-31,2013-07-01,NA,NA,TPDOSE,1728,NA,OVERALL,Total planned dose (mg),11,NA,14,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-05-31T00:00:00Z,NA,NA,2013-07-01T00:00:00Z,NA,NA,NA,NA,NA,2013-05-31,2013-07-01,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-05-31T00:00:00Z,NA,NA,2013-07-01T00:00:00Z,NA,NA,NA,NA,NA,2013-05-31,2013-07-01,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-05-31T00:00:00Z,NA,NA,2013-07-01T00:00:00Z,NA,NA,NA,NA,NA,2013-05-31,2013-07-01,NA,NA,TDOSINT,126.5625,NA,OVERALL,Overall dose intensity (%),90,NA,17,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-06-15T00:00:00Z,NA,NA,2013-07-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-15,2013-07-01,NA,NA,PDURD,17,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-06-15T00:00:00Z,NA,NA,2013-07-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-15,2013-07-01,NA,NA,PDOSE,1377,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-06-15T00:00:00Z,NA,NA,2013-07-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-15,2013-07-01,NA,NA,PPDOSE,918,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-06-15T00:00:00Z,NA,NA,2013-07-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-15,2013-07-01,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-06-15T00:00:00Z,NA,NA,2013-07-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-15,2013-07-01,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-06-15T00:00:00Z,NA,NA,2013-07-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-15,2013-07-01,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1141,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-31,2013-05-31T00:00:00Z,2013-07-01T23:59:59Z,2013-06-15T00:00:00Z,NA,NA,2013-07-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-15,2013-07-01,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1141,2013-05-31,2013-08-06,2013-05-31,2013-07-01,NA,2013-08-06T12:00,NA,NA,713,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-23,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-01,32,NA,2013-08-06,DISCONTINUED,NA,2013-05-31,NA,NA,NA,2013-08-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1179,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-09,2013-08-24,1,16,NA,0,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-09T00:00:00Z,NA,H,2013-08-24T00:00:00Z,NA,H,1,16,16,2013-08-09,2013-08-24,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1179,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-09,2013-08-24,1,16,NA,0,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-09T00:00:00Z,NA,H,2013-08-24T00:00:00Z,NA,H,1,16,16,2013-08-09,2013-08-24,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1179,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-09,2013-08-24,1,16,NA,0,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-09T00:00:00Z,NA,H,2013-08-24T00:00:00Z,NA,H,1,16,16,2013-08-09,2013-08-24,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1179,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-09,2013-08-24,1,16,NA,0,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-09T00:00:00Z,NA,H,2013-08-24T00:00:00Z,NA,H,1,16,16,2013-08-09,2013-08-24,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1179,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-09,2013-08-24,1,16,NA,0,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-09T00:00:00Z,NA,H,2013-08-24T00:00:00Z,NA,H,1,16,16,2013-08-09,2013-08-24,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1179,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-25,2014-01-24,17,169,NA,0,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-25T00:00:00Z,NA,H,2014-01-24T00:00:00Z,NA,H,17,169,153,2013-08-25,2014-01-24,0,0,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1179,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-25,2014-01-24,17,169,NA,0,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-25T00:00:00Z,NA,H,2014-01-24T00:00:00Z,NA,H,17,169,153,2013-08-25,2014-01-24,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1179,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-25,2014-01-24,17,169,NA,0,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-25T00:00:00Z,NA,H,2014-01-24T00:00:00Z,NA,H,17,169,153,2013-08-25,2014-01-24,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1179,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-25,2014-01-24,17,169,NA,0,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-25T00:00:00Z,NA,H,2014-01-24T00:00:00Z,NA,H,17,169,153,2013-08-25,2014-01-24,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1179,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-25,2014-01-24,17,169,NA,0,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-25T00:00:00Z,NA,H,2014-01-24T00:00:00Z,NA,H,17,169,153,2013-08-25,2014-01-24,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1179,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-25,2014-02-05,170,181,NA,0,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2014-01-25T00:00:00Z,NA,H,2014-02-05T00:00:00Z,NA,H,170,181,12,2014-01-25,2014-02-05,0,0,DURD,12,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1179,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-25,2014-02-05,170,181,NA,0,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2014-01-25T00:00:00Z,NA,H,2014-02-05T00:00:00Z,NA,H,170,181,12,2014-01-25,2014-02-05,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1179,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-25,2014-02-05,170,181,NA,0,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2014-01-25T00:00:00Z,NA,H,2014-02-05T00:00:00Z,NA,H,170,181,12,2014-01-25,2014-02-05,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1179,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-25,2014-02-05,170,181,NA,0,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2014-01-25T00:00:00Z,NA,H,2014-02-05T00:00:00Z,NA,H,170,181,12,2014-01-25,2014-02-05,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1179,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-01-25,2014-02-05,170,181,NA,0,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2014-01-25T00:00:00Z,NA,H,2014-02-05T00:00:00Z,NA,H,170,181,12,2014-01-25,2014-02-05,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-09T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-09,2014-02-05,NA,NA,TDURD,181,NA,OVERALL,Overall duration (days),7,>=90 days,16,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-09T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-09,2014-02-05,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-09T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-09,2014-02-05,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-09T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-09,2014-02-05,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-09T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-09,2014-02-05,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-09T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-09,2014-02-05,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-09T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-09,2014-02-05,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-25T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-25,2014-02-05,NA,NA,PDURD,165,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-25T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-25,2014-02-05,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-25T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-25,2014-02-05,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-25T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-25,2014-02-05,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-25T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-25,2014-02-05,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-25T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-25,2014-02-05,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1179,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-09,2013-08-09T00:00:00Z,2014-02-05T23:59:59Z,2013-08-25T00:00:00Z,NA,NA,2014-02-05T00:00:00Z,NA,NA,NA,NA,NA,2013-08-25,2014-02-05,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1179,2013-08-09,2014-02-05,2013-08-09,2014-02-05,NA,2014-02-05T15:15,NA,NA,713,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-07-11,-29,Placebo,Placebo,H,H,2014-02-05,181,NA,2014-02-05,COMPLETED,NA,2013-08-09,NA,NA,NA,2014-02-05,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1209,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-27,2013-06-14,1,19,NA,54,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-05-27T00:00:00Z,NA,H,2013-06-14T00:00:00Z,NA,H,1,19,19,2013-05-27,2013-06-14,1026,1026,DURD,19,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1209,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-27,2013-06-14,1,19,NA,54,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-05-27T00:00:00Z,NA,H,2013-06-14T00:00:00Z,NA,H,1,19,19,2013-05-27,2013-06-14,1026,1026,DOSE,1026,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1209,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-27,2013-06-14,1,19,NA,54,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-05-27T00:00:00Z,NA,H,2013-06-14T00:00:00Z,NA,H,1,19,19,2013-05-27,2013-06-14,1026,1026,PLDOSE,1026,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1209,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-27,2013-06-14,1,19,NA,54,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-05-27T00:00:00Z,NA,H,2013-06-14T00:00:00Z,NA,H,1,19,19,2013-05-27,2013-06-14,1026,1026,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1209,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-27,2013-06-14,1,19,NA,54,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-05-27T00:00:00Z,NA,H,2013-06-14T00:00:00Z,NA,H,1,19,19,2013-05-27,2013-06-14,1026,1026,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1209,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-15,2013-11-14,20,172,NA,54,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-06-15T00:00:00Z,NA,H,2013-11-14T00:00:00Z,NA,H,20,172,153,2013-06-15,2013-11-14,12393,8262,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1209,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-15,2013-11-14,20,172,NA,54,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-06-15T00:00:00Z,NA,H,2013-11-14T00:00:00Z,NA,H,20,172,153,2013-06-15,2013-11-14,12393,8262,DOSE,12393,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1209,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-15,2013-11-14,20,172,NA,54,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-06-15T00:00:00Z,NA,H,2013-11-14T00:00:00Z,NA,H,20,172,153,2013-06-15,2013-11-14,12393,8262,PLDOSE,8262,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1209,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-15,2013-11-14,20,172,NA,54,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-06-15T00:00:00Z,NA,H,2013-11-14T00:00:00Z,NA,H,20,172,153,2013-06-15,2013-11-14,12393,8262,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1209,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-15,2013-11-14,20,172,NA,54,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-06-15T00:00:00Z,NA,H,2013-11-14T00:00:00Z,NA,H,20,172,153,2013-06-15,2013-11-14,12393,8262,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1209,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-15,2013-11-22,173,180,NA,54,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-11-15T00:00:00Z,NA,H,2013-11-22T00:00:00Z,NA,H,173,180,8,2013-11-15,2013-11-22,432,432,DURD,8,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1209,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-15,2013-11-22,173,180,NA,54,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-11-15T00:00:00Z,NA,H,2013-11-22T00:00:00Z,NA,H,173,180,8,2013-11-15,2013-11-22,432,432,DOSE,432,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1209,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-15,2013-11-22,173,180,NA,54,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-11-15T00:00:00Z,NA,H,2013-11-22T00:00:00Z,NA,H,173,180,8,2013-11-15,2013-11-22,432,432,PLDOSE,432,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1209,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-15,2013-11-22,173,180,NA,54,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-11-15T00:00:00Z,NA,H,2013-11-22T00:00:00Z,NA,H,173,180,8,2013-11-15,2013-11-22,432,432,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1209,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-15,2013-11-22,173,180,NA,54,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-11-15T00:00:00Z,NA,H,2013-11-22T00:00:00Z,NA,H,173,180,8,2013-11-15,2013-11-22,432,432,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-05-27T00:00:00Z,NA,NA,2013-11-22T00:00:00Z,NA,NA,NA,NA,NA,2013-05-27,2013-11-22,NA,NA,TDURD,180,NA,OVERALL,Overall duration (days),7,>=90 days,16,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-05-27T00:00:00Z,NA,NA,2013-11-22T00:00:00Z,NA,NA,NA,NA,NA,2013-05-27,2013-11-22,NA,NA,TDOSE,13851,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-05-27T00:00:00Z,NA,NA,2013-11-22T00:00:00Z,NA,NA,NA,NA,NA,2013-05-27,2013-11-22,NA,NA,AVDDSE,76.95,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-05-27T00:00:00Z,NA,NA,2013-11-22T00:00:00Z,NA,NA,NA,NA,NA,2013-05-27,2013-11-22,NA,NA,TPDOSE,9720,NA,OVERALL,Total planned dose (mg),11,NA,19,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-05-27T00:00:00Z,NA,NA,2013-11-22T00:00:00Z,NA,NA,NA,NA,NA,2013-05-27,2013-11-22,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-05-27T00:00:00Z,NA,NA,2013-11-22T00:00:00Z,NA,NA,NA,NA,NA,2013-05-27,2013-11-22,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-05-27T00:00:00Z,NA,NA,2013-11-22T00:00:00Z,NA,NA,NA,NA,NA,2013-05-27,2013-11-22,NA,NA,TDOSINT,142.5,NA,OVERALL,Overall dose intensity (%),90,NA,22,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-06-15T00:00:00Z,NA,NA,2013-11-22T00:00:00Z,NA,NA,NA,NA,NA,2013-06-15,2013-11-22,NA,NA,PDURD,161,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-06-15T00:00:00Z,NA,NA,2013-11-22T00:00:00Z,NA,NA,NA,NA,NA,2013-06-15,2013-11-22,NA,NA,PDOSE,12825,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-06-15T00:00:00Z,NA,NA,2013-11-22T00:00:00Z,NA,NA,NA,NA,NA,2013-06-15,2013-11-22,NA,NA,PPDOSE,8694,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-06-15T00:00:00Z,NA,NA,2013-11-22T00:00:00Z,NA,NA,NA,NA,NA,2013-06-15,2013-11-22,NA,NA,PAVDDSE,79.6583850931677,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-06-15T00:00:00Z,NA,NA,2013-11-22T00:00:00Z,NA,NA,NA,NA,NA,2013-06-15,2013-11-22,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-06-15T00:00:00Z,NA,NA,2013-11-22T00:00:00Z,NA,NA,NA,NA,NA,2013-06-15,2013-11-22,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1209,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-27,2013-05-27T00:00:00Z,2013-11-22T23:59:59Z,2013-06-15T00:00:00Z,NA,NA,2013-11-22T00:00:00Z,NA,NA,NA,NA,NA,2013-06-15,2013-11-22,NA,NA,PDOSINT,147.51552795031054,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1209,2013-05-27,2013-11-22,2013-05-27,2013-11-22,NA,2013-11-22T10:05,NA,NA,713,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-05-16,-11,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-22,180,NA,2013-11-22,COMPLETED,NA,2013-05-27,NA,NA,NA,2013-11-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1256,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-19,2012-10-03,1,15,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-09-19T00:00:00Z,NA,H,2012-10-03T00:00:00Z,NA,H,1,15,15,2012-09-19,2012-10-03,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1256,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-19,2012-10-03,1,15,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-09-19T00:00:00Z,NA,H,2012-10-03T00:00:00Z,NA,H,1,15,15,2012-09-19,2012-10-03,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1256,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-19,2012-10-03,1,15,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-09-19T00:00:00Z,NA,H,2012-10-03T00:00:00Z,NA,H,1,15,15,2012-09-19,2012-10-03,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1256,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-19,2012-10-03,1,15,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-09-19T00:00:00Z,NA,H,2012-10-03T00:00:00Z,NA,H,1,15,15,2012-09-19,2012-10-03,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1256,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-19,2012-10-03,1,15,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-09-19T00:00:00Z,NA,H,2012-10-03T00:00:00Z,NA,H,1,15,15,2012-09-19,2012-10-03,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1256,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-04,2013-03-09,16,172,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-10-04T00:00:00Z,NA,H,2013-03-09T00:00:00Z,NA,H,16,172,157,2012-10-04,2013-03-09,0,0,DURD,157,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1256,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-04,2013-03-09,16,172,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-10-04T00:00:00Z,NA,H,2013-03-09T00:00:00Z,NA,H,16,172,157,2012-10-04,2013-03-09,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1256,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-04,2013-03-09,16,172,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-10-04T00:00:00Z,NA,H,2013-03-09T00:00:00Z,NA,H,16,172,157,2012-10-04,2013-03-09,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1256,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-04,2013-03-09,16,172,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-10-04T00:00:00Z,NA,H,2013-03-09T00:00:00Z,NA,H,16,172,157,2012-10-04,2013-03-09,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1256,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-04,2013-03-09,16,172,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-10-04T00:00:00Z,NA,H,2013-03-09T00:00:00Z,NA,H,16,172,157,2012-10-04,2013-03-09,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1256,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-10,2013-03-25,173,188,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2013-03-10T00:00:00Z,NA,H,2013-03-25T00:00:00Z,NA,H,173,188,16,2013-03-10,2013-03-25,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1256,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-10,2013-03-25,173,188,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2013-03-10T00:00:00Z,NA,H,2013-03-25T00:00:00Z,NA,H,173,188,16,2013-03-10,2013-03-25,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1256,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-10,2013-03-25,173,188,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2013-03-10T00:00:00Z,NA,H,2013-03-25T00:00:00Z,NA,H,173,188,16,2013-03-10,2013-03-25,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1256,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-10,2013-03-25,173,188,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2013-03-10T00:00:00Z,NA,H,2013-03-25T00:00:00Z,NA,H,173,188,16,2013-03-10,2013-03-25,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1256,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-10,2013-03-25,173,188,NA,0,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2013-03-10T00:00:00Z,NA,H,2013-03-25T00:00:00Z,NA,H,173,188,16,2013-03-10,2013-03-25,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2013-03-25T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2013-03-25,NA,NA,TDURD,188,NA,OVERALL,Overall duration (days),7,>=90 days,16,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2013-03-25T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2013-03-25,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2013-03-25T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2013-03-25,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2013-03-25T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2013-03-25,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2013-03-25T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2013-03-25,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2013-03-25T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2013-03-25,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2013-03-25T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2013-03-25,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-10-04T00:00:00Z,NA,NA,2013-03-25T00:00:00Z,NA,NA,NA,NA,NA,2012-10-04,2013-03-25,NA,NA,PDURD,173,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-10-04T00:00:00Z,NA,NA,2013-03-25T00:00:00Z,NA,NA,NA,NA,NA,2012-10-04,2013-03-25,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-10-04T00:00:00Z,NA,NA,2013-03-25T00:00:00Z,NA,NA,NA,NA,NA,2012-10-04,2013-03-25,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-10-04T00:00:00Z,NA,NA,2013-03-25T00:00:00Z,NA,NA,NA,NA,NA,2012-10-04,2013-03-25,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-10-04T00:00:00Z,NA,NA,2013-03-25T00:00:00Z,NA,NA,NA,NA,NA,2012-10-04,2013-03-25,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-10-04T00:00:00Z,NA,NA,2013-03-25T00:00:00Z,NA,NA,NA,NA,NA,2012-10-04,2013-03-25,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1256,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2013-03-25T23:59:59Z,2012-10-04T00:00:00Z,NA,NA,2013-03-25T00:00:00Z,NA,NA,NA,NA,NA,2012-10-04,2013-03-25,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1256,2012-09-19,2013-03-25,2012-09-19,2013-03-25,NA,2013-03-25T10:30,NA,NA,713,71,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-09-10,-9,Placebo,Placebo,H,H,2013-03-25,188,NA,2013-03-25,COMPLETED,NA,2012-09-19,NA,NA,NA,2013-03-25,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1269,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-27,2014-02-10,1,15,NA,0,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,H,2014-02-10T00:00:00Z,NA,H,1,15,15,2014-01-27,2014-02-10,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1269,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-27,2014-02-10,1,15,NA,0,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,H,2014-02-10T00:00:00Z,NA,H,1,15,15,2014-01-27,2014-02-10,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1269,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-27,2014-02-10,1,15,NA,0,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,H,2014-02-10T00:00:00Z,NA,H,1,15,15,2014-01-27,2014-02-10,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1269,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-27,2014-02-10,1,15,NA,0,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,H,2014-02-10T00:00:00Z,NA,H,1,15,15,2014-01-27,2014-02-10,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1269,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-27,2014-02-10,1,15,NA,0,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,H,2014-02-10T00:00:00Z,NA,H,1,15,15,2014-01-27,2014-02-10,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1269,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-11,2014-07-13,16,168,NA,0,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,H,2014-07-13T00:00:00Z,NA,H,16,168,153,2014-02-11,2014-07-13,0,0,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1269,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-11,2014-07-13,16,168,NA,0,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,H,2014-07-13T00:00:00Z,NA,H,16,168,153,2014-02-11,2014-07-13,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1269,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-11,2014-07-13,16,168,NA,0,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,H,2014-07-13T00:00:00Z,NA,H,16,168,153,2014-02-11,2014-07-13,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1269,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-11,2014-07-13,16,168,NA,0,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,H,2014-07-13T00:00:00Z,NA,H,16,168,153,2014-02-11,2014-07-13,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1269,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-11,2014-07-13,16,168,NA,0,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,H,2014-07-13T00:00:00Z,NA,H,16,168,153,2014-02-11,2014-07-13,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1269,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-14,2014-07-28,169,183,NA,0,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-07-14T00:00:00Z,NA,H,2014-07-28T00:00:00Z,NA,H,169,183,15,2014-07-14,2014-07-28,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1269,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-14,2014-07-28,169,183,NA,0,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-07-14T00:00:00Z,NA,H,2014-07-28T00:00:00Z,NA,H,169,183,15,2014-07-14,2014-07-28,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1269,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-14,2014-07-28,169,183,NA,0,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-07-14T00:00:00Z,NA,H,2014-07-28T00:00:00Z,NA,H,169,183,15,2014-07-14,2014-07-28,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1269,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-14,2014-07-28,169,183,NA,0,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-07-14T00:00:00Z,NA,H,2014-07-28T00:00:00Z,NA,H,169,183,15,2014-07-14,2014-07-28,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1269,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-14,2014-07-28,169,183,NA,0,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-07-14T00:00:00Z,NA,H,2014-07-28T00:00:00Z,NA,H,169,183,15,2014-07-14,2014-07-28,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-27,2014-07-28,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-27,2014-07-28,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-27,2014-07-28,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-27,2014-07-28,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-27,2014-07-28,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-27,2014-07-28,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-27,2014-07-28,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-07-28,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-07-28,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-07-28,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-07-28,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-07-28,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-07-28,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1269,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-07-28,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1269,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T14:00,NA,NA,713,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-14,-13,Placebo,Placebo,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1448,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-19,2014-02-01,1,14,NA,54,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-01-19T00:00:00Z,NA,H,2014-02-01T00:00:00Z,NA,H,1,14,14,2014-01-19,2014-02-01,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1448,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-19,2014-02-01,1,14,NA,54,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-01-19T00:00:00Z,NA,H,2014-02-01T00:00:00Z,NA,H,1,14,14,2014-01-19,2014-02-01,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1448,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-19,2014-02-01,1,14,NA,54,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-01-19T00:00:00Z,NA,H,2014-02-01T00:00:00Z,NA,H,1,14,14,2014-01-19,2014-02-01,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1448,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-19,2014-02-01,1,14,NA,54,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-01-19T00:00:00Z,NA,H,2014-02-01T00:00:00Z,NA,H,1,14,14,2014-01-19,2014-02-01,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1448,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-19,2014-02-01,1,14,NA,54,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-01-19T00:00:00Z,NA,H,2014-02-01T00:00:00Z,NA,H,1,14,14,2014-01-19,2014-02-01,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1448,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-02,2014-05-16,15,118,NA,54,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-02-02T00:00:00Z,NA,H,2014-05-16T00:00:00Z,NA,H,15,118,104,2014-02-02,2014-05-16,5616,5616,DURD,104,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1448,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-02,2014-05-16,15,118,NA,54,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-02-02T00:00:00Z,NA,H,2014-05-16T00:00:00Z,NA,H,15,118,104,2014-02-02,2014-05-16,5616,5616,DOSE,5616,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1448,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-02,2014-05-16,15,118,NA,54,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-02-02T00:00:00Z,NA,H,2014-05-16T00:00:00Z,NA,H,15,118,104,2014-02-02,2014-05-16,5616,5616,PLDOSE,5616,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1448,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-02,2014-05-16,15,118,NA,54,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-02-02T00:00:00Z,NA,H,2014-05-16T00:00:00Z,NA,H,15,118,104,2014-02-02,2014-05-16,5616,5616,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-713-1448,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-02,2014-05-16,15,118,NA,54,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-02-02T00:00:00Z,NA,H,2014-05-16T00:00:00Z,NA,H,15,118,104,2014-02-02,2014-05-16,5616,5616,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-01-19T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-19,2014-05-16,NA,NA,TDURD,118,NA,OVERALL,Overall duration (days),7,>=90 days,11,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-01-19T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-19,2014-05-16,NA,NA,TDOSE,6372,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-01-19T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-19,2014-05-16,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-01-19T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-19,2014-05-16,NA,NA,TPDOSE,6372,NA,OVERALL,Total planned dose (mg),11,NA,14,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-01-19T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-19,2014-05-16,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-01-19T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-19,2014-05-16,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-01-19T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-19,2014-05-16,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-02-02T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-02,2014-05-16,NA,NA,PDURD,104,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-02-02T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-02,2014-05-16,NA,NA,PDOSE,5616,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-02-02T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-02,2014-05-16,NA,NA,PPDOSE,5616,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-02-02T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-02,2014-05-16,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-02-02T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-02,2014-05-16,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-02-02T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-02,2014-05-16,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-713-1448,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-19,2014-01-19T00:00:00Z,2014-05-16T23:59:59Z,2014-02-02T00:00:00Z,NA,NA,2014-05-16T00:00:00Z,NA,NA,NA,NA,NA,2014-02-02,2014-05-16,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1448,2014-01-19,2014-05-17,2014-01-19,2014-05-16,NA,2014-07-27,NA,NA,713,71,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-05,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-05-16,118,NA,2014-05-17,DISCONTINUED,2014-07-27,2014-01-19,NA,NA,NA,2014-05-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1035,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-17,2014-05-01,1,15,NA,0,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-04-17T00:00:00Z,NA,H,2014-05-01T00:00:00Z,NA,H,1,15,15,2014-04-17,2014-05-01,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1035,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-17,2014-05-01,1,15,NA,0,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-04-17T00:00:00Z,NA,H,2014-05-01T00:00:00Z,NA,H,1,15,15,2014-04-17,2014-05-01,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1035,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-17,2014-05-01,1,15,NA,0,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-04-17T00:00:00Z,NA,H,2014-05-01T00:00:00Z,NA,H,1,15,15,2014-04-17,2014-05-01,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1035,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-17,2014-05-01,1,15,NA,0,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-04-17T00:00:00Z,NA,H,2014-05-01T00:00:00Z,NA,H,1,15,15,2014-04-17,2014-05-01,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1035,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-17,2014-05-01,1,15,NA,0,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-04-17T00:00:00Z,NA,H,2014-05-01T00:00:00Z,NA,H,1,15,15,2014-04-17,2014-05-01,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1035,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-02,2014-10-02,16,169,NA,0,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-05-02T00:00:00Z,NA,H,2014-10-02T00:00:00Z,NA,H,16,169,154,2014-05-02,2014-10-02,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1035,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-02,2014-10-02,16,169,NA,0,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-05-02T00:00:00Z,NA,H,2014-10-02T00:00:00Z,NA,H,16,169,154,2014-05-02,2014-10-02,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1035,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-02,2014-10-02,16,169,NA,0,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-05-02T00:00:00Z,NA,H,2014-10-02T00:00:00Z,NA,H,16,169,154,2014-05-02,2014-10-02,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1035,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-02,2014-10-02,16,169,NA,0,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-05-02T00:00:00Z,NA,H,2014-10-02T00:00:00Z,NA,H,16,169,154,2014-05-02,2014-10-02,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1035,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-02,2014-10-02,16,169,NA,0,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-05-02T00:00:00Z,NA,H,2014-10-02T00:00:00Z,NA,H,16,169,154,2014-05-02,2014-10-02,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1035,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-10-03,2014-10-16,170,183,NA,0,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-10-03T00:00:00Z,NA,H,2014-10-16T00:00:00Z,NA,H,170,183,14,2014-10-03,2014-10-16,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1035,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-10-03,2014-10-16,170,183,NA,0,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-10-03T00:00:00Z,NA,H,2014-10-16T00:00:00Z,NA,H,170,183,14,2014-10-03,2014-10-16,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1035,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-10-03,2014-10-16,170,183,NA,0,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-10-03T00:00:00Z,NA,H,2014-10-16T00:00:00Z,NA,H,170,183,14,2014-10-03,2014-10-16,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1035,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-10-03,2014-10-16,170,183,NA,0,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-10-03T00:00:00Z,NA,H,2014-10-16T00:00:00Z,NA,H,170,183,14,2014-10-03,2014-10-16,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1035,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-10-03,2014-10-16,170,183,NA,0,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-10-03T00:00:00Z,NA,H,2014-10-16T00:00:00Z,NA,H,170,183,14,2014-10-03,2014-10-16,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-04-17T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-17,2014-10-16,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-04-17T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-17,2014-10-16,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-04-17T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-17,2014-10-16,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-04-17T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-17,2014-10-16,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-04-17T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-17,2014-10-16,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-04-17T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-17,2014-10-16,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-04-17T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-17,2014-10-16,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-05-02T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-05-02,2014-10-16,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-05-02T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-05-02,2014-10-16,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-05-02T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-05-02,2014-10-16,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-05-02T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-05-02,2014-10-16,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-05-02T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-05-02,2014-10-16,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-05-02T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-05-02,2014-10-16,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1035,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-17,2014-04-17T00:00:00Z,2014-10-16T23:59:59Z,2014-05-02T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-05-02,2014-10-16,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1035,2014-04-17,2014-10-16,2014-04-17,2014-10-16,NA,2014-10-16T12:00,NA,NA,714,88,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-04-03,-14,Placebo,Placebo,H,H,2014-10-16,183,NA,2014-10-16,COMPLETED,NA,2014-04-17,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1068,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-08,2013-08-22,1,15,NA,54,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-08T00:00:00Z,NA,H,2013-08-22T00:00:00Z,NA,H,1,15,15,2013-08-08,2013-08-22,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1068,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-08,2013-08-22,1,15,NA,54,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-08T00:00:00Z,NA,H,2013-08-22T00:00:00Z,NA,H,1,15,15,2013-08-08,2013-08-22,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1068,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-08,2013-08-22,1,15,NA,54,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-08T00:00:00Z,NA,H,2013-08-22T00:00:00Z,NA,H,1,15,15,2013-08-08,2013-08-22,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1068,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-08,2013-08-22,1,15,NA,54,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-08T00:00:00Z,NA,H,2013-08-22T00:00:00Z,NA,H,1,15,15,2013-08-08,2013-08-22,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1068,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-08,2013-08-22,1,15,NA,54,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-08T00:00:00Z,NA,H,2013-08-22T00:00:00Z,NA,H,1,15,15,2013-08-08,2013-08-22,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1068,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-23,2013-10-08,16,62,NA,54,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-23T00:00:00Z,NA,H,2013-10-08T00:00:00Z,NA,H,16,62,47,2013-08-23,2013-10-08,2538,2538,DURD,47,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1068,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-23,2013-10-08,16,62,NA,54,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-23T00:00:00Z,NA,H,2013-10-08T00:00:00Z,NA,H,16,62,47,2013-08-23,2013-10-08,2538,2538,DOSE,2538,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1068,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-23,2013-10-08,16,62,NA,54,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-23T00:00:00Z,NA,H,2013-10-08T00:00:00Z,NA,H,16,62,47,2013-08-23,2013-10-08,2538,2538,PLDOSE,2538,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1068,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-23,2013-10-08,16,62,NA,54,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-23T00:00:00Z,NA,H,2013-10-08T00:00:00Z,NA,H,16,62,47,2013-08-23,2013-10-08,2538,2538,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1068,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-08-23,2013-10-08,16,62,NA,54,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-23T00:00:00Z,NA,H,2013-10-08T00:00:00Z,NA,H,16,62,47,2013-08-23,2013-10-08,2538,2538,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-08T00:00:00Z,NA,NA,2013-10-08T00:00:00Z,NA,NA,NA,NA,NA,2013-08-08,2013-10-08,NA,NA,TDURD,62,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-08T00:00:00Z,NA,NA,2013-10-08T00:00:00Z,NA,NA,NA,NA,NA,2013-08-08,2013-10-08,NA,NA,TDOSE,3348,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-08T00:00:00Z,NA,NA,2013-10-08T00:00:00Z,NA,NA,NA,NA,NA,2013-08-08,2013-10-08,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-08T00:00:00Z,NA,NA,2013-10-08T00:00:00Z,NA,NA,NA,NA,NA,2013-08-08,2013-10-08,NA,NA,TPDOSE,3348,NA,OVERALL,Total planned dose (mg),11,NA,14,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-08T00:00:00Z,NA,NA,2013-10-08T00:00:00Z,NA,NA,NA,NA,NA,2013-08-08,2013-10-08,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-08T00:00:00Z,NA,NA,2013-10-08T00:00:00Z,NA,NA,NA,NA,NA,2013-08-08,2013-10-08,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-08T00:00:00Z,NA,NA,2013-10-08T00:00:00Z,NA,NA,NA,NA,NA,2013-08-08,2013-10-08,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2013-10-08T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2013-10-08,NA,NA,PDURD,47,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2013-10-08T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2013-10-08,NA,NA,PDOSE,2538,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2013-10-08T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2013-10-08,NA,NA,PPDOSE,2538,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2013-10-08T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2013-10-08,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2013-10-08T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2013-10-08,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2013-10-08T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2013-10-08,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1068,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-08,2013-08-08T00:00:00Z,2013-10-08T23:59:59Z,2013-08-23T00:00:00Z,NA,NA,2013-10-08T00:00:00Z,NA,NA,NA,NA,NA,2013-08-23,2013-10-08,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1068,2013-08-08,2013-10-16,2013-08-08,2013-10-08,NA,2013-10-23,NA,NA,714,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-07-31,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-08,62,NA,2013-10-16,DISCONTINUED,NA,2013-08-08,NA,NA,NA,2013-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1195,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-26,2013-05-09,1,14,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-04-26T00:00:00Z,NA,H,2013-05-09T00:00:00Z,NA,H,1,14,14,2013-04-26,2013-05-09,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1195,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-26,2013-05-09,1,14,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-04-26T00:00:00Z,NA,H,2013-05-09T00:00:00Z,NA,H,1,14,14,2013-04-26,2013-05-09,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1195,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-26,2013-05-09,1,14,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-04-26T00:00:00Z,NA,H,2013-05-09T00:00:00Z,NA,H,1,14,14,2013-04-26,2013-05-09,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1195,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-26,2013-05-09,1,14,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-04-26T00:00:00Z,NA,H,2013-05-09T00:00:00Z,NA,H,1,14,14,2013-04-26,2013-05-09,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1195,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-26,2013-05-09,1,14,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-04-26T00:00:00Z,NA,H,2013-05-09T00:00:00Z,NA,H,1,14,14,2013-04-26,2013-05-09,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1195,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-10,2013-10-10,15,168,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-05-10T00:00:00Z,NA,H,2013-10-10T00:00:00Z,NA,H,15,168,154,2013-05-10,2013-10-10,8316,8316,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1195,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-10,2013-10-10,15,168,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-05-10T00:00:00Z,NA,H,2013-10-10T00:00:00Z,NA,H,15,168,154,2013-05-10,2013-10-10,8316,8316,DOSE,8316,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1195,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-10,2013-10-10,15,168,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-05-10T00:00:00Z,NA,H,2013-10-10T00:00:00Z,NA,H,15,168,154,2013-05-10,2013-10-10,8316,8316,PLDOSE,8316,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1195,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-10,2013-10-10,15,168,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-05-10T00:00:00Z,NA,H,2013-10-10T00:00:00Z,NA,H,15,168,154,2013-05-10,2013-10-10,8316,8316,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1195,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-10,2013-10-10,15,168,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-05-10T00:00:00Z,NA,H,2013-10-10T00:00:00Z,NA,H,15,168,154,2013-05-10,2013-10-10,8316,8316,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1195,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-11,2013-10-23,169,181,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-10-11T00:00:00Z,NA,H,2013-10-23T00:00:00Z,NA,H,169,181,13,2013-10-11,2013-10-23,702,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1195,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-11,2013-10-23,169,181,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-10-11T00:00:00Z,NA,H,2013-10-23T00:00:00Z,NA,H,169,181,13,2013-10-11,2013-10-23,702,702,DOSE,702,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1195,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-11,2013-10-23,169,181,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-10-11T00:00:00Z,NA,H,2013-10-23T00:00:00Z,NA,H,169,181,13,2013-10-11,2013-10-23,702,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1195,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-11,2013-10-23,169,181,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-10-11T00:00:00Z,NA,H,2013-10-23T00:00:00Z,NA,H,169,181,13,2013-10-11,2013-10-23,702,702,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1195,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-11,2013-10-23,169,181,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-10-11T00:00:00Z,NA,H,2013-10-23T00:00:00Z,NA,H,169,181,13,2013-10-11,2013-10-23,702,702,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-04-26T00:00:00Z,NA,NA,2013-10-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-26,2013-10-23,NA,NA,TDURD,181,NA,OVERALL,Overall duration (days),7,>=90 days,16,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-04-26T00:00:00Z,NA,NA,2013-10-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-26,2013-10-23,NA,NA,TDOSE,9774,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-04-26T00:00:00Z,NA,NA,2013-10-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-26,2013-10-23,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-04-26T00:00:00Z,NA,NA,2013-10-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-26,2013-10-23,NA,NA,TPDOSE,9774,NA,OVERALL,Total planned dose (mg),11,NA,19,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-04-26T00:00:00Z,NA,NA,2013-10-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-26,2013-10-23,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-04-26T00:00:00Z,NA,NA,2013-10-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-26,2013-10-23,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-04-26T00:00:00Z,NA,NA,2013-10-23T00:00:00Z,NA,NA,NA,NA,NA,2013-04-26,2013-10-23,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-05-10T00:00:00Z,NA,NA,2013-10-23T00:00:00Z,NA,NA,NA,NA,NA,2013-05-10,2013-10-23,NA,NA,PDURD,167,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-05-10T00:00:00Z,NA,NA,2013-10-23T00:00:00Z,NA,NA,NA,NA,NA,2013-05-10,2013-10-23,NA,NA,PDOSE,9018,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-05-10T00:00:00Z,NA,NA,2013-10-23T00:00:00Z,NA,NA,NA,NA,NA,2013-05-10,2013-10-23,NA,NA,PPDOSE,9018,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-05-10T00:00:00Z,NA,NA,2013-10-23T00:00:00Z,NA,NA,NA,NA,NA,2013-05-10,2013-10-23,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-05-10T00:00:00Z,NA,NA,2013-10-23T00:00:00Z,NA,NA,NA,NA,NA,2013-05-10,2013-10-23,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-05-10T00:00:00Z,NA,NA,2013-10-23T00:00:00Z,NA,NA,NA,NA,NA,2013-05-10,2013-10-23,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1195,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-10-23T23:59:59Z,2013-05-10T00:00:00Z,NA,NA,2013-10-23T00:00:00Z,NA,NA,NA,NA,NA,2013-05-10,2013-10-23,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1195,2013-04-26,2013-10-23,2013-04-26,2013-10-23,NA,2013-10-23T10:55,NA,NA,714,75,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-16,-10,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-23,181,NA,2013-10-23,COMPLETED,NA,2013-04-26,NA,NA,NA,2013-10-23,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1288,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-04,2013-12-17,1,14,NA,54,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-04T00:00:00Z,NA,H,2013-12-17T00:00:00Z,NA,H,1,14,14,2013-12-04,2013-12-17,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1288,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-04,2013-12-17,1,14,NA,54,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-04T00:00:00Z,NA,H,2013-12-17T00:00:00Z,NA,H,1,14,14,2013-12-04,2013-12-17,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1288,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-04,2013-12-17,1,14,NA,54,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-04T00:00:00Z,NA,H,2013-12-17T00:00:00Z,NA,H,1,14,14,2013-12-04,2013-12-17,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1288,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-04,2013-12-17,1,14,NA,54,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-04T00:00:00Z,NA,H,2013-12-17T00:00:00Z,NA,H,1,14,14,2013-12-04,2013-12-17,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1288,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-04,2013-12-17,1,14,NA,54,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-04T00:00:00Z,NA,H,2013-12-17T00:00:00Z,NA,H,1,14,14,2013-12-04,2013-12-17,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1288,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-18,2014-05-27,15,175,NA,54,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-18T00:00:00Z,NA,H,2014-05-27T00:00:00Z,NA,H,15,175,161,2013-12-18,2014-05-27,13041,8694,DURD,161,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1288,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-18,2014-05-27,15,175,NA,54,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-18T00:00:00Z,NA,H,2014-05-27T00:00:00Z,NA,H,15,175,161,2013-12-18,2014-05-27,13041,8694,DOSE,13041,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1288,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-18,2014-05-27,15,175,NA,54,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-18T00:00:00Z,NA,H,2014-05-27T00:00:00Z,NA,H,15,175,161,2013-12-18,2014-05-27,13041,8694,PLDOSE,8694,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1288,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-18,2014-05-27,15,175,NA,54,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-18T00:00:00Z,NA,H,2014-05-27T00:00:00Z,NA,H,15,175,161,2013-12-18,2014-05-27,13041,8694,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1288,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-18,2014-05-27,15,175,NA,54,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-18T00:00:00Z,NA,H,2014-05-27T00:00:00Z,NA,H,15,175,161,2013-12-18,2014-05-27,13041,8694,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1288,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-28,2014-06-17,176,196,NA,54,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2014-05-28T00:00:00Z,NA,H,2014-06-17T00:00:00Z,NA,H,176,196,21,2014-05-28,2014-06-17,1134,1134,DURD,21,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1288,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-28,2014-06-17,176,196,NA,54,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2014-05-28T00:00:00Z,NA,H,2014-06-17T00:00:00Z,NA,H,176,196,21,2014-05-28,2014-06-17,1134,1134,DOSE,1134,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1288,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-28,2014-06-17,176,196,NA,54,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2014-05-28T00:00:00Z,NA,H,2014-06-17T00:00:00Z,NA,H,176,196,21,2014-05-28,2014-06-17,1134,1134,PLDOSE,1134,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1288,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-28,2014-06-17,176,196,NA,54,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2014-05-28T00:00:00Z,NA,H,2014-06-17T00:00:00Z,NA,H,176,196,21,2014-05-28,2014-06-17,1134,1134,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1288,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-05-28,2014-06-17,176,196,NA,54,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2014-05-28T00:00:00Z,NA,H,2014-06-17T00:00:00Z,NA,H,176,196,21,2014-05-28,2014-06-17,1134,1134,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-04T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-04,2014-06-17,NA,NA,TDURD,196,NA,OVERALL,Overall duration (days),7,>=90 days,16,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-04T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-04,2014-06-17,NA,NA,TDOSE,14931,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-04T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-04,2014-06-17,NA,NA,AVDDSE,76.17857142857143,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-04T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-04,2014-06-17,NA,NA,TPDOSE,10584,NA,OVERALL,Total planned dose (mg),11,NA,19,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-04T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-04,2014-06-17,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-04T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-04,2014-06-17,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-04T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-04,2014-06-17,NA,NA,TDOSINT,141.07142857142858,NA,OVERALL,Overall dose intensity (%),90,NA,22,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-18T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-18,2014-06-17,NA,NA,PDURD,182,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-18T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-18,2014-06-17,NA,NA,PDOSE,14175,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-18T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-18,2014-06-17,NA,NA,PPDOSE,9828,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-18T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-18,2014-06-17,NA,NA,PAVDDSE,77.88461538461539,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-18T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-18,2014-06-17,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-18T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-18,2014-06-17,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1288,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-04,2013-12-04T00:00:00Z,2014-06-17T23:59:59Z,2013-12-18T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-18,2014-06-17,NA,NA,PDOSINT,144.23076923076923,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1288,2013-12-04,2014-06-17,2013-12-04,2014-06-17,NA,2014-06-17T13:00,NA,NA,714,77,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-11-24,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,196,NA,2014-06-17,COMPLETED,NA,2013-12-04,NA,NA,NA,2014-06-17,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1375,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-26,2013-03-19,1,22,NA,0,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,1,22,22,2013-02-26,2013-03-19,0,0,DURD,22,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1375,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-26,2013-03-19,1,22,NA,0,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,1,22,22,2013-02-26,2013-03-19,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1375,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-26,2013-03-19,1,22,NA,0,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,1,22,22,2013-02-26,2013-03-19,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1375,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-26,2013-03-19,1,22,NA,0,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,1,22,22,2013-02-26,2013-03-19,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1375,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-26,2013-03-19,1,22,NA,0,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-19T00:00:00Z,NA,H,1,22,22,2013-02-26,2013-03-19,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1375,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-20,2013-08-23,23,179,NA,0,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-03-20T00:00:00Z,NA,H,2013-08-23T00:00:00Z,NA,H,23,179,157,2013-03-20,2013-08-23,0,0,DURD,157,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1375,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-20,2013-08-23,23,179,NA,0,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-03-20T00:00:00Z,NA,H,2013-08-23T00:00:00Z,NA,H,23,179,157,2013-03-20,2013-08-23,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1375,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-20,2013-08-23,23,179,NA,0,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-03-20T00:00:00Z,NA,H,2013-08-23T00:00:00Z,NA,H,23,179,157,2013-03-20,2013-08-23,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1375,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-20,2013-08-23,23,179,NA,0,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-03-20T00:00:00Z,NA,H,2013-08-23T00:00:00Z,NA,H,23,179,157,2013-03-20,2013-08-23,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1375,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-20,2013-08-23,23,179,NA,0,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-03-20T00:00:00Z,NA,H,2013-08-23T00:00:00Z,NA,H,23,179,157,2013-03-20,2013-08-23,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1375,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-24,2013-09-07,180,194,NA,0,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-08-24T00:00:00Z,NA,H,2013-09-07T00:00:00Z,NA,H,180,194,15,2013-08-24,2013-09-07,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1375,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-24,2013-09-07,180,194,NA,0,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-08-24T00:00:00Z,NA,H,2013-09-07T00:00:00Z,NA,H,180,194,15,2013-08-24,2013-09-07,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1375,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-24,2013-09-07,180,194,NA,0,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-08-24T00:00:00Z,NA,H,2013-09-07T00:00:00Z,NA,H,180,194,15,2013-08-24,2013-09-07,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1375,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-24,2013-09-07,180,194,NA,0,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-08-24T00:00:00Z,NA,H,2013-09-07T00:00:00Z,NA,H,180,194,15,2013-08-24,2013-09-07,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1375,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-24,2013-09-07,180,194,NA,0,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-08-24T00:00:00Z,NA,H,2013-09-07T00:00:00Z,NA,H,180,194,15,2013-08-24,2013-09-07,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-09-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-09-07,NA,NA,TDURD,194,NA,OVERALL,Overall duration (days),7,>=90 days,16,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-09-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-09-07,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-09-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-09-07,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-09-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-09-07,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-09-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-09-07,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-09-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-09-07,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-09-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-09-07,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-03-20T00:00:00Z,NA,NA,2013-09-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-20,2013-09-07,NA,NA,PDURD,172,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-03-20T00:00:00Z,NA,NA,2013-09-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-20,2013-09-07,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-03-20T00:00:00Z,NA,NA,2013-09-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-20,2013-09-07,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-03-20T00:00:00Z,NA,NA,2013-09-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-20,2013-09-07,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-03-20T00:00:00Z,NA,NA,2013-09-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-20,2013-09-07,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-03-20T00:00:00Z,NA,NA,2013-09-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-20,2013-09-07,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1375,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-09-07T23:59:59Z,2013-03-20T00:00:00Z,NA,NA,2013-09-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-20,2013-09-07,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1375,2013-02-26,2013-09-07,2013-02-26,2013-09-07,NA,2013-09-07T13:58,NA,NA,714,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-23,-3,Placebo,Placebo,H,H,2013-09-07,194,NA,2013-09-07,COMPLETED,NA,2013-02-26,NA,NA,NA,2013-09-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1425,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-15,2013-08-19,1,5,NA,54,2013-08-15,2013-08-15T00:00:00Z,2013-08-19T23:59:59Z,2013-08-15T00:00:00Z,NA,H,2013-08-19T00:00:00Z,NA,H,1,5,5,2013-08-15,2013-08-19,270,270,DURD,5,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1425,2013-08-15,2013-08-22,2013-08-15,2013-08-19,NA,2013-08-22T14:55,NA,NA,714,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-11,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-19,5,NA,2013-08-22,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1425,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-15,2013-08-19,1,5,NA,54,2013-08-15,2013-08-15T00:00:00Z,2013-08-19T23:59:59Z,2013-08-15T00:00:00Z,NA,H,2013-08-19T00:00:00Z,NA,H,1,5,5,2013-08-15,2013-08-19,270,270,DOSE,270,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1425,2013-08-15,2013-08-22,2013-08-15,2013-08-19,NA,2013-08-22T14:55,NA,NA,714,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-11,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-19,5,NA,2013-08-22,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1425,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-15,2013-08-19,1,5,NA,54,2013-08-15,2013-08-15T00:00:00Z,2013-08-19T23:59:59Z,2013-08-15T00:00:00Z,NA,H,2013-08-19T00:00:00Z,NA,H,1,5,5,2013-08-15,2013-08-19,270,270,PLDOSE,270,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1425,2013-08-15,2013-08-22,2013-08-15,2013-08-19,NA,2013-08-22T14:55,NA,NA,714,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-11,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-19,5,NA,2013-08-22,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1425,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-15,2013-08-19,1,5,NA,54,2013-08-15,2013-08-15T00:00:00Z,2013-08-19T23:59:59Z,2013-08-15T00:00:00Z,NA,H,2013-08-19T00:00:00Z,NA,H,1,5,5,2013-08-15,2013-08-19,270,270,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1425,2013-08-15,2013-08-22,2013-08-15,2013-08-19,NA,2013-08-22T14:55,NA,NA,714,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-11,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-19,5,NA,2013-08-22,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-714-1425,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-15,2013-08-19,1,5,NA,54,2013-08-15,2013-08-15T00:00:00Z,2013-08-19T23:59:59Z,2013-08-15T00:00:00Z,NA,H,2013-08-19T00:00:00Z,NA,H,1,5,5,2013-08-15,2013-08-19,270,270,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1425,2013-08-15,2013-08-22,2013-08-15,2013-08-19,NA,2013-08-22T14:55,NA,NA,714,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-11,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-19,5,NA,2013-08-22,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1425,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-15,2013-08-15T00:00:00Z,2013-08-19T23:59:59Z,2013-08-15T00:00:00Z,NA,NA,2013-08-19T00:00:00Z,NA,NA,NA,NA,NA,2013-08-15,2013-08-19,NA,NA,TDURD,5,NA,OVERALL,Overall duration (days),7,< 30 days,6,1425,2013-08-15,2013-08-22,2013-08-15,2013-08-19,NA,2013-08-22T14:55,NA,NA,714,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-11,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-19,5,NA,2013-08-22,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1425,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-15,2013-08-15T00:00:00Z,2013-08-19T23:59:59Z,2013-08-15T00:00:00Z,NA,NA,2013-08-19T00:00:00Z,NA,NA,NA,NA,NA,2013-08-15,2013-08-19,NA,NA,TDOSE,270,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1425,2013-08-15,2013-08-22,2013-08-15,2013-08-19,NA,2013-08-22T14:55,NA,NA,714,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-11,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-19,5,NA,2013-08-22,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1425,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-15,2013-08-15T00:00:00Z,2013-08-19T23:59:59Z,2013-08-15T00:00:00Z,NA,NA,2013-08-19T00:00:00Z,NA,NA,NA,NA,NA,2013-08-15,2013-08-19,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1425,2013-08-15,2013-08-22,2013-08-15,2013-08-19,NA,2013-08-22T14:55,NA,NA,714,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-11,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-19,5,NA,2013-08-22,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1425,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-15,2013-08-15T00:00:00Z,2013-08-19T23:59:59Z,2013-08-15T00:00:00Z,NA,NA,2013-08-19T00:00:00Z,NA,NA,NA,NA,NA,2013-08-15,2013-08-19,NA,NA,TPDOSE,270,NA,OVERALL,Total planned dose (mg),11,NA,9,1425,2013-08-15,2013-08-22,2013-08-15,2013-08-19,NA,2013-08-22T14:55,NA,NA,714,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-11,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-19,5,NA,2013-08-22,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1425,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-15,2013-08-15T00:00:00Z,2013-08-19T23:59:59Z,2013-08-15T00:00:00Z,NA,NA,2013-08-19T00:00:00Z,NA,NA,NA,NA,NA,2013-08-15,2013-08-19,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1425,2013-08-15,2013-08-22,2013-08-15,2013-08-19,NA,2013-08-22T14:55,NA,NA,714,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-11,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-19,5,NA,2013-08-22,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1425,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-15,2013-08-15T00:00:00Z,2013-08-19T23:59:59Z,2013-08-15T00:00:00Z,NA,NA,2013-08-19T00:00:00Z,NA,NA,NA,NA,NA,2013-08-15,2013-08-19,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1425,2013-08-15,2013-08-22,2013-08-15,2013-08-19,NA,2013-08-22T14:55,NA,NA,714,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-11,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-19,5,NA,2013-08-22,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-714-1425,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-15,2013-08-15T00:00:00Z,2013-08-19T23:59:59Z,2013-08-15T00:00:00Z,NA,NA,2013-08-19T00:00:00Z,NA,NA,NA,NA,NA,2013-08-15,2013-08-19,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1425,2013-08-15,2013-08-22,2013-08-15,2013-08-19,NA,2013-08-22T14:55,NA,NA,714,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-11,-4,Xanomeline High Dose,Xanomeline Low Dose,H,H,2013-08-19,5,NA,2013-08-22,DISCONTINUED,NA,2013-08-15,NA,NA,NA,2013-08-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1085,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-16,2013-03-04,1,17,NA,54,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-02-16T00:00:00Z,NA,H,2013-03-04T00:00:00Z,NA,H,1,17,17,2013-02-16,2013-03-04,918,918,DURD,17,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1085,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-16,2013-03-04,1,17,NA,54,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-02-16T00:00:00Z,NA,H,2013-03-04T00:00:00Z,NA,H,1,17,17,2013-02-16,2013-03-04,918,918,DOSE,918,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1085,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-16,2013-03-04,1,17,NA,54,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-02-16T00:00:00Z,NA,H,2013-03-04T00:00:00Z,NA,H,1,17,17,2013-02-16,2013-03-04,918,918,PLDOSE,918,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1085,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-16,2013-03-04,1,17,NA,54,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-02-16T00:00:00Z,NA,H,2013-03-04T00:00:00Z,NA,H,1,17,17,2013-02-16,2013-03-04,918,918,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1085,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-16,2013-03-04,1,17,NA,54,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-02-16T00:00:00Z,NA,H,2013-03-04T00:00:00Z,NA,H,1,17,17,2013-02-16,2013-03-04,918,918,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1085,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-05,2013-08-04,18,170,NA,54,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-03-05T00:00:00Z,NA,H,2013-08-04T00:00:00Z,NA,H,18,170,153,2013-03-05,2013-08-04,8262,8262,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1085,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-05,2013-08-04,18,170,NA,54,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-03-05T00:00:00Z,NA,H,2013-08-04T00:00:00Z,NA,H,18,170,153,2013-03-05,2013-08-04,8262,8262,DOSE,8262,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1085,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-05,2013-08-04,18,170,NA,54,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-03-05T00:00:00Z,NA,H,2013-08-04T00:00:00Z,NA,H,18,170,153,2013-03-05,2013-08-04,8262,8262,PLDOSE,8262,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1085,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-05,2013-08-04,18,170,NA,54,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-03-05T00:00:00Z,NA,H,2013-08-04T00:00:00Z,NA,H,18,170,153,2013-03-05,2013-08-04,8262,8262,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1085,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-05,2013-08-04,18,170,NA,54,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-03-05T00:00:00Z,NA,H,2013-08-04T00:00:00Z,NA,H,18,170,153,2013-03-05,2013-08-04,8262,8262,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1085,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-05,2013-08-18,171,184,NA,54,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-08-05T00:00:00Z,NA,H,2013-08-18T00:00:00Z,NA,H,171,184,14,2013-08-05,2013-08-18,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1085,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-05,2013-08-18,171,184,NA,54,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-08-05T00:00:00Z,NA,H,2013-08-18T00:00:00Z,NA,H,171,184,14,2013-08-05,2013-08-18,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1085,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-05,2013-08-18,171,184,NA,54,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-08-05T00:00:00Z,NA,H,2013-08-18T00:00:00Z,NA,H,171,184,14,2013-08-05,2013-08-18,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1085,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-05,2013-08-18,171,184,NA,54,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-08-05T00:00:00Z,NA,H,2013-08-18T00:00:00Z,NA,H,171,184,14,2013-08-05,2013-08-18,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1085,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-05,2013-08-18,171,184,NA,54,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-08-05T00:00:00Z,NA,H,2013-08-18T00:00:00Z,NA,H,171,184,14,2013-08-05,2013-08-18,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-02-16T00:00:00Z,NA,NA,2013-08-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-16,2013-08-18,NA,NA,TDURD,184,NA,OVERALL,Overall duration (days),7,>=90 days,16,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-02-16T00:00:00Z,NA,NA,2013-08-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-16,2013-08-18,NA,NA,TDOSE,9936,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-02-16T00:00:00Z,NA,NA,2013-08-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-16,2013-08-18,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-02-16T00:00:00Z,NA,NA,2013-08-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-16,2013-08-18,NA,NA,TPDOSE,9936,NA,OVERALL,Total planned dose (mg),11,NA,19,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-02-16T00:00:00Z,NA,NA,2013-08-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-16,2013-08-18,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-02-16T00:00:00Z,NA,NA,2013-08-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-16,2013-08-18,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-02-16T00:00:00Z,NA,NA,2013-08-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-16,2013-08-18,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-03-05T00:00:00Z,NA,NA,2013-08-18T00:00:00Z,NA,NA,NA,NA,NA,2013-03-05,2013-08-18,NA,NA,PDURD,167,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-03-05T00:00:00Z,NA,NA,2013-08-18T00:00:00Z,NA,NA,NA,NA,NA,2013-03-05,2013-08-18,NA,NA,PDOSE,9018,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-03-05T00:00:00Z,NA,NA,2013-08-18T00:00:00Z,NA,NA,NA,NA,NA,2013-03-05,2013-08-18,NA,NA,PPDOSE,9018,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-03-05T00:00:00Z,NA,NA,2013-08-18T00:00:00Z,NA,NA,NA,NA,NA,2013-03-05,2013-08-18,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-03-05T00:00:00Z,NA,NA,2013-08-18T00:00:00Z,NA,NA,NA,NA,NA,2013-03-05,2013-08-18,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-03-05T00:00:00Z,NA,NA,2013-08-18T00:00:00Z,NA,NA,NA,NA,NA,2013-03-05,2013-08-18,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1085,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-16,2013-02-16T00:00:00Z,2013-08-18T23:59:59Z,2013-03-05T00:00:00Z,NA,NA,2013-08-18T00:00:00Z,NA,NA,NA,NA,NA,2013-03-05,2013-08-18,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1085,2013-02-16,2013-08-18,2013-02-16,2013-08-18,NA,2013-08-18T10:22,NA,NA,715,77,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-03,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-18,184,NA,2013-08-18,COMPLETED,NA,2013-02-16,NA,NA,NA,2013-08-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1107,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-26,2013-03-12,1,15,NA,54,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-12T00:00:00Z,NA,H,1,15,15,2013-02-26,2013-03-12,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1107,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-26,2013-03-12,1,15,NA,54,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-12T00:00:00Z,NA,H,1,15,15,2013-02-26,2013-03-12,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1107,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-26,2013-03-12,1,15,NA,54,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-12T00:00:00Z,NA,H,1,15,15,2013-02-26,2013-03-12,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1107,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-26,2013-03-12,1,15,NA,54,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-12T00:00:00Z,NA,H,1,15,15,2013-02-26,2013-03-12,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1107,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-26,2013-03-12,1,15,NA,54,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-02-26T00:00:00Z,NA,H,2013-03-12T00:00:00Z,NA,H,1,15,15,2013-02-26,2013-03-12,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1107,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-13,2013-05-07,16,71,NA,54,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-03-13T00:00:00Z,NA,H,2013-05-07T00:00:00Z,NA,H,16,71,56,2013-03-13,2013-05-07,3024,3024,DURD,56,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1107,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-13,2013-05-07,16,71,NA,54,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-03-13T00:00:00Z,NA,H,2013-05-07T00:00:00Z,NA,H,16,71,56,2013-03-13,2013-05-07,3024,3024,DOSE,3024,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1107,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-13,2013-05-07,16,71,NA,54,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-03-13T00:00:00Z,NA,H,2013-05-07T00:00:00Z,NA,H,16,71,56,2013-03-13,2013-05-07,3024,3024,PLDOSE,3024,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1107,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-13,2013-05-07,16,71,NA,54,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-03-13T00:00:00Z,NA,H,2013-05-07T00:00:00Z,NA,H,16,71,56,2013-03-13,2013-05-07,3024,3024,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1107,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-13,2013-05-07,16,71,NA,54,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-03-13T00:00:00Z,NA,H,2013-05-07T00:00:00Z,NA,H,16,71,56,2013-03-13,2013-05-07,3024,3024,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-05-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-05-07,NA,NA,TDURD,71,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-05-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-05-07,NA,NA,TDOSE,3834,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-05-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-05-07,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-05-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-05-07,NA,NA,TPDOSE,3834,NA,OVERALL,Total planned dose (mg),11,NA,14,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-05-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-05-07,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-05-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-05-07,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-02-26T00:00:00Z,NA,NA,2013-05-07T00:00:00Z,NA,NA,NA,NA,NA,2013-02-26,2013-05-07,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-03-13T00:00:00Z,NA,NA,2013-05-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-13,2013-05-07,NA,NA,PDURD,56,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-03-13T00:00:00Z,NA,NA,2013-05-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-13,2013-05-07,NA,NA,PDOSE,3024,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-03-13T00:00:00Z,NA,NA,2013-05-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-13,2013-05-07,NA,NA,PPDOSE,3024,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-03-13T00:00:00Z,NA,NA,2013-05-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-13,2013-05-07,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-03-13T00:00:00Z,NA,NA,2013-05-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-13,2013-05-07,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-03-13T00:00:00Z,NA,NA,2013-05-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-13,2013-05-07,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1107,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-26,2013-02-26T00:00:00Z,2013-05-07T23:59:59Z,2013-03-13T00:00:00Z,NA,NA,2013-05-07T00:00:00Z,NA,NA,NA,NA,NA,2013-03-13,2013-05-07,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1107,2013-02-26,2013-05-13,2013-02-26,2013-05-07,NA,2013-08-14T09:52,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-02-12,-14,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-07,71,NA,2013-05-13,DISCONTINUED,2013-08-14,2013-02-26,NA,NA,NA,2013-08-14,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1155,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-13,2013-12-27,1,15,NA,0,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-13T00:00:00Z,NA,H,2013-12-27T00:00:00Z,NA,H,1,15,15,2013-12-13,2013-12-27,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1155,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-13,2013-12-27,1,15,NA,0,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-13T00:00:00Z,NA,H,2013-12-27T00:00:00Z,NA,H,1,15,15,2013-12-13,2013-12-27,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1155,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-13,2013-12-27,1,15,NA,0,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-13T00:00:00Z,NA,H,2013-12-27T00:00:00Z,NA,H,1,15,15,2013-12-13,2013-12-27,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1155,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-13,2013-12-27,1,15,NA,0,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-13T00:00:00Z,NA,H,2013-12-27T00:00:00Z,NA,H,1,15,15,2013-12-13,2013-12-27,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1155,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-13,2013-12-27,1,15,NA,0,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-13T00:00:00Z,NA,H,2013-12-27T00:00:00Z,NA,H,1,15,15,2013-12-13,2013-12-27,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1155,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-28,2014-01-25,16,44,NA,0,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-28T00:00:00Z,NA,H,2014-01-25T00:00:00Z,NA,H,16,44,29,2013-12-28,2014-01-25,0,0,DURD,29,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1155,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-28,2014-01-25,16,44,NA,0,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-28T00:00:00Z,NA,H,2014-01-25T00:00:00Z,NA,H,16,44,29,2013-12-28,2014-01-25,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1155,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-28,2014-01-25,16,44,NA,0,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-28T00:00:00Z,NA,H,2014-01-25T00:00:00Z,NA,H,16,44,29,2013-12-28,2014-01-25,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1155,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-28,2014-01-25,16,44,NA,0,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-28T00:00:00Z,NA,H,2014-01-25T00:00:00Z,NA,H,16,44,29,2013-12-28,2014-01-25,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1155,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-12-28,2014-01-25,16,44,NA,0,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-28T00:00:00Z,NA,H,2014-01-25T00:00:00Z,NA,H,16,44,29,2013-12-28,2014-01-25,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-13T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2013-12-13,2014-01-25,NA,NA,TDURD,44,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-13T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2013-12-13,2014-01-25,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-13T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2013-12-13,2014-01-25,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-13T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2013-12-13,2014-01-25,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-13T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2013-12-13,2014-01-25,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-13T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2013-12-13,2014-01-25,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-13T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2013-12-13,2014-01-25,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-01-25,NA,NA,PDURD,29,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-01-25,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-01-25,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-01-25,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-01-25,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-01-25,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1155,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-13,2013-12-13T00:00:00Z,2014-01-25T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-01-25T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-01-25,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1155,2013-12-13,2014-04-26,2013-12-13,2014-01-25,NA,2014-04-26,NA,NA,715,59,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-11-29,-14,Placebo,Placebo,H,H,2014-01-25,44,NA,2014-04-26,DISCONTINUED,NA,2013-12-13,NA,NA,NA,2014-01-25,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1207,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-18,2012-12-02,1,15,NA,0,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-11-18T00:00:00Z,NA,H,2012-12-02T00:00:00Z,NA,H,1,15,15,2012-11-18,2012-12-02,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1207,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-18,2012-12-02,1,15,NA,0,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-11-18T00:00:00Z,NA,H,2012-12-02T00:00:00Z,NA,H,1,15,15,2012-11-18,2012-12-02,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1207,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-18,2012-12-02,1,15,NA,0,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-11-18T00:00:00Z,NA,H,2012-12-02T00:00:00Z,NA,H,1,15,15,2012-11-18,2012-12-02,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1207,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-18,2012-12-02,1,15,NA,0,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-11-18T00:00:00Z,NA,H,2012-12-02T00:00:00Z,NA,H,1,15,15,2012-11-18,2012-12-02,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1207,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-11-18,2012-12-02,1,15,NA,0,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-11-18T00:00:00Z,NA,H,2012-12-02T00:00:00Z,NA,H,1,15,15,2012-11-18,2012-12-02,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1207,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-03,2013-05-05,16,169,NA,0,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-12-03T00:00:00Z,NA,H,2013-05-05T00:00:00Z,NA,H,16,169,154,2012-12-03,2013-05-05,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1207,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-03,2013-05-05,16,169,NA,0,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-12-03T00:00:00Z,NA,H,2013-05-05T00:00:00Z,NA,H,16,169,154,2012-12-03,2013-05-05,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1207,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-03,2013-05-05,16,169,NA,0,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-12-03T00:00:00Z,NA,H,2013-05-05T00:00:00Z,NA,H,16,169,154,2012-12-03,2013-05-05,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1207,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-03,2013-05-05,16,169,NA,0,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-12-03T00:00:00Z,NA,H,2013-05-05T00:00:00Z,NA,H,16,169,154,2012-12-03,2013-05-05,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1207,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-03,2013-05-05,16,169,NA,0,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-12-03T00:00:00Z,NA,H,2013-05-05T00:00:00Z,NA,H,16,169,154,2012-12-03,2013-05-05,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1207,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-06,2013-05-27,170,191,NA,0,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2013-05-06T00:00:00Z,NA,H,2013-05-27T00:00:00Z,NA,H,170,191,22,2013-05-06,2013-05-27,0,0,DURD,22,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1207,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-06,2013-05-27,170,191,NA,0,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2013-05-06T00:00:00Z,NA,H,2013-05-27T00:00:00Z,NA,H,170,191,22,2013-05-06,2013-05-27,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1207,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-06,2013-05-27,170,191,NA,0,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2013-05-06T00:00:00Z,NA,H,2013-05-27T00:00:00Z,NA,H,170,191,22,2013-05-06,2013-05-27,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1207,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-06,2013-05-27,170,191,NA,0,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2013-05-06T00:00:00Z,NA,H,2013-05-27T00:00:00Z,NA,H,170,191,22,2013-05-06,2013-05-27,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1207,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-05-06,2013-05-27,170,191,NA,0,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2013-05-06T00:00:00Z,NA,H,2013-05-27T00:00:00Z,NA,H,170,191,22,2013-05-06,2013-05-27,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-11-18T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-11-18,2013-05-27,NA,NA,TDURD,191,NA,OVERALL,Overall duration (days),7,>=90 days,16,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-11-18T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-11-18,2013-05-27,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-11-18T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-11-18,2013-05-27,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-11-18T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-11-18,2013-05-27,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-11-18T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-11-18,2013-05-27,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-11-18T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-11-18,2013-05-27,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-11-18T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-11-18,2013-05-27,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-12-03T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-03,2013-05-27,NA,NA,PDURD,176,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-12-03T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-03,2013-05-27,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-12-03T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-03,2013-05-27,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-12-03T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-03,2013-05-27,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-12-03T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-03,2013-05-27,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-12-03T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-03,2013-05-27,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1207,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-11-18,2012-11-18T00:00:00Z,2013-05-27T23:59:59Z,2012-12-03T00:00:00Z,NA,NA,2013-05-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-03,2013-05-27,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1207,2012-11-18,2013-06-01,2012-11-18,2013-05-27,NA,2013-06-01T09:30,NA,NA,715,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-11-12,-6,Placebo,Placebo,H,H,2013-05-27,191,NA,2013-06-01,COMPLETED,NA,2012-11-18,NA,NA,NA,2013-06-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1319,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-17,2013-03-03,1,15,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-02-17T00:00:00Z,NA,H,2013-03-03T00:00:00Z,NA,H,1,15,15,2013-02-17,2013-03-03,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1319,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-17,2013-03-03,1,15,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-02-17T00:00:00Z,NA,H,2013-03-03T00:00:00Z,NA,H,1,15,15,2013-02-17,2013-03-03,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1319,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-17,2013-03-03,1,15,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-02-17T00:00:00Z,NA,H,2013-03-03T00:00:00Z,NA,H,1,15,15,2013-02-17,2013-03-03,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1319,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-17,2013-03-03,1,15,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-02-17T00:00:00Z,NA,H,2013-03-03T00:00:00Z,NA,H,1,15,15,2013-02-17,2013-03-03,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1319,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-17,2013-03-03,1,15,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-02-17T00:00:00Z,NA,H,2013-03-03T00:00:00Z,NA,H,1,15,15,2013-02-17,2013-03-03,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1319,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-04,2013-03-05,16,17,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-03-04T00:00:00Z,NA,H,2013-03-05T00:00:00Z,NA,H,16,17,2,2013-03-04,2013-03-05,162,108,DURD,2,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1319,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-04,2013-03-05,16,17,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-03-04T00:00:00Z,NA,H,2013-03-05T00:00:00Z,NA,H,16,17,2,2013-03-04,2013-03-05,162,108,DOSE,162,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1319,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-04,2013-03-05,16,17,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-03-04T00:00:00Z,NA,H,2013-03-05T00:00:00Z,NA,H,16,17,2,2013-03-04,2013-03-05,162,108,PLDOSE,108,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1319,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-04,2013-03-05,16,17,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-03-04T00:00:00Z,NA,H,2013-03-05T00:00:00Z,NA,H,16,17,2,2013-03-04,2013-03-05,162,108,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1319,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-04,2013-03-05,16,17,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-03-04T00:00:00Z,NA,H,2013-03-05T00:00:00Z,NA,H,16,17,2,2013-03-04,2013-03-05,162,108,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-02-17T00:00:00Z,NA,NA,2013-03-05T00:00:00Z,NA,NA,NA,NA,NA,2013-02-17,2013-03-05,NA,NA,TDURD,17,NA,OVERALL,Overall duration (days),7,< 30 days,11,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-02-17T00:00:00Z,NA,NA,2013-03-05T00:00:00Z,NA,NA,NA,NA,NA,2013-02-17,2013-03-05,NA,NA,TDOSE,972,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-02-17T00:00:00Z,NA,NA,2013-03-05T00:00:00Z,NA,NA,NA,NA,NA,2013-02-17,2013-03-05,NA,NA,AVDDSE,57.1764705882353,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-02-17T00:00:00Z,NA,NA,2013-03-05T00:00:00Z,NA,NA,NA,NA,NA,2013-02-17,2013-03-05,NA,NA,TPDOSE,918,NA,OVERALL,Total planned dose (mg),11,NA,14,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-02-17T00:00:00Z,NA,NA,2013-03-05T00:00:00Z,NA,NA,NA,NA,NA,2013-02-17,2013-03-05,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-02-17T00:00:00Z,NA,NA,2013-03-05T00:00:00Z,NA,NA,NA,NA,NA,2013-02-17,2013-03-05,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-02-17T00:00:00Z,NA,NA,2013-03-05T00:00:00Z,NA,NA,NA,NA,NA,2013-02-17,2013-03-05,NA,NA,TDOSINT,105.88235294117648,NA,OVERALL,Overall dose intensity (%),90,NA,17,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-03-05T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-03-05,NA,NA,PDURD,2,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-03-05T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-03-05,NA,NA,PDOSE,162,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-03-05T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-03-05,NA,NA,PPDOSE,108,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-03-05T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-03-05,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-03-05T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-03-05,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-03-05T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-03-05,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1319,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-03-05T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-03-05T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-03-05,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1319,2013-02-17,2013-03-18,2013-02-17,2013-03-05,NA,2013-03-18T10:28,NA,NA,715,65,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-03,-14,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-05,17,NA,2013-03-18,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-03-18,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1321,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-11,2014-02-26,1,16,NA,54,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-11T00:00:00Z,NA,H,2014-02-26T00:00:00Z,NA,H,1,16,16,2014-02-11,2014-02-26,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1321,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-11,2014-02-26,1,16,NA,54,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-11T00:00:00Z,NA,H,2014-02-26T00:00:00Z,NA,H,1,16,16,2014-02-11,2014-02-26,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1321,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-11,2014-02-26,1,16,NA,54,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-11T00:00:00Z,NA,H,2014-02-26T00:00:00Z,NA,H,1,16,16,2014-02-11,2014-02-26,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1321,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-11,2014-02-26,1,16,NA,54,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-11T00:00:00Z,NA,H,2014-02-26T00:00:00Z,NA,H,1,16,16,2014-02-11,2014-02-26,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1321,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-02-11,2014-02-26,1,16,NA,54,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-11T00:00:00Z,NA,H,2014-02-26T00:00:00Z,NA,H,1,16,16,2014-02-11,2014-02-26,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1321,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-27,2014-04-21,17,70,NA,54,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-27T00:00:00Z,NA,H,2014-04-21T00:00:00Z,NA,H,17,70,54,2014-02-27,2014-04-21,4374,2916,DURD,54,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1321,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-27,2014-04-21,17,70,NA,54,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-27T00:00:00Z,NA,H,2014-04-21T00:00:00Z,NA,H,17,70,54,2014-02-27,2014-04-21,4374,2916,DOSE,4374,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1321,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-27,2014-04-21,17,70,NA,54,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-27T00:00:00Z,NA,H,2014-04-21T00:00:00Z,NA,H,17,70,54,2014-02-27,2014-04-21,4374,2916,PLDOSE,2916,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1321,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-27,2014-04-21,17,70,NA,54,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-27T00:00:00Z,NA,H,2014-04-21T00:00:00Z,NA,H,17,70,54,2014-02-27,2014-04-21,4374,2916,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1321,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-27,2014-04-21,17,70,NA,54,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-27T00:00:00Z,NA,H,2014-04-21T00:00:00Z,NA,H,17,70,54,2014-02-27,2014-04-21,4374,2916,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-04-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-04-21,NA,NA,TDURD,70,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-04-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-04-21,NA,NA,TDOSE,5238,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-04-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-04-21,NA,NA,AVDDSE,74.82857142857142,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-04-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-04-21,NA,NA,TPDOSE,3780,NA,OVERALL,Total planned dose (mg),11,NA,14,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-04-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-04-21,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-04-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-04-21,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-04-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-04-21,NA,NA,TDOSINT,138.57142857142856,NA,OVERALL,Overall dose intensity (%),90,NA,17,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-27T00:00:00Z,NA,NA,2014-04-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-27,2014-04-21,NA,NA,PDURD,54,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-27T00:00:00Z,NA,NA,2014-04-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-27,2014-04-21,NA,NA,PDOSE,4374,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-27T00:00:00Z,NA,NA,2014-04-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-27,2014-04-21,NA,NA,PPDOSE,2916,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-27T00:00:00Z,NA,NA,2014-04-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-27,2014-04-21,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-27T00:00:00Z,NA,NA,2014-04-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-27,2014-04-21,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-27T00:00:00Z,NA,NA,2014-04-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-27,2014-04-21,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1321,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-02-11,2014-02-11T00:00:00Z,2014-04-21T23:59:59Z,2014-02-27T00:00:00Z,NA,NA,2014-04-21T00:00:00Z,NA,NA,NA,NA,NA,2014-02-27,2014-04-21,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1321,2014-02-11,2014-04-22,2014-02-11,2014-04-21,NA,2014-04-22T11:12,NA,NA,715,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-02-06,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-04-21,70,NA,2014-04-22,DISCONTINUED,NA,2014-02-11,NA,NA,NA,2014-04-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1397,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-03,2013-04-18,1,16,NA,0,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,1,16,16,2013-04-03,2013-04-18,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1397,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-03,2013-04-18,1,16,NA,0,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,1,16,16,2013-04-03,2013-04-18,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1397,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-03,2013-04-18,1,16,NA,0,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,1,16,16,2013-04-03,2013-04-18,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1397,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-03,2013-04-18,1,16,NA,0,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,1,16,16,2013-04-03,2013-04-18,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1397,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-03,2013-04-18,1,16,NA,0,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-03T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,1,16,16,2013-04-03,2013-04-18,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1397,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-19,2013-09-18,17,169,NA,0,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,H,2013-09-18T00:00:00Z,NA,H,17,169,153,2013-04-19,2013-09-18,0,0,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1397,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-19,2013-09-18,17,169,NA,0,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,H,2013-09-18T00:00:00Z,NA,H,17,169,153,2013-04-19,2013-09-18,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1397,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-19,2013-09-18,17,169,NA,0,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,H,2013-09-18T00:00:00Z,NA,H,17,169,153,2013-04-19,2013-09-18,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1397,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-19,2013-09-18,17,169,NA,0,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,H,2013-09-18T00:00:00Z,NA,H,17,169,153,2013-04-19,2013-09-18,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1397,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-19,2013-09-18,17,169,NA,0,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,H,2013-09-18T00:00:00Z,NA,H,17,169,153,2013-04-19,2013-09-18,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1397,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-19,2013-10-02,170,183,NA,0,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-09-19T00:00:00Z,NA,H,2013-10-02T00:00:00Z,NA,H,170,183,14,2013-09-19,2013-10-02,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1397,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-19,2013-10-02,170,183,NA,0,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-09-19T00:00:00Z,NA,H,2013-10-02T00:00:00Z,NA,H,170,183,14,2013-09-19,2013-10-02,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1397,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-19,2013-10-02,170,183,NA,0,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-09-19T00:00:00Z,NA,H,2013-10-02T00:00:00Z,NA,H,170,183,14,2013-09-19,2013-10-02,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1397,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-19,2013-10-02,170,183,NA,0,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-09-19T00:00:00Z,NA,H,2013-10-02T00:00:00Z,NA,H,170,183,14,2013-09-19,2013-10-02,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1397,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-19,2013-10-02,170,183,NA,0,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-09-19T00:00:00Z,NA,H,2013-10-02T00:00:00Z,NA,H,170,183,14,2013-09-19,2013-10-02,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-10-02,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-10-02,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-10-02,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-10-02,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-10-02,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-10-02,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-03T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-03,2013-10-02,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-19,2013-10-02,NA,NA,PDURD,167,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-19,2013-10-02,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-19,2013-10-02,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-19,2013-10-02,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-19,2013-10-02,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-19,2013-10-02,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1397,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-03,2013-04-03T00:00:00Z,2013-10-02T23:59:59Z,2013-04-19T00:00:00Z,NA,NA,2013-10-02T00:00:00Z,NA,NA,NA,NA,NA,2013-04-19,2013-10-02,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1397,2013-04-03,2013-10-03,2013-04-03,2013-10-02,NA,2013-10-03T10:50,NA,NA,715,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-20,-14,Placebo,Placebo,H,H,2013-10-02,183,NA,2013-10-03,COMPLETED,NA,2013-04-03,NA,NA,NA,2013-10-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1405,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-06,2013-07-07,1,2,NA,54,2013-07-06,2013-07-06T00:00:00Z,2013-07-07T23:59:59Z,2013-07-06T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,1,2,2,2013-07-06,2013-07-07,108,108,DURD,2,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,2,NA,2013-07-13,DISCONTINUED,2014-01-11,2013-07-06,NA,NA,NA,2013-07-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1405,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-06,2013-07-07,1,2,NA,54,2013-07-06,2013-07-06T00:00:00Z,2013-07-07T23:59:59Z,2013-07-06T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,1,2,2,2013-07-06,2013-07-07,108,108,DOSE,108,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,2,NA,2013-07-13,DISCONTINUED,2014-01-11,2013-07-06,NA,NA,NA,2013-07-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1405,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-06,2013-07-07,1,2,NA,54,2013-07-06,2013-07-06T00:00:00Z,2013-07-07T23:59:59Z,2013-07-06T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,1,2,2,2013-07-06,2013-07-07,108,108,PLDOSE,108,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,2,NA,2013-07-13,DISCONTINUED,2014-01-11,2013-07-06,NA,NA,NA,2013-07-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1405,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-06,2013-07-07,1,2,NA,54,2013-07-06,2013-07-06T00:00:00Z,2013-07-07T23:59:59Z,2013-07-06T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,1,2,2,2013-07-06,2013-07-07,108,108,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,2,NA,2013-07-13,DISCONTINUED,2014-01-11,2013-07-06,NA,NA,NA,2013-07-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-715-1405,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-06,2013-07-07,1,2,NA,54,2013-07-06,2013-07-06T00:00:00Z,2013-07-07T23:59:59Z,2013-07-06T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,1,2,2,2013-07-06,2013-07-07,108,108,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,2,NA,2013-07-13,DISCONTINUED,2014-01-11,2013-07-06,NA,NA,NA,2013-07-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-06,2013-07-06T00:00:00Z,2013-07-07T23:59:59Z,2013-07-06T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-07-06,2013-07-07,NA,NA,TDURD,2,NA,OVERALL,Overall duration (days),7,< 30 days,6,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,2,NA,2013-07-13,DISCONTINUED,2014-01-11,2013-07-06,NA,NA,NA,2013-07-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-06,2013-07-06T00:00:00Z,2013-07-07T23:59:59Z,2013-07-06T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-07-06,2013-07-07,NA,NA,TDOSE,108,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,2,NA,2013-07-13,DISCONTINUED,2014-01-11,2013-07-06,NA,NA,NA,2013-07-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-06,2013-07-06T00:00:00Z,2013-07-07T23:59:59Z,2013-07-06T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-07-06,2013-07-07,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,2,NA,2013-07-13,DISCONTINUED,2014-01-11,2013-07-06,NA,NA,NA,2013-07-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-06,2013-07-06T00:00:00Z,2013-07-07T23:59:59Z,2013-07-06T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-07-06,2013-07-07,NA,NA,TPDOSE,108,NA,OVERALL,Total planned dose (mg),11,NA,9,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,2,NA,2013-07-13,DISCONTINUED,2014-01-11,2013-07-06,NA,NA,NA,2013-07-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-06,2013-07-06T00:00:00Z,2013-07-07T23:59:59Z,2013-07-06T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-07-06,2013-07-07,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,2,NA,2013-07-13,DISCONTINUED,2014-01-11,2013-07-06,NA,NA,NA,2013-07-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-06,2013-07-06T00:00:00Z,2013-07-07T23:59:59Z,2013-07-06T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-07-06,2013-07-07,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,2,NA,2013-07-13,DISCONTINUED,2014-01-11,2013-07-06,NA,NA,NA,2013-07-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-715-1405,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-06,2013-07-06T00:00:00Z,2013-07-07T23:59:59Z,2013-07-06T00:00:00Z,NA,NA,2013-07-07T00:00:00Z,NA,NA,NA,NA,NA,2013-07-06,2013-07-07,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1405,2013-07-06,2013-07-13,2013-07-06,2013-07-07,NA,2014-01-11,NA,NA,715,69,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-27,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-07,2,NA,2013-07-13,DISCONTINUED,2014-01-11,2013-07-06,NA,NA,NA,2013-07-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1024,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-09,2012-07-23,1,15,NA,0,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-09T00:00:00Z,NA,H,2012-07-23T00:00:00Z,NA,H,1,15,15,2012-07-09,2012-07-23,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1024,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-09,2012-07-23,1,15,NA,0,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-09T00:00:00Z,NA,H,2012-07-23T00:00:00Z,NA,H,1,15,15,2012-07-09,2012-07-23,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1024,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-09,2012-07-23,1,15,NA,0,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-09T00:00:00Z,NA,H,2012-07-23T00:00:00Z,NA,H,1,15,15,2012-07-09,2012-07-23,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1024,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-09,2012-07-23,1,15,NA,0,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-09T00:00:00Z,NA,H,2012-07-23T00:00:00Z,NA,H,1,15,15,2012-07-09,2012-07-23,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1024,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-07-09,2012-07-23,1,15,NA,0,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-09T00:00:00Z,NA,H,2012-07-23T00:00:00Z,NA,H,1,15,15,2012-07-09,2012-07-23,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1024,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-07-24,2012-12-30,16,175,NA,0,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-24T00:00:00Z,NA,H,2012-12-30T00:00:00Z,NA,H,16,175,160,2012-07-24,2012-12-30,0,0,DURD,160,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1024,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-07-24,2012-12-30,16,175,NA,0,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-24T00:00:00Z,NA,H,2012-12-30T00:00:00Z,NA,H,16,175,160,2012-07-24,2012-12-30,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1024,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-07-24,2012-12-30,16,175,NA,0,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-24T00:00:00Z,NA,H,2012-12-30T00:00:00Z,NA,H,16,175,160,2012-07-24,2012-12-30,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1024,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-07-24,2012-12-30,16,175,NA,0,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-24T00:00:00Z,NA,H,2012-12-30T00:00:00Z,NA,H,16,175,160,2012-07-24,2012-12-30,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1024,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-07-24,2012-12-30,16,175,NA,0,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-24T00:00:00Z,NA,H,2012-12-30T00:00:00Z,NA,H,16,175,160,2012-07-24,2012-12-30,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1024,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2012-12-31,2013-01-20,176,196,NA,0,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-12-31T00:00:00Z,NA,H,2013-01-20T00:00:00Z,NA,H,176,196,21,2012-12-31,2013-01-20,0,0,DURD,21,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1024,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2012-12-31,2013-01-20,176,196,NA,0,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-12-31T00:00:00Z,NA,H,2013-01-20T00:00:00Z,NA,H,176,196,21,2012-12-31,2013-01-20,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1024,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2012-12-31,2013-01-20,176,196,NA,0,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-12-31T00:00:00Z,NA,H,2013-01-20T00:00:00Z,NA,H,176,196,21,2012-12-31,2013-01-20,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1024,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2012-12-31,2013-01-20,176,196,NA,0,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-12-31T00:00:00Z,NA,H,2013-01-20T00:00:00Z,NA,H,176,196,21,2012-12-31,2013-01-20,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1024,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2012-12-31,2013-01-20,176,196,NA,0,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-12-31T00:00:00Z,NA,H,2013-01-20T00:00:00Z,NA,H,176,196,21,2012-12-31,2013-01-20,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-09T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-09,2013-01-20,NA,NA,TDURD,196,NA,OVERALL,Overall duration (days),7,>=90 days,16,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-09T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-09,2013-01-20,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-09T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-09,2013-01-20,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-09T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-09,2013-01-20,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-09T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-09,2013-01-20,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-09T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-09,2013-01-20,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-09T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-09,2013-01-20,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-24T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-24,2013-01-20,NA,NA,PDURD,181,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-24T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-24,2013-01-20,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-24T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-24,2013-01-20,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-24T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-24,2013-01-20,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-24T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-24,2013-01-20,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-24T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-24,2013-01-20,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1024,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-07-09,2012-07-09T00:00:00Z,2013-01-20T23:59:59Z,2012-07-24T00:00:00Z,NA,NA,2013-01-20T00:00:00Z,NA,NA,NA,NA,NA,2012-07-24,2013-01-20,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1024,2012-07-09,2013-01-20,2012-07-09,2013-01-20,NA,2013-01-20T11:10,NA,NA,716,87,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2012-07-06,-3,Placebo,Placebo,H,H,2013-01-20,196,NA,2013-01-20,COMPLETED,NA,2012-07-09,NA,NA,NA,2013-01-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1026,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-02,2014-04-18,1,17,NA,0,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-02T00:00:00Z,NA,H,2014-04-18T00:00:00Z,NA,H,1,17,17,2014-04-02,2014-04-18,0,0,DURD,17,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1026,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-02,2014-04-18,1,17,NA,0,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-02T00:00:00Z,NA,H,2014-04-18T00:00:00Z,NA,H,1,17,17,2014-04-02,2014-04-18,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1026,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-02,2014-04-18,1,17,NA,0,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-02T00:00:00Z,NA,H,2014-04-18T00:00:00Z,NA,H,1,17,17,2014-04-02,2014-04-18,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1026,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-02,2014-04-18,1,17,NA,0,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-02T00:00:00Z,NA,H,2014-04-18T00:00:00Z,NA,H,1,17,17,2014-04-02,2014-04-18,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1026,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-04-02,2014-04-18,1,17,NA,0,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-02T00:00:00Z,NA,H,2014-04-18T00:00:00Z,NA,H,1,17,17,2014-04-02,2014-04-18,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1026,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-19,2014-09-27,18,179,NA,0,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-19T00:00:00Z,NA,H,2014-09-27T00:00:00Z,NA,H,18,179,162,2014-04-19,2014-09-27,0,0,DURD,162,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1026,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-19,2014-09-27,18,179,NA,0,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-19T00:00:00Z,NA,H,2014-09-27T00:00:00Z,NA,H,18,179,162,2014-04-19,2014-09-27,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1026,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-19,2014-09-27,18,179,NA,0,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-19T00:00:00Z,NA,H,2014-09-27T00:00:00Z,NA,H,18,179,162,2014-04-19,2014-09-27,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1026,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-19,2014-09-27,18,179,NA,0,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-19T00:00:00Z,NA,H,2014-09-27T00:00:00Z,NA,H,18,179,162,2014-04-19,2014-09-27,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1026,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-19,2014-09-27,18,179,NA,0,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-19T00:00:00Z,NA,H,2014-09-27T00:00:00Z,NA,H,18,179,162,2014-04-19,2014-09-27,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1026,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-09-28,2014-10-16,180,198,NA,0,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-09-28T00:00:00Z,NA,H,2014-10-16T00:00:00Z,NA,H,180,198,19,2014-09-28,2014-10-16,0,0,DURD,19,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1026,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-09-28,2014-10-16,180,198,NA,0,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-09-28T00:00:00Z,NA,H,2014-10-16T00:00:00Z,NA,H,180,198,19,2014-09-28,2014-10-16,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1026,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-09-28,2014-10-16,180,198,NA,0,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-09-28T00:00:00Z,NA,H,2014-10-16T00:00:00Z,NA,H,180,198,19,2014-09-28,2014-10-16,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1026,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-09-28,2014-10-16,180,198,NA,0,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-09-28T00:00:00Z,NA,H,2014-10-16T00:00:00Z,NA,H,180,198,19,2014-09-28,2014-10-16,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1026,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-09-28,2014-10-16,180,198,NA,0,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-09-28T00:00:00Z,NA,H,2014-10-16T00:00:00Z,NA,H,180,198,19,2014-09-28,2014-10-16,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-02T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-02,2014-10-16,NA,NA,TDURD,198,NA,OVERALL,Overall duration (days),7,>=90 days,16,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-02T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-02,2014-10-16,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-02T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-02,2014-10-16,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-02T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-02,2014-10-16,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-02T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-02,2014-10-16,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-02T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-02,2014-10-16,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-02T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-02,2014-10-16,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-19T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-19,2014-10-16,NA,NA,PDURD,181,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-19T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-19,2014-10-16,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-19T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-19,2014-10-16,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-19T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-19,2014-10-16,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-19T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-19,2014-10-16,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-19T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-19,2014-10-16,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1026,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-04-02,2014-04-02T00:00:00Z,2014-10-16T23:59:59Z,2014-04-19T00:00:00Z,NA,NA,2014-10-16T00:00:00Z,NA,NA,NA,NA,NA,2014-04-19,2014-10-16,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1026,2014-04-02,2014-10-16,2014-04-02,2014-10-16,NA,2014-10-16T13:35,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-03-23,-10,Placebo,Placebo,H,H,2014-10-16,198,NA,2014-10-16,COMPLETED,NA,2014-04-02,NA,NA,NA,2014-10-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1030,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-28,2014-01-02,1,6,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-01-02T23:59:59Z,2013-12-28T00:00:00Z,NA,H,2014-01-02T00:00:00Z,NA,H,1,6,6,2013-12-28,2014-01-02,324,324,DURD,6,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1030,2013-12-28,2014-01-10,2013-12-28,2014-01-02,NA,2014-01-10T12:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-25,-3,Xanomeline High Dose,Xanomeline Low Dose,H,H,2014-01-02,6,NA,2014-01-10,DISCONTINUED,NA,2013-12-28,NA,NA,NA,2014-01-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1030,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-28,2014-01-02,1,6,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-01-02T23:59:59Z,2013-12-28T00:00:00Z,NA,H,2014-01-02T00:00:00Z,NA,H,1,6,6,2013-12-28,2014-01-02,324,324,DOSE,324,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1030,2013-12-28,2014-01-10,2013-12-28,2014-01-02,NA,2014-01-10T12:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-25,-3,Xanomeline High Dose,Xanomeline Low Dose,H,H,2014-01-02,6,NA,2014-01-10,DISCONTINUED,NA,2013-12-28,NA,NA,NA,2014-01-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1030,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-28,2014-01-02,1,6,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-01-02T23:59:59Z,2013-12-28T00:00:00Z,NA,H,2014-01-02T00:00:00Z,NA,H,1,6,6,2013-12-28,2014-01-02,324,324,PLDOSE,324,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1030,2013-12-28,2014-01-10,2013-12-28,2014-01-02,NA,2014-01-10T12:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-25,-3,Xanomeline High Dose,Xanomeline Low Dose,H,H,2014-01-02,6,NA,2014-01-10,DISCONTINUED,NA,2013-12-28,NA,NA,NA,2014-01-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1030,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-28,2014-01-02,1,6,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-01-02T23:59:59Z,2013-12-28T00:00:00Z,NA,H,2014-01-02T00:00:00Z,NA,H,1,6,6,2013-12-28,2014-01-02,324,324,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1030,2013-12-28,2014-01-10,2013-12-28,2014-01-02,NA,2014-01-10T12:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-25,-3,Xanomeline High Dose,Xanomeline Low Dose,H,H,2014-01-02,6,NA,2014-01-10,DISCONTINUED,NA,2013-12-28,NA,NA,NA,2014-01-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1030,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-28,2014-01-02,1,6,NA,54,2013-12-28,2013-12-28T00:00:00Z,2014-01-02T23:59:59Z,2013-12-28T00:00:00Z,NA,H,2014-01-02T00:00:00Z,NA,H,1,6,6,2013-12-28,2014-01-02,324,324,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1030,2013-12-28,2014-01-10,2013-12-28,2014-01-02,NA,2014-01-10T12:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-25,-3,Xanomeline High Dose,Xanomeline Low Dose,H,H,2014-01-02,6,NA,2014-01-10,DISCONTINUED,NA,2013-12-28,NA,NA,NA,2014-01-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1030,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-01-02T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-01-02T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-01-02,NA,NA,TDURD,6,NA,OVERALL,Overall duration (days),7,< 30 days,6,1030,2013-12-28,2014-01-10,2013-12-28,2014-01-02,NA,2014-01-10T12:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-25,-3,Xanomeline High Dose,Xanomeline Low Dose,H,H,2014-01-02,6,NA,2014-01-10,DISCONTINUED,NA,2013-12-28,NA,NA,NA,2014-01-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1030,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-01-02T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-01-02T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-01-02,NA,NA,TDOSE,324,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1030,2013-12-28,2014-01-10,2013-12-28,2014-01-02,NA,2014-01-10T12:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-25,-3,Xanomeline High Dose,Xanomeline Low Dose,H,H,2014-01-02,6,NA,2014-01-10,DISCONTINUED,NA,2013-12-28,NA,NA,NA,2014-01-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1030,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-01-02T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-01-02T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-01-02,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1030,2013-12-28,2014-01-10,2013-12-28,2014-01-02,NA,2014-01-10T12:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-25,-3,Xanomeline High Dose,Xanomeline Low Dose,H,H,2014-01-02,6,NA,2014-01-10,DISCONTINUED,NA,2013-12-28,NA,NA,NA,2014-01-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1030,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-01-02T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-01-02T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-01-02,NA,NA,TPDOSE,324,NA,OVERALL,Total planned dose (mg),11,NA,9,1030,2013-12-28,2014-01-10,2013-12-28,2014-01-02,NA,2014-01-10T12:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-25,-3,Xanomeline High Dose,Xanomeline Low Dose,H,H,2014-01-02,6,NA,2014-01-10,DISCONTINUED,NA,2013-12-28,NA,NA,NA,2014-01-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1030,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-01-02T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-01-02T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-01-02,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1030,2013-12-28,2014-01-10,2013-12-28,2014-01-02,NA,2014-01-10T12:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-25,-3,Xanomeline High Dose,Xanomeline Low Dose,H,H,2014-01-02,6,NA,2014-01-10,DISCONTINUED,NA,2013-12-28,NA,NA,NA,2014-01-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1030,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-01-02T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-01-02T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-01-02,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1030,2013-12-28,2014-01-10,2013-12-28,2014-01-02,NA,2014-01-10T12:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-25,-3,Xanomeline High Dose,Xanomeline Low Dose,H,H,2014-01-02,6,NA,2014-01-10,DISCONTINUED,NA,2013-12-28,NA,NA,NA,2014-01-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1030,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-28,2013-12-28T00:00:00Z,2014-01-02T23:59:59Z,2013-12-28T00:00:00Z,NA,NA,2014-01-02T00:00:00Z,NA,NA,NA,NA,NA,2013-12-28,2014-01-02,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1030,2013-12-28,2014-01-10,2013-12-28,2014-01-02,NA,2014-01-10T12:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-12-25,-3,Xanomeline High Dose,Xanomeline Low Dose,H,H,2014-01-02,6,NA,2014-01-10,DISCONTINUED,NA,2013-12-28,NA,NA,NA,2014-01-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1044,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-27,2013-05-10,1,14,NA,0,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-04-27T00:00:00Z,NA,H,2013-05-10T00:00:00Z,NA,H,1,14,14,2013-04-27,2013-05-10,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1044,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-27,2013-05-10,1,14,NA,0,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-04-27T00:00:00Z,NA,H,2013-05-10T00:00:00Z,NA,H,1,14,14,2013-04-27,2013-05-10,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1044,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-27,2013-05-10,1,14,NA,0,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-04-27T00:00:00Z,NA,H,2013-05-10T00:00:00Z,NA,H,1,14,14,2013-04-27,2013-05-10,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1044,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-27,2013-05-10,1,14,NA,0,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-04-27T00:00:00Z,NA,H,2013-05-10T00:00:00Z,NA,H,1,14,14,2013-04-27,2013-05-10,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1044,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-27,2013-05-10,1,14,NA,0,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-04-27T00:00:00Z,NA,H,2013-05-10T00:00:00Z,NA,H,1,14,14,2013-04-27,2013-05-10,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1044,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-11,2013-10-16,15,173,NA,0,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-05-11T00:00:00Z,NA,H,2013-10-16T00:00:00Z,NA,H,15,173,159,2013-05-11,2013-10-16,0,0,DURD,159,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1044,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-11,2013-10-16,15,173,NA,0,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-05-11T00:00:00Z,NA,H,2013-10-16T00:00:00Z,NA,H,15,173,159,2013-05-11,2013-10-16,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1044,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-11,2013-10-16,15,173,NA,0,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-05-11T00:00:00Z,NA,H,2013-10-16T00:00:00Z,NA,H,15,173,159,2013-05-11,2013-10-16,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1044,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-11,2013-10-16,15,173,NA,0,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-05-11T00:00:00Z,NA,H,2013-10-16T00:00:00Z,NA,H,15,173,159,2013-05-11,2013-10-16,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1044,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-11,2013-10-16,15,173,NA,0,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-05-11T00:00:00Z,NA,H,2013-10-16T00:00:00Z,NA,H,15,173,159,2013-05-11,2013-10-16,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1044,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-17,2013-11-03,174,191,NA,0,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2013-11-03T00:00:00Z,NA,H,174,191,18,2013-10-17,2013-11-03,0,0,DURD,18,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1044,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-17,2013-11-03,174,191,NA,0,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2013-11-03T00:00:00Z,NA,H,174,191,18,2013-10-17,2013-11-03,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1044,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-17,2013-11-03,174,191,NA,0,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2013-11-03T00:00:00Z,NA,H,174,191,18,2013-10-17,2013-11-03,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1044,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-17,2013-11-03,174,191,NA,0,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2013-11-03T00:00:00Z,NA,H,174,191,18,2013-10-17,2013-11-03,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1044,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-10-17,2013-11-03,174,191,NA,0,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2013-11-03T00:00:00Z,NA,H,174,191,18,2013-10-17,2013-11-03,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-04-27T00:00:00Z,NA,NA,2013-11-03T00:00:00Z,NA,NA,NA,NA,NA,2013-04-27,2013-11-03,NA,NA,TDURD,191,NA,OVERALL,Overall duration (days),7,>=90 days,16,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-04-27T00:00:00Z,NA,NA,2013-11-03T00:00:00Z,NA,NA,NA,NA,NA,2013-04-27,2013-11-03,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-04-27T00:00:00Z,NA,NA,2013-11-03T00:00:00Z,NA,NA,NA,NA,NA,2013-04-27,2013-11-03,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-04-27T00:00:00Z,NA,NA,2013-11-03T00:00:00Z,NA,NA,NA,NA,NA,2013-04-27,2013-11-03,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-04-27T00:00:00Z,NA,NA,2013-11-03T00:00:00Z,NA,NA,NA,NA,NA,2013-04-27,2013-11-03,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-04-27T00:00:00Z,NA,NA,2013-11-03T00:00:00Z,NA,NA,NA,NA,NA,2013-04-27,2013-11-03,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-04-27T00:00:00Z,NA,NA,2013-11-03T00:00:00Z,NA,NA,NA,NA,NA,2013-04-27,2013-11-03,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-05-11T00:00:00Z,NA,NA,2013-11-03T00:00:00Z,NA,NA,NA,NA,NA,2013-05-11,2013-11-03,NA,NA,PDURD,177,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-05-11T00:00:00Z,NA,NA,2013-11-03T00:00:00Z,NA,NA,NA,NA,NA,2013-05-11,2013-11-03,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-05-11T00:00:00Z,NA,NA,2013-11-03T00:00:00Z,NA,NA,NA,NA,NA,2013-05-11,2013-11-03,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-05-11T00:00:00Z,NA,NA,2013-11-03T00:00:00Z,NA,NA,NA,NA,NA,2013-05-11,2013-11-03,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-05-11T00:00:00Z,NA,NA,2013-11-03T00:00:00Z,NA,NA,NA,NA,NA,2013-05-11,2013-11-03,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-05-11T00:00:00Z,NA,NA,2013-11-03T00:00:00Z,NA,NA,NA,NA,NA,2013-05-11,2013-11-03,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1044,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-27,2013-04-27T00:00:00Z,2013-11-03T23:59:59Z,2013-05-11T00:00:00Z,NA,NA,2013-11-03T00:00:00Z,NA,NA,NA,NA,NA,2013-05-11,2013-11-03,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1044,2013-04-27,2013-11-03,2013-04-27,2013-11-03,NA,2013-11-03T13:10,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-04-20,-7,Placebo,Placebo,H,H,2013-11-03,191,NA,2013-11-03,COMPLETED,NA,2013-04-27,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1063,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-09,2013-05-23,1,15,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-09T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,1,15,15,2013-05-09,2013-05-23,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1063,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-09,2013-05-23,1,15,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-09T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,1,15,15,2013-05-09,2013-05-23,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1063,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-09,2013-05-23,1,15,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-09T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,1,15,15,2013-05-09,2013-05-23,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1063,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-09,2013-05-23,1,15,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-09T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,1,15,15,2013-05-09,2013-05-23,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1063,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-09,2013-05-23,1,15,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-09T00:00:00Z,NA,H,2013-05-23T00:00:00Z,NA,H,1,15,15,2013-05-09,2013-05-23,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1063,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-24,2013-08-25,16,109,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-24T00:00:00Z,NA,H,2013-08-25T00:00:00Z,NA,H,16,109,94,2013-05-24,2013-08-25,5076,5076,DURD,94,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1063,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-24,2013-08-25,16,109,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-24T00:00:00Z,NA,H,2013-08-25T00:00:00Z,NA,H,16,109,94,2013-05-24,2013-08-25,5076,5076,DOSE,5076,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1063,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-24,2013-08-25,16,109,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-24T00:00:00Z,NA,H,2013-08-25T00:00:00Z,NA,H,16,109,94,2013-05-24,2013-08-25,5076,5076,PLDOSE,5076,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1063,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-24,2013-08-25,16,109,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-24T00:00:00Z,NA,H,2013-08-25T00:00:00Z,NA,H,16,109,94,2013-05-24,2013-08-25,5076,5076,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1063,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-24,2013-08-25,16,109,NA,54,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-24T00:00:00Z,NA,H,2013-08-25T00:00:00Z,NA,H,16,109,94,2013-05-24,2013-08-25,5076,5076,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1063,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-08-25,NA,NA,TDURD,109,NA,OVERALL,Overall duration (days),7,>=90 days,11,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1063,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-08-25,NA,NA,TDOSE,5886,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1063,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-08-25,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1063,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-08-25,NA,NA,TPDOSE,5886,NA,OVERALL,Total planned dose (mg),11,NA,14,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1063,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-08-25,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1063,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-08-25,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1063,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-08-25,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1063,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-24T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-05-24,2013-08-25,NA,NA,PDURD,94,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1063,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-24T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-05-24,2013-08-25,NA,NA,PDOSE,5076,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1063,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-24T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-05-24,2013-08-25,NA,NA,PPDOSE,5076,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1063,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-24T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-05-24,2013-08-25,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1063,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-24T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-05-24,2013-08-25,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1063,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-24T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-05-24,2013-08-25,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1063,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-09,2013-05-09T00:00:00Z,2013-08-25T23:59:59Z,2013-05-24T00:00:00Z,NA,NA,2013-08-25T00:00:00Z,NA,NA,NA,NA,NA,2013-05-24,2013-08-25,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1063,2013-05-09,2013-08-28,2013-05-09,2013-08-25,NA,2013-11-17,NA,NA,716,80,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-05-06,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-08-25,109,NA,2013-08-28,DISCONTINUED,2013-11-17,2013-05-09,NA,NA,NA,2013-08-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1071,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-08,2013-06-22,1,15,NA,54,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-08T00:00:00Z,NA,H,2013-06-22T00:00:00Z,NA,H,1,15,15,2013-06-08,2013-06-22,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1071,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-08,2013-06-22,1,15,NA,54,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-08T00:00:00Z,NA,H,2013-06-22T00:00:00Z,NA,H,1,15,15,2013-06-08,2013-06-22,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1071,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-08,2013-06-22,1,15,NA,54,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-08T00:00:00Z,NA,H,2013-06-22T00:00:00Z,NA,H,1,15,15,2013-06-08,2013-06-22,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1071,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-08,2013-06-22,1,15,NA,54,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-08T00:00:00Z,NA,H,2013-06-22T00:00:00Z,NA,H,1,15,15,2013-06-08,2013-06-22,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1071,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-06-08,2013-06-22,1,15,NA,54,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-08T00:00:00Z,NA,H,2013-06-22T00:00:00Z,NA,H,1,15,15,2013-06-08,2013-06-22,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1071,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-23,2013-08-01,16,55,NA,54,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-23T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,16,55,40,2013-06-23,2013-08-01,3240,2160,DURD,40,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1071,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-23,2013-08-01,16,55,NA,54,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-23T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,16,55,40,2013-06-23,2013-08-01,3240,2160,DOSE,3240,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1071,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-23,2013-08-01,16,55,NA,54,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-23T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,16,55,40,2013-06-23,2013-08-01,3240,2160,PLDOSE,2160,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1071,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-23,2013-08-01,16,55,NA,54,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-23T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,16,55,40,2013-06-23,2013-08-01,3240,2160,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1071,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-23,2013-08-01,16,55,NA,54,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-23T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,16,55,40,2013-06-23,2013-08-01,3240,2160,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1071,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-08T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-08,2013-08-01,NA,NA,TDURD,55,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1071,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-08T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-08,2013-08-01,NA,NA,TDOSE,4050,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1071,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-08T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-08,2013-08-01,NA,NA,AVDDSE,73.63636363636364,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1071,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-08T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-08,2013-08-01,NA,NA,TPDOSE,2970,NA,OVERALL,Total planned dose (mg),11,NA,14,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1071,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-08T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-08,2013-08-01,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1071,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-08T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-08,2013-08-01,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1071,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-08T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-08,2013-08-01,NA,NA,TDOSINT,136.36363636363635,NA,OVERALL,Overall dose intensity (%),90,NA,17,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1071,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-23T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-23,2013-08-01,NA,NA,PDURD,40,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1071,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-23T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-23,2013-08-01,NA,NA,PDOSE,3240,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1071,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-23T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-23,2013-08-01,NA,NA,PPDOSE,2160,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1071,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-23T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-23,2013-08-01,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1071,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-23T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-23,2013-08-01,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1071,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-23T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-23,2013-08-01,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1071,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-06-08,2013-06-08T00:00:00Z,2013-08-01T23:59:59Z,2013-06-23T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-06-23,2013-08-01,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1071,2013-06-08,2013-08-01,2013-06-08,2013-08-01,NA,2013-12-16,NA,NA,716,78,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-03,-5,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,55,NA,2013-08-01,DISCONTINUED,2013-12-16,2013-06-08,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1094,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-19,2013-01-06,1,19,NA,54,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2012-12-19T00:00:00Z,NA,H,2013-01-06T00:00:00Z,NA,H,1,19,19,2012-12-19,2013-01-06,1026,1026,DURD,19,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1094,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-19,2013-01-06,1,19,NA,54,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2012-12-19T00:00:00Z,NA,H,2013-01-06T00:00:00Z,NA,H,1,19,19,2012-12-19,2013-01-06,1026,1026,DOSE,1026,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1094,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-19,2013-01-06,1,19,NA,54,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2012-12-19T00:00:00Z,NA,H,2013-01-06T00:00:00Z,NA,H,1,19,19,2012-12-19,2013-01-06,1026,1026,PLDOSE,1026,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1094,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-19,2013-01-06,1,19,NA,54,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2012-12-19T00:00:00Z,NA,H,2013-01-06T00:00:00Z,NA,H,1,19,19,2012-12-19,2013-01-06,1026,1026,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1094,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-19,2013-01-06,1,19,NA,54,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2012-12-19T00:00:00Z,NA,H,2013-01-06T00:00:00Z,NA,H,1,19,19,2012-12-19,2013-01-06,1026,1026,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1094,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-07,2013-01-24,20,37,NA,54,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2013-01-07T00:00:00Z,NA,H,2013-01-24T00:00:00Z,NA,H,20,37,18,2013-01-07,2013-01-24,972,972,DURD,18,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1094,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-07,2013-01-24,20,37,NA,54,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2013-01-07T00:00:00Z,NA,H,2013-01-24T00:00:00Z,NA,H,20,37,18,2013-01-07,2013-01-24,972,972,DOSE,972,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1094,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-07,2013-01-24,20,37,NA,54,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2013-01-07T00:00:00Z,NA,H,2013-01-24T00:00:00Z,NA,H,20,37,18,2013-01-07,2013-01-24,972,972,PLDOSE,972,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1094,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-07,2013-01-24,20,37,NA,54,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2013-01-07T00:00:00Z,NA,H,2013-01-24T00:00:00Z,NA,H,20,37,18,2013-01-07,2013-01-24,972,972,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1094,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-07,2013-01-24,20,37,NA,54,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2013-01-07T00:00:00Z,NA,H,2013-01-24T00:00:00Z,NA,H,20,37,18,2013-01-07,2013-01-24,972,972,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2012-12-19T00:00:00Z,NA,NA,2013-01-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-19,2013-01-24,NA,NA,TDURD,37,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2012-12-19T00:00:00Z,NA,NA,2013-01-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-19,2013-01-24,NA,NA,TDOSE,1998,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2012-12-19T00:00:00Z,NA,NA,2013-01-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-19,2013-01-24,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2012-12-19T00:00:00Z,NA,NA,2013-01-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-19,2013-01-24,NA,NA,TPDOSE,1998,NA,OVERALL,Total planned dose (mg),11,NA,14,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2012-12-19T00:00:00Z,NA,NA,2013-01-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-19,2013-01-24,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2012-12-19T00:00:00Z,NA,NA,2013-01-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-19,2013-01-24,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2012-12-19T00:00:00Z,NA,NA,2013-01-24T00:00:00Z,NA,NA,NA,NA,NA,2012-12-19,2013-01-24,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2013-01-07T00:00:00Z,NA,NA,2013-01-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-07,2013-01-24,NA,NA,PDURD,18,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2013-01-07T00:00:00Z,NA,NA,2013-01-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-07,2013-01-24,NA,NA,PDOSE,972,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2013-01-07T00:00:00Z,NA,NA,2013-01-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-07,2013-01-24,NA,NA,PPDOSE,972,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2013-01-07T00:00:00Z,NA,NA,2013-01-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-07,2013-01-24,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2013-01-07T00:00:00Z,NA,NA,2013-01-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-07,2013-01-24,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2013-01-07T00:00:00Z,NA,NA,2013-01-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-07,2013-01-24,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1094,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-19,2012-12-19T00:00:00Z,2013-01-24T23:59:59Z,2013-01-07T00:00:00Z,NA,NA,2013-01-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-07,2013-01-24,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1094,2012-12-19,2013-01-26,2012-12-19,2013-01-24,NA,2013-06-22,NA,NA,716,82,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-12-16,-3,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-01-24,37,NA,2013-01-26,DISCONTINUED,2013-06-22,2012-12-19,NA,NA,NA,2013-01-26,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1103,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-20,2014-04-05,1,17,NA,54,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-03-20T00:00:00Z,NA,H,2014-04-05T00:00:00Z,NA,H,1,17,17,2014-03-20,2014-04-05,918,918,DURD,17,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1103,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-20,2014-04-05,1,17,NA,54,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-03-20T00:00:00Z,NA,H,2014-04-05T00:00:00Z,NA,H,1,17,17,2014-03-20,2014-04-05,918,918,DOSE,918,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1103,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-20,2014-04-05,1,17,NA,54,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-03-20T00:00:00Z,NA,H,2014-04-05T00:00:00Z,NA,H,1,17,17,2014-03-20,2014-04-05,918,918,PLDOSE,918,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1103,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-20,2014-04-05,1,17,NA,54,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-03-20T00:00:00Z,NA,H,2014-04-05T00:00:00Z,NA,H,1,17,17,2014-03-20,2014-04-05,918,918,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1103,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-03-20,2014-04-05,1,17,NA,54,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-03-20T00:00:00Z,NA,H,2014-04-05T00:00:00Z,NA,H,1,17,17,2014-03-20,2014-04-05,918,918,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1103,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-06,2014-08-30,18,164,NA,54,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-04-06T00:00:00Z,NA,H,2014-08-30T00:00:00Z,NA,H,18,164,147,2014-04-06,2014-08-30,7938,7938,DURD,147,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1103,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-06,2014-08-30,18,164,NA,54,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-04-06T00:00:00Z,NA,H,2014-08-30T00:00:00Z,NA,H,18,164,147,2014-04-06,2014-08-30,7938,7938,DOSE,7938,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1103,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-06,2014-08-30,18,164,NA,54,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-04-06T00:00:00Z,NA,H,2014-08-30T00:00:00Z,NA,H,18,164,147,2014-04-06,2014-08-30,7938,7938,PLDOSE,7938,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1103,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-06,2014-08-30,18,164,NA,54,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-04-06T00:00:00Z,NA,H,2014-08-30T00:00:00Z,NA,H,18,164,147,2014-04-06,2014-08-30,7938,7938,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1103,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-04-06,2014-08-30,18,164,NA,54,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-04-06T00:00:00Z,NA,H,2014-08-30T00:00:00Z,NA,H,18,164,147,2014-04-06,2014-08-30,7938,7938,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1103,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-31,2014-09-20,165,185,NA,54,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-08-31T00:00:00Z,NA,H,2014-09-20T00:00:00Z,NA,H,165,185,21,2014-08-31,2014-09-20,1134,1134,DURD,21,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1103,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-31,2014-09-20,165,185,NA,54,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-08-31T00:00:00Z,NA,H,2014-09-20T00:00:00Z,NA,H,165,185,21,2014-08-31,2014-09-20,1134,1134,DOSE,1134,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1103,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-31,2014-09-20,165,185,NA,54,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-08-31T00:00:00Z,NA,H,2014-09-20T00:00:00Z,NA,H,165,185,21,2014-08-31,2014-09-20,1134,1134,PLDOSE,1134,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1103,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-31,2014-09-20,165,185,NA,54,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-08-31T00:00:00Z,NA,H,2014-09-20T00:00:00Z,NA,H,165,185,21,2014-08-31,2014-09-20,1134,1134,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1103,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-08-31,2014-09-20,165,185,NA,54,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-08-31T00:00:00Z,NA,H,2014-09-20T00:00:00Z,NA,H,165,185,21,2014-08-31,2014-09-20,1134,1134,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-03-20T00:00:00Z,NA,NA,2014-09-20T00:00:00Z,NA,NA,NA,NA,NA,2014-03-20,2014-09-20,NA,NA,TDURD,185,NA,OVERALL,Overall duration (days),7,>=90 days,16,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-03-20T00:00:00Z,NA,NA,2014-09-20T00:00:00Z,NA,NA,NA,NA,NA,2014-03-20,2014-09-20,NA,NA,TDOSE,9990,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-03-20T00:00:00Z,NA,NA,2014-09-20T00:00:00Z,NA,NA,NA,NA,NA,2014-03-20,2014-09-20,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-03-20T00:00:00Z,NA,NA,2014-09-20T00:00:00Z,NA,NA,NA,NA,NA,2014-03-20,2014-09-20,NA,NA,TPDOSE,9990,NA,OVERALL,Total planned dose (mg),11,NA,19,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-03-20T00:00:00Z,NA,NA,2014-09-20T00:00:00Z,NA,NA,NA,NA,NA,2014-03-20,2014-09-20,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-03-20T00:00:00Z,NA,NA,2014-09-20T00:00:00Z,NA,NA,NA,NA,NA,2014-03-20,2014-09-20,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-03-20T00:00:00Z,NA,NA,2014-09-20T00:00:00Z,NA,NA,NA,NA,NA,2014-03-20,2014-09-20,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-04-06T00:00:00Z,NA,NA,2014-09-20T00:00:00Z,NA,NA,NA,NA,NA,2014-04-06,2014-09-20,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-04-06T00:00:00Z,NA,NA,2014-09-20T00:00:00Z,NA,NA,NA,NA,NA,2014-04-06,2014-09-20,NA,NA,PDOSE,9072,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-04-06T00:00:00Z,NA,NA,2014-09-20T00:00:00Z,NA,NA,NA,NA,NA,2014-04-06,2014-09-20,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-04-06T00:00:00Z,NA,NA,2014-09-20T00:00:00Z,NA,NA,NA,NA,NA,2014-04-06,2014-09-20,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-04-06T00:00:00Z,NA,NA,2014-09-20T00:00:00Z,NA,NA,NA,NA,NA,2014-04-06,2014-09-20,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-04-06T00:00:00Z,NA,NA,2014-09-20T00:00:00Z,NA,NA,NA,NA,NA,2014-04-06,2014-09-20,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1103,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-03-20,2014-03-20T00:00:00Z,2014-09-20T23:59:59Z,2014-04-06T00:00:00Z,NA,NA,2014-09-20T00:00:00Z,NA,NA,NA,NA,NA,2014-04-06,2014-09-20,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1103,2014-03-20,2014-09-20,2014-03-20,2014-09-20,NA,2014-09-20T12:10,NA,NA,716,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-03-18,-2,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-20,185,NA,2014-09-20,COMPLETED,NA,2014-03-20,NA,NA,NA,2014-09-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1108,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-12,2013-02-26,1,15,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-12T00:00:00Z,NA,H,2013-02-26T00:00:00Z,NA,H,1,15,15,2013-02-12,2013-02-26,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1108,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-12,2013-02-26,1,15,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-12T00:00:00Z,NA,H,2013-02-26T00:00:00Z,NA,H,1,15,15,2013-02-12,2013-02-26,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1108,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-12,2013-02-26,1,15,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-12T00:00:00Z,NA,H,2013-02-26T00:00:00Z,NA,H,1,15,15,2013-02-12,2013-02-26,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1108,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-12,2013-02-26,1,15,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-12T00:00:00Z,NA,H,2013-02-26T00:00:00Z,NA,H,1,15,15,2013-02-12,2013-02-26,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1108,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-12,2013-02-26,1,15,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-12T00:00:00Z,NA,H,2013-02-26T00:00:00Z,NA,H,1,15,15,2013-02-12,2013-02-26,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1108,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-27,2013-08-02,16,172,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-27T00:00:00Z,NA,H,2013-08-02T00:00:00Z,NA,H,16,172,157,2013-02-27,2013-08-02,0,0,DURD,157,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1108,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-27,2013-08-02,16,172,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-27T00:00:00Z,NA,H,2013-08-02T00:00:00Z,NA,H,16,172,157,2013-02-27,2013-08-02,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1108,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-27,2013-08-02,16,172,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-27T00:00:00Z,NA,H,2013-08-02T00:00:00Z,NA,H,16,172,157,2013-02-27,2013-08-02,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1108,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-27,2013-08-02,16,172,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-27T00:00:00Z,NA,H,2013-08-02T00:00:00Z,NA,H,16,172,157,2013-02-27,2013-08-02,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1108,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-27,2013-08-02,16,172,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-27T00:00:00Z,NA,H,2013-08-02T00:00:00Z,NA,H,16,172,157,2013-02-27,2013-08-02,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1108,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-03,2013-08-10,173,180,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-08-03T00:00:00Z,NA,H,2013-08-10T00:00:00Z,NA,H,173,180,8,2013-08-03,2013-08-10,0,0,DURD,8,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1108,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-03,2013-08-10,173,180,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-08-03T00:00:00Z,NA,H,2013-08-10T00:00:00Z,NA,H,173,180,8,2013-08-03,2013-08-10,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1108,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-03,2013-08-10,173,180,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-08-03T00:00:00Z,NA,H,2013-08-10T00:00:00Z,NA,H,173,180,8,2013-08-03,2013-08-10,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1108,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-03,2013-08-10,173,180,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-08-03T00:00:00Z,NA,H,2013-08-10T00:00:00Z,NA,H,173,180,8,2013-08-03,2013-08-10,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1108,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-03,2013-08-10,173,180,NA,0,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-08-03T00:00:00Z,NA,H,2013-08-10T00:00:00Z,NA,H,173,180,8,2013-08-03,2013-08-10,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-08-10T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-08-10,NA,NA,TDURD,180,NA,OVERALL,Overall duration (days),7,>=90 days,16,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-08-10T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-08-10,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-08-10T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-08-10,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-08-10T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-08-10,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-08-10T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-08-10,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-08-10T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-08-10,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-12T00:00:00Z,NA,NA,2013-08-10T00:00:00Z,NA,NA,NA,NA,NA,2013-02-12,2013-08-10,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-27T00:00:00Z,NA,NA,2013-08-10T00:00:00Z,NA,NA,NA,NA,NA,2013-02-27,2013-08-10,NA,NA,PDURD,165,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-27T00:00:00Z,NA,NA,2013-08-10T00:00:00Z,NA,NA,NA,NA,NA,2013-02-27,2013-08-10,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-27T00:00:00Z,NA,NA,2013-08-10T00:00:00Z,NA,NA,NA,NA,NA,2013-02-27,2013-08-10,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-27T00:00:00Z,NA,NA,2013-08-10T00:00:00Z,NA,NA,NA,NA,NA,2013-02-27,2013-08-10,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-27T00:00:00Z,NA,NA,2013-08-10T00:00:00Z,NA,NA,NA,NA,NA,2013-02-27,2013-08-10,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-27T00:00:00Z,NA,NA,2013-08-10T00:00:00Z,NA,NA,NA,NA,NA,2013-02-27,2013-08-10,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1108,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-12,2013-02-12T00:00:00Z,2013-08-10T23:59:59Z,2013-02-27T00:00:00Z,NA,NA,2013-08-10T00:00:00Z,NA,NA,NA,NA,NA,2013-02-27,2013-08-10,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1108,2013-02-12,2013-08-10,2013-02-12,2013-08-10,NA,2013-08-10T09:55,NA,NA,716,86,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-04,-8,Placebo,Placebo,H,H,2013-08-10,180,NA,2013-08-10,COMPLETED,NA,2013-02-12,NA,NA,NA,2013-08-10,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1151,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-01,2013-02-15,1,15,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-01T00:00:00Z,NA,H,2013-02-15T00:00:00Z,NA,H,1,15,15,2013-02-01,2013-02-15,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1151,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-01,2013-02-15,1,15,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-01T00:00:00Z,NA,H,2013-02-15T00:00:00Z,NA,H,1,15,15,2013-02-01,2013-02-15,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1151,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-01,2013-02-15,1,15,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-01T00:00:00Z,NA,H,2013-02-15T00:00:00Z,NA,H,1,15,15,2013-02-01,2013-02-15,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1151,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-01,2013-02-15,1,15,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-01T00:00:00Z,NA,H,2013-02-15T00:00:00Z,NA,H,1,15,15,2013-02-01,2013-02-15,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1151,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-01,2013-02-15,1,15,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-01T00:00:00Z,NA,H,2013-02-15T00:00:00Z,NA,H,1,15,15,2013-02-01,2013-02-15,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1151,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-16,2013-05-11,16,100,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-16T00:00:00Z,NA,H,2013-05-11T00:00:00Z,NA,H,16,100,85,2013-02-16,2013-05-11,4590,4590,DURD,85,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1151,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-16,2013-05-11,16,100,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-16T00:00:00Z,NA,H,2013-05-11T00:00:00Z,NA,H,16,100,85,2013-02-16,2013-05-11,4590,4590,DOSE,4590,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1151,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-16,2013-05-11,16,100,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-16T00:00:00Z,NA,H,2013-05-11T00:00:00Z,NA,H,16,100,85,2013-02-16,2013-05-11,4590,4590,PLDOSE,4590,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1151,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-16,2013-05-11,16,100,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-16T00:00:00Z,NA,H,2013-05-11T00:00:00Z,NA,H,16,100,85,2013-02-16,2013-05-11,4590,4590,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1151,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-16,2013-05-11,16,100,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-16T00:00:00Z,NA,H,2013-05-11T00:00:00Z,NA,H,16,100,85,2013-02-16,2013-05-11,4590,4590,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-05-11T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-05-11,NA,NA,TDURD,100,NA,OVERALL,Overall duration (days),7,>=90 days,11,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-05-11T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-05-11,NA,NA,TDOSE,5400,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-05-11T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-05-11,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-05-11T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-05-11,NA,NA,TPDOSE,5400,NA,OVERALL,Total planned dose (mg),11,NA,14,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-05-11T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-05-11,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-05-11T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-05-11,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-05-11T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-05-11,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-16T00:00:00Z,NA,NA,2013-05-11T00:00:00Z,NA,NA,NA,NA,NA,2013-02-16,2013-05-11,NA,NA,PDURD,85,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-16T00:00:00Z,NA,NA,2013-05-11T00:00:00Z,NA,NA,NA,NA,NA,2013-02-16,2013-05-11,NA,NA,PDOSE,4590,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-16T00:00:00Z,NA,NA,2013-05-11T00:00:00Z,NA,NA,NA,NA,NA,2013-02-16,2013-05-11,NA,NA,PPDOSE,4590,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-16T00:00:00Z,NA,NA,2013-05-11T00:00:00Z,NA,NA,NA,NA,NA,2013-02-16,2013-05-11,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-16T00:00:00Z,NA,NA,2013-05-11T00:00:00Z,NA,NA,NA,NA,NA,2013-02-16,2013-05-11,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-16T00:00:00Z,NA,NA,2013-05-11T00:00:00Z,NA,NA,NA,NA,NA,2013-02-16,2013-05-11,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1151,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-05-11T23:59:59Z,2013-02-16T00:00:00Z,NA,NA,2013-05-11T00:00:00Z,NA,NA,NA,NA,NA,2013-02-16,2013-05-11,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1151,2013-02-01,2013-06-07,2013-02-01,2013-05-11,NA,2013-08-13,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-01-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-05-11,100,NA,2013-06-07,DISCONTINUED,2013-08-13,2013-02-01,NA,NA,NA,2013-06-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1157,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-02,2013-10-16,1,15,NA,54,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-02T00:00:00Z,NA,H,2013-10-16T00:00:00Z,NA,H,1,15,15,2013-10-02,2013-10-16,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1157,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-02,2013-10-16,1,15,NA,54,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-02T00:00:00Z,NA,H,2013-10-16T00:00:00Z,NA,H,1,15,15,2013-10-02,2013-10-16,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1157,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-02,2013-10-16,1,15,NA,54,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-02T00:00:00Z,NA,H,2013-10-16T00:00:00Z,NA,H,1,15,15,2013-10-02,2013-10-16,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1157,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-02,2013-10-16,1,15,NA,54,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-02T00:00:00Z,NA,H,2013-10-16T00:00:00Z,NA,H,1,15,15,2013-10-02,2013-10-16,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1157,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-10-02,2013-10-16,1,15,NA,54,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-02T00:00:00Z,NA,H,2013-10-16T00:00:00Z,NA,H,1,15,15,2013-10-02,2013-10-16,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1157,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-17,2014-03-26,16,176,NA,54,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2014-03-26T00:00:00Z,NA,H,16,176,161,2013-10-17,2014-03-26,8694,8694,DURD,161,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1157,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-17,2014-03-26,16,176,NA,54,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2014-03-26T00:00:00Z,NA,H,16,176,161,2013-10-17,2014-03-26,8694,8694,DOSE,8694,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1157,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-17,2014-03-26,16,176,NA,54,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2014-03-26T00:00:00Z,NA,H,16,176,161,2013-10-17,2014-03-26,8694,8694,PLDOSE,8694,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1157,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-17,2014-03-26,16,176,NA,54,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2014-03-26T00:00:00Z,NA,H,16,176,161,2013-10-17,2014-03-26,8694,8694,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1157,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-17,2014-03-26,16,176,NA,54,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-17T00:00:00Z,NA,H,2014-03-26T00:00:00Z,NA,H,16,176,161,2013-10-17,2014-03-26,8694,8694,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1157,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-27,2014-04-04,177,185,NA,54,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2014-03-27T00:00:00Z,NA,H,2014-04-04T00:00:00Z,NA,H,177,185,9,2014-03-27,2014-04-04,486,486,DURD,9,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1157,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-27,2014-04-04,177,185,NA,54,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2014-03-27T00:00:00Z,NA,H,2014-04-04T00:00:00Z,NA,H,177,185,9,2014-03-27,2014-04-04,486,486,DOSE,486,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1157,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-27,2014-04-04,177,185,NA,54,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2014-03-27T00:00:00Z,NA,H,2014-04-04T00:00:00Z,NA,H,177,185,9,2014-03-27,2014-04-04,486,486,PLDOSE,486,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1157,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-27,2014-04-04,177,185,NA,54,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2014-03-27T00:00:00Z,NA,H,2014-04-04T00:00:00Z,NA,H,177,185,9,2014-03-27,2014-04-04,486,486,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1157,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-03-27,2014-04-04,177,185,NA,54,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2014-03-27T00:00:00Z,NA,H,2014-04-04T00:00:00Z,NA,H,177,185,9,2014-03-27,2014-04-04,486,486,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1157,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-02T00:00:00Z,NA,NA,2014-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-10-02,2014-04-04,NA,NA,TDURD,185,NA,OVERALL,Overall duration (days),7,>=90 days,16,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1157,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-02T00:00:00Z,NA,NA,2014-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-10-02,2014-04-04,NA,NA,TDOSE,9990,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1157,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-02T00:00:00Z,NA,NA,2014-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-10-02,2014-04-04,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1157,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-02T00:00:00Z,NA,NA,2014-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-10-02,2014-04-04,NA,NA,TPDOSE,9990,NA,OVERALL,Total planned dose (mg),11,NA,19,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1157,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-02T00:00:00Z,NA,NA,2014-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-10-02,2014-04-04,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1157,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-02T00:00:00Z,NA,NA,2014-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-10-02,2014-04-04,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1157,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-02T00:00:00Z,NA,NA,2014-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-10-02,2014-04-04,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1157,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2014-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2014-04-04,NA,NA,PDURD,170,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1157,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2014-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2014-04-04,NA,NA,PDOSE,9180,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1157,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2014-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2014-04-04,NA,NA,PPDOSE,9180,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1157,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2014-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2014-04-04,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1157,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2014-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2014-04-04,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1157,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2014-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2014-04-04,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1157,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-10-02,2013-10-02T00:00:00Z,2014-04-04T23:59:59Z,2013-10-17T00:00:00Z,NA,NA,2014-04-04T00:00:00Z,NA,NA,NA,NA,NA,2013-10-17,2014-04-04,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1157,2013-10-02,2014-04-05,2013-10-02,2014-04-04,NA,2014-04-05T11:10,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-09-23,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-04-04,185,NA,2014-04-05,COMPLETED,NA,2013-10-02,NA,NA,NA,2014-04-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1160,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-05,2013-04-19,1,15,NA,0,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-05T00:00:00Z,NA,H,2013-04-19T00:00:00Z,NA,H,1,15,15,2013-04-05,2013-04-19,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1160,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-05,2013-04-19,1,15,NA,0,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-05T00:00:00Z,NA,H,2013-04-19T00:00:00Z,NA,H,1,15,15,2013-04-05,2013-04-19,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1160,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-05,2013-04-19,1,15,NA,0,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-05T00:00:00Z,NA,H,2013-04-19T00:00:00Z,NA,H,1,15,15,2013-04-05,2013-04-19,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1160,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-05,2013-04-19,1,15,NA,0,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-05T00:00:00Z,NA,H,2013-04-19T00:00:00Z,NA,H,1,15,15,2013-04-05,2013-04-19,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1160,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-05,2013-04-19,1,15,NA,0,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-05T00:00:00Z,NA,H,2013-04-19T00:00:00Z,NA,H,1,15,15,2013-04-05,2013-04-19,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1160,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-20,2013-09-27,16,176,NA,0,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-20T00:00:00Z,NA,H,2013-09-27T00:00:00Z,NA,H,16,176,161,2013-04-20,2013-09-27,0,0,DURD,161,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1160,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-20,2013-09-27,16,176,NA,0,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-20T00:00:00Z,NA,H,2013-09-27T00:00:00Z,NA,H,16,176,161,2013-04-20,2013-09-27,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1160,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-20,2013-09-27,16,176,NA,0,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-20T00:00:00Z,NA,H,2013-09-27T00:00:00Z,NA,H,16,176,161,2013-04-20,2013-09-27,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1160,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-20,2013-09-27,16,176,NA,0,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-20T00:00:00Z,NA,H,2013-09-27T00:00:00Z,NA,H,16,176,161,2013-04-20,2013-09-27,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1160,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-20,2013-09-27,16,176,NA,0,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-20T00:00:00Z,NA,H,2013-09-27T00:00:00Z,NA,H,16,176,161,2013-04-20,2013-09-27,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1160,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-28,2013-10-11,177,190,NA,0,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-09-28T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,177,190,14,2013-09-28,2013-10-11,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1160,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-28,2013-10-11,177,190,NA,0,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-09-28T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,177,190,14,2013-09-28,2013-10-11,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1160,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-28,2013-10-11,177,190,NA,0,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-09-28T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,177,190,14,2013-09-28,2013-10-11,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1160,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-28,2013-10-11,177,190,NA,0,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-09-28T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,177,190,14,2013-09-28,2013-10-11,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1160,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-09-28,2013-10-11,177,190,NA,0,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-09-28T00:00:00Z,NA,H,2013-10-11T00:00:00Z,NA,H,177,190,14,2013-09-28,2013-10-11,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1160,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-10-11,NA,NA,TDURD,190,NA,OVERALL,Overall duration (days),7,>=90 days,16,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1160,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-10-11,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1160,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-10-11,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1160,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-10-11,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1160,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-10-11,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1160,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-10-11,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1160,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-05T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-04-05,2013-10-11,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1160,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-20T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-04-20,2013-10-11,NA,NA,PDURD,175,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1160,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-20T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-04-20,2013-10-11,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1160,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-20T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-04-20,2013-10-11,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1160,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-20T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-04-20,2013-10-11,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1160,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-20T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-04-20,2013-10-11,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1160,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-20T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-04-20,2013-10-11,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1160,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-05,2013-04-05T00:00:00Z,2013-10-11T23:59:59Z,2013-04-20T00:00:00Z,NA,NA,2013-10-11T00:00:00Z,NA,NA,NA,NA,NA,2013-04-20,2013-10-11,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1160,2013-04-05,2013-10-11,2013-04-05,2013-10-11,NA,2013-10-11T13:30,NA,NA,716,83,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-03-23,-13,Placebo,Placebo,H,H,2013-10-11,190,NA,2013-10-11,COMPLETED,NA,2013-04-05,NA,NA,NA,2013-10-11,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1167,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-08,2012-10-29,1,22,NA,54,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-08T00:00:00Z,NA,H,2012-10-29T00:00:00Z,NA,H,1,22,22,2012-10-08,2012-10-29,1188,1188,DURD,22,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1167,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-08,2012-10-29,1,22,NA,54,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-08T00:00:00Z,NA,H,2012-10-29T00:00:00Z,NA,H,1,22,22,2012-10-08,2012-10-29,1188,1188,DOSE,1188,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1167,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-08,2012-10-29,1,22,NA,54,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-08T00:00:00Z,NA,H,2012-10-29T00:00:00Z,NA,H,1,22,22,2012-10-08,2012-10-29,1188,1188,PLDOSE,1188,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1167,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-08,2012-10-29,1,22,NA,54,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-08T00:00:00Z,NA,H,2012-10-29T00:00:00Z,NA,H,1,22,22,2012-10-08,2012-10-29,1188,1188,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1167,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-08,2012-10-29,1,22,NA,54,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-08T00:00:00Z,NA,H,2012-10-29T00:00:00Z,NA,H,1,22,22,2012-10-08,2012-10-29,1188,1188,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1167,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-30,2013-03-24,23,168,NA,54,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-30T00:00:00Z,NA,H,2013-03-24T00:00:00Z,NA,H,23,168,146,2012-10-30,2013-03-24,7884,7884,DURD,146,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1167,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-30,2013-03-24,23,168,NA,54,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-30T00:00:00Z,NA,H,2013-03-24T00:00:00Z,NA,H,23,168,146,2012-10-30,2013-03-24,7884,7884,DOSE,7884,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1167,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-30,2013-03-24,23,168,NA,54,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-30T00:00:00Z,NA,H,2013-03-24T00:00:00Z,NA,H,23,168,146,2012-10-30,2013-03-24,7884,7884,PLDOSE,7884,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1167,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-30,2013-03-24,23,168,NA,54,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-30T00:00:00Z,NA,H,2013-03-24T00:00:00Z,NA,H,23,168,146,2012-10-30,2013-03-24,7884,7884,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1167,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-30,2013-03-24,23,168,NA,54,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-30T00:00:00Z,NA,H,2013-03-24T00:00:00Z,NA,H,23,168,146,2012-10-30,2013-03-24,7884,7884,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1167,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-25,2013-04-12,169,187,NA,54,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2013-03-25T00:00:00Z,NA,H,2013-04-12T00:00:00Z,NA,H,169,187,19,2013-03-25,2013-04-12,1026,1026,DURD,19,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1167,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-25,2013-04-12,169,187,NA,54,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2013-03-25T00:00:00Z,NA,H,2013-04-12T00:00:00Z,NA,H,169,187,19,2013-03-25,2013-04-12,1026,1026,DOSE,1026,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1167,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-25,2013-04-12,169,187,NA,54,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2013-03-25T00:00:00Z,NA,H,2013-04-12T00:00:00Z,NA,H,169,187,19,2013-03-25,2013-04-12,1026,1026,PLDOSE,1026,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1167,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-25,2013-04-12,169,187,NA,54,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2013-03-25T00:00:00Z,NA,H,2013-04-12T00:00:00Z,NA,H,169,187,19,2013-03-25,2013-04-12,1026,1026,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1167,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-03-25,2013-04-12,169,187,NA,54,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2013-03-25T00:00:00Z,NA,H,2013-04-12T00:00:00Z,NA,H,169,187,19,2013-03-25,2013-04-12,1026,1026,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-08T00:00:00Z,NA,NA,2013-04-12T00:00:00Z,NA,NA,NA,NA,NA,2012-10-08,2013-04-12,NA,NA,TDURD,187,NA,OVERALL,Overall duration (days),7,>=90 days,16,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-08T00:00:00Z,NA,NA,2013-04-12T00:00:00Z,NA,NA,NA,NA,NA,2012-10-08,2013-04-12,NA,NA,TDOSE,10098,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-08T00:00:00Z,NA,NA,2013-04-12T00:00:00Z,NA,NA,NA,NA,NA,2012-10-08,2013-04-12,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-08T00:00:00Z,NA,NA,2013-04-12T00:00:00Z,NA,NA,NA,NA,NA,2012-10-08,2013-04-12,NA,NA,TPDOSE,10098,NA,OVERALL,Total planned dose (mg),11,NA,19,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-08T00:00:00Z,NA,NA,2013-04-12T00:00:00Z,NA,NA,NA,NA,NA,2012-10-08,2013-04-12,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-08T00:00:00Z,NA,NA,2013-04-12T00:00:00Z,NA,NA,NA,NA,NA,2012-10-08,2013-04-12,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-08T00:00:00Z,NA,NA,2013-04-12T00:00:00Z,NA,NA,NA,NA,NA,2012-10-08,2013-04-12,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-30T00:00:00Z,NA,NA,2013-04-12T00:00:00Z,NA,NA,NA,NA,NA,2012-10-30,2013-04-12,NA,NA,PDURD,165,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-30T00:00:00Z,NA,NA,2013-04-12T00:00:00Z,NA,NA,NA,NA,NA,2012-10-30,2013-04-12,NA,NA,PDOSE,8910,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-30T00:00:00Z,NA,NA,2013-04-12T00:00:00Z,NA,NA,NA,NA,NA,2012-10-30,2013-04-12,NA,NA,PPDOSE,8910,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-30T00:00:00Z,NA,NA,2013-04-12T00:00:00Z,NA,NA,NA,NA,NA,2012-10-30,2013-04-12,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-30T00:00:00Z,NA,NA,2013-04-12T00:00:00Z,NA,NA,NA,NA,NA,2012-10-30,2013-04-12,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-30T00:00:00Z,NA,NA,2013-04-12T00:00:00Z,NA,NA,NA,NA,NA,2012-10-30,2013-04-12,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1167,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-08,2012-10-08T00:00:00Z,2013-04-12T23:59:59Z,2012-10-30T00:00:00Z,NA,NA,2013-04-12T00:00:00Z,NA,NA,NA,NA,NA,2012-10-30,2013-04-12,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1167,2012-10-08,2013-04-13,2012-10-08,2013-04-12,NA,2013-04-13T11:10,NA,NA,716,68,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-30,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-04-12,187,NA,2013-04-13,COMPLETED,NA,2012-10-08,NA,NA,NA,2013-04-13,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1177,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-09-02,2014-09-16,1,15,NA,0,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-02T00:00:00Z,NA,H,2014-09-16T00:00:00Z,NA,H,1,15,15,2014-09-02,2014-09-16,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1177,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-09-02,2014-09-16,1,15,NA,0,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-02T00:00:00Z,NA,H,2014-09-16T00:00:00Z,NA,H,1,15,15,2014-09-02,2014-09-16,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1177,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-09-02,2014-09-16,1,15,NA,0,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-02T00:00:00Z,NA,H,2014-09-16T00:00:00Z,NA,H,1,15,15,2014-09-02,2014-09-16,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1177,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-09-02,2014-09-16,1,15,NA,0,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-02T00:00:00Z,NA,H,2014-09-16T00:00:00Z,NA,H,1,15,15,2014-09-02,2014-09-16,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1177,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-09-02,2014-09-16,1,15,NA,0,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-02T00:00:00Z,NA,H,2014-09-16T00:00:00Z,NA,H,1,15,15,2014-09-02,2014-09-16,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1177,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-09-17,2015-02-17,16,169,NA,0,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-17T00:00:00Z,NA,H,2015-02-17T00:00:00Z,NA,H,16,169,154,2014-09-17,2015-02-17,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1177,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-09-17,2015-02-17,16,169,NA,0,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-17T00:00:00Z,NA,H,2015-02-17T00:00:00Z,NA,H,16,169,154,2014-09-17,2015-02-17,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1177,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-09-17,2015-02-17,16,169,NA,0,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-17T00:00:00Z,NA,H,2015-02-17T00:00:00Z,NA,H,16,169,154,2014-09-17,2015-02-17,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1177,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-09-17,2015-02-17,16,169,NA,0,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-17T00:00:00Z,NA,H,2015-02-17T00:00:00Z,NA,H,16,169,154,2014-09-17,2015-02-17,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1177,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-09-17,2015-02-17,16,169,NA,0,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-17T00:00:00Z,NA,H,2015-02-17T00:00:00Z,NA,H,16,169,154,2014-09-17,2015-02-17,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1177,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2015-02-18,2015-03-05,170,185,NA,0,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2015-02-18T00:00:00Z,NA,H,2015-03-05T00:00:00Z,NA,H,170,185,16,2015-02-18,2015-03-05,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1177,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2015-02-18,2015-03-05,170,185,NA,0,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2015-02-18T00:00:00Z,NA,H,2015-03-05T00:00:00Z,NA,H,170,185,16,2015-02-18,2015-03-05,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1177,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2015-02-18,2015-03-05,170,185,NA,0,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2015-02-18T00:00:00Z,NA,H,2015-03-05T00:00:00Z,NA,H,170,185,16,2015-02-18,2015-03-05,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1177,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2015-02-18,2015-03-05,170,185,NA,0,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2015-02-18T00:00:00Z,NA,H,2015-03-05T00:00:00Z,NA,H,170,185,16,2015-02-18,2015-03-05,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1177,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2015-02-18,2015-03-05,170,185,NA,0,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2015-02-18T00:00:00Z,NA,H,2015-03-05T00:00:00Z,NA,H,170,185,16,2015-02-18,2015-03-05,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-02T00:00:00Z,NA,NA,2015-03-05T00:00:00Z,NA,NA,NA,NA,NA,2014-09-02,2015-03-05,NA,NA,TDURD,185,NA,OVERALL,Overall duration (days),7,>=90 days,16,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-02T00:00:00Z,NA,NA,2015-03-05T00:00:00Z,NA,NA,NA,NA,NA,2014-09-02,2015-03-05,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-02T00:00:00Z,NA,NA,2015-03-05T00:00:00Z,NA,NA,NA,NA,NA,2014-09-02,2015-03-05,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-02T00:00:00Z,NA,NA,2015-03-05T00:00:00Z,NA,NA,NA,NA,NA,2014-09-02,2015-03-05,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-02T00:00:00Z,NA,NA,2015-03-05T00:00:00Z,NA,NA,NA,NA,NA,2014-09-02,2015-03-05,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-02T00:00:00Z,NA,NA,2015-03-05T00:00:00Z,NA,NA,NA,NA,NA,2014-09-02,2015-03-05,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-02T00:00:00Z,NA,NA,2015-03-05T00:00:00Z,NA,NA,NA,NA,NA,2014-09-02,2015-03-05,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-17T00:00:00Z,NA,NA,2015-03-05T00:00:00Z,NA,NA,NA,NA,NA,2014-09-17,2015-03-05,NA,NA,PDURD,170,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-17T00:00:00Z,NA,NA,2015-03-05T00:00:00Z,NA,NA,NA,NA,NA,2014-09-17,2015-03-05,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-17T00:00:00Z,NA,NA,2015-03-05T00:00:00Z,NA,NA,NA,NA,NA,2014-09-17,2015-03-05,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-17T00:00:00Z,NA,NA,2015-03-05T00:00:00Z,NA,NA,NA,NA,NA,2014-09-17,2015-03-05,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-17T00:00:00Z,NA,NA,2015-03-05T00:00:00Z,NA,NA,NA,NA,NA,2014-09-17,2015-03-05,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-17T00:00:00Z,NA,NA,2015-03-05T00:00:00Z,NA,NA,NA,NA,NA,2014-09-17,2015-03-05,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1177,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-09-02,2014-09-02T00:00:00Z,2015-03-05T23:59:59Z,2014-09-17T00:00:00Z,NA,NA,2015-03-05T00:00:00Z,NA,NA,NA,NA,NA,2014-09-17,2015-03-05,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1177,2014-09-02,2015-03-05,2014-09-02,2015-03-05,NA,2015-03-05T14:40,NA,NA,716,72,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-08-29,-4,Placebo,Placebo,H,H,2015-03-05,185,NA,2015-03-05,COMPLETED,NA,2014-09-02,NA,NA,NA,2015-03-05,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1189,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-09,2012-10-24,1,16,NA,54,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-09T00:00:00Z,NA,H,2012-10-24T00:00:00Z,NA,H,1,16,16,2012-10-09,2012-10-24,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1189,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-09,2012-10-24,1,16,NA,54,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-09T00:00:00Z,NA,H,2012-10-24T00:00:00Z,NA,H,1,16,16,2012-10-09,2012-10-24,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1189,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-09,2012-10-24,1,16,NA,54,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-09T00:00:00Z,NA,H,2012-10-24T00:00:00Z,NA,H,1,16,16,2012-10-09,2012-10-24,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1189,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-09,2012-10-24,1,16,NA,54,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-09T00:00:00Z,NA,H,2012-10-24T00:00:00Z,NA,H,1,16,16,2012-10-09,2012-10-24,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1189,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-10-09,2012-10-24,1,16,NA,54,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-09T00:00:00Z,NA,H,2012-10-24T00:00:00Z,NA,H,1,16,16,2012-10-09,2012-10-24,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1189,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-25,2013-02-27,17,142,NA,54,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-25T00:00:00Z,NA,H,2013-02-27T00:00:00Z,NA,H,17,142,126,2012-10-25,2013-02-27,10206,6804,DURD,126,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1189,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-25,2013-02-27,17,142,NA,54,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-25T00:00:00Z,NA,H,2013-02-27T00:00:00Z,NA,H,17,142,126,2012-10-25,2013-02-27,10206,6804,DOSE,10206,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1189,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-25,2013-02-27,17,142,NA,54,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-25T00:00:00Z,NA,H,2013-02-27T00:00:00Z,NA,H,17,142,126,2012-10-25,2013-02-27,10206,6804,PLDOSE,6804,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1189,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-25,2013-02-27,17,142,NA,54,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-25T00:00:00Z,NA,H,2013-02-27T00:00:00Z,NA,H,17,142,126,2012-10-25,2013-02-27,10206,6804,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1189,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-25,2013-02-27,17,142,NA,54,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-25T00:00:00Z,NA,H,2013-02-27T00:00:00Z,NA,H,17,142,126,2012-10-25,2013-02-27,10206,6804,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-09T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-09,2013-02-27,NA,NA,TDURD,142,NA,OVERALL,Overall duration (days),7,>=90 days,11,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-09T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-09,2013-02-27,NA,NA,TDOSE,11070,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-09T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-09,2013-02-27,NA,NA,AVDDSE,77.95774647887323,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-09T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-09,2013-02-27,NA,NA,TPDOSE,7668,NA,OVERALL,Total planned dose (mg),11,NA,14,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-09T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-09,2013-02-27,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-09T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-09,2013-02-27,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-09T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-09,2013-02-27,NA,NA,TDOSINT,144.3661971830986,NA,OVERALL,Overall dose intensity (%),90,NA,17,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-25T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-25,2013-02-27,NA,NA,PDURD,126,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-25T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-25,2013-02-27,NA,NA,PDOSE,10206,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-25T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-25,2013-02-27,NA,NA,PPDOSE,6804,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-25T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-25,2013-02-27,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-25T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-25,2013-02-27,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-25T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-25,2013-02-27,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1189,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-10-09,2012-10-09T00:00:00Z,2013-02-27T23:59:59Z,2012-10-25T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-10-25,2013-02-27,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1189,2012-10-09,2013-03-03,2012-10-09,2013-02-27,NA,2013-04-08,NA,NA,716,81,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-10-07,-2,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,142,NA,2013-03-03,DISCONTINUED,2013-04-08,2012-10-09,NA,NA,NA,2013-03-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1229,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-20,2013-03-06,1,15,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-02-20T00:00:00Z,NA,H,2013-03-06T00:00:00Z,NA,H,1,15,15,2013-02-20,2013-03-06,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1229,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-20,2013-03-06,1,15,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-02-20T00:00:00Z,NA,H,2013-03-06T00:00:00Z,NA,H,1,15,15,2013-02-20,2013-03-06,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1229,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-20,2013-03-06,1,15,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-02-20T00:00:00Z,NA,H,2013-03-06T00:00:00Z,NA,H,1,15,15,2013-02-20,2013-03-06,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1229,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-20,2013-03-06,1,15,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-02-20T00:00:00Z,NA,H,2013-03-06T00:00:00Z,NA,H,1,15,15,2013-02-20,2013-03-06,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1229,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-20,2013-03-06,1,15,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-02-20T00:00:00Z,NA,H,2013-03-06T00:00:00Z,NA,H,1,15,15,2013-02-20,2013-03-06,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1229,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-07,2013-03-31,16,40,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-03-07T00:00:00Z,NA,H,2013-03-31T00:00:00Z,NA,H,16,40,25,2013-03-07,2013-03-31,2025,1350,DURD,25,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1229,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-07,2013-03-31,16,40,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-03-07T00:00:00Z,NA,H,2013-03-31T00:00:00Z,NA,H,16,40,25,2013-03-07,2013-03-31,2025,1350,DOSE,2025,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1229,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-07,2013-03-31,16,40,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-03-07T00:00:00Z,NA,H,2013-03-31T00:00:00Z,NA,H,16,40,25,2013-03-07,2013-03-31,2025,1350,PLDOSE,1350,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1229,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-07,2013-03-31,16,40,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-03-07T00:00:00Z,NA,H,2013-03-31T00:00:00Z,NA,H,16,40,25,2013-03-07,2013-03-31,2025,1350,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1229,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-07,2013-03-31,16,40,NA,54,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-03-07T00:00:00Z,NA,H,2013-03-31T00:00:00Z,NA,H,16,40,25,2013-03-07,2013-03-31,2025,1350,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-03-31,NA,NA,TDURD,40,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-03-31,NA,NA,TDOSE,2835,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-03-31,NA,NA,AVDDSE,70.875,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-03-31,NA,NA,TPDOSE,2160,NA,OVERALL,Total planned dose (mg),11,NA,14,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-03-31,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-03-31,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-02-20T00:00:00Z,NA,NA,2013-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-02-20,2013-03-31,NA,NA,TDOSINT,131.25,NA,OVERALL,Overall dose intensity (%),90,NA,17,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-03-07T00:00:00Z,NA,NA,2013-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-07,2013-03-31,NA,NA,PDURD,25,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-03-07T00:00:00Z,NA,NA,2013-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-07,2013-03-31,NA,NA,PDOSE,2025,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-03-07T00:00:00Z,NA,NA,2013-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-07,2013-03-31,NA,NA,PPDOSE,1350,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-03-07T00:00:00Z,NA,NA,2013-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-07,2013-03-31,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-03-07T00:00:00Z,NA,NA,2013-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-07,2013-03-31,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-03-07T00:00:00Z,NA,NA,2013-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-07,2013-03-31,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1229,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-20,2013-02-20T00:00:00Z,2013-03-31T23:59:59Z,2013-03-07T00:00:00Z,NA,NA,2013-03-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-07,2013-03-31,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1229,2013-02-20,2013-04-02,2013-02-20,2013-03-31,NA,2013-04-02T11:15,NA,NA,716,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-14,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-03-31,40,NA,2013-04-02,DISCONTINUED,NA,2013-02-20,NA,NA,NA,2013-04-02,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1298,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-08,2013-04-22,1,15,NA,54,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-08T00:00:00Z,NA,H,2013-04-22T00:00:00Z,NA,H,1,15,15,2013-04-08,2013-04-22,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1298,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-08,2013-04-22,1,15,NA,54,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-08T00:00:00Z,NA,H,2013-04-22T00:00:00Z,NA,H,1,15,15,2013-04-08,2013-04-22,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1298,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-08,2013-04-22,1,15,NA,54,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-08T00:00:00Z,NA,H,2013-04-22T00:00:00Z,NA,H,1,15,15,2013-04-08,2013-04-22,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1298,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-08,2013-04-22,1,15,NA,54,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-08T00:00:00Z,NA,H,2013-04-22T00:00:00Z,NA,H,1,15,15,2013-04-08,2013-04-22,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1298,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-08,2013-04-22,1,15,NA,54,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-08T00:00:00Z,NA,H,2013-04-22T00:00:00Z,NA,H,1,15,15,2013-04-08,2013-04-22,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1298,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-23,2013-06-28,16,82,NA,54,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-23T00:00:00Z,NA,H,2013-06-28T00:00:00Z,NA,H,16,82,67,2013-04-23,2013-06-28,3618,3618,DURD,67,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1298,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-23,2013-06-28,16,82,NA,54,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-23T00:00:00Z,NA,H,2013-06-28T00:00:00Z,NA,H,16,82,67,2013-04-23,2013-06-28,3618,3618,DOSE,3618,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1298,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-23,2013-06-28,16,82,NA,54,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-23T00:00:00Z,NA,H,2013-06-28T00:00:00Z,NA,H,16,82,67,2013-04-23,2013-06-28,3618,3618,PLDOSE,3618,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1298,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-23,2013-06-28,16,82,NA,54,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-23T00:00:00Z,NA,H,2013-06-28T00:00:00Z,NA,H,16,82,67,2013-04-23,2013-06-28,3618,3618,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1298,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-04-23,2013-06-28,16,82,NA,54,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-23T00:00:00Z,NA,H,2013-06-28T00:00:00Z,NA,H,16,82,67,2013-04-23,2013-06-28,3618,3618,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-08T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-04-08,2013-06-28,NA,NA,TDURD,82,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-08T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-04-08,2013-06-28,NA,NA,TDOSE,4428,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-08T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-04-08,2013-06-28,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-08T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-04-08,2013-06-28,NA,NA,TPDOSE,4428,NA,OVERALL,Total planned dose (mg),11,NA,14,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-08T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-04-08,2013-06-28,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-08T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-04-08,2013-06-28,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-08T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-04-08,2013-06-28,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-23T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-04-23,2013-06-28,NA,NA,PDURD,67,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-23T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-04-23,2013-06-28,NA,NA,PDOSE,3618,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-23T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-04-23,2013-06-28,NA,NA,PPDOSE,3618,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-23T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-04-23,2013-06-28,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-23T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-04-23,2013-06-28,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-23T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-04-23,2013-06-28,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1298,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-08,2013-04-08T00:00:00Z,2013-06-28T23:59:59Z,2013-04-23T00:00:00Z,NA,NA,2013-06-28T00:00:00Z,NA,NA,NA,NA,NA,2013-04-23,2013-06-28,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1298,2013-04-08,2013-07-06,2013-04-08,2013-06-28,NA,2013-10-07,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-04-04,-4,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-06-28,82,NA,2013-07-06,DISCONTINUED,2013-10-07,2013-04-08,NA,NA,NA,2013-07-06,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1308,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-28,2013-09-12,1,16,NA,0,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-08-28T00:00:00Z,NA,H,2013-09-12T00:00:00Z,NA,H,1,16,16,2013-08-28,2013-09-12,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1308,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-28,2013-09-12,1,16,NA,0,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-08-28T00:00:00Z,NA,H,2013-09-12T00:00:00Z,NA,H,1,16,16,2013-08-28,2013-09-12,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1308,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-28,2013-09-12,1,16,NA,0,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-08-28T00:00:00Z,NA,H,2013-09-12T00:00:00Z,NA,H,1,16,16,2013-08-28,2013-09-12,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1308,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-28,2013-09-12,1,16,NA,0,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-08-28T00:00:00Z,NA,H,2013-09-12T00:00:00Z,NA,H,1,16,16,2013-08-28,2013-09-12,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1308,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-08-28,2013-09-12,1,16,NA,0,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-08-28T00:00:00Z,NA,H,2013-09-12T00:00:00Z,NA,H,1,16,16,2013-08-28,2013-09-12,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1308,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-13,2013-10-07,17,41,NA,0,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-09-13T00:00:00Z,NA,H,2013-10-07T00:00:00Z,NA,H,17,41,25,2013-09-13,2013-10-07,0,0,DURD,25,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1308,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-13,2013-10-07,17,41,NA,0,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-09-13T00:00:00Z,NA,H,2013-10-07T00:00:00Z,NA,H,17,41,25,2013-09-13,2013-10-07,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1308,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-13,2013-10-07,17,41,NA,0,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-09-13T00:00:00Z,NA,H,2013-10-07T00:00:00Z,NA,H,17,41,25,2013-09-13,2013-10-07,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1308,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-13,2013-10-07,17,41,NA,0,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-09-13T00:00:00Z,NA,H,2013-10-07T00:00:00Z,NA,H,17,41,25,2013-09-13,2013-10-07,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1308,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-13,2013-10-07,17,41,NA,0,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-09-13T00:00:00Z,NA,H,2013-10-07T00:00:00Z,NA,H,17,41,25,2013-09-13,2013-10-07,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-08-28T00:00:00Z,NA,NA,2013-10-07T00:00:00Z,NA,NA,NA,NA,NA,2013-08-28,2013-10-07,NA,NA,TDURD,41,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-08-28T00:00:00Z,NA,NA,2013-10-07T00:00:00Z,NA,NA,NA,NA,NA,2013-08-28,2013-10-07,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-08-28T00:00:00Z,NA,NA,2013-10-07T00:00:00Z,NA,NA,NA,NA,NA,2013-08-28,2013-10-07,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-08-28T00:00:00Z,NA,NA,2013-10-07T00:00:00Z,NA,NA,NA,NA,NA,2013-08-28,2013-10-07,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-08-28T00:00:00Z,NA,NA,2013-10-07T00:00:00Z,NA,NA,NA,NA,NA,2013-08-28,2013-10-07,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-08-28T00:00:00Z,NA,NA,2013-10-07T00:00:00Z,NA,NA,NA,NA,NA,2013-08-28,2013-10-07,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-08-28T00:00:00Z,NA,NA,2013-10-07T00:00:00Z,NA,NA,NA,NA,NA,2013-08-28,2013-10-07,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-09-13T00:00:00Z,NA,NA,2013-10-07T00:00:00Z,NA,NA,NA,NA,NA,2013-09-13,2013-10-07,NA,NA,PDURD,25,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-09-13T00:00:00Z,NA,NA,2013-10-07T00:00:00Z,NA,NA,NA,NA,NA,2013-09-13,2013-10-07,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-09-13T00:00:00Z,NA,NA,2013-10-07T00:00:00Z,NA,NA,NA,NA,NA,2013-09-13,2013-10-07,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-09-13T00:00:00Z,NA,NA,2013-10-07T00:00:00Z,NA,NA,NA,NA,NA,2013-09-13,2013-10-07,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-09-13T00:00:00Z,NA,NA,2013-10-07T00:00:00Z,NA,NA,NA,NA,NA,2013-09-13,2013-10-07,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-09-13T00:00:00Z,NA,NA,2013-10-07T00:00:00Z,NA,NA,NA,NA,NA,2013-09-13,2013-10-07,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1308,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-08-28,2013-08-28T00:00:00Z,2013-10-07T23:59:59Z,2013-09-13T00:00:00Z,NA,NA,2013-10-07T00:00:00Z,NA,NA,NA,NA,NA,2013-09-13,2013-10-07,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1308,2013-08-28,2013-10-07,2013-08-28,2013-10-07,NA,2013-10-07T15:50,NA,NA,716,76,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-08-23,-5,Placebo,Placebo,H,H,2013-10-07,41,NA,2013-10-07,DISCONTINUED,NA,2013-08-28,NA,NA,NA,2013-10-07,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1311,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-05-14,2014-05-28,1,15,NA,54,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-14T00:00:00Z,NA,H,2014-05-28T00:00:00Z,NA,H,1,15,15,2014-05-14,2014-05-28,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1311,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-05-14,2014-05-28,1,15,NA,54,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-14T00:00:00Z,NA,H,2014-05-28T00:00:00Z,NA,H,1,15,15,2014-05-14,2014-05-28,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1311,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-05-14,2014-05-28,1,15,NA,54,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-14T00:00:00Z,NA,H,2014-05-28T00:00:00Z,NA,H,1,15,15,2014-05-14,2014-05-28,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1311,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-05-14,2014-05-28,1,15,NA,54,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-14T00:00:00Z,NA,H,2014-05-28T00:00:00Z,NA,H,1,15,15,2014-05-14,2014-05-28,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1311,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-05-14,2014-05-28,1,15,NA,54,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-14T00:00:00Z,NA,H,2014-05-28T00:00:00Z,NA,H,1,15,15,2014-05-14,2014-05-28,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1311,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-29,2014-09-21,16,131,NA,54,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-29T00:00:00Z,NA,H,2014-09-21T00:00:00Z,NA,H,16,131,116,2014-05-29,2014-09-21,6264,6264,DURD,116,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1311,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-29,2014-09-21,16,131,NA,54,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-29T00:00:00Z,NA,H,2014-09-21T00:00:00Z,NA,H,16,131,116,2014-05-29,2014-09-21,6264,6264,DOSE,6264,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1311,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-29,2014-09-21,16,131,NA,54,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-29T00:00:00Z,NA,H,2014-09-21T00:00:00Z,NA,H,16,131,116,2014-05-29,2014-09-21,6264,6264,PLDOSE,6264,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1311,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-29,2014-09-21,16,131,NA,54,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-29T00:00:00Z,NA,H,2014-09-21T00:00:00Z,NA,H,16,131,116,2014-05-29,2014-09-21,6264,6264,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1311,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-05-29,2014-09-21,16,131,NA,54,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-29T00:00:00Z,NA,H,2014-09-21T00:00:00Z,NA,H,16,131,116,2014-05-29,2014-09-21,6264,6264,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-14T00:00:00Z,NA,NA,2014-09-21T00:00:00Z,NA,NA,NA,NA,NA,2014-05-14,2014-09-21,NA,NA,TDURD,131,NA,OVERALL,Overall duration (days),7,>=90 days,11,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-14T00:00:00Z,NA,NA,2014-09-21T00:00:00Z,NA,NA,NA,NA,NA,2014-05-14,2014-09-21,NA,NA,TDOSE,7074,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-14T00:00:00Z,NA,NA,2014-09-21T00:00:00Z,NA,NA,NA,NA,NA,2014-05-14,2014-09-21,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-14T00:00:00Z,NA,NA,2014-09-21T00:00:00Z,NA,NA,NA,NA,NA,2014-05-14,2014-09-21,NA,NA,TPDOSE,7074,NA,OVERALL,Total planned dose (mg),11,NA,14,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-14T00:00:00Z,NA,NA,2014-09-21T00:00:00Z,NA,NA,NA,NA,NA,2014-05-14,2014-09-21,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-14T00:00:00Z,NA,NA,2014-09-21T00:00:00Z,NA,NA,NA,NA,NA,2014-05-14,2014-09-21,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-14T00:00:00Z,NA,NA,2014-09-21T00:00:00Z,NA,NA,NA,NA,NA,2014-05-14,2014-09-21,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-29T00:00:00Z,NA,NA,2014-09-21T00:00:00Z,NA,NA,NA,NA,NA,2014-05-29,2014-09-21,NA,NA,PDURD,116,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-29T00:00:00Z,NA,NA,2014-09-21T00:00:00Z,NA,NA,NA,NA,NA,2014-05-29,2014-09-21,NA,NA,PDOSE,6264,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-29T00:00:00Z,NA,NA,2014-09-21T00:00:00Z,NA,NA,NA,NA,NA,2014-05-29,2014-09-21,NA,NA,PPDOSE,6264,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-29T00:00:00Z,NA,NA,2014-09-21T00:00:00Z,NA,NA,NA,NA,NA,2014-05-29,2014-09-21,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-29T00:00:00Z,NA,NA,2014-09-21T00:00:00Z,NA,NA,NA,NA,NA,2014-05-29,2014-09-21,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-29T00:00:00Z,NA,NA,2014-09-21T00:00:00Z,NA,NA,NA,NA,NA,2014-05-29,2014-09-21,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1311,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-05-14,2014-05-14T00:00:00Z,2014-09-21T23:59:59Z,2014-05-29T00:00:00Z,NA,NA,2014-09-21T00:00:00Z,NA,NA,NA,NA,NA,2014-05-29,2014-09-21,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1311,2014-05-14,2014-09-30,2014-05-14,2014-09-21,NA,2014-11-15,NA,NA,716,78,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-05-08,-6,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-09-21,131,NA,2014-09-30,DISCONTINUED,2014-11-15,2014-05-14,NA,NA,NA,2014-09-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1364,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-04,2013-07-17,1,14,NA,54,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-04T00:00:00Z,NA,H,2013-07-17T00:00:00Z,NA,H,1,14,14,2013-07-04,2013-07-17,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1364,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-04,2013-07-17,1,14,NA,54,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-04T00:00:00Z,NA,H,2013-07-17T00:00:00Z,NA,H,1,14,14,2013-07-04,2013-07-17,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1364,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-04,2013-07-17,1,14,NA,54,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-04T00:00:00Z,NA,H,2013-07-17T00:00:00Z,NA,H,1,14,14,2013-07-04,2013-07-17,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1364,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-04,2013-07-17,1,14,NA,54,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-04T00:00:00Z,NA,H,2013-07-17T00:00:00Z,NA,H,1,14,14,2013-07-04,2013-07-17,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1364,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-04,2013-07-17,1,14,NA,54,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-04T00:00:00Z,NA,H,2013-07-17T00:00:00Z,NA,H,1,14,14,2013-07-04,2013-07-17,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1364,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-18,2013-12-23,15,173,NA,54,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-18T00:00:00Z,NA,H,2013-12-23T00:00:00Z,NA,H,15,173,159,2013-07-18,2013-12-23,12879,8586,DURD,159,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1364,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-18,2013-12-23,15,173,NA,54,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-18T00:00:00Z,NA,H,2013-12-23T00:00:00Z,NA,H,15,173,159,2013-07-18,2013-12-23,12879,8586,DOSE,12879,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1364,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-18,2013-12-23,15,173,NA,54,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-18T00:00:00Z,NA,H,2013-12-23T00:00:00Z,NA,H,15,173,159,2013-07-18,2013-12-23,12879,8586,PLDOSE,8586,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1364,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-18,2013-12-23,15,173,NA,54,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-18T00:00:00Z,NA,H,2013-12-23T00:00:00Z,NA,H,15,173,159,2013-07-18,2013-12-23,12879,8586,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1364,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-18,2013-12-23,15,173,NA,54,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-18T00:00:00Z,NA,H,2013-12-23T00:00:00Z,NA,H,15,173,159,2013-07-18,2013-12-23,12879,8586,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1364,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-24,2014-01-09,174,190,NA,54,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-12-24T00:00:00Z,NA,H,2014-01-09T00:00:00Z,NA,H,174,190,17,2013-12-24,2014-01-09,918,918,DURD,17,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1364,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-24,2014-01-09,174,190,NA,54,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-12-24T00:00:00Z,NA,H,2014-01-09T00:00:00Z,NA,H,174,190,17,2013-12-24,2014-01-09,918,918,DOSE,918,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1364,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-24,2014-01-09,174,190,NA,54,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-12-24T00:00:00Z,NA,H,2014-01-09T00:00:00Z,NA,H,174,190,17,2013-12-24,2014-01-09,918,918,PLDOSE,918,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1364,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-24,2014-01-09,174,190,NA,54,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-12-24T00:00:00Z,NA,H,2014-01-09T00:00:00Z,NA,H,174,190,17,2013-12-24,2014-01-09,918,918,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1364,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-24,2014-01-09,174,190,NA,54,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-12-24T00:00:00Z,NA,H,2014-01-09T00:00:00Z,NA,H,174,190,17,2013-12-24,2014-01-09,918,918,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-04T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-04,2014-01-09,NA,NA,TDURD,190,NA,OVERALL,Overall duration (days),7,>=90 days,16,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-04T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-04,2014-01-09,NA,NA,TDOSE,14553,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-04T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-04,2014-01-09,NA,NA,AVDDSE,76.59473684210526,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-04T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-04,2014-01-09,NA,NA,TPDOSE,10260,NA,OVERALL,Total planned dose (mg),11,NA,19,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-04T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-04,2014-01-09,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-04T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-04,2014-01-09,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-04T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-04,2014-01-09,NA,NA,TDOSINT,141.8421052631579,NA,OVERALL,Overall dose intensity (%),90,NA,22,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-18T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-18,2014-01-09,NA,NA,PDURD,176,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-18T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-18,2014-01-09,NA,NA,PDOSE,13797,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-18T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-18,2014-01-09,NA,NA,PPDOSE,9504,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-18T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-18,2014-01-09,NA,NA,PAVDDSE,78.39204545454545,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-18T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-18,2014-01-09,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-18T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-18,2014-01-09,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1364,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-04,2013-07-04T00:00:00Z,2014-01-09T23:59:59Z,2013-07-18T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-18,2014-01-09,NA,NA,PDOSINT,145.17045454545453,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1364,2013-07-04,2014-01-09,2013-07-04,2014-01-09,NA,2014-01-09T15:30,NA,NA,716,84,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-06-27,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-01-09,190,NA,2014-01-09,COMPLETED,NA,2013-07-04,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1373,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-14,2012-12-30,1,17,NA,54,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-14T00:00:00Z,NA,H,2012-12-30T00:00:00Z,NA,H,1,17,17,2012-12-14,2012-12-30,918,918,DURD,17,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1373,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-14,2012-12-30,1,17,NA,54,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-14T00:00:00Z,NA,H,2012-12-30T00:00:00Z,NA,H,1,17,17,2012-12-14,2012-12-30,918,918,DOSE,918,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1373,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-14,2012-12-30,1,17,NA,54,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-14T00:00:00Z,NA,H,2012-12-30T00:00:00Z,NA,H,1,17,17,2012-12-14,2012-12-30,918,918,PLDOSE,918,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1373,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-14,2012-12-30,1,17,NA,54,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-14T00:00:00Z,NA,H,2012-12-30T00:00:00Z,NA,H,1,17,17,2012-12-14,2012-12-30,918,918,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1373,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-14,2012-12-30,1,17,NA,54,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-14T00:00:00Z,NA,H,2012-12-30T00:00:00Z,NA,H,1,17,17,2012-12-14,2012-12-30,918,918,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1373,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-31,2013-02-27,18,76,NA,54,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-31T00:00:00Z,NA,H,2013-02-27T00:00:00Z,NA,H,18,76,59,2012-12-31,2013-02-27,4779,3186,DURD,59,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1373,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-31,2013-02-27,18,76,NA,54,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-31T00:00:00Z,NA,H,2013-02-27T00:00:00Z,NA,H,18,76,59,2012-12-31,2013-02-27,4779,3186,DOSE,4779,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1373,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-31,2013-02-27,18,76,NA,54,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-31T00:00:00Z,NA,H,2013-02-27T00:00:00Z,NA,H,18,76,59,2012-12-31,2013-02-27,4779,3186,PLDOSE,3186,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1373,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-31,2013-02-27,18,76,NA,54,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-31T00:00:00Z,NA,H,2013-02-27T00:00:00Z,NA,H,18,76,59,2012-12-31,2013-02-27,4779,3186,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1373,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-12-31,2013-02-27,18,76,NA,54,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-31T00:00:00Z,NA,H,2013-02-27T00:00:00Z,NA,H,18,76,59,2012-12-31,2013-02-27,4779,3186,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-14T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-14,2013-02-27,NA,NA,TDURD,76,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-14T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-14,2013-02-27,NA,NA,TDOSE,5697,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-14T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-14,2013-02-27,NA,NA,AVDDSE,74.96052631578948,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-14T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-14,2013-02-27,NA,NA,TPDOSE,4104,NA,OVERALL,Total planned dose (mg),11,NA,14,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-14T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-14,2013-02-27,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-14T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-14,2013-02-27,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-14T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-14,2013-02-27,NA,NA,TDOSINT,138.8157894736842,NA,OVERALL,Overall dose intensity (%),90,NA,17,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-31T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-31,2013-02-27,NA,NA,PDURD,59,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-31T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-31,2013-02-27,NA,NA,PDOSE,4779,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-31T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-31,2013-02-27,NA,NA,PPDOSE,3186,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-31T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-31,2013-02-27,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-31T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-31,2013-02-27,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-31T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-31,2013-02-27,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1373,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-14,2012-12-14T00:00:00Z,2013-02-27T23:59:59Z,2012-12-31T00:00:00Z,NA,NA,2013-02-27T00:00:00Z,NA,NA,NA,NA,NA,2012-12-31,2013-02-27,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1373,2012-12-14,2013-02-28,2012-12-14,2013-02-27,NA,2013-02-28T10:23,NA,NA,716,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-11-24,-20,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-27,76,NA,2013-02-28,DISCONTINUED,NA,2012-12-14,NA,NA,NA,2013-02-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1418,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-05,2013-05-19,1,15,NA,54,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-05T00:00:00Z,NA,H,2013-05-19T00:00:00Z,NA,H,1,15,15,2013-05-05,2013-05-19,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1418,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-05,2013-05-19,1,15,NA,54,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-05T00:00:00Z,NA,H,2013-05-19T00:00:00Z,NA,H,1,15,15,2013-05-05,2013-05-19,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1418,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-05,2013-05-19,1,15,NA,54,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-05T00:00:00Z,NA,H,2013-05-19T00:00:00Z,NA,H,1,15,15,2013-05-05,2013-05-19,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1418,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-05,2013-05-19,1,15,NA,54,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-05T00:00:00Z,NA,H,2013-05-19T00:00:00Z,NA,H,1,15,15,2013-05-05,2013-05-19,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1418,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-05,2013-05-19,1,15,NA,54,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-05T00:00:00Z,NA,H,2013-05-19T00:00:00Z,NA,H,1,15,15,2013-05-05,2013-05-19,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1418,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-20,2013-11-06,16,186,NA,54,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-20T00:00:00Z,NA,H,2013-11-06T00:00:00Z,NA,H,16,186,171,2013-05-20,2013-11-06,13851,9234,DURD,171,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1418,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-20,2013-11-06,16,186,NA,54,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-20T00:00:00Z,NA,H,2013-11-06T00:00:00Z,NA,H,16,186,171,2013-05-20,2013-11-06,13851,9234,DOSE,13851,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1418,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-20,2013-11-06,16,186,NA,54,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-20T00:00:00Z,NA,H,2013-11-06T00:00:00Z,NA,H,16,186,171,2013-05-20,2013-11-06,13851,9234,PLDOSE,9234,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1418,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-20,2013-11-06,16,186,NA,54,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-20T00:00:00Z,NA,H,2013-11-06T00:00:00Z,NA,H,16,186,171,2013-05-20,2013-11-06,13851,9234,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1418,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-20,2013-11-06,16,186,NA,54,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-20T00:00:00Z,NA,H,2013-11-06T00:00:00Z,NA,H,16,186,171,2013-05-20,2013-11-06,13851,9234,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1418,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-07,2013-11-20,187,200,NA,54,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-11-07T00:00:00Z,NA,H,2013-11-20T00:00:00Z,NA,H,187,200,14,2013-11-07,2013-11-20,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1418,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-07,2013-11-20,187,200,NA,54,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-11-07T00:00:00Z,NA,H,2013-11-20T00:00:00Z,NA,H,187,200,14,2013-11-07,2013-11-20,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1418,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-07,2013-11-20,187,200,NA,54,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-11-07T00:00:00Z,NA,H,2013-11-20T00:00:00Z,NA,H,187,200,14,2013-11-07,2013-11-20,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1418,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-07,2013-11-20,187,200,NA,54,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-11-07T00:00:00Z,NA,H,2013-11-20T00:00:00Z,NA,H,187,200,14,2013-11-07,2013-11-20,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1418,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-07,2013-11-20,187,200,NA,54,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-11-07T00:00:00Z,NA,H,2013-11-20T00:00:00Z,NA,H,187,200,14,2013-11-07,2013-11-20,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-05T00:00:00Z,NA,NA,2013-11-20T00:00:00Z,NA,NA,NA,NA,NA,2013-05-05,2013-11-20,NA,NA,TDURD,200,NA,OVERALL,Overall duration (days),7,>=90 days,16,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-05T00:00:00Z,NA,NA,2013-11-20T00:00:00Z,NA,NA,NA,NA,NA,2013-05-05,2013-11-20,NA,NA,TDOSE,15417,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-05T00:00:00Z,NA,NA,2013-11-20T00:00:00Z,NA,NA,NA,NA,NA,2013-05-05,2013-11-20,NA,NA,AVDDSE,77.085,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-05T00:00:00Z,NA,NA,2013-11-20T00:00:00Z,NA,NA,NA,NA,NA,2013-05-05,2013-11-20,NA,NA,TPDOSE,10800,NA,OVERALL,Total planned dose (mg),11,NA,19,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-05T00:00:00Z,NA,NA,2013-11-20T00:00:00Z,NA,NA,NA,NA,NA,2013-05-05,2013-11-20,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-05T00:00:00Z,NA,NA,2013-11-20T00:00:00Z,NA,NA,NA,NA,NA,2013-05-05,2013-11-20,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-05T00:00:00Z,NA,NA,2013-11-20T00:00:00Z,NA,NA,NA,NA,NA,2013-05-05,2013-11-20,NA,NA,TDOSINT,142.75,NA,OVERALL,Overall dose intensity (%),90,NA,22,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-20T00:00:00Z,NA,NA,2013-11-20T00:00:00Z,NA,NA,NA,NA,NA,2013-05-20,2013-11-20,NA,NA,PDURD,185,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-20T00:00:00Z,NA,NA,2013-11-20T00:00:00Z,NA,NA,NA,NA,NA,2013-05-20,2013-11-20,NA,NA,PDOSE,14607,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-20T00:00:00Z,NA,NA,2013-11-20T00:00:00Z,NA,NA,NA,NA,NA,2013-05-20,2013-11-20,NA,NA,PPDOSE,9990,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-20T00:00:00Z,NA,NA,2013-11-20T00:00:00Z,NA,NA,NA,NA,NA,2013-05-20,2013-11-20,NA,NA,PAVDDSE,78.95675675675676,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-20T00:00:00Z,NA,NA,2013-11-20T00:00:00Z,NA,NA,NA,NA,NA,2013-05-20,2013-11-20,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-20T00:00:00Z,NA,NA,2013-11-20T00:00:00Z,NA,NA,NA,NA,NA,2013-05-20,2013-11-20,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1418,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-05,2013-05-05T00:00:00Z,2013-11-20T23:59:59Z,2013-05-20T00:00:00Z,NA,NA,2013-11-20T00:00:00Z,NA,NA,NA,NA,NA,2013-05-20,2013-11-20,NA,NA,PDOSINT,146.2162162162162,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1418,2013-05-05,2013-11-20,2013-05-05,2013-11-20,NA,2013-11-20T11:44,NA,NA,716,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-27,-8,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-11-20,200,NA,2013-11-20,COMPLETED,NA,2013-05-05,NA,NA,NA,2013-11-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1441,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-22,2014-02-06,1,16,NA,0,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-01-22T00:00:00Z,NA,H,2014-02-06T00:00:00Z,NA,H,1,16,16,2014-01-22,2014-02-06,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1441,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-22,2014-02-06,1,16,NA,0,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-01-22T00:00:00Z,NA,H,2014-02-06T00:00:00Z,NA,H,1,16,16,2014-01-22,2014-02-06,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1441,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-22,2014-02-06,1,16,NA,0,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-01-22T00:00:00Z,NA,H,2014-02-06T00:00:00Z,NA,H,1,16,16,2014-01-22,2014-02-06,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1441,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-22,2014-02-06,1,16,NA,0,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-01-22T00:00:00Z,NA,H,2014-02-06T00:00:00Z,NA,H,1,16,16,2014-01-22,2014-02-06,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1441,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-22,2014-02-06,1,16,NA,0,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-01-22T00:00:00Z,NA,H,2014-02-06T00:00:00Z,NA,H,1,16,16,2014-01-22,2014-02-06,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1441,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-07,2014-07-08,17,168,NA,0,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-02-07T00:00:00Z,NA,H,2014-07-08T00:00:00Z,NA,H,17,168,152,2014-02-07,2014-07-08,0,0,DURD,152,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1441,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-07,2014-07-08,17,168,NA,0,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-02-07T00:00:00Z,NA,H,2014-07-08T00:00:00Z,NA,H,17,168,152,2014-02-07,2014-07-08,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1441,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-07,2014-07-08,17,168,NA,0,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-02-07T00:00:00Z,NA,H,2014-07-08T00:00:00Z,NA,H,17,168,152,2014-02-07,2014-07-08,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1441,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-07,2014-07-08,17,168,NA,0,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-02-07T00:00:00Z,NA,H,2014-07-08T00:00:00Z,NA,H,17,168,152,2014-02-07,2014-07-08,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1441,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-07,2014-07-08,17,168,NA,0,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-02-07T00:00:00Z,NA,H,2014-07-08T00:00:00Z,NA,H,17,168,152,2014-02-07,2014-07-08,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1441,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-09,2014-07-22,169,182,NA,0,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-07-09T00:00:00Z,NA,H,2014-07-22T00:00:00Z,NA,H,169,182,14,2014-07-09,2014-07-22,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1441,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-09,2014-07-22,169,182,NA,0,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-07-09T00:00:00Z,NA,H,2014-07-22T00:00:00Z,NA,H,169,182,14,2014-07-09,2014-07-22,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1441,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-09,2014-07-22,169,182,NA,0,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-07-09T00:00:00Z,NA,H,2014-07-22T00:00:00Z,NA,H,169,182,14,2014-07-09,2014-07-22,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1441,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-09,2014-07-22,169,182,NA,0,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-07-09T00:00:00Z,NA,H,2014-07-22T00:00:00Z,NA,H,169,182,14,2014-07-09,2014-07-22,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1441,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-09,2014-07-22,169,182,NA,0,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-07-09T00:00:00Z,NA,H,2014-07-22T00:00:00Z,NA,H,169,182,14,2014-07-09,2014-07-22,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-01-22T00:00:00Z,NA,NA,2014-07-22T00:00:00Z,NA,NA,NA,NA,NA,2014-01-22,2014-07-22,NA,NA,TDURD,182,NA,OVERALL,Overall duration (days),7,>=90 days,16,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-01-22T00:00:00Z,NA,NA,2014-07-22T00:00:00Z,NA,NA,NA,NA,NA,2014-01-22,2014-07-22,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-01-22T00:00:00Z,NA,NA,2014-07-22T00:00:00Z,NA,NA,NA,NA,NA,2014-01-22,2014-07-22,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-01-22T00:00:00Z,NA,NA,2014-07-22T00:00:00Z,NA,NA,NA,NA,NA,2014-01-22,2014-07-22,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-01-22T00:00:00Z,NA,NA,2014-07-22T00:00:00Z,NA,NA,NA,NA,NA,2014-01-22,2014-07-22,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-01-22T00:00:00Z,NA,NA,2014-07-22T00:00:00Z,NA,NA,NA,NA,NA,2014-01-22,2014-07-22,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-01-22T00:00:00Z,NA,NA,2014-07-22T00:00:00Z,NA,NA,NA,NA,NA,2014-01-22,2014-07-22,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-02-07T00:00:00Z,NA,NA,2014-07-22T00:00:00Z,NA,NA,NA,NA,NA,2014-02-07,2014-07-22,NA,NA,PDURD,166,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-02-07T00:00:00Z,NA,NA,2014-07-22T00:00:00Z,NA,NA,NA,NA,NA,2014-02-07,2014-07-22,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-02-07T00:00:00Z,NA,NA,2014-07-22T00:00:00Z,NA,NA,NA,NA,NA,2014-02-07,2014-07-22,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-02-07T00:00:00Z,NA,NA,2014-07-22T00:00:00Z,NA,NA,NA,NA,NA,2014-02-07,2014-07-22,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-02-07T00:00:00Z,NA,NA,2014-07-22T00:00:00Z,NA,NA,NA,NA,NA,2014-02-07,2014-07-22,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-02-07T00:00:00Z,NA,NA,2014-07-22T00:00:00Z,NA,NA,NA,NA,NA,2014-02-07,2014-07-22,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1441,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-22,2014-01-22T00:00:00Z,2014-07-22T23:59:59Z,2014-02-07T00:00:00Z,NA,NA,2014-07-22T00:00:00Z,NA,NA,NA,NA,NA,2014-02-07,2014-07-22,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1441,2014-01-22,2014-07-22,2014-01-22,2014-07-22,NA,2014-07-22T10:00,NA,NA,716,85,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-13,-9,Placebo,Placebo,H,H,2014-07-22,182,NA,2014-07-22,COMPLETED,NA,2014-01-22,NA,NA,NA,2014-07-22,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1447,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-16,2013-12-31,1,16,NA,54,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2013-12-31T00:00:00Z,NA,H,1,16,16,2013-12-16,2013-12-31,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1447,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-16,2013-12-31,1,16,NA,54,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2013-12-31T00:00:00Z,NA,H,1,16,16,2013-12-16,2013-12-31,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1447,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-16,2013-12-31,1,16,NA,54,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2013-12-31T00:00:00Z,NA,H,1,16,16,2013-12-16,2013-12-31,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1447,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-16,2013-12-31,1,16,NA,54,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2013-12-31T00:00:00Z,NA,H,1,16,16,2013-12-16,2013-12-31,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1447,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-16,2013-12-31,1,16,NA,54,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2013-12-16T00:00:00Z,NA,H,2013-12-31T00:00:00Z,NA,H,1,16,16,2013-12-16,2013-12-31,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1447,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-01,2014-06-07,17,174,NA,54,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-01-01T00:00:00Z,NA,H,2014-06-07T00:00:00Z,NA,H,17,174,158,2014-01-01,2014-06-07,12798,8532,DURD,158,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1447,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-01,2014-06-07,17,174,NA,54,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-01-01T00:00:00Z,NA,H,2014-06-07T00:00:00Z,NA,H,17,174,158,2014-01-01,2014-06-07,12798,8532,DOSE,12798,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1447,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-01,2014-06-07,17,174,NA,54,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-01-01T00:00:00Z,NA,H,2014-06-07T00:00:00Z,NA,H,17,174,158,2014-01-01,2014-06-07,12798,8532,PLDOSE,8532,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1447,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-01,2014-06-07,17,174,NA,54,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-01-01T00:00:00Z,NA,H,2014-06-07T00:00:00Z,NA,H,17,174,158,2014-01-01,2014-06-07,12798,8532,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1447,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-01,2014-06-07,17,174,NA,54,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-01-01T00:00:00Z,NA,H,2014-06-07T00:00:00Z,NA,H,17,174,158,2014-01-01,2014-06-07,12798,8532,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1447,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-08,2014-06-17,175,184,NA,54,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-06-08T00:00:00Z,NA,H,2014-06-17T00:00:00Z,NA,H,175,184,10,2014-06-08,2014-06-17,540,540,DURD,10,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1447,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-08,2014-06-17,175,184,NA,54,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-06-08T00:00:00Z,NA,H,2014-06-17T00:00:00Z,NA,H,175,184,10,2014-06-08,2014-06-17,540,540,DOSE,540,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1447,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-08,2014-06-17,175,184,NA,54,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-06-08T00:00:00Z,NA,H,2014-06-17T00:00:00Z,NA,H,175,184,10,2014-06-08,2014-06-17,540,540,PLDOSE,540,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1447,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-08,2014-06-17,175,184,NA,54,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-06-08T00:00:00Z,NA,H,2014-06-17T00:00:00Z,NA,H,175,184,10,2014-06-08,2014-06-17,540,540,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-716-1447,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-06-08,2014-06-17,175,184,NA,54,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-06-08T00:00:00Z,NA,H,2014-06-17T00:00:00Z,NA,H,175,184,10,2014-06-08,2014-06-17,540,540,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-06-17,NA,NA,TDURD,184,NA,OVERALL,Overall duration (days),7,>=90 days,16,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-06-17,NA,NA,TDOSE,14202,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-06-17,NA,NA,AVDDSE,77.18478260869566,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-06-17,NA,NA,TPDOSE,9936,NA,OVERALL,Total planned dose (mg),11,NA,19,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-06-17,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-06-17,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2013-12-16T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2013-12-16,2014-06-17,NA,NA,TDOSINT,142.93478260869566,NA,OVERALL,Overall dose intensity (%),90,NA,22,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-01-01T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2014-01-01,2014-06-17,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-01-01T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2014-01-01,2014-06-17,NA,NA,PDOSE,13338,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-01-01T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2014-01-01,2014-06-17,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-01-01T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2014-01-01,2014-06-17,NA,NA,PAVDDSE,79.39285714285714,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-01-01T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2014-01-01,2014-06-17,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-01-01T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2014-01-01,2014-06-17,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-716-1447,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-16,2013-12-16T00:00:00Z,2014-06-17T23:59:59Z,2014-01-01T00:00:00Z,NA,NA,2014-06-17T00:00:00Z,NA,NA,NA,NA,NA,2014-01-01,2014-06-17,NA,NA,PDOSINT,147.02380952380955,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1447,2013-12-16,2014-06-17,2013-12-16,2014-06-17,NA,2014-06-17T12:00,NA,NA,716,72,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-12-10,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-06-17,184,NA,2014-06-17,COMPLETED,NA,2013-12-16,NA,NA,NA,2014-06-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1004,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-14,2014-01-28,1,15,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-14T00:00:00Z,NA,H,2014-01-28T00:00:00Z,NA,H,1,15,15,2014-01-14,2014-01-28,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1004,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-14,2014-01-28,1,15,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-14T00:00:00Z,NA,H,2014-01-28T00:00:00Z,NA,H,1,15,15,2014-01-14,2014-01-28,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1004,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-14,2014-01-28,1,15,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-14T00:00:00Z,NA,H,2014-01-28T00:00:00Z,NA,H,1,15,15,2014-01-14,2014-01-28,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1004,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-14,2014-01-28,1,15,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-14T00:00:00Z,NA,H,2014-01-28T00:00:00Z,NA,H,1,15,15,2014-01-14,2014-01-28,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1004,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-14,2014-01-28,1,15,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-14T00:00:00Z,NA,H,2014-01-28T00:00:00Z,NA,H,1,15,15,2014-01-14,2014-01-28,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1004,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-29,2014-07-01,16,169,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-29T00:00:00Z,NA,H,2014-07-01T00:00:00Z,NA,H,16,169,154,2014-01-29,2014-07-01,8316,8316,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1004,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-29,2014-07-01,16,169,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-29T00:00:00Z,NA,H,2014-07-01T00:00:00Z,NA,H,16,169,154,2014-01-29,2014-07-01,8316,8316,DOSE,8316,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1004,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-29,2014-07-01,16,169,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-29T00:00:00Z,NA,H,2014-07-01T00:00:00Z,NA,H,16,169,154,2014-01-29,2014-07-01,8316,8316,PLDOSE,8316,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1004,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-29,2014-07-01,16,169,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-29T00:00:00Z,NA,H,2014-07-01T00:00:00Z,NA,H,16,169,154,2014-01-29,2014-07-01,8316,8316,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1004,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-29,2014-07-01,16,169,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-29T00:00:00Z,NA,H,2014-07-01T00:00:00Z,NA,H,16,169,154,2014-01-29,2014-07-01,8316,8316,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1004,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-02,2014-07-16,170,184,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-07-02T00:00:00Z,NA,H,2014-07-16T00:00:00Z,NA,H,170,184,15,2014-07-02,2014-07-16,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1004,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-02,2014-07-16,170,184,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-07-02T00:00:00Z,NA,H,2014-07-16T00:00:00Z,NA,H,170,184,15,2014-07-02,2014-07-16,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1004,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-02,2014-07-16,170,184,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-07-02T00:00:00Z,NA,H,2014-07-16T00:00:00Z,NA,H,170,184,15,2014-07-02,2014-07-16,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1004,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-02,2014-07-16,170,184,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-07-02T00:00:00Z,NA,H,2014-07-16T00:00:00Z,NA,H,170,184,15,2014-07-02,2014-07-16,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1004,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-02,2014-07-16,170,184,NA,54,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-07-02T00:00:00Z,NA,H,2014-07-16T00:00:00Z,NA,H,170,184,15,2014-07-02,2014-07-16,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1004,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-14T00:00:00Z,NA,NA,2014-07-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-14,2014-07-16,NA,NA,TDURD,184,NA,OVERALL,Overall duration (days),7,>=90 days,16,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1004,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-14T00:00:00Z,NA,NA,2014-07-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-14,2014-07-16,NA,NA,TDOSE,9936,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1004,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-14T00:00:00Z,NA,NA,2014-07-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-14,2014-07-16,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1004,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-14T00:00:00Z,NA,NA,2014-07-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-14,2014-07-16,NA,NA,TPDOSE,9936,NA,OVERALL,Total planned dose (mg),11,NA,19,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1004,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-14T00:00:00Z,NA,NA,2014-07-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-14,2014-07-16,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1004,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-14T00:00:00Z,NA,NA,2014-07-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-14,2014-07-16,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1004,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-14T00:00:00Z,NA,NA,2014-07-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-14,2014-07-16,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1004,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-29T00:00:00Z,NA,NA,2014-07-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-29,2014-07-16,NA,NA,PDURD,169,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1004,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-29T00:00:00Z,NA,NA,2014-07-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-29,2014-07-16,NA,NA,PDOSE,9126,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1004,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-29T00:00:00Z,NA,NA,2014-07-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-29,2014-07-16,NA,NA,PPDOSE,9126,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1004,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-29T00:00:00Z,NA,NA,2014-07-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-29,2014-07-16,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1004,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-29T00:00:00Z,NA,NA,2014-07-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-29,2014-07-16,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1004,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-29T00:00:00Z,NA,NA,2014-07-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-29,2014-07-16,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1004,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-14,2014-01-14T00:00:00Z,2014-07-16T23:59:59Z,2014-01-29T00:00:00Z,NA,NA,2014-07-16T00:00:00Z,NA,NA,NA,NA,NA,2014-01-29,2014-07-16,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1004,2014-01-14,2014-07-16,2014-01-14,2014-07-16,NA,2014-07-16T13:21,NA,NA,717,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2014-01-01,-13,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-07-16,184,NA,2014-07-16,COMPLETED,NA,2014-01-14,NA,NA,NA,2014-07-16,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1109,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-27,2014-02-10,1,15,NA,54,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,H,2014-02-10T00:00:00Z,NA,H,1,15,15,2014-01-27,2014-02-10,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1109,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-27,2014-02-10,1,15,NA,54,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,H,2014-02-10T00:00:00Z,NA,H,1,15,15,2014-01-27,2014-02-10,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1109,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-27,2014-02-10,1,15,NA,54,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,H,2014-02-10T00:00:00Z,NA,H,1,15,15,2014-01-27,2014-02-10,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1109,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-27,2014-02-10,1,15,NA,54,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,H,2014-02-10T00:00:00Z,NA,H,1,15,15,2014-01-27,2014-02-10,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1109,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-27,2014-02-10,1,15,NA,54,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,H,2014-02-10T00:00:00Z,NA,H,1,15,15,2014-01-27,2014-02-10,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1109,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-11,2014-07-18,16,173,NA,54,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,H,2014-07-18T00:00:00Z,NA,H,16,173,158,2014-02-11,2014-07-18,12798,8532,DURD,158,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1109,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-11,2014-07-18,16,173,NA,54,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,H,2014-07-18T00:00:00Z,NA,H,16,173,158,2014-02-11,2014-07-18,12798,8532,DOSE,12798,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1109,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-11,2014-07-18,16,173,NA,54,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,H,2014-07-18T00:00:00Z,NA,H,16,173,158,2014-02-11,2014-07-18,12798,8532,PLDOSE,8532,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1109,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-11,2014-07-18,16,173,NA,54,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,H,2014-07-18T00:00:00Z,NA,H,16,173,158,2014-02-11,2014-07-18,12798,8532,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1109,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-02-11,2014-07-18,16,173,NA,54,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,H,2014-07-18T00:00:00Z,NA,H,16,173,158,2014-02-11,2014-07-18,12798,8532,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1109,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-19,2014-07-28,174,183,NA,54,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-07-19T00:00:00Z,NA,H,2014-07-28T00:00:00Z,NA,H,174,183,10,2014-07-19,2014-07-28,540,540,DURD,10,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1109,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-19,2014-07-28,174,183,NA,54,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-07-19T00:00:00Z,NA,H,2014-07-28T00:00:00Z,NA,H,174,183,10,2014-07-19,2014-07-28,540,540,DOSE,540,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1109,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-19,2014-07-28,174,183,NA,54,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-07-19T00:00:00Z,NA,H,2014-07-28T00:00:00Z,NA,H,174,183,10,2014-07-19,2014-07-28,540,540,PLDOSE,540,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1109,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-19,2014-07-28,174,183,NA,54,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-07-19T00:00:00Z,NA,H,2014-07-28T00:00:00Z,NA,H,174,183,10,2014-07-19,2014-07-28,540,540,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1109,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-07-19,2014-07-28,174,183,NA,54,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-07-19T00:00:00Z,NA,H,2014-07-28T00:00:00Z,NA,H,174,183,10,2014-07-19,2014-07-28,540,540,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-27,2014-07-28,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-27,2014-07-28,NA,NA,TDOSE,14148,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-27,2014-07-28,NA,NA,AVDDSE,77.31147540983606,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-27,2014-07-28,NA,NA,TPDOSE,9882,NA,OVERALL,Total planned dose (mg),11,NA,19,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-27,2014-07-28,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-27,2014-07-28,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-01-27T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-01-27,2014-07-28,NA,NA,TDOSINT,143.16939890710384,NA,OVERALL,Overall dose intensity (%),90,NA,22,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-07-28,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-07-28,NA,NA,PDOSE,13338,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-07-28,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-07-28,NA,NA,PAVDDSE,79.39285714285714,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-07-28,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-07-28,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1109,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-27,2014-01-27T00:00:00Z,2014-07-28T23:59:59Z,2014-02-11T00:00:00Z,NA,NA,2014-07-28T00:00:00Z,NA,NA,NA,NA,NA,2014-02-11,2014-07-28,NA,NA,PDOSINT,147.02380952380955,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1109,2014-01-27,2014-07-28,2014-01-27,2014-07-28,NA,2014-07-28T10:53,NA,NA,717,84,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2014-01-20,-7,Xanomeline High Dose,Xanomeline High Dose,H,H,2014-07-28,183,NA,2014-07-28,COMPLETED,NA,2014-01-27,NA,NA,NA,2014-07-28,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1174,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-22,2013-02-04,1,14,NA,54,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-01-22T00:00:00Z,NA,H,2013-02-04T00:00:00Z,NA,H,1,14,14,2013-01-22,2013-02-04,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1174,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-22,2013-02-04,1,14,NA,54,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-01-22T00:00:00Z,NA,H,2013-02-04T00:00:00Z,NA,H,1,14,14,2013-01-22,2013-02-04,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1174,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-22,2013-02-04,1,14,NA,54,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-01-22T00:00:00Z,NA,H,2013-02-04T00:00:00Z,NA,H,1,14,14,2013-01-22,2013-02-04,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1174,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-22,2013-02-04,1,14,NA,54,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-01-22T00:00:00Z,NA,H,2013-02-04T00:00:00Z,NA,H,1,14,14,2013-01-22,2013-02-04,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1174,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-22,2013-02-04,1,14,NA,54,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-01-22T00:00:00Z,NA,H,2013-02-04T00:00:00Z,NA,H,1,14,14,2013-01-22,2013-02-04,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1174,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-05,2013-07-07,15,167,NA,54,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-02-05T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,15,167,153,2013-02-05,2013-07-07,12393,8262,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1174,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-05,2013-07-07,15,167,NA,54,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-02-05T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,15,167,153,2013-02-05,2013-07-07,12393,8262,DOSE,12393,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1174,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-05,2013-07-07,15,167,NA,54,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-02-05T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,15,167,153,2013-02-05,2013-07-07,12393,8262,PLDOSE,8262,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1174,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-05,2013-07-07,15,167,NA,54,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-02-05T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,15,167,153,2013-02-05,2013-07-07,12393,8262,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1174,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-05,2013-07-07,15,167,NA,54,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-02-05T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,15,167,153,2013-02-05,2013-07-07,12393,8262,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1174,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-08,2013-07-24,168,184,NA,54,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-07-24T00:00:00Z,NA,H,168,184,17,2013-07-08,2013-07-24,918,918,DURD,17,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1174,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-08,2013-07-24,168,184,NA,54,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-07-24T00:00:00Z,NA,H,168,184,17,2013-07-08,2013-07-24,918,918,DOSE,918,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1174,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-08,2013-07-24,168,184,NA,54,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-07-24T00:00:00Z,NA,H,168,184,17,2013-07-08,2013-07-24,918,918,PLDOSE,918,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1174,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-08,2013-07-24,168,184,NA,54,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-07-24T00:00:00Z,NA,H,168,184,17,2013-07-08,2013-07-24,918,918,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1174,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-08,2013-07-24,168,184,NA,54,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-07-24T00:00:00Z,NA,H,168,184,17,2013-07-08,2013-07-24,918,918,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-01-22T00:00:00Z,NA,NA,2013-07-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-22,2013-07-24,NA,NA,TDURD,184,NA,OVERALL,Overall duration (days),7,>=90 days,16,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-01-22T00:00:00Z,NA,NA,2013-07-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-22,2013-07-24,NA,NA,TDOSE,14067,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-01-22T00:00:00Z,NA,NA,2013-07-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-22,2013-07-24,NA,NA,AVDDSE,76.45108695652173,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-01-22T00:00:00Z,NA,NA,2013-07-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-22,2013-07-24,NA,NA,TPDOSE,9936,NA,OVERALL,Total planned dose (mg),11,NA,19,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-01-22T00:00:00Z,NA,NA,2013-07-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-22,2013-07-24,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-01-22T00:00:00Z,NA,NA,2013-07-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-22,2013-07-24,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-01-22T00:00:00Z,NA,NA,2013-07-24T00:00:00Z,NA,NA,NA,NA,NA,2013-01-22,2013-07-24,NA,NA,TDOSINT,141.57608695652172,NA,OVERALL,Overall dose intensity (%),90,NA,22,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-02-05T00:00:00Z,NA,NA,2013-07-24T00:00:00Z,NA,NA,NA,NA,NA,2013-02-05,2013-07-24,NA,NA,PDURD,170,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-02-05T00:00:00Z,NA,NA,2013-07-24T00:00:00Z,NA,NA,NA,NA,NA,2013-02-05,2013-07-24,NA,NA,PDOSE,13311,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-02-05T00:00:00Z,NA,NA,2013-07-24T00:00:00Z,NA,NA,NA,NA,NA,2013-02-05,2013-07-24,NA,NA,PPDOSE,9180,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-02-05T00:00:00Z,NA,NA,2013-07-24T00:00:00Z,NA,NA,NA,NA,NA,2013-02-05,2013-07-24,NA,NA,PAVDDSE,78.3,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-02-05T00:00:00Z,NA,NA,2013-07-24T00:00:00Z,NA,NA,NA,NA,NA,2013-02-05,2013-07-24,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-02-05T00:00:00Z,NA,NA,2013-07-24T00:00:00Z,NA,NA,NA,NA,NA,2013-02-05,2013-07-24,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1174,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-22,2013-01-22T00:00:00Z,2013-07-24T23:59:59Z,2013-02-05T00:00:00Z,NA,NA,2013-07-24T00:00:00Z,NA,NA,NA,NA,NA,2013-02-05,2013-07-24,NA,NA,PDOSINT,145,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1174,2013-01-22,2013-07-24,2013-01-22,2013-07-24,NA,2013-07-24T15:15,NA,NA,717,73,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-16,-6,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-24,184,NA,2013-07-24,COMPLETED,NA,2013-01-22,NA,NA,NA,2013-07-24,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1201,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-19,2014-01-03,1,16,NA,0,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2013-12-19T00:00:00Z,NA,H,2014-01-03T00:00:00Z,NA,H,1,16,16,2013-12-19,2014-01-03,0,0,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1201,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-19,2014-01-03,1,16,NA,0,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2013-12-19T00:00:00Z,NA,H,2014-01-03T00:00:00Z,NA,H,1,16,16,2013-12-19,2014-01-03,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1201,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-19,2014-01-03,1,16,NA,0,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2013-12-19T00:00:00Z,NA,H,2014-01-03T00:00:00Z,NA,H,1,16,16,2013-12-19,2014-01-03,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1201,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-19,2014-01-03,1,16,NA,0,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2013-12-19T00:00:00Z,NA,H,2014-01-03T00:00:00Z,NA,H,1,16,16,2013-12-19,2014-01-03,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1201,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-12-19,2014-01-03,1,16,NA,0,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2013-12-19T00:00:00Z,NA,H,2014-01-03T00:00:00Z,NA,H,1,16,16,2013-12-19,2014-01-03,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1201,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-04,2014-02-21,17,65,NA,0,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2014-01-04T00:00:00Z,NA,H,2014-02-21T00:00:00Z,NA,H,17,65,49,2014-01-04,2014-02-21,0,0,DURD,49,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1201,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-04,2014-02-21,17,65,NA,0,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2014-01-04T00:00:00Z,NA,H,2014-02-21T00:00:00Z,NA,H,17,65,49,2014-01-04,2014-02-21,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1201,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-04,2014-02-21,17,65,NA,0,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2014-01-04T00:00:00Z,NA,H,2014-02-21T00:00:00Z,NA,H,17,65,49,2014-01-04,2014-02-21,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1201,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-04,2014-02-21,17,65,NA,0,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2014-01-04T00:00:00Z,NA,H,2014-02-21T00:00:00Z,NA,H,17,65,49,2014-01-04,2014-02-21,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1201,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-04,2014-02-21,17,65,NA,0,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2014-01-04T00:00:00Z,NA,H,2014-02-21T00:00:00Z,NA,H,17,65,49,2014-01-04,2014-02-21,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1201,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2013-12-19T00:00:00Z,NA,NA,2014-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-12-19,2014-02-21,NA,NA,TDURD,65,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1201,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2013-12-19T00:00:00Z,NA,NA,2014-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-12-19,2014-02-21,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1201,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2013-12-19T00:00:00Z,NA,NA,2014-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-12-19,2014-02-21,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1201,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2013-12-19T00:00:00Z,NA,NA,2014-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-12-19,2014-02-21,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1201,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2013-12-19T00:00:00Z,NA,NA,2014-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-12-19,2014-02-21,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1201,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2013-12-19T00:00:00Z,NA,NA,2014-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-12-19,2014-02-21,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1201,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2013-12-19T00:00:00Z,NA,NA,2014-02-21T00:00:00Z,NA,NA,NA,NA,NA,2013-12-19,2014-02-21,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1201,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2014-01-04T00:00:00Z,NA,NA,2014-02-21T00:00:00Z,NA,NA,NA,NA,NA,2014-01-04,2014-02-21,NA,NA,PDURD,49,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1201,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2014-01-04T00:00:00Z,NA,NA,2014-02-21T00:00:00Z,NA,NA,NA,NA,NA,2014-01-04,2014-02-21,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1201,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2014-01-04T00:00:00Z,NA,NA,2014-02-21T00:00:00Z,NA,NA,NA,NA,NA,2014-01-04,2014-02-21,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1201,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2014-01-04T00:00:00Z,NA,NA,2014-02-21T00:00:00Z,NA,NA,NA,NA,NA,2014-01-04,2014-02-21,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1201,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2014-01-04T00:00:00Z,NA,NA,2014-02-21T00:00:00Z,NA,NA,NA,NA,NA,2014-01-04,2014-02-21,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1201,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2014-01-04T00:00:00Z,NA,NA,2014-02-21T00:00:00Z,NA,NA,NA,NA,NA,2014-01-04,2014-02-21,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1201,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-12-19,2013-12-19T00:00:00Z,2014-02-21T23:59:59Z,2014-01-04T00:00:00Z,NA,NA,2014-02-21T00:00:00Z,NA,NA,NA,NA,NA,2014-01-04,2014-02-21,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1201,2013-12-19,2014-02-21,2013-12-19,2014-02-21,NA,2014-02-21T11:14,NA,NA,717,85,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-12-12,-7,Placebo,Placebo,H,H,2014-02-21,65,NA,2014-02-21,DISCONTINUED,NA,2013-12-19,NA,NA,NA,2014-02-21,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1344,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-11,2014-01-24,1,14,NA,0,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-11T00:00:00Z,NA,H,2014-01-24T00:00:00Z,NA,H,1,14,14,2014-01-11,2014-01-24,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1344,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-11,2014-01-24,1,14,NA,0,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-11T00:00:00Z,NA,H,2014-01-24T00:00:00Z,NA,H,1,14,14,2014-01-11,2014-01-24,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1344,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-11,2014-01-24,1,14,NA,0,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-11T00:00:00Z,NA,H,2014-01-24T00:00:00Z,NA,H,1,14,14,2014-01-11,2014-01-24,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1344,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-11,2014-01-24,1,14,NA,0,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-11T00:00:00Z,NA,H,2014-01-24T00:00:00Z,NA,H,1,14,14,2014-01-11,2014-01-24,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1344,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2014-01-11,2014-01-24,1,14,NA,0,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-11T00:00:00Z,NA,H,2014-01-24T00:00:00Z,NA,H,1,14,14,2014-01-11,2014-01-24,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1344,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-25,2014-03-14,15,63,NA,0,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-25T00:00:00Z,NA,H,2014-03-14T00:00:00Z,NA,H,15,63,49,2014-01-25,2014-03-14,0,0,DURD,49,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1344,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-25,2014-03-14,15,63,NA,0,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-25T00:00:00Z,NA,H,2014-03-14T00:00:00Z,NA,H,15,63,49,2014-01-25,2014-03-14,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1344,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-25,2014-03-14,15,63,NA,0,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-25T00:00:00Z,NA,H,2014-03-14T00:00:00Z,NA,H,15,63,49,2014-01-25,2014-03-14,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1344,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-25,2014-03-14,15,63,NA,0,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-25T00:00:00Z,NA,H,2014-03-14T00:00:00Z,NA,H,15,63,49,2014-01-25,2014-03-14,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1344,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2014-01-25,2014-03-14,15,63,NA,0,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-25T00:00:00Z,NA,H,2014-03-14T00:00:00Z,NA,H,15,63,49,2014-01-25,2014-03-14,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-11T00:00:00Z,NA,NA,2014-03-14T00:00:00Z,NA,NA,NA,NA,NA,2014-01-11,2014-03-14,NA,NA,TDURD,63,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-11T00:00:00Z,NA,NA,2014-03-14T00:00:00Z,NA,NA,NA,NA,NA,2014-01-11,2014-03-14,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-11T00:00:00Z,NA,NA,2014-03-14T00:00:00Z,NA,NA,NA,NA,NA,2014-01-11,2014-03-14,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-11T00:00:00Z,NA,NA,2014-03-14T00:00:00Z,NA,NA,NA,NA,NA,2014-01-11,2014-03-14,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-11T00:00:00Z,NA,NA,2014-03-14T00:00:00Z,NA,NA,NA,NA,NA,2014-01-11,2014-03-14,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-11T00:00:00Z,NA,NA,2014-03-14T00:00:00Z,NA,NA,NA,NA,NA,2014-01-11,2014-03-14,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-11T00:00:00Z,NA,NA,2014-03-14T00:00:00Z,NA,NA,NA,NA,NA,2014-01-11,2014-03-14,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-25T00:00:00Z,NA,NA,2014-03-14T00:00:00Z,NA,NA,NA,NA,NA,2014-01-25,2014-03-14,NA,NA,PDURD,49,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-25T00:00:00Z,NA,NA,2014-03-14T00:00:00Z,NA,NA,NA,NA,NA,2014-01-25,2014-03-14,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-25T00:00:00Z,NA,NA,2014-03-14T00:00:00Z,NA,NA,NA,NA,NA,2014-01-25,2014-03-14,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-25T00:00:00Z,NA,NA,2014-03-14T00:00:00Z,NA,NA,NA,NA,NA,2014-01-25,2014-03-14,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-25T00:00:00Z,NA,NA,2014-03-14T00:00:00Z,NA,NA,NA,NA,NA,2014-01-25,2014-03-14,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-25T00:00:00Z,NA,NA,2014-03-14T00:00:00Z,NA,NA,NA,NA,NA,2014-01-25,2014-03-14,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1344,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2014-01-11,2014-01-11T00:00:00Z,2014-03-14T23:59:59Z,2014-01-25T00:00:00Z,NA,NA,2014-03-14T00:00:00Z,NA,NA,NA,NA,NA,2014-01-25,2014-03-14,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1344,2014-01-11,2014-03-14,2014-01-11,2014-03-14,NA,2014-03-14T14:14,NA,NA,717,64,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2014-01-01,-10,Placebo,Placebo,H,H,2014-03-14,63,NA,2014-03-14,DISCONTINUED,NA,2014-01-11,NA,NA,NA,2014-03-14,18-64,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1357,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-01,2013-05-15,1,15,NA,54,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-01T00:00:00Z,NA,H,2013-05-15T00:00:00Z,NA,H,1,15,15,2013-05-01,2013-05-15,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1357,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-01,2013-05-15,1,15,NA,54,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-01T00:00:00Z,NA,H,2013-05-15T00:00:00Z,NA,H,1,15,15,2013-05-01,2013-05-15,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1357,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-01,2013-05-15,1,15,NA,54,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-01T00:00:00Z,NA,H,2013-05-15T00:00:00Z,NA,H,1,15,15,2013-05-01,2013-05-15,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1357,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-01,2013-05-15,1,15,NA,54,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-01T00:00:00Z,NA,H,2013-05-15T00:00:00Z,NA,H,1,15,15,2013-05-01,2013-05-15,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1357,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-01,2013-05-15,1,15,NA,54,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-01T00:00:00Z,NA,H,2013-05-15T00:00:00Z,NA,H,1,15,15,2013-05-01,2013-05-15,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1357,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-16,2013-10-14,16,167,NA,54,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-16T00:00:00Z,NA,H,2013-10-14T00:00:00Z,NA,H,16,167,152,2013-05-16,2013-10-14,12312,8208,DURD,152,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1357,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-16,2013-10-14,16,167,NA,54,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-16T00:00:00Z,NA,H,2013-10-14T00:00:00Z,NA,H,16,167,152,2013-05-16,2013-10-14,12312,8208,DOSE,12312,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1357,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-16,2013-10-14,16,167,NA,54,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-16T00:00:00Z,NA,H,2013-10-14T00:00:00Z,NA,H,16,167,152,2013-05-16,2013-10-14,12312,8208,PLDOSE,8208,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1357,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-16,2013-10-14,16,167,NA,54,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-16T00:00:00Z,NA,H,2013-10-14T00:00:00Z,NA,H,16,167,152,2013-05-16,2013-10-14,12312,8208,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1357,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-16,2013-10-14,16,167,NA,54,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-16T00:00:00Z,NA,H,2013-10-14T00:00:00Z,NA,H,16,167,152,2013-05-16,2013-10-14,12312,8208,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-01T00:00:00Z,NA,NA,2013-10-14T00:00:00Z,NA,NA,NA,NA,NA,2013-05-01,2013-10-14,NA,NA,TDURD,167,NA,OVERALL,Overall duration (days),7,>=90 days,11,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-01T00:00:00Z,NA,NA,2013-10-14T00:00:00Z,NA,NA,NA,NA,NA,2013-05-01,2013-10-14,NA,NA,TDOSE,13122,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-01T00:00:00Z,NA,NA,2013-10-14T00:00:00Z,NA,NA,NA,NA,NA,2013-05-01,2013-10-14,NA,NA,AVDDSE,78.57485029940119,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-01T00:00:00Z,NA,NA,2013-10-14T00:00:00Z,NA,NA,NA,NA,NA,2013-05-01,2013-10-14,NA,NA,TPDOSE,9018,NA,OVERALL,Total planned dose (mg),11,NA,14,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-01T00:00:00Z,NA,NA,2013-10-14T00:00:00Z,NA,NA,NA,NA,NA,2013-05-01,2013-10-14,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-01T00:00:00Z,NA,NA,2013-10-14T00:00:00Z,NA,NA,NA,NA,NA,2013-05-01,2013-10-14,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-01T00:00:00Z,NA,NA,2013-10-14T00:00:00Z,NA,NA,NA,NA,NA,2013-05-01,2013-10-14,NA,NA,TDOSINT,145.50898203592814,NA,OVERALL,Overall dose intensity (%),90,NA,17,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-16T00:00:00Z,NA,NA,2013-10-14T00:00:00Z,NA,NA,NA,NA,NA,2013-05-16,2013-10-14,NA,NA,PDURD,152,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-16T00:00:00Z,NA,NA,2013-10-14T00:00:00Z,NA,NA,NA,NA,NA,2013-05-16,2013-10-14,NA,NA,PDOSE,12312,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-16T00:00:00Z,NA,NA,2013-10-14T00:00:00Z,NA,NA,NA,NA,NA,2013-05-16,2013-10-14,NA,NA,PPDOSE,8208,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-16T00:00:00Z,NA,NA,2013-10-14T00:00:00Z,NA,NA,NA,NA,NA,2013-05-16,2013-10-14,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-16T00:00:00Z,NA,NA,2013-10-14T00:00:00Z,NA,NA,NA,NA,NA,2013-05-16,2013-10-14,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-16T00:00:00Z,NA,NA,2013-10-14T00:00:00Z,NA,NA,NA,NA,NA,2013-05-16,2013-10-14,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1357,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-01,2013-05-01T00:00:00Z,2013-10-14T23:59:59Z,2013-05-16T00:00:00Z,NA,NA,2013-10-14T00:00:00Z,NA,NA,NA,NA,NA,2013-05-16,2013-10-14,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1357,2013-05-01,2013-10-20,2013-05-01,2013-10-14,NA,2013-10-20T10:52,NA,NA,717,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-21,-10,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-10-14,167,NA,2013-10-20,DISCONTINUED,NA,2013-05-01,NA,NA,NA,2013-10-20,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1446,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-01,2013-09-16,1,16,NA,54,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-01T00:00:00Z,NA,H,2013-09-16T00:00:00Z,NA,H,1,16,16,2013-09-01,2013-09-16,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1446,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-01,2013-09-16,1,16,NA,54,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-01T00:00:00Z,NA,H,2013-09-16T00:00:00Z,NA,H,1,16,16,2013-09-01,2013-09-16,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1446,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-01,2013-09-16,1,16,NA,54,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-01T00:00:00Z,NA,H,2013-09-16T00:00:00Z,NA,H,1,16,16,2013-09-01,2013-09-16,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1446,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-01,2013-09-16,1,16,NA,54,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-01T00:00:00Z,NA,H,2013-09-16T00:00:00Z,NA,H,1,16,16,2013-09-01,2013-09-16,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1446,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-01,2013-09-16,1,16,NA,54,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-01T00:00:00Z,NA,H,2013-09-16T00:00:00Z,NA,H,1,16,16,2013-09-01,2013-09-16,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1446,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-17,2014-02-16,17,169,NA,54,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-17T00:00:00Z,NA,H,2014-02-16T00:00:00Z,NA,H,17,169,153,2013-09-17,2014-02-16,8262,8262,DURD,153,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1446,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-17,2014-02-16,17,169,NA,54,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-17T00:00:00Z,NA,H,2014-02-16T00:00:00Z,NA,H,17,169,153,2013-09-17,2014-02-16,8262,8262,DOSE,8262,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1446,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-17,2014-02-16,17,169,NA,54,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-17T00:00:00Z,NA,H,2014-02-16T00:00:00Z,NA,H,17,169,153,2013-09-17,2014-02-16,8262,8262,PLDOSE,8262,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1446,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-17,2014-02-16,17,169,NA,54,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-17T00:00:00Z,NA,H,2014-02-16T00:00:00Z,NA,H,17,169,153,2013-09-17,2014-02-16,8262,8262,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1446,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-17,2014-02-16,17,169,NA,54,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-17T00:00:00Z,NA,H,2014-02-16T00:00:00Z,NA,H,17,169,153,2013-09-17,2014-02-16,8262,8262,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1446,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-17,2014-03-03,170,184,NA,54,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2014-02-17T00:00:00Z,NA,H,2014-03-03T00:00:00Z,NA,H,170,184,15,2014-02-17,2014-03-03,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1446,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-17,2014-03-03,170,184,NA,54,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2014-02-17T00:00:00Z,NA,H,2014-03-03T00:00:00Z,NA,H,170,184,15,2014-02-17,2014-03-03,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1446,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-17,2014-03-03,170,184,NA,54,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2014-02-17T00:00:00Z,NA,H,2014-03-03T00:00:00Z,NA,H,170,184,15,2014-02-17,2014-03-03,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1446,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-17,2014-03-03,170,184,NA,54,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2014-02-17T00:00:00Z,NA,H,2014-03-03T00:00:00Z,NA,H,170,184,15,2014-02-17,2014-03-03,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-717-1446,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2014-02-17,2014-03-03,170,184,NA,54,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2014-02-17T00:00:00Z,NA,H,2014-03-03T00:00:00Z,NA,H,170,184,15,2014-02-17,2014-03-03,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1446,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-01T00:00:00Z,NA,NA,2014-03-03T00:00:00Z,NA,NA,NA,NA,NA,2013-09-01,2014-03-03,NA,NA,TDURD,184,NA,OVERALL,Overall duration (days),7,>=90 days,16,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1446,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-01T00:00:00Z,NA,NA,2014-03-03T00:00:00Z,NA,NA,NA,NA,NA,2013-09-01,2014-03-03,NA,NA,TDOSE,9936,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1446,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-01T00:00:00Z,NA,NA,2014-03-03T00:00:00Z,NA,NA,NA,NA,NA,2013-09-01,2014-03-03,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1446,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-01T00:00:00Z,NA,NA,2014-03-03T00:00:00Z,NA,NA,NA,NA,NA,2013-09-01,2014-03-03,NA,NA,TPDOSE,9936,NA,OVERALL,Total planned dose (mg),11,NA,19,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1446,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-01T00:00:00Z,NA,NA,2014-03-03T00:00:00Z,NA,NA,NA,NA,NA,2013-09-01,2014-03-03,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1446,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-01T00:00:00Z,NA,NA,2014-03-03T00:00:00Z,NA,NA,NA,NA,NA,2013-09-01,2014-03-03,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1446,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-01T00:00:00Z,NA,NA,2014-03-03T00:00:00Z,NA,NA,NA,NA,NA,2013-09-01,2014-03-03,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1446,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-17T00:00:00Z,NA,NA,2014-03-03T00:00:00Z,NA,NA,NA,NA,NA,2013-09-17,2014-03-03,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1446,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-17T00:00:00Z,NA,NA,2014-03-03T00:00:00Z,NA,NA,NA,NA,NA,2013-09-17,2014-03-03,NA,NA,PDOSE,9072,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1446,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-17T00:00:00Z,NA,NA,2014-03-03T00:00:00Z,NA,NA,NA,NA,NA,2013-09-17,2014-03-03,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1446,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-17T00:00:00Z,NA,NA,2014-03-03T00:00:00Z,NA,NA,NA,NA,NA,2013-09-17,2014-03-03,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1446,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-17T00:00:00Z,NA,NA,2014-03-03T00:00:00Z,NA,NA,NA,NA,NA,2013-09-17,2014-03-03,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1446,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-17T00:00:00Z,NA,NA,2014-03-03T00:00:00Z,NA,NA,NA,NA,NA,2013-09-17,2014-03-03,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-717-1446,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-01,2013-09-01T00:00:00Z,2014-03-03T23:59:59Z,2013-09-17T00:00:00Z,NA,NA,2014-03-03T00:00:00Z,NA,NA,NA,NA,NA,2013-09-17,2014-03-03,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1446,2013-09-01,2014-03-04,2013-09-01,2014-03-03,NA,2014-03-17T09:52,NA,NA,717,75,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-20,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-03-03,184,NA,2014-03-04,COMPLETED,NA,2013-09-01,NA,NA,NA,2014-03-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1066,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-07,2013-07-16,1,10,NA,54,2013-07-07,2013-07-07T00:00:00Z,2013-07-16T23:59:59Z,2013-07-07T00:00:00Z,NA,H,2013-07-16T00:00:00Z,NA,H,1,10,10,2013-07-07,2013-07-16,540,540,DURD,10,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-16,10,NA,2013-07-30,DISCONTINUED,NA,2013-07-07,NA,NA,NA,2013-07-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1066,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-07,2013-07-16,1,10,NA,54,2013-07-07,2013-07-07T00:00:00Z,2013-07-16T23:59:59Z,2013-07-07T00:00:00Z,NA,H,2013-07-16T00:00:00Z,NA,H,1,10,10,2013-07-07,2013-07-16,540,540,DOSE,540,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-16,10,NA,2013-07-30,DISCONTINUED,NA,2013-07-07,NA,NA,NA,2013-07-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1066,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-07,2013-07-16,1,10,NA,54,2013-07-07,2013-07-07T00:00:00Z,2013-07-16T23:59:59Z,2013-07-07T00:00:00Z,NA,H,2013-07-16T00:00:00Z,NA,H,1,10,10,2013-07-07,2013-07-16,540,540,PLDOSE,540,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-16,10,NA,2013-07-30,DISCONTINUED,NA,2013-07-07,NA,NA,NA,2013-07-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1066,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-07,2013-07-16,1,10,NA,54,2013-07-07,2013-07-07T00:00:00Z,2013-07-16T23:59:59Z,2013-07-07T00:00:00Z,NA,H,2013-07-16T00:00:00Z,NA,H,1,10,10,2013-07-07,2013-07-16,540,540,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-16,10,NA,2013-07-30,DISCONTINUED,NA,2013-07-07,NA,NA,NA,2013-07-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1066,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-07,2013-07-16,1,10,NA,54,2013-07-07,2013-07-07T00:00:00Z,2013-07-16T23:59:59Z,2013-07-07T00:00:00Z,NA,H,2013-07-16T00:00:00Z,NA,H,1,10,10,2013-07-07,2013-07-16,540,540,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-16,10,NA,2013-07-30,DISCONTINUED,NA,2013-07-07,NA,NA,NA,2013-07-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1066,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-07,2013-07-07T00:00:00Z,2013-07-16T23:59:59Z,2013-07-07T00:00:00Z,NA,NA,2013-07-16T00:00:00Z,NA,NA,NA,NA,NA,2013-07-07,2013-07-16,NA,NA,TDURD,10,NA,OVERALL,Overall duration (days),7,< 30 days,6,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-16,10,NA,2013-07-30,DISCONTINUED,NA,2013-07-07,NA,NA,NA,2013-07-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1066,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-07,2013-07-07T00:00:00Z,2013-07-16T23:59:59Z,2013-07-07T00:00:00Z,NA,NA,2013-07-16T00:00:00Z,NA,NA,NA,NA,NA,2013-07-07,2013-07-16,NA,NA,TDOSE,540,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,7,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-16,10,NA,2013-07-30,DISCONTINUED,NA,2013-07-07,NA,NA,NA,2013-07-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1066,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-07,2013-07-07T00:00:00Z,2013-07-16T23:59:59Z,2013-07-07T00:00:00Z,NA,NA,2013-07-16T00:00:00Z,NA,NA,NA,NA,NA,2013-07-07,2013-07-16,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,8,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-16,10,NA,2013-07-30,DISCONTINUED,NA,2013-07-07,NA,NA,NA,2013-07-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1066,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-07,2013-07-07T00:00:00Z,2013-07-16T23:59:59Z,2013-07-07T00:00:00Z,NA,NA,2013-07-16T00:00:00Z,NA,NA,NA,NA,NA,2013-07-07,2013-07-16,NA,NA,TPDOSE,540,NA,OVERALL,Total planned dose (mg),11,NA,9,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-16,10,NA,2013-07-30,DISCONTINUED,NA,2013-07-07,NA,NA,NA,2013-07-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1066,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-07,2013-07-07T00:00:00Z,2013-07-16T23:59:59Z,2013-07-07T00:00:00Z,NA,NA,2013-07-16T00:00:00Z,NA,NA,NA,NA,NA,2013-07-07,2013-07-16,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,10,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-16,10,NA,2013-07-30,DISCONTINUED,NA,2013-07-07,NA,NA,NA,2013-07-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1066,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-07,2013-07-07T00:00:00Z,2013-07-16T23:59:59Z,2013-07-07T00:00:00Z,NA,NA,2013-07-16T00:00:00Z,NA,NA,NA,NA,NA,2013-07-07,2013-07-16,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,11,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-16,10,NA,2013-07-30,DISCONTINUED,NA,2013-07-07,NA,NA,NA,2013-07-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1066,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-07,2013-07-07T00:00:00Z,2013-07-16T23:59:59Z,2013-07-07T00:00:00Z,NA,NA,2013-07-16T00:00:00Z,NA,NA,NA,NA,NA,2013-07-07,2013-07-16,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,12,1066,2013-07-07,2013-07-30,2013-07-07,2013-07-16,NA,2014-01-13,NA,NA,718,79,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-9,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-07-16,10,NA,2013-07-30,DISCONTINUED,NA,2013-07-07,NA,NA,NA,2013-07-30,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1079,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-19,2012-10-03,1,15,NA,54,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-09-19T00:00:00Z,NA,H,2012-10-03T00:00:00Z,NA,H,1,15,15,2012-09-19,2012-10-03,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1079,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-19,2012-10-03,1,15,NA,54,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-09-19T00:00:00Z,NA,H,2012-10-03T00:00:00Z,NA,H,1,15,15,2012-09-19,2012-10-03,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1079,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-19,2012-10-03,1,15,NA,54,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-09-19T00:00:00Z,NA,H,2012-10-03T00:00:00Z,NA,H,1,15,15,2012-09-19,2012-10-03,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1079,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-19,2012-10-03,1,15,NA,54,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-09-19T00:00:00Z,NA,H,2012-10-03T00:00:00Z,NA,H,1,15,15,2012-09-19,2012-10-03,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1079,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-09-19,2012-10-03,1,15,NA,54,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-09-19T00:00:00Z,NA,H,2012-10-03T00:00:00Z,NA,H,1,15,15,2012-09-19,2012-10-03,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1079,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-04,2012-10-31,16,43,NA,54,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-10-04T00:00:00Z,NA,H,2012-10-31T00:00:00Z,NA,H,16,43,28,2012-10-04,2012-10-31,1512,1512,DURD,28,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1079,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-04,2012-10-31,16,43,NA,54,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-10-04T00:00:00Z,NA,H,2012-10-31T00:00:00Z,NA,H,16,43,28,2012-10-04,2012-10-31,1512,1512,DOSE,1512,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1079,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-04,2012-10-31,16,43,NA,54,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-10-04T00:00:00Z,NA,H,2012-10-31T00:00:00Z,NA,H,16,43,28,2012-10-04,2012-10-31,1512,1512,PLDOSE,1512,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1079,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-04,2012-10-31,16,43,NA,54,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-10-04T00:00:00Z,NA,H,2012-10-31T00:00:00Z,NA,H,16,43,28,2012-10-04,2012-10-31,1512,1512,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1079,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2012-10-04,2012-10-31,16,43,NA,54,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-10-04T00:00:00Z,NA,H,2012-10-31T00:00:00Z,NA,H,16,43,28,2012-10-04,2012-10-31,1512,1512,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2012-10-31T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2012-10-31,NA,NA,TDURD,43,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2012-10-31T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2012-10-31,NA,NA,TDOSE,2322,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2012-10-31T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2012-10-31,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2012-10-31T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2012-10-31,NA,NA,TPDOSE,2322,NA,OVERALL,Total planned dose (mg),11,NA,14,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2012-10-31T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2012-10-31,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2012-10-31T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2012-10-31,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-09-19T00:00:00Z,NA,NA,2012-10-31T00:00:00Z,NA,NA,NA,NA,NA,2012-09-19,2012-10-31,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-10-04T00:00:00Z,NA,NA,2012-10-31T00:00:00Z,NA,NA,NA,NA,NA,2012-10-04,2012-10-31,NA,NA,PDURD,28,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-10-04T00:00:00Z,NA,NA,2012-10-31T00:00:00Z,NA,NA,NA,NA,NA,2012-10-04,2012-10-31,NA,NA,PDOSE,1512,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-10-04T00:00:00Z,NA,NA,2012-10-31T00:00:00Z,NA,NA,NA,NA,NA,2012-10-04,2012-10-31,NA,NA,PPDOSE,1512,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-10-04T00:00:00Z,NA,NA,2012-10-31T00:00:00Z,NA,NA,NA,NA,NA,2012-10-04,2012-10-31,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-10-04T00:00:00Z,NA,NA,2012-10-31T00:00:00Z,NA,NA,NA,NA,NA,2012-10-04,2012-10-31,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-10-04T00:00:00Z,NA,NA,2012-10-31T00:00:00Z,NA,NA,NA,NA,NA,2012-10-04,2012-10-31,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1079,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-09-19,2012-09-19T00:00:00Z,2012-10-31T23:59:59Z,2012-10-04T00:00:00Z,NA,NA,2012-10-31T00:00:00Z,NA,NA,NA,NA,NA,2012-10-04,2012-10-31,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1079,2012-09-19,2012-11-06,2012-09-19,2012-10-31,NA,2013-03-05,NA,NA,718,67,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2012-09-11,-8,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2012-10-31,43,NA,2012-11-06,DISCONTINUED,2013-03-05,2012-09-19,NA,NA,NA,2012-10-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1101,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-17,2013-03-03,1,15,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-02-17T00:00:00Z,NA,H,2013-03-03T00:00:00Z,NA,H,1,15,15,2013-02-17,2013-03-03,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1101,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-17,2013-03-03,1,15,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-02-17T00:00:00Z,NA,H,2013-03-03T00:00:00Z,NA,H,1,15,15,2013-02-17,2013-03-03,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1101,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-17,2013-03-03,1,15,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-02-17T00:00:00Z,NA,H,2013-03-03T00:00:00Z,NA,H,1,15,15,2013-02-17,2013-03-03,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1101,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-17,2013-03-03,1,15,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-02-17T00:00:00Z,NA,H,2013-03-03T00:00:00Z,NA,H,1,15,15,2013-02-17,2013-03-03,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1101,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-17,2013-03-03,1,15,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-02-17T00:00:00Z,NA,H,2013-03-03T00:00:00Z,NA,H,1,15,15,2013-02-17,2013-03-03,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1101,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-04,2013-07-31,16,165,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-03-04T00:00:00Z,NA,H,2013-07-31T00:00:00Z,NA,H,16,165,150,2013-03-04,2013-07-31,12150,8100,DURD,150,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1101,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-04,2013-07-31,16,165,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-03-04T00:00:00Z,NA,H,2013-07-31T00:00:00Z,NA,H,16,165,150,2013-03-04,2013-07-31,12150,8100,DOSE,12150,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1101,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-04,2013-07-31,16,165,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-03-04T00:00:00Z,NA,H,2013-07-31T00:00:00Z,NA,H,16,165,150,2013-03-04,2013-07-31,12150,8100,PLDOSE,8100,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1101,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-04,2013-07-31,16,165,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-03-04T00:00:00Z,NA,H,2013-07-31T00:00:00Z,NA,H,16,165,150,2013-03-04,2013-07-31,12150,8100,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1101,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-04,2013-07-31,16,165,NA,54,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-03-04T00:00:00Z,NA,H,2013-07-31T00:00:00Z,NA,H,16,165,150,2013-03-04,2013-07-31,12150,8100,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-02-17T00:00:00Z,NA,NA,2013-07-31T00:00:00Z,NA,NA,NA,NA,NA,2013-02-17,2013-07-31,NA,NA,TDURD,165,NA,OVERALL,Overall duration (days),7,>=90 days,11,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-02-17T00:00:00Z,NA,NA,2013-07-31T00:00:00Z,NA,NA,NA,NA,NA,2013-02-17,2013-07-31,NA,NA,TDOSE,12960,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-02-17T00:00:00Z,NA,NA,2013-07-31T00:00:00Z,NA,NA,NA,NA,NA,2013-02-17,2013-07-31,NA,NA,AVDDSE,78.54545454545455,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-02-17T00:00:00Z,NA,NA,2013-07-31T00:00:00Z,NA,NA,NA,NA,NA,2013-02-17,2013-07-31,NA,NA,TPDOSE,8910,NA,OVERALL,Total planned dose (mg),11,NA,14,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-02-17T00:00:00Z,NA,NA,2013-07-31T00:00:00Z,NA,NA,NA,NA,NA,2013-02-17,2013-07-31,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-02-17T00:00:00Z,NA,NA,2013-07-31T00:00:00Z,NA,NA,NA,NA,NA,2013-02-17,2013-07-31,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-02-17T00:00:00Z,NA,NA,2013-07-31T00:00:00Z,NA,NA,NA,NA,NA,2013-02-17,2013-07-31,NA,NA,TDOSINT,145.45454545454547,NA,OVERALL,Overall dose intensity (%),90,NA,17,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-07-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-07-31,NA,NA,PDURD,150,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-07-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-07-31,NA,NA,PDOSE,12150,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-07-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-07-31,NA,NA,PPDOSE,8100,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-07-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-07-31,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-07-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-07-31,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-07-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-07-31,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1101,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-17,2013-02-17T00:00:00Z,2013-07-31T23:59:59Z,2013-03-04T00:00:00Z,NA,NA,2013-07-31T00:00:00Z,NA,NA,NA,NA,NA,2013-03-04,2013-07-31,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1101,2013-02-17,2013-08-02,2013-02-17,2013-07-31,NA,2013-08-02T11:30,NA,NA,718,82,YEARS,M,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-02-01,-16,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-07-31,165,NA,2013-08-02,DISCONTINUED,NA,2013-02-17,NA,NA,NA,2013-08-02,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1139,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-19,2013-06-02,1,15,NA,0,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-05-19T00:00:00Z,NA,H,2013-06-02T00:00:00Z,NA,H,1,15,15,2013-05-19,2013-06-02,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1139,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-19,2013-06-02,1,15,NA,0,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-05-19T00:00:00Z,NA,H,2013-06-02T00:00:00Z,NA,H,1,15,15,2013-05-19,2013-06-02,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1139,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-19,2013-06-02,1,15,NA,0,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-05-19T00:00:00Z,NA,H,2013-06-02T00:00:00Z,NA,H,1,15,15,2013-05-19,2013-06-02,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1139,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-19,2013-06-02,1,15,NA,0,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-05-19T00:00:00Z,NA,H,2013-06-02T00:00:00Z,NA,H,1,15,15,2013-05-19,2013-06-02,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1139,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-05-19,2013-06-02,1,15,NA,0,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-05-19T00:00:00Z,NA,H,2013-06-02T00:00:00Z,NA,H,1,15,15,2013-05-19,2013-06-02,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1139,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-03,2013-11-03,16,169,NA,0,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-06-03T00:00:00Z,NA,H,2013-11-03T00:00:00Z,NA,H,16,169,154,2013-06-03,2013-11-03,0,0,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1139,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-03,2013-11-03,16,169,NA,0,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-06-03T00:00:00Z,NA,H,2013-11-03T00:00:00Z,NA,H,16,169,154,2013-06-03,2013-11-03,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1139,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-03,2013-11-03,16,169,NA,0,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-06-03T00:00:00Z,NA,H,2013-11-03T00:00:00Z,NA,H,16,169,154,2013-06-03,2013-11-03,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1139,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-03,2013-11-03,16,169,NA,0,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-06-03T00:00:00Z,NA,H,2013-11-03T00:00:00Z,NA,H,16,169,154,2013-06-03,2013-11-03,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1139,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-06-03,2013-11-03,16,169,NA,0,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-06-03T00:00:00Z,NA,H,2013-11-03T00:00:00Z,NA,H,16,169,154,2013-06-03,2013-11-03,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1139,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-04,2013-11-17,170,183,NA,0,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-11-04T00:00:00Z,NA,H,2013-11-17T00:00:00Z,NA,H,170,183,14,2013-11-04,2013-11-17,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1139,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-04,2013-11-17,170,183,NA,0,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-11-04T00:00:00Z,NA,H,2013-11-17T00:00:00Z,NA,H,170,183,14,2013-11-04,2013-11-17,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1139,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-04,2013-11-17,170,183,NA,0,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-11-04T00:00:00Z,NA,H,2013-11-17T00:00:00Z,NA,H,170,183,14,2013-11-04,2013-11-17,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1139,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-04,2013-11-17,170,183,NA,0,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-11-04T00:00:00Z,NA,H,2013-11-17T00:00:00Z,NA,H,170,183,14,2013-11-04,2013-11-17,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1139,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-11-04,2013-11-17,170,183,NA,0,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-11-04T00:00:00Z,NA,H,2013-11-17T00:00:00Z,NA,H,170,183,14,2013-11-04,2013-11-17,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-05-19T00:00:00Z,NA,NA,2013-11-17T00:00:00Z,NA,NA,NA,NA,NA,2013-05-19,2013-11-17,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-05-19T00:00:00Z,NA,NA,2013-11-17T00:00:00Z,NA,NA,NA,NA,NA,2013-05-19,2013-11-17,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-05-19T00:00:00Z,NA,NA,2013-11-17T00:00:00Z,NA,NA,NA,NA,NA,2013-05-19,2013-11-17,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-05-19T00:00:00Z,NA,NA,2013-11-17T00:00:00Z,NA,NA,NA,NA,NA,2013-05-19,2013-11-17,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-05-19T00:00:00Z,NA,NA,2013-11-17T00:00:00Z,NA,NA,NA,NA,NA,2013-05-19,2013-11-17,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-05-19T00:00:00Z,NA,NA,2013-11-17T00:00:00Z,NA,NA,NA,NA,NA,2013-05-19,2013-11-17,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-05-19T00:00:00Z,NA,NA,2013-11-17T00:00:00Z,NA,NA,NA,NA,NA,2013-05-19,2013-11-17,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-06-03T00:00:00Z,NA,NA,2013-11-17T00:00:00Z,NA,NA,NA,NA,NA,2013-06-03,2013-11-17,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-06-03T00:00:00Z,NA,NA,2013-11-17T00:00:00Z,NA,NA,NA,NA,NA,2013-06-03,2013-11-17,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-06-03T00:00:00Z,NA,NA,2013-11-17T00:00:00Z,NA,NA,NA,NA,NA,2013-06-03,2013-11-17,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-06-03T00:00:00Z,NA,NA,2013-11-17T00:00:00Z,NA,NA,NA,NA,NA,2013-06-03,2013-11-17,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-06-03T00:00:00Z,NA,NA,2013-11-17T00:00:00Z,NA,NA,NA,NA,NA,2013-06-03,2013-11-17,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-06-03T00:00:00Z,NA,NA,2013-11-17T00:00:00Z,NA,NA,NA,NA,NA,2013-06-03,2013-11-17,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1139,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-05-19,2013-05-19T00:00:00Z,2013-11-17T23:59:59Z,2013-06-03T00:00:00Z,NA,NA,2013-11-17T00:00:00Z,NA,NA,NA,NA,NA,2013-06-03,2013-11-17,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1139,2013-05-19,2013-11-17,2013-05-19,2013-11-17,NA,2013-11-17T10:30,NA,NA,718,77,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-05-03,-16,Placebo,Placebo,H,H,2013-11-17,183,NA,2013-11-17,COMPLETED,NA,2013-05-19,NA,NA,NA,2013-11-17,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1150,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-19,2013-02-02,1,15,NA,0,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-01-19T00:00:00Z,NA,H,2013-02-02T00:00:00Z,NA,H,1,15,15,2013-01-19,2013-02-02,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1150,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-19,2013-02-02,1,15,NA,0,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-01-19T00:00:00Z,NA,H,2013-02-02T00:00:00Z,NA,H,1,15,15,2013-01-19,2013-02-02,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1150,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-19,2013-02-02,1,15,NA,0,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-01-19T00:00:00Z,NA,H,2013-02-02T00:00:00Z,NA,H,1,15,15,2013-01-19,2013-02-02,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1150,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-19,2013-02-02,1,15,NA,0,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-01-19T00:00:00Z,NA,H,2013-02-02T00:00:00Z,NA,H,1,15,15,2013-01-19,2013-02-02,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1150,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-01-19,2013-02-02,1,15,NA,0,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-01-19T00:00:00Z,NA,H,2013-02-02T00:00:00Z,NA,H,1,15,15,2013-01-19,2013-02-02,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1150,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-03,2013-07-07,16,170,NA,0,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-02-03T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,16,170,155,2013-02-03,2013-07-07,0,0,DURD,155,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1150,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-03,2013-07-07,16,170,NA,0,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-02-03T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,16,170,155,2013-02-03,2013-07-07,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1150,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-03,2013-07-07,16,170,NA,0,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-02-03T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,16,170,155,2013-02-03,2013-07-07,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1150,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-03,2013-07-07,16,170,NA,0,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-02-03T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,16,170,155,2013-02-03,2013-07-07,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1150,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-03,2013-07-07,16,170,NA,0,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-02-03T00:00:00Z,NA,H,2013-07-07T00:00:00Z,NA,H,16,170,155,2013-02-03,2013-07-07,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1150,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-08,2013-07-29,171,192,NA,0,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-07-29T00:00:00Z,NA,H,171,192,22,2013-07-08,2013-07-29,0,0,DURD,22,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1150,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-08,2013-07-29,171,192,NA,0,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-07-29T00:00:00Z,NA,H,171,192,22,2013-07-08,2013-07-29,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1150,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-08,2013-07-29,171,192,NA,0,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-07-29T00:00:00Z,NA,H,171,192,22,2013-07-08,2013-07-29,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1150,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-08,2013-07-29,171,192,NA,0,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-07-29T00:00:00Z,NA,H,171,192,22,2013-07-08,2013-07-29,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1150,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-07-08,2013-07-29,171,192,NA,0,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-07-08T00:00:00Z,NA,H,2013-07-29T00:00:00Z,NA,H,171,192,22,2013-07-08,2013-07-29,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1150,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-07-29T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-07-29,NA,NA,TDURD,192,NA,OVERALL,Overall duration (days),7,>=90 days,16,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1150,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-07-29T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-07-29,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1150,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-07-29T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-07-29,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1150,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-07-29T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-07-29,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1150,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-07-29T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-07-29,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1150,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-07-29T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-07-29,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1150,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-01-19T00:00:00Z,NA,NA,2013-07-29T00:00:00Z,NA,NA,NA,NA,NA,2013-01-19,2013-07-29,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1150,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-02-03T00:00:00Z,NA,NA,2013-07-29T00:00:00Z,NA,NA,NA,NA,NA,2013-02-03,2013-07-29,NA,NA,PDURD,177,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1150,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-02-03T00:00:00Z,NA,NA,2013-07-29T00:00:00Z,NA,NA,NA,NA,NA,2013-02-03,2013-07-29,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1150,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-02-03T00:00:00Z,NA,NA,2013-07-29T00:00:00Z,NA,NA,NA,NA,NA,2013-02-03,2013-07-29,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1150,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-02-03T00:00:00Z,NA,NA,2013-07-29T00:00:00Z,NA,NA,NA,NA,NA,2013-02-03,2013-07-29,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1150,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-02-03T00:00:00Z,NA,NA,2013-07-29T00:00:00Z,NA,NA,NA,NA,NA,2013-02-03,2013-07-29,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1150,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-02-03T00:00:00Z,NA,NA,2013-07-29T00:00:00Z,NA,NA,NA,NA,NA,2013-02-03,2013-07-29,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1150,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-01-19,2013-01-19T00:00:00Z,2013-07-29T23:59:59Z,2013-02-03T00:00:00Z,NA,NA,2013-07-29T00:00:00Z,NA,NA,NA,NA,NA,2013-02-03,2013-07-29,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1150,2013-01-19,2013-07-31,2013-01-19,2013-07-29,NA,2013-07-31T14:05,NA,NA,718,73,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-01-12,-7,Placebo,Placebo,H,H,2013-07-29,192,NA,2013-07-31,COMPLETED,NA,2013-01-19,NA,NA,NA,2013-07-31,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1170,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-16,2013-09-29,1,14,NA,54,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-16T00:00:00Z,NA,H,2013-09-29T00:00:00Z,NA,H,1,14,14,2013-09-16,2013-09-29,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1170,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-16,2013-09-29,1,14,NA,54,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-16T00:00:00Z,NA,H,2013-09-29T00:00:00Z,NA,H,1,14,14,2013-09-16,2013-09-29,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1170,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-16,2013-09-29,1,14,NA,54,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-16T00:00:00Z,NA,H,2013-09-29T00:00:00Z,NA,H,1,14,14,2013-09-16,2013-09-29,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1170,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-16,2013-09-29,1,14,NA,54,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-16T00:00:00Z,NA,H,2013-09-29T00:00:00Z,NA,H,1,14,14,2013-09-16,2013-09-29,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1170,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-16,2013-09-29,1,14,NA,54,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-16T00:00:00Z,NA,H,2013-09-29T00:00:00Z,NA,H,1,14,14,2013-09-16,2013-09-29,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1170,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-30,2013-10-12,15,27,NA,54,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-30T00:00:00Z,NA,H,2013-10-12T00:00:00Z,NA,H,15,27,13,2013-09-30,2013-10-12,702,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1170,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-30,2013-10-12,15,27,NA,54,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-30T00:00:00Z,NA,H,2013-10-12T00:00:00Z,NA,H,15,27,13,2013-09-30,2013-10-12,702,702,DOSE,702,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1170,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-30,2013-10-12,15,27,NA,54,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-30T00:00:00Z,NA,H,2013-10-12T00:00:00Z,NA,H,15,27,13,2013-09-30,2013-10-12,702,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1170,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-30,2013-10-12,15,27,NA,54,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-30T00:00:00Z,NA,H,2013-10-12T00:00:00Z,NA,H,15,27,13,2013-09-30,2013-10-12,702,702,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1170,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-09-30,2013-10-12,15,27,NA,54,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-30T00:00:00Z,NA,H,2013-10-12T00:00:00Z,NA,H,15,27,13,2013-09-30,2013-10-12,702,702,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-10-12T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-10-12,NA,NA,TDURD,27,NA,OVERALL,Overall duration (days),7,< 30 days,11,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-10-12T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-10-12,NA,NA,TDOSE,1458,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-10-12T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-10-12,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-10-12T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-10-12,NA,NA,TPDOSE,1458,NA,OVERALL,Total planned dose (mg),11,NA,14,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-10-12T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-10-12,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-10-12T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-10-12,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-16T00:00:00Z,NA,NA,2013-10-12T00:00:00Z,NA,NA,NA,NA,NA,2013-09-16,2013-10-12,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-30T00:00:00Z,NA,NA,2013-10-12T00:00:00Z,NA,NA,NA,NA,NA,2013-09-30,2013-10-12,NA,NA,PDURD,13,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,< 30 days,18,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-30T00:00:00Z,NA,NA,2013-10-12T00:00:00Z,NA,NA,NA,NA,NA,2013-09-30,2013-10-12,NA,NA,PDOSE,702,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-30T00:00:00Z,NA,NA,2013-10-12T00:00:00Z,NA,NA,NA,NA,NA,2013-09-30,2013-10-12,NA,NA,PPDOSE,702,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-30T00:00:00Z,NA,NA,2013-10-12T00:00:00Z,NA,NA,NA,NA,NA,2013-09-30,2013-10-12,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-30T00:00:00Z,NA,NA,2013-10-12T00:00:00Z,NA,NA,NA,NA,NA,2013-09-30,2013-10-12,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-30T00:00:00Z,NA,NA,2013-10-12T00:00:00Z,NA,NA,NA,NA,NA,2013-09-30,2013-10-12,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1170,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-16,2013-09-16T00:00:00Z,2013-10-12T23:59:59Z,2013-09-30T00:00:00Z,NA,NA,2013-10-12T00:00:00Z,NA,NA,NA,NA,NA,2013-09-30,2013-10-12,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1170,2013-09-16,2013-11-03,2013-09-16,2013-10-12,NA,2014-03-15,NA,NA,718,80,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-25,-22,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2013-10-12,27,NA,2013-11-03,DISCONTINUED,2014-03-15,2013-09-16,NA,NA,NA,2013-11-03,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1172,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-21,2013-10-05,1,15,NA,0,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-10-05T00:00:00Z,NA,H,1,15,15,2013-09-21,2013-10-05,0,0,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1172,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-21,2013-10-05,1,15,NA,0,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-10-05T00:00:00Z,NA,H,1,15,15,2013-09-21,2013-10-05,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1172,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-21,2013-10-05,1,15,NA,0,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-10-05T00:00:00Z,NA,H,1,15,15,2013-09-21,2013-10-05,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1172,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-21,2013-10-05,1,15,NA,0,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-10-05T00:00:00Z,NA,H,1,15,15,2013-09-21,2013-10-05,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1172,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-21,2013-10-05,1,15,NA,0,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-10-05T00:00:00Z,NA,H,1,15,15,2013-09-21,2013-10-05,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1172,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-06,2013-11-29,16,70,NA,0,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-10-06T00:00:00Z,NA,H,2013-11-29T00:00:00Z,NA,H,16,70,55,2013-10-06,2013-11-29,0,0,DURD,55,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1172,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-06,2013-11-29,16,70,NA,0,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-10-06T00:00:00Z,NA,H,2013-11-29T00:00:00Z,NA,H,16,70,55,2013-10-06,2013-11-29,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1172,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-06,2013-11-29,16,70,NA,0,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-10-06T00:00:00Z,NA,H,2013-11-29T00:00:00Z,NA,H,16,70,55,2013-10-06,2013-11-29,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1172,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-06,2013-11-29,16,70,NA,0,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-10-06T00:00:00Z,NA,H,2013-11-29T00:00:00Z,NA,H,16,70,55,2013-10-06,2013-11-29,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1172,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-06,2013-11-29,16,70,NA,0,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-10-06T00:00:00Z,NA,H,2013-11-29T00:00:00Z,NA,H,16,70,55,2013-10-06,2013-11-29,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2013-11-29T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2013-11-29,NA,NA,TDURD,70,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2013-11-29T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2013-11-29,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,12,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2013-11-29T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2013-11-29,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2013-11-29T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2013-11-29,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,14,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2013-11-29T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2013-11-29,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2013-11-29T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2013-11-29,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2013-11-29T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2013-11-29,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,17,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-10-06T00:00:00Z,NA,NA,2013-11-29T00:00:00Z,NA,NA,NA,NA,NA,2013-10-06,2013-11-29,NA,NA,PDURD,55,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-10-06T00:00:00Z,NA,NA,2013-11-29T00:00:00Z,NA,NA,NA,NA,NA,2013-10-06,2013-11-29,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,19,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-10-06T00:00:00Z,NA,NA,2013-11-29T00:00:00Z,NA,NA,NA,NA,NA,2013-10-06,2013-11-29,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-10-06T00:00:00Z,NA,NA,2013-11-29T00:00:00Z,NA,NA,NA,NA,NA,2013-10-06,2013-11-29,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-10-06T00:00:00Z,NA,NA,2013-11-29T00:00:00Z,NA,NA,NA,NA,NA,2013-10-06,2013-11-29,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-10-06T00:00:00Z,NA,NA,2013-11-29T00:00:00Z,NA,NA,NA,NA,NA,2013-10-06,2013-11-29,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1172,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2013-11-29T23:59:59Z,2013-10-06T00:00:00Z,NA,NA,2013-11-29T00:00:00Z,NA,NA,NA,NA,NA,2013-10-06,2013-11-29,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1172,2013-09-21,2013-11-29,2013-09-21,2013-11-29,NA,2014-03-21,NA,NA,718,74,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-09-15,-6,Placebo,Placebo,H,H,2013-11-29,70,NA,2013-11-29,DISCONTINUED,2014-03-21,2013-09-21,NA,NA,NA,2013-11-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1250,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-21,2013-10-03,1,13,NA,54,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-10-03T00:00:00Z,NA,H,1,13,13,2013-09-21,2013-10-03,702,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1250,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-21,2013-10-03,1,13,NA,54,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-10-03T00:00:00Z,NA,H,1,13,13,2013-09-21,2013-10-03,702,702,DOSE,702,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1250,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-21,2013-10-03,1,13,NA,54,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-10-03T00:00:00Z,NA,H,1,13,13,2013-09-21,2013-10-03,702,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1250,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-21,2013-10-03,1,13,NA,54,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-10-03T00:00:00Z,NA,H,1,13,13,2013-09-21,2013-10-03,702,702,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1250,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-09-21,2013-10-03,1,13,NA,54,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-09-21T00:00:00Z,NA,H,2013-10-03T00:00:00Z,NA,H,1,13,13,2013-09-21,2013-10-03,702,702,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1250,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-04,2014-01-31,14,133,NA,54,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-10-04T00:00:00Z,NA,H,2014-01-31T00:00:00Z,NA,H,14,133,120,2013-10-04,2014-01-31,6480,6480,DURD,120,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1250,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-04,2014-01-31,14,133,NA,54,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-10-04T00:00:00Z,NA,H,2014-01-31T00:00:00Z,NA,H,14,133,120,2013-10-04,2014-01-31,6480,6480,DOSE,6480,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1250,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-04,2014-01-31,14,133,NA,54,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-10-04T00:00:00Z,NA,H,2014-01-31T00:00:00Z,NA,H,14,133,120,2013-10-04,2014-01-31,6480,6480,PLDOSE,6480,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1250,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-04,2014-01-31,14,133,NA,54,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-10-04T00:00:00Z,NA,H,2014-01-31T00:00:00Z,NA,H,14,133,120,2013-10-04,2014-01-31,6480,6480,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1250,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-10-04,2014-01-31,14,133,NA,54,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-10-04T00:00:00Z,NA,H,2014-01-31T00:00:00Z,NA,H,14,133,120,2013-10-04,2014-01-31,6480,6480,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1250,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2014-01-31T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2014-01-31,NA,NA,TDURD,133,NA,OVERALL,Overall duration (days),7,>=90 days,11,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1250,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2014-01-31T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2014-01-31,NA,NA,TDOSE,7182,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1250,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2014-01-31T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2014-01-31,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1250,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2014-01-31T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2014-01-31,NA,NA,TPDOSE,7182,NA,OVERALL,Total planned dose (mg),11,NA,14,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1250,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2014-01-31T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2014-01-31,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1250,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2014-01-31T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2014-01-31,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1250,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-09-21T00:00:00Z,NA,NA,2014-01-31T00:00:00Z,NA,NA,NA,NA,NA,2013-09-21,2014-01-31,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,17,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1250,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-10-04T00:00:00Z,NA,NA,2014-01-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-04,2014-01-31,NA,NA,PDURD,120,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,18,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1250,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-10-04T00:00:00Z,NA,NA,2014-01-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-04,2014-01-31,NA,NA,PDOSE,6480,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1250,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-10-04T00:00:00Z,NA,NA,2014-01-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-04,2014-01-31,NA,NA,PPDOSE,6480,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1250,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-10-04T00:00:00Z,NA,NA,2014-01-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-04,2014-01-31,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1250,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-10-04T00:00:00Z,NA,NA,2014-01-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-04,2014-01-31,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1250,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-10-04T00:00:00Z,NA,NA,2014-01-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-04,2014-01-31,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1250,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-09-21,2013-09-21T00:00:00Z,2014-01-31T23:59:59Z,2013-10-04T00:00:00Z,NA,NA,2014-01-31T00:00:00Z,NA,NA,NA,NA,NA,2013-10-04,2014-01-31,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1250,2013-09-21,2014-02-08,2013-09-21,2014-01-31,NA,2014-03-08,NA,NA,718,82,YEARS,F,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-08-21,-31,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-31,133,NA,2014-02-08,DISCONTINUED,2014-03-08,2013-09-21,NA,NA,NA,2014-02-19,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1254,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-10,2013-07-25,1,16,NA,54,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-10T00:00:00Z,NA,H,2013-07-25T00:00:00Z,NA,H,1,16,16,2013-07-10,2013-07-25,864,864,DURD,16,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1254,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-10,2013-07-25,1,16,NA,54,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-10T00:00:00Z,NA,H,2013-07-25T00:00:00Z,NA,H,1,16,16,2013-07-10,2013-07-25,864,864,DOSE,864,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1254,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-10,2013-07-25,1,16,NA,54,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-10T00:00:00Z,NA,H,2013-07-25T00:00:00Z,NA,H,1,16,16,2013-07-10,2013-07-25,864,864,PLDOSE,864,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1254,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-10,2013-07-25,1,16,NA,54,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-10T00:00:00Z,NA,H,2013-07-25T00:00:00Z,NA,H,1,16,16,2013-07-10,2013-07-25,864,864,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1254,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-07-10,2013-07-25,1,16,NA,54,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-10T00:00:00Z,NA,H,2013-07-25T00:00:00Z,NA,H,1,16,16,2013-07-10,2013-07-25,864,864,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1254,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-26,2013-12-26,17,170,NA,54,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-26T00:00:00Z,NA,H,2013-12-26T00:00:00Z,NA,H,17,170,154,2013-07-26,2013-12-26,8316,8316,DURD,154,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1254,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-26,2013-12-26,17,170,NA,54,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-26T00:00:00Z,NA,H,2013-12-26T00:00:00Z,NA,H,17,170,154,2013-07-26,2013-12-26,8316,8316,DOSE,8316,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1254,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-26,2013-12-26,17,170,NA,54,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-26T00:00:00Z,NA,H,2013-12-26T00:00:00Z,NA,H,17,170,154,2013-07-26,2013-12-26,8316,8316,PLDOSE,8316,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1254,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-26,2013-12-26,17,170,NA,54,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-26T00:00:00Z,NA,H,2013-12-26T00:00:00Z,NA,H,17,170,154,2013-07-26,2013-12-26,8316,8316,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1254,2,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-07-26,2013-12-26,17,170,NA,54,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-26T00:00:00Z,NA,H,2013-12-26T00:00:00Z,NA,H,17,170,154,2013-07-26,2013-12-26,8316,8316,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1254,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-27,2014-01-09,171,184,NA,54,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-12-27T00:00:00Z,NA,H,2014-01-09T00:00:00Z,NA,H,171,184,14,2013-12-27,2014-01-09,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1254,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-27,2014-01-09,171,184,NA,54,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-12-27T00:00:00Z,NA,H,2014-01-09T00:00:00Z,NA,H,171,184,14,2013-12-27,2014-01-09,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1254,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-27,2014-01-09,171,184,NA,54,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-12-27T00:00:00Z,NA,H,2014-01-09T00:00:00Z,NA,H,171,184,14,2013-12-27,2014-01-09,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1254,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-27,2014-01-09,171,184,NA,54,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-12-27T00:00:00Z,NA,H,2014-01-09T00:00:00Z,NA,H,171,184,14,2013-12-27,2014-01-09,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1254,3,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-12-27,2014-01-09,171,184,NA,54,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-12-27T00:00:00Z,NA,H,2014-01-09T00:00:00Z,NA,H,171,184,14,2013-12-27,2014-01-09,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-10T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-10,2014-01-09,NA,NA,TDURD,184,NA,OVERALL,Overall duration (days),7,>=90 days,16,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-10T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-10,2014-01-09,NA,NA,TDOSE,9936,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,17,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-10T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-10,2014-01-09,NA,NA,AVDDSE,54,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-10T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-10,2014-01-09,NA,NA,TPDOSE,9936,NA,OVERALL,Total planned dose (mg),11,NA,19,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-10T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-10,2014-01-09,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-10T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-10,2014-01-09,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-10T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-10,2014-01-09,NA,NA,TDOSINT,100,NA,OVERALL,Overall dose intensity (%),90,NA,22,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-26T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-26,2014-01-09,NA,NA,PDURD,168,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-26T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-26,2014-01-09,NA,NA,PDOSE,9072,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,24,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-26T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-26,2014-01-09,NA,NA,PPDOSE,9072,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-26T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-26,2014-01-09,NA,NA,PAVDDSE,54,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-26T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-26,2014-01-09,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-26T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-26,2014-01-09,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1254,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-07-10,2013-07-10T00:00:00Z,2014-01-09T23:59:59Z,2013-07-26T00:00:00Z,NA,NA,2014-01-09T00:00:00Z,NA,NA,NA,NA,NA,2013-07-26,2014-01-09,NA,NA,PDOSINT,100,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1254,2013-07-10,2014-01-09,2013-07-10,2014-01-09,NA,2014-01-09T11:10,NA,NA,718,78,YEARS,M,WHITE,HISPANIC OR LATINO,Xan_Lo,Xanomeline Low Dose,Xan_Lo,Xanomeline Low Dose,USA,2013-06-28,-12,Xanomeline Low Dose,Xanomeline Low Dose,H,H,2014-01-09,184,NA,2014-01-09,COMPLETED,NA,2013-07-10,NA,NA,NA,2014-01-09,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1328,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-01,2013-02-14,1,14,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-01T00:00:00Z,NA,H,2013-02-14T00:00:00Z,NA,H,1,14,14,2013-02-01,2013-02-14,756,756,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1328,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-01,2013-02-14,1,14,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-01T00:00:00Z,NA,H,2013-02-14T00:00:00Z,NA,H,1,14,14,2013-02-01,2013-02-14,756,756,DOSE,756,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1328,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-01,2013-02-14,1,14,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-01T00:00:00Z,NA,H,2013-02-14T00:00:00Z,NA,H,1,14,14,2013-02-01,2013-02-14,756,756,PLDOSE,756,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1328,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-01,2013-02-14,1,14,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-01T00:00:00Z,NA,H,2013-02-14T00:00:00Z,NA,H,1,14,14,2013-02-01,2013-02-14,756,756,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1328,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-01,2013-02-14,1,14,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-01T00:00:00Z,NA,H,2013-02-14T00:00:00Z,NA,H,1,14,14,2013-02-01,2013-02-14,756,756,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1328,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-15,2013-04-18,15,77,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-15T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,15,77,63,2013-02-15,2013-04-18,5103,3402,DURD,63,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1328,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-15,2013-04-18,15,77,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-15T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,15,77,63,2013-02-15,2013-04-18,5103,3402,DOSE,5103,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1328,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-15,2013-04-18,15,77,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-15T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,15,77,63,2013-02-15,2013-04-18,5103,3402,PLDOSE,3402,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1328,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-15,2013-04-18,15,77,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-15T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,15,77,63,2013-02-15,2013-04-18,5103,3402,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1328,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-02-15,2013-04-18,15,77,NA,54,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-15T00:00:00Z,NA,H,2013-04-18T00:00:00Z,NA,H,15,77,63,2013-02-15,2013-04-18,5103,3402,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-04-18,NA,NA,TDURD,77,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-04-18,NA,NA,TDOSE,5859,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-04-18,NA,NA,AVDDSE,76.0909090909091,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-04-18,NA,NA,TPDOSE,4158,NA,OVERALL,Total planned dose (mg),11,NA,14,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-04-18,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-04-18,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-01T00:00:00Z,NA,NA,2013-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-01,2013-04-18,NA,NA,TDOSINT,140.9090909090909,NA,OVERALL,Overall dose intensity (%),90,NA,17,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-15T00:00:00Z,NA,NA,2013-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-15,2013-04-18,NA,NA,PDURD,63,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-15T00:00:00Z,NA,NA,2013-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-15,2013-04-18,NA,NA,PDOSE,5103,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-15T00:00:00Z,NA,NA,2013-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-15,2013-04-18,NA,NA,PPDOSE,3402,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-15T00:00:00Z,NA,NA,2013-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-15,2013-04-18,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-15T00:00:00Z,NA,NA,2013-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-15,2013-04-18,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-15T00:00:00Z,NA,NA,2013-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-15,2013-04-18,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1328,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-01,2013-02-01T00:00:00Z,2013-04-18T23:59:59Z,2013-02-15T00:00:00Z,NA,NA,2013-04-18T00:00:00Z,NA,NA,NA,NA,NA,2013-02-15,2013-04-18,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1328,2013-02-01,2013-05-01,2013-02-01,2013-04-18,NA,2013-07-24,NA,NA,718,86,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-01-28,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-04-18,77,NA,2013-05-01,DISCONTINUED,2013-07-24,2013-02-01,NA,NA,NA,2013-05-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1355,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-28,2013-03-16,1,17,NA,0,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-02-28T00:00:00Z,NA,H,2013-03-16T00:00:00Z,NA,H,1,17,17,2013-02-28,2013-03-16,0,0,DURD,17,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1355,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-28,2013-03-16,1,17,NA,0,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-02-28T00:00:00Z,NA,H,2013-03-16T00:00:00Z,NA,H,1,17,17,2013-02-28,2013-03-16,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1355,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-28,2013-03-16,1,17,NA,0,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-02-28T00:00:00Z,NA,H,2013-03-16T00:00:00Z,NA,H,1,17,17,2013-02-28,2013-03-16,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1355,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-28,2013-03-16,1,17,NA,0,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-02-28T00:00:00Z,NA,H,2013-03-16T00:00:00Z,NA,H,1,17,17,2013-02-28,2013-03-16,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1355,1,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-02-28,2013-03-16,1,17,NA,0,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-02-28T00:00:00Z,NA,H,2013-03-16T00:00:00Z,NA,H,1,17,17,2013-02-28,2013-03-16,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1355,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-17,2013-08-15,18,169,NA,0,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-03-17T00:00:00Z,NA,H,2013-08-15T00:00:00Z,NA,H,18,169,152,2013-03-17,2013-08-15,0,0,DURD,152,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1355,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-17,2013-08-15,18,169,NA,0,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-03-17T00:00:00Z,NA,H,2013-08-15T00:00:00Z,NA,H,18,169,152,2013-03-17,2013-08-15,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1355,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-17,2013-08-15,18,169,NA,0,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-03-17T00:00:00Z,NA,H,2013-08-15T00:00:00Z,NA,H,18,169,152,2013-03-17,2013-08-15,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1355,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-17,2013-08-15,18,169,NA,0,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-03-17T00:00:00Z,NA,H,2013-08-15T00:00:00Z,NA,H,18,169,152,2013-03-17,2013-08-15,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1355,2,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-03-17,2013-08-15,18,169,NA,0,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-03-17T00:00:00Z,NA,H,2013-08-15T00:00:00Z,NA,H,18,169,152,2013-03-17,2013-08-15,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1355,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-16,2013-08-29,170,183,NA,0,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-08-16T00:00:00Z,NA,H,2013-08-29T00:00:00Z,NA,H,170,183,14,2013-08-16,2013-08-29,0,0,DURD,14,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,11,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1355,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-16,2013-08-29,170,183,NA,0,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-08-16T00:00:00Z,NA,H,2013-08-29T00:00:00Z,NA,H,170,183,14,2013-08-16,2013-08-29,0,0,DOSE,0,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,12,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1355,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-16,2013-08-29,170,183,NA,0,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-08-16T00:00:00Z,NA,H,2013-08-29T00:00:00Z,NA,H,170,183,14,2013-08-16,2013-08-29,0,0,PLDOSE,0,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,13,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1355,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-16,2013-08-29,170,183,NA,0,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-08-16T00:00:00Z,NA,H,2013-08-29T00:00:00Z,NA,H,170,183,14,2013-08-16,2013-08-29,0,0,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,14,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1355,3,PLACEBO,0,mg,PATCH,QD,TRANSDERMAL,12,WEEK 24,168,2013-08-16,2013-08-29,170,183,NA,0,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-08-16T00:00:00Z,NA,H,2013-08-29T00:00:00Z,NA,H,170,183,14,2013-08-16,2013-08-29,0,0,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,15,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-02-28T00:00:00Z,NA,NA,2013-08-29T00:00:00Z,NA,NA,NA,NA,NA,2013-02-28,2013-08-29,NA,NA,TDURD,183,NA,OVERALL,Overall duration (days),7,>=90 days,16,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-02-28T00:00:00Z,NA,NA,2013-08-29T00:00:00Z,NA,NA,NA,NA,NA,2013-02-28,2013-08-29,NA,NA,TDOSE,0,NA,OVERALL,Total dose administered (mg),8,< 100 mg,17,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-02-28T00:00:00Z,NA,NA,2013-08-29T00:00:00Z,NA,NA,NA,NA,NA,2013-02-28,2013-08-29,NA,NA,AVDDSE,0,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,18,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-02-28T00:00:00Z,NA,NA,2013-08-29T00:00:00Z,NA,NA,NA,NA,NA,2013-02-28,2013-08-29,NA,NA,TPDOSE,0,NA,OVERALL,Total planned dose (mg),11,NA,19,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-02-28T00:00:00Z,NA,NA,2013-08-29T00:00:00Z,NA,NA,NA,NA,NA,2013-02-28,2013-08-29,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,20,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-02-28T00:00:00Z,NA,NA,2013-08-29T00:00:00Z,NA,NA,NA,NA,NA,2013-02-28,2013-08-29,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,21,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-02-28T00:00:00Z,NA,NA,2013-08-29T00:00:00Z,NA,NA,NA,NA,NA,2013-02-28,2013-08-29,NA,NA,TDOSINT,NA,NA,OVERALL,Overall dose intensity (%),90,NA,22,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-03-17T00:00:00Z,NA,NA,2013-08-29T00:00:00Z,NA,NA,NA,NA,NA,2013-03-17,2013-08-29,NA,NA,PDURD,166,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>=90 days,23,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-03-17T00:00:00Z,NA,NA,2013-08-29T00:00:00Z,NA,NA,NA,NA,NA,2013-03-17,2013-08-29,NA,NA,PDOSE,0,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,< 100 mg,24,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-03-17T00:00:00Z,NA,NA,2013-08-29T00:00:00Z,NA,NA,NA,NA,NA,2013-03-17,2013-08-29,NA,NA,PPDOSE,0,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,25,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-03-17T00:00:00Z,NA,NA,2013-08-29T00:00:00Z,NA,NA,NA,NA,NA,2013-03-17,2013-08-29,NA,NA,PAVDDSE,0,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,26,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-03-17T00:00:00Z,NA,NA,2013-08-29T00:00:00Z,NA,NA,NA,NA,NA,2013-03-17,2013-08-29,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,27,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-03-17T00:00:00Z,NA,NA,2013-08-29T00:00:00Z,NA,NA,NA,NA,NA,2013-03-17,2013-08-29,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,28,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1355,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-02-28,2013-02-28T00:00:00Z,2013-08-29T23:59:59Z,2013-03-17T00:00:00Z,NA,NA,2013-08-29T00:00:00Z,NA,NA,NA,NA,NA,2013-03-17,2013-08-29,NA,NA,PDOSINT,NA,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,29,1355,2013-02-28,2013-08-29,2013-02-28,2013-08-29,NA,2013-08-29T14:00,NA,NA,718,79,YEARS,M,WHITE,NOT HISPANIC OR LATINO,Pbo,Placebo,Pbo,Placebo,USA,2013-02-12,-16,Placebo,Placebo,H,H,2013-08-29,183,NA,2013-08-29,COMPLETED,NA,2013-02-28,NA,NA,NA,2013-08-29,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1371,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-26,2013-05-08,1,13,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-04-26T00:00:00Z,NA,H,2013-05-08T00:00:00Z,NA,H,1,13,13,2013-04-26,2013-05-08,702,702,DURD,13,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1371,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-26,2013-05-08,1,13,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-04-26T00:00:00Z,NA,H,2013-05-08T00:00:00Z,NA,H,1,13,13,2013-04-26,2013-05-08,702,702,DOSE,702,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1371,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-26,2013-05-08,1,13,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-04-26T00:00:00Z,NA,H,2013-05-08T00:00:00Z,NA,H,1,13,13,2013-04-26,2013-05-08,702,702,PLDOSE,702,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1371,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-26,2013-05-08,1,13,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-04-26T00:00:00Z,NA,H,2013-05-08T00:00:00Z,NA,H,1,13,13,2013-04-26,2013-05-08,702,702,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1371,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2013-04-26,2013-05-08,1,13,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-04-26T00:00:00Z,NA,H,2013-05-08T00:00:00Z,NA,H,1,13,13,2013-04-26,2013-05-08,702,702,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1371,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-09,2013-08-01,14,98,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-05-09T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,14,98,85,2013-05-09,2013-08-01,6885,4590,DURD,85,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1371,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-09,2013-08-01,14,98,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-05-09T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,14,98,85,2013-05-09,2013-08-01,6885,4590,DOSE,6885,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1371,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-09,2013-08-01,14,98,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-05-09T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,14,98,85,2013-05-09,2013-08-01,6885,4590,PLDOSE,4590,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1371,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-09,2013-08-01,14,98,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-05-09T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,14,98,85,2013-05-09,2013-08-01,6885,4590,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1371,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-05-09,2013-08-01,14,98,NA,54,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-05-09T00:00:00Z,NA,H,2013-08-01T00:00:00Z,NA,H,14,98,85,2013-05-09,2013-08-01,6885,4590,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-04-26T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-04-26,2013-08-01,NA,NA,TDURD,98,NA,OVERALL,Overall duration (days),7,>=90 days,11,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-04-26T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-04-26,2013-08-01,NA,NA,TDOSE,7587,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-04-26T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-04-26,2013-08-01,NA,NA,AVDDSE,77.41836734693878,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-04-26T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-04-26,2013-08-01,NA,NA,TPDOSE,5292,NA,OVERALL,Total planned dose (mg),11,NA,14,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-04-26T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-04-26,2013-08-01,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-04-26T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-04-26,2013-08-01,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-04-26T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-04-26,2013-08-01,NA,NA,TDOSINT,143.3673469387755,NA,OVERALL,Overall dose intensity (%),90,NA,17,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-08-01,NA,NA,PDURD,85,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-08-01,NA,NA,PDOSE,6885,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-08-01,NA,NA,PPDOSE,4590,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-08-01,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-08-01,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-08-01,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1371,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2013-04-26,2013-04-26T00:00:00Z,2013-08-01T23:59:59Z,2013-05-09T00:00:00Z,NA,NA,2013-08-01T00:00:00Z,NA,NA,NA,NA,NA,2013-05-09,2013-08-01,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1371,2013-04-26,2013-08-08,2013-04-26,2013-08-01,NA,2013-08-08,NA,NA,718,69,YEARS,F,WHITE,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2013-04-11,-15,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-08-01,98,NA,2013-08-08,DISCONTINUED,NA,2013-04-26,NA,NA,NA,2013-08-01,>=65,Y,White,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1427,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-17,2012-12-31,1,15,NA,54,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2012-12-17T00:00:00Z,NA,H,2012-12-31T00:00:00Z,NA,H,1,15,15,2012-12-17,2012-12-31,810,810,DURD,15,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,1,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1427,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-17,2012-12-31,1,15,NA,54,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2012-12-17T00:00:00Z,NA,H,2012-12-31T00:00:00Z,NA,H,1,15,15,2012-12-17,2012-12-31,810,810,DOSE,810,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,2,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1427,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-17,2012-12-31,1,15,NA,54,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2012-12-17T00:00:00Z,NA,H,2012-12-31T00:00:00Z,NA,H,1,15,15,2012-12-17,2012-12-31,810,810,PLDOSE,810,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,3,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1427,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-17,2012-12-31,1,15,NA,54,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2012-12-17T00:00:00Z,NA,H,2012-12-31T00:00:00Z,NA,H,1,15,15,2012-12-17,2012-12-31,810,810,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,4,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1427,1,XANOMELINE,54,mg,PATCH,QD,TRANSDERMAL,3,BASELINE,1,2012-12-17,2012-12-31,1,15,NA,54,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2012-12-17T00:00:00Z,NA,H,2012-12-31T00:00:00Z,NA,H,1,15,15,2012-12-17,2012-12-31,810,810,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,5,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1427,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-01,2013-02-11,16,57,NA,54,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2013-01-01T00:00:00Z,NA,H,2013-02-11T00:00:00Z,NA,H,16,57,42,2013-01-01,2013-02-11,3402,2268,DURD,42,NA,INDIVIDUAL,Study drug duration during constant dosing interval (days),1,NA,6,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1427,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-01,2013-02-11,16,57,NA,54,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2013-01-01T00:00:00Z,NA,H,2013-02-11T00:00:00Z,NA,H,16,57,42,2013-01-01,2013-02-11,3402,2268,DOSE,3402,NA,INDIVIDUAL,Dose administered during constant dosing interval (mg),2,NA,7,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1427,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-01,2013-02-11,16,57,NA,54,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2013-01-01T00:00:00Z,NA,H,2013-02-11T00:00:00Z,NA,H,16,57,42,2013-01-01,2013-02-11,3402,2268,PLDOSE,2268,NA,INDIVIDUAL,Planned dose during constant dosing interval (mg),3,NA,8,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1427,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-01,2013-02-11,16,57,NA,54,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2013-01-01T00:00:00Z,NA,H,2013-02-11T00:00:00Z,NA,H,16,57,42,2013-01-01,2013-02-11,3402,2268,ADJ,NA,NA,INDIVIDUAL,Dose adjusted during constant dosing interval,4,NA,9,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,EX,01-718-1427,2,XANOMELINE,81,mg,PATCH,QD,TRANSDERMAL,4,WEEK 2,14,2013-01-01,2013-02-11,16,57,NA,54,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2013-01-01T00:00:00Z,NA,H,2013-02-11T00:00:00Z,NA,H,16,57,42,2013-01-01,2013-02-11,3402,2268,ADJAE,NA,NA,INDIVIDUAL,Dose adjusted  due to AE during constant dosing interval,5,NA,10,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2012-12-17T00:00:00Z,NA,NA,2013-02-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-17,2013-02-11,NA,NA,TDURD,57,NA,OVERALL,Overall duration (days),7,>= 30 and < 90 days,11,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2012-12-17T00:00:00Z,NA,NA,2013-02-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-17,2013-02-11,NA,NA,TDOSE,4212,NA,OVERALL,Total dose administered (mg),8,>= 100 mg,12,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2012-12-17T00:00:00Z,NA,NA,2013-02-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-17,2013-02-11,NA,NA,AVDDSE,73.89473684210526,NA,OVERALL,Average daily dose administered (mg/mg),10,NA,13,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2012-12-17T00:00:00Z,NA,NA,2013-02-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-17,2013-02-11,NA,NA,TPDOSE,3078,NA,OVERALL,Total planned dose (mg),11,NA,14,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2012-12-17T00:00:00Z,NA,NA,2013-02-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-17,2013-02-11,NA,NA,TADJ,NA,NA,OVERALL,Dose adjusted during study,13,NA,15,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2012-12-17T00:00:00Z,NA,NA,2013-02-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-17,2013-02-11,NA,NA,TADJAE,NA,NA,OVERALL,Dose adjusted during study due to AE,14,NA,16,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2012-12-17T00:00:00Z,NA,NA,2013-02-11T00:00:00Z,NA,NA,NA,NA,NA,2012-12-17,2013-02-11,NA,NA,TDOSINT,136.8421052631579,NA,OVERALL,Overall dose intensity (%),90,NA,17,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2013-01-01T00:00:00Z,NA,NA,2013-02-11T00:00:00Z,NA,NA,NA,NA,NA,2013-01-01,2013-02-11,NA,NA,PDURD,42,NA,WEEK 2-24,Overall duration in W2-W24 (days),19,>= 30 and < 90 days,18,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2013-01-01T00:00:00Z,NA,NA,2013-02-11T00:00:00Z,NA,NA,NA,NA,NA,2013-01-01,2013-02-11,NA,NA,PDOSE,3402,NA,WEEK 2-24,Total dose administered in W2-W2 (mg)4,20,>= 100 mg,19,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2013-01-01T00:00:00Z,NA,NA,2013-02-11T00:00:00Z,NA,NA,NA,NA,NA,2013-01-01,2013-02-11,NA,NA,PPDOSE,2268,NA,WEEK 2-24,Total planned dose in W2-W24 (mg),21,NA,20,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2013-01-01T00:00:00Z,NA,NA,2013-02-11T00:00:00Z,NA,NA,NA,NA,NA,2013-01-01,2013-02-11,NA,NA,PAVDDSE,81,NA,WEEK 2-24,Average daily dose administered in W2-W24 (mg),23,NA,21,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2013-01-01T00:00:00Z,NA,NA,2013-02-11T00:00:00Z,NA,NA,NA,NA,NA,2013-01-01,2013-02-11,NA,NA,PADJ,NA,NA,WEEK 2-24,Dose adjusted during W2-W24,24,NA,22,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2013-01-01T00:00:00Z,NA,NA,2013-02-11T00:00:00Z,NA,NA,NA,NA,NA,2013-01-01,2013-02-11,NA,NA,PADJAE,NA,NA,WEEK 2-24,Dose adjusted  in W2-W24 due to AE,25,NA,23,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
CDISCPILOT01,NA,01-718-1427,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2012-12-17,2012-12-17T00:00:00Z,2013-02-11T23:59:59Z,2013-01-01T00:00:00Z,NA,NA,2013-02-11T00:00:00Z,NA,NA,NA,NA,NA,2013-01-01,2013-02-11,NA,NA,PDOSINT,150,NA,WEEK 2-24,W2-24 dose intensity (%),91,NA,24,1427,2012-12-17,2013-02-18,2012-12-17,2013-02-11,NA,2013-06-03,NA,NA,718,74,YEARS,F,BLACK OR AFRICAN AMERICAN,NOT HISPANIC OR LATINO,Xan_Hi,Xanomeline High Dose,Xan_Hi,Xanomeline High Dose,USA,2012-12-13,-4,Xanomeline High Dose,Xanomeline High Dose,H,H,2013-02-11,57,NA,2013-02-18,DISCONTINUED,2013-06-03,2012-12-17,NA,NA,NA,2013-02-18,>=65,Y,Non-white,"NA",NA,NA,NA,NA
